Citrus Sinensis ID: 047375
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 496 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LMN8 | 741 | Wall-associated receptor | yes | no | 0.625 | 0.418 | 0.411 | 6e-62 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.647 | 0.437 | 0.418 | 7e-61 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.625 | 0.423 | 0.408 | 2e-59 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.635 | 0.428 | 0.397 | 5e-59 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.612 | 0.411 | 0.398 | 2e-58 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.574 | 0.390 | 0.435 | 2e-58 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.542 | 0.353 | 0.421 | 7e-57 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.566 | 0.354 | 0.417 | 1e-56 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.552 | 0.364 | 0.414 | 3e-56 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.538 | 0.365 | 0.424 | 4e-56 |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 238 bits (608), Expect = 6e-62, Method: Compositional matrix adjust.
Identities = 142/345 (41%), Positives = 210/345 (60%), Gaps = 35/345 (10%)
Query: 169 GLAFSRMKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRI 226
GL+ KIF++ + +AT + LG GG G+VYKG+LPDNT VA+KK AD ++
Sbjct: 394 GLSNIDFKIFTEEGMKEATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQV 453
Query: 227 TEW--EFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWK 284
++ E L ++SQ+ H+NVVKILG CLET+V LLVYEF++NG L ++H W+
Sbjct: 454 DQFIHEVL-VLSQINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWE 512
Query: 285 TCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES--LVPISSDDE 342
LRIA E A + YLHS AS IIH D+K+ANILLD+N TAKV+DF + L+P+ D+
Sbjct: 513 HRLRIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPM---DK 569
Query: 343 TAMSTMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISM 385
++TM++GT+GYLDPEY T ELL+G + +++ +
Sbjct: 570 EQLTTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQASKH--L 627
Query: 386 VPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDR 445
V YF+ + E N +I++ QV +E ++EI+ A +A++C R+ G ERP MKEV+ +L+
Sbjct: 628 VSYFVSATEENRLHEIIDDQVLNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEA 687
Query: 446 LRRLQENY-WARKNNEESEHLLGESSTYATAVIAQPETQTVVSID 489
LR + + W+ + EE+EHL+G + AQ ET + + D
Sbjct: 688 LRVEKTKHKWSDQYPEENEHLIG-----GHILSAQGETSSSIGYD 727
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (599), Expect = 7e-61, Method: Compositional matrix adjust.
Identities = 151/361 (41%), Positives = 216/361 (59%), Gaps = 40/361 (11%)
Query: 159 RLGGGGRDPPGLAFSRMKIFSKSELLKATKNFHHC--LGMGGFGSVYKGVLPDNTQVAVK 216
RL G G P + +KIF++ + +AT ++ LG GG G+VYKG+L DN+ VA+K
Sbjct: 382 RLSGAG--PSNV---DVKIFTEEGMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIK 436
Query: 217 KYMCADEIRITEW--EFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHD 274
K D ++ ++ E L ++SQ+ H+NVVK+LG CLET+V LLVYEF+S+G L ++H
Sbjct: 437 KARLGDRSQVEQFINEVL-VLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHG 495
Query: 275 KSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES- 333
W+ LRIA E A + YLHS AS IIH DVK+ANILLD+N TAKV+DF +
Sbjct: 496 SMFDSSLTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGAS 555
Query: 334 -LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYV--------ALASNEKI- 383
L+P+ D+ ++TM++GT+GYLDPEY +T LL N S V L S EK
Sbjct: 556 RLIPM---DQEQLTTMVQGTLGYLDPEYYNTGLL---NEKSDVYSFGVVLMELLSGEKAL 609
Query: 384 ---------SMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERP 434
+V YF+ +++ N +I++ QV +E EI+ A +A +C RI G ERP
Sbjct: 610 CFERPQSSKHLVSYFVSAMKENRLHEIIDGQVMNEYNQREIQESARIAVECTRIMGEERP 669
Query: 435 TMKEVSEELDRLR-RLQENYWARKNNEESEHLLGE---SSTYATAVIAQPETQTVVSIDI 490
+MKEV+ EL+ LR + ++ W+ + +E EHLLG S+ T+ I Q V +DI
Sbjct: 670 SMKEVAAELEALRVKTTKHQWSDQYPKEVEHLLGVQILSTQGDTSSIGYDSIQNVTRLDI 729
Query: 491 E 491
E
Sbjct: 730 E 730
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 230 bits (586), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 142/348 (40%), Positives = 209/348 (60%), Gaps = 38/348 (10%)
Query: 175 MKIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW--E 230
+KIF++ + +AT +H LG GG G+VYKG+LPDN+ VA+KK + ++ ++ E
Sbjct: 389 VKIFTEKGMKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINE 448
Query: 231 FLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIA 290
L ++SQ+ H+NVVK+LG CLET+V LLVYEF+++G L ++H W+ LRIA
Sbjct: 449 VL-VLSQINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLRIA 507
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES--LVPISSDDETAMSTM 348
E A ++ YLHS AS IIH D+K+ANILLD N TAKV+DF + L+P+ D+ ++T+
Sbjct: 508 TEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPM---DKEQLTTI 564
Query: 349 IRGTVGYLDPEYAHTELLTGMNPNSYV--------ALASNEKI----------SMVPYFL 390
++GT+GYLDPEY +T LL N S V L S +K ++V F
Sbjct: 565 VQGTLGYLDPEYYNTGLL---NEKSDVYSFGVVLMELLSGQKALCFERPHCPKNLVSCFA 621
Query: 391 DSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450
+ +NN F +I++ QV +E EI+ A +A++C R+ G ERP MKEV+ EL+ LR
Sbjct: 622 SATKNNRFHEIIDGQVMNEDNQREIQEAARIAAECTRLMGEERPRMKEVAAELEALRVKT 681
Query: 451 ENY-WARKNNE--ESEHLLG----ESSTYATAVIAQPETQTVVSIDIE 491
Y W+ + E E EHLLG + ++ I + V ++DIE
Sbjct: 682 TKYKWSDQYRETGEIEHLLGVQILSAQGETSSSIGYDSIRNVTTLDIE 729
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 229 bits (583), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 141/355 (39%), Positives = 210/355 (59%), Gaps = 40/355 (11%)
Query: 159 RLGGGGRDPPGLAFSRMKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVK 216
RL G G P + +KIF++ + KAT + LG GG G+VYKG+LPDN+ VA+K
Sbjct: 383 RLSGAG--PSNV---DVKIFTEDGMKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIK 437
Query: 217 KYMCADEIRITEW--EFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHD 274
K D ++ ++ E L ++SQ+ H+NVVK+LG CLET+V LLVYEF++NG L ++H
Sbjct: 438 KARLGDSSQVEQFINEVL-VLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHG 496
Query: 275 KSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES- 333
W+ L+IA E A + YLHS AS IIH D+K+ANILLD N TAKV+DF +
Sbjct: 497 SMIDSSLTWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGAS 556
Query: 334 -LVPISSDDETAMSTMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYV 375
L+P+ D+ + TM++GT+GYLDPEY +T ELL+G +
Sbjct: 557 RLIPM---DKEELETMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFK 613
Query: 376 ALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPT 435
S++ +V YF + + N +I+ +V +E ++EI+ A +A++C R+ G ERP
Sbjct: 614 RPQSSKH--LVSYFATATKENRLDEIIGGEVMNEDNLKEIQEAARIAAECTRLMGEERPR 671
Query: 436 MKEVSEELDRLRRLQENY-WARKNNEESEHLLGESSTYATAVIAQPETQTVVSID 489
MKEV+ +L+ LR + + W+ + EE+EHL+G + AQ ET + + D
Sbjct: 672 MKEVAAKLEALRVEKTKHKWSDQYPEENEHLIG-----GHILSAQGETSSSIGYD 721
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 227 bits (578), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 136/341 (39%), Positives = 206/341 (60%), Gaps = 37/341 (10%)
Query: 175 MKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW--E 230
+KIF++ + +AT + + LG GG G+VYKG+LPDN+ VA+KK D ++ ++ E
Sbjct: 395 VKIFTEEGMKEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINE 454
Query: 231 FLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIA 290
L ++SQ+ H+NVVK+LG CLET+V LLVYEF+S+G L ++H W+ LR+A
Sbjct: 455 VL-VLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRMA 513
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES--LVPISSDDETAMSTM 348
E A + YLHS AS IIH D+K+ANILLD+N TAKV+DF + L+P+ +D ++TM
Sbjct: 514 VEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKED---LATM 570
Query: 349 IRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLD 391
++GT+GYLDPEY +T ELL+G + +++ I V YF
Sbjct: 571 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHI--VSYFAS 628
Query: 392 SIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451
+ + N +I++ QV +E+ EI+ A +A +C R+ G ERP MKEV+ EL+ LR +
Sbjct: 629 ATKENRLHEIIDGQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALRVTKT 688
Query: 452 NY-WARK--NNEESEHLLGESSTYATAVIAQPETQTVVSID 489
+ W+ + E++EHL+G + AQ ET + + D
Sbjct: 689 KHKWSDEYPEQEDTEHLVG-----VQKLSAQGETSSSIGYD 724
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (577), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 134/308 (43%), Positives = 190/308 (61%), Gaps = 23/308 (7%)
Query: 176 KIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFL 232
KIFS EL KAT NF LG GG G+VYKG+L D + VAVK+ DE ++ E+ +
Sbjct: 415 KIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEI 474
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE 292
++SQ+ H+N+VK+LG CLET+V +LVYE++ NG L +HD+S W+ LRIA E
Sbjct: 475 VLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIE 534
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A A+ Y+HS AS I H D+K+ NILLD+ Y AKVSDF + ++ D+T ++T++ GT
Sbjct: 535 IAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTL-DQTHLTTLVAGT 593
Query: 353 VGYLDPE------YAH-----------TELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395
GY+DPE Y H EL+TG P S V S E + +FL++++
Sbjct: 594 FGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRV--RSEEGRGLATHFLEAMKE 651
Query: 396 NSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWA 455
N I++ ++ DES++E++ VA+LA KCL +G RP MKEVS EL+R+R E+
Sbjct: 652 NRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDV 711
Query: 456 RKNNEESE 463
R NE+ E
Sbjct: 712 RTENEDEE 719
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 7e-57, Method: Compositional matrix adjust.
Identities = 123/292 (42%), Positives = 180/292 (61%), Gaps = 23/292 (7%)
Query: 176 KIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFL 232
KIFS +EL KAT NF+ LG GG G+VYKG+L D VAVK+ DE ++ E+ +
Sbjct: 410 KIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEV 469
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE 292
+++Q+ H+N+VK+LG CLET+V +LVYEFV NG L + D+ + W+ L IA E
Sbjct: 470 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIE 529
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A A+ YLHS AS I H D+K+ NILLD+ Y KVSDF + ++ D+T ++T + GT
Sbjct: 530 IAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTI-DQTHLTTQVAGT 588
Query: 353 VGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395
GY+DPEY + EL+TG NP+S V S E +F+ +++
Sbjct: 589 FGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRV--QSEENRGFAAHFVAAVKE 646
Query: 396 NSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447
N F I++ ++ DE ++++ VA+LA +CL +G +RP M+EVS EL+R+R
Sbjct: 647 NRFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIR 698
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 131/314 (41%), Positives = 189/314 (60%), Gaps = 33/314 (10%)
Query: 177 IFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFLG 233
+FS EL KAT+NF + LG GG G+VYKG+L D VAVKK DE ++ E+ +
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDK-SSQVLKNWKTCLRIAAE 292
I+SQ+ H+N+VK+LG CLETKV +LVYEF+ NG L ++HD+ ++ W LRIA +
Sbjct: 494 ILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAID 553
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A A+ YLHS AS I H DVKS NI+LD+ Y AKVSDF + ++ D T ++T++ GT
Sbjct: 554 IAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTV-DHTHLTTVVSGT 612
Query: 353 VGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395
VGY+DPEY + EL+TG S+ L S E ++ YF+ +++
Sbjct: 613 VGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISF--LRSQENRTLATYFILAMKE 670
Query: 396 NSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR------RL 449
N I++ ++ D + ++ A++A KCL ++G +RP+M+EVS ELD +R +L
Sbjct: 671 NKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQL 730
Query: 450 QENYWARKNNEESE 463
QE NEE E
Sbjct: 731 QE---CVSENEEGE 741
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (559), Expect = 3e-56, Method: Compositional matrix adjust.
Identities = 123/297 (41%), Positives = 180/297 (60%), Gaps = 23/297 (7%)
Query: 176 KIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFL 232
KIFS EL KAT NF+ LG GG G+VYKG+L D VAVK+ DE ++ E+ +
Sbjct: 407 KIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEV 466
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE 292
G++SQ+ H+N+VK++G CLET+V +LVYE + NG L +H S W LRI+ E
Sbjct: 467 GVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVE 526
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A A+ YLHS AS + H DVK+ NILLD+ Y AKVSDF + I+ D+T ++T++ GT
Sbjct: 527 IAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINV-DQTHLTTLVAGT 585
Query: 353 VGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395
GYLDPEY T EL+TG P + + E +V +F ++++
Sbjct: 586 FGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKP--FSVMRPEENRGLVSHFNEAMKQ 643
Query: 396 NSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452
N I++ ++ + +E++ VA+LA +CL ++G +RP M+EVS EL+R+R E+
Sbjct: 644 NRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPED 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 219 bits (558), Expect = 4e-56, Method: Compositional matrix adjust.
Identities = 124/292 (42%), Positives = 183/292 (62%), Gaps = 25/292 (8%)
Query: 176 KIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFL 232
KIFS EL KAT NF LG GG G+VYK +L D + VAVK+ DE ++ E+ +
Sbjct: 414 KIFSSRELEKATDNFSIDRVLGQGGQGTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEI 473
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE 292
++SQ+ H+N+VK+LG CLET+V +LVYE++ NG L +HD+ + W+ LRIA E
Sbjct: 474 VLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDEYDDYMMTWEVRLRIAVE 533
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A A+ Y+HS AS I H D+K+ NILLD+ Y AK+SDF + +++ D+T ++T++ GT
Sbjct: 534 IAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVAT-DQTHLTTLVAGT 592
Query: 353 VGYLDPE------YAH-----------TELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395
GY+DPE Y H EL+TG P S V S E I + YFL++++
Sbjct: 593 FGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPMSRV--RSEEGIGLATYFLEAMKE 650
Query: 396 NSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447
N I++ ++ DES +++ VA+LA +CL +G +RP M+EVS +L+R+R
Sbjct: 651 NRAVDIIDIRIKDES--KQVMAVAKLARRCLNRKGNKRPNMREVSIKLERIR 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 496 | ||||||
| 224102957 | 615 | predicted protein [Populus trichocarpa] | 0.681 | 0.549 | 0.523 | 2e-90 | |
| 255565901 | 457 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.643 | 0.698 | 0.545 | 1e-88 | |
| 255573255 | 739 | kinase, putative [Ricinus communis] gi|2 | 0.639 | 0.428 | 0.560 | 1e-88 | |
| 255573259 | 771 | serine-threonine protein kinase, plant-t | 0.641 | 0.412 | 0.536 | 6e-86 | |
| 224132202 | 721 | predicted protein [Populus trichocarpa] | 0.639 | 0.439 | 0.505 | 2e-84 | |
| 224132144 | 646 | predicted protein [Populus trichocarpa] | 0.596 | 0.458 | 0.537 | 3e-84 | |
| 224145581 | 584 | predicted protein [Populus trichocarpa] | 0.639 | 0.542 | 0.514 | 4e-84 | |
| 224132160 | 667 | predicted protein [Populus trichocarpa] | 0.556 | 0.413 | 0.562 | 3e-81 | |
| 224132156 | 667 | predicted protein [Populus trichocarpa] | 0.556 | 0.413 | 0.562 | 3e-81 | |
| 224132168 | 321 | predicted protein [Populus trichocarpa] | 0.564 | 0.872 | 0.537 | 3e-80 |
| >gi|224102957|ref|XP_002312869.1| predicted protein [Populus trichocarpa] gi|222849277|gb|EEE86824.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 339 bits (870), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 192/367 (52%), Positives = 242/367 (65%), Gaps = 29/367 (7%)
Query: 153 VILSAVRLGGGGRDPPG--LAFSRMKIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLP 208
+ILS R R+ G L R++IFS++EL KAT N+ +G GGFGSVYKG+L
Sbjct: 248 MILSKRRKDKNFRENGGTVLKHQRVRIFSEAELTKATNNYDDDKKIGEGGFGSVYKGILA 307
Query: 209 DNTQVAVKKYMCADEIRITEWEF---LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265
DNT VAVKK D+ ++ E +F + ++SQV HKNVVK+LGLCLETKV LLVYEF+SN
Sbjct: 308 DNTVVAVKKSKGVDKAQMNE-DFQHEICVVSQVNHKNVVKLLGLCLETKVPLLVYEFISN 366
Query: 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT 325
G L +IHDK SQVL +W LRIA+E A A+ YLHSLA P +IH DVKS NILLDDNYT
Sbjct: 367 GTLFKHIHDKRSQVLASWSNRLRIASEAALALDYLHSLADPPVIHGDVKSVNILLDDNYT 426
Query: 326 AKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT-----------------ELLTG 368
AKV+DF + V IS ++T I+GT GYLDPEY T ELLTG
Sbjct: 427 AKVADFGASVLISPGQTNILATKIQGTFGYLDPEYLLTGNLTEKSDVYSFGVVLVELLTG 486
Query: 369 MNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRI 428
PNS S K + + YF ++ENN IL+FQ ADE+EM+EIE VAELA +CL
Sbjct: 487 EKPNSNA--KSGNKRNFIQYFNSALENNDLFGILDFQAADEAEMDEIEAVAELAKRCLNS 544
Query: 429 RGTERPTMKEVSEELDRLRRLQENYWARKNNEESEHLLGESSTYATAVIAQP--ETQTVV 486
G RP+MKEVSEEL +L+ L + WA++N++E+EHLLGE S + P ++QTV+
Sbjct: 545 IGVNRPSMKEVSEELAKLKALNQKSWAQQNSDETEHLLGEPSQSFRNNASPPTSQSQTVI 604
Query: 487 SIDIENY 493
S +IENY
Sbjct: 605 SFEIENY 611
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565901|ref|XP_002523939.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223536786|gb|EEF38426.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 333 bits (854), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 191/350 (54%), Positives = 238/350 (68%), Gaps = 31/350 (8%)
Query: 170 LAFSRMKIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRIT 227
L R++I S++EL KAT+N+ LG GGFGSVYKG+L D TQVAVKK D +I
Sbjct: 108 LKHQRVRILSEAELTKATRNYETSQFLGEGGFGSVYKGILADGTQVAVKKPKDLDRTQIN 167
Query: 228 EWEF---LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWK 284
+ EF L I+SQV H NVVKILGLCLETKV LLVYEF+SNG+L +IH K SQ+L +WK
Sbjct: 168 Q-EFQKELAIVSQVNHINVVKILGLCLETKVPLLVYEFISNGSLYQHIHQKRSQILTSWK 226
Query: 285 TCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344
LRIA ETA AI YLHSLA+P IIH DVKSANILLDDNYTAKVSDF + V IS T
Sbjct: 227 NRLRIATETALAIDYLHSLANPPIIHGDVKSANILLDDNYTAKVSDFGASVLISP-GYTD 285
Query: 345 MSTMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVP 387
M+T I+GT GYLDPEY T E+LTG PNS S K +++
Sbjct: 286 MATKIQGTFGYLDPEYLMTGKLTEKSDVYSFGVVLVEILTGEKPNSNA--RSGVKSNIIQ 343
Query: 388 YFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447
YFL S+E+ + L F V +E E+EEI+V +ELA +CL G +RPTMKEV+EEL RLR
Sbjct: 344 YFLSSLESKNISGTLCFMV-NEDELEEIKVFSELAKRCLSSTGIKRPTMKEVAEELGRLR 402
Query: 448 RLQENYWARKNNEESEHLLGESSTYA----TAVIAQPETQTVVSIDIENY 493
+L E+ WA++N++E+EHLLG++S + TA I+QP+T + DI+ Y
Sbjct: 403 KLNESLWAQENSKETEHLLGDASYHCIHFQTANISQPDTHIMRRFDIDLY 452
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573255|ref|XP_002527556.1| kinase, putative [Ricinus communis] gi|223533048|gb|EEF34808.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 333 bits (854), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 194/346 (56%), Positives = 235/346 (67%), Gaps = 29/346 (8%)
Query: 170 LAFSRMKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRI- 226
L R++IFS++EL KATKN+ LG GGFG VYKGVL DNTQ+AVKK D+ +I
Sbjct: 393 LKHQRVRIFSEAELAKATKNYDPSQLLGEGGFGYVYKGVLADNTQIAVKKPKDIDKAQIK 452
Query: 227 TEWEF-LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKT 285
E++ +GI+SQV HKNVVKILGLCLETKV LLVYEF+SNG L H+IH K SQ+L NWK
Sbjct: 453 QEYQHEIGIVSQVNHKNVVKILGLCLETKVPLLVYEFISNGTLFHHIHHKRSQILANWKN 512
Query: 286 CLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345
LRIAAETA A YLHSLA P IIH DVKS NILLDD YTAKVSDF + V ISS E+ +
Sbjct: 513 RLRIAAETALAFDYLHSLADPPIIHGDVKSLNILLDDTYTAKVSDFGASVLISS-GESDI 571
Query: 346 STMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPY 388
++GT GYLDPEY T ELLTG PNS + S E I + Y
Sbjct: 572 GAKLQGTFGYLDPEYLMTGILTEKSDVYSFGVVLVELLTGEKPNS--SARSGEHI--IQY 627
Query: 389 FLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448
FL S+E+++ QIL F V +E+EMEEI V AELA +CLR G +RPTMKE +EEL RL++
Sbjct: 628 FLSSLESHNLSQILCFNVTNENEMEEIVVFAELAKQCLRSCGVKRPTMKEAAEELGRLKK 687
Query: 449 LQENYWARKNN--EESEHLLGESST-YATAVIAQPETQTVVSIDIE 491
L EN W ++ EE+++LLGESS TA + E ++ S DIE
Sbjct: 688 LNENSWNHDDHSGEETQYLLGESSIDIGTAKLNHQEILSIRSYDIE 733
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573259|ref|XP_002527558.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533050|gb|EEF34810.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 324 bits (831), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 186/347 (53%), Positives = 233/347 (67%), Gaps = 29/347 (8%)
Query: 170 LAFSRMKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRIT 227
L R++IF ++EL KAT + + LG GGFG VYKGVL D TQVAVK+ +++++
Sbjct: 423 LKHQRVRIFKEAELAKATNYYTTSNFLGEGGFGCVYKGVLADGTQVAVKRPKDIEKMKMN 482
Query: 228 EWEF---LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWK 284
+ EF +GI+SQV H NVVK+LGLCLET V LLVYEFVSNG L +IH K SQ+L WK
Sbjct: 483 Q-EFQKEIGIVSQVNHINVVKVLGLCLETNVPLLVYEFVSNGNLYQHIHQKRSQLLTAWK 541
Query: 285 TCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344
LRIAAETA A+ YLHSLA+P IIH DVKSANILLD+NYTAKVSDF + V ISS ++T
Sbjct: 542 NILRIAAETALALDYLHSLANPPIIHGDVKSANILLDENYTAKVSDFGASVLISS-NQTD 600
Query: 345 MSTMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVP 387
M+T I+GT GYLDPEY T ELLTG PNS S EK +++
Sbjct: 601 MATKIQGTFGYLDPEYLMTGNLTEKSDVYSFGVVLVELLTGEKPNS--NPKSGEKNNIIQ 658
Query: 388 YFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447
YFL S+EN QI F++ + EMEEIEV AELA +CLR G +RPTM EV+ EL RLR
Sbjct: 659 YFLSSLENGDLNQIPCFEITSKEEMEEIEVFAELAKQCLRSSGIKRPTMNEVAHELVRLR 718
Query: 448 RLQENYWARKNNEESEHLLGESSTYATAVIAQPETQTVVSI---DIE 491
+L E+ W++ N+ E+EHLL + S+ I + Q V+S+ DIE
Sbjct: 719 KLHESSWSQHNSNETEHLLQDDSSSFFVDIGKLNLQEVLSVKANDIE 765
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132202|ref|XP_002328210.1| predicted protein [Populus trichocarpa] gi|222837725|gb|EEE76090.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 319 bits (817), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 174/344 (50%), Positives = 231/344 (67%), Gaps = 27/344 (7%)
Query: 174 RMKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF 231
R++IFS++EL+KAT N+ +G GGFGSVY GVL DNT VAVKK D+ ++ EF
Sbjct: 377 RVRIFSEAELVKATNNYADDRKIGEGGFGSVYSGVLTDNTMVAVKKSKGVDKAQMNA-EF 435
Query: 232 ---LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR 288
+ I+SQV HKNVVK+LGLCLETKV LLVYEF+SNG LS +IHDK S++L +W LR
Sbjct: 436 QKEMSIVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHIHDKGSRILASWTNRLR 495
Query: 289 IAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348
+A+E A A+ YLHSLA P +IH DVKS NILLD+N+T KV+DF + V +S ++T
Sbjct: 496 VASEAALALDYLHSLADPPVIHGDVKSVNILLDNNHTTKVADFGASVLMSPGQTDILATK 555
Query: 349 IRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLD 391
I+GT+GYLDPEY T ELLTG PNS S EK +++ +F+
Sbjct: 556 IQGTLGYLDPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNSIS--KSGEKRNVIQHFIS 613
Query: 392 SIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451
++ENN +IL+FQ ADE +M+EIE VAELA CL G RP MKEVS+EL +L+ L +
Sbjct: 614 ALENNHLFKILDFQTADEGDMDEIEAVAELAKGCLNSMGVNRPAMKEVSDELAKLKALHQ 673
Query: 452 NYWARKNNEESEHLLGESSTYATAVIAQP--ETQTVVSIDIENY 493
A + +EE+++LLGESS + P ++ TV+S+ +ENY
Sbjct: 674 KSLAHEKSEETDYLLGESSQSFCKNASPPMNQSHTVISLQMENY 717
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132144|ref|XP_002328196.1| predicted protein [Populus trichocarpa] gi|222837711|gb|EEE76076.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 318 bits (816), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 173/322 (53%), Positives = 223/322 (69%), Gaps = 26/322 (8%)
Query: 170 LAFSRMKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRIT 227
L R++IF ++EL KAT N+ LG GGFG VYKGVL DNT VAVKK+ D+ ++
Sbjct: 329 LKHQRVRIFREAELEKATNNYVDDQKLGEGGFGYVYKGVLADNTLVAVKKFKGVDKDQLN 388
Query: 228 EWEF---LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWK 284
E EF +GI+SQV H+NVVK+LGLCLETKV LLVYEF+SNG L +IHDK SQ+L +W
Sbjct: 389 E-EFQKEIGIVSQVNHRNVVKLLGLCLETKVPLLVYEFISNGTLYKHIHDKRSQILASWS 447
Query: 285 TCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344
LRIA+E A A+ YLHSLA P +IH DVKS NILLD+NYTAKV+DF + V ISS ++
Sbjct: 448 NRLRIASEIALALDYLHSLADPPVIHGDVKSVNILLDNNYTAKVADFGASVLISS-GQSF 506
Query: 345 MSTMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVP 387
++T I+GT GYLDPEY T ELL G PNS+ S E +++
Sbjct: 507 IATKIQGTFGYLDPEYLMTGNLTPKSDVFSFGVVLLELLIGQKPNSHA--KSGETRNIIE 564
Query: 388 YFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447
YF+ ++ENN+ IL+FQ ADE EM+EIEVVAE+A +C+ G RPTMKEVS+EL + +
Sbjct: 565 YFISALENNNLFGILDFQAADEGEMDEIEVVAEIAKRCVNSMGINRPTMKEVSDELAKQK 624
Query: 448 RLQENYWARKNNEESEHLLGES 469
L E+ WA+ N++++HLL ES
Sbjct: 625 ALHESSWAQHKNDDTKHLLSES 646
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145581|ref|XP_002325694.1| predicted protein [Populus trichocarpa] gi|222862569|gb|EEF00076.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 318 bits (815), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 177/344 (51%), Positives = 233/344 (67%), Gaps = 27/344 (7%)
Query: 174 RMKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF 231
R++IFS++EL+KAT N+ LG G FGSVYKGVL DNT VAVKK D+ ++ EF
Sbjct: 240 RVRIFSEAELVKATNNYADDRKLGEGSFGSVYKGVLTDNTVVAVKKSKGVDKAQMNA-EF 298
Query: 232 ---LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR 288
+ I+SQV HKNVVK+LGLCLETKV LLVYEF+SNG LS +IHDK S++L +W LR
Sbjct: 299 QKEMSIVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHIHDKGSRILVSWTNRLR 358
Query: 289 IAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348
+A+E A A+ YLHSLA P +IH DVKS NILLD+N+TAKV+DF + V +S +T
Sbjct: 359 VASEAALALDYLHSLADPPVIHGDVKSVNILLDNNHTAKVADFGASVLMSPGQTDISATK 418
Query: 349 IRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLD 391
I+GT+GYLDPEY T ELLTG PNS S EK +++ +F+
Sbjct: 419 IQGTLGYLDPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNSIS--KSGEKRNVIQHFIS 476
Query: 392 SIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451
++ENN +IL+FQ ADE +M+EIE VAELA +CL G RP MKEVS+EL +L+ L +
Sbjct: 477 ALENNHLFKILDFQTADEDDMDEIEAVAELAKRCLNSMGVNRPAMKEVSDELAKLKALHQ 536
Query: 452 NYWARKNNEESEHLLGESST--YATAVIAQPETQTVVSIDIENY 493
A++N+EE+++LL ESS A ++QTV+S+ +ENY
Sbjct: 537 KSLAQQNSEETDYLLDESSQSFCENASHLMNQSQTVISLQMENY 580
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132160|ref|XP_002328200.1| predicted protein [Populus trichocarpa] gi|222837715|gb|EEE76080.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 309 bits (791), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 170/302 (56%), Positives = 216/302 (71%), Gaps = 26/302 (8%)
Query: 170 LAFSRMKIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRIT 227
L R++IFS++EL KATKN+ LG GGFGSVY+GVL DN QVAVKK+ D+ ++
Sbjct: 370 LKHQRVRIFSEAELEKATKNYDDDQKLGEGGFGSVYRGVLADNAQVAVKKFKGVDKAQMN 429
Query: 228 EWEF---LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWK 284
E EF +G++SQV HKNVVK+LGLCLETKV LLVYEF+SNG L +IHDK+SQ+L +W
Sbjct: 430 E-EFQNEMGVVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLFKHIHDKTSQLLASWS 488
Query: 285 TCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344
+ LRIA+E A A++YLHSLA P IIH DVKS NILLD+N TAKV+DF + V ISS D+T
Sbjct: 489 SRLRIASEIALALNYLHSLADPPIIHGDVKSVNILLDNNNTAKVADFGASVLISS-DQTI 547
Query: 345 MSTMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVP 387
++T I+GT GYLDPEY T ELLTG PNS + +S EK +++
Sbjct: 548 IATKIQGTFGYLDPEYLMTGILTARSDVFSFGVVLVELLTGEKPNS--SSSSGEKRNLIQ 605
Query: 388 YFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447
+F+ ++E N+ +IL+FQ ADE EM+EIE VAELA CL G RPTMKEVS+EL +L+
Sbjct: 606 HFISALETNNLFRILDFQAADEGEMDEIEAVAELAKGCLNSMGLNRPTMKEVSDELAKLK 665
Query: 448 RL 449
L
Sbjct: 666 DL 667
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132156|ref|XP_002328199.1| predicted protein [Populus trichocarpa] gi|222837714|gb|EEE76079.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 308 bits (790), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 170/302 (56%), Positives = 215/302 (71%), Gaps = 26/302 (8%)
Query: 170 LAFSRMKIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRIT 227
L R++IFS++EL KATKN+ LG GGFGSVY+GVL DN QVAVKK+ D+ ++
Sbjct: 370 LKHQRVRIFSEAELEKATKNYDDDQKLGEGGFGSVYRGVLADNAQVAVKKFKGVDKAQMN 429
Query: 228 EWEF---LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWK 284
E EF +G++SQV HKNVVK+LGLCLETKV LLVYEF+SNG L +IHDK+SQ+L +W
Sbjct: 430 E-EFQNEMGVVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLFKHIHDKTSQLLASWS 488
Query: 285 TCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344
+ LRIA+E A A++YLHSLA P IIH DVKS NILLD+N TAKV+DF + V ISS D+T
Sbjct: 489 SRLRIASEIALALNYLHSLADPPIIHGDVKSVNILLDNNNTAKVADFGASVLISS-DQTI 547
Query: 345 MSTMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVP 387
++T I+GT GYLDPEY T ELLTG PNS + S EK +++
Sbjct: 548 IATKIQGTFGYLDPEYLMTGILTARSDVFSFGVVLVELLTGEKPNS--SSTSGEKRNLIQ 605
Query: 388 YFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447
+F+ ++E N+ +IL+FQ ADE EM+EIE VAELA CL G RPTMKEVS+EL +L+
Sbjct: 606 HFISALETNNLFRILDFQAADEGEMDEIEAVAELAKGCLNSMGLNRPTMKEVSDELAKLK 665
Query: 448 RL 449
L
Sbjct: 666 DL 667
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132168|ref|XP_002328202.1| predicted protein [Populus trichocarpa] gi|222837717|gb|EEE76082.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 305 bits (782), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 164/305 (53%), Positives = 207/305 (67%), Gaps = 25/305 (8%)
Query: 174 RMKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF 231
R++IFS++EL+KAT N+ LG GGFGSVYKGVL DNT VAVKK D+ ++ EF
Sbjct: 20 RVRIFSEAELVKATNNYADDRKLGEGGFGSVYKGVLTDNTVVAVKKSKGVDKAQMNA-EF 78
Query: 232 ---LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR 288
+ I+SQV HKNVVK+LGLCLETKV LLVYEF+SNG LS ++HDK S++L +W LR
Sbjct: 79 QKEMSIVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHVHDKGSRILASWTNRLR 138
Query: 289 IAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348
+A+E A A+ YLHSLA P +IH DVKS NILLD NYTAKV+DF + V +S ++T
Sbjct: 139 VASEAALALDYLHSLADPPVIHGDVKSVNILLDSNYTAKVADFGASVLMSPGKTDILATK 198
Query: 349 IRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLD 391
I+GT+GYLDPEY T ELLTG PNS S EK +++ +F+
Sbjct: 199 IQGTLGYLDPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNSIS--KSGEKRNVIQHFIS 256
Query: 392 SIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451
++ENN +IL+FQ ADE EM+EIE VAELA CL G RPTMKEVS+EL +L+ L +
Sbjct: 257 ALENNHLFKILDFQTADEGEMDEIEAVAELAKGCLNSMGVNRPTMKEVSDELAKLKALHQ 316
Query: 452 NYWAR 456
A
Sbjct: 317 KSLAH 321
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 496 | ||||||
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.620 | 0.415 | 0.405 | 7.8e-55 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.582 | 0.394 | 0.412 | 1.1e-53 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.574 | 0.390 | 0.409 | 8e-53 | |
| TAIR|locus:2014902 | 735 | WAK1 "cell wall-associated kin | 0.622 | 0.420 | 0.390 | 2.1e-52 | |
| TAIR|locus:2014912 | 732 | WAK2 "wall-associated kinase 2 | 0.627 | 0.424 | 0.387 | 1.5e-51 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.627 | 0.421 | 0.381 | 8.3e-51 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.540 | 0.338 | 0.414 | 8.6e-51 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.574 | 0.379 | 0.392 | 6e-50 | |
| TAIR|locus:2094468 | 433 | AT3G25490 [Arabidopsis thalian | 0.584 | 0.669 | 0.395 | 2.5e-49 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.614 | 0.396 | 0.374 | 4.1e-49 |
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 7.8e-55, P = 7.8e-55
Identities = 138/340 (40%), Positives = 199/340 (58%)
Query: 176 KIFSKSELLKATKNFHHC--LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW--EF 231
KIF++ + +AT + LG GG G+VYKG+LPDNT VA+KK AD ++ ++ E
Sbjct: 401 KIFTEEGMKEATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEV 460
Query: 232 LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA 291
L ++SQ+ H+NVVKILG CLET+V LLVYEF++NG L ++H W+ LRIA
Sbjct: 461 L-VLSQINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAI 519
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF--ESLVPISSDDETAMSTMI 349
E A + YLHS AS IIH D+K+ANILLD+N TAKV+DF L+P+ D+ ++TM+
Sbjct: 520 EVAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPM---DKEQLTTMV 576
Query: 350 RGTVGYLDPEYAHTELLTGMNP-NSY----VALASNEKI----------SMVPYFLDSIE 394
+GT+GYLDPEY T LL + S+ + L S +K +V YF+ + E
Sbjct: 577 QGTLGYLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQASKHLVSYFVSATE 636
Query: 395 NNSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLR-RLQENY 453
N +I++ Q ++C R+ G ERP MKEV+ +L+ LR ++
Sbjct: 637 ENRLHEIIDDQVLNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRVEKTKHK 696
Query: 454 WARKNNEESEHLLGESSTYATAVIAQPETQTVVSID-IEN 492
W+ + EE+EHL+G + AQ ET + + D I+N
Sbjct: 697 WSDQYPEENEHLIG-----GHILSAQGETSSSIGYDSIKN 731
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 555 (200.4 bits), Expect = 1.1e-53, P = 1.1e-53
Identities = 130/315 (41%), Positives = 191/315 (60%)
Query: 175 MKIFSKSELLKATKNFHHC--LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW--E 230
+KIF++ + +AT ++ LG GG G+VYKG+L DN+ VA+KK D ++ ++ E
Sbjct: 393 VKIFTEEGMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINE 452
Query: 231 FLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIA 290
L ++SQ+ H+NVVK+LG CLET+V LLVYEF+S+G L ++H W+ LRIA
Sbjct: 453 VL-VLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRIA 511
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES--LVPISSDDETAMSTM 348
E A + YLHS AS IIH DVK+ANILLD+N TAKV+DF + L+P+ D+ ++TM
Sbjct: 512 IEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPM---DQEQLTTM 568
Query: 349 IRGTVGYLDPEYAHTELLTGMNP-NSY----VALASNEKI----------SMVPYFLDSI 393
++GT+GYLDPEY +T LL + S+ + L S EK +V YF+ ++
Sbjct: 569 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAM 628
Query: 394 ENNSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLR-RLQEN 452
+ N +I++ Q +C RI G ERP+MKEV+ EL+ LR + ++
Sbjct: 629 KENRLHEIIDGQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALRVKTTKH 688
Query: 453 YWARKNNEESEHLLG 467
W+ + +E EHLLG
Sbjct: 689 QWSDQYPKEVEHLLG 703
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 8.0e-53, P = 8.0e-53
Identities = 126/308 (40%), Positives = 176/308 (57%)
Query: 176 KIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFL 232
KIFS EL KAT NF LG GG G+VYKG+L D + VAVK+ DE ++ E+ +
Sbjct: 415 KIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEI 474
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE 292
++SQ+ H+N+VK+LG CLET+V +LVYE++ NG L +HD+S W+ LRIA E
Sbjct: 475 VLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIE 534
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A A+ Y+HS AS I H D+K+ NILLD+ Y AKVSDF + ++ D +T ++T++ GT
Sbjct: 535 IAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLD-QTHLTTLVAGT 593
Query: 353 VGYLDPEY------AH-----------TELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395
GY+DPEY H EL+TG P S V S E + +FL++++
Sbjct: 594 FGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVR--SEEGRGLATHFLEAMKE 651
Query: 396 NSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLRRLQENYWA 455
N I++ + KCL +G RP MKEVS EL+R+R E+
Sbjct: 652 NRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDV 711
Query: 456 RKNNEESE 463
R NE+ E
Sbjct: 712 RTENEDEE 719
|
|
| TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 2.1e-52, P = 2.1e-52
Identities = 133/341 (39%), Positives = 197/341 (57%)
Query: 175 MKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW--E 230
+KIF++ + KAT + LG GG G+VYKG+LPDN+ VA+KK D ++ ++ E
Sbjct: 394 VKIFTEDGMKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINE 453
Query: 231 FLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIA 290
L ++SQ+ H+NVVK+LG CLET+V LLVYEF++NG L ++H W+ L+IA
Sbjct: 454 VL-VLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIA 512
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES--LVPISSDDETAMSTM 348
E A + YLHS AS IIH D+K+ANILLD N TAKV+DF + L+P+ D+ + TM
Sbjct: 513 IEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPM---DKEELETM 569
Query: 349 IRGTVGYLDPEYAHTELLTGMNP-NSY----VALASNEKI----------SMVPYFLDSI 393
++GT+GYLDPEY +T LL + S+ + L S +K +V YF +
Sbjct: 570 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSKHLVSYFATAT 629
Query: 394 ENNSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLR-RLQEN 452
+ N +I+ + ++C R+ G ERP MKEV+ +L+ LR ++
Sbjct: 630 KENRLDEIIGGEVMNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRVEKTKH 689
Query: 453 YWARKNNEESEHLLGESSTYATAVIAQPETQTVVSID-IEN 492
W+ + EE+EHL+G + AQ ET + + D I+N
Sbjct: 690 KWSDQYPEENEHLIG-----GHILSAQGETSSSIGYDSIKN 725
|
|
| TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 1.5e-51, P = 1.5e-51
Identities = 132/341 (38%), Positives = 196/341 (57%)
Query: 175 MKIFSKSELLKATKNFHHC--LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW--E 230
+KIF++ + +AT +H LG GG G+VYKG+LPDN+ VA+KK + ++ ++ E
Sbjct: 389 VKIFTEKGMKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINE 448
Query: 231 FLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIA 290
L ++SQ+ H+NVVK+LG CLET+V LLVYEF+++G L ++H W+ LRIA
Sbjct: 449 VL-VLSQINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLRIA 507
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES--LVPISSDDETAMSTM 348
E A ++ YLHS AS IIH D+K+ANILLD N TAKV+DF + L+P+ D+ ++T+
Sbjct: 508 TEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPM---DKEQLTTI 564
Query: 349 IRGTVGYLDPEYAHTELLTGMNP-NSY----VALASNEKI----------SMVPYFLDSI 393
++GT+GYLDPEY +T LL + S+ + L S +K ++V F +
Sbjct: 565 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPHCPKNLVSCFASAT 624
Query: 394 ENNSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLRRLQENY 453
+NN F +I++ Q ++C R+ G ERP MKEV+ EL+ LR Y
Sbjct: 625 KNNRFHEIIDGQVMNEDNQREIQEAARIAAECTRLMGEERPRMKEVAAELEALRVKTTKY 684
Query: 454 -WARKNNEESEHLLGESSTYATAVIAQPETQTVVSID-IEN 492
W+ + E E E + AQ ET + + D I N
Sbjct: 685 KWSDQYRETGEI---EHLLGVQILSAQGETSSSIGYDSIRN 722
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 528 (190.9 bits), Expect = 8.3e-51, P = 8.3e-51
Identities = 130/341 (38%), Positives = 195/341 (57%)
Query: 175 MKIFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW--E 230
+KIF++ + +AT + + LG GG G+VYKG+LPDN+ VA+KK D ++ ++ E
Sbjct: 395 VKIFTEEGMKEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINE 454
Query: 231 FLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIA 290
L ++SQ+ H+NVVK+LG CLET+V LLVYEF+S+G L ++H W+ LR+A
Sbjct: 455 VL-VLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRMA 513
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES--LVPISSDDETAMSTM 348
E A + YLHS AS IIH D+K+ANILLD+N TAKV+DF + L+P+ +D ++TM
Sbjct: 514 VEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKED---LATM 570
Query: 349 IRGTVGYLDPEYAHTELLTGMNP-NSY----VALASNEKI----------SMVPYFLDSI 393
++GT+GYLDPEY +T LL + S+ + L S +K +V YF +
Sbjct: 571 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASAT 630
Query: 394 ENNSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLRRLQENY 453
+ N +I++ Q +C R+ G ERP MKEV+ EL+ LR + +
Sbjct: 631 KENRLHEIIDGQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALRVTKTKH 690
Query: 454 -WARKNNEESEHLLGESSTYATAVIAQPETQTVVSID-IEN 492
W+ + E+ + E + AQ ET + + D I N
Sbjct: 691 KWSDEYPEQEDT---EHLVGVQKLSAQGETSSSIGYDSIRN 728
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 8.6e-51, P = 8.6e-51
Identities = 121/292 (41%), Positives = 173/292 (59%)
Query: 177 IFSKSELLKATKNF--HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFLG 233
+FS EL KAT+NF + LG GG G+VYKG+L D VAVKK DE ++ E+ +
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQ-VLKNWKTCLRIAAE 292
I+SQ+ H+N+VK+LG CLETKV +LVYEF+ NG L ++HD+ + ++ W LRIA +
Sbjct: 494 ILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAID 553
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A A+ YLHS AS I H DVKS NI+LD+ Y AKVSDF + ++ D T ++T++ GT
Sbjct: 554 IAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVD-HTHLTTVVSGT 612
Query: 353 VGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395
VGY+DPEY + EL+TG S+ L S E ++ YF+ +++
Sbjct: 613 VGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISF--LRSQENRTLATYFILAMKE 670
Query: 396 NSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLR 447
N I++ + KCL ++G +RP+M+EVS ELD +R
Sbjct: 671 NKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 521 (188.5 bits), Expect = 6.0e-50, P = 6.0e-50
Identities = 121/308 (39%), Positives = 172/308 (55%)
Query: 176 KIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFL 232
KIFS EL KAT NF+ LG GG G+VYKG+L D VAVK+ DE ++ E+ +
Sbjct: 407 KIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEV 466
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE 292
G++SQ+ H+N+VK++G CLET+V +LVYE + NG L +H S W LRI+ E
Sbjct: 467 GVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVE 526
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A A+ YLHS AS + H DVK+ NILLD+ Y AKVSDF + I+ D +T ++T++ GT
Sbjct: 527 IAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVD-QTHLTTLVAGT 585
Query: 353 VGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395
GYLDPEY T EL+TG P S + E +V +F ++++
Sbjct: 586 FGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFS--VMRPEENRGLVSHFNEAMKQ 643
Query: 396 NSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLRRLQENYWA 455
N I++ + +CL ++G +RP M+EVS EL+R+R E+
Sbjct: 644 NRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPEDLEL 703
Query: 456 RKNNEESE 463
E+ E
Sbjct: 704 HIEEEDEE 711
|
|
| TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 514 (186.0 bits), Expect = 2.5e-49, P = 2.5e-49
Identities = 125/316 (39%), Positives = 184/316 (58%)
Query: 176 KIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW--EF 231
KIF++ ++ +AT + LG GG +VYKG+LPDN+ VA+KK D ++ ++ E
Sbjct: 94 KIFTEEDMKEATNGYDVSRILGQGGQWTVYKGILPDNSIVAIKKTRLGDNNQVEQFINEV 153
Query: 232 LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA 291
L ++SQ+ H+NVVK+LG CLET+V LLVYEF++ G+L ++H W+ L IA
Sbjct: 154 L-VLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGSMFVSSLTWEHRLEIAI 212
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF--ESLVPISSDDETAMSTMI 349
E A AI YLHS AS IIH D+K+ NILLD+N TAKV+DF L P+ D+ ++TM+
Sbjct: 213 EVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPM---DKEQLTTMV 269
Query: 350 RGTVGYLDPEYAHTELLTGMNP-NSY----VALASNEKI----------SMVPYFLDSIE 394
+GT+GYLDPEY T LL + S+ + L S +K +V YF+ + +
Sbjct: 270 QGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQKALCFERPETSKHLVSYFVLATK 329
Query: 395 NNSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLR-RLQENY 453
N +I++ Q +C R++G ERP M EV+ EL+ LR + ++
Sbjct: 330 ENRLHEIIDDQVLNEENQREIHEAARVAVECTRLKGEERPRMIEVAAELETLRAKTTKHN 389
Query: 454 WARKNNEESEHLLGES 469
W + EE+ HLLG +
Sbjct: 390 WLDQYPEENVHLLGSN 405
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 4.1e-49, P = 4.1e-49
Identities = 125/334 (37%), Positives = 186/334 (55%)
Query: 176 KIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFL 232
++F+ EL KAT+NF LG GG G+VYKG+L D VAVKK DE ++ E+ +
Sbjct: 419 RVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 478
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQ-VLKNWKTCLRIAA 291
I+SQ+ H+N+VK+LG CLET V +LVYEF+ NG L ++HD S + W+ LRIA
Sbjct: 479 VILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAV 538
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRG 351
+ A A+ YLHS AS I H D+KS NI+LD+ + AKVSDF + ++ D T ++T++ G
Sbjct: 539 DIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVD-HTHLTTVVSG 597
Query: 352 TVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLDSIE 394
TVGY+DPEY + EL+TG S+ L S E ++ YF +++
Sbjct: 598 TVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSF--LRSQEYRTLATYFTLAMK 655
Query: 395 NNSFRQILNFQXXXXXXXXXXXXXXXXXSKCLRIRGTERPTMKEVSEELDRLRRLQENYW 454
N I++ + KCL ++G +RP+M++VS EL+++R E+
Sbjct: 656 ENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDMQ 715
Query: 455 ARKNNEESEHLLGESSTYATAVIAQPETQTVVSI 488
+ E+E E T V E++ VS+
Sbjct: 716 PYEYASENEEEKKE-----TLVDVNVESRNYVSV 744
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 496 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-30 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-27 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-11 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.001 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.001 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.001 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.001 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.002 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.002 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.002 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.002 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 0.003 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.004 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.004 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.004 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.004 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 11/170 (6%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITE--WEFLGIISQVKHKNVVKILGLC 250
LG GGFG+VY +VA+K D + E + I+ ++ H N+VK+ G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
+ LV E+ G+L + + ++ + LRI + + YLHS IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKL--SEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 311 SDVKSANILLD-DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
D+K NILLD DN K++DF ++SD + I GT Y+ PE
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 71/280 (25%), Positives = 106/280 (37%), Gaps = 58/280 (20%)
Query: 190 FHHCLGMGGFGSVYKGV-LPDNTQVAVKK------YMCADEIRITEWEFLGIISQVKHKN 242
LG G FG+VYK VAVK D+ E + I+ ++ H N
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARRE---IRILRRLSHPN 59
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+V+++ + LV E+ G L Y+ S + +IA + + YLHS
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE--- 359
IIH D+K NILLD+N K++DF + + + GT Y+ PE
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLL 171
Query: 360 --YAHT-------------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNS---FRQI 401
+ ELLTG P F + R+I
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPP-----------------FSGENILDQLQLIRRI 214
Query: 402 LNFQV-ADESEMEEI-EVVAELASKCLRIRGTERPTMKEV 439
L + DE + E +L KCL ++RPT +E+
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 49/146 (33%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 194 LGMGGFGSVYKGVLPDN-----TQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVK 245
LG G FG VYKG L +VAVK + D EFL I+ ++ H N+VK
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+LG+C E + ++V E++ G L Y+ + L + L A + A + YL S
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYLESK-- 122
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
+ IH D+ + N L+ +N K+SDF
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDF 147
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 6e-28
Identities = 49/146 (33%), Positives = 72/146 (49%), Gaps = 14/146 (9%)
Query: 194 LGMGGFGSVYKGVL---PDNT--QVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVK 245
LG G FG VYKG L +VAVK + D EFL I+ ++ H NVVK
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+LG+C E + +V E++ G L Y+ ++ + L A + A + YL S
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL--SLSDLLSFALQIARGMEYLESK-- 121
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
+ IH D+ + N L+ +N K+SDF
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDF 146
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 190 FHHCLGMGGFGSVYKGVL-----PDNTQVAVKKYMCADEIRITEW-EFL---GIISQVKH 240
LG G FG VYKG L T+VAVK + E EFL I+ ++ H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK--TLKEGASEEEREEFLEEASIMKKLSH 60
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
N+V++LG+C + + +V E++ G L ++ ++ L++A + A + YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL--LQMALQIAKGMEYL 118
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
S + +H D+ + N L+ +N K+SDF
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDF 146
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 67/274 (24%), Positives = 104/274 (37%), Gaps = 56/274 (20%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKK----YMCADEIRITEWEFLGIISQVKHKNVVKILG 248
LG G FG VY VA+K + D RI E + I+ ++KH N+V++
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR-E-IKILKKLKHPNIVRLYD 64
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+ + LV E+ G L + + L + SA+ YLHS I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSE-DEARFYLRQILSALEYLHSK---GI 118
Query: 309 IHSDVKSANILLDDNYTAKVSDFESLVPISS--DDETAMSTMIRGTVGYLDPE------Y 360
+H D+K NILLD++ K++DF ++ D ++T + GT Y+ PE Y
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFG----LARQLDPGEKLTTFV-GTPEYMAPEVLLGKGY 173
Query: 361 AHT-----------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNS-FRQILNFQVAD 408
ELLTG P F + F++I +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP-----------------FPGDDQLLELFKKIGKPKPPF 216
Query: 409 ESEMEEI-EVVAELASKCLRIRGTERPTMKEVSE 441
+I +L K L +R T +E +
Sbjct: 217 PPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 17/151 (11%)
Query: 194 LGMGGFGSVYKGVLPDN----TQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKI 246
LG G FG VYKG L T+VAVK + D +FL ++ ++ H NVV++
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC------LRIAAETASAIHYL 300
LG+C E + LV E++ G L Y+ K+ L A + A + YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
S +H D+ + N L+ ++ K+SDF
Sbjct: 122 ASK---KFVHRDLAARNCLVGEDLVVKISDF 149
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 20/178 (11%)
Query: 192 HCLGMGGFGSVYKGVLPDNTQ-VAVKK----YMCADEIRITEWEFLGIISQVKHKNVVKI 246
LG G FGSVY + D + +AVK +E+ E E I+S ++H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREI-RILSSLQHPNIVRY 64
Query: 247 LGLCL-ETKVTLLVY-EFVSNGALSHYIHDKSS---QVLKNWKTCLRIAAETASAIHYLH 301
G E K TL ++ E+VS G+LS + V++ + + + YLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY------TRQILEGLAYLH 118
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
S I+H D+K ANIL+D + K++DF + + + +RGT ++ PE
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 90.6 bits (223), Expect = 1e-19
Identities = 75/324 (23%), Positives = 128/324 (39%), Gaps = 31/324 (9%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF----LGIISQVKH-KNVVKILG 248
LG G FG VY D VA+K E + E E + I++ + H N+VK+
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+ LV E+V G+L + + + L I A+ SA+ YLHS I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GI 122
Query: 309 IHSDVKSANILLDDNYT-AKVSDFESLVPISSDDET----AMSTMIRGTVGYLDPEYAHT 363
IH D+K NILLD + K+ DF + T A+ + GT GY+ PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 364 ELLTGMNPNSYV---ALASNEKISMVPYFLDSIENNSFRQIL-----------NFQVADE 409
L + +S + + E ++ +P F +++ Q L ++
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 410 SEMEEIEVVAELASKCLRIRGTERPTMKE-VSEELDRLRRLQENYWARKNNE-ESEHLLG 467
+ + ++L K L R + +S +L +L+E+ + +S L
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRL 302
Query: 468 ESSTYATAVIAQPETQTVVSIDIE 491
A+I+ + + D++
Sbjct: 303 SLPPSLEALISSLNSLAISGSDLK 326
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 57/182 (31%), Positives = 83/182 (45%), Gaps = 34/182 (18%)
Query: 192 HCLGMGGFGSVYKG-VLPDNTQVAVKKYMCADEIRI---TEWEFL----GIISQVKHKNV 243
+G GGFG VYK +VA+K I++ + E + I+ + KH N+
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKV------IKLESKEKKEKIINEIQILKKCKHPNI 59
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR------IAAETASAI 297
VK G L+ +V EF S G+L +LK+ L + E +
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLK--------DLLKSTNQTLTESQIAYVCKELLKGL 111
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLD 357
YLHS IIH D+K+ANILL + K+ DF +S D A +TM+ GT ++
Sbjct: 112 EYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMV-GTPYWMA 165
Query: 358 PE 359
PE
Sbjct: 166 PE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 8e-18
Identities = 46/140 (32%), Positives = 80/140 (57%), Gaps = 7/140 (5%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVK--KYMCADEIRITEWEFLGIISQVKHKNVVKILGLCL 251
+G G FG VYKGVL NT+VAVK + +++ + I+ Q H N+VK++G+C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 252 ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHS 311
+ + +V E V G+L ++ K +++ K L+++ + A+ + YL S + IH
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLE---SKNCIHR 117
Query: 312 DVKSANILLDDNYTAKVSDF 331
D+ + N L+ +N K+SDF
Sbjct: 118 DLAARNCLVGENNVLKISDF 137
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 70/291 (24%), Positives = 108/291 (37%), Gaps = 66/291 (22%)
Query: 194 LGMGGFGSVYKGVL-PDNTQVAVK--------KYMCADEIRITEWEFLGIISQVKHKNVV 244
+G G F +V N + A+K K + E E L ++ H ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV-KIEKEVLTRLNG--HPGII 65
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
K+ + + L V E+ NG L YI S + K AAE A+ YLHS
Sbjct: 66 KLYY-TFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLHSK 121
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD--------DETAMSTMIR----- 350
IIH D+K NILLD + K++DF + + + D T + + I
Sbjct: 122 ---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 351 -----GTVGYLDPEYAHTELLTG--MNPNS---------YVALASNEKISMVPYFLDSIE 394
GT Y+ PE LL +S Y + ++ P F S E
Sbjct: 179 FASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIY------QMLTGKPPFRGSNE 227
Query: 395 NNSFRQILNFQVADESEMEEI--EVVAELASKCLRIRGTERPTMKEVSEEL 443
+F++IL + +L K L + +R + E +EL
Sbjct: 228 YLTFQKILKLEY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-17
Identities = 49/140 (35%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVK--KYMCADEIRITEWEFLGIISQVKHKNVVKILGLCL 251
LG G FG V+KG L D T VAVK K E++I I+ Q H N+VK++G+C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 252 ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHS 311
+ + +V E V G ++ K + LK K ++ A + A+ + YL S + IH
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE-LKT-KQLVKFALDAAAGMAYLE---SKNCIHR 117
Query: 312 DVKSANILLDDNYTAKVSDF 331
D+ + N L+ +N K+SDF
Sbjct: 118 DLAARNCLVGENNVLKISDF 137
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 11/142 (7%)
Query: 193 CLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGL 249
+G G FG V G +VAVK D FL +++ ++H N+V++LG+
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKD-DSTAAQA--FLAEASVMTTLRHPNLVQLLGV 68
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
L+ +V E+++ G+L Y+ + V+ L A + + YL + +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI-TLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 310 HSDVKSANILLDDNYTAKVSDF 331
H D+ + N+L+ ++ AKVSDF
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDF 146
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 30/183 (16%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQ-VAVKKYMCADEIRITEWEFLGIISQV------KHKN 242
+G G FG VYKG+ + VA+K+ +I E I+ ++ KH N
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQI---SLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 243 VVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKT-----CLRIAAETASA 296
+VK +G +ET +L ++ E+ NG+L Q++K + +
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSLR--------QIIKKFGPFPESLVAVYVYQVLQG 111
Query: 297 IHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYL 356
+ YLH +IH D+K+ANIL + K++DF ++ + + GT ++
Sbjct: 112 LAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWM 166
Query: 357 DPE 359
PE
Sbjct: 167 APE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 50/180 (27%), Positives = 77/180 (42%), Gaps = 28/180 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEF---------LGIISQVKHKNV 243
+G G FG VY V L +AVK EIRI + + + ++ +KH N+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVK------EIRIQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRI-AAETASAIHYLHS 302
VK G+ + + + E+ S G L + +R+ + + YLHS
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH----VIRVYTLQLLEGLAYLHS 117
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVG---YLDPE 359
I+H D+K ANI LD N K+ DF V ++ T M ++ G Y+ PE
Sbjct: 118 ---HGIVHRDIKPANIFLDHNGVIKLGDFGCAV-KLKNNTTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 19/147 (12%)
Query: 194 LGMGGFGSVYKGV--LPDNTQVAVK-KYMCADEIRITEWEFLG---IISQVKHKNVVKIL 247
LG G FGSV KGV + +V V K + + I + EFL +++Q+ H +V+++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSS-QV--LKNWKTCLRIAAETASAIHYLHSLA 304
G+C + +LV E G L Y+ + V LK A + A + YL S
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
+H D+ + N+LL + + AK+SDF
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDF 139
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 11/154 (7%)
Query: 182 ELLKATKNFHHCLGMGGFGSVYKGVLPD-NTQVAVKKYMCADEIRITEWEFL---GIISQ 237
E+ + H LG G +G VY+GV + VAVK + D + + E FL ++ +
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEE--FLKEAAVMKE 58
Query: 238 VKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAI 297
+KH N+V++LG+C ++ EF++ G L Y+ + + Q + N L +A + +SA+
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAM 117
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
YL + IH D+ + N L+ +N+ KV+DF
Sbjct: 118 EYLE---KKNFIHRDLAARNCLVGENHLVKVADF 148
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (185), Expect = 4e-15
Identities = 52/176 (29%), Positives = 70/176 (39%), Gaps = 20/176 (11%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKK----YMCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G FG VY D +K+ M E E + I+ ++ H N++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNE-VKILKKLNHPNIIKYYE 66
Query: 249 LCLETKVTLL-VYEFVSNGALSHYIHD-KSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
E K L V E+ G LS I K + L + A+ YLHS
Sbjct: 67 -SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---R 122
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPIS---SDDETAMSTMIRGTVGYLDPE 359
I+H D+K NI L N K+ DF IS S T++ GT YL PE
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFG----ISKVLSSTVDLAKTVV-GTPYYLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 12/169 (7%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGLC 250
+G G FG V+ G + +VA+K E ++E +F+ ++ ++ H +V++ G+C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
E LV+EF+ +G LS Y+ + + + +T L + + + YL S ++IH
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQ--ETLLGMCLDVCEGMAYLE---SSNVIH 123
Query: 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
D+ + N L+ +N KVSDF + DD+ ST + V + PE
Sbjct: 124 RDLAARNCLVGENQVVKVSDF-GMTRFVLDDQYTSSTGTKFPVKWSSPE 171
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 16/148 (10%)
Query: 194 LGMGGFGSVYKG---VLPDNT--QVAVK--KYMCADEIRITEWEF-LGIISQVKHKNVVK 245
LG G FG V L DNT QVAVK + ++ R +++E + I+ + H+N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRTLDHENIVK 70
Query: 246 ILGLCLET--KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
G+C + + L+ E++ +G+L Y+ Q+ N K L +++ + YL S
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI--NLKRLLLFSSQICKGMDYLGSQ 128
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
IH D+ + NIL++ K+SDF
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDF 153
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 38/204 (18%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIR--------ITEWEFLGIISQVKHKNVVK 245
LG G FG V D ++ K + +I +TE I+S++ H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERN---ILSRINHPFIVK 57
Query: 246 ILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
L +T+ L LV E+ G L ++ S + + + AAE A+ YLHSL
Sbjct: 58 -LHYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLHSL- 112
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEY---- 360
II+ D+K NILLD + K++DF L S + + +T GT YL PE
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDF-GLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 361 AHT-------------ELLTGMNP 371
+ E+LTG P
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKY----MCADEIRITEWEFL---GIISQVKHKNVVKI 246
LG G FG V+ G T+VAVK M + FL I+ +++H +V++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-------FLQEAQIMKKLRHDKLVQL 66
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+C E + +V E++S G+L ++ + L+ + +AA+ A + YL S
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLESR--- 122
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342
+ IH D+ + NIL+ +N K++DF L + DDE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADF-GLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 34/139 (24%), Positives = 74/139 (53%), Gaps = 5/139 (3%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF-LGIISQVKHKNVVKILGLCLE 252
LG G FG V++G+ + +VA+K D ++ +++ + + +++HK+++ + +C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 253 TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSD 312
+ ++ E + G+L ++ QVL + + +A + A + YL + IH D
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPV-ASLIDMACQVAEGMAYLEE---QNSIHRD 129
Query: 313 VKSANILLDDNYTAKVSDF 331
+ + NIL+ ++ KV+DF
Sbjct: 130 LAARNILVGEDLVCKVADF 148
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKY----MCADEIRITEWEFL---GIISQVKHKNVVKI 246
LG G FG V++G+ + T VAVK M +FL I+ +++H ++++
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-------DFLAEAQIMKKLRHPKLIQL 66
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+C + +V E + G+L Y+ + + LK + +AA+ AS + YL +
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK-LPQLIDMAAQVASGMAYLEAQ--- 122
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAH 362
+ IH D+ + N+L+ +N KV+DF L + +D + + + PE A
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADF-GLARVIKEDIYEAREGAKFPIKWTAPEAAL 177
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 22/157 (14%)
Query: 194 LGMGGFGSVYKG----VLPDN--TQVAVK--KYMCADEIRITEWEFLGIISQVKHKNVVK 245
LG G FG V+ G + P+N VAVK K +++ R +++ +H+N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYI--HDKSSQVLKNWKT---------CLRIAAETA 294
G+C E ++V+E++ +G L+ ++ H + LK+ + L+IA + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 295 SAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
S + Y LAS +H D+ + N L+ + K+ DF
Sbjct: 133 SGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDF 166
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 75/270 (27%), Positives = 113/270 (41%), Gaps = 45/270 (16%)
Query: 197 GGFGSVY---KGVLPDNTQVAVKKYMCADEIR-------ITEWEFLGIISQVKHKNVVKI 246
G +G V+ K D A+K AD IR +TE + L SQ + VVK+
Sbjct: 4 GAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDIL---SQAQSPYVVKL 58
Query: 247 LGLCLETKVTL-LVYEFVSNGALSHYIHDKSS---QVLKNWKTCLRIAAETASAIHYLHS 302
+ K L LV E++ G L+ + + S V + AE A+ YLHS
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI------YIAEIVLALEYLHS 111
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF----ESLV--PISSDDETAMSTMIRGTVGYL 356
IIH D+K NIL+D N K++DF LV I+ +D+ I GT Y+
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 357 DPEYAHTELLTGMN---PNSYVALAS--NEKISMVPYFLDSIENNSFRQILNFQVADESE 411
P E++ G + +L E + +P F F+ ILN ++ +
Sbjct: 169 AP-----EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED 223
Query: 412 MEEIEVVAELASKCLRIRGTERPTMKEVSE 441
+E + +L SK L +R K + E
Sbjct: 224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 18/164 (10%)
Query: 194 LGMGGFGSVYKGVLPDNTQ----VAVK--KYMCADEIRITEWEFLG---IISQVKHKNVV 244
+G G FG V +G L + VA+K K +D+ R +FL I+ Q H N++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR---LDFLTEASIMGQFDHPNII 68
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
++ G+ +++ +++ E++ NG+L ++ + + + + AS + YL +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSEMN 126
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348
+H D+ + NIL++ N KVSDF L D E +T
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDF-GLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (172), Expect = 3e-13
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKKY-MCADE-------IR-ITEWEFLGIISQVKHKN 242
LG G +G VYK VA+KK + +E +R I+ ++ ++KH N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS------LLKELKHPN 59
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+VK+L + + LV+E+ L Y+ + + N I + + Y HS
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMD-LKKYLDKRPGPLSPN--LIKSIMYQLLRGLAYCHS 116
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
I+H D+K NIL++ + K++DF
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADF 142
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 49/148 (33%), Positives = 78/148 (52%), Gaps = 18/148 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEI--RITEWE----FL--GII-SQVKHKNVV 244
+G G FG VY G L D+ +K CA + RIT+ E FL GII H NV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDG---QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 245 KILGLCLETK-VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+LG+CL ++ L+V ++ +G L ++I ++ K + + A + YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYL--- 114
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
AS +H D+ + N +LD+++T KV+DF
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADF 142
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 40/143 (27%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 194 LGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILG 248
+G G FG V+ G L DNT VAVK C + +++ + I+ Q H N+V+++G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKS--CRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+C + + +V E V G ++ + ++ K +++ A+ + YL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRL--KVKELIQMVENAAAGMEYLE---SKHC 115
Query: 309 IHSDVKSANILLDDNYTAKVSDF 331
IH D+ + N L+ + K+SDF
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDF 138
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 20/149 (13%)
Query: 193 CLGMGGFGSVYKGVL----PDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVK 245
C+G G FG VY+GV + VAVK + E +FL I+ Q H ++VK
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE-KFLQEAYIMRQFDHPHIVK 71
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRI---AAETASAIHYLHS 302
++G+ E V +V E G L Y+ QV K + + + ++A+ YL S
Sbjct: 72 LIGVITENPV-WIVMELAPLGELRSYL-----QVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
+H D+ + N+L+ K+ DF
Sbjct: 126 K---RFVHRDIAARNVLVSSPDCVKLGDF 151
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 7/140 (5%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCL 251
LG G +GSVYK + VA+K ++++ E + I+ Q +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE-ISILKQCDSPYIVKYYGSYF 68
Query: 252 ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHS 311
+ +V E+ G++S + K + + I +T + YLHS IH
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHR 123
Query: 312 DVKSANILLDDNYTAKVSDF 331
D+K+ NILL++ AK++DF
Sbjct: 124 DIKAGNILLNEEGQAKLADF 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 12/166 (7%)
Query: 194 LGMGGFGSVYKGVL--PDNTQVAVK-KYMCADEIRITEWEFLG---IISQVKHKNVVKIL 247
+G G FG V++G+L P +VAV K + +FL I+ Q H N++++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
G+ + K +++ E++ NGAL Y+ D + + ++ + L+ +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEF-----SSYQLVGMLRGIAAGMKYLSDMN 127
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTV 353
+H D+ + NIL++ N KVSDF L + DD T G +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDF-GLSRVLEDDPEGTYTTSGGKI 172
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 15/132 (11%)
Query: 211 TQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267
VAVK D +FL I+S++ N+ ++LG+C ++ E++ NG
Sbjct: 47 VLVAVKVLRP-DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 268 LSHYIH---DKSSQVLKNWK-----TCLRIAAETASAIHYLHSLASPSIIHSDVKSANIL 319
L+ ++ ++S + N K T L +A + AS + YL SL + +H D+ + N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL 162
Query: 320 LDDNYTAKVSDF 331
+ NYT K++DF
Sbjct: 163 VGKNYTIKIADF 174
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 44/181 (24%), Positives = 71/181 (39%), Gaps = 32/181 (17%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYM------------CADEIRITEWEFLGIISQVKHK 241
+G G FG V+K V + +V K + DE R+ ++++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARV--------LAKLDSS 59
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKN---WKTCLRIAAETASAIH 298
+++ L+ +V E+ NG L + + + L W R + +
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115
Query: 299 YLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDP 358
+LHS I+H D+KS N+ LD K+ D V D T + I GT YL P
Sbjct: 116 HLHS---KKILHRDIKSLNLFLDAYDNVKIGDLG--VAKLLSDNTNFANTIVGTPYYLSP 170
Query: 359 E 359
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 26/172 (15%)
Query: 182 ELLKATKNFHHCLGMGGFGSVYKG--VLPDN----TQVAVKKYMCADEIRITEWEF---L 232
E+ + F LG G FG VYKG P+ T VA+K E ++ + EF
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-EFRQEA 59
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYI--HDKSSQV--------LKN 282
++S ++H N+V +LG+C + + T +++E++++G L ++ + S V +K+
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 283 WKTC---LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
C L IA + A+ + Y L+S +H D+ + N L+ + T K+SDF
Sbjct: 120 SLDCSDFLHIAIQIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDF 168
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 6/168 (3%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLET 253
LG G FG V+ G NT+VAVK + E I+ +++H +V++ + E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 254 KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDV 313
+ +V E++S G+L ++ D + LK + +AA+ A+ + Y+ + + IH D+
Sbjct: 74 PI-YIVTEYMSKGSLLDFLKDGEGRALK-LPNLVDMAAQVAAGMAYIERM---NYIHRDL 128
Query: 314 KSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYA 361
+SANIL+ D K++DF L + D+E + + + PE A
Sbjct: 129 RSANILVGDGLVCKIADF-GLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 26/168 (15%)
Query: 175 MKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWE 230
++I ++EL K LG G FG+VYKGV +P+ +V + K + + E
Sbjct: 1 LRILKETELEKIK-----VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE 55
Query: 231 FLG---IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKS----SQVLKNW 283
L +++ V H +VV++LG+CL + L+ + + G L Y+ + SQ L NW
Sbjct: 56 ILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW 114
Query: 284 KTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
C++I A + YL ++H D+ + N+L+ K++DF
Sbjct: 115 --CVQI----AKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDF 153
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 19/160 (11%)
Query: 192 HCLGMGGFGSV----YKGVLPDNTQVAVK--KYMCADEIRITEWEFLGIISQVKHKNVVK 245
+G G FG V Y+G +VAVK K + + E +++Q++H N+V+
Sbjct: 12 QTIGKGEFGDVMLGDYRG-----NKVAVKCIKNDATAQAFLAE---ASVMTQLRHSNLVQ 63
Query: 246 ILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+LG+ +E K L +V E+++ G+L Y+ + VL L+ + + A+ YL +
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVCEAMEYLEA-- 120
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344
+ +H D+ + N+L+ ++ AKVSDF SS +T
Sbjct: 121 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 62/257 (24%), Positives = 119/257 (46%), Gaps = 32/257 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKY---MCADEIRITEWEFLGIISQVKHKNVVKILGLC 250
LG G FG V+ G T+VA+K + E + E + ++ +++H+ +V++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ---VMKKLRHEKLVQLYAVV 70
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
E + +V E++S G+L ++ + + L+ + +AA+ AS + Y+ + + +H
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLR-LPQLVDMAAQIASGMAYVERM---NYVH 125
Query: 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYA-HTELLTGM 369
D+++ANIL+ +N KV+DF L + D+E + + + PE A +
Sbjct: 126 RDLRAANILVGENLVCKVADF-GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 370 NPNSY-VALASNEKISMVPYFLDSIENNSFRQILNFQVADESEM--------EEIEVVAE 420
+ S+ + L VPY ++N +V D+ E E E + +
Sbjct: 185 DVWSFGILLTELTTKGRVPY----------PGMVNREVLDQVERGYRMPCPPECPESLHD 234
Query: 421 LASKCLRIRGTERPTMK 437
L +C R ERPT +
Sbjct: 235 LMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 21/149 (14%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADE-------IRITEWEFLGIISQVKHKNVVK 245
LG G FGSVY+G+ L D AVK+ AD+ ++ E E + ++S+++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQE-IALLSKLQHPNIVQ 66
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSS---QVLKNWKTCLRIAAETASAIHYLHS 302
LG E + E V G+L+ + S V++ + + + YLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY------TRQILLGLEYLHD 120
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ +H D+K ANIL+D N K++DF
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADF 146
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 31/165 (18%)
Query: 194 LGMGGFGSVY----KGVL-----PDNTQ------VAVKKYMCADEIRITEWEFLG---II 235
LG G FG V+ +G+ VAVK + AD + +FL I+
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKM-LRADVTKTARNDFLKEIKIM 71
Query: 236 SQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKS--SQVLK-------NWKTC 286
S++K+ N++++LG+C+ ++ E++ NG L+ ++ + S +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 287 LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L +A + AS + YL SL + +H D+ + N L+ ++YT K++DF
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADF 173
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 22/150 (14%)
Query: 192 HCLGMGGFGSVYKGVLPDNTQ-VAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKIL 247
+G G +G V K + VA+KK+ +++ ++ T + ++ Q++H+N+V +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA------ETASAIHYLH 301
LV+E+V L ++L+ L A + AI Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLL---------ELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
S +IIH D+K NIL+ ++ K+ DF
Sbjct: 118 SH---NIIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 194 LGMGGFGSVYKGVL--PDNTQ--VAVKKYMCADEIRITEWE-FLGIISQVK---HKNVVK 245
LG G FGSV +G L D +Q VAVK M D +E E FL + +K H NV+K
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKT-MKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 246 ILGLCLETK------VTLLVYEFVSNGALSHYIHDKSSQVLKNW---KTCLRIAAETASA 296
++G+C E +++ F+ +G L ++ L +T L+ + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 297 IHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ YL ++ + IH D+ + N +L ++ T V+DF
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADF 157
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 68/291 (23%), Positives = 128/291 (43%), Gaps = 28/291 (9%)
Query: 175 MKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWE 230
++I ++EL + LG G FG+VYKG+ +P+ V + K + E
Sbjct: 1 LRILKETELKRVK-----VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 55
Query: 231 FLG---IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKS----SQVLKNW 283
F+ I++ + H ++V++LG+CL + LV + + +G L Y+H+ SQ+L NW
Sbjct: 56 FMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114
Query: 284 KTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343
C++I A + YL ++H D+ + N+L+ K++DF + D++
Sbjct: 115 --CVQI----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165
Query: 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL- 402
+ + + ++ E H T + + E ++ D I +L
Sbjct: 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225
Query: 403 NFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENY 453
+ + + I+V + KC I RP KE++ E R+ R + Y
Sbjct: 226 KGERLPQPPICTIDVYMVMV-KCWMIDADSRPKFKELAAEFSRMARDPQRY 275
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 30/151 (19%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQV------KHKNVVKI 246
+G G G VYK +VA+KK +R+ + II+++ KH N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKK------MRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL------RIAAETASAIHYL 300
L +V E++ G+L+ ++ + + E + YL
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLT--------DIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
HS ++IH D+KS NILL + + K++DF
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 22/154 (14%)
Query: 194 LGMGGFGSVYKGVLPDNT---------QVAVKKYMCADEIRITE--WEFLGIISQVKHKN 242
LG G F ++YKGVL + +V+V + + R + +E ++SQ+ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+VK+ G+C+ + ++V E+V G L ++H + + V +WK L +A + ASA+HYL
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336
++H +V NIL+ A+ E VP
Sbjct: 120 K---KLVHGNVCGKNILV-----ARYGLNEGYVP 145
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 12/169 (7%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGLC 250
LG G FG V+ G VA+K E ++E +F+ ++ ++ H N+V++ G+C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
+ + +V E+++NG L +Y+ ++ ++ W L + ++ A+ YL S IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLE---SNGFIH 123
Query: 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
D+ + N L+ ++ KVSDF L DD+ S + V + PE
Sbjct: 124 RDLAARNCLVGEDNVVKVSDF-GLARYVLDDQYTSSQGTKFPVKWAPPE 171
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 67/296 (22%), Positives = 122/296 (41%), Gaps = 44/296 (14%)
Query: 175 MKIFSKSELLKATKNFHHCLGMGGFGSVYKGVLPDN-TQVAVKKYMCADEIRITEWEFLG 233
K + +++L + K + + G G+ YKG N Q VK+ + I +E +G
Sbjct: 680 SKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG 738
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKN--WKTCLRIAA 291
+++H N+VK++GLC K L++E++ L S+VL+N W+ +IA
Sbjct: 739 ---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL--------SEVLRNLSWERRRKIAI 787
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRG 351
A A+ +LH SP+++ ++ I++D E + +S T
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-------EPHLRLSLPGLLCTDTKCFI 840
Query: 352 TVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLDSIE 394
+ Y+ PE T ELLTG +P + + S+V +
Sbjct: 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVHG--SIVEWARYCYS 897
Query: 395 NNSFRQILNFQVADESEMEEIEVV--AELASKCLRIRGTERPTMKEVSEELDRLRR 448
+ ++ + + + + E+V LA C T RP +V + L+ R
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 34/147 (23%), Positives = 65/147 (44%), Gaps = 18/147 (12%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKY---MCADEIRITEWEFLGIISQVKHKNVVKILGL 249
+G G +G VYK VA+KK + IT + ++ +++H N+V++ +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 250 CLE--TKVTLLVYEFVS---NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+V+E++ G L + +K + + YLHS
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK------CYMKQLLEGLQYLHSNG 120
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
I+H D+K +NIL++++ K++DF
Sbjct: 121 ---ILHRDIKGSNILINNDGVLKLADF 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 43/141 (30%), Positives = 77/141 (54%), Gaps = 13/141 (9%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGLC 250
+G G FG+V +G +VAVK C +T FL +++++ HKN+V++LG+
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC----DVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
L + +V E +S G L +++ + + L + L+ + + A + YL S ++H
Sbjct: 69 LHNGL-YIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES---KKLVH 123
Query: 311 SDVKSANILLDDNYTAKVSDF 331
D+ + NIL+ ++ AKVSDF
Sbjct: 124 RDLAARNILVSEDGVAKVSDF 144
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 36/136 (26%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 194 LGMGGFGSVYKGV---LPDNTQV----AVKKYMCADEIRITE--WEFLGIISQVKHKNVV 244
LG G F ++KG+ + D ++ + K + +E +E ++SQ+ HK++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
G+C+ +++V E+V G+L Y+ + + +WK L +A + A A+H+L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLE--- 117
Query: 305 SPSIIHSDVKSANILL 320
+ H +V + N+LL
Sbjct: 118 DKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 69/302 (22%), Positives = 123/302 (40%), Gaps = 62/302 (20%)
Query: 176 KIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGI 234
+I ++EL K LG G FG+V+KG+ +P+ + + + + R F I
Sbjct: 2 RILKETELRKLK-----LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56
Query: 235 ------ISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDK----SSQVLKNWK 284
+ + H +V++LG+C + L V + G+L ++ Q L NW
Sbjct: 57 TDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW- 114
Query: 285 TCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344
C++IA ++YL ++H ++ + NILL + +++DF + DD+
Sbjct: 115 -CVQIA----KGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 345 MSTMIRGTVGYLDPE------YAHT-----------ELLT-GMNPNSYVALASNEKISMV 386
+ + + ++ E Y H E+++ G P Y + +E V
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP--YAGMRPHE----V 220
Query: 387 PYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446
P L+ E + QI V + KC I RPT KE++ E R+
Sbjct: 221 PDLLEKGERLAQPQICTIDVY------------MVMVKCWMIDENVRPTFKELANEFTRM 268
Query: 447 RR 448
R
Sbjct: 269 AR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 11/177 (6%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKY----MCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G F VYK + L D VA+KK M + R + + ++ Q+ H NV+K L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 249 LCLETKVTLLVYEFVSNGALSHYI-HDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
+E +V E G LS I H K + L +T + + SA+ ++HS
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KR 126
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE 364
I+H D+K AN+ + K+ D L S TA +++ GT Y+ PE H
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDL-GLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 23/150 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKK------YMCADEIRITEWEFLGIISQVKHKNVVKI 246
LG G + VYK VA+KK D I T + ++ ++KH N++ +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKS-----SQVLKNWKTCLRIAAETASAIHYLH 301
L + LV+EF+ L I DKS + + K++ T + YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADI-KSY------MLMTLRGLEYLH 119
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
S I+H D+K N+L+ + K++DF
Sbjct: 120 SN---WILHRDLKPNNLLIASDGVLKLADF 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 43/167 (25%), Positives = 80/167 (47%), Gaps = 34/167 (20%)
Query: 194 LGMGGFGSVYK----GVLP--DNTQVAVKKYMCADEIRI-TEWEFL---GIISQVKHKNV 243
+G G FG V++ G+LP T VAVK M +E + +F ++++ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKS----SQVLKNWKTC------------- 286
VK+LG+C K L++E+++ G L+ ++ +S + + +
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 287 --LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L IA + A+ + Y L+ +H D+ + N L+ +N K++DF
Sbjct: 131 EQLCIAKQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADF 174
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 12/172 (6%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGLC 250
LG G FG V+ G +VA+K +E ++E +F+ ++ ++ H +V++ G+C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
+ K +V EF+ NG L +Y+ + ++ K+ L + + + YL S IH
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAH 362
D+ + N L+ KVSDF + DDE S+ + V + PE +
Sbjct: 124 RDLAARNCLVSSTGVVKVSDF-GMTRYVLDDEYTSSSGAKFPVKWSPPEVFN 174
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 8e-11
Identities = 62/279 (22%), Positives = 98/279 (35%), Gaps = 65/279 (23%)
Query: 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRI-----TEWEFLGIISQVKHKNVVK 245
LG G G VYK P A+KK + E L + + VVK
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRE---LKTLRSCESPYVVK 63
Query: 246 ILGLCLETKVTLLVYEFVSNGALS--HYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHS 302
G + +V E++ G+L+ K VL IA + + YLH+
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA------YIARQILKGLDYLHT 117
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM---STMIRGTVGYLDPE 359
IIH D+K +N+L++ K++DF IS E + +T + GTV Y+ PE
Sbjct: 118 KRH--IIHRDIKPSNLLINSKGEVKIADFG----ISKVLENTLDQCNTFV-GTVTYMSPE 170
Query: 360 ------YAHT-----------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL 402
Y++ E G P ++ ++ + I
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFELM------------QAIC 216
Query: 403 NFQVADESEMEEIEVVAELA---SKCLRIRGTERPTMKE 438
+ + E E S CL+ +RP+ E
Sbjct: 217 DGPPP---SLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 64/295 (21%), Positives = 112/295 (37%), Gaps = 58/295 (19%)
Query: 194 LGMGGFGSVYKGV------LPDNTQVAVK---KYMCADEIRITEWEFLGIISQVKHKNVV 244
LG G FG V K T VAVK + + E+R EF ++ QV H +V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF-NLLKQVNHPHVI 66
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIH---------------------DKSSQVLKNW 283
K+ G C + LL+ E+ G+L ++ D +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 284 KTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343
+ A + + + YL + ++H D+ + N+L+ + K+SDF + +D
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 344 AMSTMIRGTVGYLDPEYAHTELLT--------GMNPNSYVALASNEKISMVPYFLDSIEN 395
+ R V ++ E + T G+ V L N + P L ++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243
Query: 396 NSFRQILNFQVADESEMEEIEVVAE----LASKCLRIRGTERPTMKEVSEELDRL 446
+R ME E +E L C + +RPT ++S+EL+++
Sbjct: 244 TGYR------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 20/154 (12%)
Query: 194 LGMGGFGSVY----KGVLPDN--TQVAVKKYMCADEIRITEWEFLGIISQVKHKN---VV 244
LG G FG VY KGV+ D T+VA+K A +R EFL S +K N VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVV 72
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYI-------HDKSSQVLKNWKTCLRIAAETASAI 297
++LG+ + + TL++ E ++ G L Y+ + Q + K +++A E A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
YL++ +H D+ + N ++ +++T K+ DF
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 163
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 28/179 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEF-------LGIISQVKHKNVVK 245
LG G +G VY L ++A+K EI + + + + S +KH+N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIK------EIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
LG E + E V G+LS + K + N +T + + + YLH
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-- 127
Query: 306 PSIIHSDVKSANILLDDNYTA--KVSDF---ESLVPISSDDETAMSTMIRGTVGYLDPE 359
I+H D+K N+L+ + Y+ K+SDF + L I+ ET GT+ Y+ PE
Sbjct: 128 -QIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPCTET-----FTGTLQYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 17/177 (9%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKY-MCADEIRITEWEF------LGIISQVKHKNVVKI 246
LG G +G+VY G+ +AVK+ + + E E+ + ++ +KH N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
LG CL+ + EFV G++S + L C + + + YLH +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFC-KYTKQILDGVAYLH---NN 121
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPIS----SDDETAMSTMIRGTVGYLDPE 359
++H D+K N++L N K+ DF ++ + M + GT ++ PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 11/175 (6%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKY----MCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G F VY+ L D VA+KK M + R + + ++ Q+ H NV+K L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 249 LCLETKVTLLVYEFVSNGALSHYI-HDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
+E +V E G LS I + K + L +T + + SA+ ++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAH 362
++H D+K AN+ + K+ D L S TA +++ GT Y+ PE H
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDL-GLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 27/184 (14%)
Query: 193 CLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
+G G FG+V K + ++ V K + + E + L I+ ++KH N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 249 -LCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWK---------TCLRIAAETASAI 297
+ + TL +V E+ G L+ Q+++ K RI + A+
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLA--------QLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 298 HYLH--SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGY 355
+ H S +++H D+K ANI LD N K+ DF L I D + T + GT Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF-GLAKILGHDSSFAKTYV-GTPYY 176
Query: 356 LDPE 359
+ PE
Sbjct: 177 MSPE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 15/144 (10%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK--KYMCADEIRITEWEFLGIISQVKHKNVVKILGLC 250
+G G +G VYK + VA+K K D+ I + E + ++ + +H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE-ISMLKECRHPNIVAYFGSY 69
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIA---AETASAIHYLHSLASPS 307
L +V E+ G+L I+ + L L+IA ET + YLH
Sbjct: 70 LRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE----LQIAYVCRETLKGLAYLHET---G 121
Query: 308 IIHSDVKSANILLDDNYTAKVSDF 331
IH D+K ANILL ++ K++DF
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADF 145
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGLC 250
LG G FG V G VA+K E ++E EF+ ++ ++ H+ +V++ G+C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 251 LETKVTLLVYEFVSNGALSHYI--HDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+ + +V E++SNG L +Y+ H K Q + + C + + YL S
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC----KDVCEGMAYLES---KQF 121
Query: 309 IHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAH 362
IH D+ + N L+DD KVSDF L DDE S + V + PE
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDF-GLSRYVLDDEYTSSVGSKFPVRWSPPEVLL 174
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 44/168 (26%), Positives = 82/168 (48%), Gaps = 6/168 (3%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLET 253
LG G FG V+ G T+VA+K + + I+ +++H +V + + E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 254 KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDV 313
+ +V EF+ G+L ++ + + LK + +AA+ A + Y+ + + IH D+
Sbjct: 74 PI-YIVTEFMGKGSLLDFLKEGDGKYLK-LPQLVDMAAQIADGMAYIERM---NYIHRDL 128
Query: 314 KSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYA 361
++ANIL+ DN K++DF L + D+E + + + PE A
Sbjct: 129 RAANILVGDNLVCKIADF-GLARLIEDNEYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 17/181 (9%)
Query: 190 FHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADEIRITEWEFL----GIISQV- 238
F LG G FG V + +VAVK M +E E L I+S +
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK--MLKPTAHSSEREALMSELKIMSHLG 96
Query: 239 KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIH 298
H+N+V +LG C L++ E+ G L +++ K L L + + A +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMA 155
Query: 299 YLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDP 358
+ LAS + IH D+ + N+LL K+ DF I +D + R V ++ P
Sbjct: 156 F---LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 359 E 359
E
Sbjct: 213 E 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 20/154 (12%)
Query: 194 LGMGGFGSVYKGVLPD------NTQVAVKKYMCADEIRITEWEFLGIISQVKH---KNVV 244
LG G FG VY+G D T+VAVK + +R EFL S +K +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVV 72
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYI-------HDKSSQVLKNWKTCLRIAAETASAI 297
++LG+ + + TL+V E +++G L Y+ + + + +++AAE A +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
YL++ +H D+ + N ++ ++T K+ DF
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDF 163
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 26/157 (16%)
Query: 194 LGMGGFGSVYKG----VLPDN--TQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVV 244
LG G FG VY+G V+ T+VA+K +R EFL ++ + +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-ERIEFLNEASVMKEFNCHHVV 72
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC----------LRIAAETA 294
++LG+ + TL+V E ++ G L Y+ + + +++AAE A
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPE---AENNPGLGPPTLQKFIQMAAEIA 129
Query: 295 SAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ YL + +H D+ + N ++ ++ T K+ DF
Sbjct: 130 DGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDF 163
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 27/163 (16%)
Query: 192 HCLGMGGFGSVYKGVL-----PDNTQ-VAVKKYMCADEIRITEWEFLGIISQV------- 238
LG G FG V K P+ T VAVK M D+ TE + ++S++
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVK--MLKDDA--TEKDLSDLVSEMEMMKMIG 73
Query: 239 KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIH 298
KHKN++ +LG+C + +V E+ ++G L ++ + R ET +
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 299 Y----------LHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ LAS IH D+ + N+L+ +++ K++DF
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADF 176
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 194 LGMGGFGSVYKGVL--PDNTQVAVK-KYMCADEIRITEWEFLG---IISQVKHKNVVKIL 247
+G G FG V G L P ++ V K + A +FL I+ Q H N++ +
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 248 GLCLETKVTLLVYEFVSNGALSHYI--HDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
G+ ++K ++V E++ NG+L ++ HD V++ + + AS + YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ----LVGMLRGIASGMKYLSDM-- 125
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347
+H D+ + NIL++ N KVSDF + D E A +T
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 22/167 (13%)
Query: 194 LGMGGFGSVY----KGVLP--DNTQVAVKKYMCADE-IRITEWEFLGIISQVKHKNVVKI 246
LG G FG V+ +LP D VAVK A E R +++ ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYI--HDKSSQVLKNWKTC----------LRIAAETA 294
G+C E + L+V+E++ +G L+ ++ H +++L + L IA++ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 295 SAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341
S + YL SL +H D+ + N L+ K+ DF I S D
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 39/290 (13%)
Query: 190 FHHCLGMGGFGSVYK------GVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNV 243
F +G G FG V K G+ D +K+Y D+ R E + H N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAI------ 297
+ +LG C L E+ +G L ++ + S+VL+ IA TAS +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLET-DPAFAIANSTASTLSSQQLL 127
Query: 298 HY-------LHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIR 350
H+ + L+ IH D+ + NIL+ +NY AK++DF +S E ++
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG----LSRGQE----VYVK 179
Query: 351 GTVGYLDPEYAHTELL------TGMNPNSY-VALASNEKISMVPYFLDSIENNSFRQILN 403
T+G L + E L T + SY V L + PY + +
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239
Query: 404 FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENY 453
+++ E + + V +L +C R + ERP+ ++ L+R+ ++ Y
Sbjct: 240 YRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 28/158 (17%)
Query: 194 LGMGGFGSVYKGVL----PDNT--QVAVK--KYMCADEIRITEWEFLG---IISQVKHKN 242
LG G FG VY+G+ D QVAVK C+++ E +FL I+S+ H+N
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ---DESDFLMEALIMSKFNHQN 70
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIH------DKSSQVLKNWKTCLRIAAETASA 296
+V+++G+ E ++ E ++ G L ++ ++ S + K L A + A
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSL--TMKDLLFCARDVAKG 128
Query: 297 IHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDF 331
YL IH D+ + N LL AK++DF
Sbjct: 129 CKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF 163
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 27/159 (16%)
Query: 194 LGMGGFGSVYKGVLPD-------NTQVAVK--KYMCADEIRITEWEFLG---IISQVKHK 241
LG G FG VY+G D +VAVK + D+ + EFL ++S H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK---EFLKEAHLMSNFNHP 59
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV----LKNWKTCLRIAAETASAI 297
N+VK+LG+CL + ++ E + G L Y+ D + L K L I + A
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 298 HYLHSLASPSIIHSDVKSANILL-----DDNYTAKVSDF 331
YL + IH D+ + N L+ D + K+ DF
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 17/148 (11%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
+G G FG+VY + VA+KK + + +W+ + + Q++H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR---IAAETASAIHYLHSLAS 305
L LV E+ A S +L+ K L+ IAA A+ L L S
Sbjct: 83 CYLREHTAWLVMEYCLGSA---------SDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFES 333
IH D+K+ NILL + T K++DF S
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGS 161
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 42/144 (29%), Positives = 66/144 (45%), Gaps = 12/144 (8%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD-EIRITEWEFL----GIISQVKHKNVVKIL 247
+G+G VY + LP+N +VA+K D E T + L +SQ H NVVK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIK---RIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
+ LV ++S G+L + + + + E + YLHS
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 308 IIHSDVKSANILLDDNYTAKVSDF 331
IH D+K+ NILL ++ + K++DF
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADF 146
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 11/175 (6%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILG 248
+G G F VY+ L D VA+KK D + R + + ++ Q+ H NV+K
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 249 LCLETKVTLLVYEFVSNGALSHYI-HDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
+E +V E G LS I H K + L KT + + SA+ ++HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RR 126
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAH 362
++H D+K AN+ + K+ D L S TA +++ GT Y+ PE H
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDL-GLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 193 CLGMGGFGSVYKGVLPDN-TQVAVKKY-MCAD------EIRITEWEFLGIISQVKHKNVV 244
LG G FG VY D ++AVK+ D E+ E E + ++ ++H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECE-IQLLKNLQHERIV 67
Query: 245 KILGLCLETKVTLLVY-EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+ G CL TL ++ E++ G++ + K+ L T + + + YLHS
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVT-RKYTRQILEGVEYLHS- 122
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFES---LVPISSDDETAMSTMIRGTVGYLDPE 359
I+H D+K ANIL D K+ DF + L I S T M ++ GT ++ PE
Sbjct: 123 --NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS-SGTGMKSVT-GTPYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 20/184 (10%)
Query: 194 LGMGGFGSVYKGVLPDNTQVA---VKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLC 250
+G G +G VYK + ++A V K ++ + + E + ++ KH N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEII-MMKDCKHSNIVAYFGSY 75
Query: 251 LETKVTLLVYEFVSNGALSHYIHD----KSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
L + EF G+L H SQ+ ++ ET ++YLHS
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIA-------YVSRETLQGLYYLHSKGK- 127
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELL 366
+H D+K ANILL DN K++DF I++ A GT ++ PE A E
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 367 TGMN 370
G N
Sbjct: 184 GGYN 187
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 37/183 (20%)
Query: 194 LGMGGFGSVYK-GVLPDNTQVAVKK-----------YMCADEIRITEWEFLGIISQVKHK 241
+G G G V+K VA+KK EI+ + +H
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA--------LQACQHP 59
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKS-----SQVLKNWKTCLRIAAETASA 296
VVK+L + +LV E++ + LS + D+ +QV K+ +R+ +
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQV----KSYMRMLLK---G 111
Query: 297 IHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYL 356
+ Y+H+ I+H D+K AN+L+ + K++DF S ++ S + T Y
Sbjct: 112 VAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYR 167
Query: 357 DPE 359
PE
Sbjct: 168 APE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 23/150 (15%)
Query: 194 LGMGGFGSVYKGVLP----DNTQVAVK--KYMCADEIRITEWEFLG---IISQVKHKNVV 244
+G G FG V +G L VA+K K ++ R +FL I+ Q H N++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNII 68
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE---TASAIHYLH 301
+ G+ +++ +++ EF+ NGAL ++ Q T +++ A+ + YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQF-----TVIQLVGMLRGIAAGMKYLS 123
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ + +H D+ + NIL++ N KVSDF
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDF 150
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 38/152 (25%), Positives = 77/152 (50%), Gaps = 12/152 (7%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKILGLC 250
LG G FG V+ G +T+VA+K + ++ FL ++ Q++H +V++ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
+ + ++ E++ NG+L ++ L K + +AA+ A + ++ IH
Sbjct: 71 TQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKL-IDMAAQIAEGMAFIERKNY---IH 125
Query: 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDE 342
D+++ANIL+ + K++DF L + D+E
Sbjct: 126 RDLRAANILVSETLCCKIADF-GLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 3e-09
Identities = 37/150 (24%), Positives = 68/150 (45%), Gaps = 23/150 (15%)
Query: 193 CLGMGGFGSVYKGVLPDNTQ-VAVK----KYMCADE-IRITEWEFLGIISQVKHKNVVKI 246
LG G FGSVY + + VA+K K+ +E + + E + L ++ +H N+VK+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN--EHPNIVKL 63
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDK-----SSQVLKNWKTCLRIAAETASAIHYLH 301
+ E V+E++ G L + D+ S V+++ I + + ++H
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRS------IIYQILQGLAHIH 116
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
H D+K N+L+ K++DF
Sbjct: 117 KHG---FFHRDLKPENLLVSGPEVVKIADF 143
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 30/106 (28%), Positives = 62/106 (58%), Gaps = 11/106 (10%)
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIH--------DKSSQVLKNWKT 285
I+S++K N++++L +C+ + ++ E++ NG L+ ++ +K+ V ++ T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 286 CLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ +A + AS + YL SL + +H D+ + N L+ NYT K++DF
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADF 174
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKY-----MCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G FG V+ + ++ + K M DE R+ ++ + H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHPNIIEYYE 66
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
LE K ++V E+ G L+ YI + + +L T L + A+H++H + I
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE-DTILHFFVQILLALHHVH---TKLI 122
Query: 309 IHSDVKSANILLDDNYT-AKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+H D+K+ NILLD + K+ DF +SS ++ T++ GT Y+ PE
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSS--KSKAYTVV-GTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 194 LGMGGFGS--VYKGVLPDNTQVAVKK---YMCADEIRITEWEFLGIISQVKHKNVVKILG 248
LG G FG +Y+ D++ V K+ +++ R + I+S ++H N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
++ L+ E+ + G L I + Q+ + + L + SA+ Y+H I
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE-EMVLWYLFQIVSAVSYIHKA---GI 122
Query: 309 IHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+H D+K+ NI L K+ DF + I E +M+ + GT Y+ PE
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDF-GISKILG-SEYSMAETVVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGL 249
LG G FG VYK + VA+KK + +E IT + I+ ++KH NVV ++ +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 250 CLE----TKVTLLVYEFVS-------NGALSH-YIHDKSSQVLKNWKTCLRIAAETASAI 297
+E +K V+ +G L + + SQ+ K + I
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI-KC------YMLQLLEGI 128
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+YLH I+H D+K+ANIL+D+ K++DF
Sbjct: 129 NYLH---ENHILHRDIKAANILIDNQGILKIADF 159
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 19/141 (13%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRI--------------TEWEFLGIISQVK 239
LG G +Y G+L Y EI++ +E ++ QV
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 240 HKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
HK++V + G+C+ ++V EFV G L ++H KS + WK ++A + ASA+ Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASALSY 120
Query: 300 LHSLASPSIIHSDVKSANILL 320
L ++H +V + NILL
Sbjct: 121 LE---DKDLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKI 246
H +G G FG+VY N VAVKK + + +W+ + + Q+KH N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 247 LGLCLETKVTLLVYEFVSNGALSHY-IHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
G L+ LV E+ A +H K Q ++ IAA T A+ L L S
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVE-------IAAITHGALQGLAYLHS 139
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFES 333
++IH D+K+ NILL + K++DF S
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGS 167
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 55/183 (30%), Positives = 80/183 (43%), Gaps = 18/183 (9%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK--KYMCADEIRITEWEFLGIISQVKHKNVVKILGLC 250
+G G +G VYK L AVK K D+ + + E ++ + KH N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF-MVKECKHCNIVAYFGSY 75
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIA---AETASAIHYLHSLASPS 307
L + + E+ G+L H + + L+IA ET + YLHS
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYH------VTGPLSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLT 367
+H D+K ANILL DN K++DF I++ A GT ++ PE A E
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 368 GMN 370
G N
Sbjct: 185 GYN 187
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 52/181 (28%), Positives = 74/181 (40%), Gaps = 32/181 (17%)
Query: 194 LGMGGFGSVYK-GVLPDNTQVAVK-----------KYMCADEIRITEWEFLGIISQVKHK 241
LG G +GSVYK L DN A+K + +EIRI ++ V H
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRI--------LASVNHP 59
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNW---KTCLRIAAETASAIH 298
N++ L+ +V E+ G LS I + + + RI + +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 299 YLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDP 358
LH I+H D+KSANILL N K+ D IS + M+ GT Y+ P
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLG----ISKVLKKNMAKTQIGTPHYMAP 170
Query: 359 E 359
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 61/202 (30%)
Query: 194 LGMGGFGSVYK------------GVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHK 241
+G G G+VYK V+ N + V++ +C EI I + V H
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR-EIEI--------LRDVNHP 132
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGAL-------SHYIHDKSSQVLKNWKTCLRIAAETA 294
NVVK + ++ EF+ G+L ++ D + Q+L
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL-------------- 178
Query: 295 SAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF-------ESLVPISSDDETAMST 347
S I YLH I+H D+K +N+L++ K++DF +++ P +S
Sbjct: 179 SGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS------- 228
Query: 348 MIRGTVGYLDPEYAHTELLTGM 369
GT+ Y+ PE +T+L G
Sbjct: 229 --VGTIAYMSPERINTDLNHGA 248
|
Length = 353 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 39/138 (28%), Positives = 72/138 (52%), Gaps = 23/138 (16%)
Query: 213 VAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL- 268
VAVK + D + +FL I+S++K N++++LG+C++ ++ E++ NG L
Sbjct: 49 VAVK-ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 269 ----SHYIHDKSSQ-----------VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDV 313
SH++ DK ++ + L +A + AS + YL SL + +H D+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164
Query: 314 KSANILLDDNYTAKVSDF 331
+ N L+ +N T K++DF
Sbjct: 165 ATRNCLVGENLTIKIADF 182
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 23/153 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKY-MCADE-------IRITEWEFLGIISQVKHKNVV 244
+G G +G+VYK L VA+KK + E +R E L + +H N+V
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR--EIALLKQLESFEHPNIV 64
Query: 245 KILGLCL------ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIH 298
++L +C E K+TL V+E V L+ Y+ L + + +
Sbjct: 65 RLLDVCHGPRTDRELKLTL-VFEHVDQD-LATYLSKCPKPGLPPETI-KDLMRQLLRGVD 121
Query: 299 YLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+LHS I+H D+K NIL+ + K++DF
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADF 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 41/143 (28%), Positives = 61/143 (42%), Gaps = 12/143 (8%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKKY---MCADEIRITEWEFLGIISQVKHKNVVKILG 248
C+G G FG VYK + N VA+K DEI + E + +SQ + + K G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQE-IQFLSQCRSPYITKYYG 66
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
L+ ++ E+ G+ + L I E + YLH
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAF-ILREVLLGLEYLHE---EGK 119
Query: 309 IHSDVKSANILLDDNYTAKVSDF 331
IH D+K+ANILL + K++DF
Sbjct: 120 IHRDIKAANILLSEEGDVKLADF 142
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 64/294 (21%), Positives = 118/294 (40%), Gaps = 47/294 (15%)
Query: 190 FHHCLGMGGFGSVYKGVLP-DNTQVA-----VKKYMCADEIRITEWEFLGIISQVKHKNV 243
F +G G FG V + ++ D ++ +K++ ++ R E + H N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLK---------------NWKTCLR 288
+ +LG C + E+ G L ++ + S+VL+ + L+
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 289 IAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM-ST 347
A++ A+ + YL + IH D+ + N+L+ +N +K++DF +S +E + T
Sbjct: 124 FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFG----LSRGEEVYVKKT 176
Query: 348 MIRGTVGYLDPEYAHTELLT--------GMNPNSYVALASNEKISMVPYFLDSIENNSFR 399
M R V ++ E + + T G+ V+L M L +R
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236
Query: 400 QILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENY 453
DE V EL +C R R ERP ++S +L R+ ++ Y
Sbjct: 237 MEKPRNCDDE--------VYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 12/146 (8%)
Query: 194 LGMGGFGSVYKG---VLPDNTQVAVKKYMCADEIRITEWEFLGIIS---QVKHKNVVKIL 247
+G G FG V G +V VK+ + + FL + ++ H NV++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD-EQLLFLQEVQPYRELNHPNVLQCL 61
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQV--LKNWKTCLRIAAETASAIHYLHSLAS 305
G C+E+ LLV EF G L +Y+ V + R+A E AS + +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
IHSD+ N L + + K+ D+
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDY 144
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 28/177 (15%)
Query: 195 GMGGFGSVYKGVLPDNTQVAVKKYM----C--ADEIR--ITEWEFLGIISQVKHKNVVKI 246
G G FG V D ++ KYM C +R + E L ++ H +V +
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRIL---QELNHPFLVNL 65
Query: 247 -LGLCLETKVTLLVYEFVSNGALSHYIHDK---SSQVLKNWKTCLRIAAETASAIHYLHS 302
E + L+V + + G L +++ K S + +K W E A+ YLHS
Sbjct: 66 WYSFQDEENMYLVV-DLLLGGDLRYHLSQKVKFSEEQVKFW------ICEIVLALEYLHS 118
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
IIH D+K NILLD+ ++DF ++ + D ++T GT GY+ PE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDF-NIATKVTPDT--LTTSTSGTPGYMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 194 LGMGGFGSVY------KGVLPDNT--QVAVK--KYMCADEIRITEWEFLGIISQVKHKNV 243
LG G FG V +G DNT QVAVK K + + I+ + H+N+
Sbjct: 12 LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 244 VKILGLCLET--KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
VK G+C E L+ EF+ +G+L Y+ +++ N K L+ A + + YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI--NLKQQLKYAVQICKGMDYL- 125
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342
S +H D+ + N+L++ + K+ DF I +D E
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 61/258 (23%), Positives = 105/258 (40%), Gaps = 54/258 (20%)
Query: 226 ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLK---- 281
I+E E + +I KHKN++ +LG C + ++ E+ S G L Y+ + ++
Sbjct: 71 ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128
Query: 282 ---------NWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332
++K + A + A + Y LAS IH D+ + N+L+ ++ K++DF
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEY---LASKKCIHRDLAARNVLVTEDNVMKIADFG 185
Query: 333 SLVPISSDDETAMSTMIRGTVGYLDPE------YAHT-----------ELLT-GMNPNSY 374
I D +T R V ++ PE Y H E+ T G +P
Sbjct: 186 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245
Query: 375 VALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERP 434
V + K+ + +D N +E M + C ++RP
Sbjct: 246 VPVEELFKLLKEGHRMDKPSN----------CTNELYM--------MMRDCWHAVPSQRP 287
Query: 435 TMKEVSEELDRLRRLQEN 452
T K++ E+LDR+ L N
Sbjct: 288 TFKQLVEDLDRILALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 44/150 (29%), Positives = 79/150 (52%), Gaps = 23/150 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQ----VAVKKYMCADEIRITEWEFLG---IISQVKHKNVVK 245
LG G FG+VYKG+ +P+ + VA+K+ A + + E L +++ V + +V +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVDNPHVCR 73
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKS----SQVLKNWKTCLRIAAETASAIHYLH 301
+LG+CL + V L+ + + G L Y+ + SQ L NW C++I A ++YL
Sbjct: 74 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKGMNYLE 126
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
++H D+ + N+L+ K++DF
Sbjct: 127 ---ERRLVHRDLAARNVLVKTPQHVKITDF 153
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 19/151 (12%)
Query: 194 LGMGGFGSVYKGVLP------DNTQVAVKKYMCADEIRITEWEF---LGIISQVKHKNVV 244
LG G FG V+ T V VK + + EF L + ++ HKNVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVV 71
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNW------KTCLRIAAETASAIH 298
++LGLC E + ++ E+ G L ++ S+ K K + + + A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 299 YLHSLASPSIIHSDVKSANILLDDNYTAKVS 329
+ L++ +H D+ + N L+ KVS
Sbjct: 132 H---LSNARFVHRDLAARNCLVSSQREVKVS 159
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 12/146 (8%)
Query: 194 LGMGGFGSVYKGVLPDN---TQVAVKKYMCADEIRITEWEFLGIIS---QVKHKNVVKIL 247
+G G FG V G + QV VK+ + ++ + +FL ++H N+++ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ-EQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHD--KSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
G C E LLV EF G L Y+ K+ + + T R+A E A + +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
+ IHSD+ N LL + T K+ D+
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDY 144
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 44/191 (23%), Positives = 86/191 (45%), Gaps = 36/191 (18%)
Query: 194 LGMGGFGSVYKGVLPDNTQV-AVKKYMCADEIRITEWE-----FLGIISQVK-------- 239
+G G +G VY + ++ AVK+ E+ T ++ ++
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQV----ELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 240 --HKNVVKILGLCLETKVTLLVY-EFVSNGALSHYI--HDK-SSQVLKNWKTCLRIAAET 293
H N+V+ LG T+ L ++ E+V G++ + + + Q+++ + +
Sbjct: 65 LDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE------QV 117
Query: 294 ASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM-IRGT 352
+ YLHS I+H D+K+ N+L+D + K+SDF + S D M ++G+
Sbjct: 118 LEGLAYLHS---KGILHRDLKADNLLVDADGICKISDF-GISKKSDDIYDNDQNMSMQGS 173
Query: 353 VGYLDPEYAHT 363
V ++ PE H+
Sbjct: 174 VFWMAPEVIHS 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 75/304 (24%), Positives = 126/304 (41%), Gaps = 64/304 (21%)
Query: 175 MKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWE 230
M+I ++EL K LG G FG+VYKG+ +PD V + K + + E
Sbjct: 1 MRILKETELKKV-----KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE 55
Query: 231 FLG---IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDK----SSQVLKNW 283
L +++ V V ++LG+CL + V LV + + G L Y+ + SQ L NW
Sbjct: 56 ILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW 114
Query: 284 KTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343
C++I A + YL + ++H D+ + N+L+ K++DF L + DET
Sbjct: 115 --CVQI----AKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDF-GLARLLDIDET 164
Query: 344 --------------AMSTMIRGTVGYLDPEYAHT----ELLT-GMNPNSYVALASNEKIS 384
A+ +++ + +++ EL+T G P Y + + E
Sbjct: 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP--YDGIPARE--- 219
Query: 385 MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444
+P L+ E I V + KC I RP +E+ +E
Sbjct: 220 -IPDLLEKGERLPQPPICTID------------VYMIMVKCWMIDSECRPRFRELVDEFS 266
Query: 445 RLRR 448
R+ R
Sbjct: 267 RMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 48/172 (27%), Positives = 70/172 (40%), Gaps = 13/172 (7%)
Query: 194 LGMGGFGSVYKGVLPDNTQV-AVKKYMCADEIRITEWEF--LGIISQVKHKNVVKILGLC 250
LG G GSV K L + + A+K + + L I K +VK G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 251 LETKVTLL--VYEFVSNGAL-SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
L+ + + E+ G+L S Y K K +IA + YLHS
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RK 125
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
IIH D+K +NILL K+ DF +S + +++ GT Y+ PE
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 35/194 (18%)
Query: 194 LGMGGFGSVYK----GVLPDN----TQVAVKKYMCADEIR-------ITEWEFLGIISQV 238
LG G FG V + G+ VAVK M D I+E E + +I
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK--MLKDNATDKDLADLISEMELMKLIG-- 75
Query: 239 KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIH-------------DKSSQVLKNWKT 285
KHKN++ +LG+C + ++ E+ + G L ++ K + ++K
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 286 CLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345
+ A + A + Y L S IH D+ + N+L+ ++ K++DF + D
Sbjct: 136 LVSCAYQVARGMEY---LESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 346 STMIRGTVGYLDPE 359
++ R V ++ PE
Sbjct: 193 TSNGRLPVKWMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADE------IRITEWEFLGIISQVKHKNVVKI 246
+G G +G V K + Q VA+KK++ +++ I + E L Q++H+N+V +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRML---KQLRHENLVNL 65
Query: 247 LGLCLETKVTLLVYEFVSNGALS---HYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+ + K LV+EFV + L Y + ++ + + I + HS
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR------KYLFQILRGIEFCHS- 118
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
+IIH D+K NIL+ + K+ DF
Sbjct: 119 --HNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 55/239 (23%), Positives = 101/239 (42%), Gaps = 16/239 (6%)
Query: 226 ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKT 285
++E E + +I KHKN++ +LG C + ++ E+ S G L Y+ + ++
Sbjct: 68 VSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 286 CLRIAAE----------TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335
R+ E T + LAS IH D+ + N+L+ +N K++DF
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM--VPYFLDSI 393
+++ D +T R V ++ PE + T + + E ++ PY +
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245
Query: 394 ENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452
E F+ + D+ E+ + C + RPT K++ E+LDR+ L N
Sbjct: 246 E-ELFKLLKEGHRMDKPANCTNELYM-MMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 51/177 (28%), Positives = 89/177 (50%), Gaps = 29/177 (16%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILG 248
+G G G+VY + + +VA+K+ E+ I E + ++ + KH N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINE---ILVMRENKHPNIVNYLD 83
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL---RIAA---ETASAIHYLHS 302
L +V E+++ G+L+ + + TC+ +IAA E A+ +LHS
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTE----------TCMDEGQIAAVCRECLQALEFLHS 133
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+IH D+KS NILL + + K++DF I+ +++ STM+ GT ++ PE
Sbjct: 134 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMV-GTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 25/181 (13%)
Query: 194 LGMGGFGSVYK------GVLPDNTQVAVKKYMCADEIRITE--WEFLGIISQVKHKNVVK 245
LG G F S Y+ G L QV + +++ + E + + +++++ H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHD----KSSQVLKNWKTCLRIAAETASAIHYLH 301
+LG E L E+++ G++SH + K + ++ + LR + YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR-------GLSYLH 120
Query: 302 SLASPSIIHSDVKSANILLDDN-YTAKVSDFESLVPISSDDETA--MSTMIRGTVGYLDP 358
IIH DVK AN+L+D +++DF + +++ A + GT+ ++ P
Sbjct: 121 E---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 359 E 359
E
Sbjct: 178 E 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 45/183 (24%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 194 LGMGGFGSVY----KGVLP--DNTQVAVKKYM-CADEIRITEWEFLGIISQVKHKNVVKI 246
LG G FG V+ + P D VAVK +D R +++ ++H+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYI--HDKSSQVLK--------NWKTCLRIAAETASA 296
G+C+E ++V+E++ +G L+ ++ H + ++ L IA + A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 297 IHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYL 356
+ Y LAS +H D+ + N L+ +N K+ DF + S D + + ++
Sbjct: 133 MVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 357 DPE 359
PE
Sbjct: 190 PPE 192
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 38/167 (22%), Positives = 82/167 (49%), Gaps = 7/167 (4%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLET 253
LG G FG V+ G ++T+VAVK E ++ ++H +V++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 254 KVTLLVYEFVSNGALSHYIH-DKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSD 312
+ ++ E+++ G+L ++ D+ +VL + +A+ A + Y+ + IH D
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAYIER---KNYIHRD 128
Query: 313 VKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+++AN+L+ ++ K++DF L + D+E + + + PE
Sbjct: 129 LRAANVLVSESLMCKIADF-GLARVIEDNEYTAREGAKFPIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 24/270 (8%)
Query: 194 LGMGGFGSVYKGVLPDNT---QVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKIL 247
LG G FGSV +G L + +VAVK A R +FL + + H NV++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 248 GLCLETK------VTLLVYEFVSNGALSHYIH----DKSSQVLKNWKTCLRIAAETASAI 297
G+CL+T +++ F+ +G L ++ Q L + ++ + AS +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT-QMLVKFMTDIASGM 125
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLD 357
YL +S S IH D+ + N +L++N V+DF I + D + + V ++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 358 PEYAHTELLTGMNP--NSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI 415
E + T + + V + PY +EN+ L + + +
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPY--PGVENSEIYDYLRQGNRLKQPPDCL 240
Query: 416 EVVAELASKCLRIRGTERPTMKEVSEELDR 445
+ + L S C + +RP+ + + EL++
Sbjct: 241 DGLYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 69/295 (23%), Positives = 118/295 (40%), Gaps = 35/295 (11%)
Query: 180 KSELLKATKNFHHCLGMGGFGSVYK----GVLPDNTQ----VAVKKYMCADEIR------ 225
K EL + LG G FG V G+ D VAVK M D+
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK--MLKDDATDKDLSD 63
Query: 226 -ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIH-------DKSS 277
++E E + +I KHKN++ +LG C + ++ E+ S G L Y+ D S
Sbjct: 64 LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 278 QVLK------NWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
K +K + A + A + YL AS IH D+ + N+L+ ++ K++DF
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 332 ESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLD 391
+ + D +T R V ++ PE + T + + E ++
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238
Query: 392 SIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446
I ++L + + + +C ++RPT K++ E+LDR+
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 13/145 (8%)
Query: 194 LGMGGFGSVYKG----VLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKI 246
LG G FG V +G VAVK + +D++ +FL I+ + H+N++++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
G+ L T ++V E G+L + + T A + A+ + YL S
Sbjct: 62 YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLES---K 116
Query: 307 SIIHSDVKSANILLDDNYTAKVSDF 331
IH D+ + NILL + K+ DF
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDF 141
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 15/147 (10%)
Query: 194 LGMGGFGSVYK---GVLPDNTQ--VAVKK--YMCADEIRITEWEFLGIISQVKHKNVVKI 246
LG G FGSV L DNT VAVKK + A+ +R E E + I+ ++H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFERE-IEILKSLQHDNIVKY 70
Query: 247 LGLCLET-KVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
G+C + L LV E++ G+L Y+ ++ + + L A++ + YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL--DHRKLLLYASQICKGMEYL---G 125
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
S +H D+ + NIL++ K+ DF
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDF 152
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 47/150 (31%), Positives = 66/150 (44%), Gaps = 22/150 (14%)
Query: 194 LGMGGFGSV----YKGVLPDN----TQVAVK--KYMCADEIRITEWEFLGIISQVKHKNV 243
LG G FG V Y P N VAVK K C + + + I+ + H+N+
Sbjct: 12 LGEGHFGKVSLYCYD---PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 244 VKILGLCLET--KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
VK G C E K L+ E+V G+L Y+ N L A + + YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL----NLAQLLLFAQQICEGMAYLH 124
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
S IH D+ + N+LLD++ K+ DF
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDF 151
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 172 FSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGVLPDNTQ-VAVKKYMCADE---IRIT 227
F SK E L K +G G FG V+K Q VA+KK + +E IT
Sbjct: 5 FPFCDEVSKYEKL--AK-----IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT 57
Query: 228 EWEFLGIISQVKHKNVVKILGLCLETKVT---------LLVYEFVSN--GALSHYIHDKS 276
+ I+ +KH+NVV ++ +C TK T LV+EF + L + K
Sbjct: 58 ALREIKILQLLKHENVVNLIEIC-RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF 116
Query: 277 SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ L K ++ + ++Y+H I+H D+K+ANIL+ + K++DF
Sbjct: 117 T--LSEIKKVMK---MLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 41/154 (26%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 194 LGMGGFGSVYKGVL---PDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKIL 247
LG G FG V KGV VA+K +E + + E + I+ Q+ + +V+++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRMI 61
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
G+C E + +LV E S G L+ ++ K ++ + + + + + + YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYLEG---KN 115
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341
+H D+ + N+LL + + AK+SDF + +DD
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 71/230 (30%), Positives = 102/230 (44%), Gaps = 45/230 (19%)
Query: 194 LGMGGFGSVY---KGVLPDNTQVAVKKYM------CADEIRITEWEFLGIISQVKHKNVV 244
LG G FG V+ K PD Q+ K + D +R T+ E I+++V H +V
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKME-RDILAEVNHPFIV 61
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
K L +T+ L L+ +F+ G L + S +V+ + AE A A+ +LHSL
Sbjct: 62 K-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEY--- 360
II+ D+K NILLD+ K++DF L S D E + GTV Y+ PE
Sbjct: 118 G---IIYRDLKPENILLDEEGHIKLTDF-GLSKESIDHEKKAYSFC-GTVEYMAPEVVNR 172
Query: 361 -AHT-------------ELLTGMNP------NSYVALASNEKISMVPYFL 390
HT E+LTG P + + K+ M P FL
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM-PQFL 221
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 23/168 (13%)
Query: 194 LGMGGFGSVY----KGVLPDNTQVAVKKYMCADEIRITEWEF---LGIISQVKHKNVVKI 246
LG G FG V+ + P ++ V D +F +++ ++H+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYI--HDKSSQVLKNWK-----------TCLRIAAET 293
G+C + ++V+E++ +G L+ ++ H + +L + + L IA++
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 294 ASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341
AS + Y LAS +H D+ + N L+ N K+ DF + S D
Sbjct: 133 ASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 22/176 (12%)
Query: 194 LGMGGFGSVYKGVLPDNT--QVAVKKY-------MCADEIRITEWEFLGIISQVKHKNVV 244
LG GGFG V V NT A KK +++ + E E L ++ +
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP----FI 55
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
L E+K L LV ++ G L ++I++ + L+ + + +A+ I +LHS+
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLE-MERVIHYSAQITCGILHLHSM 114
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I++ D+K N+LLDD ++SD V + T GT GY+ PE
Sbjct: 115 ---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVK------HKNVVKI 246
+G G FG+VY + ++ VA+KK + + +W+ II +V+ H N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ--DIIKEVRFLQKLRHPNTIQY 80
Query: 247 LGLCLETKVTLLVYEFVSNGALSHY-IHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
G L LV E+ A +H K Q ++ IAA T A+ L L S
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-------IAAVTHGALQGLAYLHS 133
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFES 333
++IH DVK+ NILL + K+ DF S
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGS 161
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 11/143 (7%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
+G G FG V+ A+K + IR+ + + + ++ +V H ++++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+ + ++ E+V G L Y+ ++S N T L A+E A+ YLHS I
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSN-STGLFYASEIVCALEYLHSK---EI 122
Query: 309 IHSDVKSANILLDDNYTAKVSDF 331
++ D+K NILLD K++DF
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 212 QVAVKKYMCADEIRITEWEF--LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALS 269
QVAVKK + R E F + I+ +H N+V++ L +V EF+ GAL+
Sbjct: 46 QVAVKKMDLRKQQR-RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104
Query: 270 HYI-HDKSS--QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTA 326
+ H + + Q+ L+ A+ +LH+ +IH D+KS +ILL +
Sbjct: 105 DIVTHTRMNEEQIATVCLAVLK-------ALSFLHA---QGVIHRDIKSDSILLTSDGRV 154
Query: 327 KVSDFESLVPISSD 340
K+SDF +S +
Sbjct: 155 KLSDFGFCAQVSKE 168
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 42/154 (27%), Positives = 58/154 (37%), Gaps = 26/154 (16%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRIT----EWEFLGIISQVKHKNVVKILGL 249
+G G +G VYK Q+ K M E E+ L S H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN--HPNIATFYGA 71
Query: 250 CLETKVTL------LVYEFVSNGA---LSHYIHDKSSQVLKNWKTCLRIA---AETASAI 297
++ LV E G+ L + K ++ + W IA ET +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGL 126
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
YLH +IH D+K NILL N K+ DF
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDF 157
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 57/209 (27%), Positives = 81/209 (38%), Gaps = 49/209 (23%)
Query: 194 LGMGGFGSVYK-GVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKH----KNVVKILG 248
LG+GGFG V V N A+K C + I E Q +H K +++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALK---CVKKRHIVET------GQQEHIFSEKEILEECN 51
Query: 249 ----LCL-----ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+ L + K ++ E+ G L + D+ L + T A A Y
Sbjct: 52 HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEY 108
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
LH+ II+ D+K N+LLD N K+ DF + S +T T GT Y+ PE
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT--WTFC-GTPEYVAPE 162
Query: 360 ------YAHT-----------ELLTGMNP 371
Y + ELLTG P
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 43/175 (24%), Positives = 82/175 (46%), Gaps = 21/175 (12%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKY-MCADEIRITE-WEFLGIISQVKH---KNVVKIL 247
+G G +G+VY+G +P VA+K + + +++ + ++SQ++ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
G L+ ++ E+ G++ + + + + I E A+ Y+H +
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISV-IIREVLVALKYIHKV---G 121
Query: 308 IIHSDVKSANILLDDNYTAKVSDF---ESLVPISSDDETAMSTMIRGTVGYLDPE 359
+IH D+K+ANIL+ + K+ DF L SS ST + GT ++ PE
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS----KRSTFV-GTPYWMAPE 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG-----IISQVKHKNVVKILG 248
LG GGFG V + ++ K + ++ + E + I+ +V + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 249 LCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
ETK L LV ++ G L ++I++ + + AA+ + +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARA-IFYAAQIICGLEHLHQR---R 115
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I++ D+K N+LLDD+ ++SD V + + GT GY+ PE
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 19/146 (13%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG-------IISQVKHKNVVKI 246
LG G FG VYK + A K I+I E L I+S+ KH N+V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI-----IQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 247 LGLCL-ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
E K+ +L+ EF GAL I + + L + + + A+++LHS
Sbjct: 68 YEAYFYENKLWILI-EFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHS--- 121
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
+IH D+K+ NILL + K++DF
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADF 147
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 17/148 (11%)
Query: 194 LGMGGFGSVYKGVLPDNTQVA--VKKYMCADEIRITEWEFL--GIISQV-KHKNVVKILG 248
+G G FG V + +T VA V K + A+ + EFL G ++ +H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 249 LCLETKVTLLVYEFVSNGALSHYI-----HDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
C+E LLV+E+ G L Y+ H ++SQ+L R+A E A+ + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAAGVTHMHKH 118
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ +HSD+ N L + T KV D+
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDY 143
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 34/157 (21%), Positives = 61/157 (38%), Gaps = 36/157 (22%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLG--------IISQVKHKNVV 244
+G G +G V V +VA+KK + + ++ ++H+N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-----NVFDDLIDAKRILREIKLLRHLRHENII 62
Query: 245 KILGLCLETKVT-----LLVYEFVSNGALSHYIHD-----KSSQVLKNWKTCLRIAAETA 294
+L + +V E + D KS Q L + +
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELME--------TDLHKVIKSPQPLTD-DHIQYFLYQIL 113
Query: 295 SAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ YLHS ++IH D+K +NIL++ N K+ DF
Sbjct: 114 RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDF 147
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 14/176 (7%)
Query: 182 ELLKATKNFHHCLGMGGFGSVYKGVL--PDNTQVAVKKYM----CADEIRITEWEFLGII 235
EL + LG G FG + +G L P ++ V + C+D+ R +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 236 SQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETAS 295
Q H N+V++ G+ ++V E++SNGAL ++ Q++ + + AS
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAG--QLMGMLPGLAS 118
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRG 351
+ YL + +H + + +L++ + K+S F + D A+ T + G
Sbjct: 119 GMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSG 168
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 41/177 (23%), Positives = 73/177 (41%), Gaps = 38/177 (21%)
Query: 193 CLGMGGFGSVYKGVL---PDNTQVAVKKYMCADEIRITEWEFLGI----------ISQVK 239
C+G G +G VYK D + A+KK + + ++ GI + ++K
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKK------FKGDKEQYTGISQSACREIALLRELK 60
Query: 240 HKNVVKILGLCLE--TKVTLLVYEFVSNGALSHYIHDKSSQVLK--NWKTCLRIAAETAS 295
H+NVV ++ + LE K L++++ + L I + + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 296 AIHYLHSLASPSIIHSDVKSANILL----DDNYTAKVSDF-------ESLVPISSDD 341
+HYLHS ++H D+K ANIL+ + K+ D L P++ D
Sbjct: 120 GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 13/146 (8%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
+G G FG+VY + N VA+KK + + +W+ + + ++KH N ++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 249 LCLETKVTLLVYEFVSNGALSHY-IHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
L LV E+ A +H K Q ++ IAA T A+ L L S +
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-------IAAITHGALQGLAYLHSHN 145
Query: 308 IIHSDVKSANILLDDNYTAKVSDFES 333
+IH D+K+ NILL + K++DF S
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGS 171
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 26/182 (14%)
Query: 182 ELLKATKNFHHCLGMGGFGSVYKG--VLP--DNTQVAVKKYMCADEIRITEW-EF---LG 233
EL + F LG FG +YKG LP D+ Q+ K + D +W EF
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEAS 59
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYI--------------HDKSSQV 279
+++++ H N+V +LG+ + + +++E+++ G L ++ D + +
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 280 LKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339
+ L IA + A+ + Y L+S +H D+ + NIL+ + K+SD I S
Sbjct: 120 SLDHGDFLHIAIQIAAGMEY---LSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 340 DD 341
D
Sbjct: 177 AD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 39/156 (25%), Positives = 62/156 (39%), Gaps = 27/156 (17%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQVAVKKYM-------------CADEIRITEWEFLGII 235
F LG G FG V + + K + +E RI +
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRI--------L 55
Query: 236 SQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETAS 295
++H +V + G + LV E+V G L ++ + S AA+
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPE-PVARFYAAQVVL 112
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
A+ YLHSL I++ D+K N+LLD + K++DF
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 61/258 (23%), Positives = 115/258 (44%), Gaps = 30/258 (11%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILG 248
+G G G+VY + + +VA+K+ E+ I E + ++ + K+ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE---ILVMRENKNPNIVNYLD 83
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL---RIAAETASAIHYLHSLAS 305
L +V E+++ G+L+ + + TC+ +IAA + L L S
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTE----------TCMDEGQIAAVCRECLQALDFLHS 133
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTEL 365
+IH D+KS NILL + + K++DF I+ +++ STM+ GT ++ PE +
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 366 LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIE----VVAEL 421
+ + + E + P +L+ N R + E++ E V +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATNGTPELQNPERLSAVFRDF 248
Query: 422 ASKCLRIRGTERPTMKEV 439
++CL + R + KE+
Sbjct: 249 LNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 31/170 (18%)
Query: 194 LGMGGFGSVYKGVLP--DNT--QVAVK----KYMCADEIRITEWEFL---GIISQVKHKN 242
LG G FGSV + L D + +VAVK + +I EFL + + H N
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE----EFLREAACMKEFDHPN 62
Query: 243 VVKILGLCLETK------VTLLVYEFVSNGALSHYIHDKSSQVLKN-----WKTCLRIAA 291
V+K++G+ L ++ + +++ F+ +G L ++ S++ + +T +R
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL--LMSRIGEEPFTLPLQTLVRFMI 120
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341
+ AS + YL +S + IH D+ + N +L++N T V+DF I S D
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 61/282 (21%), Positives = 118/282 (41%), Gaps = 45/282 (15%)
Query: 194 LGMGGFGSVYKGVLPD-----NTQVA-VKKYMCADEIRITEWEFLGIISQVKHKNVVKIL 247
+G G FG V K + + + +K+Y D+ R E + H N++ +L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLK---------------NWKTCLRIAAE 292
G C L E+ +G L ++ + S+VL+ + + L AA+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A + YL + IH D+ + NIL+ +NY AK++DF +S E ++ T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG----LSRGQE----VYVKKT 169
Query: 353 VGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQI----LNFQVAD 408
+G L + E +N + Y + ++ + + S+ + + L ++
Sbjct: 170 MGRLPVRWMAIE---SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226
Query: 409 ESEMEEI----EVVAELASKCLRIRGTERPTMKEVSEELDRL 446
+E+ + V +L +C R + ERP+ ++ L+R+
Sbjct: 227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 31/75 (41%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 290 AAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMI 349
AAE ASA+ YLHSL +II+ D+K NILLD ++DF L + ST
Sbjct: 102 AAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF-GLCKEGIEHSKTTSTFC 157
Query: 350 RGTVGYLDPEYAHTE 364
GT YL PE +
Sbjct: 158 -GTPEYLAPEVLRKQ 171
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 51/183 (27%), Positives = 81/183 (44%), Gaps = 20/183 (10%)
Query: 191 HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG-----IISQVKHKNVVK 245
+ LG GGFG V + ++ K + I+ + E + I+ +V + VV
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 246 ILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
L ETK L LV ++ G L +I++ + + + L AAE + LH
Sbjct: 65 -LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-LFYAAEILCGLEDLHR-- 120
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIR---GTVGYLDPEYA 361
+ ++ D+K NILLDD ++SD V I + IR GTVGY+ PE
Sbjct: 121 -ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE------SIRGRVGTVGYMAPEVL 173
Query: 362 HTE 364
+ +
Sbjct: 174 NNQ 176
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 36/145 (24%), Positives = 70/145 (48%), Gaps = 16/145 (11%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGL 249
+G G +G V+K + Q VA+KK++ +++ I+ + ++ Q+KH N+V ++ +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 250 CLETKVTLLVYEFVSNGALSH---YIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+ LV+E+ + L+ ++K +I +T A+++ H
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK------KIIWQTLQAVNFCHKH--- 119
Query: 307 SIIHSDVKSANILLDDNYTAKVSDF 331
+ IH DVK NIL+ K+ DF
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 29/98 (29%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 223 EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKN 282
+I + +E ++SQV H ++ + G+C+ ++V EFV +G L + + +V
Sbjct: 58 DIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVA 117
Query: 283 WKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL 320
WK + +A + ASA+ YL +++H +V + NILL
Sbjct: 118 WK--ITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 14/183 (7%)
Query: 191 HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG-----IISQVKHKNVVK 245
+ LG GGFG V + ++ K + I+ + E + I+ +V + VV
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 246 ILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
L ETK L LV ++ G L +I+ + + AAE + LH
Sbjct: 65 -LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQ-- 120
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE 364
I++ D+K NILLDD+ ++SD V + + +T + GTVGY+ PE E
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV--GTVGYMAPEVVKNE 176
Query: 365 LLT 367
T
Sbjct: 177 RYT 179
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 9/80 (11%)
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIR 350
AE AIH +H + +H D+K N+L+D K++DF S +++ ++ S +
Sbjct: 109 AELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPV 164
Query: 351 GTVGYLDPEYAHTELLTGMN 370
GT P+Y E+LT MN
Sbjct: 165 GT-----PDYIAPEVLTTMN 179
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 55/204 (26%), Positives = 77/204 (37%), Gaps = 33/204 (16%)
Query: 165 RDPPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYM--CAD 222
RDP G IF EL+ G G +G VYKG Q+A K M D
Sbjct: 2 RDPAG-------IFELVELV----------GNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 44
Query: 223 EIRITEWEFLGIISQVKHKNVVKILGLCLETK------VTLLVYEFVSNGALSHYIHDKS 276
E + E + H+N+ G ++ LV EF G+++ I +
Sbjct: 45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 104
Query: 277 SQVLKN-WKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335
LK W I E + +LH +IH D+K N+LL +N K+ DF V
Sbjct: 105 GNTLKEEW--IAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG--V 157
Query: 336 PISSDDETAMSTMIRGTVGYLDPE 359
D GT ++ PE
Sbjct: 158 SAQLDRTVGRRNTFIGTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 33/70 (47%), Positives = 39/70 (55%), Gaps = 5/70 (7%)
Query: 290 AAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMI 349
AAE ASAI YLHSL +II+ D+K NILLD ++DF L + E ST
Sbjct: 102 AAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF-GLCKEGVEPEETTSTFC 157
Query: 350 RGTVGYLDPE 359
GT YL PE
Sbjct: 158 -GTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 40/126 (31%), Positives = 61/126 (48%), Gaps = 9/126 (7%)
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAET 293
I+ +H+NVV++ L + ++ EF+ GAL+ D SQ N + +
Sbjct: 71 IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESV 126
Query: 294 ASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTV 353
A+ YLHS +IH D+KS +ILL + K+SDF IS D S + GT
Sbjct: 127 LQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTP 181
Query: 354 GYLDPE 359
++ PE
Sbjct: 182 YWMAPE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 35/142 (24%), Positives = 66/142 (46%), Gaps = 8/142 (5%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGL 249
+G G +G VYKG Q VA+KK E + T + ++ +++H N+V + +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
++ L++EF+S L Y+ + + + I + HS ++
Sbjct: 68 LMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVL 123
Query: 310 HSDVKSANILLDDNYTAKVSDF 331
H D+K N+L+D+ K++DF
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADF 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 34/150 (22%), Positives = 60/150 (40%), Gaps = 26/150 (17%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKY-----------MCADEIRITEWEFLGIISQVKHK 241
+G G +G VYK + VA+KK EI++ + ++ H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKL--------LKELNHP 58
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
N++K+L + LV+EF+ L I + L + + + H
Sbjct: 59 NIIKLLDVFRHKGDLYLVFEFMDTD-LYKLI-KDRQRGLPESLIK-SYLYQLLQGLAFCH 115
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
S I+H D+K N+L++ K++DF
Sbjct: 116 S---HGILHRDLKPENLLINTEGVLKLADF 142
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 35/158 (22%)
Query: 194 LGMGGFGSVY------KGVLPDNTQVAV-----------KKYMCADEIRITEWEFLGIIS 236
+G G FGSVY G L QV + + + A I ++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIA------LLK 61
Query: 237 QVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSS---QVLKNWKTCLRIAAET 293
+++H+N+V+ LG L+ + E+V G+++ +++ + +++N+ +
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF------VRQI 115
Query: 294 ASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
++YLH+ IIH D+K ANIL+D+ K+SDF
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDF 150
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 16/171 (9%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYM----CADEIRITEWEFLGIISQVKHKNVVKILGL 249
+G G FG VYKG+ +V K + DEI + E + ++SQ + + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQE-ITVLSQCDSPYITRYYGS 70
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNW-KTCLRIAAETASAIHYLHSLASPSI 308
L+ ++ E++ G+ + K + + + T LR E + YLHS
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILR---EILKGLDYLHSERK--- 122
Query: 309 IHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
IH D+K+AN+LL + K++DF + +D + +T + GT ++ PE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADF-GVAGQLTDTQIKRNTFV-GTPFWMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 57/258 (22%), Positives = 117/258 (45%), Gaps = 30/258 (11%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKY----MCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G G+V+ + + +VA+K+ E+ I E + ++ ++K+ N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE---ILVMKELKNPNIVNFLD 83
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL---RIAAETASAIHYLHSLAS 305
L +V E+++ G+L+ + + TC+ +IAA + L L +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTE----------TCMDEAQIAAVCRECLQALEFLHA 133
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTEL 365
+IH D+KS N+LL + + K++DF I+ +++ STM+ GT ++ PE +
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 366 LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIE----VVAEL 421
+ + + E + P +L+ N R + E++ E + +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATNGTPELQNPEKLSPIFRDF 248
Query: 422 ASKCLRIRGTERPTMKEV 439
++CL + +R + KE+
Sbjct: 249 LNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 35/149 (23%), Positives = 69/149 (46%), Gaps = 20/149 (13%)
Query: 197 GGFGSVYKGVL----PDNTQVAVKKYMC--ADEIRITEW--EFLGIISQVKHKNVVKILG 248
G FG ++ G+L P + K + A EI++T E + + H+N++ IL
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LSHQNILPILH 75
Query: 249 LCLE-TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR------IAAETASAIHYLH 301
+C+E + ++Y +++ G L ++ + N L +A + A + YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSD 330
+IH D+ + N ++D+ K++D
Sbjct: 135 KR---GVIHKDIAARNCVIDEELQVKITD 160
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 28/152 (18%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKIL-- 247
+G G +G VY+ VA+KK +E I I+ + ++ ++H N+V++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 248 --GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA------ETASAIHY 299
G L++ LV E+ D +S +L N T + + + Y
Sbjct: 75 VVGKHLDS--IFLVMEYCE--------QDLAS-LLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
LH IIH D+K +N+LL D K++DF
Sbjct: 124 LHE---NFIIHRDLKVSNLLLTDKGCLKIADF 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 41/150 (27%), Positives = 62/150 (41%), Gaps = 21/150 (14%)
Query: 194 LGMGGFGSVYKGVLPD-NTQVAVKKYMCADEIRITE---------WEFLGIISQVKHKNV 243
+G G FG+V K + T +AVK+ IR T + ++ +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKR------IRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 244 VKILGLCLETKVTLLVYEF--VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
VK G + E +S Y+++ V+ + +IA T A++YL
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVI-PEEILGKIAVATVKALNYLK 124
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
IIH DVK +NILLD N K+ DF
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDF 152
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 19/151 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADE------IRITEWEFLGIISQVKHKNVVKI 246
+G+G +G+VYK P + VA+K + E L + H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 247 LGLCL------ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
+ +C ETKVTL V+E V L Y+ DK +T + + + +L
Sbjct: 68 MDVCATSRTDRETKVTL-VFEHVDQD-LRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
H+ I+H D+K NIL+ K++DF
Sbjct: 125 HA---NCIVHRDLKPENILVTSGGQVKLADF 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 54/186 (29%), Positives = 81/186 (43%), Gaps = 16/186 (8%)
Query: 190 FHH--CLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG-----IISQVKHKN 242
F H LG GGFG V + ++ K + I+ + E + I+ +V +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 243 VVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
VV L ETK L LV ++ G L +I++ + + AAE + L
Sbjct: 62 VVS-LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-YAAELCCGLEDLQ 119
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYA 361
I++ D+K NILLDD ++SD V I + ET + GTVGY+ PE
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV--GTVGYMAPEVI 173
Query: 362 HTELLT 367
+ E T
Sbjct: 174 NNEKYT 179
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 26/172 (15%)
Query: 182 ELLKATKNFHHCLGMGGFGSVYKGVL-----PDNTQ-VAVKKYMCADEIRITEWEF---L 232
E+ +T F LG FG VYKG L + TQ VA+K E + E EF
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE-EFKHEA 59
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYI-------------HDKSSQV 279
+ S+++H N+V +LG+ + + +++ + S+ L ++ DK+ +
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 280 LKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ I + A+ + +L +S ++H D+ + N+L+ D K+SD
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDL 168
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 13/154 (8%)
Query: 194 LGMGGFGSVYKGVL---PDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKIL 247
LG G FG+V KG+ VAVK + + E L ++ Q+ + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
G+C E + +LV E G L+ ++ KN + + + + YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKN---ITELVHQVSMGMKYLEE---TN 115
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341
+H D+ + N+LL + AK+SDF + +D+
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 4/69 (5%)
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIR 350
AE AI +H L +H D+K N+LLD N +++DF S + + D T S +
Sbjct: 109 AEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRL-LADGTVQSNVAV 164
Query: 351 GTVGYLDPE 359
GT Y+ PE
Sbjct: 165 GTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 60/258 (23%), Positives = 116/258 (44%), Gaps = 30/258 (11%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILG 248
+G G G+VY + + +VA+++ E+ I E + ++ + K+ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE---ILVMRENKNPNIVNYLD 84
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL---RIAAETASAIHYLHSLAS 305
L +V E+++ G+L+ + + TC+ +IAA + L L S
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTE----------TCMDEGQIAAVCRECLQALEFLHS 134
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTEL 365
+IH D+KS NILL + + K++DF I+ +++ STM+ GT ++ PE +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 366 LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIE----VVAEL 421
+ + + E I P +L+ N R + E++ E + +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNE---NPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 422 ASKCLRIRGTERPTMKEV 439
++CL + +R + KE+
Sbjct: 250 LNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 23/149 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGI-------IS---QVKHKN 242
+G G +G VYK VA+KK IR+ E E G+ IS ++ H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK------IRL-ETEDEGVPSTAIREISLLKELNHPN 59
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+V++L + LV+EF+ + L Y+ D S + + I Y HS
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
++H D+K N+L+D K++DF
Sbjct: 118 ---HRVLHRDLKPQNLLIDREGALKLADF 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 20/183 (10%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG-----IISQVKHKNVVKILG 248
LG GGFG V + ++ K + I+ + E + I+ +V + VV L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66
Query: 249 LCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
ETK L LV ++ G L +I++ + + + AAE + LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-ERAVFYAAEITCGLEDLHR---ER 122
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIR---GTVGYLDPEYAHTE 364
I++ D+K NILLDD ++SD V I + IR GTVGY+ PE E
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE------TIRGRVGTVGYMAPEVVKNE 176
Query: 365 LLT 367
T
Sbjct: 177 RYT 179
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 21/179 (11%)
Query: 189 NFHHCLGMGGFGSV----YKGVLPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKH 240
NF LG G FG V YK D VA+K++ + I+ + + + I++ + H
Sbjct: 33 NFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
V + G + LV EFV G ++ + ++ N C AA+ YL
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCF-YAAQIVLIFEYL 147
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
SL +I++ D+K N+LLD + K++DF + +T T+ GT Y+ PE
Sbjct: 148 QSL---NIVYRDLKPENLLLDKDGFIKMTDFG----FAKVVDTRTYTLC-GTPEYIAPE 198
|
Length = 340 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 4/69 (5%)
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIR 350
AE AIH +H L +H D+K N+LLD N +++DF S + + + D T S++
Sbjct: 109 AEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM-NQDGTVQSSVAV 164
Query: 351 GTVGYLDPE 359
GT Y+ PE
Sbjct: 165 GTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 41/145 (28%), Positives = 67/145 (46%), Gaps = 18/145 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYM----CADEIRITEWEFLGIISQVKHKNVVKILGL 249
+G G FG V+KG+ +V K + DEI + E + ++SQ V K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE-ITVLSQCDSPYVTKYYGS 70
Query: 250 CLETKVTLLVYEFVSNGALSHYIHD---KSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
L+ ++ E++ G+ + +Q+ T LR E + YLHS
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDYLHSEKK- 122
Query: 307 SIIHSDVKSANILLDDNYTAKVSDF 331
IH D+K+AN+LL ++ K++DF
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADF 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 49/175 (28%), Positives = 71/175 (40%), Gaps = 21/175 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRIT--EWEFLGIISQ--VKHKNV----VK 245
LG G +GSVYK VL T V M EIR+ E +F II + + HK V V
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVT----MAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
G + E++ G+L + RI + L L
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV---VKGLKFLKE 120
Query: 306 P-SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+IIH DVK N+L++ N K+ DF +S + +++ G Y+ PE
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKTNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 44/147 (29%), Positives = 66/147 (44%), Gaps = 18/147 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCAD--------EIRITEWEFLGIISQVKHKNVVK 245
LG G FG V L ++ ++ K + D E +TE L + H + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 60
Query: 246 ILGLCLETKVTLL-VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
L C +T L V EFV+ G L +I + S+ + AAE SA+ +LH
Sbjct: 61 -LYCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARF-YAAEITSALMFLHD-- 114
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
II+ D+K N+LLD K++DF
Sbjct: 115 -KGIIYRDLKLDNVLLDHEGHCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 69/296 (23%), Positives = 117/296 (39%), Gaps = 49/296 (16%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMC------ADEIR--ITEWEFLGIISQVKHKNVVK 245
+G GG+G V+ D ++ K M +E+R +TE + I++ K + +VK
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERD---ILTTTKSEWLVK 65
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+L + + L E+V G +++ VL +A E A+ LH L
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMA-EMFEAVDALHELG- 121
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTEL 365
IH D+K N L+D + K++DF +S + T VG P+Y E+
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFG----LSK----GIVTYANSVVG--SPDYMAPEV 169
Query: 366 LTGMNPNSYVALAS-----NEKISMVPYFLDSIENNSFRQILNFQ------VADESEMEE 414
L G + V S E + P F S N ++ + ++ V D+
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229
Query: 415 IEVVAELASKCL-----RIRGTE----RPTMKEVSEELDRLRRLQENYWARKNNEE 461
+ +L +K + R E P KEV + + LR L+ + +E
Sbjct: 230 SDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV--DWNELRELKPPFVPELESEI 283
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 44/151 (29%), Positives = 70/151 (46%), Gaps = 29/151 (19%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYM---CADEIR--ITEWEFLGIISQVKHKNVVKILG 248
LG G FG VYK + +A K + +E+ + E E I++ H +VK+LG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE---ILATCNHPYIVKLLG 76
Query: 249 -LCLETKVTLLVYEFVSNGA-------LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
+ K+ +++ EF GA L + + QV I + A+ YL
Sbjct: 77 AFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---------ICRQMLEALQYL 126
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
HS+ IIH D+K+ N+LL + K++DF
Sbjct: 127 HSM---KIIHRDLKAGNVLLTLDGDIKLADF 154
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 15/173 (8%)
Query: 194 LGMGGFGSVY--KGVLPDNTQVAVKK----YMCADEIRITEWEFLGIISQVKHKNVVKIL 247
+G G FG +Y K D+ +K+ M E ++ E + +++++KH N+V
Sbjct: 8 IGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVI-LLAKMKHPNIVTFF 65
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
E +V E+ G L I ++ VL + L + + + ++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD---RK 121
Query: 308 IIHSDVKSANILLDDN-YTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I+H D+KS NI L N AK+ DF ++ E A + + GT YL PE
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV--GTPYYLSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 212 QVAVKKY-MCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSH 270
QVAVKK + + R + + I+ H+NVV + L +V EF+ GAL+
Sbjct: 49 QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT- 107
Query: 271 YIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSD 330
D + N + + A+ YLH+ +IH D+KS +ILL + K+SD
Sbjct: 108 ---DIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSD 161
Query: 331 FESLVPISSDDETAMSTMIRGTVGYLDPE 359
F +S E + GT ++ PE
Sbjct: 162 FGFCAQVSK--EVPKRKSLVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 31/75 (41%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 290 AAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMI 349
AAE ASA+ YLHSL +I++ D+K NILLD ++DF L + + ST
Sbjct: 102 AAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF-GLCKENIEHNGTTSTFC 157
Query: 350 RGTVGYLDPEYAHTE 364
GT YL PE H +
Sbjct: 158 -GTPEYLAPEVLHKQ 171
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 14/170 (8%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYM----CADEIRITEWEFLGIISQVKHKNVVKILGL 249
+G G FG V+KG+ QV K + DEI + E + ++SQ V K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE-ITVLSQCDSPYVTKYYGS 70
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
L+ ++ E++ G+ + + T L+ E + YLHS I
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ-IATMLK---EILKGLDYLHSEKK---I 123
Query: 310 HSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
H D+K+AN+LL + K++DF + +D + +T + GT ++ PE
Sbjct: 124 HRDIKAANVLLSEQGDVKLADF-GVAGQLTDTQIKRNTFV-GTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 20/177 (11%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVK----HKNVVKILGL 249
+G G +G VYKG Q+A K M D E E I+ +K H+N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 250 CLETKVT------LLVYEFVSNGALSHYIHDKSSQVLK-NWKTCLRIAAETASAIHYLHS 302
++ LV EF G+++ + + LK +W I E + +LH+
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHLHA 139
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+IH D+K N+LL +N K+ DF V D GT ++ PE
Sbjct: 140 ---HKVIHRDIKGQNVLLTENAEVKLVDFG--VSAQLDRTVGRRNTFIGTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 11/127 (8%)
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYI-HDKSSQVLKNWKTCLRIAAE 292
I+ +H+NVV++ L +V EF+ GAL+ + H + ++ +IAA
Sbjct: 70 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIAAV 121
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
+ + L L + +IH D+KS +ILL + K+SDF +S E + GT
Sbjct: 122 CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGT 179
Query: 353 VGYLDPE 359
++ PE
Sbjct: 180 PYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 41/127 (32%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAET 293
++ VKH +V + T+ V +FV+ G L + H + + + AAE
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARF-YAAEI 105
Query: 294 ASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP-ISSDDETAMSTMIRGT 352
ASA+ YLHS+ +I++ D+K NILLD ++DF I+ D T T GT
Sbjct: 106 ASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGT 159
Query: 353 VGYLDPE 359
YL PE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 38/179 (21%), Positives = 82/179 (45%), Gaps = 8/179 (4%)
Query: 182 ELLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW-EFLGIISQVKH 240
E+ + + LG G FG V+ +T+VAVK M + + + ++ ++H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT-MKPGSMSVEAFLAEANVMKTLQH 60
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
+VK+ + + + ++ EF++ G+L ++ K + +A+ A + ++
Sbjct: 61 DKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFI 118
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+ IH D+++ANIL+ + K++DF L + D+E + + + PE
Sbjct: 119 EQ---RNYIHRDLRAANILVSASLVCKIADF-GLARVIEDNEYTAREGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 11/142 (7%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYM---CADEIRITEWEFLGIISQVKHKNVVKIL-GL 249
LG G FG VYK + +A K + +E+ E + I++ H N+VK+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE-IDILASCDHPNIVKLLDAF 71
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
E + +L+ EF + GA+ + + + + + +T A++YLH II
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRV--VCKQTLEALNYLHE---NKII 125
Query: 310 HSDVKSANILLDDNYTAKVSDF 331
H D+K+ NIL + K++DF
Sbjct: 126 HRDLKAGNILFTLDGDIKLADF 147
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 194 LGMGGFGSVYKGVLPDN-TQVAVKKY-------MCADEIRITEWEFLGIISQVKHKNVVK 245
LG G FG VY D ++AVK+ + E+ E E + ++ ++H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECE-IQLLKNLRHDRIVQ 68
Query: 246 ILGLCL----ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
G CL E K+++ V E++ G++ + K+ L R + + YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFV-EYMPGGSIKDQL--KAYGALTE-NVTRRYTRQILQGVSYLH 123
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
S I+H D+K ANIL D K+ DF
Sbjct: 124 S---NMIVHRDIKGANILRDSAGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 46/190 (24%), Positives = 72/190 (37%), Gaps = 28/190 (14%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF-----------------LGII- 235
LG G FG VYK +N Q + EI + F + II
Sbjct: 8 LGSGAFGCVYKVRKKNNGQ----NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63
Query: 236 SQVKHKNVVKILGLCLETKVTLLVYEFVSNGALS-HYIHDKSSQVLKNWKTCLRIAAETA 294
Q++H N+V+ LE +V + + L H+ K + + I +
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 295 SAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVG 354
A+ YLH I+H D+ NI+L ++ ++DF L + S + GT+
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF-GLAKQKQPESKLTSVV--GTIL 178
Query: 355 YLDPEYAHTE 364
Y PE E
Sbjct: 179 YSCPEIVKNE 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 40/156 (25%), Positives = 66/156 (42%), Gaps = 37/156 (23%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADEIRI-TEWEF--------LGIISQVKHKNV 243
+G G +G VYK + VA+KK IR+ TE E + ++ ++ H N+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKK------IRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAI-HYLHS 302
VK+L + LV+EF+ Q LK + ++ I YL
Sbjct: 62 VKLLDVIHTENKLYLVFEFLH-------------QDLKKFMDASPLSGIPLPLIKSYLFQ 108
Query: 303 LA-------SPSIIHSDVKSANILLDDNYTAKVSDF 331
L S ++H D+K N+L++ K++DF
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 19/170 (11%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILG-L 249
LG G G+VYK ++ K + D E++ L I+ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
+E ++++ EF+ G+L Y VL RIA + YL SL I+
Sbjct: 69 FVENRISICT-EFMDGGSLDVY-RKIPEHVLG------RIAVAVVKGLTYLWSL---KIL 117
Query: 310 HSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
H DVK +N+L++ K+ DF +S+ +++ GT Y+ PE
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFG----VSTQLVNSIAKTYVGTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 19/41 (46%), Positives = 23/41 (56%), Gaps = 3/41 (7%)
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
AET AI +H L IH D+K N+LLD K+SDF
Sbjct: 108 AETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDF 145
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 18/131 (13%)
Query: 234 IISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE 292
I+ VKH +V ++ +T L L+ E++S G L ++H + + C ++ E
Sbjct: 53 ILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLS-E 108
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTM 348
+ A+ +LH II+ D+K NILLD K++DF ES+ E ++
Sbjct: 109 ISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI------HEGTVTHT 159
Query: 349 IRGTVGYLDPE 359
GT+ Y+ PE
Sbjct: 160 FCGTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 24/149 (16%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGL 249
+G G +G+V+K + + VA+K+ D+ + + + ++ ++KHKN+V++ +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR--IAAETASAIHY--LHSLA- 304
K LV+E+ Q LK + I E + + L LA
Sbjct: 68 LHSDKKLTLVFEYCD-------------QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 305 --SPSIIHSDVKSANILLDDNYTAKVSDF 331
S +++H D+K N+L++ N K++DF
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADF 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 17/44 (38%), Positives = 24/44 (54%), Gaps = 2/44 (4%)
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
++ A+HYL +IH DVK +NILLD + K+ DF
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDF 159
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADE-IRITE----WEFLGIISQVKHKNVVKILG 248
+G G FG V + QV K + E I+ ++ WE I++ + +V++
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+ K +V E++ G L + + + + + W AE A+ +HS+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFY--TAEVVLALDAIHSMG---F 163
Query: 309 IHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
IH DVK N+LLD + K++DF + + + ++ T + GT Y+ PE
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 38/143 (26%), Positives = 61/143 (42%), Gaps = 11/143 (7%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEI-RITEWEFL----GIISQVKHKNVVKILG 248
LG G FG V + K + EI ++ + + + I+ ++ H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+ + EFV G L + H + + N AE A YLHS I
Sbjct: 86 SFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPN-DVAKFYHAELVLAFEYLHSK---DI 139
Query: 309 IHSDVKSANILLDDNYTAKVSDF 331
I+ D+K N+LLD+ KV+DF
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDF 162
|
Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 17/148 (11%)
Query: 194 LGMGGFGSVYKGVLPDN-TQVAVKKYM-------CADEIRITEWEFLGIISQVKHKNVVK 245
LG G FG VY D ++AVK+ + E+ E E + ++ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECE-IQLLKNLLHERIVQ 68
Query: 246 ILGLCLET-KVTLLVY-EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
G + + TL ++ E + G++ + KS L + + + YLHS
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTE-NVTRKYTRQILEGVSYLHS- 124
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
I+H D+K ANIL D K+ DF
Sbjct: 125 --NMIVHRDIKGANILRDSVGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 39/114 (34%), Positives = 54/114 (47%), Gaps = 9/114 (7%)
Query: 247 LGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
L +TK L V E+V+ G L + H +V +T AE SA+ YLHS
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRF-YGAEIVSALDYLHS--- 113
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I++ D+K N++LD + K++DF L D M T GT YL PE
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDF-GLCKEGITDAATMKTFC-GTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 36/133 (27%), Positives = 55/133 (41%), Gaps = 26/133 (19%)
Query: 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSAN 317
L+ ++V+ G L + H + + + IA E A+ +LH L II+ D+K N
Sbjct: 82 LILDYVNGGEL--FTHLYQREHFTESEVRVYIA-EIVLALDHLHQLG---IIYRDIKLEN 135
Query: 318 ILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT-------------- 363
ILLD ++DF L +E + GT+ Y+ PE
Sbjct: 136 ILLDSEGHVVLTDF-GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194
Query: 364 -----ELLTGMNP 371
ELLTG +P
Sbjct: 195 GVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 19/44 (43%), Positives = 27/44 (61%), Gaps = 2/44 (4%)
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+IA A+ YLHS S+IH DVK +N+L++ N K+ DF
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDF 148
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 26/69 (37%), Positives = 36/69 (52%), Gaps = 5/69 (7%)
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIR 350
AE SA+ YLHS +++ D+K N++LD + K++DF L D M T
Sbjct: 102 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDF-GLCKEGISDGATMKTFC- 156
Query: 351 GTVGYLDPE 359
GT YL PE
Sbjct: 157 GTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 48/178 (26%), Positives = 69/178 (38%), Gaps = 29/178 (16%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIR--ITEWEF------LGIISQVKHKNVV 244
LG G G V K + P +AVK IR I E L I+ + +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVK------TIRLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
G + E++ G+L + K Q + +IA + YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHE-- 118
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF---ESLVPISSDDETAMSTMIRGTVGYLDPE 359
IIH DVK +NIL++ K+ DF LV + A + + GT Y+ PE
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-----NSLAKTFV--GTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 32/153 (20%), Positives = 59/153 (38%), Gaps = 8/153 (5%)
Query: 193 CLGMGGFGSVYKGVLPDNTQVAVKKYM--CADEIRITEWEFLGIIS-QVKHKNVVKILGL 249
C + K P NT VAVKK + + + I S Q++H N++ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
+ +V ++ G+ + + L I + +A+ Y+HS I
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSKG---FI 123
Query: 310 HSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342
H VK+++ILL + +S V + +
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 17/115 (14%)
Query: 250 CLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
C +TK L V E+V+ G L +I S + AAE + +LH I
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARF-YAAEIVLGLQFLHE---RGI 117
Query: 309 IHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVGYLDPE 359
I+ D+K N+LLD K++DF E ++ T + GT Y+ PE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILG---GVTT---STFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 25/149 (16%)
Query: 194 LGMGGFGSVYKG--VLPDNTQVAVKKYMCADEIRITEWEF--------LGIISQVKHKNV 243
LG G + +VYKG L DN VA+K EIR+ E + ++ +KH N+
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALK------EIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV-LKNWKTCLRIAAETASAIHYLHS 302
V + + K LV+E++ L Y+ D + + + N K L + ++Y H
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKLFL---FQLLRGLNYCHR 122
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
++H D+K N+L+++ K++DF
Sbjct: 123 ---RKVLHRDLKPQNLLINERGELKLADF 148
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 33/156 (21%)
Query: 193 CLGMGGFGSVYKGVLPDNT---QVAVKKYMCA-DEIRITEWEF--LGIISQVKHKNVVKI 246
+G G +G V + D +VA+KK A D + + L I+ KH N++ I
Sbjct: 12 NIGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 247 LGLCLETKVTL-----LVYEFVSNGALSHYIHDKSSQVLKNWKTC------LRIAAETAS 295
+ L +V + + + L H IH S Q L LR
Sbjct: 70 RDI-LRPPGADFKDVYVVMDLMESD-LHHIIH--SDQPLTEEHIRYFLYQLLR------- 118
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ Y+HS ++IH D+K +N+L++++ ++ DF
Sbjct: 119 GLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDF 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 229 WEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR 288
WE I++ VV++ + K +V E++ G L + + + V + W
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFY- 147
Query: 289 IAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348
AE A+ +HS+ +IH DVK N+LLD + K++DF + + + DET M
Sbjct: 148 -TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM---DETG---M 197
Query: 349 IRGTVGYLDPEYAHTELLTGMNPNSY 374
+R P+Y E+L + Y
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGY 223
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 23/67 (34%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF---ESLVPISSDDETAMSTMIRGT 352
A+ Y+HS ++IH D+K +NILL+ + K++DF SL + + E + T T
Sbjct: 119 ALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 353 VGYLDPE 359
Y PE
Sbjct: 176 RWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 43/154 (27%), Positives = 63/154 (40%), Gaps = 31/154 (20%)
Query: 194 LGMGGFGSV----YKG--------VLPDNTQVA---VKKYMCADEIRITEWEFLGIISQV 238
LG G FG V YK L +A V+ MC E RI E +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMC--EKRIFE-----TANSE 59
Query: 239 KHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAI 297
+H +V + C +T+ + V E+ + G L +IH V + AA +
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVF-YAACVVLGL 114
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
YLH I++ D+K N+LLD K++DF
Sbjct: 115 QYLHE---NKIVYRDLKLDNLLLDTEGFVKIADF 145
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 8/101 (7%)
Query: 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANI 318
V E+ + G L + H +V + AE SA+ YLHS +++ D+K N+
Sbjct: 73 VMEYANGGEL--FFHLSRERVFSEDRARF-YGAEIVSALGYLHS---CDVVYRDLKLENL 126
Query: 319 LLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+LD + K++DF L D M T GT YL PE
Sbjct: 127 MLDKDGHIKITDF-GLCKEGISDGATMKTFC-GTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 36/156 (23%), Positives = 63/156 (40%), Gaps = 27/156 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKY-----------------MCADEIRITEWEFLGII 235
LG G +G V K VA+KK MC I T L I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG--IHFTTLRELKIM 74
Query: 236 SQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETAS 295
+++KH+N++ ++ + +E LV + ++ L + K K L + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILL---QILN 130
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
++ LH +H D+ ANI ++ K++DF
Sbjct: 131 GLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 7/127 (5%)
Query: 234 IISQVKHKNVVKIL-GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE 292
++SQ+KH N+V E + +V F G L H + ++ ++L + +
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQ 110
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A A+ YLH I+H D+K+ N+ L KV D + + + A ST+I GT
Sbjct: 111 IAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA-STLI-GT 165
Query: 353 VGYLDPE 359
Y+ PE
Sbjct: 166 PYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 25/149 (16%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADEIRITEWE---FLGI-----ISQVKHKNVV 244
LG G + +VYKG Q VA+K EIR+ E F I + +KH N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK------EIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQV-LKNWKTCLRIAAETASAIHYLHS 302
L + TK TL LV+E++ L Y+ D + + N + L + H
Sbjct: 67 -TLHDIIHTKKTLTLVFEYLDTD-LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
++H D+K N+L+ + K++DF
Sbjct: 124 -----VLHRDLKPQNLLISERGELKLADF 147
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 25/69 (36%), Positives = 38/69 (55%), Gaps = 4/69 (5%)
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIR 350
AE AI +H L +H D+K NIL+D N +++DF S + + +D T S++
Sbjct: 109 AEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAV 164
Query: 351 GTVGYLDPE 359
GT Y+ PE
Sbjct: 165 GTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 34/159 (21%)
Query: 194 LGMGGFGSVYKGVLPD-NTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGL 249
+G G +G VYK D VA+KK +E IT + I+ Q+ H+N+V + +
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 250 CLETKVTL----------LVYEFVSN-------GALSHYIHDKSSQVLKNWKTCLRIAAE 292
+ + L LV+E++ + L H+ D +K +
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK----------Q 124
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
++Y H + +H D+K +NILL++ K++DF
Sbjct: 125 LLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADF 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 34/131 (25%), Positives = 61/131 (46%), Gaps = 8/131 (6%)
Query: 229 WEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR 288
WE I++ VV++ + + +V E++ G L + + + V + W
Sbjct: 91 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFY- 147
Query: 289 IAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348
AE A+ +HS+ IH DVK N+LLD + K++DF + + ++ + T
Sbjct: 148 -TAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 349 IRGTVGYLDPE 359
+ GT Y+ PE
Sbjct: 204 V-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 18/36 (50%), Positives = 24/36 (66%), Gaps = 3/36 (8%)
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
A+H++HS +IH D+KSANILL N K+ DF
Sbjct: 155 AVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDF 187
|
Length = 496 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGL 249
+G G +G VYK N +A+KK E + T + ++ +++H N+V++ +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
K LV+E++ H D S KN + + I Y HS ++
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVL 124
Query: 310 HSDVKSANILLDDNYTA-KVSDF 331
H D+K N+L+D A K++DF
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADF 147
|
Length = 294 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 15/44 (34%), Positives = 22/44 (50%)
Query: 289 IAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332
IA + A + LH L + H D+ NIL+DD + D+E
Sbjct: 91 IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 16/42 (38%), Positives = 23/42 (54%), Gaps = 3/42 (7%)
Query: 290 AAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
AE A+ +H L IH D+K NIL+D + K++DF
Sbjct: 107 IAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADF 145
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 16/173 (9%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNV-------VKI 246
+G GGFG VY D ++ K + I++ + E L + ++ V +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+ T L + NG HY H V K A E + ++H+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHY-HLSQHGVFSE-KEMRFYATEIILGLEHMHNRF-- 117
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+++ D+K ANILLD++ ++SD S A GT GY+ PE
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWE---------FLGIISQVKHKNVV 244
LG G FG+VY ++ D VA ++ EI + E ++S++ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHD--KSSQVLKNWKTCLRIAAETASAIHYLHS 302
K LE ++ E+ L + + + + L + C + +HY+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC-EWFIQLLLGVHYMHQ 124
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFE-SLVPISSDDETAMSTMIRGTVGYLDPE 359
I+H D+K+ NI L +N K+ DF S + + S D ++T GT Y+ PE
Sbjct: 125 ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD---LATTFTGTPYYMSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 50/180 (27%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQ--VAVKKYMCADEIR------ITEWEFLGIISQVKHKNVVK 245
+G G +G V+K N VA+K+ I E L + +H NVV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 246 ILGLCL------ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+ +C ETK+TL V+E V L+ Y+ DK + +T + + + +
Sbjct: 69 LFDVCTVSRTDRETKLTL-VFEHVDQD-LTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
LHS ++H D+K NIL+ + K++DF L I S T + T+ Y PE
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADF-GLARIYSFQ--MALTSVVVTLWYRAPE 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGLC 250
LG G + +VYKG N ++ K + E T + + ++ +KH N+V +L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLHDI 71
Query: 251 LETKVTL-LVYEFVSNGALSHYIHDKSSQVL--KNWKTCLRIAAETASAIHYLHSLASPS 307
+ TK TL LV+E+V L Y+ DK L +N K L S IH +
Sbjct: 72 IHTKETLTLVFEYVHTD-LCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIHQRY------ 123
Query: 308 IIHSDVKSANILLDDNYTAKVSDF 331
I+H D+K N+L+ D K++DF
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADF 147
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 18/150 (12%)
Query: 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSAN 317
LV F++ G L H++ + L + AE A+ LH ++I+ D+K N
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARF---YTAELLCALENLHKF---NVIYRDLKPEN 123
Query: 318 ILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYV-- 375
ILLD + DF L ++ D+ +T GT PEY ELL G V
Sbjct: 124 ILLDYQGHIALCDF-GLCKLNMKDDDKTNTFC-GT-----PEYLAPELLLGHGYTKAVDW 176
Query: 376 ---ALASNEKISMVPYFLDSIENNSFRQIL 402
+ E ++ +P F D N +R+IL
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 22/70 (31%), Positives = 31/70 (44%), Gaps = 9/70 (12%)
Query: 290 AAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMI 349
AE + LH IIH D+K N+L+D K++DF +S + +
Sbjct: 103 IAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFG----LSRNGL--ENKKF 153
Query: 350 RGTVGYLDPE 359
GT YL PE
Sbjct: 154 VGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 6/126 (4%)
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAET 293
+++++KH N+V +V E+ G L I + ++ T L+ +
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQM 109
Query: 294 ASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTV 353
+ ++H ++H D+KS NI L N K+ DF S ++S A + + GT
Sbjct: 110 CLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GTP 164
Query: 354 GYLDPE 359
Y+ PE
Sbjct: 165 YYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 35/203 (17%)
Query: 194 LGMGGFGSVYKGVLPDNTQV----AVKK--YMCADEIRITEWEFLGIISQVKHKNVVKIL 247
LG G FG V L + A+KK + D++ T E + +H + +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 248 GLC-LETKVTLL-VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
C +TK L V E+++ G L +I + AAE + +LH
Sbjct: 63 --CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF---YAAEIICGLQFLHK--- 114
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE------ 359
II+ D+K N+LLD + K++DF + + + E ST GT Y+ PE
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADF-GMCKENMNGEGKASTFC-GTPDYIAPEILKGQK 172
Query: 360 YAHT-----------ELLTGMNP 371
Y + E+L G +P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 47/178 (26%), Positives = 83/178 (46%), Gaps = 23/178 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCA--DEIRITEWE-FLG------IISQVKHKNVV 244
LG GGFG V + + K Y C ++ R+ + + + G I+++V H +
Sbjct: 1 LGKGGFGEVSACQM----RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFI 55
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIH--DKSSQVLKNWKTCLRIAAETASAIHYLH 301
L +TK L LV ++ G L ++I+ D+ + + C A+ S + +LH
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF-YTAQIISGLEHLH 114
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
II+ D+K N+LLD++ ++SD V + D + + GT G++ PE
Sbjct: 115 Q---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELK--DGQSKTKGYAGTPGFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 38/134 (28%), Positives = 62/134 (46%), Gaps = 22/134 (16%)
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDK------SSQVLKNW--KT 285
++S +KH N+V+ E +V ++ G L I+ + Q+L +W +
Sbjct: 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL-DWFVQI 110
Query: 286 CLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345
CL A+ ++H I+H D+KS NI L + T K+ DF ++S E A
Sbjct: 111 CL--------ALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159
Query: 346 STMIRGTVGYLDPE 359
+ + GT YL PE
Sbjct: 160 TCI--GTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 19/165 (11%)
Query: 193 CLGMGGFGSVYKGVLPD-NTQVAVKKYMCADEIRI----TEWEFLGIISQVKHKNVVKIL 247
+G G +G V + N +VA+KK A + RI T E + ++ + H+NV+ I
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE-IKLLRHLDHENVIAIK 70
Query: 248 GLCLET-----KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+ +VYE + L I +SSQ L + C + + Y+HS
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTD-LHQII--RSSQTLSD-DHCQYFLYQLLRGLKYIHS 126
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347
+++H D+K +N+LL+ N K+ DF L +S+ M+
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDF-GLARTTSEKGDFMTE 167
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 496 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.16 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.76 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.52 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.47 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.33 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.95 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.92 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.73 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.37 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.28 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.25 | |
| PLN02236 | 344 | choline kinase | 97.22 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.14 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.95 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.89 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.83 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.8 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.68 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.62 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.6 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.57 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.18 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.03 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.77 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.67 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.63 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.39 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 94.88 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.53 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.51 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.33 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=383.02 Aligned_cols=258 Identities=22% Similarity=0.227 Sum_probs=220.2
Q ss_pred HHHhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhh--------hhHHHHHHHHhcCCCCceeeEEEEEeeCC
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIR--------ITEWEFLGIISQVKHKNVVKILGLCLETK 254 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~hpnIv~l~~~~~~~~ 254 (496)
....|.+.+.||+|+||.|-+|. ..+|+.||||++....... ....+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 44557778999999999999998 4689999999986543222 12248999999999999999999999999
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC---CceEEccC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN---YTAKVSDF 331 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~---~~~kL~DF 331 (496)
..|+||||++||+|.+.+-.++. +.+.....++.|++.|+.|||+ +||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999987654 5667788899999999999999 889999999999999755 78999999
Q ss_pred CCccccCCCCCccceecccccceeecCcccccccccC---CCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccC
Q 047375 332 ESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTG---MNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVA 407 (496)
Q Consensus 332 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~---~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~ 407 (496)
|+|+.... .....+.||||.|.|||++.+..++. +.|+||+||++|.+++|.+||....... ...+|..+.+.
T Consensus 324 GlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 324 GLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred chhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 99998763 34467889999999999999865544 5699999999999999999999988777 66777766554
Q ss_pred --CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 408 --DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 408 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
++.+...+++..+||.+||..||++|||+.|+ .+++|.+....
T Consensus 401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea----------L~hpW~~~~~~ 445 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLINWMLVVDPENRPSADEA----------LNHPWFKDAPC 445 (475)
T ss_pred ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH----------hcChhhhcccc
Confidence 45667888999999999999999999999998 46778876653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=391.16 Aligned_cols=273 Identities=41% Similarity=0.605 Sum_probs=230.1
Q ss_pred cccccCHHHHHHHhcchh--hhcccCCceEEEEeEeCCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEE
Q 047375 174 RMKIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLC 250 (496)
Q Consensus 174 ~~~~~~~~~l~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~ 250 (496)
..+.|++.++..+|.+|. +.||+|+||.||+|...++..||||++...... ...+..|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 577899999999999997 799999999999999988899999988765543 44467999999999999999999999
Q ss_pred eeCC-eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEc
Q 047375 251 LETK-VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 251 ~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
.+.+ ..+||+||+++|+|.++|...... +++|..+++|+.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 599999999999999999886544 68999999999999999999999887789999999999999999999999
Q ss_pred cCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhc---------------c
Q 047375 330 DFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSI---------------E 394 (496)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~---------------~ 394 (496)
|||+|+..... .....+...||.+|+|||++....+|.++|+||+|+++.|+++|.++..... .
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999766541 1111111169999999999999899999999999999999999986554321 1
Q ss_pred cchhhhhhhcccC-CcccH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 395 NNSFRQILNFQVA-DESEM-EEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 395 ~~~~~~i~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
...+..++++.+. ..... .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 1234556666654 33332 567789999999999999999999999999966543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=367.84 Aligned_cols=257 Identities=23% Similarity=0.265 Sum_probs=216.4
Q ss_pred HhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecc---hhhhhhHHHHHHHHhcCCCCceeeEEE-EEeeCCe-eeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCA---DEIRITEWEFLGIISQVKHKNVVKILG-LCLETKV-TLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~-~~~~~~~-~~lv 259 (496)
..|.+.++||.|+||.||++. ..+|..||.|.+.-. ...+.....|+.+|++|+|||||++++ .+..++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 347778899999999999998 568999999988632 222334448999999999999999999 4555555 8999
Q ss_pred EeeccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCC-CcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 260 YEFVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASP-SIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~-~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
||||.+|+|.+.++.. .....+++..+|+++.|++.||.++|...++ .|+||||||.||+|+.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999763 3344579999999999999999999985422 3999999999999999999999999999998
Q ss_pred CCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
.+. .......+|||.||+||.+.+..|+.++|+||+||++|||+...+||.+.+-...-.+|.+...++-+..-.+..
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTD 256 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence 764 334567789999999999999999999999999999999999999999986666666777776665555778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
+..||..|+..||..||+...++..+.
T Consensus 257 l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHHHccCCcccCCCcchHHHHHH
Confidence 999999999999999998655555443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=373.37 Aligned_cols=242 Identities=21% Similarity=0.225 Sum_probs=206.4
Q ss_pred hhhcccCCceEEEEeEeC-CCcEEEEEEeec--chhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC-eeeEEEeeccCC
Q 047375 191 HHCLGMGGFGSVYKGVLP-DNTQVAVKKYMC--ADEIRITEWEFLGIISQVKHKNVVKILGLCLETK-VTLLVYEFVSNG 266 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~E~~~~g 266 (496)
...||+|..|+||++.+. ++..+|+|.+.. ....+.+..+|+++++.++||+||.+||.|..++ ..+|+||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 467999999999999964 688899999843 3444555669999999999999999999999988 499999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.+++...+. +++....+|+.+|++||.|||+. ++||||||||+|||++..|.|||||||.++.+... ..
T Consensus 164 SLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 164 SLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 99999987533 68889999999999999999963 67999999999999999999999999999887543 45
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhc-----ccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSI-----ENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.+++||..|||||.+.++.|+.++||||+|+.+.|+..|..|+.... ....+..|++...+......++++++.|
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 67889999999999999999999999999999999999988877641 1234455555433333333588999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~ 441 (496)
|..||+.||.+|||+.|+++
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=391.62 Aligned_cols=245 Identities=22% Similarity=0.277 Sum_probs=220.6
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeec----chhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMC----ADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+|...++||+|||+.||.++. .+|..||+|++.. ....+....+|++|.+.|+|||||+++++|++.++.|||.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 477788999999999999996 8899999999876 34455566699999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
+|+.|+|..+++.+. ++++.+++.+++||+.||.|||+ ++|||||||..|+||+++.+|||+|||+|..+..+.
T Consensus 99 LC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred ecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999998544 37899999999999999999999 789999999999999999999999999999987653
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
+. ..+.||||.|.|||++.....+...|+||+||++|.++.|.|||....-.+.+..|....+..|. ..+.++++|
T Consensus 173 Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~dL 248 (592)
T KOG0575|consen 173 ER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKDL 248 (592)
T ss_pred cc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHHH
Confidence 33 45688999999999999999999999999999999999999999998888888888876655544 566789999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~ 441 (496)
|.++|+.||.+|||+++|+.
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999964
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=385.54 Aligned_cols=255 Identities=27% Similarity=0.332 Sum_probs=218.0
Q ss_pred hhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCC-eeeEEEeeccC
Q 047375 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETK-VTLLVYEFVSN 265 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~E~~~~ 265 (496)
+.+.||+|+||+||+|.+.....||||++...... ...+.+|+.+|.+++|||||+++|+|.... ..+|||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34569999999999999954444999999754332 335669999999999999999999999887 79999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCC-cccCCCCcCceeeCCCC-ceEEccCCCccccCCCCCc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS-IIHSDVKSANILLDDNY-TAKVSDFESLVPISSDDET 343 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~-ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~~~~~~ 343 (496)
|+|.+++... ....+++..+++|+.|||+||.|||+ ++ ||||||||+|||++.++ ++||||||+++......
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 9999999884 23358999999999999999999999 55 99999999999999997 99999999998765432
Q ss_pred cceecccccceeecCcccc--cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAH--TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~--~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
...+...||+.|||||++. ...|+.++|+||+|+++||++++..||...........+......+..+..+++.+..|
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 1223356999999999999 55999999999999999999999999988777666666665666666666688999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 422 ASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
+.+||..||..||++.+|+..|+.+....
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999987643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=365.51 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=206.2
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|+||+||+|++ .++..||||.+.... ........|+.+|+.++|||||++++++..++..|+|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 56667799999999999996 468899999986553 22333358999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC------CceEEccCCCcccc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN------YTAKVSDFESLVPI 337 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~------~~~kL~DFGla~~~ 337 (496)
.||+|.++++.++. +++.++..++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 92 ~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 92 NGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999998764 7889999999999999999999 889999999999999764 46899999999998
Q ss_pred CCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-ccCCcccHHHHH
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF-QVADESEMEEIE 416 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 416 (496)
... ....+.||||.|||||++..+.|+.|.|+||.|+++|++++|.+||......+.+..+... ......+...++
T Consensus 166 ~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 166 QPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred Cch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 743 3346788999999999999999999999999999999999999999987766666555432 333344445556
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.+.+|+...++.+|.+|-+..+-.
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhh
Confidence 677888888999998887766543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=359.71 Aligned_cols=239 Identities=22% Similarity=0.214 Sum_probs=207.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh----hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR----ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.+.+.||+|+||+||.++. ++++.+|+|++....-.. .....|..+|.+++||+||+++..|++...+|+|+||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 56678999999999999994 578899999987554333 2334789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+.||.|...|.+.+. +++..+.-++.+|+.||.|||+ ++||||||||+|||||.+|+++|+|||+|+.....+.
T Consensus 107 ~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 107 LNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred cCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999999987654 7888899999999999999999 8899999999999999999999999999996544322
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.+.++|||+.|||||++.+..|+...||||+|+++|+|++|.+||.+......+..|.......+ +.-.+.+.++++
T Consensus 181 --~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~-p~~ls~~ardll 257 (357)
T KOG0598|consen 181 --ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP-PGYLSEEARDLL 257 (357)
T ss_pred --ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC-CccCCHHHHHHH
Confidence 34568999999999999999999999999999999999999999999888888888887663222 222456799999
Q ss_pred HHhcccCCCCCCC
Q 047375 423 SKCLRIRGTERPT 435 (496)
Q Consensus 423 ~~cl~~dP~~RPs 435 (496)
.++|..||.+|..
T Consensus 258 ~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 258 KKLLKRDPRQRLG 270 (357)
T ss_pred HHHhccCHHHhcC
Confidence 9999999999963
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=367.33 Aligned_cols=245 Identities=24% Similarity=0.247 Sum_probs=211.7
Q ss_pred hcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhh----hHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRI----TEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~----~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.+.|.+.||.|+|++|++|+ ..+++.||||++...--.+. ....|-.+|.+| .||.|++||-.|.+...+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 37788999999999999999 45799999998854322221 122566777778 8999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++|+|.++|++.+. +++..++.++.+|+.||+|||+ +|||||||||+|||||.++++||+|||.|+.+...
T Consensus 154 e~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999998754 7888999999999999999999 88999999999999999999999999999988653
Q ss_pred CCc---------cc--eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc
Q 047375 341 DET---------AM--STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE 409 (496)
Q Consensus 341 ~~~---------~~--~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 409 (496)
... .. ...++||..|.+||++.....+..+|+|++||++|.|+.|.|||.+.++...+++|+.-.+..+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 222 11 2458899999999999999999999999999999999999999999999999999986554433
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEV 439 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 439 (496)
...++.+.+||.+.|..||.+|+|+.+|
T Consensus 308 --~~fp~~a~dLv~KLLv~dp~~Rlt~~qI 335 (604)
T KOG0592|consen 308 --EGFPEDARDLIKKLLVRDPSDRLTSQQI 335 (604)
T ss_pred --CCCCHHHHHHHHHHHccCccccccHHHH
Confidence 3344779999999999999999999776
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=365.96 Aligned_cols=257 Identities=24% Similarity=0.309 Sum_probs=220.0
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
...+.+.||+|-||.||.|.+.....||+|.++........+.+|+++|++|+|+|||+++|+|..+..+||||||++.|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 35667899999999999999977779999999887666677779999999999999999999999988999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.++|+.... ..+.....+.++.|||+|++||++ +++|||||-..||||+++..+||+|||+|+.+..+ .....
T Consensus 287 sLl~yLr~~~~-~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~ 361 (468)
T KOG0197|consen 287 SLLDYLRTREG-GLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS 361 (468)
T ss_pred cHHHHhhhcCC-CccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence 99999998333 336778899999999999999999 78999999999999999999999999999955443 22222
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
....-...|.|||.+....++.++|+||+|++++|+++....+.+.......-..+.....-+.+..|++.+.+++..||
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW 441 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCW 441 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHh
Confidence 22334678999999999999999999999999999998755554444444555555667777888889999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhHh
Q 047375 427 RIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 427 ~~dP~~RPs~~eil~~L~~l~~ 448 (496)
..+|++|||+..+...|+++..
T Consensus 442 ~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 442 HEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred hCCcccCCCHHHHHHHHHHhhh
Confidence 9999999999999888887754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=334.30 Aligned_cols=256 Identities=24% Similarity=0.277 Sum_probs=222.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhH----HHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITE----WEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~----~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+++.+.||.|+||.|.+++. .+|.-+|+|.+......+... .+|..+|+.+.||+++++++.|.+.++.|+||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 45567899999999999995 468889999987665444332 3788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
++||.|..++++.+. +++..++.++.||+.||+|||+ .+|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 126 v~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 126 VPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred cCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 999999999988654 7889999999999999999999 77999999999999999999999999999987543
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
+.+.||||.|+|||++....|....|||++|+++|||+.|.+||........+.+|+...+..|. -.++.+++|+
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~--~fs~~~kdLl 272 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS--YFSSDAKDLL 272 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc--ccCHHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999988776553 3447799999
Q ss_pred HHhcccCCCCCC-CHHHHHHHHHhhHhhhhhhhhccCcccc
Q 047375 423 SKCLRIRGTERP-TMKEVSEELDRLRRLQENYWARKNNEES 462 (496)
Q Consensus 423 ~~cl~~dP~~RP-s~~eil~~L~~l~~~~~~~~~~~~~~~~ 462 (496)
..+|+.|-.+|- +.. .....+..++|++...|+.
T Consensus 273 ~~LL~vD~t~R~gnlk------nG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLK------NGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred HHHHhhhhHhhhcCcC------CCccccccCcccccccHHH
Confidence 999999999992 221 2344557899999888753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=357.52 Aligned_cols=250 Identities=21% Similarity=0.226 Sum_probs=211.0
Q ss_pred HHHhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhh--hhhHHHHHHHHhcCC-CCceeeEEEEEeeCC-eeeE
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEI--RITEWEFLGIISQVK-HKNVVKILGLCLETK-VTLL 258 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~-~~~l 258 (496)
...+|...+.||.|+||.||+|. ..+|..||||+++..-.. .....+|+..|++++ |||||++.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34568888999999999999999 457899999998765333 233448999999999 999999999999887 9999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||||+. +|+++++++. .++++..+..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~Md~-NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 9999986 9999999873 458999999999999999999999 899999999999999988899999999999987
Q ss_pred CCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc------------
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ------------ 405 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------ 405 (496)
+... -+.++.|..|+|||++.. ..|+.+.|+|++||+++|+.+..|.|.+..+-..+.+|+.--
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 5433 467789999999998765 788999999999999999999999999887766666555311
Q ss_pred ---------cCCc-------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 406 ---------VADE-------SEMEEIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 406 ---------~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
++.- .....+.++.+||.+|+.+||.+|||+.++++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000 001245789999999999999999999999754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=346.14 Aligned_cols=251 Identities=24% Similarity=0.286 Sum_probs=201.9
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCC--eeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETK--VTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~E~~ 263 (496)
+...+.||+|+||.||++... +|...|||.+....... ....+|+.+|++++|||||+++|...... .++|+|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 445678999999999999964 48999999876542222 23458899999999999999999855444 689999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCCccccCCCC-
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPISSDD- 341 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~~~~~- 341 (496)
++|+|.+++...+. .+++..+.++.+||+.||.|||+ ++||||||||+|||++. ++.+||+|||+++......
T Consensus 99 ~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred CCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999988764 37899999999999999999998 88999999999999999 7999999999998776411
Q ss_pred CccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhh-cccchhhhhhhcccCCcccHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDS-IENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
.........||+.|||||++... .....+|+||+||++.||++|.+||... ........+......+..+...++..+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence 11123346799999999999953 2334899999999999999998888763 222223333333333456666788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L 443 (496)
+|+.+|+..||.+||||.++++..
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhCh
Confidence 999999999999999999997543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=356.30 Aligned_cols=258 Identities=19% Similarity=0.222 Sum_probs=217.7
Q ss_pred cchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhhhH----HHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITE----WEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~----~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.....||+|+||.||+|+ ..+|..+|+|+++.+......+ ..|-.+|....+|+||+||..|.+...+||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 4445789999999999999 4579999999998765544322 3667889889999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC-
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD- 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~- 341 (496)
+|||++..+|..... +++..+..++.+++.|+..||+ .|+|||||||+|+|||..|++||+|||+|+.+....
T Consensus 223 lPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 223 LPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred cCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999987653 7888999999999999999999 789999999999999999999999999986432200
Q ss_pred ---------------------Ccc----c-------------------eecccccceeecCcccccccccCCCCCchhhh
Q 047375 342 ---------------------ETA----M-------------------STMIRGTVGYLDPEYAHTELLTGMNPNSYVAL 377 (496)
Q Consensus 342 ---------------------~~~----~-------------------~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~ 377 (496)
... . ....+|||-|||||++.+..|+...||||+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 000 0 01246999999999999999999999999999
Q ss_pred hcccccccccchhhhcccchhhhhhhcc--cCCcccHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHhhHhhhhh
Q 047375 378 ASNEKISMVPYFLDSIENNSFRQILNFQ--VADESEMEEIEVVAELASKCLRIRGTERPT---MKEVSEELDRLRRLQEN 452 (496)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~L~~l~~~~~~ 452 (496)
++|||+.|.|||.+......+.+|++.. +..+.....++++++||.+||. ||.+|.. +.|| ..+
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI----------K~H 445 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI----------KKH 445 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH----------hcC
Confidence 9999999999999999999999999876 4555556677899999999999 9999964 4444 677
Q ss_pred hhhccCcccc
Q 047375 453 YWARKNNEES 462 (496)
Q Consensus 453 ~~~~~~~~~~ 462 (496)
+|++..+|+.
T Consensus 446 PfF~~v~W~~ 455 (550)
T KOG0605|consen 446 PFFKGVDWDH 455 (550)
T ss_pred CccccCCcch
Confidence 8888777753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=356.54 Aligned_cols=242 Identities=21% Similarity=0.289 Sum_probs=213.2
Q ss_pred hhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhhh-HHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 191 HHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT-EWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
...||+|+.|.||.+. ..++..||||++......... .++|+.+|+..+|+|||++++.|...+.+|+||||++||+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 3679999999999998 457889999998765554443 45999999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
.+++.... +++.++..|+++++.||+|||. ++|+|||||.+|||++.+|.+||+|||+|..+..... ...+
T Consensus 358 TDvVt~~~----~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~T 428 (550)
T KOG0578|consen 358 TDVVTKTR----MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRST 428 (550)
T ss_pred hhhhhccc----ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cccc
Confidence 99987543 7889999999999999999999 8899999999999999999999999999998876543 3566
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh-cccCCcccHHHHHHHHHHHHHhcc
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN-FQVADESEMEEIEVVAELASKCLR 427 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~l~~li~~cl~ 427 (496)
.+|||+|||||++....|..+.||||+|++.+||+.|.|||.....-..+..|.+ +......+...++.+++|+.+||+
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~ 508 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV 508 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence 7899999999999999999999999999999999999999987666666666654 344455666788999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 047375 428 IRGTERPTMKEVSE 441 (496)
Q Consensus 428 ~dP~~RPs~~eil~ 441 (496)
.||.+|||+.|+|+
T Consensus 509 ~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 509 VDVEQRASAKELLE 522 (550)
T ss_pred cchhcCCCHHHHhc
Confidence 99999999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=329.50 Aligned_cols=246 Identities=20% Similarity=0.267 Sum_probs=201.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|+-..++|+|+||.||+|+. .+|+.||||+|..+.+ ......+|+++|++++|||+|.++.+|......++|+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 44446799999999999995 4799999999976544 3344559999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
+. ++.+-|...... ++...+..++.|++.|+.|+|+ ++||||||||+||||+.+|.+||||||+|+.+......
T Consensus 84 dh-TvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 84 DH-TVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred ch-HHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 87 666666655443 5778899999999999999999 88999999999999999999999999999998753222
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc------------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF------------------ 404 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------------ 404 (496)
-+.++.|..|+|||.+.+ -.|....|+|+.||++.||++|.|.|.+..+-..+..|...
T Consensus 158 --YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 158 --YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred --hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 356779999999999998 67888899999999999999999999877665443333210
Q ss_pred ---ccCCcc--------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ---QVADES--------EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ---~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.++.+. ....+.-+.+|+..||..||++|++.++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 001111 1133457899999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=353.52 Aligned_cols=246 Identities=24% Similarity=0.251 Sum_probs=210.4
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecc----hh--hhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCA----DE--IRITEWEFLGIISQVK-HKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~--~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~ 257 (496)
..|.+.+.||+|+||+|+.|.. .++..||+|.+... .. ......+|+.+++.++ ||||++++.++......|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 4578889999999999999984 47899999966443 11 1223337999999999 999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-CceEEccCCCccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-YTAKVSDFESLVP 336 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-~~~kL~DFGla~~ 336 (496)
+|||||.||+|.+++...+. +.+..+..++.|++.|+.|||+ ++|+||||||+|||++.+ +++||+|||++..
T Consensus 97 ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999988443 6778999999999999999999 889999999999999999 9999999999988
Q ss_pred cCCCCCccceecccccceeecCccccccc-cc-CCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHH
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTEL-LT-GMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEE 414 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~t-~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 414 (496)
... ......+.+||+.|+|||++.+.. |+ .+.|+||+|+++|.|++|..||........+..+....+..+....
T Consensus 171 ~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~- 247 (370)
T KOG0583|consen 171 SPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL- 247 (370)
T ss_pred cCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC-
Confidence 741 223356778999999999999977 86 5789999999999999999999987777777777766655554433
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
++++..|+.+||..||.+|+|+.+|+
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 78899999999999999999999994
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.99 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=204.0
Q ss_pred HhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeC-Ce
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLET-KV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~-~~ 255 (496)
..|.+.+.||+|+||.||+|.+ ..+..||||++..... ......+|+.++..+ +||||++++++|... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 4477788999999999999973 2356799999864322 223445889999999 899999999998764 45
Q ss_pred eeEEEeeccCCchhhhhhhcCc----------------------------------------------------------
Q 047375 256 TLLVYEFVSNGALSHYIHDKSS---------------------------------------------------------- 277 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~---------------------------------------------------------- 277 (496)
.++|||||++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 7899999999999999975321
Q ss_pred -ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccceee
Q 047375 278 -QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYL 356 (496)
Q Consensus 278 -~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 356 (496)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...............+|+.|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 1236778889999999999999999 789999999999999999999999999998764332222222334678899
Q ss_pred cCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCC
Q 047375 357 DPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPT 435 (496)
Q Consensus 357 aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 435 (496)
|||++.+..++.++|+||+|+++|++++ +.+||........+............+...++.+.+|+.+||+.||.+|||
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999999899999999999999999986 888876544333333332222222223345677999999999999999999
Q ss_pred HHHHHHHHHhhHh
Q 047375 436 MKEVSEELDRLRR 448 (496)
Q Consensus 436 ~~eil~~L~~l~~ 448 (496)
+.+|++.|+.+..
T Consensus 324 ~~el~~~l~~~~~ 336 (338)
T cd05102 324 FSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.91 Aligned_cols=249 Identities=21% Similarity=0.243 Sum_probs=206.1
Q ss_pred HhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLET--KVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv 259 (496)
..|.-.++||+|+||.||+|+ ..+|+.||+|++..... ......+|+.||++|+||||++|.+..... ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345556889999999999999 56899999999865432 233445999999999999999999999876 689999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
+|||+. +|.-++.... ..++..++..++.|++.||.|||+ ++|+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 197 FeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999988 9998887543 347889999999999999999999 8899999999999999999999999999998876
Q ss_pred CCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--c----------c
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--Q----------V 406 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~----------~ 406 (496)
..... .+..+-|..|.|||.+.+ ..|+...|+||.||++.||+.|.|.+.+..+-..+..|..- . +
T Consensus 271 ~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 271 SGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 54333 455568999999999998 57899999999999999999999999998877766666521 0 0
Q ss_pred C--------Ccc-------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 407 A--------DES-------EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 407 ~--------~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+ .+. ....+....+|+..+|..||.+|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 000 0122367889999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.63 Aligned_cols=246 Identities=22% Similarity=0.231 Sum_probs=206.3
Q ss_pred hcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+|.-.+.||+|.||.||+|+ ..+|+.||||+++..... .....+|++.|+.++||||+.++++|...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 35556789999999999999 468999999999765333 45566999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
++. +|...+++... .++...+..++.++++||+|||. +.|+||||||.|+||+.+|.+||+|||+|+.+.+...
T Consensus 83 m~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 986 99999987653 47788999999999999999999 7899999999999999999999999999999877644
Q ss_pred ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc---C-----------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV---A----------- 407 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~---~----------- 407 (496)
.. +..+-|..|.|||.+.| ..|+...|+||.||++.|++.+.|.|.+..+-+.+..|...-. .
T Consensus 157 ~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 157 IQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 33 23367999999999887 6788899999999999999999999988777665555442100 0
Q ss_pred --------Cc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 408 --------DE----SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 408 --------~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.+ ....+++.+.+|+.+|+.+||.+|+|+.|++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 00 1113346789999999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=335.88 Aligned_cols=253 Identities=20% Similarity=0.218 Sum_probs=211.2
Q ss_pred HhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhh--hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIR--ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|++...||.|..++||+|+ .+.+..||||++.-..... ....+|+..|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 348888999999999999999 4678999999996543332 3344899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|.+|++.+++...-... +++..+..|.+++++||.|||. +|.||||||+.||||+.+|.|||+|||.+..+.....
T Consensus 106 Ma~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999998865443 7889999999999999999999 8899999999999999999999999998776655432
Q ss_pred cc-ce-ecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--------Ccc
Q 047375 343 TA-MS-TMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--------DES 410 (496)
Q Consensus 343 ~~-~~-~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--------~~~ 410 (496)
.. .. ..++||++|||||++.. ..|+.|+||||+|++..|+.+|..||........+..-++...+ ...
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 21 12 56789999999999544 67999999999999999999999999877665555444443332 222
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
....+..++++|..||+.||.+|||+.++++.
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 33455789999999999999999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=349.17 Aligned_cols=242 Identities=24% Similarity=0.250 Sum_probs=211.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh---hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR---ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|+||.||||+. .+.+.||+|.+.+..... ....+|++|++.++|||||.++++|+...++|+|.|||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 55667899999999999994 467889999886543322 33458999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
.| +|..+|...+. ++++.+..|+.+++.||.|||+ ++|+|||+||.|||++.+|++|+||||+|+.... .+
T Consensus 84 ~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 84 VG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred hh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 77 99999988765 7899999999999999999999 8899999999999999999999999999998866 34
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
...+.+.|||.|||||.+.+..|+..+|.||+||++||++.|.|||....-......|.......+ ...+..+..|+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p--~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP--STASSSFVNFLQ 232 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc--ccccHHHHHHHH
Confidence 456778899999999999999999999999999999999999999998766666666665444333 367788999999
Q ss_pred HhcccCCCCCCCHHHHH
Q 047375 424 KCLRIRGTERPTMKEVS 440 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil 440 (496)
..|..||.+|.|..+++
T Consensus 233 gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLL 249 (808)
T ss_pred HHhhcChhhcccHHHHh
Confidence 99999999999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=336.57 Aligned_cols=261 Identities=21% Similarity=0.250 Sum_probs=214.9
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh---------------hhHHHHHHHHhcCCCCceeeEEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR---------------ITEWEFLGIISQVKHKNVVKILGL 249 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~hpnIv~l~~~ 249 (496)
+.|.+.+.||+|.||.|-+|+. .+++.||||++....... ....+|+.+|++++|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 4577888999999999999994 478999999985432111 234589999999999999999999
Q ss_pred Eee--CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceE
Q 047375 250 CLE--TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAK 327 (496)
Q Consensus 250 ~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~k 327 (496)
..+ .+.+|||+|||..|.+...-... ..+++.+++.++++++.||.|||. ++||||||||+|+||+++|+||
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~---~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDK---PELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCc---ccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEE
Confidence 876 45789999999988876443222 227889999999999999999999 8899999999999999999999
Q ss_pred EccCCCccccCCCCC---ccceecccccceeecCccccc---cccc-CCCCCchhhhhcccccccccchhhhcccchhhh
Q 047375 328 VSDFESLVPISSDDE---TAMSTMIRGTVGYLDPEYAHT---ELLT-GMNPNSYVALASNEKISMVPYFLDSIENNSFRQ 400 (496)
Q Consensus 328 L~DFGla~~~~~~~~---~~~~~~~~gt~~Y~aPE~l~~---~~~t-~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|+|||.+........ .......+|||.|+|||.+.+ ..+. .+.|+|++|+++|+++.|..||.+......+.+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 999999876633211 111223569999999999987 3343 468999999999999999999999999999999
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcccc
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEES 462 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~ 462 (496)
|.+..+..+...+..+.+++||.++|..||++|.+..+| ..++|-.......
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i----------k~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDI----------KLHPWVTRDGDSP 382 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhh----------eecceeccCCCCC
Confidence 999888888887888999999999999999999998887 4566665554433
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=347.94 Aligned_cols=239 Identities=23% Similarity=0.295 Sum_probs=208.6
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchhhh
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHY 271 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 271 (496)
+-||+|+.|.||+|++ .++.||||++.... ..+++.|++|+|||||.+.|+|.....+|||||||..|-|.++
T Consensus 130 eWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 4599999999999999 68899999874322 2347889999999999999999999999999999999999999
Q ss_pred hhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccc
Q 047375 272 IHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRG 351 (496)
Q Consensus 272 l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 351 (496)
|+.... +.......+..+||.|+.|||. +.|||||||.-||||..+..|||+|||.++..... .....++|
T Consensus 203 Lka~~~---itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 203 LKAGRP---ITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred HhccCc---cCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 987543 5567788999999999999999 78999999999999999999999999999877543 23456789
Q ss_pred cceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCC
Q 047375 352 TVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGT 431 (496)
Q Consensus 352 t~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 431 (496)
|..|||||++.++..+.|.||||+|+++|||+++..|+.+......+-.+-...+..+.+..+++.++-|+++||+..|.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR 353 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR 353 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999999999999998776555555555555666777788889999999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 047375 432 ERPTMKEVSEELDRL 446 (496)
Q Consensus 432 ~RPs~~eil~~L~~l 446 (496)
+|||+.+|+..|+-.
T Consensus 354 NRPSFrqil~HldIa 368 (904)
T KOG4721|consen 354 NRPSFRQILLHLDIA 368 (904)
T ss_pred CCccHHHHHHHHhhc
Confidence 999999999998643
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=334.99 Aligned_cols=246 Identities=15% Similarity=0.176 Sum_probs=205.2
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhh----hhHHHHHHHHhcCCCCceeeEEEEEee----CCeeeEEEeec
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIR----ITEWEFLGIISQVKHKNVVKILGLCLE----TKVTLLVYEFV 263 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~E~~ 263 (496)
..||+|++|.||+|.+ +|..||||.+....... ..+.+|+.+|.+++||||++++|++.+ ....++|||||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4699999999999998 78999999986543322 334489999999999999999999977 34678999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++.... .+++.....++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999997653 368889999999999999999973 368899999999999999999999999988654321
Q ss_pred cceecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
....||+.|+|||++.+ ..++.++|+||+|+++|++++|..||........+..+.......+.+..+++.+.+|
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 254 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCI 254 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHH
Confidence 23358999999999976 6789999999999999999999999987655555555544433334444567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 422 ASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
+.+||+.||.+|||+.|+++.|+.+..
T Consensus 255 i~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 255 VEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 999999999999999999999987753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=329.47 Aligned_cols=249 Identities=21% Similarity=0.263 Sum_probs=217.2
Q ss_pred HHHHHHhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCe
Q 047375 181 SELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKV 255 (496)
Q Consensus 181 ~~l~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 255 (496)
..-++.+|.+.+.||+|+||+|-+|. ...|+.||||.+....-. -....+|++||+.|+||||+.+|.+|.+.+.
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 33456779999999999999999998 468999999988654322 2233489999999999999999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
..|||||..+|.|++|+..++. +++.++..+++||..|+.|||. ++++|||||.+|||+|.++++||+|||++.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhh
Confidence 9999999999999999988664 7899999999999999999999 889999999999999999999999999998
Q ss_pred ccCCCCCccceecccccceeecCcccccccccC-CCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHH
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTG-MNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEE 414 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~-~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 414 (496)
.+... ....++||+|.|.+||++.+..|+| ..|-||+|+++|.++.|..||.+........+|..+.+..+...
T Consensus 202 ly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~P-- 276 (668)
T KOG0611|consen 202 LYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETP-- 276 (668)
T ss_pred hhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCC--
Confidence 87643 3457899999999999999999976 57899999999999999999998877777788877766655332
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....-||++||..||++|.|+.+|..
T Consensus 277 -SdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 277 -SDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -chHHHHHHHHHhcCcccchhHHHHhh
Confidence 34788999999999999999999854
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=341.23 Aligned_cols=249 Identities=21% Similarity=0.247 Sum_probs=219.2
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCe-eeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKV-TLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-~~lv~E 261 (496)
.|.+.+.+|+|+||.++.++++ ++..+++|++.-.. ..+....+|+.++++++|||||.+.+.|..++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4677889999999999999853 57789999886432 233345689999999999999999999998887 999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||+||+|.+.+.+.. ...++++.+..++.|++.|+.|||+ ++|+|||||+.||+++.++.|||+|||+|+.+....
T Consensus 85 Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred ecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999998866 3457999999999999999999998 789999999999999999999999999999987653
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
....+++||+.||+||++.+..|..++|+||+||++|||++..+.|..........+|.... ..+.+...+.+++.+
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSL 237 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHH
Confidence 23456779999999999999999999999999999999999999999988877777777655 455566777889999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~ 442 (496)
|..||..+|..||++.+++..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999987
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=338.66 Aligned_cols=246 Identities=20% Similarity=0.222 Sum_probs=207.0
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|.-.+.||+|+||.||+|.. .+++.||+|.+.-.... .....+|+.+|..++++||.++||.+..+..++++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 33447899999999999995 57889999998643322 2334478999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
||++.+.|..... +.+..+.-|+++++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+..+......
T Consensus 95 gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r- 167 (467)
T KOG0201|consen 95 GGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR- 167 (467)
T ss_pred CcchhhhhccCCC---CccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc-
Confidence 9999999976542 4667777899999999999999 78999999999999999999999999999888664332
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
..+++|||.|||||++....|+.++||||+|++.+||.+|.||+........+..|- ...++.....+++.+++|+..
T Consensus 168 -r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 168 -RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred -cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHH
Confidence 367889999999999999999999999999999999999999998776643333332 233333344777889999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 047375 425 CLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~ 442 (496)
||+.||+.||||.++++.
T Consensus 246 CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HhhcCcccCcCHHHHhhh
Confidence 999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=345.80 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=204.0
Q ss_pred HhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 256 (496)
..+.+.+.||+|+||.||+|.+ .++..||||++..... ......+|+.++..+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3477889999999999999963 2456899999864332 223345889999999 899999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc-----------------------------------------------------------
Q 047375 257 LLVYEFVSNGALSHYIHDKSS----------------------------------------------------------- 277 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~----------------------------------------------------------- 277 (496)
++|||||++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999865321
Q ss_pred -------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 278 -------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 278 -------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1236788899999999999999999 789999999999999999999999999998765432222
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......++..|+|||++.+..++.++|+||+|++++++++ +.+||........+............+...+.++.+|+.
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 351 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK 351 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHH
Confidence 2222335678999999999999999999999999999987 777776544333333443333222222334567999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHh
Q 047375 424 KCLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~~ 445 (496)
+||+.||++|||+.+|++.|+.
T Consensus 352 ~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHccCChhHCcCHHHHHHHHHh
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=343.52 Aligned_cols=256 Identities=18% Similarity=0.165 Sum_probs=219.0
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.+++.||.|+.|.|-+|++ .+|+.+|||.+..... ......+|+-+|+-+.||||+++|+++.++.++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 56678899999999999995 5899999999865422 122334889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|.|.+++-.++. +++.++.++++||+.|+.|||. .+|+||||||+|+|||..+++||+|||+|.....+
T Consensus 94 v~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred cCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 999999999988764 7889999999999999999999 67999999999999999999999999999876543
Q ss_pred ccceecccccceeecCcccccccccC-CCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTG-MNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~-~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
....+.||+|.|.|||++.+..|.| ++|+||.|+++|.+++|..||.+.+-...+.++..+.+.-+ ...+.++++|
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP--s~Is~eaQdL 242 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP--SNISSEAQDL 242 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC--CcCCHHHHHH
Confidence 2345678999999999999999976 78999999999999999999987776677777766554433 5667889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcccccc
Q 047375 422 ASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEESEH 464 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~~~ 464 (496)
+.+|+..||..|.|+.|| ..|+|....+.....
T Consensus 243 Lr~ml~VDp~~RiT~~eI----------~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEI----------LKHPFLSGYTSLPSS 275 (786)
T ss_pred HHHHhccCccccccHHHH----------hhCchhhcCCCCChh
Confidence 999999999999999998 567777766654444
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.18 Aligned_cols=244 Identities=22% Similarity=0.280 Sum_probs=213.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+++.+.||+|.||.||.|+. .++-.||+|++....- ...+..+|++|-+.|+||||+++|++|.+....|+++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 56778999999999999995 5678899999865432 223445889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
.++|+|...|...... .+++.....+..|+|.||.|+|. ++||||||||+|+|++..+..||+|||.+.....
T Consensus 104 a~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~--- 176 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 176 (281)
T ss_pred cCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC---
Confidence 9999999999865433 26778889999999999999999 8899999999999999999999999999877642
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
....+.|||..|.|||+..+...+...|+|++|++.|+++.|.+||........+.+|..-....+ ...+..+.++|
T Consensus 177 -~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p--~~is~~a~dlI 253 (281)
T KOG0580|consen 177 -NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP--STISGGAADLI 253 (281)
T ss_pred -CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC--cccChhHHHHH
Confidence 224677899999999999999999999999999999999999999999998899999987655544 55667899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+|+..+|.+|.+..|+++
T Consensus 254 ~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 254 SRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHHhccCccccccHHHHhh
Confidence 9999999999999988853
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=344.82 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=206.0
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 256 (496)
..+.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.+++.+ +|||||+++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 34777899999999999998741 335799999865332 223345889999999 899999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc-----------------------------------------------------------
Q 047375 257 LLVYEFVSNGALSHYIHDKSS----------------------------------------------------------- 277 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~----------------------------------------------------------- 277 (496)
|+|||||++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864311
Q ss_pred --------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecc
Q 047375 278 --------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMI 349 (496)
Q Consensus 278 --------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 349 (496)
...+++..+++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1236788899999999999999999 78999999999999999999999999998876443222222233
Q ss_pred cccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhccc
Q 047375 350 RGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRI 428 (496)
Q Consensus 350 ~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~ 428 (496)
.+++.|||||++.+..++.++|+||+|+++|++++ |.+||........+............+...++.+.+++.+||+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 354 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNL 354 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCC
Confidence 35678999999988889999999999999999986 88888765544444444433333333333457899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhH
Q 047375 429 RGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 429 dP~~RPs~~eil~~L~~l~ 447 (496)
||.+|||+.+|++.|+++.
T Consensus 355 dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 355 EPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ChhhCcCHHHHHHHHHHHh
Confidence 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.72 Aligned_cols=256 Identities=20% Similarity=0.253 Sum_probs=198.0
Q ss_pred HhcchhhhcccCCceEEEEeEeCC-----------------CcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPD-----------------NTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKI 246 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l 246 (496)
..|.+.+.||+|+||.||+|.+.+ +..||+|.+.... .......+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 457778899999999999997532 3369999886532 223345589999999999999999
Q ss_pred EEEEeeCCeeeEEEeeccCCchhhhhhhcCc----------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCccc
Q 047375 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSS----------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310 (496)
Q Consensus 247 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH 310 (496)
++++.+.+..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+ ++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999999865321 1235778899999999999999999 78999
Q ss_pred CCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc--cccc
Q 047375 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS--MVPY 388 (496)
Q Consensus 311 rDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~--~~~~ 388 (496)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|+||+|++++++++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999886644322222233446889999999988889999999999999999875 3445
Q ss_pred hhhhcccchhhhhhh------cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 389 FLDSIENNSFRQILN------FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 389 ~~~~~~~~~~~~i~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
|...........+.. .......+..+++.+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 544332222221111 01111112234567999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=334.47 Aligned_cols=240 Identities=20% Similarity=0.153 Sum_probs=198.1
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+.||+|+||.||+|.. .++..||+|++..... ......+|+.++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 4788999999875322 1223447889999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 9999987643 36888999999999999999999 7899999999999999999999999999876432211 12
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
...+||+.|+|||++.+..++.++|+||+||++|+|++|..||...........+...... .+...++.+.+|+.+||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L 230 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLAGLL 230 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHc
Confidence 3456999999999999989999999999999999999999998765544444444433222 22345677999999999
Q ss_pred ccCCCCCC-----CHHHHHH
Q 047375 427 RIRGTERP-----TMKEVSE 441 (496)
Q Consensus 427 ~~dP~~RP-----s~~eil~ 441 (496)
+.||.+|| ++.++++
T Consensus 231 ~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 231 KKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred cCCHHHcCCCCCCCHHHHHc
Confidence 99999999 6787754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=338.68 Aligned_cols=253 Identities=19% Similarity=0.294 Sum_probs=207.4
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecc---hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCA---DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
..+...||+|+||+||+|.| ...||||.+.-. +.....+.+|+..+++-+|.||+-+.|+|..+.. .||+.+|+
T Consensus 394 v~l~~rIGsGsFGtV~Rg~w--hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 394 VLLGERIGSGSFGTVYRGRW--HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred hhccceeccccccceeeccc--ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence 34457899999999999998 357999998643 2333344589999999999999999999998887 89999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
|.+|+.+++.... .++....+.|+.|||+|+.|||. ++|||||||..||++.++++|||+|||++..-.......
T Consensus 471 GsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 471 GSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred Cchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 9999999987653 36778899999999999999999 889999999999999999999999999987654432333
Q ss_pred ceecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC---CcccHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA---DESEMEEIEVV 418 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~l 418 (496)
......|...|||||++.. ..|+..+|+|++|+++|||+++..|+.....+..+-.+-.+-.. .....+++..+
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m 625 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM 625 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence 3334458999999999875 67899999999999999999999998855555444443333111 12334566789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
++|+..||.+++++||.+.+|+..|+.+..
T Consensus 626 k~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 626 KRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 999999999999999999999998887765
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=342.42 Aligned_cols=239 Identities=23% Similarity=0.218 Sum_probs=203.7
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhh----hHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRI----TEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.+.+.+.||+|+||+|+++.. .+++.+|||.+++..-... ....|.+|+... +||.+++++..|.+.+++|+||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 366779999999999999995 4678999999876543322 222455555544 6999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+.||++..+.+.. .+++..+..++..|+.||.|||+ ++||+||||.+|||||.+|.+||+|||+++.....
T Consensus 449 ey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 449 EYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999999966555432 37889999999999999999999 88999999999999999999999999999976533
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
. ..++++||||.|||||++.+..|+...|||++|+++|+|+.|.+||.+..+++.+..|++..+..+ ...+.+...
T Consensus 522 g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP--~~ls~ea~~ 597 (694)
T KOG0694|consen 522 G--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP--RFLSKEAIA 597 (694)
T ss_pred C--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC--CcccHHHHH
Confidence 2 246789999999999999999999999999999999999999999999999999999987655444 345577999
Q ss_pred HHHHhcccCCCCCCCH
Q 047375 421 LASKCLRIRGTERPTM 436 (496)
Q Consensus 421 li~~cl~~dP~~RPs~ 436 (496)
++.++|..||++|..+
T Consensus 598 il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHhccCcccccCC
Confidence 9999999999999755
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=336.36 Aligned_cols=235 Identities=22% Similarity=0.198 Sum_probs=198.4
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|... +++.||+|.+..... ......+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 677889999999999999964 688999999865432 122344789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 100 VVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred CCCChHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 999999999976542 6778889999999999999999 789999999999999999999999999988764321
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
....||+.|+|||++.+..++.++|+||+|+++|+|++|.+||.+......+..+.......+ ...+..+.+|+
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li 246 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP--NWFDGRARDLV 246 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC--CCCCHHHHHHH
Confidence 234699999999999998899999999999999999999999977655555555555433322 22456789999
Q ss_pred HHhcccCCCCCCC
Q 047375 423 SKCLRIRGTERPT 435 (496)
Q Consensus 423 ~~cl~~dP~~RPs 435 (496)
.+||+.||.+||+
T Consensus 247 ~~~L~~dP~~R~~ 259 (329)
T PTZ00263 247 KGLLQTDHTKRLG 259 (329)
T ss_pred HHHhhcCHHHcCC
Confidence 9999999999997
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.81 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=207.2
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|... +++.||+|.+..... ......+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 566788999999999999964 688999999864322 122344789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 83 VPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99999999997654 36788889999999999999999 78999999999999999999999999998876432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.....||+.|+|||++.+..++.++|+||+|+++|++++|..||........+..+....... +...++.+.+|+
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li 229 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF--PRHLDLYAKDLI 229 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC--CccCCHHHHHHH
Confidence 123469999999999999889999999999999999999999988766555555555443322 223356799999
Q ss_pred HHhcccCCCCCCC-----HHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 423 SKCLRIRGTERPT-----MKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 423 ~~cl~~dP~~RPs-----~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
.+||+.||.+||+ +.++ ..+.|.+...+.
T Consensus 230 ~~~l~~dp~~R~~~~~~~~~~~----------l~h~~~~~~~~~ 263 (291)
T cd05612 230 KKLLVVDRTRRLGNMKNGADDV----------KNHRWFKSVDWD 263 (291)
T ss_pred HHHcCCCHHHccCCccCCHHHH----------hcCccccCCCHH
Confidence 9999999999995 5555 356677665553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=335.81 Aligned_cols=256 Identities=23% Similarity=0.285 Sum_probs=214.3
Q ss_pred hhhhcccCCceEEEEeEeCC--C---cEEEEEEeecc----hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 190 FHHCLGMGGFGSVYKGVLPD--N---TQVAVKKYMCA----DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+.++||+|+||.||+|.+.. + ..||||..... ......+.+|.++|++++|||||++||++.....++|||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 34789999999999999632 2 23899987742 223344558999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|+|.||+|.++|+.... .++..+..+++.++|.||+|||+ +++|||||-.+|+|++.++.+||+|||+++.-...
T Consensus 241 El~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 99999999999998764 36788999999999999999999 78999999999999999999999999998765421
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
... .....-...|+|||.+....|+.++|+||+|+++||+++ |..|+.+.........+....++.+.+...+..+.
T Consensus 316 ~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 316 VMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 111 111124578999999999999999999999999999987 67788777777777777665666666667778899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhh
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~ 452 (496)
.++.+||..||++||||.++.+.|+.+.....+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999776554
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=310.80 Aligned_cols=247 Identities=20% Similarity=0.215 Sum_probs=210.9
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
..|.+.+.||+|.|+.||++.. ++|+.+|+|.+....-. .....+|++|.+.++|||||++.+.+......|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 3467778999999999999984 57899999987543222 2233488999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCccccC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVPIS 338 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~~~ 338 (496)
++.||+|..-+-.+ ...++..+-..+.||+.+|.|+|. ++|||||+||+|+|+.+ .--+||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999997655443 236778888999999999999999 88999999999999943 3469999999999887
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--cCCcccHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--VADESEMEEIE 416 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 416 (496)
.. ......+|||+|||||++....|+...|+|+.|+++|.++.|.+||++......+++|..+. ++.+.+...++
T Consensus 165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 32 22355679999999999999999999999999999999999999999988888899988654 45556678889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.++|+++||..||.+|.|+.|.++
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhC
Confidence 9999999999999999999999875
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=307.49 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=210.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---------hhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---------EIRITEWEFLGIISQV-KHKNVVKILGLCLETKV 255 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~ 255 (496)
.|.-.+.||.|..++|-++.. .+|..+|+|++.... .......+|+.||+++ .||||+.+.+++..+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 355568899999999999885 578899999884321 1112223788999988 59999999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.++|+|.|+.|.|.++|... ..++++...+|++|+..|+.|||. ++||||||||+|||++++.++||+|||+|+
T Consensus 98 ~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred hhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999764 347899999999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCCccceecccccceeecCccccc------ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccC
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHT------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVA 407 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~ 407 (496)
.+..+. ..+..||||+|.|||.+.. ..|+...|.|+.|+++|.++.|.|||+....-..+..|+.+ .+.
T Consensus 172 ~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 172 QLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred ccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence 987653 2467889999999998875 55677889999999999999999999987666666677755 445
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.+.+.+...++||.+||+.||.+|.|++|++.
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 6677788999999999999999999999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=326.04 Aligned_cols=242 Identities=22% Similarity=0.176 Sum_probs=194.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|...+.||+|+||.||+|.. .++..||+|.+...... .....+|+.++..++||||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 45567899999999999985 57899999988643221 22344789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|..++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999999988865432 236889999999999999999999 7899999999999999999999999999887543211
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh--cccCCcccHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN--FQVADESEMEEIEVVAE 420 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~l~~ 420 (496)
.....||+.|+|||++.+..++.++|+||+|+++|++++|.+||...........+.. ...........++.+.+
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 2334699999999999998999999999999999999999999876543322222211 11112223345678999
Q ss_pred HHHHhcccCCCCCCCH
Q 047375 421 LASKCLRIRGTERPTM 436 (496)
Q Consensus 421 li~~cl~~dP~~RPs~ 436 (496)
|+.+||+.||.+||++
T Consensus 235 li~~~l~~~P~~R~~~ 250 (285)
T cd05631 235 ICRMLLTKNPKERLGC 250 (285)
T ss_pred HHHHHhhcCHHHhcCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.08 Aligned_cols=260 Identities=23% Similarity=0.289 Sum_probs=222.3
Q ss_pred cchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
..+.+.||+|.||+||+|+.. ....||||.++..... +..+.+|++++..++|||||+|+|+|..++..|+|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 355688999999999999853 3457999999866544 45666999999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCc-----------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 260 YEFVSNGALSHYIHDKSS-----------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
+|||..|||.++|+.+.+ +.+++..+.+.|+.|||.|+.||-+ +.+|||||-.+|+||.++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEe
Confidence 999999999999986422 2347788999999999999999999 77999999999999999999999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccC
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
+|||+++.+-+.+.......-.-...|||||.+....+|.++|+||+|+++||+++ |.-|+.+....+.+..+.++.+
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l- 723 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL- 723 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-
Confidence 99999998765433332222224678999999999999999999999999999976 4667777777888888888777
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhh
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 451 (496)
.+.+.+++.++.+|+..||+.+|.+||++.||-..|+......+
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 78888999999999999999999999999999999998765443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=309.74 Aligned_cols=245 Identities=20% Similarity=0.202 Sum_probs=201.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E 261 (496)
|...+.|++|+||.||+|+. .+++.||+|+++...+ ......+|+.+|.+++|||||.+-.+... -+..|||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 33346799999999999995 5788999999975543 23455699999999999999999988764 457999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||+. +|..++..... ++...++..++.|+++||.|||. +.|+||||||+|+|++..|.+||+|||+|+.+.+..
T Consensus 158 ~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9987 99999987653 36778889999999999999999 779999999999999999999999999999987652
Q ss_pred CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc----------cCCc-
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ----------VADE- 409 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~~- 409 (496)
...+..+-|..|.|||.+.+ ..|+...|+||+||++.|++.+.|.|.+..+-..+.+|..-- +...
T Consensus 232 --k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 --KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred --ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 23456678999999999988 678999999999999999999999998887766666654210 0000
Q ss_pred ---------cc---------H-HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 410 ---------SE---------M-EEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 410 ---------~~---------~-~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.+ . ..++.-.+|+..+|.+||.+|.|+.+.|
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 00 0 1236678999999999999999999984
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=329.78 Aligned_cols=236 Identities=22% Similarity=0.186 Sum_probs=195.0
Q ss_pred cccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 194 LGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
||+|+||.||+|... ++..||+|.+..... ......+|+.++..++||||+++++++...+..|+|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 678999999864321 122344788999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 99997643 26888999999999999999999 7899999999999999999999999999876433221 2344
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhccc
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRI 428 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~ 428 (496)
.+||+.|+|||++.+..++.++|+||+|+++|++++|.+||........+..+...... .+...++.+.+++.+||+.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~ 230 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKDLLIGLLSR 230 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHHcCC
Confidence 56999999999999999999999999999999999999999776555555555443322 2334557799999999999
Q ss_pred CCCCCCCHHHH
Q 047375 429 RGTERPTMKEV 439 (496)
Q Consensus 429 dP~~RPs~~ei 439 (496)
||.+||++..+
T Consensus 231 dp~~R~~~~~~ 241 (312)
T cd05585 231 DPTRRLGYNGA 241 (312)
T ss_pred CHHHcCCCCCH
Confidence 99999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=316.78 Aligned_cols=262 Identities=22% Similarity=0.184 Sum_probs=220.6
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh----hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR----ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
..+++.+.||.|.-|+||++... ++..+|+|++....-.. .+...|-+||+.++||.++.||..|...+..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 34556688999999999999964 46889999986543322 23336778999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC-
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS- 339 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~- 339 (496)
|||+||+|..+++++.... +++..++.++.+++-||+|||- .|||.|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~-fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKR-FSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCCc-cchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999988776544 7889999999999999999999 6799999999999999999999999987653211
Q ss_pred --------------------------------CCC---------------------ccceecccccceeecCcccccccc
Q 047375 340 --------------------------------DDE---------------------TAMSTMIRGTVGYLDPEYAHTELL 366 (496)
Q Consensus 340 --------------------------------~~~---------------------~~~~~~~~gt~~Y~aPE~l~~~~~ 366 (496)
... ...+..++||-.|.|||++.++..
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011234679999999999999999
Q ss_pred cCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 047375 367 TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPT----MKEVSEE 442 (496)
Q Consensus 367 t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~~ 442 (496)
+...|||.+|+.+|||+.|..||.+......+..|+......+.....+..+++||+++|..||.+|.. +.||
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI--- 389 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI--- 389 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh---
Confidence 999999999999999999999999999999999999888777777788889999999999999999987 5555
Q ss_pred HHhhHhhhhhhhhccCccc
Q 047375 443 LDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 443 L~~l~~~~~~~~~~~~~~~ 461 (496)
..|++++..+|.
T Consensus 390 -------K~HpFF~gVnWa 401 (459)
T KOG0610|consen 390 -------KRHPFFEGVNWA 401 (459)
T ss_pred -------hcCccccCCChh
Confidence 455666666654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=347.42 Aligned_cols=256 Identities=22% Similarity=0.249 Sum_probs=212.5
Q ss_pred cchhhhcccCCceEEEEeEeCCC-cEEEEEEeecchhhhhhHH-HHHHHHhcCC-CCceeeEEEEEe-e---C---Ceee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDN-TQVAVKKYMCADEIRITEW-EFLGIISQVK-HKNVVKILGLCL-E---T---KVTL 257 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~-~e~~~l~~l~-hpnIv~l~~~~~-~---~---~~~~ 257 (496)
..+.+.|.+|||+.||.|....+ ..||+|++...++...... +|+++|+.|+ |+|||.+++... . . -..+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 56678999999999999997555 9999999876655544444 9999999997 999999999432 1 1 2567
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
|.||||.||.|-+++..+.... +++.++++|+.++|+|+.+||.+. .+|||||||-+||||+.+++.||||||.+...
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred eehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 9999999999999999765544 899999999999999999999977 78999999999999999999999999988765
Q ss_pred CCCCCccce-------ecccccceeecCcccc---cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC
Q 047375 338 SSDDETAMS-------TMIRGTVGYLDPEYAH---TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 338 ~~~~~~~~~-------~~~~gt~~Y~aPE~l~---~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
......... -....|+.|+|||++. +..++.|+|||++||++|.++....||... .-..|++..+.
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s----g~laIlng~Y~ 272 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES----GKLAILNGNYS 272 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC----cceeEEecccc
Confidence 433211110 0123799999999874 578889999999999999999999888653 23467777777
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+.....+..+.+||..||+.||.+||++-+++..+-++...
T Consensus 273 ~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 273 FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 777788899999999999999999999999999999888654
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=338.27 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=204.5
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCC-CCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVK-HKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~ 256 (496)
..+.+.+.||+|+||.||+|... .+..||||++...... .....+|+.++..+. ||||++++++|...+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 45677799999999999999842 2346999998643322 234458999999996 99999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc-----------------------------------------------------------
Q 047375 257 LLVYEFVSNGALSHYIHDKSS----------------------------------------------------------- 277 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~----------------------------------------------------------- 277 (496)
|||||||++|+|.+++.....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 999999999999998865311
Q ss_pred ----------------------------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC
Q 047375 278 ----------------------------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN 323 (496)
Q Consensus 278 ----------------------------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~ 323 (496)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCC
Confidence 1136778889999999999999999 789999999999999999
Q ss_pred CceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhh
Q 047375 324 YTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQIL 402 (496)
Q Consensus 324 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~ 402 (496)
+.+||+|||+++...............+++.|+|||++.+..++.++|+||+|++++++++ +..||........+....
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~ 353 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI 353 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence 9999999999887644322222233347788999999998889999999999999999985 767765543333333333
Q ss_pred hcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 403 NFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 403 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
......+.+...+..+.+++.+||+.||++|||+.+|.+.|+++.
T Consensus 354 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 354 KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 222233334455678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=333.53 Aligned_cols=241 Identities=22% Similarity=0.206 Sum_probs=200.2
Q ss_pred hcchhhhcccCCceEEEEeEeCC--CcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPD--NTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|.+.. +..||+|.+..... ......+|+.++..++||||+++++++.+.+..|+||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 37778899999999999998532 36899998864322 1223347899999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|.+++..... +++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 111 Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred eCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999976543 6888899999999999999999 78999999999999999999999999998876432
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
.....||+.|+|||++.+..++.++|+||+|+++|+|++|.+||........+..+....... +...++.+.+
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~ 257 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF--PKFLDNNCKH 257 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCHHHHH
Confidence 234569999999999998889999999999999999999999998765555555555443322 2234567899
Q ss_pred HHHHhcccCCCCCC-----CHHHHH
Q 047375 421 LASKCLRIRGTERP-----TMKEVS 440 (496)
Q Consensus 421 li~~cl~~dP~~RP-----s~~eil 440 (496)
++.+||+.||.+|+ |+.+++
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHH
Confidence 99999999999995 676663
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=321.65 Aligned_cols=254 Identities=17% Similarity=0.255 Sum_probs=204.2
Q ss_pred HhcchhhhcccCCceEEEEeEeC----CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
..+.+.+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.++..++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778889999999999999752 356899998865422 223455889999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999976532 36889999999999999999999 7899999999999999999999999998765432
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhccccc-ccccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKI-SMVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
... .......++..|+|||.+.+..++.++|+||+|+++++++ .|.+||...........+.+. ...+.+..++..+
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPAPRNCPNLL 237 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHH
Confidence 211 1112233567899999999989999999999999999965 488888665444433333322 2223344566789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
.+++.+||+.+|.+|||+.+|++.|.++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=328.96 Aligned_cols=248 Identities=24% Similarity=0.243 Sum_probs=218.7
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh----hhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeee
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI----RITEWEFLGIISQVK-HKNVVKILGLCLETKVTL 257 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~ 257 (496)
....|.+.+.||.|.||.||++... +|+.+|+|.+...... .....+|+.+|+++. |||||.++++|.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3445888899999999999999964 5999999998655432 234558999999998 999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC----CCceEEccCCC
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD----NYTAKVSDFES 333 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~----~~~~kL~DFGl 333 (496)
+|||+|.||.|.+.+... . +++..+..++.|++.++.|||+ .+|+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999876 1 7889999999999999999999 78999999999999953 35799999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--cCCccc
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--VADESE 411 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~ 411 (496)
+..... .......+||+.|+|||++....|+...|+||.|+++|.|++|.+||.+......+..+.... +..+.+
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w 262 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW 262 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc
Confidence 998865 223567789999999999999999999999999999999999999999998888888887654 456667
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...+..+.++|..|+..||..|+|+.++++
T Consensus 263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 263 DDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred cccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 788899999999999999999999999976
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=317.75 Aligned_cols=244 Identities=21% Similarity=0.234 Sum_probs=194.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC-----eeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETK-----VTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv~E 261 (496)
+.-.+++|+|+||.||+|.. .+++.||||+......... +|+.+|+.++|||||++.-+|.... ...+|||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn---rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN---RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc---HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 44457899999999999995 4578999999876555443 6788999999999999998886422 3358999
Q ss_pred eccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-CceEEccCCCccccCC
Q 047375 262 FVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-YTAKVSDFESLVPISS 339 (496)
Q Consensus 262 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-~~~kL~DFGla~~~~~ 339 (496)
|+|. +|..+++.. .....++.-.+.-+..||++||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|+.+..
T Consensus 103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9997 999999852 111235666778899999999999999 789999999999999976 8999999999999876
Q ss_pred CCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--------------
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF-------------- 404 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~-------------- 404 (496)
+... ..+..|..|+|||.+.+ ..||.+.|+||.||++.||+.|.+.|.+......+..|.+-
T Consensus 179 ~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 179 GEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred CCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 5433 34557999999999988 78999999999999999999999999887665555444321
Q ss_pred c--------cCC-c----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 Q--------VAD-E----SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ~--------~~~-~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
. +.. + .....++++.+|+.++|.++|.+|.++.|++.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 000 0 11233478999999999999999999999874
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=331.07 Aligned_cols=244 Identities=18% Similarity=0.207 Sum_probs=201.6
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|... ++..||+|++..... ......+|+.++..++||||+++++++...+..|+||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 667789999999999999964 588999999865422 122344788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 83 VPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999997643 36788899999999999999999 7899999999999999999999999999876543
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc--CCcc----cHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV--ADES----EMEEIE 416 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~----~~~~~~ 416 (496)
......||+.|+|||++.+..++.++|+||+|+++|+|++|.+||........+..+..... ..+. ....++
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 12345699999999999998999999999999999999999999876555444444432211 1111 124467
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
.+.+++.+||..+|.+|||+.++++.
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 89999999999999999999988653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=347.64 Aligned_cols=250 Identities=19% Similarity=0.166 Sum_probs=205.3
Q ss_pred cchhhhcccCCceEEEEeEeC-C-CcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-D-NTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|.+.+.||+|+||.||+|... + +..||+|.+....... ....+|+.+++.++|||||+++++|...+..||||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777889999999999999853 3 6778888765443332 233478999999999999999999999999999999999
Q ss_pred CCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 265 NGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 265 ~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
+|+|.+++... ....++++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988653 223347888999999999999999999 78999999999999999999999999999876543222
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......+||+.|+|||++.+..++.++|+||+||++++|+++..||........+..+...... +.+...+..+.+||.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~ 304 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLD 304 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHHHH
Confidence 2334567999999999999989999999999999999999999998765554445555443322 223345578999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~ 441 (496)
+||+.||.+|||+.+++.
T Consensus 305 ~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 305 PLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHhccChhhCcCHHHHHh
Confidence 999999999999999875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.52 Aligned_cols=255 Identities=17% Similarity=0.257 Sum_probs=207.4
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..+.+.+.||+|+||.||+|...++..||+|.+...........+|+.+++.++||||+++++++...+..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 34677789999999999999987788899998865444444556889999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......... .
T Consensus 86 ~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 160 (261)
T cd05072 86 GSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-A 160 (261)
T ss_pred CcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-c
Confidence 999999976432 236788899999999999999999 78999999999999999999999999999876543211 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....++..|+|||++.+..++.+.|+||+|+++|++++ +..||...........+... ...+.....+..+.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELYDIMKT 239 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 222346778999999988888999999999999999997 88887654443333333322 2222223455679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l 446 (496)
||..+|++|||+.++.+.|+.+
T Consensus 240 ~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 240 CWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.88 Aligned_cols=239 Identities=22% Similarity=0.286 Sum_probs=206.4
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh----hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR----ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.+.||.|+||.||-|+. .+...||||++.-+.... .....|+..|.+++|||+|.+-|+|......|||||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 46799999999999995 577889999986543322 334588999999999999999999999999999999995
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+-.+++.-... ++.+..+..|+.+.+.||.|||+ ++.||||||..|||+++.|.|||+|||.|....+
T Consensus 110 GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------ 178 (948)
T KOG0577|consen 110 GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ 178 (948)
T ss_pred ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc------
Confidence 588888876543 46778889999999999999999 7899999999999999999999999998877644
Q ss_pred eecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
...++|||+|||||++.. +.|+++.|+||+|+++.++....||..+.+....+..|.....+.-...+.+..++.|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 356789999999998864 78999999999999999999999998888777777777765555555667788899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
..||+.-|.+|||..+++.
T Consensus 259 d~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHhhCcccCCcHHHHhh
Confidence 9999999999999998875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=316.37 Aligned_cols=249 Identities=22% Similarity=0.240 Sum_probs=203.8
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
+.+.+.||+|+||.||++.+.++..+|+|.+...........+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 56678899999999999998777889999876544444455689999999999999999999999999999999999999
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcccee
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 347 (496)
|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.++........ ...
T Consensus 86 L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~ 159 (256)
T cd05114 86 LLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSS 159 (256)
T ss_pred HHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccC
Confidence 9999876432 36889999999999999999999 78999999999999999999999999998865432211 112
Q ss_pred cccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 348 MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 348 ~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
...++..|+|||++.+..++.++|+||+|++++++++ +.+||...........+..... ...+...+..+.+++.+||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~c~ 238 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-LYRPKLASMTVYEVMYSCW 238 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHc
Confidence 2235678999999998889999999999999999998 7888766554444444443221 1112233467999999999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 047375 427 RIRGTERPTMKEVSEEL 443 (496)
Q Consensus 427 ~~dP~~RPs~~eil~~L 443 (496)
+.+|.+|||+.++++.|
T Consensus 239 ~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 239 HEKPEGRPTFAELLRAI 255 (256)
T ss_pred cCCcccCcCHHHHHHhh
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=312.29 Aligned_cols=243 Identities=20% Similarity=0.220 Sum_probs=199.7
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEee-----CCeeeEEEe
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLE-----TKVTLLVYE 261 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-----~~~~~lv~E 261 (496)
.+.||.|+||.|..+.. .+|..||||++...- ....+..+|+++|+.++|+||+.+++++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 57899999999999984 578999999987332 233455699999999999999999999875 346899999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
+|+ .+|.+.++.... ++...+..++.||++||.|+|+ .+|+||||||+|+|++.+..+||||||+|+......
T Consensus 107 lMe-tDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LME-TDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HHh-hHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 995 499999987543 7788999999999999999999 779999999999999999999999999999986543
Q ss_pred CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC------------
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD------------ 408 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~------------ 408 (496)
.....+.++-|..|.|||++.. ..||...|+||.||++.||+++.+.|.+...-..+..|+.-...+
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 3444577789999999998865 789999999999999999999999998776555444443211110
Q ss_pred ------------cc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 409 ------------ES-----EMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 409 ------------~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
+. .....+...+|+.+||..||.+|+|++|++
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 00 012236789999999999999999999985
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.14 Aligned_cols=240 Identities=20% Similarity=0.158 Sum_probs=197.3
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+.||+|+||.||++.. .+|..||+|.+..... ......+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999985 4688999999865322 1223347889999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 9998887643 36889999999999999999999 7899999999999999999999999999875432211 12
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
....||+.|+|||++.+..++.++|+||+|+++|++++|..||...........+...... .+...++.+.+++.+||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L 230 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLL 230 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHc
Confidence 3456999999999999989999999999999999999999998766555444544433322 22345677999999999
Q ss_pred ccCCCCCC-----CHHHHHH
Q 047375 427 RIRGTERP-----TMKEVSE 441 (496)
Q Consensus 427 ~~dP~~RP-----s~~eil~ 441 (496)
+.||.+|| ++.++++
T Consensus 231 ~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 231 KKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred cCCHHHhCCCCCCCHHHHHc
Confidence 99999998 7777754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=328.86 Aligned_cols=240 Identities=21% Similarity=0.155 Sum_probs=196.9
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+.||+|+||.||++.. .++..||+|++..... ......+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 4688999999865322 1223447889999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 9998886643 36888999999999999999999 789999999999999999999999999987643221 112
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
...+||+.|+|||++.+..++.++|+||+|+++|++++|..||...........+..... ..+...++.+.+|+.+||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L 230 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI--KFPRTLSADAKSLLSGLL 230 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc--cCCCCCCHHHHHHHHHHc
Confidence 345699999999999988899999999999999999999999876544444444433222 222345577999999999
Q ss_pred ccCCCCCC-----CHHHHHH
Q 047375 427 RIRGTERP-----TMKEVSE 441 (496)
Q Consensus 427 ~~dP~~RP-----s~~eil~ 441 (496)
+.||.+|| ++.++++
T Consensus 231 ~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 231 IKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHcCCCCCCCHHHHhc
Confidence 99999997 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=329.30 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=204.4
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcC-CCCceeeEEEEEee-CCe
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQV-KHKNVVKILGLCLE-TKV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpnIv~l~~~~~~-~~~ 255 (496)
..|.+.+.||+|+||.||+|... +++.||+|++...... ......|+.++.++ +||||++++++|.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 35778899999999999999732 3478999988643222 22344788999999 79999999998875 456
Q ss_pred eeEEEeeccCCchhhhhhhcCc----------------------------------------------------------
Q 047375 256 TLLVYEFVSNGALSHYIHDKSS---------------------------------------------------------- 277 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~---------------------------------------------------------- 277 (496)
.+++|||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999999864321
Q ss_pred ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccceeec
Q 047375 278 QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLD 357 (496)
Q Consensus 278 ~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 357 (496)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1246889999999999999999999 7899999999999999999999999999987644322222233446788999
Q ss_pred CcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCH
Q 047375 358 PEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTM 436 (496)
Q Consensus 358 PE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 436 (496)
||++.+..++.++|+||+||+++++++ +.+||........+............+...++.+.+++.+||+.+|++|||+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999999999999999999987 8888765433333333333222222233445779999999999999999999
Q ss_pred HHHHHHHHhhHh
Q 047375 437 KEVSEELDRLRR 448 (496)
Q Consensus 437 ~eil~~L~~l~~ 448 (496)
.||++.|+.+.+
T Consensus 324 ~ell~~l~~~~~ 335 (337)
T cd05054 324 SELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHHh
Confidence 999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.33 Aligned_cols=256 Identities=19% Similarity=0.263 Sum_probs=208.1
Q ss_pred HHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
...+.+.+.||+|+||.||+|...++..||+|.+...........+|+.++++++||||+++++++...+..|+||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 34577789999999999999998777889999986544334445588999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 85 YGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred CCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999976542 236889999999999999999999 78999999999999999999999999998876532111
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......++..|+|||++.+..++.++|+||+|++++++++ +..||.+.........+.. ....+.....+..+.+++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-GYRMPCPPGCPKELYDIML 238 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHH
Confidence 1111223468999999998889999999999999999998 8888766544433333322 2222233445678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhh
Q 047375 424 KCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~~l 446 (496)
+||+.+|.+||++.++++.|+.+
T Consensus 239 ~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 239 DCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=320.44 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=206.1
Q ss_pred hcchhhhcccCCceEEEEeEeCC------CcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPD------NTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
.+.+.+.||+|+||.||+|.... ...||+|.+..... ......+|+.++..++||||+++++++......|+
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 36677899999999999998532 25799998864332 22334588999999999999999999999889999
Q ss_pred EEeeccCCchhhhhhhcCcc-------------cccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc
Q 047375 259 VYEFVSNGALSHYIHDKSSQ-------------VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT 325 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~ 325 (496)
+|||+++|+|.+++...... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 99999999999999764221 236788899999999999999999 78999999999999999999
Q ss_pred eEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhc
Q 047375 326 AKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNF 404 (496)
Q Consensus 326 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~ 404 (496)
+||+|||++................+++.|+|||.+.+..++.++|+||+|+++|++++ +..||.+.........+...
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876543322222233457889999999988889999999999999999997 88787765544444444332
Q ss_pred ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 047375 405 QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 405 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 445 (496)
. ....+..+++.+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 243 ~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 243 Q-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred C-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2 233345567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=332.03 Aligned_cols=244 Identities=22% Similarity=0.304 Sum_probs=206.4
Q ss_pred hcccCCceEEEEeEe-CCCcEEEEEEeecchhhhh-hHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchhh
Q 047375 193 CLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRI-TEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSH 270 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~ 270 (496)
.||+|+||+||-|+. .+...+|||.+...+.... ...+|+.+.+.++|.|||+++|.|..++++-|.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 599999999999995 3566789998865443333 33488999999999999999999999999999999999999999
Q ss_pred hhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC-CCCceEEccCCCccccCCCCCccceecc
Q 047375 271 YIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAKVSDFESLVPISSDDETAMSTMI 349 (496)
Q Consensus 271 ~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~-~~~~~kL~DFGla~~~~~~~~~~~~~~~ 349 (496)
+|+..-.+..-++.++-.+..||++||.|||+ +.|||||||-+||||+ -.|.+||+|||.++.+..- ...+.++
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence 99987554434788889999999999999999 7799999999999995 5789999999999987653 3335667
Q ss_pred cccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 350 RGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 350 ~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
.||..|||||++.. ..|...+||||+||++.||.+|.|||....... .+-++--....++.+.+.+.+.+.+|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 79999999999976 467789999999999999999999998654332 233333456677888899999999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 047375 427 RIRGTERPTMKEVSE 441 (496)
Q Consensus 427 ~~dP~~RPs~~eil~ 441 (496)
..||.+||++.+++.
T Consensus 817 epd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcccCccHHHhcc
Confidence 999999999999975
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=326.18 Aligned_cols=237 Identities=23% Similarity=0.208 Sum_probs=192.5
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh----hhHHHH-HHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR----ITEWEF-LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~e-~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.. .++..||+|.+....... .....| ..+++.++||||+++++++...+..|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999996 468899999986432211 122233 3356789999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 99999987643 36788889999999999999999 789999999999999999999999999987543221 12
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||........+..+....... ....++.+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~ 230 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL--KPNISVSARHLLEGL 230 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHH
Confidence 334569999999999999999999999999999999999999987765555555555433222 223467799999999
Q ss_pred cccCCCCCCCHHH
Q 047375 426 LRIRGTERPTMKE 438 (496)
Q Consensus 426 l~~dP~~RPs~~e 438 (496)
|+.||.+||++.+
T Consensus 231 l~~~p~~R~~~~~ 243 (323)
T cd05575 231 LQKDRTKRLGAKD 243 (323)
T ss_pred hhcCHHhCCCCCC
Confidence 9999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=309.91 Aligned_cols=249 Identities=21% Similarity=0.212 Sum_probs=202.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCc-eeeEEEEEeeCC------ee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKN-VVKILGLCLETK------VT 256 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~------~~ 256 (496)
|...++||+|+||+||+|+. .+|..||+|++..... ......+|+.+++.++|+| ||++++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 44556799999999999994 5788999999976544 3345569999999999999 999999999877 78
Q ss_pred eEEEeeccCCchhhhhhhcCcc-cccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQ-VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
++|+||++. +|..++...... ..++...+..+++||+.||.|||+ ++|+||||||.||||+++|.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHH
Confidence 999999976 999999876532 235668899999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCCccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc---------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--------- 405 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--------- 405 (496)
...-+... .+..++|..|.|||++.+. .|+...|+||+||++.||+++.+.|.+..+...+..|..-.
T Consensus 169 a~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 169 AFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 77643322 3445689999999999985 78999999999999999999999998877755544443210
Q ss_pred -------cC---Ccc--cHHH-------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 406 -------VA---DES--EMEE-------IEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 406 -------~~---~~~--~~~~-------~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
.. ..+ +... .+...+++.+||+++|.+|.|+..++..
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 000 1111 1478999999999999999999998643
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=319.09 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=206.5
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..|.+.+.||+|+||.||+|... ++..||+|.+...... .....+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777889999999999999853 3478999988654332 334558899999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCc-----------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCce
Q 047375 258 LVYEFVSNGALSHYIHDKSS-----------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTA 326 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~ 326 (496)
+||||+++|+|.+++..... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 99999999999999976431 2336788899999999999999999 789999999999999999999
Q ss_pred EEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcc
Q 047375 327 KVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQ 405 (496)
Q Consensus 327 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~ 405 (496)
||+|||++................+++.|+|||++.+..++.++|+||+|++++++++ +..||...........+....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876543322222233346789999999999999999999999999999997 888876655444444444322
Q ss_pred cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 406 VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 406 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
. ...+...+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 242 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 242 L-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred c-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2 2223345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.67 Aligned_cols=254 Identities=21% Similarity=0.176 Sum_probs=201.8
Q ss_pred hhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|... +++.||+|.+..... .......|..++..+ +||||+++++++...+..|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 678999999864321 122334667777665 699999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 99999887654 26788999999999999999999 7899999999999999999999999999876432211 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
.....||+.|+|||++.+..++.++|+||+|+++|++++|.+||........+..+.......+ ...+..+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~ 230 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLSQDAVDILKAF 230 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHH
Confidence 3345699999999999998899999999999999999999999987666555666654433222 23456799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 426 LRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
|+.||.+||++.++ ........++|.....
T Consensus 231 L~~dP~~R~~~~~~----~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 231 MTKNPTMRLGSLTL----GGEEAILRHPFFKELD 260 (320)
T ss_pred cccCHHHCCCCCCC----CCHHHHHcCCCcCCCC
Confidence 99999999998542 2233334556655443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=320.21 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=209.5
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
..+.+.+.||+|+||.||++... ++..+|+|.+...... .....+|+.++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 34667789999999999999741 3456899988654332 3344588999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCc----------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 259 VYEFVSNGALSHYIHDKSS----------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~----------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 9999999999999975431 2237889999999999999999999 78999999999999999999999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccC
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
+|||++................+++.|+|||++.+..++.++|+||+|+++++|++ +.+||...........+......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999886643322222223346788999999998889999999999999999997 88887665544444444443322
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhh
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 451 (496)
......+..+.+|+.+||+.||.+|||+.++++.|+.+.+...
T Consensus 242 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 242 -QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 1222345679999999999999999999999999999876533
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=325.44 Aligned_cols=241 Identities=20% Similarity=0.146 Sum_probs=196.7
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+.||+|+||.||++.. .++..||+|.+..... ......+|+.++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 4788999999865321 1223347788999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|..++.... .+++..+..++.||+.||.|||+. ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TM 153 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cc
Confidence 9998887643 368899999999999999999962 5799999999999999999999999999875432211 12
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
....||+.|+|||++.+..++.++|+||+|+++|++++|..||...........+....... +...++.+.+|+.+||
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~li~~~L 231 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPEAKSLLSGLL 231 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCHHHHHHHHHHh
Confidence 34569999999999998889999999999999999999999987665544444444333222 2234567999999999
Q ss_pred ccCCCCCC-----CHHHHHH
Q 047375 427 RIRGTERP-----TMKEVSE 441 (496)
Q Consensus 427 ~~dP~~RP-----s~~eil~ 441 (496)
+.||.+|+ ++.++++
T Consensus 232 ~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhc
Confidence 99999997 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=331.16 Aligned_cols=247 Identities=20% Similarity=0.232 Sum_probs=202.3
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||++.. .++..||+|.+..... ......+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 467778999999999999985 4688999999864321 12223478999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++.... ++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 124 y~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 124 YMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred CCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999986532 5677888899999999999999 789999999999999999999999999988764332
Q ss_pred CccceecccccceeecCcccccc----cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--cCCcccHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTE----LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--VADESEMEEI 415 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~----~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~ 415 (496)
. ......+||+.|+|||++.+. .++.++|+||+||++|+|++|.+||........+..+.... ...+.....+
T Consensus 197 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred c-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 1 122345699999999998753 47889999999999999999999998776666666665432 2222233456
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHH
Q 047375 416 EVVAELASKCLRIRGTE--RPTMKEVSE 441 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~--RPs~~eil~ 441 (496)
..+.+||.+||+.+|.+ |||+.++++
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 78999999999999987 999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=320.97 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=196.4
Q ss_pred hhhhcccCCceEEEEeEeC-----CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 190 FHHCLGMGGFGSVYKGVLP-----DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.+.||.|.||.||+|.+. .+..|+||.+..... ....+.+|++.+++++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3567999999999999974 367899999965322 234556889999999999999999999988889999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.++|..... ..+++..+..|+.||+.||.|||+ ++|+|+||+|+||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999999988622 236889999999999999999999 7899999999999999999999999999987733222
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
........+...|+|||.+....++.++|+||+|++++++++ +..|+...........+.+.. ..+.+..++..+.++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-RLPIPDNCPKDIYSL 237 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-ETTSBTTSBHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cceeccchhHHHHHH
Confidence 222233447789999999999889999999999999999999 567776654444445553332 233344556779999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L 443 (496)
+.+||+.||.+|||+.+|++.|
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=325.07 Aligned_cols=240 Identities=21% Similarity=0.206 Sum_probs=196.9
Q ss_pred hhcccCCceEEEEeEe----CCCcEEEEEEeecchh-----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 192 HCLGMGGFGSVYKGVL----PDNTQVAVKKYMCADE-----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.||+|+||.||++.. ..+..||+|.+..... ......+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999984 3578899999865321 112334788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREGI---FMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999976542 5678888899999999999999 7899999999999999999999999999875433211
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
......||+.|+|||++.+..++.++|+||+|+++|++++|.+||...........+...... .+...++.+.+++
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 231 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN--LPPYLTPEARDLL 231 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHH
Confidence 223456999999999999888899999999999999999999999776555555555544332 2233456799999
Q ss_pred HHhcccCCCCCC-----CHHHHHH
Q 047375 423 SKCLRIRGTERP-----TMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RP-----s~~eil~ 441 (496)
.+||+.||.+|| ++.++++
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhc
Confidence 999999999999 6776654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=332.40 Aligned_cols=248 Identities=19% Similarity=0.204 Sum_probs=197.8
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|.. .++..||+|++..... ......+|+.++..++||||+++++++.+.+..|+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 55668899999999999985 4688999999865432 122344789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 83 IPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999997654 26788889999999999999999 7899999999999999999999999999764321000
Q ss_pred ---------------------------------------------ccceecccccceeecCcccccccccCCCCCchhhh
Q 047375 343 ---------------------------------------------TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVAL 377 (496)
Q Consensus 343 ---------------------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~ 377 (496)
.......+||+.|+|||++.+..++.++|+||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012356999999999999888999999999999
Q ss_pred hcccccccccchhhhcccchhhhhhhc--ccCCcccHHHHHHHHHHHHH--hcccCCCCCCCHHHHHH
Q 047375 378 ASNEKISMVPYFLDSIENNSFRQILNF--QVADESEMEEIEVVAELASK--CLRIRGTERPTMKEVSE 441 (496)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~eil~ 441 (496)
++|+|++|.+||...........+... ....+.....++++.+|+.+ |+..+|..||++.++++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999999776554444444432 22222233456789999998 44556667999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=329.83 Aligned_cols=247 Identities=20% Similarity=0.227 Sum_probs=200.0
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||++... ++..||+|.+..... ......+|+.+++.++||||+++++++.+++..|+|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 4777789999999999999964 678899998864321 12233478899999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++.... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 124 y~~gg~L~~~l~~~~----~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 124 YMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred CCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999996532 5778889999999999999999 789999999999999999999999999998764322
Q ss_pred CccceecccccceeecCcccccc----cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--cCCcccHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTE----LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--VADESEMEEI 415 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~----~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~ 415 (496)
. ......+||+.|+|||++.+. .++.++|+||+|+++|+|++|.+||........+..+.... ...+.....+
T Consensus 197 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred c-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 1 122355699999999998764 37789999999999999999999998776666666666432 2223333456
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHH
Q 047375 416 EVVAELASKCLRIRGTE--RPTMKEVSE 441 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~--RPs~~eil~ 441 (496)
..+.+++.+||..+|.+ |||+.|+++
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 78999999999855543 889888854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=320.37 Aligned_cols=248 Identities=21% Similarity=0.200 Sum_probs=195.3
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|... ++..||+|++..... ......+|+.+++.++||||+++++++...+..|+||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 3667788999999999999964 678899998865422 223445889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
++++.+..+.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 82 VEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9987776554332 236788899999999999999999 7899999999999999999999999999987643322
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc----------------c-
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF----------------Q- 405 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------------~- 405 (496)
. ......||+.|+|||++.+..++.++|+||+|+++|++++|.+||...........+... .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 A-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred c-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 1 123456899999999999888999999999999999999999988754332221111100 0
Q ss_pred ----cCC---c------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 ----VAD---E------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ----~~~---~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+. . .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 0 00123567999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.30 Aligned_cols=247 Identities=19% Similarity=0.194 Sum_probs=204.7
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|... ++..||+|++..... ......+|+.++..++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 667789999999999999964 689999999865432 222344788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC-
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD- 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~- 341 (496)
+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 83 MPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999998753 36888999999999999999999 789999999999999999999999999988765432
Q ss_pred --------------------------CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc
Q 047375 342 --------------------------ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395 (496)
Q Consensus 342 --------------------------~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~ 395 (496)
.........||+.|+|||++.+..++.++|+||+||++|+|++|..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001123456999999999999999999999999999999999999999876655
Q ss_pred chhhhhhh--cccCCcccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 047375 396 NSFRQILN--FQVADESEMEEIEVVAELASKCLRIRGTERPT-MKEVSE 441 (496)
Q Consensus 396 ~~~~~i~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 441 (496)
..+..+.. .....+.....++.+.+||.+|+. ||.+||+ +.++++
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 55555554 222222223356789999999997 9999999 999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=331.18 Aligned_cols=248 Identities=21% Similarity=0.216 Sum_probs=198.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|.. .++..||+|++...... .....+|+.++..++||||+++++.+.+....|+||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 55678899999999999985 46889999998653221 12334788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 83 LPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999997654 36889999999999999999999 7899999999999999999999999999876532110
Q ss_pred c---------------------------------cceecccccceeecCcccccccccCCCCCchhhhhcccccccccch
Q 047375 343 T---------------------------------AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYF 389 (496)
Q Consensus 343 ~---------------------------------~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~ 389 (496)
. ......+||+.|+|||++.+..++.++|+||+||++|+|++|.+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012357999999999999989999999999999999999999999
Q ss_pred hhhcccchhhhhhhcc--cCCcccHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHH
Q 047375 390 LDSIENNSFRQILNFQ--VADESEMEEIEVVAELASKCLR--IRGTERPTMKEVSE 441 (496)
Q Consensus 390 ~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~eil~ 441 (496)
.+......+..+.... ...+.....++.+.+++.+++. .++..||++.||++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 8766666666665422 2222222345678899988654 23335689998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=313.46 Aligned_cols=253 Identities=19% Similarity=0.294 Sum_probs=209.6
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh-hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE-IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.|.+.+.||.|+||.||+|....+..+|+|.+..... .......|+.+++.++||||+++++++...+..++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 4777889999999999999987789999999876544 233445789999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-- 160 (261)
T cd05148 87 GSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-- 160 (261)
T ss_pred CCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--
Confidence 999999986543 336889999999999999999999 78999999999999999999999999998776433211
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....++..|+|||.+....++.++|+|++|++++++++ +..||........+..+.. ....+.+...++.+.+++.+
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCCCCHHHHHHHHH
Confidence 123346788999999988889999999999999999997 7788766554444444443 22333344556789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l 446 (496)
||+.||.+|||+.++++.|+.+
T Consensus 240 ~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 240 CWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HcCCCchhCcCHHHHHHHHhcC
Confidence 9999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=325.66 Aligned_cols=246 Identities=20% Similarity=0.161 Sum_probs=201.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||++.. .++..||+|.+..... ......+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 66778999999999999985 4688999999875432 222334778899999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 83 QPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999987532 36888999999999999999999 7899999999999999999999999999987654322
Q ss_pred ccceecccccceeecCcccc------cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc--CCcccHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAH------TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV--ADESEMEE 414 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~------~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~ 414 (496)
. ......||+.|+|||++. ...++.++|+||+|+++|+|++|..||........+..+..... ..+.....
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 2 223456999999999987 45677899999999999999999999976655555555554321 12222335
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
++.+.+|+.+||. +|.+|||+.+++
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 6779999999998 999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=323.80 Aligned_cols=237 Identities=22% Similarity=0.180 Sum_probs=196.0
Q ss_pred hhcccCCceEEEEeEe----CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 192 HCLGMGGFGSVYKGVL----PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
+.||+|+||.||++.. .++..||+|++..... ......+|+.++++++||||+++++++...+..|+|||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 3678999999865332 22234478899999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999999986643 37889999999999999999999 789999999999999999999999999987654321 1
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
......||+.|+|||++.+..++.++|+||+|+++|+|++|..||...........+...... .+...++.+.+|+.+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~ 231 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--MPQFLSPEAQSLLRA 231 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence 223456999999999999888899999999999999999999998766555455555433322 223345679999999
Q ss_pred hcccCCCCCCCHHH
Q 047375 425 CLRIRGTERPTMKE 438 (496)
Q Consensus 425 cl~~dP~~RPs~~e 438 (496)
||+.||.+|||+.+
T Consensus 232 ~l~~~P~~R~~a~~ 245 (318)
T cd05582 232 LFKRNPANRLGAGP 245 (318)
T ss_pred HhhcCHhHcCCCCC
Confidence 99999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=314.23 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=206.2
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.+.+.+.||+|+||.||+|... .+..||+|.+...........+|+.+++.++||||+++++++...+..++||||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 3566788999999999999964 588899998865544444456889999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......... .
T Consensus 87 ~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~ 161 (263)
T cd05052 87 GNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-A 161 (263)
T ss_pred CcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee-c
Confidence 999999976443 236888999999999999999999 78999999999999999999999999998876543211 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....++..|+|||.+.+..++.++|+||+|++++++++ +.+|+.+......+..+.. ......+...+..+.+++.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHH
Confidence 112224678999999998889999999999999999997 7778765443333333322 22333344456789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l 446 (496)
||+.||++|||+.++++.|+.+
T Consensus 241 cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=323.76 Aligned_cols=239 Identities=21% Similarity=0.174 Sum_probs=195.5
Q ss_pred hhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|... ++..||+|.+..... .......|..++..+ +||||+++++++...+..|+|||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999864 578999999865322 122234667777755 799999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 99999887654 26788899999999999999999 7899999999999999999999999999876433221 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
.....||+.|+|||++.+..++.++|+||+|+++|++++|.+||........+..+.......+ ...+..+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~ll~~~ 230 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP--VWLSKEAVSILKAF 230 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHH
Confidence 2345699999999999998899999999999999999999999987766666666655433222 22456799999999
Q ss_pred cccCCCCCC-------CHHHHH
Q 047375 426 LRIRGTERP-------TMKEVS 440 (496)
Q Consensus 426 l~~dP~~RP-------s~~eil 440 (496)
|+.||.+|| ++.+++
T Consensus 231 L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 231 MTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred hccCHHHcCCCCCCCCCHHHHh
Confidence 999999999 556664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=322.21 Aligned_cols=236 Identities=20% Similarity=0.191 Sum_probs=190.7
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhc-CCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQ-VKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.. .++..||+|.+...... ......|..++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999996 46788999998653221 1122344555553 4899999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99999987644 36788899999999999999999 789999999999999999999999999987653322 22
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+||+.|+|||++.+..++.++|+||+|+++++|++|..||.+......+..+..... ..+...+..+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~ 230 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP--HFPRWISKEAKDCLSKL 230 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 3445699999999999998899999999999999999999999987655555554443221 22233456789999999
Q ss_pred cccCCCCCCCHH
Q 047375 426 LRIRGTERPTMK 437 (496)
Q Consensus 426 l~~dP~~RPs~~ 437 (496)
|+.||.+||++.
T Consensus 231 l~~~P~~R~~~~ 242 (316)
T cd05592 231 FERDPTKRLGVD 242 (316)
T ss_pred ccCCHHHcCCCh
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=325.22 Aligned_cols=246 Identities=18% Similarity=0.148 Sum_probs=197.2
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|.+.+.||+|+||.||++... ++..||+|.+.... .......+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 34667788999999999999964 67889999886432 2234455899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... +++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 85 MDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999976542 67888999999999999999982 359999999999999999999999999987664321
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh-------------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN------------------- 403 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~------------------- 403 (496)
.....||+.|+|||++.+..++.++|+||+|+++|++++|..||....... +..+..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccc
Confidence 234569999999999999889999999999999999999998885432211 111100
Q ss_pred ----------------------------cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 404 ----------------------------FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 404 ----------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...+.......++.+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000011134567999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=331.27 Aligned_cols=247 Identities=20% Similarity=0.212 Sum_probs=200.2
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|.. .+++.||||++..... ......+|+.++..++||||+++++++.+++..|+||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 56678899999999999995 4688999999865421 122334789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 83 ~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 83 LPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999997654 37888999999999999999999 7899999999999999999999999999876532211
Q ss_pred cc------------------------------------ceecccccceeecCcccccccccCCCCCchhhhhcccccccc
Q 047375 343 TA------------------------------------MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMV 386 (496)
Q Consensus 343 ~~------------------------------------~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~ 386 (496)
.. .....+||+.|+|||++.+..++.++|+||+||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011246999999999999988999999999999999999999
Q ss_pred cchhhhcccchhhhhhhcc--cCCcccHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 047375 387 PYFLDSIENNSFRQILNFQ--VADESEMEEIEVVAELASKCLRIRGTERPT---MKEVSE 441 (496)
Q Consensus 387 ~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 441 (496)
+||...........+.... ...+.....++.+.+||.+|+. +|.+|++ +.++++
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9997765555555554322 1222222346789999999997 9999997 777754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=317.79 Aligned_cols=261 Identities=20% Similarity=0.246 Sum_probs=208.7
Q ss_pred cchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+.+.+.||+|+||.||+|... ++..+++|.+....... ....+|+.++++++||||+++++++...+..++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 566688999999999999742 34568889876543332 33458899999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceE
Q 047375 261 EFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAK 327 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~k 327 (496)
||+++++|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 99999999999976432 1236889999999999999999999 7899999999999999999999
Q ss_pred EccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhccc
Q 047375 328 VSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQV 406 (496)
Q Consensus 328 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~ 406 (496)
|+|||++................|+..|+|||++.+..++.++|+||+|++++++++ +.+||...........+.....
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 243 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCC
Confidence 999999876654322222233457889999999999889999999999999999997 8888765544433333333222
Q ss_pred CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhh
Q 047375 407 ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452 (496)
Q Consensus 407 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~ 452 (496)
.......+..+.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus 244 -~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 244 -LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred -CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 222334457799999999999999999999999999999765433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=323.13 Aligned_cols=260 Identities=19% Similarity=0.270 Sum_probs=204.2
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCc----EEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNT----QVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
..|...+.||+|+||.||+|.+. ++. .||+|.+.... .......+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 34666788999999999999853 333 48999886432 2233455788999999999999999999865 5679
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|+||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999986543 36788899999999999999999 789999999999999999999999999998775
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
............++..|+|||++.+..++.++|+||+|+++|++++ +.+||.+.... .+..+.......+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhCCCCCCCCCCCCHH
Confidence 4322222222335678999999999899999999999999999886 77777554322 233333333333333345567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~ 452 (496)
+.+++.+||..||.+|||+.+++..|..+.+...+
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~ 274 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 274 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence 99999999999999999999999999888654433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.00 Aligned_cols=255 Identities=19% Similarity=0.276 Sum_probs=202.7
Q ss_pred hcchhhhcccCCceEEEEeEe-----CCCcEEEEEEeecchhhh--hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-----PDNTQVAVKKYMCADEIR--ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
.+.+.+.||+|+||.||+|.. ..+..|++|.+....... ....+|+.+++.++||||+++++++...+..|+|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 356778899999999999984 245789999886432222 2344789999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCc--------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc
Q 047375 260 YEFVSNGALSHYIHDKSS--------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT 325 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~ 325 (496)
|||+++|+|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence 999999999999864321 1236788889999999999999999 78999999999999999999
Q ss_pred eEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhc
Q 047375 326 AKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNF 404 (496)
Q Consensus 326 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~ 404 (496)
+||+|||+++...............++..|+|||++.+..++.++|+||+|++++++++ +.+||.+.........+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK- 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 99999999987644322222233446788999999988889999999999999999998 8878765443333333322
Q ss_pred ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 047375 405 QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 405 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 445 (496)
....+.+..+++.+.+++.+||+.||.+||++.+|++.|..
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 22223334456789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=312.65 Aligned_cols=251 Identities=22% Similarity=0.254 Sum_probs=203.0
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.+.+.+.||+|+||.||+|.+.++..+|+|.+...........+|+.++.+++||||+++++++......++||||+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 36677889999999999999866677999988654433444568899999999999999999999888899999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.+++..... .+++..++.++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||.++........ ..
T Consensus 85 ~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05113 85 CLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SS 158 (256)
T ss_pred cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ec
Confidence 99999976433 36889999999999999999999 78999999999999999999999999998765433211 11
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....++..|+|||++.+..++.++|+||+|++++++++ +..||...........+..... ...+...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-LYRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHH
Confidence 12235678999999988889999999999999999997 7777765444333444433221 122223457899999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 047375 426 LRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~ 444 (496)
|+.||.+|||+.+|++.|+
T Consensus 238 l~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 238 WHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCCcccCCCHHHHHHhhC
Confidence 9999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=324.44 Aligned_cols=238 Identities=21% Similarity=0.162 Sum_probs=192.2
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh----hhHHHHH---HHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR----ITEWEFL---GIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~e~---~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
|.+.+.||+|+||.||+|.. .++..||||.+....... ....+|. ..++.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 34567899999999999985 468899999986442111 1222343 345677899999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||||++|+|..++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999887542 37889999999999999999999 7899999999999999999999999999875432
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
.. ......+||+.|+|||++.+..++.++|+||+|+++|++++|..||...........+...... .+...++.+.
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~ 229 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRFLSREAI 229 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHHHH
Confidence 21 1223466999999999999988999999999999999999999998776555555555543322 2223457789
Q ss_pred HHHHHhcccCCCCCCCH
Q 047375 420 ELASKCLRIRGTERPTM 436 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~ 436 (496)
+++.+||+.||.+||++
T Consensus 230 ~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 230 SIMRRLLRRNPERRLGS 246 (324)
T ss_pred HHHHHHhhcCHhHcCCC
Confidence 99999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=316.55 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=201.7
Q ss_pred HHhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
...|.+.+.||+|+||.||+|.+. .+..||+|++..... ......+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 345777889999999999998752 346799998754322 222345788999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc-------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEc
Q 047375 257 LLVYEFVSNGALSHYIHDKSS-------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEEC
Confidence 999999999999999975322 1235778889999999999999999 789999999999999999999999
Q ss_pred cCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCC
Q 047375 330 DFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVAD 408 (496)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~ 408 (496)
|||++................+++.|+|||++.+..++.++|+||+|++++++++ +.+||...........+..... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL-L 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C
Confidence 9999876543322211222346788999999998889999999999999999998 5677765444333333333222 1
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 409 ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 409 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
..+...+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 222344567999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=309.38 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=196.0
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecc--hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCA--DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
+.||+|+||.||+|.. .+++.||+|.+... ........+|+.+++.++||||++++++|......|+||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999986 47889999987543 22234455889999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999975432 36888999999999999999999 7899999999999999999999999999876543211111111
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcc
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLR 427 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 427 (496)
..++..|+|||.+.+..++.++|+||+|++++++++ +.+|+...........+ ........+...+..+.+++.+||+
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-HcCCCCCCcccCCHHHHHHHHHHcC
Confidence 123567999999988889999999999999999987 77776543332222222 2222233344456789999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 047375 428 IRGTERPTMKEVSEELD 444 (496)
Q Consensus 428 ~dP~~RPs~~eil~~L~ 444 (496)
.+|++|||+.++++.|+
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.77 Aligned_cols=246 Identities=19% Similarity=0.197 Sum_probs=196.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++|||||++++.+.+.+..|+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 55678899999999999995 4688999999865432 122334789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 83 IPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999997653 36778889999999999999999 7899999999999999999999999999753321000
Q ss_pred ---------------------------------------------ccceecccccceeecCcccccccccCCCCCchhhh
Q 047375 343 ---------------------------------------------TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVAL 377 (496)
Q Consensus 343 ---------------------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~ 377 (496)
.......+||+.|+|||++.+..++.++|+||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346999999999999989999999999999
Q ss_pred hcccccccccchhhhcccchhhhhhhcc--cCCcccHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 047375 378 ASNEKISMVPYFLDSIENNSFRQILNFQ--VADESEMEEIEVVAELASKCLRIRGTERPT---MKEVS 440 (496)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil 440 (496)
++|+|++|.+||...........+.... ...+.....++.+.++|.+|+ .+|.+|++ +.+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 9999999999998765544444444322 222233345677899998876 49999987 66664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.09 Aligned_cols=258 Identities=19% Similarity=0.271 Sum_probs=203.2
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCC-CCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVK-HKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~ 256 (496)
..+.+.+.||+|+||.||+|.+. .+..||+|++...... .....+|+.++.++. |||||+++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 34566789999999999999853 3467999999754222 224458899999997 99999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc-----------------------------------------------------------
Q 047375 257 LLVYEFVSNGALSHYIHDKSS----------------------------------------------------------- 277 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~----------------------------------------------------------- 277 (496)
++|||||++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975321
Q ss_pred ------------------------------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 278 ------------------------------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 278 ------------------------------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
...+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 1235677888999999999999998 7899999999999999
Q ss_pred CCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhh
Q 047375 322 DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQ 400 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 400 (496)
.++.+||+|||+++...............+++.|+|||.+.+..++.+.|+||+|++++++++ +..||...........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 999999999999886543222111223347889999999998888999999999999999987 6666654333333333
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
........+.+...+..+.+|+.+||..+|.+||++.+|++.|+.+
T Consensus 354 ~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 354 AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3333333333334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=318.91 Aligned_cols=246 Identities=19% Similarity=0.212 Sum_probs=194.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|.+.+.||.|+||.||+|.. .++..||+|.+..... ......+|+.+++.++||||+++++++...+..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 66778999999999999985 4688999998864322 22344588999999999999999999999999999999997
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+ +|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~- 159 (288)
T cd07871 87 S-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT- 159 (288)
T ss_pred c-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-
Confidence 5 89988875432 35788899999999999999999 78999999999999999999999999998765432211
Q ss_pred ceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc------------------
Q 047375 345 MSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ------------------ 405 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------------ 405 (496)
.....||+.|+|||++.+ ..++.++|+||+|++++++++|.+||.+......+..+....
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 160 -YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred -ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 233458999999998865 567889999999999999999999987654333322221100
Q ss_pred ---cCC---c----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 ---VAD---E----SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ---~~~---~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+. . .....++.+.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0 00122457899999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=317.36 Aligned_cols=255 Identities=21% Similarity=0.241 Sum_probs=204.4
Q ss_pred hcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
.+.+.+.||+|+||.||+|... .+..||+|.+...... .....+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999853 2468999998644322 2334478899999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcC-------------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc
Q 047375 259 VYEFVSNGALSHYIHDKS-------------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT 325 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~ 325 (496)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999985321 12236788899999999999999999 78999999999999999999
Q ss_pred eEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhc
Q 047375 326 AKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNF 404 (496)
Q Consensus 326 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~ 404 (496)
+||+|||+++...............+++.|+|||++.+..++.++|+||+|++++++++ +.+||.+.........+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999887644322222233446789999999988889999999999999999987 77777665544444444443
Q ss_pred ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 047375 405 QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 405 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 445 (496)
.. .+.+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 243 ~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 243 QV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred Cc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 32 22334566779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=310.97 Aligned_cols=254 Identities=20% Similarity=0.324 Sum_probs=203.7
Q ss_pred hcchhhhcccCCceEEEEeEeC----CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.+.+.+.||+|+||.||+|.+. +...||+|.+..... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 4677789999999999999863 245799998764322 2234457899999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 85 EYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999976543 46889999999999999999999 78999999999999999999999999999887522
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
..........+++.|+|||.+.+..++.++|+||+|++++++++ +..||...........+... ...+.+...++.+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 238 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPPMDCPSALY 238 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHH
Confidence 22211222335678999999998889999999999999999886 77776554433333333322 22223344567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
+++.+||+.+|++||++.+|++.|+.+
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=324.17 Aligned_cols=242 Identities=22% Similarity=0.213 Sum_probs=194.5
Q ss_pred hhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh----hhHHHH-HHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR----ITEWEF-LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e-~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|... ++..||+|.+....... .....+ ..+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999964 57789999986532211 122223 3456788999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 81 GELFYHLQRERC---FLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 999999976432 5677888899999999999999 7899999999999999999999999999876432211 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||........+..+...... .....+..+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGL 230 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC--CCCCCCHHHHHHHHHH
Confidence 34456999999999999999999999999999999999999999876555555555443322 2234557799999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 047375 426 LRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L 443 (496)
|+.||.+||++.+.+..+
T Consensus 231 l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 231 LQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred cccCHHHCCCCCCCHHHH
Confidence 999999999987654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=330.30 Aligned_cols=248 Identities=19% Similarity=0.197 Sum_probs=197.6
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||++.. .+++.||||++...... .....+|+.++..++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 56678899999999999985 47889999988643221 12334788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 83 LPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999997643 36788889999999999999999 7899999999999999999999999999864321000
Q ss_pred c---------------------------------------------cceecccccceeecCcccccccccCCCCCchhhh
Q 047375 343 T---------------------------------------------AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVAL 377 (496)
Q Consensus 343 ~---------------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~ 377 (496)
. ......+||+.|+|||++.+..++.++|+||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001246999999999999988999999999999
Q ss_pred hcccccccccchhhhcccchhhhhhhcc--cCCcccHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 047375 378 ASNEKISMVPYFLDSIENNSFRQILNFQ--VADESEMEEIEVVAELASKCLRIRGTER---PTMKEVSEE 442 (496)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~ 442 (496)
++|+|++|.+||........+..+.... ...+.....+..+.+|+.+||. +|.+| ||+.+++..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999997665555555554322 2222222345779999999997 77765 588888653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=322.47 Aligned_cols=245 Identities=20% Similarity=0.161 Sum_probs=193.7
Q ss_pred cchhhhcccCCceEEEEeEe----CCCcEEEEEEeecchh-----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL----PDNTQVAVKKYMCADE-----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~ 257 (496)
|.+.+.||+|+||.||++.. .++..||+|.+..... .......|+.++..+ +||||+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 56678899999999999874 3578999999864321 122334788899998 4999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+|||||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999876542 6888999999999999999999 78999999999999999999999999998865
Q ss_pred CCCCCccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchh----hhhhhcccCCcccH
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSF----RQILNFQVADESEM 412 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~----~~i~~~~~~~~~~~ 412 (496)
...... .....+||+.|+|||++.+. .++.++|+||+|+++|++++|..||......... ..+... ....+.
T Consensus 156 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 232 (332)
T cd05614 156 LSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--DPPFPS 232 (332)
T ss_pred cccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC--CCCCCC
Confidence 433221 22345699999999999875 4788999999999999999999998643322211 122221 122233
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERP-----TMKEVSE 441 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 441 (496)
..++.+.+++.+||+.||.+|| ++.++++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 4557799999999999999999 5566643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=309.79 Aligned_cols=249 Identities=21% Similarity=0.260 Sum_probs=201.9
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
+.+.+.||+|+||.||+|.+.++..+|+|.+...........+|+.+++.++||||+++++++...+..|+||||+++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 56778899999999999998777789999886544334455688999999999999999999999999999999999999
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcccee
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 347 (496)
|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 86 L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~ 159 (256)
T cd05059 86 LLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQ 159 (256)
T ss_pred HHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccC
Confidence 9999976543 46889999999999999999999 78999999999999999999999999998765432111 111
Q ss_pred cccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 348 MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 348 ~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
...++..|+|||.+.+..++.++|+||+|+++|++++ +.+||...........+.. ......+...+..+.+++.+||
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl 238 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMYSCW 238 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHh
Confidence 1224567999999998889999999999999999998 6777765443333333322 2222233345678999999999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 047375 427 RIRGTERPTMKEVSEEL 443 (496)
Q Consensus 427 ~~dP~~RPs~~eil~~L 443 (496)
..+|++|||+.++++.|
T Consensus 239 ~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 239 HEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCChhhCcCHHHHHHHh
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=320.85 Aligned_cols=238 Identities=21% Similarity=0.163 Sum_probs=191.9
Q ss_pred hhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhc-CCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQ-VKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|... ++..||+|.+..... .......|..++.. ++||||+++++++.+.+..|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999964 688999999865421 12223355666654 5899999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 99999987643 26788899999999999999999 789999999999999999999999999987543221 12
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+||+.|+|||++.+..++.++|+||+|+++|++++|..||........+..+...... .+...+..+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~ 230 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPH--YPRWITKESKDILEKL 230 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHH
Confidence 34566999999999999989999999999999999999999998766554444444332221 1223456799999999
Q ss_pred cccCCCCCCCHH-HH
Q 047375 426 LRIRGTERPTMK-EV 439 (496)
Q Consensus 426 l~~dP~~RPs~~-ei 439 (496)
|+.||.+||++. ++
T Consensus 231 l~~dP~~R~~~~~~~ 245 (316)
T cd05620 231 FERDPTRRLGVVGNI 245 (316)
T ss_pred ccCCHHHcCCChHHH
Confidence 999999999974 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.46 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=206.2
Q ss_pred HHhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchhh--hhhHHHHHHHHhcC-CCCceeeEEEEEeeCCe
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADEI--RITEWEFLGIISQV-KHKNVVKILGLCLETKV 255 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~ 255 (496)
...+.+.+.||+|+||.||+|.. ..+..||+|.+...... .....+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 34577789999999999999973 13457999988654322 23345789999999 79999999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.|+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+|+||||+|||++.++.+||+|||++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999976432 236889999999999999999999 789999999999999999999999999988
Q ss_pred ccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHH
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEE 414 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 414 (496)
...............+++.|+|||++.+..++.++|+||+|++++++++ +.+||........+............+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 7654322112223346788999999988889999999999999999987 888876654444444443333222223334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 56799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.32 Aligned_cols=238 Identities=20% Similarity=0.172 Sum_probs=191.7
Q ss_pred hhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhc-CCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQ-VKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|... ++..||||.+..... .......|..++.. ++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 578899999865421 12223355666664 5899999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 99999997643 36788899999999999999999 7899999999999999999999999999875432211 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
.....||+.|+|||++.+..++.++|+||+|+++|++++|..||........+..+...... .+...+..+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC--YPRWLTREAKDILVKL 230 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCccCCHHHHHHHHHH
Confidence 23456999999999999988999999999999999999999998765544444444322211 2223456789999999
Q ss_pred cccCCCCCCCHH-HH
Q 047375 426 LRIRGTERPTMK-EV 439 (496)
Q Consensus 426 l~~dP~~RPs~~-ei 439 (496)
|+.||.+||++. ++
T Consensus 231 l~~~P~~R~~~~~~l 245 (316)
T cd05619 231 FVREPERRLGVKGDI 245 (316)
T ss_pred hccCHhhcCCChHHH
Confidence 999999999996 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=317.84 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=205.6
Q ss_pred HHhcchhhhcccCCceEEEEeEeC--------CCcEEEEEEeecch--hhhhhHHHHHHHHhcC-CCCceeeEEEEEeeC
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP--------DNTQVAVKKYMCAD--EIRITEWEFLGIISQV-KHKNVVKILGLCLET 253 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~ 253 (496)
...|.+.+.||+|+||.||++... ....+|+|.+.... .......+|+.++..+ +||||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456888899999999999999742 23469999886432 1223344788999999 799999999999999
Q ss_pred CeeeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee
Q 047375 254 KVTLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL 320 (496)
Q Consensus 254 ~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll 320 (496)
+..|+||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 999999999999999999976432 1236889999999999999999999 789999999999999
Q ss_pred CCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhh
Q 047375 321 DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFR 399 (496)
Q Consensus 321 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~ 399 (496)
+.++.+||+|||++................+++.|+|||++.+..++.++|+||+|+++|++++ +.+||..........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999876643211111122234578999999998889999999999999999987 677765443322222
Q ss_pred hhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 400 QILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 400 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
. .......+.+...+..+.+|+.+||..+|.+|||+.++++.|+++...
T Consensus 254 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 254 L-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred H-HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 2 222222233344567899999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=310.18 Aligned_cols=253 Identities=22% Similarity=0.278 Sum_probs=204.9
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..|.+.+.||+|+||.||+|....+..||+|.+...........+|+.++++++||||+++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 357778899999999999999877888999998765444445568899999999999999999885 4567899999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++......... .
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 85 GSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 999999976432 236889999999999999999999 78999999999999999999999999998766433211 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....++..|+|||++.+..++.++|+||+|++++++++ +.+||...........+.. ....+.+...+..+.+|+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHH
Confidence 122235678999999988889999999999999999998 7888765444333333332 22333344556789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHh
Q 047375 425 CLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~ 445 (496)
||..+|.+|||+.++.+.|+.
T Consensus 239 ~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 239 CWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HcccCcccCcCHHHHHHHHhc
Confidence 999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=322.13 Aligned_cols=242 Identities=23% Similarity=0.190 Sum_probs=194.1
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHH-HHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFL-GIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.. .+|..||+|++...... ......|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999985 46889999998644221 11222333 357789999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 99998887543 36888999999999999999999 7899999999999999999999999999875432211 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||........+..+....... ....+..+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~l 230 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL--RPGASLTAWSILEEL 230 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC--CCCCCHHHHHHHHHH
Confidence 244569999999999999899999999999999999999999987765555555555433221 123456789999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 047375 426 LRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L 443 (496)
|+.||.+||++.+.++.+
T Consensus 231 l~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 231 LEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred hccCHHhcCCCCCCHHHH
Confidence 999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=313.76 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=204.4
Q ss_pred HHhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
...+.+.+.||+|+||.||+|... .+..||+|.+..... ......+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 345677789999999999999853 236899999764432 223345788999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc-------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEc
Q 047375 257 LLVYEFVSNGALSHYIHDKSS-------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 999999999999999975422 1235788999999999999999999 789999999999999999999999
Q ss_pred cCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCC
Q 047375 330 DFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVAD 408 (496)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~ 408 (496)
|||+++...............+|..|+|||.+.+..++.++|+||+|++++++++ +.+||...........+.... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG-HL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC-CC
Confidence 9999876644322222233447889999999988889999999999999999997 777776554444444333222 22
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 409 ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 409 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 223334678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.33 Aligned_cols=239 Identities=20% Similarity=0.166 Sum_probs=195.2
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCC-ceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHK-NVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~E 261 (496)
|.+.+.||+|+||.||+|... ++..||+|.+..... .......|..++..++|+ +|+++++++...+..|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 566788999999999999854 577899999865321 222334677888888764 58889999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 82 YVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999876542 6788899999999999999999 789999999999999999999999999987543221
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
. .....+||+.|+|||++.+..++.++|+||+|+++|++++|.+||........+..+...... .+...++.+.++
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~l 231 (324)
T cd05587 156 K--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--YPKSLSKEAVSI 231 (324)
T ss_pred C--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHH
Confidence 1 233456999999999999988999999999999999999999999776655555555543322 223445779999
Q ss_pred HHHhcccCCCCCCCH
Q 047375 422 ASKCLRIRGTERPTM 436 (496)
Q Consensus 422 i~~cl~~dP~~RPs~ 436 (496)
+.+||..||.+||+.
T Consensus 232 i~~~l~~~P~~R~~~ 246 (324)
T cd05587 232 CKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHhhcCHHHcCCC
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.66 Aligned_cols=252 Identities=19% Similarity=0.160 Sum_probs=204.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC--------
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETK-------- 254 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-------- 254 (496)
.|.+.+.||+|+||.||+|.. .++..||||.+.... .......+|+.++..++|+||+++++.+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 578889999999999999984 578999999986432 22233457889999999999999988775432
Q ss_pred eeeEEEeeccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 3689999999999999997532 22347888999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHH
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEME 413 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 413 (496)
++..............+||+.|+|||++.+..++.++|+||+|+++|+++++..||........+..+..... .+.+..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~ 268 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-DPLPPS 268 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-CCCCCC
Confidence 9876543222223456799999999999998899999999999999999999999876554444444443322 223344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
.++.+.+++.+||+.||.+|||+.++++.
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 56789999999999999999999999763
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=309.31 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=205.1
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..|.+.+.||+|+||.||+|...++..||+|++...........+|+.+++.++||||+++++.+. ....++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 457888999999999999999766678999998754443445568899999999999999999875 4567999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.+......... .
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 85 GSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred CcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 999999976432 236889999999999999999999 78999999999999999999999999998766433221 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....++..|+|||+..+..++.++|+||+|++++++++ +.+||...........+.. ....+.....+..+.+++.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCccccCHHHHHHHHH
Confidence 122346778999999988889999999999999999998 7777765544443433332 22223334566789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l 446 (496)
||+.||.+|||+.++++.|+..
T Consensus 239 ~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 239 CWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HccCCcccCCCHHHHHHHHHHh
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.73 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=192.1
Q ss_pred hcchhhhcccCCceEEEEeEe-C-CCcEEEEEEeecchhh---hhhHHHHHHHHhc---CCCCceeeEEEEEee-----C
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-P-DNTQVAVKKYMCADEI---RITEWEFLGIISQ---VKHKNVVKILGLCLE-----T 253 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~---l~hpnIv~l~~~~~~-----~ 253 (496)
.|.+.+.||+|+||.||+|.. . ++..||+|.+...... .....+|+.+++. ++||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 367778899999999999985 2 4678999988643221 1223355555554 479999999999862 4
Q ss_pred CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 254 KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 254 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
...++||||++ ++|.+++...... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 56899999997 5899998764432 36889999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC---c-
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD---E- 409 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~---~- 409 (496)
+...... .......||+.|+|||++.+..++.++|+||+|+++|+++++.+||.+......+..+.+..... .
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 8766432 12234568999999999988889999999999999999999999998765544444443211000 0
Q ss_pred ---------------------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 410 ---------------------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 410 ---------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.....++.+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00123456889999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.79 Aligned_cols=248 Identities=19% Similarity=0.210 Sum_probs=197.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|.. .++..||||.+..... ......+|+.++..++||||+++++.+.+++..|+||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 66778999999999999995 4688999999864322 122334789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC-
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD- 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~- 341 (496)
|++|+|.+++.... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|..+....
T Consensus 83 ~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999997653 36778888999999999999999 789999999999999999999999999975331000
Q ss_pred ----------------------------------------CccceecccccceeecCcccccccccCCCCCchhhhhccc
Q 047375 342 ----------------------------------------ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNE 381 (496)
Q Consensus 342 ----------------------------------------~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~ 381 (496)
........+||+.|+|||++.+..++.++|+||+||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000123569999999999999999999999999999999
Q ss_pred ccccccchhhhcccchhhhhhhcc--cCCcccHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 047375 382 KISMVPYFLDSIENNSFRQILNFQ--VADESEMEEIEVVAELASKCLRIRGTERP---TMKEVSEE 442 (496)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~~ 442 (496)
|++|.+||...........+.... ...+.....++.+.++|.+|+ .+|.+|+ |+.++++.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999998765544444443321 122222345677899999977 4999999 88888643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=319.27 Aligned_cols=235 Identities=20% Similarity=0.167 Sum_probs=192.5
Q ss_pred hhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|... ++..||+|.+..... .......|..++..+ +||||+++++++...+..|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 578999999875421 122233667777777 699999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 99998887653 37889999999999999999999 7899999999999999999999999999875332211 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+||+.|+|||++.+..++.++|+||+|++++++++|..||........+..+....... +...+..+.+|+.+|
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~ 230 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY--PRWLSKEAKSILKSF 230 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--CCcCCHHHHHHHHHH
Confidence 234569999999999999999999999999999999999999987665554445444433222 233457799999999
Q ss_pred cccCCCCCCCH
Q 047375 426 LRIRGTERPTM 436 (496)
Q Consensus 426 l~~dP~~RPs~ 436 (496)
|+.||.+|||+
T Consensus 231 l~~dP~~R~s~ 241 (318)
T cd05570 231 LTKNPEKRLGC 241 (318)
T ss_pred ccCCHHHcCCC
Confidence 99999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=325.94 Aligned_cols=259 Identities=20% Similarity=0.209 Sum_probs=203.0
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||++.. .++..||+|.+..... ......+|+.++..++||||+++++.+.+.+..|+||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 55668899999999999985 4688999999864322 122334688899999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 83 LPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999997654 26788899999999999999999 7899999999999999999999999999875532110
Q ss_pred c---------------------------------cceecccccceeecCcccccccccCCCCCchhhhhcccccccccch
Q 047375 343 T---------------------------------AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYF 389 (496)
Q Consensus 343 ~---------------------------------~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~ 389 (496)
. ......+||+.|+|||++.+..++.++|+||+||++|+|++|.+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0012346999999999999999999999999999999999999999
Q ss_pred hhhcccchhhhhhhcc--cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 390 LDSIENNSFRQILNFQ--VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 390 ~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
........+..+.... ...+.....++.+.+||.+|+. ||.+|++...+ ..+..++|....++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~-------~ei~~hp~f~~~~~ 301 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGV-------EEIKSHPFFEGVDW 301 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCH-------HHHhcCCCCCCCCH
Confidence 8766665555555422 2222222345779999999875 99999864222 12245666655544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=315.07 Aligned_cols=257 Identities=22% Similarity=0.291 Sum_probs=203.2
Q ss_pred hcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQV-KHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~ 257 (496)
.|.+.+.||+|+||.||++... ....+|+|.+...... .....+|+.++.++ +||||+++++++...+..+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 4667789999999999999853 2357899988643222 22344788999999 7999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcC-------------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC
Q 047375 258 LVYEFVSNGALSHYIHDKS-------------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY 324 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~ 324 (496)
++|||+++|+|..++.... ....+++..++.++.|++.||.|||+ ++|+||||||+||+++.++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCC
Confidence 9999999999999996531 12347889999999999999999999 7899999999999999999
Q ss_pred ceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhh
Q 047375 325 TAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILN 403 (496)
Q Consensus 325 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~ 403 (496)
.+||+|||+++...............++..|+|||++.+..++.++|+||+|+++|++++ +..||........+..+..
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 249 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987654322222222335678999999988889999999999999999886 7777655433333333322
Q ss_pred cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 404 FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 404 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
......+...+..+.+|+.+||..||.+|||+.++++.|+.+.
T Consensus 250 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 250 -GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2222333345577999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=316.43 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=207.8
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC--------CCcEEEEEEeecch--hhhhhHHHHHHHHhcC-CCCceeeEEEEEee
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP--------DNTQVAVKKYMCAD--EIRITEWEFLGIISQV-KHKNVVKILGLCLE 252 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~ 252 (496)
....+.+.+.||+|+||.||+|... .+..||+|.+.... .......+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3445777899999999999999731 23479999876432 2223445889999999 79999999999999
Q ss_pred CCeeeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCcee
Q 047375 253 TKVTLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANIL 319 (496)
Q Consensus 253 ~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIl 319 (496)
.+..|+||||+++|+|.+++..... ...+++..+..++.||+.||.|||+ ++|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 9999999999999999999976421 1236788899999999999999999 78999999999999
Q ss_pred eCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchh
Q 047375 320 LDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSF 398 (496)
Q Consensus 320 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~ 398 (496)
++.++.+||+|||+++...............+++.|+|||++.+..++.++|+||+|++++++++ +..|+.........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999987654322222233346788999999998889999999999999999987 66666554333333
Q ss_pred hhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 399 RQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 399 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
..+... .....+..++..+.+|+.+||+.+|.+|||+.++++.|+++....
T Consensus 250 ~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 250 KLLKEG-HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHcC-CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 333222 222233455678999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=309.71 Aligned_cols=256 Identities=18% Similarity=0.266 Sum_probs=207.2
Q ss_pred HHHHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 183 LLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 183 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+....|.+.+.||+|+||.||+|...++..||+|.+...........+|+.+++.++||||+++++++. .+..+++|||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 345668888999999999999999878899999998755444445568899999999999999999874 4568999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999999876443 246888999999999999999998 7899999999999999999999999999877653211
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
. ......++..|+|||++....++.++|+||+|++++++++ +.+||...........+. .....+.+...+..+.++
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYEL 235 (260)
T ss_pred c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHH
Confidence 1 1122346778999999988888999999999999999998 888886554333333322 222223333445679999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHh
Q 047375 422 ASKCLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L~~ 445 (496)
+.+||+.+|++|||+++++..|+.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=320.97 Aligned_cols=235 Identities=20% Similarity=0.124 Sum_probs=186.8
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.. .++..||+|.+..... ......+|+.++.++ +||||+++++++...+..|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 4678999999865321 112233667777665 799999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 99998886643 36888999999999999999999 7899999999999999999999999999875432211 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc---------cchhhhhhhcccCCcccHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE---------NNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~---------~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
.....||+.|+|||++.+..++.++|+||+|+++|++++|..||..... ......+..... ..+...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~ 230 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSV 230 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCH
Confidence 2345699999999999999999999999999999999999998842111 011222222222 22234456
Q ss_pred HHHHHHHHhcccCCCCCCCH
Q 047375 417 VVAELASKCLRIRGTERPTM 436 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~ 436 (496)
.+.+++.+||+.||.+|||+
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCC
Confidence 78999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=313.21 Aligned_cols=258 Identities=19% Similarity=0.141 Sum_probs=197.6
Q ss_pred cccCCceEEEEeEe-CCCcEEEEEEeecchhhh----hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 194 LGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR----ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 194 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
||+|+||+||++.. .+++.||+|++....... .....|+.+++.++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 468899999986432211 2234688999999999999999999999999999999999999
Q ss_pred hhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcccee
Q 047375 269 SHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347 (496)
Q Consensus 269 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 347 (496)
..++.... ....+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98875422 22347889999999999999999999 7899999999999999999999999999876644322 123
Q ss_pred cccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc--CCcccHHHHHHHHHHHHHh
Q 047375 348 MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV--ADESEMEEIEVVAELASKC 425 (496)
Q Consensus 348 ~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~l~~li~~c 425 (496)
...||+.|+|||++.+..++.++|+||+|+++|+++++..||...........+..... ....+...++.+.+++.+|
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence 45699999999999999999999999999999999999998865433221111111111 1122234567799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 426 LRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
|+.||.+||++.+. .+..+..++|.+...+.
T Consensus 236 l~~~P~~R~~~~~~-----~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 236 LAKDPEKRLGFRDG-----NCDGLRTHPLFRDLNWR 266 (280)
T ss_pred hcCCHHHhcCCCCC-----CHHHHhcChhhhcCCHh
Confidence 99999999954331 01111346676665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.54 Aligned_cols=258 Identities=21% Similarity=0.316 Sum_probs=212.6
Q ss_pred cchhhhcccCCceEEEEeEeC--CCc----EEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP--DNT----QVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
..+.+.||+|.||.||+|.+. .+. .||||.+.... .....+.+|..+|+.++|||||+++|+|.+...++|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 455688999999999999963 232 48999887553 3334556999999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCc----ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 260 YEFVSNGALSHYIHDKSS----QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
+|||++|+|..+|++... ...+.....+.++.|||+|+.||++ +++|||||..+|+||+....|||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhH
Confidence 999999999999987521 2346788999999999999999999 779999999999999999999999999999
Q ss_pred ccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCcccHHH
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADESEMEE 414 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 414 (496)
.+-............-...|||||.+....+|.++|+||+|+++||+++. ..|+.+......+..++... ..+.+..|
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~C 929 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYC 929 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCC
Confidence 66544333222221234689999999999999999999999999999875 45555555555555455555 66677788
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
+..+.+++..||+.+|++||++..|++.+..+...
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 89999999999999999999999999988888654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.60 Aligned_cols=261 Identities=21% Similarity=0.206 Sum_probs=211.7
Q ss_pred HHhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecch-hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----Ceee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCAD-EIRITEWEFLGIISQVKHKNVVKILGLCLET-----KVTL 257 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 257 (496)
..+|.+.+.||+|||+.||.+. ..++..+|+|++.+.. +......+|++..++++||||++++++...+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3468889999999999999999 5688999999998776 3344455999999999999999999887643 3589
Q ss_pred EEEeeccCCchhhhhhhcCc-ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 258 LVYEFVSNGALSHYIHDKSS-QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+++|...|+|.+.+..... +..+++..++.|+.+|++||.+||+.. .++.||||||.|||+.+.+.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999987533 235789999999999999999999965 4699999999999999999999999998876
Q ss_pred cCCCCCccc-------eecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccc--hhhhhhhc
Q 047375 337 ISSDDETAM-------STMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENN--SFRQILNF 404 (496)
Q Consensus 337 ~~~~~~~~~-------~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~--~~~~i~~~ 404 (496)
..-.-.... ...-..|..|.|||.+.- ...+.+.|+||+||++|.|+.+..||......+ ..-.+.++
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA 258 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence 542111100 112347899999998865 556789999999999999999999987654432 22334455
Q ss_pred ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 405 QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 405 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
.+..+.....++.+.++|..|++.||.+||++.+++..++.+
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 555555555788999999999999999999999999988765
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=310.80 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=196.4
Q ss_pred hhhhcccCCceEEEEeEeCCCc---EEEEEEeecc---hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeC------Ceee
Q 047375 190 FHHCLGMGGFGSVYKGVLPDNT---QVAVKKYMCA---DEIRITEWEFLGIISQVKHKNVVKILGLCLET------KVTL 257 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~~~ 257 (496)
+.+.||+|+||.||+|.+..+. .||+|.+... ........+|+.+++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4578999999999999964332 5899987543 22223445788999999999999999987532 2468
Q ss_pred EEEeeccCCchhhhhhhc---CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 258 LVYEFVSNGALSHYIHDK---SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
++|||+++|+|.+++... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999887432 122346889999999999999999999 78999999999999999999999999998
Q ss_pred cccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHH
Q 047375 335 VPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEME 413 (496)
Q Consensus 335 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 413 (496)
+...............+++.|+|||++.+..++.++|+||+|++++++++ +.+||...........+..... .+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-LKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Confidence 87654322111222346778999999998889999999999999999988 7777765443333333333221 122334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
.+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 556799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=321.85 Aligned_cols=247 Identities=18% Similarity=0.156 Sum_probs=195.5
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
...|.+.+.||+|+||.||++... ++..+|+|.+.... .......+|+++++.++||||++++++|...+..|+|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 455777889999999999999964 67788998876432 223345589999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999997643 267888899999999999999972 36999999999999999999999999998765332
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhh-------------------
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL------------------- 402 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~------------------- 402 (496)
......||+.|+|||++.+..++.++|+||+|+++|+++++..||........ ..+.
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCC
Confidence 12334689999999999988899999999999999999999887754322111 0000
Q ss_pred --------------------------hcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 403 --------------------------NFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 403 --------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....+.......+.++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000000000113457899999999999999999999963
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=303.84 Aligned_cols=247 Identities=22% Similarity=0.262 Sum_probs=208.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+.+..+||+|+||.||++.+ .+|..+|||++...... ....+|+.+|.+++.|+||++||.+.....+|||||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDL-QEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDL-QEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchH-HHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 45567899999999999996 47899999988543322 23458899999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
++.++++.+.. ++++.++..+++..++||+|||.+ .-||||||..|||++.+|.+||+|||.|..+... ....
T Consensus 114 SiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR 186 (502)
T KOG0574|consen 114 SISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR 186 (502)
T ss_pred cHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence 99999987654 478899999999999999999994 4899999999999999999999999999887653 2334
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhh-hcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL-NFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~l~~li~~c 425 (496)
+++.|||.|||||++..-.|..+.|+||+|++..+|..|.||+.+-.....+-.|- ++......+...+.++.++++.|
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 66789999999999999999999999999999999999999987655443333332 23333344567788999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 047375 426 LRIRGTERPTMKEVSEE 442 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~ 442 (496)
|..+|++|-|+.++++.
T Consensus 267 LiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEH 283 (502)
T ss_pred hcCCHHHHHHHHHHhhh
Confidence 99999999999988764
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=320.20 Aligned_cols=239 Identities=21% Similarity=0.181 Sum_probs=195.6
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh----hhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR----ITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
|.+.+.||+|+||.||+|... ++..||+|.+....... .....|..++..+ +||+|+++++++...+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 556788999999999999854 57799999986532211 1223556666665 58999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 82 YVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999876543 6788999999999999999999 789999999999999999999999999987643221
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
. .....+||+.|+|||++.+..++.++|+||+||++|++++|.+||........+..+...... .+...++.+.++
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 231 (323)
T cd05616 156 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAI 231 (323)
T ss_pred C--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCcCCHHHHHH
Confidence 1 123456999999999999999999999999999999999999999876666566666544332 223456789999
Q ss_pred HHHhcccCCCCCCCH
Q 047375 422 ASKCLRIRGTERPTM 436 (496)
Q Consensus 422 i~~cl~~dP~~RPs~ 436 (496)
+.+||+.||.+|++.
T Consensus 232 i~~~l~~~p~~R~~~ 246 (323)
T cd05616 232 CKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHcccCHHhcCCC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=312.38 Aligned_cols=260 Identities=16% Similarity=0.233 Sum_probs=206.3
Q ss_pred HHhcchhhhcccCCceEEEEeEeCC-----CcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEee-CCee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLPD-----NTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLE-TKVT 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~ 256 (496)
...|.+.+.||+|+||.||+|.... +..|++|.+...... .....+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3457778899999999999999654 678999987643222 2334578899999999999999999876 5678
Q ss_pred eEEEeeccCCchhhhhhhcCcc-----cccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccC
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQ-----VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DF 331 (496)
++++||+++|+|.+++...... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999764322 347889999999999999999999 78999999999999999999999999
Q ss_pred CCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcc
Q 047375 332 ESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADES 410 (496)
Q Consensus 332 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~ 410 (496)
|+++.+.............++..|+|||++.+..++.++|+||+|++++++++ +.+||......... ...........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-HHHHcCCCCCC
Confidence 99986643322211222346778999999998889999999999999999998 88887654332222 22222222223
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
...+++.+.+++.+||..||++|||+.++++.|+.+.+
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 33456789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=315.90 Aligned_cols=256 Identities=20% Similarity=0.238 Sum_probs=197.8
Q ss_pred HhcchhhhcccCCceEEEEeEeCC---------------CcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPD---------------NTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILG 248 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~ 248 (496)
..|.+.+.||+|+||.||++.... ...||+|.+.... .......+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 457788899999999999987532 2348999886532 22234558899999999999999999
Q ss_pred EEeeCCeeeEEEeeccCCchhhhhhhcCc---------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCcee
Q 047375 249 LCLETKVTLLVYEFVSNGALSHYIHDKSS---------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANIL 319 (496)
Q Consensus 249 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIl 319 (496)
++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ ++++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999865321 1235788899999999999999999 78999999999999
Q ss_pred eCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc--cccchhhhcccch
Q 047375 320 LDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS--MVPYFLDSIENNS 397 (496)
Q Consensus 320 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~--~~~~~~~~~~~~~ 397 (496)
++.++.+||+|||++................++..|+|||++.+..++.++|+||+|++++++++ +..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999876543322222223346789999999988889999999999999999987 4555544333222
Q ss_pred hhhhhh------cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 398 FRQILN------FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 398 ~~~i~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
...+.. .......+...++.+.+|+.+||+.||.+|||+.+|++.|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 222211 11111112234567999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=322.06 Aligned_cols=260 Identities=22% Similarity=0.269 Sum_probs=200.0
Q ss_pred HhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeC-Ce
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLET-KV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~-~~ 255 (496)
..|.+.+.||+|+||.||+|.+ .+++.||||.+..... ......+|+.++..+ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4578889999999999999973 3467899999865322 223345789999999 689999999988754 46
Q ss_pred eeEEEeeccCCchhhhhhhcCc----------------------------------------------------------
Q 047375 256 TLLVYEFVSNGALSHYIHDKSS---------------------------------------------------------- 277 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~---------------------------------------------------------- 277 (496)
.++|||||++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999865321
Q ss_pred ------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccc
Q 047375 278 ------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRG 351 (496)
Q Consensus 278 ------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 351 (496)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1135778889999999999999999 7899999999999999999999999999877543322212223346
Q ss_pred cceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCC
Q 047375 352 TVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRG 430 (496)
Q Consensus 352 t~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP 430 (496)
++.|+|||++.+..++.++|+|++|++++++++ +..|+........+............+...++.+.+++.+||+.||
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p 323 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 323 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 778999999988889999999999999999985 7777654332222222222222222222244679999999999999
Q ss_pred CCCCCHHHHHHHHHhhHh
Q 047375 431 TERPTMKEVSEELDRLRR 448 (496)
Q Consensus 431 ~~RPs~~eil~~L~~l~~ 448 (496)
.+|||+.+|++.|+.+.+
T Consensus 324 ~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 324 SQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=319.70 Aligned_cols=235 Identities=19% Similarity=0.114 Sum_probs=188.3
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.. .++..||+|.+...... ......|..++..+ +||||+++++++.+.+..|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999995 46889999998753221 12234678888887 699999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 99998886643 37889999999999999999999 7899999999999999999999999999875322211 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc---------cchhhhhhhcccCCcccHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE---------NNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~---------~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
....+||+.|+|||++.+..++.++|+||+|+++|++++|..||..... ......+...... .+...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~~~~ 230 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPRSLSV 230 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--CCCCCCH
Confidence 2345799999999999999999999999999999999999999853211 1112223322222 2233456
Q ss_pred HHHHHHHHhcccCCCCCCCH
Q 047375 417 VVAELASKCLRIRGTERPTM 436 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~ 436 (496)
.+.+++.+||+.||.+|||+
T Consensus 231 ~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHhccCHHHcCCC
Confidence 79999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=308.62 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=204.6
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..+.+...||+|+||.||+|....+..+|+|.+...........+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 447777889999999999999877778999987654444445568899999999999999999875 4568999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++......... .
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 85 GSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 999999976432 236889999999999999999999 78999999999999999999999999998766433211 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....++..|+|||+..+..++.+.|+||+|+++|++++ +..||.+.........+.. ....+.+...+..+.+++.+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHH
Confidence 122336778999999988889999999999999999998 7888766544444443332 22223334556789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHh
Q 047375 425 CLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~ 445 (496)
||+.||.+||++.+|++.|+.
T Consensus 239 ~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 239 CWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HccCCcccCcCHHHHHHHHhc
Confidence 999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=325.27 Aligned_cols=248 Identities=19% Similarity=0.216 Sum_probs=199.9
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
..|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++.+.+..|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45777899999999999999964 678899998864321 1223347889999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|.+++.... ++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 123 Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 123 EYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred cCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999986532 5777888999999999999999 78999999999999999999999999999876433
Q ss_pred CCccceecccccceeecCcccccc----cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--cCCcccHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTE----LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--VADESEMEE 414 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~----~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~ 414 (496)
. .......+||+.|+|||++.+. .++.++|+||+|+++|+|++|.+||........+..+.... ...+.....
T Consensus 196 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (371)
T cd05622 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 274 (371)
T ss_pred C-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCC
Confidence 2 1122345699999999998764 37889999999999999999999998766655666665432 222333356
Q ss_pred HHHHHHHHHHhcccCCCC---CCCHHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTE---RPTMKEVSEE 442 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~---RPs~~eil~~ 442 (496)
+..+.++|.+||. +|.. ||++.++++.
T Consensus 275 s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 275 SKEAKNLICAFLT-DREVRLGRNGVEEIKRH 304 (371)
T ss_pred CHHHHHHHHHHcC-ChhhhcCCCCHHHHhcC
Confidence 6789999999998 4444 6788877643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=323.48 Aligned_cols=246 Identities=19% Similarity=0.204 Sum_probs=189.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----CeeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET-----KVTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~~l 258 (496)
|.+.+.||+|+||.||+|.. .++..||||++.... .......+|+.+++.++||||+++++++... ...|+
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 66778999999999999995 468999999886421 1222345889999999999999999998643 24799
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||||+ ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999995 68998887643 36889999999999999999999 789999999999999999999999999988653
Q ss_pred CCCCc-cceecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh------------
Q 047375 339 SDDET-AMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN------------ 403 (496)
Q Consensus 339 ~~~~~-~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~------------ 403 (496)
..... .......||+.|+|||++.+ ..++.++|+||+|+++|+|++|.+||...........+.+
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 32211 11234569999999999876 6788999999999999999999998865432211111100
Q ss_pred --------------cccCCcc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 404 --------------FQVADES---EMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 404 --------------~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.....+. ....++.+.+++.+||+.||++|||+.|++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 0000000 011235688999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=312.34 Aligned_cols=253 Identities=21% Similarity=0.193 Sum_probs=199.1
Q ss_pred cccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 194 LGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 194 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
||+|+||.||++.. .+|..||+|.+...... ......|+.++++++||||+++++++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 46899999988543211 12233688999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 988865432 236888889999999999999999 789999999999999999999999999987764321 1233
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchh----hhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSF----RQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~----~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
..||+.|+|||++.+..++.++|+||+|+++|++++|..||......... .......... .....++.+.+|+.+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 232 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRL 232 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHH
Confidence 45899999999999888999999999999999999999998654332111 1222211111 112346779999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
||+.||.+||++.|+++.+. .+.|.+..++
T Consensus 233 ~L~~~P~~R~~~~~~~~~~~------~h~~f~~~~~ 262 (277)
T cd05607 233 FLAKKPEDRLGSREKNDDPR------KHEFFKTINF 262 (277)
T ss_pred HhccCHhhCCCCccchhhhh------cChhhcCCCH
Confidence 99999999999988764433 4666655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=307.96 Aligned_cols=255 Identities=23% Similarity=0.267 Sum_probs=204.0
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|.. .++..||||.+.... .......+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 66778899999999999995 478999999875422 2223345789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 263 VSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
+++|+|.+++.... ....++...+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99999999886432 12336788899999999999999999 789999999999999999999999999988765432
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-chh-hhhhhcccCCcccHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSF-RQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~-~~i~~~~~~~~~~~~~~~~l~ 419 (496)
. ......|++.|+|||.+.+..++.++|+||+|+++++++++..||...... ..+ ..+.....+.......+..+.
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred H--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 1 122345889999999998888889999999999999999998887543221 112 222222222222334567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
+++.+||..+|++|||+.+|++.|+.++
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 9999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=310.57 Aligned_cols=256 Identities=20% Similarity=0.229 Sum_probs=198.6
Q ss_pred cchhhhcccCCceEEEEeEeC-CCc----EEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNT----QVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+.+.+.||+|+||.||+|.+. ++. .+++|.+...... ......++..++.++||||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 556688999999999999863 344 4777876432221 1223356778889999999999999864 4578899
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++|+|.+++..... .+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 88 e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 88 QLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999976433 36889999999999999999999 78999999999999999999999999999876443
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
..........++..|+|||++.+..++.++|+||+|+++|++++ +..||.+..... ...+.......+.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCCCCCCHHHH
Confidence 22222334457789999999988889999999999999999997 887776543322 2223322222222223445689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
+++.+||..||.+|||+.|+++.|..+.+-.
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 9999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=317.81 Aligned_cols=236 Identities=23% Similarity=0.212 Sum_probs=190.4
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHH-HHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEF-LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e-~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.. .++..||+|.+...... ......| ..+++.++||||+++++++.+.+..|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999996 46789999998643221 1122233 3467889999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|...+.... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 99998886543 25778888999999999999999 7899999999999999999999999999875432211 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+||+.|+|||++.+..++.+.|+||+|+++|+|++|.+||........+..+...... .+...+..+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAACDLLVGL 230 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHH
Confidence 23456999999999999988999999999999999999999999776554445555443322 2223456789999999
Q ss_pred cccCCCCCCCHH
Q 047375 426 LRIRGTERPTMK 437 (496)
Q Consensus 426 l~~dP~~RPs~~ 437 (496)
|+.||.+||++.
T Consensus 231 l~~~p~~R~~~~ 242 (321)
T cd05603 231 LHKDQRRRLGAK 242 (321)
T ss_pred ccCCHhhcCCCC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.74 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=200.3
Q ss_pred chhhhcccCCceEEEEeEeC----CCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCe------
Q 047375 189 NFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKV------ 255 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~------ 255 (496)
.+.+.||+|+||.||+|... .+..||+|.+...... .....+|+..++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 45678999999999999853 2367999988653222 2234578899999999999999999876544
Q ss_pred eeEEEeeccCCchhhhhhhcC---cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCC
Q 047375 256 TLLVYEFVSNGALSHYIHDKS---SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
.++||||+++|+|..++.... ....+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 799999999999999985532 12347888999999999999999999 789999999999999999999999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCccc
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESE 411 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~ 411 (496)
+++...............++..|+|||++.+..++.++|+||+|++++++++ +.+||........+..+.... ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC
Confidence 9887654322211222335678999999988889999999999999999998 777776544444443333322 22233
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
..++..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 45567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=312.51 Aligned_cols=245 Identities=23% Similarity=0.187 Sum_probs=196.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|...+.||+|+||.||++.. .++..||+|++...... .....+|+.+++.++||||+++++.+..++..|+||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 55668899999999999995 46889999998643221 22334789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999988865432 237889999999999999999999 7899999999999999999999999999877543221
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccCCcccHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVADESEMEEIEVVAE 420 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~l~~ 420 (496)
.....||+.|+|||++.+..++.++|+||+|+++|++++|..||.+.........+... ......+...+..+.+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARS 234 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHH
Confidence 12346899999999999888999999999999999999999998765433222222111 1112223345677999
Q ss_pred HHHHhcccCCCCCC-----CHHHH
Q 047375 421 LASKCLRIRGTERP-----TMKEV 439 (496)
Q Consensus 421 li~~cl~~dP~~RP-----s~~ei 439 (496)
|+.+||+.||.+|| ++.++
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l 258 (285)
T cd05605 235 ICRQLLTKDPGFRLGCRGEGAEEV 258 (285)
T ss_pred HHHHHccCCHHHhcCCCCCCHHHH
Confidence 99999999999999 56565
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=312.52 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=202.5
Q ss_pred cchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
+.+.+.||+|+||.||+|... ....+++|.+...... .....+|+.+++.++||||+++++.|...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 445678999999999999852 2356888877543222 23345789999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcC---------------------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCce
Q 047375 260 YEFVSNGALSHYIHDKS---------------------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANI 318 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NI 318 (496)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+ ++|+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 99999999999986421 11246788999999999999999999 7899999999999
Q ss_pred eeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccch
Q 047375 319 LLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNS 397 (496)
Q Consensus 319 ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~ 397 (496)
|+++++.+||+|||+++...............++..|+|||++.+..++.++|+||+|++++++++ +..||.+......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999876543322211223346778999999988889999999999999999997 8777755433332
Q ss_pred hhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 398 FRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 398 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
.. ........+.+...+..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 239 FN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH-HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 22 222222333334456789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=313.04 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=204.7
Q ss_pred cchhhhcccCCceEEEEeEeC-CC--cEEEEEEeecc--hhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DN--TQVAVKKYMCA--DEIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
|.+.+.||+|+||.||+|... ++ ..+++|.+... ........+|+.++.++ +||||+++++++...+..|+|||
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 567788999999999999864 33 24788877532 22223445788999888 79999999999999999999999
Q ss_pred eccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 262 FVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
|+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence 9999999999975321 1236788999999999999999999 78999999999999999999999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccC
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
+|||++....... .......+..|+|||++.+..++.++|+||+|+++++|++ +.+||...........+.. ...
T Consensus 161 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~~ 236 (297)
T cd05089 161 ADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 236 (297)
T ss_pred CCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCC
Confidence 9999886432110 1111223567999999998889999999999999999996 8888766544444444332 222
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhh
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWA 455 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~ 455 (496)
...+..++..+.+|+.+||+.+|.+|||+.++++.|..+......++.
T Consensus 237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~ 284 (297)
T cd05089 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVN 284 (297)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccccc
Confidence 223334567799999999999999999999999999998876655543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=316.28 Aligned_cols=246 Identities=20% Similarity=0.216 Sum_probs=190.6
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|... ++..||+|++...... .....+|+.+++.++||||+++++++.+....|+||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 4677789999999999999964 6889999998643322 223458899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
+ ++|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 86 H-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred C-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 6 588888765432 36778899999999999999999 7899999999999999999999999999876533211
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhccc-chhhhhhh---c-------------c
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILN---F-------------Q 405 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~---~-------------~ 405 (496)
......||+.|+|||++.+ ..++.++|+||+|++++++++|.+||.+.... ..+..+.. . .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 1233458999999998865 45788899999999999999999998653221 11111100 0 0
Q ss_pred cC-------Cccc-H------HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 406 VA-------DESE-M------EEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 406 ~~-------~~~~-~------~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.. .+.. . ..++.+.+|+.+||+.||.+|||+.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 00 0000 0 1125688999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=310.48 Aligned_cols=256 Identities=20% Similarity=0.270 Sum_probs=200.1
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCc----EEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNT----QVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
.+.+.+.||+|+||.||+|.+ .++. .||+|.+..... ......+|+.++..++||||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEE
Confidence 356678999999999999985 3444 489998864322 233444788899999999999999999754 46899
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999976432 36888999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
...........+++.|+|||.+.+..++.++|+||+|+++|++++ +.+||........ ..........+.+...+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCccCCHHH
Confidence 322211122235678999999988889999999999999999887 7777654333222 22222222223334456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+++.+||+.||++||++.++++.|..+.+.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 9999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=321.24 Aligned_cols=241 Identities=21% Similarity=0.253 Sum_probs=189.0
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
+.+.+.||+|+||.||+|.. .+++.||||.+..... ......+|+.+++.++|+||+++++++...+..++|||||+
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 45567899999999999995 4689999999854322 23345589999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.... ..++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 99986532 23556778899999999999999 7899999999999999999999999999887643211
Q ss_pred ceecccccceeecCcccccc-----cccCCCCCchhhhhcccccccccchhhhcccchhhhhh---hcccCCcccHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTE-----LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL---NFQVADESEMEEIE 416 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~-----~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~---~~~~~~~~~~~~~~ 416 (496)
......||..|+|||++... ..+.++|+||+|+++|+++++..||...... .+.... ............+.
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhccCCCCCCCccCH
Confidence 12344699999999988542 2345899999999999999999888632221 111111 11112222334567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.+||.+||+.||++|||+.|+++
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 8999999999999999999999953
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=310.39 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=201.7
Q ss_pred cchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+.+.+.||+|+||.||++... ++..+|+|.+...... .....+|+.+++.++||||+++++++...+..++||
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 455688999999999999632 3567899987644332 234458899999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCc------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 261 EFVSNGALSHYIHDKSS------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
||+++|+|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEE
Confidence 99999999999976432 1236889999999999999999999 78999999999999999999999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccC
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
+|||++................+++.|+|||++.+..++.++|+||+|++++++++ +.+||...........+.... .
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~ 242 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-E 242 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-c
Confidence 99999876543222111222335788999999998889999999999999999987 788876554444444443322 2
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
...+..+++.+.+|+.+||+.||.+||++.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 243 LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 2223345677999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=311.71 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=201.5
Q ss_pred HHhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
...|.+.+.||+|+||.||+|... .+..||+|.+...... .....+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 345778899999999999999742 2457999987543322 22345788999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc-------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEc
Q 047375 257 LLVYEFVSNGALSHYIHDKSS-------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
|+||||+++|+|.+++..... ....++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999975321 1234667888999999999999999 789999999999999999999999
Q ss_pred cCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCC
Q 047375 330 DFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVAD 408 (496)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~ 408 (496)
|||+++...............++..|+|||.+.+..++.++|+||+|++++++++ +.+||...........+..... .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-L 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C
Confidence 9999886543322211222335778999999988889999999999999999987 5667655443333333333221 1
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 409 ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 409 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
..+...++.+.+++.+||+.||.+|||+.++++.|...
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 22233457799999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.26 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=199.4
Q ss_pred hcchhhhcccCCceEEEEeEeCC-----------------CcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPD-----------------NTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKIL 247 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~ 247 (496)
.|.+.+.||+|+||.||+|.... +..||+|.+..... ......+|+.++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 46777899999999999987532 24589998865432 223344789999999999999999
Q ss_pred EEEeeCCeeeEEEeeccCCchhhhhhhcCc--------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCcee
Q 047375 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSS--------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANIL 319 (496)
Q Consensus 248 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIl 319 (496)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhcee
Confidence 999999999999999999999999976431 1246889999999999999999999 78999999999999
Q ss_pred eCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc--cccchhhhcccch
Q 047375 320 LDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS--MVPYFLDSIENNS 397 (496)
Q Consensus 320 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~--~~~~~~~~~~~~~ 397 (496)
++.++.++|+|||++................+++.|+|||++.+..++.++|+||+|+++|++++ +..|+........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 99999999999999876544322222334457789999999988889999999999999999986 4555544333332
Q ss_pred hhhhhhc------ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 398 FRQILNF------QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 398 ~~~i~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
+...... ....+.+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 2222211 1111222234567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=324.74 Aligned_cols=242 Identities=18% Similarity=0.152 Sum_probs=190.8
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
..|.+.+.||+|+||.||+|.. .+++.||+|... .....+|+.+++.++|||||++++++......++|||++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 4577889999999999999995 468899999643 2234578999999999999999999999999999999995
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
++|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 167 -~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 167 -TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred -CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 68988886643 26788999999999999999999 789999999999999999999999999987543221 11
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc-------cchhhhhhh--------------
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE-------NNSFRQILN-------------- 403 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-------~~~~~~i~~-------------- 403 (496)
......||+.|+|||++.+..++.++|+||+|+++|++++|..++..... ...+..+..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22345699999999999998899999999999999999999866543211 000111100
Q ss_pred ------------cccC----Cc---ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 404 ------------FQVA----DE---SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 404 ------------~~~~----~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.... .+ .....+..+.+|+.+||+.||.+|||+.|++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 0000 00 0112356789999999999999999999995
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=322.03 Aligned_cols=250 Identities=21% Similarity=0.218 Sum_probs=207.2
Q ss_pred HHHHHhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-C-----CceeeEEEEEeeCC
Q 047375 182 ELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVK-H-----KNVVKILGLCLETK 254 (496)
Q Consensus 182 ~l~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-----pnIv~l~~~~~~~~ 254 (496)
+.+..+|.+.+.||+|+||.|-+|. ..+++.||||++++......+...|+.+|..++ | -|+|+++++|...+
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3344468888999999999999999 457999999999988888888889999999887 3 58999999999999
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC--CceEEccCC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN--YTAKVSDFE 332 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~--~~~kL~DFG 332 (496)
+.|||+|.+.. +|+++++.+.... ++...++.|+.||+.||.+||+ .+|||+||||+||||.+. ..+||+|||
T Consensus 262 HlciVfELL~~-NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELLST-NLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhhhh-hHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999965 9999999876544 7899999999999999999999 789999999999999643 379999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc------
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV------ 406 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~------ 406 (496)
.|+...... ..++-+..|+|||++.+..|+.+.|+||+||++.||++|.|.|.+..+...+..|..-.-
T Consensus 337 SSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 337 SSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 998865432 255678999999999999999999999999999999999999887766544433321000
Q ss_pred ----------------------------------------------CCc-c--------cHHHHHHHHHHHHHhcccCCC
Q 047375 407 ----------------------------------------------ADE-S--------EMEEIEVVAELASKCLRIRGT 431 (496)
Q Consensus 407 ----------------------------------------------~~~-~--------~~~~~~~l~~li~~cl~~dP~ 431 (496)
..+ . .......+.+++.+||.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 000 0 001124689999999999999
Q ss_pred CCCCHHHHHH
Q 047375 432 ERPTMKEVSE 441 (496)
Q Consensus 432 ~RPs~~eil~ 441 (496)
+|+|+.++++
T Consensus 492 ~R~tp~qal~ 501 (586)
T KOG0667|consen 492 ERITPAQALN 501 (586)
T ss_pred hcCCHHHHhc
Confidence 9999999864
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=318.12 Aligned_cols=236 Identities=19% Similarity=0.130 Sum_probs=188.9
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.. .++..||+|.+...... .....+|..++.++ +||||+++++++...+..|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 46788999998754221 12234677788777 699999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 99998886543 37889999999999999999999 7899999999999999999999999999875332211 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-------chhhhhhhcccCCcccHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-------NSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||...... .....+..... ..+...+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~ 230 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--RIPRFLSVKA 230 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--CCCCCCCHHH
Confidence 24466999999999999999999999999999999999999998532211 11222222221 2233345678
Q ss_pred HHHHHHhcccCCCCCCCHH
Q 047375 419 AELASKCLRIRGTERPTMK 437 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~ 437 (496)
.+++.+||+.||.+||++.
T Consensus 231 ~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 231 SHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHhccCHHHcCCCC
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=311.94 Aligned_cols=246 Identities=18% Similarity=0.212 Sum_probs=215.0
Q ss_pred HHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
...|.+.+.||+|.|..|-+|++ -+|..||||++.... ......++|++.|+.++|||||+||.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34477788999999999999984 489999999985432 23345669999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee-CCCCceEEccCCCccccCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL-DDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll-~~~~~~kL~DFGla~~~~~ 339 (496)
|+-++|+|.+|+-++... +.+..+.+++.||+.|+.|+|+. .+|||||||+||++ ..-|-|||.|||++..+.+
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999887653 68889999999999999999995 49999999999987 4568899999999988765
Q ss_pred CCCccceecccccceeecCccccccccc-CCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLT-GMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t-~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
.. ..++.||+..|.|||++.+..|+ +..||||+|+++|.+++|.+||...++.+.+..|++..+.-+ ...+.++
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP--shvS~eC 246 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP--SHVSKEC 246 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc--hhhhHHH
Confidence 43 24677899999999999998886 578999999999999999999999999999999998766544 4567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil 440 (496)
++||..||..||.+|.|.+||.
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHh
Confidence 9999999999999999999885
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=306.32 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=205.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|.. .++..+|||.+..... ......+|+.+++.++||||+++++++...+..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 66778899999999999995 5789999998754321 223344789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 263 VSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
+++++|.+++.... ....+++..++.++.||+.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 99999999987522 22347889999999999999999999 789999999999999999999999999887664332
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc--chhhhhhhcccCCcccHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN--NSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
. ......|+..|+|||++.+..++.++|+||+|+++++++++..||...... .....+.....+.......++.+.
T Consensus 161 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred c--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 1 123345899999999998888899999999999999999998887643221 112222222222222334667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
+++.+||+.||.+|||+.+|++.+.++.
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=319.22 Aligned_cols=240 Identities=19% Similarity=0.173 Sum_probs=196.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+++.+.||+|+||.||+|.. .++..||+|++...... ......|..++..+. ||+|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56678899999999999985 46889999998653221 122346677777775 5778889999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999987654 37889999999999999999999 789999999999999999999999999987643321
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
. ......||+.|+|||++.+..++.++|+||+|++++++++|.+||...........+...... .+...+..+.++
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~l 231 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--YPKSLSKEAVSI 231 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCccCCHHHHHH
Confidence 1 123456999999999999988999999999999999999999999876665555665544332 223445678999
Q ss_pred HHHhcccCCCCCCCHH
Q 047375 422 ASKCLRIRGTERPTMK 437 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~ 437 (496)
+.+||+.||.+|++..
T Consensus 232 i~~~l~~~p~~R~~~~ 247 (323)
T cd05615 232 CKGLMTKHPSKRLGCG 247 (323)
T ss_pred HHHHcccCHhhCCCCC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.76 Aligned_cols=235 Identities=20% Similarity=0.139 Sum_probs=186.6
Q ss_pred cccCCceEEEEeEe-CCCcEEEEEEeecchhhh----hhHHHHHHHHhcC---CCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 194 LGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR----ITEWEFLGIISQV---KHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 194 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
||+|+||.||+|.. .++..||||++....... .....|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999985 468899999986432211 1222455555544 699999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 999998876442 6888999999999999999999 7899999999999999999999999999876433221 1
Q ss_pred eecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
....+||+.|+|||++.+. .++.++|+||+|+++|+|++|..||........+..+.......+ ....++.+.+++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~ 231 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKG 231 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHH
Confidence 2345699999999998764 478999999999999999999999876655444444443332222 12245678999999
Q ss_pred hcccCCCCCCCHH
Q 047375 425 CLRIRGTERPTMK 437 (496)
Q Consensus 425 cl~~dP~~RPs~~ 437 (496)
||+.||.+||++.
T Consensus 232 ~L~~~P~~R~~~~ 244 (330)
T cd05586 232 LLNRNPQHRLGAH 244 (330)
T ss_pred HcCCCHHHCCCCC
Confidence 9999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=306.60 Aligned_cols=249 Identities=18% Similarity=0.238 Sum_probs=196.7
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeC------CeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLET------KVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~------~~~~l 258 (496)
.|.+.+.||+|+||.||+|.. .++..||+|.+............|+.++.++ +||||+++++++... ...|+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 466678899999999999985 4678899999865544444455788888888 699999999998753 46799
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999976432 236888999999999999999999 789999999999999999999999999987654
Q ss_pred CCCCccceecccccceeecCcccc-----cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAH-----TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEME 413 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 413 (496)
.... ......|++.|+|||++. ...++.++|+||+|++++++++|.+||...........+............
T Consensus 163 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 163 RTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 3211 223456899999999986 346788999999999999999999888654333222222222222222233
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+..+.+|+.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 4567999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.02 Aligned_cols=246 Identities=21% Similarity=0.266 Sum_probs=196.4
Q ss_pred hcccCCceEEEEeEe---CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 193 CLGMGGFGSVYKGVL---PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.||+|+||.||+|.+ .++..+|+|.+..... ......+|+.+++.++||||+++++++. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 3578899998754322 2233457889999999999999999986 44678999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc-
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM- 345 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~- 345 (496)
+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997543 36888999999999999999999 7899999999999999999999999999887654322111
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....+++.|+|||.+....++.++|+||+|+++|++++ +.+||...........+... ...+.+...++.+.++|.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQRCPPEMYDLMKL 233 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHH
Confidence 122234678999999988888999999999999999997 88888665444444433332 2233344566789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l 446 (496)
||+.||.+||++.+|.+.|+..
T Consensus 234 ~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 234 CWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.84 Aligned_cols=248 Identities=21% Similarity=0.235 Sum_probs=196.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .++..||+|++....... ....+|+.++.+++||||+++++++...+..|+||||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 477788999999999999995 568889999886443222 233478999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 90 GGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 999999987543 36888999999999999999999 7899999999999999999999999999886643211
Q ss_pred ceecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc---ccHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE---SEMEEIEVV 418 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~l 418 (496)
......|++.|+|||.+.. ..++.++|+||+|+++++++++.+|+...........+.......+ .....+..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 1233458999999998853 4467789999999999999999888754432222222211111111 112345789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
.+++.+||+.+|++|||+.+|++.
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcC
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=304.23 Aligned_cols=248 Identities=20% Similarity=0.252 Sum_probs=198.9
Q ss_pred hhcccCCceEEEEeEeCC--C--cEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLPD--N--TQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|++|.||+|.+.. + ..||+|.+..... ......+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998632 2 3689998865443 23344588999999999999999999988 889999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc-
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA- 344 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~- 344 (496)
|+|.+++..... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999987543 347899999999999999999999 789999999999999999999999999988775432211
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......++..|+|||++.+..++.++|+||+|+++++|++ |.+||...........+.........+...+..+.+++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence 1123457889999999998889999999999999999997 888875444333333333222222223345578999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~ 444 (496)
+||+.+|.+|||+.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.88 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=204.1
Q ss_pred hhcccCCceEEEEeEeCC----CcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLPD----NTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.... +..|++|.+...... .....+|+..+..++||||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999643 788999998755443 23445889999999999999999999999999999999999
Q ss_pred CchhhhhhhcCc------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 266 GALSHYIHDKSS------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 266 g~L~~~l~~~~~------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
++|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 1347899999999999999999999 7899999999999999999999999999987765
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
...........+++.|+|||.+....++.++|+||+|++++++++ |..||...........+.. ......+...+..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 432222334457899999999988889999999999999999988 5777766544444444433 22223334456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
.+++.+||..||.+|||+.++++.|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=317.10 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=212.1
Q ss_pred cchhhhcccCCceEEEEeEeCC---C--cEEEEEEeecc--hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPD---N--TQVAVKKYMCA--DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
....++||.|-||.||+|.+.+ | -.||||..+.. ......+..|..+|+.++|||||+++|+|.+. ..||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 3445889999999999999632 2 35889987653 33345566899999999999999999999865 479999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|+++.|.|..+|..+... ++......++.||+.||.|||+ .++|||||-..|||+...-.|||+|||+++.+...
T Consensus 470 EL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 999999999999987653 6778888999999999999999 78999999999999999999999999999998765
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhccccc-ccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKI-SMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
.... .+...-...|||||.+....+|..+|+|-||+++||++ .|..||.+......+..+-+ +-..+.+..|++.+.
T Consensus 545 ~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-GeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 545 AYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-GERLPCPPNCPPALY 622 (974)
T ss_pred chhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-CCCCCCCCCCChHHH
Confidence 4332 23333467899999999999999999999999999985 46778877666555555544 445677788899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
.|+.+||+++|.+||.+.+|...|..+..
T Consensus 623 slmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999876
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=307.62 Aligned_cols=253 Identities=21% Similarity=0.230 Sum_probs=197.3
Q ss_pred cchhhhcccCCceEEEEeEe-----CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-----PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLET--KVTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~l 258 (496)
+.+.+.||+|+||.||++.+ .++..||+|.+..... ......+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 36778899999999988653 3577899998865432 233445889999999999999999998753 46789
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++|+|.+++.... +++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 86 v~e~~~~~~l~~~~~~~~----l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHcC----CCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999997532 6889999999999999999999 789999999999999999999999999988765
Q ss_pred CCCCccc-eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc--------------chhhhhhh
Q 047375 339 SDDETAM-STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN--------------NSFRQILN 403 (496)
Q Consensus 339 ~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~--------------~~~~~i~~ 403 (496)
....... .....++..|+|||++.+..++.++|+||+|+++++++++..|+...... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 4322111 12233667899999998888999999999999999999998776432211 00111111
Q ss_pred cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 404 FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 404 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
.....+.+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11112223344578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=332.26 Aligned_cols=245 Identities=20% Similarity=0.227 Sum_probs=189.1
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeC--------Ceee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLET--------KVTL 257 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--------~~~~ 257 (496)
.|.+.+.||+|+||.||+|.. .++..||||++..... ...+|+.+++.++|||||++++++... ...+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 477789999999999999995 4688999998854322 234689999999999999999887532 2467
Q ss_pred EEEeeccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-ceEEccCCCcc
Q 047375 258 LVYEFVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-TAKVSDFESLV 335 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~ 335 (496)
+|||||++ +|.+++... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+|+
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 99999985 777776542 122347888999999999999999999 7899999999999998654 79999999998
Q ss_pred ccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc---------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--------- 405 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--------- 405 (496)
....... .....||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.+......+..+....
T Consensus 220 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 220 NLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 7654322 233468999999998876 468999999999999999999999997654433333322100
Q ss_pred ----------cCCc--------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 ----------VADE--------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ----------~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.. .+...++++.+|+.+||+.||.+|||+.|+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000 01123467999999999999999999999864
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.52 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=208.2
Q ss_pred HHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
...+.+.+.||+|+||.||+|...++..||||.+...........+|+.+++.++||||+++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 34577788999999999999998777889999987655444556688999999999999999999998889999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++..... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (261)
T cd05034 85 KGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT- 159 (261)
T ss_pred CCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh-
Confidence 9999999976542 236889999999999999999999 78999999999999999999999999998776432111
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......++..|+|||.+.+..++.++|+||+|++++++++ +..||.+.........+.. ....+.+...+..+.+++.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Confidence 1112225678999999998889999999999999999997 8888866544444444432 2222223334677999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHh
Q 047375 424 KCLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~~ 445 (496)
+||+.+|.+||++.++.+.|+.
T Consensus 239 ~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 239 QCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=303.99 Aligned_cols=255 Identities=18% Similarity=0.254 Sum_probs=205.9
Q ss_pred HHHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
....+.+.+.||+|+||.||++....+..+|+|.+...........+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 345678889999999999999997777889999887554444455688999999999999999999887 7789999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++..... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 99999999976432 236888899999999999999999 78999999999999999999999999998766432211
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
......++..|+|||++....++.++|+||+|++++++++ +.+||...........+. .....+.....+..+.+++
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIM 236 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHHHHH
Confidence 1122336678999999988888999999999999999998 888876543333333222 2222223334556799999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHh
Q 047375 423 SKCLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~~L~~ 445 (496)
.+||+.+|++||++.++++.|+.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=302.06 Aligned_cols=245 Identities=24% Similarity=0.329 Sum_probs=197.2
Q ss_pred hcccCCceEEEEeEeCCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchhh
Q 047375 193 CLGMGGFGSVYKGVLPDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSH 270 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~ 270 (496)
.||+|+||.||+|...++..||+|.+..... ......+|+.+++.++||||+++++++...+..++||||+++|+|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6899999999999987888999998764432 22344578999999999999999999999999999999999999999
Q ss_pred hhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceeccc
Q 047375 271 YIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIR 350 (496)
Q Consensus 271 ~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 350 (496)
++..... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........ .......
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05085 82 FLRKKKD--ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQ 155 (250)
T ss_pred HHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCC
Confidence 9876432 36789999999999999999999 7899999999999999999999999999875433211 1111223
Q ss_pred ccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccC
Q 047375 351 GTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIR 429 (496)
Q Consensus 351 gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~d 429 (496)
+++.|+|||++.+..++.+.|+||+|++++++++ +..||...........+.. ......+...+..+.+++.+||+.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccC
Confidence 5678999999998888999999999999999987 7777765443333333322 2222223345678999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 047375 430 GTERPTMKEVSEELD 444 (496)
Q Consensus 430 P~~RPs~~eil~~L~ 444 (496)
|.+|||+.++++.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=312.22 Aligned_cols=259 Identities=20% Similarity=0.273 Sum_probs=202.9
Q ss_pred HhcchhhhcccCCceEEEEeEeC--------CCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP--------DNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETK 254 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~ 254 (496)
..+.+.+.||+|+||.||+|... ....+|+|.+..... .......|+.++..+ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 34677889999999999999741 245689998764322 222344788899988 6999999999999989
Q ss_pred eeeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
..|+||||+++|+|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999976421 1236888999999999999999999 7899999999999999
Q ss_pred CCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhh
Q 047375 322 DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQ 400 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 400 (496)
.++.+||+|||+++...............++..|+|||++.+..++.++|+||+|+++|++++ +..||........+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986643222111122234568999999988889999999999999999987 6777655443333333
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
+.... ....+..++..+.+++.+||+.||.+|||+.++++.|..+..
T Consensus 249 ~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 249 LREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 33321 222233445679999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=303.37 Aligned_cols=248 Identities=17% Similarity=0.206 Sum_probs=200.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh------hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI------RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
|...+.||+|++|.||+|.. .++..||+|.+...... .....+|+.++++++||||+++++++......++||
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 55668899999999999985 46889999987643211 123447889999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++.....
T Consensus 84 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999987654 26778889999999999999999 78999999999999999999999999998765432
Q ss_pred CCccc-eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 341 DETAM-STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 341 ~~~~~-~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
..... .....|+..|+|||++.+..++.++|+||+|+++|++++|.+||...........+.........+...+..+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence 11111 12345889999999999988999999999999999999999998664333333333333333334445567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~ 441 (496)
+++.+||..+|.+|||+.++++
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhh
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=301.80 Aligned_cols=247 Identities=19% Similarity=0.232 Sum_probs=203.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecc---hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCA---DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|++|.||+|.. .++..|++|.+... ........+|+.+++.++||||+++++++...+..|+||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 45667899999999999986 46889999988643 222334447889999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|.+++..... ..+++..++.++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 82 ENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999999987532 247888999999999999999999 7899999999999999999999999999887654322
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......|++.|+|||++.+..++.++|+||+|++++++++|..||...........+..... .+.....+..+.+++.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~ 234 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-PPVSQMYSQQLAQLID 234 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCccccCHHHHHHHH
Confidence 12344689999999999998899999999999999999999999876554444444433322 2223355678999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~ 441 (496)
+||+.+|++||++.++++
T Consensus 235 ~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 235 QCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHccCCcccCcCHHHHhh
Confidence 999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=314.63 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=206.6
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC--------CCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEee
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP--------DNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLE 252 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~ 252 (496)
....|.+.+.||+|+||.||+|... ....||+|.+..... ......+|+.++.++ +||||++++++|..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3445788899999999999999742 123689998764322 223445889999999 79999999999999
Q ss_pred CCeeeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCcee
Q 047375 253 TKVTLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANIL 319 (496)
Q Consensus 253 ~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIl 319 (496)
.+..+++|||+++|+|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEE
Confidence 9999999999999999999976421 1236788899999999999999999 78999999999999
Q ss_pred eCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchh
Q 047375 320 LDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSF 398 (496)
Q Consensus 320 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~ 398 (496)
++.++.+||+|||+++...............++..|+|||++.+..++.++|+||+|++++++++ +.+||.........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999886643222211222335678999999999889999999999999999987 67777654433333
Q ss_pred hhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 399 RQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 399 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
..+... ...+.+...+..+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus 247 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 247 KLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 333322 222233345567999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=304.43 Aligned_cols=254 Identities=20% Similarity=0.314 Sum_probs=200.8
Q ss_pred hcchhhhcccCCceEEEEeEeCC-C---cEEEEEEeecc--hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPD-N---TQVAVKKYMCA--DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.+.+.+.||+|+||.||+|.... + ..||+|.+... ......+..|+.+++.++||||+++++++......++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998642 2 36999988643 222334558899999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999976533 36888999999999999999999 78999999999999999999999999998765432
Q ss_pred CCccc-eecc--cccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHH
Q 047375 341 DETAM-STMI--RGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 341 ~~~~~-~~~~--~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
..... .... .++..|+|||++.+..++.++|+||+|++++++++ +..||...........+. .....+.+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCH
Confidence 22111 1111 12457999999998889999999999999999775 777776544333333332 2222233345567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
.+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 799999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=303.94 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=202.5
Q ss_pred HhcchhhhcccCCceEEEEeEeC----CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
..|.+.+.||+|+||.||+|... .+..+|+|.+.... .......+|+.++..++||||+++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34677789999999999999853 23379999875432 2223445789999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999976542 36888999999999999999999 7899999999999999999999999999887654
Q ss_pred CCCccc-eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 340 DDETAM-STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 340 ~~~~~~-~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
...... .....++..|+|||++.+..++.+.|+|++|++++++++ +..||...........+... ...+.....++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHH
Confidence 322111 112224578999999998889999999999999999775 88777654443333333332 222333345677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=302.28 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=203.6
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.+.+.+.||.|+||.||+|.. .++.||+|.+...........+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred hccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 466778899999999999997 5889999998766553445568899999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.+++...... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.+.......
T Consensus 86 ~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----- 156 (256)
T cd05039 86 SLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----- 156 (256)
T ss_pred cHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc-----
Confidence 999999765432 36889999999999999999999 789999999999999999999999999988763321
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....++..|+|||++....++.++|+||+|++++++++ +..||...........+. .......+...++.+.+++.+|
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHHHHH
Confidence 12235678999999988888999999999999999986 777765443332222222 1222222334567899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhh
Q 047375 426 LRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l 446 (496)
|..+|.+|||+.++++.|+.+
T Consensus 236 l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 236 WELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred hccChhhCcCHHHHHHHHhcC
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=300.79 Aligned_cols=248 Identities=18% Similarity=0.173 Sum_probs=201.6
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|.+.+.||.|+||.||++.. .++..+|+|.+.... .......+|+.+++.++||||+++++.+.+.+..|+||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 55678899999999999985 468899999875332 222334478889999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++..... ..++...+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 82 GGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 9999998875432 236788899999999999999999 7899999999999999999999999999876643221
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
......|++.|+|||++.+..++.++|+||+|+++++|+++.+||...........+..... .+.+...+..+.+++.+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-KPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-CCCCcccCHHHHHHHHH
Confidence 12345689999999999888899999999999999999999999876544333333333222 22233455679999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 047375 425 CLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~ 442 (496)
||+.||.+|||+.+++..
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=309.90 Aligned_cols=256 Identities=22% Similarity=0.305 Sum_probs=200.0
Q ss_pred cchhhhcccCCceEEEEeEeC-CCc--EEEEEEeecch--hhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNT--QVAVKKYMCAD--EIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+.+.+.||+|+||.||+|.+. ++. .+++|.+.... .......+|+.++.++ +||||+++++++...+..|+|||
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence 667788999999999999863 444 45777765322 2223445789999999 89999999999999999999999
Q ss_pred eccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 262 FVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
|+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEe
Confidence 9999999999975421 1246888999999999999999999 78999999999999999999999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccC
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
+|||++...... .......++..|+|||++.+..++.++|+||+|++++++++ +.+||...........+.. ...
T Consensus 166 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~ 241 (303)
T cd05088 166 ADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 241 (303)
T ss_pred CccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCc
Confidence 999998643211 11112234678999999988888999999999999999997 7888765443333333322 222
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
...+...++.+.+|+.+||+.+|.+|||+.+++..|..+....
T Consensus 242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 2222334567999999999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.40 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=201.2
Q ss_pred hcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
.+.+...||+|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++......++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 3666788999999999999853 467899998864322 22334578999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCc-------------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCcee
Q 047375 259 VYEFVSNGALSHYIHDKSS-------------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANIL 319 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~-------------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIl 319 (496)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheE
Confidence 9999999999999975321 1236788889999999999999999 78999999999999
Q ss_pred eCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchh
Q 047375 320 LDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSF 398 (496)
Q Consensus 320 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~ 398 (496)
++.++.+||+|||++................++..|+|||.+.+..++.++|+||+|++++++++ +..||.+.......
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999876543322111222235678999999988889999999999999999986 66666554444433
Q ss_pred hhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 047375 399 RQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 399 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 445 (496)
..+.+.... +.+...+..+.+|+.+||+.+|.+|||+.|+++.|++
T Consensus 243 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 243 YYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 433333221 2223455779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=308.41 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=197.0
Q ss_pred hcchhhhcccCCceEEEEeEeC-----------------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-----------------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKIL 247 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~ 247 (496)
.|.+.+.||+|+||.||++... +...||+|.+..... ......+|+.+++.++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4677889999999999998532 234689998864322 233455889999999999999999
Q ss_pred EEEeeCCeeeEEEeeccCCchhhhhhhcCcc--------cccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCcee
Q 047375 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQ--------VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANIL 319 (496)
Q Consensus 248 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~--------~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIl 319 (496)
+++...+..++||||+++|+|.+++...... ..+++..+..++.|++.||.|||+ ++|+||||||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence 9999999999999999999999999764321 235678899999999999999999 78999999999999
Q ss_pred eCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc--cccchhhhcccch
Q 047375 320 LDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS--MVPYFLDSIENNS 397 (496)
Q Consensus 320 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~--~~~~~~~~~~~~~ 397 (496)
++.++.++|+|||+++...............+++.|+|||...+..++.++|+||+|+++|++++ +..||........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999886643322111222335678999999888889999999999999999987 5566644332222
Q ss_pred hhhhh---h---cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 398 FRQIL---N---FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 398 ~~~i~---~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
..... . .....+.+..+++.+.+|+.+||+.||.+|||+.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 21111 0 01111222334578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=302.22 Aligned_cols=247 Identities=22% Similarity=0.261 Sum_probs=196.4
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .++..||+|.+....... ....+|+.+++.++||||+++++++...+..|+||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 467778999999999999985 468899999886543222 233478899999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++.... .+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++....... .
T Consensus 90 ~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06645 90 GGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A 161 (267)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence 999999987654 36889999999999999999999 789999999999999999999999999987654321 1
Q ss_pred ceecccccceeecCcccc---cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcc---cHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAH---TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADES---EMEEIEVV 418 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~---~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~l 418 (496)
......||+.|+|||++. ...++.++|+||+|+++++++++.+|+...................+. ....+..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 123456999999999874 345788999999999999999998887654332222222211111111 11234678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+++.+||+.+|++|||+.+|++
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhc
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=301.55 Aligned_cols=256 Identities=23% Similarity=0.278 Sum_probs=205.4
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||+|.+.... .......+|+.++++++|+||+++++++...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 3677789999999999999965 78999999875322 123344588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 262 FVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|+++|+|.+++.... ....+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999986532 22346889999999999999999999 78999999999999999999999999998765433
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc--chhhhhhhcccCCcccHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN--NSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
... .....|++.|+|||.+.+..++.++|+||+|+++++++++..||...... .....+.............+..+
T Consensus 160 ~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 160 TTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred Ccc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 211 23345899999999998888899999999999999999998887543211 11112212112222222456689
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
.+++.+||..+|++|||+.+|++.|+.+.
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=304.33 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=197.7
Q ss_pred hcchhhhcccCCceEEEEeEe-----CCCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeC--Ceee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-----PDNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLET--KVTL 257 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~ 257 (496)
.|.+.+.||+|+||.||++.+ .++..||+|.+...... .....+|+.+++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 456678899999999999974 35778999998644222 23445889999999999999999998865 5688
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+||||+++++|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999976432 36889999999999999999999 88999999999999999999999999998876
Q ss_pred CCCCCc-cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc-----------cch---hhhhh
Q 047375 338 SSDDET-AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE-----------NNS---FRQIL 402 (496)
Q Consensus 338 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-----------~~~---~~~i~ 402 (496)
...... .......|+..|+|||++.+..++.++|+||+|+++++++++..+...... ... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 543221 112234577889999999888899999999999999999986543321110 000 00111
Q ss_pred hcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 403 NFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 403 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
......+.+..++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11112222334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=301.14 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=195.2
Q ss_pred hcccCCceEEEEeEeC---CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 193 CLGMGGFGSVYKGVLP---DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
.||+|+||.||+|.+. .+..||+|.+...... .....+|+.++++++||||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 3556999988654322 233458899999999999999999886 456899999999999
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc-e
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM-S 346 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~ 346 (496)
|.+++..... .+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999875432 36889999999999999999999 7899999999999999999999999999876543322111 1
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+++.|+|||++.+..++.++|+||+|+++|++++ +.+||...........+.. ......+..+++.+.+++.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-GKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHH
Confidence 11224678999999988889999999999999999885 8888766544333333322 222333445567899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhh
Q 047375 426 LRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l 446 (496)
|..||++||++.+|.+.|+.+
T Consensus 235 ~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 235 WIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=313.32 Aligned_cols=248 Identities=17% Similarity=0.181 Sum_probs=195.7
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||++... ++..||+|.+...... .....+|..++..++||||+++++++.+.+..|+||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 667789999999999999954 6788999988643211 12234678889999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 83 YVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999976432 36788889999999999999999 7899999999999999999999999999877654322
Q ss_pred ccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc---ccHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE---SEMEE 414 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~~~ 414 (496)
.......||+.|+|||++.+ ..++.++|+||+|+++|+|++|..||........+..+.......+ .....
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 12234569999999999875 4577899999999999999999999976655555555544322111 11234
Q ss_pred HHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTE--RPTMKEVSE 441 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~--RPs~~eil~ 441 (496)
++.+.+++.+|+..++.+ |+++.++++
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 678999999999865543 356776643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=303.79 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=201.9
Q ss_pred hcchhhhcccCCceEEEEeEeC-CC---cEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DN---TQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.+...+.||+|+||.||+|... ++ ..+|+|.+.... ........|+.+++.++||||+++++++...+..|+||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 3556788999999999999864 23 369999876432 22334457889999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++++|.+++..... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 86 EYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999976432 36888999999999999999999 78999999999999999999999999998766433
Q ss_pred CCccce-ecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 341 DETAMS-TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 341 ~~~~~~-~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
...... .....++.|+|||++.+..++.++|+||+|+++|++++ +..||...........+.. ....+.....+..+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~ 239 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAV 239 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCHHH
Confidence 221111 11223567999999988888999999999999999886 8878765444444444432 22333334456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
.+++.+||+.+|.+||++.+|++.|+++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=303.00 Aligned_cols=248 Identities=22% Similarity=0.260 Sum_probs=188.6
Q ss_pred hcccCCceEEEEeEeC---CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 193 CLGMGGFGSVYKGVLP---DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
.||+|+||.||+|... ++..+|+|.+..... ......+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999853 345799998765432 22344578999999999999999999999889999999999999
Q ss_pred hhhhhhhcCc--ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 268 LSHYIHDKSS--QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 268 L~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|.+++..... ....++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975432 2234667788899999999999999 7899999999999999999999999999876543322112
Q ss_pred eecccccceeecCcccccc-------cccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhh-ccc--CC-cccHH
Q 047375 346 STMIRGTVGYLDPEYAHTE-------LLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILN-FQV--AD-ESEME 413 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~-------~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~-~~~--~~-~~~~~ 413 (496)
.....|++.|+|||++.+. .++.++|+||+|++++++++ |.+||.............. ... .. .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 2334578899999988642 35779999999999999985 8877754433322222111 111 11 11113
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
.++.+.+++.+|| .+|++|||+.||+..|+
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 4466889999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=305.58 Aligned_cols=255 Identities=19% Similarity=0.259 Sum_probs=196.2
Q ss_pred hcchhhhcccCCceEEEEeEe-----CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-----PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~l 258 (496)
.+.+.+.||+|+||.||+|.+ .++..||+|++....... ....+|+.+++.++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 356678899999999999974 257889999986544332 234488999999999999999998754 346889
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999975432 36889999999999999999999 789999999999999999999999999998765
Q ss_pred CCCCccc-eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc---------------chhhhhh
Q 047375 339 SDDETAM-STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN---------------NSFRQIL 402 (496)
Q Consensus 339 ~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---------------~~~~~i~ 402 (496)
....... .....++..|+|||++.+..++.+.|+||+|+++++++++..++...... ..+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 4322111 11222456799999998888999999999999999999875443221110 0011111
Q ss_pred hcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 403 NFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 403 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
......+.....+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11112222334456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=320.47 Aligned_cols=248 Identities=19% Similarity=0.215 Sum_probs=203.6
Q ss_pred cchhhhcccCCceEEEEeEeCCC-cEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDN-TQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+++...||.|+||.||+|..... -..|.|.+....... ....-|+.||..++||+||+|++.|+..+.+||..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 34455689999999999986543 344667765443332 3344789999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|-...++-.-+. ++.+..+..+++|++.||.|||+ ++|||||||..|||++-+|.++|+|||.+...... ...
T Consensus 114 GAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk 186 (1187)
T KOG0579|consen 114 GAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK 186 (1187)
T ss_pred chHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence 999988876543 47889999999999999999999 88999999999999999999999999987765432 223
Q ss_pred eecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-CcccHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVA 419 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~l~ 419 (496)
...+.|||+|||||++.. .+|+.++||||+|+++.+|..+.||....+....+-+|.....+ ...+...+..+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence 456789999999998765 68999999999999999999999998776666666666543322 233456677899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~ 442 (496)
+|+.+||..||..||++.++++.
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhhC
Confidence 99999999999999999999863
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=299.97 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=196.5
Q ss_pred hhcccCCceEEEEeEeC-C---CcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLP-D---NTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.+. . +..+|+|.+..... ......+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999852 2 26899998865443 2334457899999999999999999876 4467999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++.... .+++..+..++.|++.||.|||. ++++||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999998654 36889999999999999999999 7899999999999999999999999999887644322111
Q ss_pred -eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 346 -STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 346 -~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
.....++..|+|||.+.+..++.++|+||+|++++++++ +.+||...........+.. ....+.+...+..+.+++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEECPQEIYSIML 232 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHH
Confidence 111224568999999998889999999999999999997 7888765443333333222 2222333445578999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhh
Q 047375 424 KCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~~l 446 (496)
+||..+|.+|||+.++++.|+.+
T Consensus 233 ~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 233 SCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHhcCChhhCcCHHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=302.86 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=194.6
Q ss_pred hcccCCceEEEEeEeC-CCc--EEEEEEeecc--hhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 193 CLGMGGFGSVYKGVLP-DNT--QVAVKKYMCA--DEIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.||+|+||.||+|... ++. .+++|.+... ........+|+.++.++ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999964 333 4688877632 22233455789999999 7999999999999999999999999999
Q ss_pred chhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 267 ALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 267 ~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
+|.+++..... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 99999975421 1236788999999999999999999 7899999999999999999999999998
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccH
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEM 412 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 412 (496)
+...... ........+..|+|||++....++.+.|+||+|++++++++ +..||........+..+.. ....+.+.
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPL 234 (270)
T ss_pred ccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCC
Confidence 7533211 11112224667999999988889999999999999999996 7788765443333333322 11222233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
..+..+.+++.+||+.||.+|||+.+++..|+.+.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 34567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=306.50 Aligned_cols=246 Identities=28% Similarity=0.379 Sum_probs=197.5
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhH---HHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITE---WEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|+||+||++... ++..||+|.+.......... .+|+.+++.++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999964 56689999997665443322 35889999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|.+++.... .+++..+..++.|++.||.+||+ ++|+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred ccccccccccccc---ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cc
Confidence 9999999998333 36889999999999999999999 7899999999999999999999999999876422 12
Q ss_pred cceecccccceeecCcccc-cccccCCCCCchhhhhcccccccccchhhhc---ccchhhhhhhcccCCccc--HHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAH-TELLTGMNPNSYVALASNEKISMVPYFLDSI---ENNSFRQILNFQVADESE--MEEIEV 417 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~-~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~---~~~~~~~i~~~~~~~~~~--~~~~~~ 417 (496)
.......+|..|+|||++. +..++.++|+||+|+++++|+++..|+.... .................. ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHH
Confidence 2234456899999999998 7889999999999999999999988887652 122222222211111111 111267
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+++.+||+.||++|||+.++++
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=300.15 Aligned_cols=248 Identities=20% Similarity=0.303 Sum_probs=199.4
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEe-eCCeeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCL-ETKVTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E~~~~ 265 (496)
.+.+.+.||+|+||.||++.. .+..||+|.+.... ......+|+.+++.++||||+++++++. ..+..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 467778999999999999987 57889999875433 2334558899999999999999999865 45678999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 85 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 999999976543 236888999999999999999999 789999999999999999999999999987654321
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
....++..|+|||++.+..++.++|+||+|+++|++++ +.+||...........+.. .........+++.+.+++.+
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHH
Confidence 22335678999999998889999999999999999986 7777654333222222221 22222333456789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l 446 (496)
||+.+|.+|||+.++++.|+.+
T Consensus 235 ~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 235 CWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=311.95 Aligned_cols=249 Identities=17% Similarity=0.181 Sum_probs=194.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||++.. .++..||+|.+...... .....+|+.++..++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 66778999999999999995 46889999998643221 22234778899999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999976432 36788899999999999999999 7899999999999999999999999999876543321
Q ss_pred ccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC---CcccHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA---DESEMEE 414 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~ 414 (496)
.......||+.|+|||++.. ..++.++|+||+|+++|+|++|..||........+..+...... .+.....
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 11233469999999999873 45678999999999999999999998765544444444432211 1111235
Q ss_pred HHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 047375 415 IEVVAELASKCLRIRGT--ERPTMKEVSEE 442 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~--~RPs~~eil~~ 442 (496)
++.+.+++.+|+..++. .||++.++++.
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 67799999998865433 37788887543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=300.78 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=192.1
Q ss_pred hhcccCCceEEEEeEeC----CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEe-eCCeeeEEEeecc
Q 047375 192 HCLGMGGFGSVYKGVLP----DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCL-ETKVTLLVYEFVS 264 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E~~~ 264 (496)
+.||+|+||.||+|... ....||+|.+..... ......+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999852 235799998754322 2234447888999999999999999876 4556899999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc-
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET- 343 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~- 343 (496)
+|+|.+++..... ..++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999976432 24667788899999999999999 78999999999999999999999999998765432111
Q ss_pred -cceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 344 -AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 344 -~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.......+++.|+|||.+.+..++.++|+||+|++++++++ +.+|+...........+.... ....+...++.+.++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 234 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLLQPEYCPDPLYEV 234 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHH
Confidence 11123346778999999988888999999999999999988 466665433322222222221 222223345679999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 422 ASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
+.+||+.+|++||++.++++.|+.+.
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=305.76 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=199.0
Q ss_pred hcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
.+.+.+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 3566788999999999999864 356789998753322 22345578999999999999999999999889999
Q ss_pred EEeeccCCchhhhhhhcCc----ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC---ceEEccC
Q 047375 259 VYEFVSNGALSHYIHDKSS----QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY---TAKVSDF 331 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~---~~kL~DF 331 (496)
||||+++|+|.+++..... ...+++..+..++.||+.||.|||+ ++++||||||+||+++.++ .+||+||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccC
Confidence 9999999999999976432 1247889999999999999999999 7899999999999998654 6999999
Q ss_pred CCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcc
Q 047375 332 ESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADES 410 (496)
Q Consensus 332 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~ 410 (496)
|+++...............++..|+|||++.+..++.++|+||+|++++++++ +..||...........+.. ......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~ 242 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GGRLDP 242 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCcCCC
Confidence 99887643221111122234568999999988889999999999999999986 7777765443333333222 222223
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 243 ~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 243 PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 3445677999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=310.74 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=211.1
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
..-.|.++||+|-||.|.+|....+..||||+++..... +..+.+|+++|.+++|||||+++|+|..++.+++|+||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 344567899999999999999877799999999865443 445669999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++..+.... ..-....+|+.||+.||+||.+ -++|||||.+.|+|++.++++||+|||+++.+-+....
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999875433 3445667899999999999999 56999999999999999999999999999977665554
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhccccccc--ccchhhhcccchhhh---hhhc---ccCCcccHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM--VPYFLDSIENNSFRQ---ILNF---QVADESEMEEI 415 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~--~~~~~~~~~~~~~~~---i~~~---~~~~~~~~~~~ 415 (496)
......+-...|||||.+....+|.++|+|++|+++||++.. ..|+....++..... +... ......+.-++
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 444455567899999999999999999999999999998654 456655544433322 2221 22334455677
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 416 EVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
..+.+++.+||..+..+|||++++...|.+.
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 8899999999999999999999998877653
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=314.51 Aligned_cols=244 Identities=23% Similarity=0.198 Sum_probs=189.7
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------e
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETK------V 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~ 255 (496)
..|.+.+.||+|+||.||++.. .++..||+|++.... .......+|+.+++.++||||+++++++...+ .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 4577789999999999999985 468899999986432 22334458899999999999999999986543 4
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 7999999976 66666532 25778888999999999999999 789999999999999999999999999987
Q ss_pred ccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-----------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF----------- 404 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------- 404 (496)
...... ......||+.|+|||++.+..++.++|+||+|+++|+|++|..||.+......+..+...
T Consensus 172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 653321 123346899999999999999999999999999999999999998754332221111100
Q ss_pred -------------ccCC----------------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 -------------QVAD----------------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 -------------~~~~----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.... ......++.+.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 000112356899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.43 Aligned_cols=246 Identities=20% Similarity=0.185 Sum_probs=195.9
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
|.+.+.||+|+||.||+|... ++..+++|.+...... .....+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556678999999999999964 5778888887644322 23345789999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|..++..... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999988765332 37889999999999999999999 789999999999999999999999999987654321 11
Q ss_pred eecccccceeecCcccc-----cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc-CCcccHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAH-----TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-ADESEMEEIEVVA 419 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~-----~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~l~ 419 (496)
.....||+.|+|||++. +..++.++|+||+|+++++++++.+||...........+..... ....+...+..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 23446899999999984 35567899999999999999999998876544333333322211 1122234557899
Q ss_pred HHHHHhcccCCCCCCCHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil 440 (496)
+++.+||+.||.+|||+.+++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred HHHHHHccCChhhCcCHHHHh
Confidence 999999999999999998884
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.24 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=216.8
Q ss_pred cchhhhcccCCceEEEEeEeC----CCcEEEEEEeecc--hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCA--DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
..+.+.||.|.||.|++|+++ ....||||.++.. ...+..+..|..||.+++||||++|-|+........||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 445688999999999999964 2457999999754 3445667799999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|+.+|+.+..+ +++.+..-++++|+.|+.||-+ .++|||||...|||++.+..+|++|||+++.+..+.
T Consensus 711 yMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999988754 6778889999999999999999 569999999999999999999999999999886654
Q ss_pred Ccccee-cccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 342 ETAMST-MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 342 ~~~~~~-~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
....++ ...-...|.|||.+....+|..+|+||+|+++||.++ |..|+.+....+.+..| ...+..+.+.+|+..|.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-HhccCCCCCCCCcHHHH
Confidence 322222 1123468999999999999999999999999999765 55666665555555554 45677788889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.|+..||++|..+||.+.+|+..|+++-+.
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 999999999999999999999999999654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=305.65 Aligned_cols=246 Identities=20% Similarity=0.244 Sum_probs=189.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhc---CCCCceeeEEEEEee-----CCe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQ---VKHKNVVKILGLCLE-----TKV 255 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~---l~hpnIv~l~~~~~~-----~~~ 255 (496)
|.+.+.||+|+||.||+|.. .+++.||+|.+...... .....+|+.+++. ++||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 56678899999999999985 46889999988643211 1223355555544 579999999999864 345
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.++||||+++ +|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 7999999975 89888876443 236889999999999999999999 789999999999999999999999999988
Q ss_pred ccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc----------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ---------- 405 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~---------- 405 (496)
....... .....||+.|+|||++.+..++.++|+||+|+++++++++.++|........+..+....
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 7643211 233458999999999998889999999999999999999999986654433333332110
Q ss_pred --------cCC-------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 --------VAD-------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 --------~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... ......+..+.+++.+||+.||.+|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 001123466899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=310.85 Aligned_cols=249 Identities=17% Similarity=0.169 Sum_probs=196.9
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||++... ++..||+|.+..... ......+|+.++..++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 566789999999999999964 577899998854221 112234678889999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999976432 36788889999999999999999 7899999999999999999999999999876543221
Q ss_pred ccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc---ccHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE---SEMEE 414 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~~~ 414 (496)
......+||+.|+|||++.. ..++.++|+||+|+++|++++|..||........+..+........ .....
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 12234569999999999863 4678899999999999999999999987655555555554322111 12245
Q ss_pred HHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTE--RPTMKEVSEE 442 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~--RPs~~eil~~ 442 (496)
++.+.+|+.+|+..+|.. ||++.++++.
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 678999999998665444 6788888543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.44 Aligned_cols=237 Identities=22% Similarity=0.302 Sum_probs=184.0
Q ss_pred hcccCCceEEEEeEeCC-------------CcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 193 CLGMGGFGSVYKGVLPD-------------NTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
.||+|+||.||+|.... ...|++|.+....... ..+.+++.++..++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 2258888875543322 234577889999999999999999999989999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc-------eEEccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT-------AKVSDF 331 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~-------~kL~DF 331 (496)
||||+++|+|..++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +|++||
T Consensus 82 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999988865432 36888899999999999999999 78999999999999986654 899999
Q ss_pred CCccccCCCCCccceecccccceeecCcccc-cccccCCCCCchhhhhccccc-ccccchhhhcccchhhhhhhcccCCc
Q 047375 332 ESLVPISSDDETAMSTMIRGTVGYLDPEYAH-TELLTGMNPNSYVALASNEKI-SMVPYFLDSIENNSFRQILNFQVADE 409 (496)
Q Consensus 332 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-~~~~t~~~d~~s~g~~~~~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~ 409 (496)
|++...... ....|+..|+|||.+. +..++.++|+||+|+++|+++ .+..|+....... ...+.......
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~- 228 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KERFYEGQCML- 228 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHhcCccC-
Confidence 988665322 2334888999999886 467888999999999999997 5666654432211 11111111111
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 443 (496)
....++.+.+|+.+||+.||.+||++.+|++.|
T Consensus 229 -~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 -VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 112245689999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.27 Aligned_cols=258 Identities=20% Similarity=0.252 Sum_probs=203.9
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCc----EEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNT----QVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
.+.+.+.||+|+||.||+|.+. ++. .||+|.+..... ......+|+.++.+++||||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 3667789999999999999853 232 589998764432 22344578999999999999999999987 788999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999976543 26889999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
...........++..|+|||.+....++.++|+||+|++++++++ +.+||...........+... ...+.+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCCCCCCCCCHHH
Confidence 322211122224678999999988888999999999999999997 88887665443333333322 2222223344678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 451 (496)
.+++.+||..||.+|||+.++++.|..+.+...
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 999999999999999999999999999866433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.23 Aligned_cols=247 Identities=25% Similarity=0.328 Sum_probs=197.9
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchh
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALS 269 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 269 (496)
++||.|+||.||++....+..||+|.+..... ......+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999976699999998765432 2334458899999999999999999999999999999999999999
Q ss_pred hhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecc
Q 047375 270 HYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMI 349 (496)
Q Consensus 270 ~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 349 (496)
+++..... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99976432 36788899999999999999999 78999999999999999999999999998765432111111222
Q ss_pred cccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhccc
Q 047375 350 RGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRI 428 (496)
Q Consensus 350 ~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~ 428 (496)
.++..|+|||++.+..++.++|+||+|++++++++ +..||...........+. .......+...+..+.+++.+||..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhcc
Confidence 34677999999988889999999999999999998 677765544333223222 2222223334567899999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 047375 429 RGTERPTMKEVSEELD 444 (496)
Q Consensus 429 dP~~RPs~~eil~~L~ 444 (496)
+|.+|||+.|+++.|+
T Consensus 235 ~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 235 DPENRPSFSEIYNELQ 250 (251)
T ss_pred ChhhCcCHHHHHHHhh
Confidence 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=302.40 Aligned_cols=253 Identities=18% Similarity=0.238 Sum_probs=200.7
Q ss_pred cchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
+.....||.|+||.||+|... ....|++|.+...... .....+|+.++++++||||+++++++.+.+..|+|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 455678999999999999853 2457899987654332 33455889999999999999999999998999999
Q ss_pred EeeccCCchhhhhhhcCcc------cccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 260 YEFVSNGALSHYIHDKSSQ------VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
|||+++|+|.+++...... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccc
Confidence 9999999999999765421 147899999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccH
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEM 412 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 412 (496)
+........ .......++..|+|||.+.+...+.++|+||+|++++++++ +..||...........+...........
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd05046 164 SKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242 (275)
T ss_pred ccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCC
Confidence 875533211 11223346788999999988778889999999999999987 6667654443333333333332222333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
..+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 243 ~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 243 GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 45578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=305.25 Aligned_cols=246 Identities=20% Similarity=0.278 Sum_probs=199.4
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .++..|++|.+...... .....+|+.+++.++||||+++++.+......|+||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 366677899999999999985 46889999988654332 2334478899999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred CCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 99999998643 25788899999999999999999 7899999999999999999999999999876543221
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhh-hcccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL-NFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~l~~li~ 423 (496)
......|++.|+|||.+.+..++.++|+|++|++++++++|.+||...........+. ........+...+..+.+++.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 1233458999999999998888999999999999999999999987654333222222 111111223345577999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~ 441 (496)
+||..||.+|||+.++++
T Consensus 252 ~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHCcCCcccCcCHHHHhh
Confidence 999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=341.31 Aligned_cols=244 Identities=22% Similarity=0.243 Sum_probs=201.8
Q ss_pred hhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhh---hHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRI---TEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
.+||.|.||.||-|. ..+|...|+|.+...+.... ...+|..++..++|||+|++||+-......+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 679999999999999 56788999998754433322 22388999999999999999999999999999999999999
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc--c
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA--M 345 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~--~ 345 (496)
|.+++..... .++.....+..|++.|+.|||+ +|||||||||.||+++.+|.+|++|||.|..+.....+. .
T Consensus 1321 La~ll~~gri---~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1321 LASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 9999976543 5666777889999999999999 889999999999999999999999999999886542211 1
Q ss_pred eecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.....||+.|||||++.+ +.-.+..||||+||++.||++|..||.....+..+.--+.....++.+...+++-.+++
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence 234579999999999987 44567899999999999999999888776555444433334445556666889999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+||..||..|.++.|+++
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHHHhcCchhhhHHHHHHH
Confidence 9999999999998887753
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=299.45 Aligned_cols=238 Identities=24% Similarity=0.337 Sum_probs=187.3
Q ss_pred hhcccCCceEEEEeEeCCCc-----------EEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 192 HCLGMGGFGSVYKGVLPDNT-----------QVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+.||+|+||.||+|...... .|++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 36899999999999974332 47888776544434455688999999999999999999988 7789999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-------ceEEccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-------TAKVSDFES 333 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-------~~kL~DFGl 333 (496)
||+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999987543 36888899999999999999999 7899999999999999887 799999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccc--cccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCcc
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTE--LLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADES 410 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~ 410 (496)
+...... ....++..|+|||++.+. .++.+.|+||+|+++++++++ ..|+................. .+
T Consensus 155 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~-~~- 226 (259)
T cd05037 155 PITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR-LP- 226 (259)
T ss_pred ccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC-CC-
Confidence 8765431 223477889999999876 788899999999999999884 555544322221111111111 11
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
......+.+++.+||..+|.+|||+.++++.|+
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 227 -MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111267899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=301.52 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=202.1
Q ss_pred hcchhhhcccCCceEEEEeEeC-----CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEee--CCeee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-----DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLE--TKVTL 257 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~ 257 (496)
.+.+.+.||+|+||.||+|.+. ++..||||.+...... .....+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3566688999999999999853 3678999998755443 3445588999999999999999999887 56789
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+||||+++++|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999976543 37889999999999999999999 78999999999999999999999999999877
Q ss_pred CCCCCccc-eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc--------------hhhhhh
Q 047375 338 SSDDETAM-STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN--------------SFRQIL 402 (496)
Q Consensus 338 ~~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~--------------~~~~i~ 402 (496)
........ .....++..|+|||.+.+..++.++|+||+|+++++++++..|+....... .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 53322111 112235667999999988889999999999999999999887765432211 111122
Q ss_pred hcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 403 NFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 403 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
......+.+..++..+.+++.+||+.+|.+|||+.||+++|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22222222334457799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=302.15 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=187.2
Q ss_pred hcccCCceEEEEeEeC---CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 193 CLGMGGFGSVYKGVLP---DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
.||+|+||.||+|... ....+++|.+..... ......+|+.+++.++||||+++++.+......|+||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999743 235688887654322 22234478899999999999999999999999999999999999
Q ss_pred hhhhhhhcCc--ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 268 LSHYIHDKSS--QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 268 L~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|.+++..... ....++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976532 1224567788999999999999999 7899999999999999999999999999865433221111
Q ss_pred eecccccceeecCccccc-------ccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcc---c-CCcccHH
Q 047375 346 STMIRGTVGYLDPEYAHT-------ELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQ---V-ADESEME 413 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~-------~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~---~-~~~~~~~ 413 (496)
.....+++.|+|||++.. ..++.++|+||+|++++++++ +.+||...........+.... . .+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 223346778999998753 456779999999999999998 666665443333333322211 1 1112234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
.++.+.+++..|| .||++|||+.+|++.|.
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 5567888999999 59999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=304.06 Aligned_cols=244 Identities=21% Similarity=0.166 Sum_probs=194.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|...+.||+|+||+||+|.. .+++.||+|.+..... ......+|+.+++.++|+||+.+++++..++..|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 44557899999999999985 4688999998864321 122344789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|..++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 999999988865432 237899999999999999999999 7899999999999999999999999999876543211
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccCCcccHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVADESEMEEIEVVAE 420 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~l~~ 420 (496)
.....|++.|+|||++.+..++.++|+||+|+++++++++..||...........+... ..........+..+.+
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHH
Confidence 12345899999999999888999999999999999999999998765433222222111 1111222344567899
Q ss_pred HHHHhcccCCCCCCCHHH
Q 047375 421 LASKCLRIRGTERPTMKE 438 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~e 438 (496)
|+.+||+.||.+||++.+
T Consensus 235 li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred HHHHHccCCHhHcCCCcc
Confidence 999999999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.30 Aligned_cols=237 Identities=21% Similarity=0.266 Sum_probs=183.4
Q ss_pred hcccCCceEEEEeEeCC-------------------------CcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeE
Q 047375 193 CLGMGGFGSVYKGVLPD-------------------------NTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKI 246 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l 246 (496)
.||+|+||.||+|.+.. ...|++|.+...... ...+.+++.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997411 135888887544332 2344577889999999999999
Q ss_pred EEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC--
Q 047375 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-- 324 (496)
Q Consensus 247 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-- 324 (496)
+++|...+..++|||||++|+|..++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999875432 36788899999999999999999 7899999999999997543
Q ss_pred -----ceEEccCCCccccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccc-cccccchhhhcccch
Q 047375 325 -----TAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEK-ISMVPYFLDSIENNS 397 (496)
Q Consensus 325 -----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~-~~~~~~~~~~~~~~~ 397 (496)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|+||+|++++++ +++.+||........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 4899999987654322 12347888999998865 5678899999999999998 467777765433222
Q ss_pred hhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047375 398 FRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 398 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 443 (496)
..+.......+ ....+.+.+++.+||+.+|.+|||+.+|++.|
T Consensus 231 -~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 -ERFYEKKHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHHHHhccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 12222111111 11235689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=301.96 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=196.3
Q ss_pred hhcccCCceEEEEeEeCC-------CcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 192 HCLGMGGFGSVYKGVLPD-------NTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.||+|+||.||+|...+ +..+|+|.+.... .......+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998532 2578999875432 2233445889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcC----cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-----ceEEccCCC
Q 047375 263 VSNGALSHYIHDKS----SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-----TAKVSDFES 333 (496)
Q Consensus 263 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-----~~kL~DFGl 333 (496)
+++|+|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 12336888999999999999999998 7799999999999999877 899999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccH
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEM 412 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 412 (496)
+................++..|+|||++.+..++.++|+||+|+++|++++ +..||...........+.. ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 236 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GGRLQKPE 236 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCccCCcc
Confidence 876643322222223346788999999998889999999999999999987 7777754433333332222 12222334
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
..+..+.+++.+||..+|.+||++.++++.|+
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 45678999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=317.80 Aligned_cols=250 Identities=19% Similarity=0.219 Sum_probs=196.2
Q ss_pred HHHHHHhcchhhhcccCCceEEEEeEeC---CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 181 SELLKATKNFHHCLGMGGFGSVYKGVLP---DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 181 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..+....|.+.+.||.|+||.||++... .+..||+|.+.... ...+|+.+++.++|||||++++++......|
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3344556888899999999999999742 45789999875432 2347899999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+|||++. ++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 163 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999996 58888884432 37889999999999999999999 78999999999999999999999999998876
Q ss_pred CCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc---hhhhhhh-----------
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN---SFRQILN----------- 403 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~---~~~~i~~----------- 403 (496)
.............||+.|+|||++.+..++.++|+||+||++|+++++..||.+..... .+..+..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 54333322334569999999999999899999999999999999999988886543221 1111110
Q ss_pred --------------cccCCc--cc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 404 --------------FQVADE--SE-----MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 404 --------------~~~~~~--~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.....+ .+ ...+..+.++|.+||..||.+|||+.|++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 00 112356889999999999999999999953
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=301.42 Aligned_cols=255 Identities=21% Similarity=0.299 Sum_probs=202.0
Q ss_pred HhcchhhhcccCCceEEEEeEeCC----CcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPD----NTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
..+.+.+.||+|+||.||+|.+.+ ...|++|...... .......+|+.+++.++||||+++++++.+ ...|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 346677899999999999998532 2468999876443 223345588999999999999999999875 457899
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999976432 36889999999999999999999 7899999999999999999999999999877654
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
.... ..+...++..|+|||.+....++.++|+||+|++++++++ +.+||...........+.... ..+.+..++..+
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (270)
T cd05056 160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTL 237 (270)
T ss_pred ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHH
Confidence 3211 1122235578999999988889999999999999999875 888876554443333333221 222233456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.32 Aligned_cols=248 Identities=16% Similarity=0.171 Sum_probs=190.4
Q ss_pred hhhhcccC--CceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 190 FHHCLGMG--GFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 190 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
+.++||+| +||+||++.. .+|..||+|++.... .......+|+.+++.++||||++++++|..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 7899999985 578999999986432 22233347899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++..+... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999764322 36888999999999999999999 78999999999999999999999999865443221110
Q ss_pred -----cceecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc----------
Q 047375 344 -----AMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV---------- 406 (496)
Q Consensus 344 -----~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 406 (496)
.......++..|+|||++.+ ..++.++|+||+|++++++++|..||.................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 01122347788999999876 4588999999999999999999998864322211111110000
Q ss_pred ----------------------------------CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 407 ----------------------------------ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 407 ----------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+.....++.+.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00111234567999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=298.33 Aligned_cols=249 Identities=23% Similarity=0.290 Sum_probs=200.1
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
+.+.+.||+|+||.||+|.+.++..+|+|.+...........+|+++++.++||||+++++++......++||||+++|+
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 56678899999999999997668899999886544434455688999999999999999999999999999999999999
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcccee
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 347 (496)
|.+++..... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......... ...
T Consensus 86 L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~ 159 (256)
T cd05112 86 LSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SST 159 (256)
T ss_pred HHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-ccC
Confidence 9999876432 36788899999999999999999 78999999999999999999999999998765432111 111
Q ss_pred cccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 348 MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 348 ~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
...++..|+|||++.+..++.++|+||+|+++|++++ +.+||...........+... .....+...+..+.+|+.+||
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l 238 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHCW 238 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHc
Confidence 2235678999999998889999999999999999987 77877654433333333221 111112223467999999999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 047375 427 RIRGTERPTMKEVSEEL 443 (496)
Q Consensus 427 ~~dP~~RPs~~eil~~L 443 (496)
+.+|.+|||+.++++.|
T Consensus 239 ~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 239 KERPEDRPSFSLLLHQL 255 (256)
T ss_pred ccChhhCCCHHHHHHhh
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=299.08 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=198.8
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----------hhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----------RITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
+.+...||.|+||.||+|.. .++..||+|.+...... .....+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 45667899999999999985 46789999987543211 12334788999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||.++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999997653 36788889999999999999999 7899999999999999999999999999887
Q ss_pred cCCCCCc----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccH
Q 047375 337 ISSDDET----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEM 412 (496)
Q Consensus 337 ~~~~~~~----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 412 (496)
....... .......|+..|+|||.+.+..++.++|+|++|+++++++++..||...........+.. ......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 234 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPS 234 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCc
Confidence 6532111 111234588999999999888888999999999999999999998876543333333322 11222333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+..+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 45678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=301.10 Aligned_cols=240 Identities=21% Similarity=0.243 Sum_probs=192.2
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
+.+.+.||+|+||.||+|.. .++..||+|.+.... .......+|+.++.+++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 45667899999999999985 578899999886432 222334588999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|..+. .+++..+..++.|++.||.|||+ ++|+|+||||+|||++.++.+||+|||++......
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 99996542 25677888999999999999999 78999999999999999999999999998765432
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc-------hhhhhhhcccCCcccHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN-------SFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-------~~~~i~~~~~~~~~~~~~~~~ 417 (496)
......||..|+|||++.+..++.++|+||+|++++++++|..||....... ....+.+...........++.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence 1234569999999999998889999999999999999999998886532211 111111111111112234567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+++.+||+.||.+||++.++++
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhc
Confidence 999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=308.48 Aligned_cols=247 Identities=21% Similarity=0.237 Sum_probs=193.6
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
+|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3667789999999999999854 678899998864332 2233457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++ +|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 87 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 87 DK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 75 88888765432 36788889999999999999999 78999999999999999999999999998765432211
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc------------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF------------------ 404 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------------ 404 (496)
.....+|+.|+|||++.+ ..++.++|+||+|++++++++|.+||........+..+...
T Consensus 161 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 161 --YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred --cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 223458999999998865 45788999999999999999999998665433322222110
Q ss_pred ---ccCCc-------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ---QVADE-------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ---~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+.. .....++.+.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 00123467899999999999999999999953
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=317.95 Aligned_cols=246 Identities=20% Similarity=0.180 Sum_probs=191.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC-----eeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETK-----VTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~l 258 (496)
+.+.+.||+|+||.||+|.. .++..||+|++.... .......+|+.+++.++||||+++++++...+ ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 34567899999999999995 478999999885431 12234458899999999999999999998776 7899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred Eeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 999997 57888775543 37889999999999999999999 789999999999999999999999999988654
Q ss_pred CCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-------------
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF------------- 404 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------- 404 (496)
.... .......+|+.|+|||++.+ ..++.+.|+||+||++++|++|.+||.+......+..+.+.
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 3321 12233458999999999877 44788999999999999999999998665433322222110
Q ss_pred ----------ccCCc-------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ----------QVADE-------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ----------~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....+ .....++.+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000 01122467899999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=335.40 Aligned_cols=259 Identities=17% Similarity=0.225 Sum_probs=201.6
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... +++.||+|++.... .......+|+.+++.++||||+++++++.+++..|+|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 3667789999999999999954 68899999986432 223345588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCc--------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 262 FVSNGALSHYIHDKSS--------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
|++||+|.+++..... ....++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999864211 1224567788999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCC----------------ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch
Q 047375 334 LVPISSDDE----------------TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS 397 (496)
Q Consensus 334 a~~~~~~~~----------------~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~ 397 (496)
++....... .......+||+.|+|||++.+..++.++|+||+||++++|++|.+||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 987621110 0011234699999999999999999999999999999999999999865332211
Q ss_pred hh-hhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhHh
Q 047375 398 FR-QILNFQVADESEMEEIEVVAELASKCLRIRGTERP-TMKEVSEELDRLRR 448 (496)
Q Consensus 398 ~~-~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~ 448 (496)
.. ...............++.+.+++.+||+.||.+|| +++++++.|+...+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 11111111111224557799999999999999996 67778888887754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=303.58 Aligned_cols=245 Identities=23% Similarity=0.200 Sum_probs=195.0
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|...+.||+|+||.||++.. .+++.||+|.+...... .....+|+.+++.++|+||+.+++.+.+.+..|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 44557899999999999985 46889999988643221 12334789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999998865432 236888999999999999999999 7899999999999999999999999999876543221
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc---hhhhhhhcccCCcccHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN---SFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
.....||+.|+|||++.+..++.++|+||+|+++|++++|.+||....... ....+.. ..........++.+.
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDAR 233 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHH
Confidence 123458999999999998889999999999999999999999987543221 1111111 111122233456799
Q ss_pred HHHHHhcccCCCCCCC-----HHHHH
Q 047375 420 ELASKCLRIRGTERPT-----MKEVS 440 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs-----~~eil 440 (496)
+|+.+||+.||.+||| +.|++
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~ 259 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVK 259 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHH
Confidence 9999999999999999 66664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=298.99 Aligned_cols=248 Identities=21% Similarity=0.243 Sum_probs=185.9
Q ss_pred hcccCCceEEEEeEeCCC---cEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 193 CLGMGGFGSVYKGVLPDN---TQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
.||+|+||.||+|...++ ..+++|.+.... .......+|+.+++.++||||+++++.|......|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975333 345666654332 223345588899999999999999999999999999999999999
Q ss_pred hhhhhhhcCc-ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 268 LSHYIHDKSS-QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 268 L~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
|.+++..... ....++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976422 2234666778899999999999999 78999999999999999999999999987653322111122
Q ss_pred ecccccceeecCccccc-------ccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhccc----CCcccHHH
Q 047375 347 TMIRGTVGYLDPEYAHT-------ELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQV----ADESEMEE 414 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~-------~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~----~~~~~~~~ 414 (496)
....|+..|+|||++.. ..++.++|+||+|++++++++ +.+||........+..+..... .+......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34458899999998753 235678999999999999986 4556654433333333332211 11122234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
++.+.+++..|| .+|++|||+.+|++.|.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 567889999999 68999999999988774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=298.63 Aligned_cols=248 Identities=20% Similarity=0.253 Sum_probs=198.7
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh-------hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE-------IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
|...+.||.|+||.||+|...++..+|+|.+..... ......+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 455678999999999999987889999998764321 1123347889999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 82 EFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999997653 26788889999999999999999 78999999999999999999999999998765321
Q ss_pred CC----ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-ccCCcccHHHH
Q 047375 341 DE----TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF-QVADESEMEEI 415 (496)
Q Consensus 341 ~~----~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~ 415 (496)
.. ........|+..|+|||++.+..++.++|+||+|++++++++|..||...........+... ......+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence 11 11122345899999999999888899999999999999999999988654333222222221 11222333456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 416 EVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 77999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=296.15 Aligned_cols=248 Identities=21% Similarity=0.223 Sum_probs=204.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||.|+||.||.+.. .++..+++|.+.... .......+|+.++++++||||+++++++.+.+..+++||||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 56678999999999999884 468899999875432 22334458899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 82 NGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999986532 346889999999999999999999 7799999999999999999999999999887644321
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......|++.|+|||++.+..++.++|+||+|+++++++++..||...........+....... .....+..+.+++.
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 234 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVH 234 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHH
Confidence 2234568999999999988778899999999999999999998887655444444444333222 22445677999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~ 442 (496)
+||..+|.+|||+.++++.
T Consensus 235 ~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 235 SLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHcccCcccCCCHHHHhhC
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=301.01 Aligned_cols=238 Identities=21% Similarity=0.302 Sum_probs=185.7
Q ss_pred hhcccCCceEEEEeEeCC--------CcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 192 HCLGMGGFGSVYKGVLPD--------NTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.||+|+||.||+|.... ...|++|.+...... .....+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 234888877543322 23345788899999999999999999998999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc--------eEEccCCCc
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT--------AKVSDFESL 334 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~--------~kL~DFGla 334 (496)
+++|+|..++..... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999976543 36888899999999999999999 78999999999999987664 699999987
Q ss_pred cccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccc-cchhhhcccchhhhhhhcccCCcccH
Q 047375 335 VPISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMV-PYFLDSIENNSFRQILNFQVADESEM 412 (496)
Q Consensus 335 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~-~~~~~~~~~~~~~~i~~~~~~~~~~~ 412 (496)
...... ....+++.|+|||++.+ ..++.++|+||+|+++|+++++. +|+...... ....+..... ..+.
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~--~~~~ 226 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KKLQFYEDRH--QLPA 226 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HHHHHHHccc--cCCC
Confidence 654321 23458899999999986 45788999999999999999984 554433222 1122222111 1122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 443 (496)
.....+.+|+.+||+.||.+|||+.+|++.|
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 227 PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2335689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=300.95 Aligned_cols=249 Identities=18% Similarity=0.230 Sum_probs=196.5
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEee------CCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLE------TKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~------~~~~~l 258 (496)
.|.+.+.||.|+||.||+|.. .++..+|+|.+............|+.++.++ +||||+++++++.. .+..|+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 466678899999999999996 4678999998865544444455778888888 69999999999863 457899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
+|||+++|+|.+++...... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.++|+|||++....
T Consensus 97 v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEeCCCCcHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 99999999999999764432 36778888999999999999999 789999999999999999999999999987654
Q ss_pred CCCCccceecccccceeecCcccc-----cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAH-----TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEME 413 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 413 (496)
.... ......|++.|+|||.+. ...++.++|+||+|+++++++++.+||...........+............
T Consensus 173 ~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd06636 173 RTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK 250 (282)
T ss_pred cccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence 3211 123456899999999886 345778999999999999999999988654433333322222222222234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+..+.+||.+||+.||.+|||+.||++
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 5678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=300.49 Aligned_cols=249 Identities=20% Similarity=0.176 Sum_probs=197.7
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
..|.+.+.||.|+||.||+|... ++..|++|.+...... .....+|+.+++.++||||+++++.+...+..|+||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 34677788999999999999964 5789999998654333 233447889999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|..++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 99999888765432 36889999999999999999999 7899999999999999999999999998876433211
Q ss_pred cceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc-CCcccHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-ADESEMEEIEV 417 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 417 (496)
......+++.|+|||++.+ ..++.++|+||+|+++|+++++.+||...........+..... ....+...+..
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 1234458899999999853 4467789999999999999999998866543333333332211 11122344567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+++.+||..||++||++.++++
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhc
Confidence 999999999999999999998853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=320.91 Aligned_cols=244 Identities=21% Similarity=0.226 Sum_probs=189.2
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.|.+.+.||+|+||.||+|... .+..||||.... ....+|+.++++++|||||++++++...+..++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 4666789999999999999964 578899996422 234578999999999999999999999999999999995
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
++|..++..... .+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..........
T Consensus 244 ~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 244 SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 689888865432 47899999999999999999999 7899999999999999999999999999987644322222
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-------chhhhhhh-ccc-----C-----
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-------NSFRQILN-FQV-----A----- 407 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-------~~~~~i~~-~~~-----~----- 407 (496)
.....||+.|+|||++.+..++.++|+||+||++|+++.+..++...... ..+..++. ... .
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 33456999999999999989999999999999999998765433221110 11111111 000 0
Q ss_pred -------------------CcccH---HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 408 -------------------DESEM---EEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 408 -------------------~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...+. .....+.+||.+||+.||.+|||+.|+++
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00000 12346889999999999999999999964
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=314.23 Aligned_cols=244 Identities=21% Similarity=0.179 Sum_probs=189.6
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC------Ce
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET------KV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~ 255 (496)
..|.+.+.||+|+||.||++.. ..+..||||++.... .......+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 3577778999999999999985 468899999886432 2223445789999999999999999998643 35
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 7999999975 67666643 25778889999999999999999 789999999999999999999999999998
Q ss_pred ccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-----------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF----------- 404 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------- 404 (496)
...... ......||+.|+|||++.+..++.++|+||+|+++++|+++..||.+......+..+...
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 654321 123456899999999999988999999999999999999999888654322221111100
Q ss_pred -----------cc------------------CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 -----------QV------------------ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 -----------~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.. ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00 00001112356899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=296.15 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=197.9
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.|.+.+.||+|+||.||+|.. .+..||+|.+.... ......+|+.+++.++||||+++++++... ..++||||+++|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 477788999999999999986 68889999886433 233455889999999999999999998765 479999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.+++..... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99999976543 236888999999999999999999 789999999999999999999999999987643221
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
.....+..|+|||++.+..++.+.|+||+|++++++++ +.+||...........+.. ..........+..+.+++.+|
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLMTSC 233 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHHH
Confidence 12234678999999988889999999999999999986 7888765543333332222 222223334567899999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 047375 426 LRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~ 444 (496)
|+.+|.+||++.++++.|+
T Consensus 234 l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 234 WETEPKKRPSFHKLREKLE 252 (254)
T ss_pred cCCChhhCcCHHHHHHHHc
Confidence 9999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.11 Aligned_cols=246 Identities=21% Similarity=0.269 Sum_probs=184.5
Q ss_pred hhhcccCCceEEEEeEeC---CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeEEEeeccC
Q 047375 191 HHCLGMGGFGSVYKGVLP---DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLLVYEFVSN 265 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~ 265 (496)
...||+|+||.||+|... ++..||+|.+.... ......+|+.+++.++||||+++++++.. ....|+||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999999853 46789999886432 22334588999999999999999999864 4568999999965
Q ss_pred CchhhhhhhcC------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee----CCCCceEEccCCCcc
Q 047375 266 GALSHYIHDKS------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL----DDNYTAKVSDFESLV 335 (496)
Q Consensus 266 g~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll----~~~~~~kL~DFGla~ 335 (496)
+|.+++.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 8888875421 12246888999999999999999999 789999999999999 456789999999998
Q ss_pred ccCCCCCc-cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccc---------hhhhhhhc
Q 047375 336 PISSDDET-AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENN---------SFRQILNF 404 (496)
Q Consensus 336 ~~~~~~~~-~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~---------~~~~i~~~ 404 (496)
........ .......||+.|+|||++.+ ..++.+.|+||+||+++++++|.+||....... .+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 76543211 11234568999999999877 458889999999999999999999886433210 01111100
Q ss_pred c-------------cCC--------------c---------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 Q-------------VAD--------------E---------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ~-------------~~~--------------~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
. .+. . ........+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000 0 00001245789999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=307.72 Aligned_cols=248 Identities=19% Similarity=0.209 Sum_probs=202.5
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecc---hhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCA---DEIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|...+.||+||.+.||++...+.+.||+|++... ......+.+|+..|.+|+ |.+||++|+|-..++.+|+||||=
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 5667899999999999999878888999977432 222334558999999996 999999999999999999999987
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
+. +|..+|+...... ..| .+..+..|++.++.++|. +||||.||||.|+|+- .|.+||+|||+|..+..+...
T Consensus 443 d~-DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 443 DI-DLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred cc-cHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 54 9999998876543 234 677889999999999999 8899999999999998 468999999999999887666
Q ss_pred cceecccccceeecCcccccc-----------cccCCCCCchhhhhcccccccccchhhhc-ccchhhhhhhcccCCccc
Q 047375 344 AMSTMIRGTVGYLDPEYAHTE-----------LLTGMNPNSYVALASNEKISMVPYFLDSI-ENNSFRQILNFQVADESE 411 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~-----------~~t~~~d~~s~g~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~ 411 (496)
-.....+||+.||+||.+... ....++|+||+||++|+|+.|.+||.... ....+..|.++....+++
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 666778899999999998752 24578999999999999999999998765 345566666664432222
Q ss_pred HHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 412 MEE-IEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 412 ~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
.-- ..++.++++.||..||.+|||+.|+|+.
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 211 1239999999999999999999999763
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=298.13 Aligned_cols=245 Identities=22% Similarity=0.246 Sum_probs=200.2
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|.+.+.||.|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++.+....|+|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 566788999999999999954 688999998864321 12234478999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++... .+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+++...... .
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 83 GGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred CCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 99999998754 46889999999999999999999 789999999999999999999999999998775432 1
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
......|++.|+|||++.+..++.++|+|++|++++++++|.+||...........+.....+.......++.+.+++.+
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 233 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL 233 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHH
Confidence 22345689999999999988899999999999999999999999865443333333222221111111256779999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 047375 425 CLRIRGTERPTMKEVSE 441 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~ 441 (496)
||..+|++|||+.++++
T Consensus 234 ~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 234 CLNKDPKERPSAKELLK 250 (274)
T ss_pred HhhCChhhCcCHHHHhh
Confidence 99999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=302.56 Aligned_cols=244 Identities=18% Similarity=0.281 Sum_probs=199.6
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
|.+.+.||.|+||.||+|.. .+++.|++|.+...... .....+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 56678899999999999984 57889999988654332 23344789999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
++|..++... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........ .
T Consensus 101 ~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 171 (296)
T cd06655 101 GSLTDVVTET----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K 171 (296)
T ss_pred CcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence 9999988653 26889999999999999999999 7899999999999999999999999999876654322 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc-CCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-ADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~l~~li~~ 424 (496)
.....|++.|+|||.+.+..++.++|+||+|+++|++++|.+||...........+..... ....+...++.+.++|.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 2334589999999999988889999999999999999999999876544333333322111 112233455779999999
Q ss_pred hcccCCCCCCCHHHHH
Q 047375 425 CLRIRGTERPTMKEVS 440 (496)
Q Consensus 425 cl~~dP~~RPs~~eil 440 (496)
||..||.+|||+.+++
T Consensus 252 ~l~~dp~~Rpt~~~il 267 (296)
T cd06655 252 CLEMDVEKRGSAKELL 267 (296)
T ss_pred HhhcChhhCCCHHHHh
Confidence 9999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=312.05 Aligned_cols=261 Identities=22% Similarity=0.280 Sum_probs=221.0
Q ss_pred HHHHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 182 ELLKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 182 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
++........++||-|.||.||.|.|+ ....||||.++........+..|..+|+.++|||+|+|+|+|.....+|||+
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 333333445688999999999999985 4668999999877777777779999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||.+|+|.+||++..... ++.-..+.++.||..|+.||.. +++|||||-..|+|+.++..||++|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRecnr~e-v~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSE-VPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhchhh-cchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999999999866443 5667788999999999999999 88999999999999999999999999999998765
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
..+. .....-...|.|||-+....++-++|+|+||+++||+.+...-.+...+......++...+.-..+..|++.+.+
T Consensus 419 TYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYe 497 (1157)
T KOG4278|consen 419 TYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYE 497 (1157)
T ss_pred ceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHH
Confidence 3332 122224568999999999999999999999999999977544444445556666677777888888899999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 421 LASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
|+..||+++|.+||++.||-+.++.+-
T Consensus 498 LMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 999999999999999999999887763
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=300.68 Aligned_cols=248 Identities=22% Similarity=0.220 Sum_probs=199.6
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|.+.+.||+|+||.||++.. .++..||+|.+.... .......+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4477788999999999999995 468889999876432 2233455889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++.... .+++..+..++.+++.||.|||+. ++|+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999999987643 368899999999999999999972 479999999999999999999999999876543221
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-----------chhhhhhhcccCCccc
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-----------NSFRQILNFQVADESE 411 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-----------~~~~~i~~~~~~~~~~ 411 (496)
.....||..|+|||++.+..++.+.|+||+|+++++++++..||...... .....+..........
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 22346899999999998888899999999999999999999988754331 1112222211111112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 2355779999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.18 Aligned_cols=244 Identities=21% Similarity=0.176 Sum_probs=190.8
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC------Ce
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET------KV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~ 255 (496)
..|.+.+.||+|+||.||+|.. ..+..||||++.... .......+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 3477788999999999999985 468889999986432 2223445889999999999999999987643 35
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 7999999975 77777643 25778889999999999999999 789999999999999999999999999998
Q ss_pred ccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-------- 407 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-------- 407 (496)
...... ......||+.|+|||++.+..++.++|+||+|+++|+|++|..||........+..++.....
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 654321 123456899999999999999999999999999999999999988654433333222210000
Q ss_pred --------------------------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 408 --------------------------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 408 --------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..........+.+|+.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000012346899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=295.00 Aligned_cols=248 Identities=21% Similarity=0.275 Sum_probs=200.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||.|+||.||+|.. .++..+++|.+...... .....+|+.+++.++||||+++++++...+..|++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 366778899999999999986 45788999988754333 2334488999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++..... .++...+..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 84 GGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999876522 36788999999999999999999 7899999999999999999999999999877643211
Q ss_pred ceecccccceeecCcccccc---cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC---cccHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTE---LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD---ESEMEEIEVV 418 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~---~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~l 418 (496)
......|+..|+|||.+.+. .++.++|+||+|+++++|++|.+|+...........+....... ......+..+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 12345688999999999876 78889999999999999999999887654333332222221111 1223456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+++.+||..+|.+|||+.+|+.
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhc
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.46 Aligned_cols=247 Identities=20% Similarity=0.273 Sum_probs=199.8
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
..|.+.+.||+|+||.||+|.. .++..||+|.+....... ....+|+.+++.++||||+++++++...+..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 3467778999999999999995 578999999886543322 33347889999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 999999998653 25778899999999999999999 7899999999999999999999999999876543321
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh-cccCCcccHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN-FQVADESEMEEIEVVAELA 422 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~l~~li 422 (496)
......|++.|+|||.+.+..++.++|+||+|++++++++|.+||...........+.. .......+...+..+.+++
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 12334589999999999988889999999999999999999999866443322222211 1111122334456789999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+||..||.+|||+.++++
T Consensus 250 ~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=300.35 Aligned_cols=251 Identities=21% Similarity=0.208 Sum_probs=194.4
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEe-----eCCeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCL-----ETKVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~-----~~~~~~lv 259 (496)
.|.+.+.||+|+||.||+|.. .++..+|+|.+...........+|+.++..+ +||||+++++++. ..+..++|
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 466778899999999999985 4678999998765443334445788889888 6999999999884 34568999
Q ss_pred EeeccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 260 YEFVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||+++|+|.+++... .....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 9999999999988642 122346888899999999999999999 789999999999999999999999999987764
Q ss_pred CCCCccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc-CCcccH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-ADESEM 412 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~ 412 (496)
.... ......|++.|+|||++.. ..++.++|+||+|+++++++++..|+........+..+..... ....+.
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T cd06638 176 STRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE 253 (286)
T ss_pred cCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCC
Confidence 3221 1233459999999998853 4478899999999999999999988765433322222211111 111112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
..+..+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 234579999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=336.05 Aligned_cols=254 Identities=19% Similarity=0.189 Sum_probs=196.4
Q ss_pred HHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecc---hhhhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeee
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCA---DEIRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTL 257 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~ 257 (496)
....|.+.+.||.|+||.||+|.. .++..||+|.+... ......+..|+.++..++|||||+++++|.. ...+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 334588889999999999999995 45678899987643 2223345588999999999999999999864 45689
Q ss_pred EEEeeccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCC----CCcccCCCCcCceeeCC----------
Q 047375 258 LVYEFVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLAS----PSIIHSDVKSANILLDD---------- 322 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~----~~ivHrDlKp~NIll~~---------- 322 (496)
||||||++|+|.++|.... ....+++..++.|+.||+.||.|||+.+. ++||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999997532 12347889999999999999999998431 45999999999999964
Q ss_pred -------CCceEEccCCCccccCCCCCccceecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhc
Q 047375 323 -------NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSI 393 (496)
Q Consensus 323 -------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~ 393 (496)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|+||+||++|+|+++.+||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3358999999998764322 1234569999999999864 457889999999999999999999986543
Q ss_pred ccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 394 ENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 394 ~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....+...+..... ......+..+.+||..||+.+|.+|||+.+++.
T Consensus 248 ~~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 33222222222111 111234567999999999999999999999984
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=303.78 Aligned_cols=244 Identities=19% Similarity=0.193 Sum_probs=193.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|.+.+.||+|+||.||++.. .++..+|+|.+.... .......+|++++.+++||||++++++|..++..|+||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 56678899999999999985 467788888875432 222344588999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++.... .+++..+..++.|++.||.|||+. .+++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 83 GGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence 999999997653 367888999999999999999972 47999999999999999999999999998765332
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc-------------------
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ------------------- 405 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------------- 405 (496)
......|++.|+|||++.+..++.++|+||+|+++++++++..||....... ...+....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCCC
Confidence 1234568999999999988888999999999999999999988875432211 11111100
Q ss_pred ------------------cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 ------------------VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.......+..+.+|+.+||..||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000123467999999999999999999998853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.52 Aligned_cols=244 Identities=16% Similarity=0.129 Sum_probs=184.4
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC------CCceeeEEEEEeeC-Ceee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK------HKNVVKILGLCLET-KVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~------hpnIv~l~~~~~~~-~~~~ 257 (496)
..|.+.+.||+|+||.||+|.. ..+..||||++............|+.++..++ |++|+++++++... .+.|
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 4577788999999999999985 46788999998654333333345566665554 45689999988754 5789
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-------------
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY------------- 324 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~------------- 324 (496)
+|||++ +++|.+++.... .+++..+..|+.||+.||.|||+. .+||||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred EEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 999998 678988887653 378889999999999999999972 3799999999999998665
Q ss_pred ---ceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhh
Q 047375 325 ---TAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQI 401 (496)
Q Consensus 325 ---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i 401 (496)
.+||+|||.+..... .....+||+.|+|||++.+..++.+.|+||+||++|+|++|.+||........+..+
T Consensus 283 ~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998764322 123467999999999999999999999999999999999999998654332222111
Q ss_pred hhc--cc-----------------------CCcc---------------cHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 402 LNF--QV-----------------------ADES---------------EMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 402 ~~~--~~-----------------------~~~~---------------~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
... .+ .... .....+.+.+||.+||++||.+|||+.|++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 100 00 0000 001135578999999999999999999995
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=315.12 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=198.1
Q ss_pred chhhhcccCCceEEEEeEeC-CCcEEEEEE-----eecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCe--eeEEE
Q 047375 189 NFHHCLGMGGFGSVYKGVLP-DNTQVAVKK-----YMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKV--TLLVY 260 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~-----~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~--~~lv~ 260 (496)
.|...||+|+|-+||+|... +|-.||=-. +........++..|+.+|+.|+|||||++|.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34567999999999999963 566665222 22333344667799999999999999999999987655 77899
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCCccccCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPISS 339 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~~~ 339 (496)
|.+..|+|..|+.+.+. .+...+..|++||++||.|||+.. ++|||||||.+||+|+. .|.|||+|+|+|+....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999988765 577899999999999999999976 78999999999999975 58999999999998754
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhc-ccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSI-ENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
.. ...+.|||.|||||++. +.|+...||||||+++.||+++..|+.... ....+.++..+..+.....-..+++
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPev 273 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEV 273 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHH
Confidence 32 23367999999999888 789999999999999999999988877654 3456666665544433333334789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~ 441 (496)
++||.+||.. ..+|||+.|+|+
T Consensus 274 r~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 274 REFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHHhcC-chhccCHHHHhh
Confidence 9999999999 999999999964
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=297.80 Aligned_cols=248 Identities=21% Similarity=0.219 Sum_probs=199.4
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||.|+||.||+|.. .++..||+|.+....... .....|+.++++++||||+++++++..+...|+||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 367778899999999999996 468899999886543332 234478999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++..... .+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 86 GGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred CCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999876432 37889999999999999999999 7899999999999999999999999998776543211
Q ss_pred ceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-CcccHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVV 418 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~l 418 (496)
......||+.|+|||++.. ..++.++|+||+|+++|+++++.+||...........+.....+ ...+...+..+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 1234558999999998753 44677899999999999999999998765443333333322111 11223445679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+++.+||+.+|.+|||+.++++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhc
Confidence 99999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=296.97 Aligned_cols=252 Identities=20% Similarity=0.247 Sum_probs=200.1
Q ss_pred cchhhhcccCCceEEEEeEeCC--CcEEEEEEeecch-----------hhhhhHHHHHHHHhc-CCCCceeeEEEEEeeC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPD--NTQVAVKKYMCAD-----------EIRITEWEFLGIISQ-VKHKNVVKILGLCLET 253 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~ 253 (496)
|.+.+.||+|+||.||+|.... +..+|+|.+.... ........|+.++.+ ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5567889999999999999643 6789999875321 111223466776654 7999999999999999
Q ss_pred CeeeEEEeeccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCC
Q 047375 254 KVTLLVYEFVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 254 ~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 9999999999999999988542 2223478889999999999999999962 579999999999999999999999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccH
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEM 412 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 412 (496)
.+....... ......|+..|+|||++.+..++.++|+||+|+++|+++++.+||...........+...........
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 988765432 22345589999999999988889999999999999999999998865544333334433333322222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
..++.+.+++.+||+.||++||++.|+..++.
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 44578999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=299.78 Aligned_cols=247 Identities=20% Similarity=0.205 Sum_probs=198.0
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|++.+.||+|+||.||++... ++..||+|.+.... .......+|+.++.+++||||+++++.+...+..|+||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 667789999999999999964 78999999886432 222345588999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|..++........+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 999999987643233478999999999999999999962 479999999999999999999999999987653321
Q ss_pred ceecccccceeecCcccccc------cccCCCCCchhhhhcccccccccchhhhcccchhhh---hhhcccCCcccHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTE------LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQ---ILNFQVADESEMEEI 415 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~------~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~---i~~~~~~~~~~~~~~ 415 (496)
.....|++.|+|||.+.+. .++.++|+||+|+++++++++..||........... +... .....+...+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-DPPTLPSGYS 235 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCCcccC
Confidence 2334588999999998653 357899999999999999999998865433322222 2221 2223334467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 416 EVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhc
Confidence 88999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=293.86 Aligned_cols=247 Identities=21% Similarity=0.260 Sum_probs=199.3
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEee-CCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLE-TKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E~ 262 (496)
|.+.+.||.|++|.||++... ++..||+|++..... ......+|+.++++++||||+++++.+.. .+..|+||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 667789999999999999853 578899999864322 22334578899999999999999998764 4468999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++++|.+++..... ..+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999976432 236889999999999999999999 7899999999999999999999999999887643221
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
......|++.|+|||++.+..++.++|+||+|+++++++++..||...........+..... ...+...++.+.+++
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li 234 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPELGELI 234 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCccccCHHHHHHH
Confidence 22345689999999999988889999999999999999999988765443333333333222 223345667899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+||+.||.+|||+.++++
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHhccCcccCCCHHHHhc
Confidence 9999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=294.59 Aligned_cols=246 Identities=21% Similarity=0.221 Sum_probs=200.7
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|...+.||.|+||.||+|.. .++..||+|.+.... .......+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 355667899999999999986 468899999876432 22234457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++... .+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999998653 25778889999999999999999 7899999999999999999999999999877644321
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......++..|+|||++.+...+.++|+||+|++++++++|.+|+...........+ ............+..+.+++.
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhhHHHHHHHH
Confidence 123345889999999998888899999999999999999999988654433322222 112223334456778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~ 442 (496)
+||+.+|.+||++.++++.
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHcccCcccCcCHHHHHhC
Confidence 9999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.89 Aligned_cols=256 Identities=19% Similarity=0.172 Sum_probs=218.1
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.|..++. .+++.||+|++..-.. ....+++|-.+|...+.+.|++++-.|.+++++|+|||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 367778999999999999996 4688899999865322 23345588899999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|++||+|-.++.... .+|+..+..++..|+.||.-||+ -|+|||||||+|||||..|++||+|||.|-.+..++
T Consensus 156 Y~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred cccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 999999999998766 36788889999999999999999 569999999999999999999999999998887653
Q ss_pred CccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccCCcccHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVADESEMEE 414 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~ 414 (496)
...+...+|||-|++||++.. ..|....||||+|+++|||+.|..||+...--+.+.+|++. .+..|.....
T Consensus 230 -~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V 308 (1317)
T KOG0612|consen 230 -TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV 308 (1317)
T ss_pred -cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence 344566779999999999975 56778899999999999999999999999888999999976 4444445668
Q ss_pred HHHHHHHHHHhcccCCCCCCC---HHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 415 IEVVAELASKCLRIRGTERPT---MKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs---~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
++++++||.+.+. +|+.|.. +.++ ..|+|+...+|
T Consensus 309 SeeakdLI~~ll~-~~e~RLgrngiedi----------k~HpFF~g~~W 346 (1317)
T KOG0612|consen 309 SEEAKDLIEALLC-DREVRLGRNGIEDI----------KNHPFFEGIDW 346 (1317)
T ss_pred CHHHHHHHHHHhc-ChhhhcccccHHHH----------HhCccccCCCh
Confidence 8999999999886 7888876 6555 56777777766
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=303.67 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=196.4
Q ss_pred cchhhhcccCCceEEEEeEeC-CCc----EEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNT----QVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+...+.||+|+||.||+|.+. ++. .||+|.+...... .....+|+.+++.++||||++++|+|... ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence 445578999999999999853 343 4788877643222 22344788999999999999999998754 467999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 88 QLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred hhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999876532 36788899999999999999999 78999999999999999999999999999876543
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
..........++..|+|||++.+..++.++|+||+|++++++++ +..||.+.... ....+.......+.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-EIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHCCCCCCCCCCCCHHHH
Confidence 22212223346778999999998889999999999999999886 66666543222 22233322222222233456789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
+++.+||..+|++||++.++++.|..+.+
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987744
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=293.49 Aligned_cols=245 Identities=22% Similarity=0.249 Sum_probs=198.5
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh------hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE------IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
|...+.||+|+||.||+|... ++..|++|.+..... ......+|+.+++.++||||+++++++......++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 445678999999999999965 788999998764331 2234457899999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999997653 26788899999999999999999 78999999999999999999999999998776443
Q ss_pred CCccceecccccceeecCccccccc-ccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTEL-LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~-~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
. ......|++.|+|||.+.... ++.+.|+|++|+++++++++.+||...........+.........+...++.+.
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAK 232 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHH
Confidence 2 123455899999999987766 888999999999999999999998655432222222221112222334557799
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~ 441 (496)
+++.+||+.+|.+|||+.+++.
T Consensus 233 ~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 233 DFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHhhcCcccCcCHHHHhc
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=299.97 Aligned_cols=248 Identities=20% Similarity=0.219 Sum_probs=192.8
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|++|.||+|.. .++..||+|++...... .....+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 45667899999999999996 46889999988643221 233457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
+ ++|.+++........+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 7 5898888765433457889999999999999999999 7899999999999999999999999999876543211
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc------------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF------------------ 404 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------------ 404 (496)
......+++.|+|||++.+ ..++.++|+||+|+++++++++.+||...........+...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 1123347899999998865 44688899999999999999999988654332211111000
Q ss_pred --ccC-------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 --QVA-------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 --~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... .......++++.++|.+||+.||.+|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0001123467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.12 Aligned_cols=243 Identities=18% Similarity=0.206 Sum_probs=189.0
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeC------Ce
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLET------KV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~ 255 (496)
..|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 3577778999999999999985 4678999999864322 122344789999999999999999987643 35
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.|++|+++ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 68999998 67998887542 26889999999999999999999 789999999999999999999999999988
Q ss_pred ccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc---------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--------- 405 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--------- 405 (496)
..... .....||+.|+|||++.+ ..++.++|+||+|+++++|++|.+||........+..+....
T Consensus 167 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 167 QADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred ecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 75432 234468999999999877 568889999999999999999998886543222222221100
Q ss_pred -------------cCCccc-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 -------------VADESE-------MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 -------------~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...... ....+.+.+|+.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 012245789999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.24 Aligned_cols=265 Identities=22% Similarity=0.177 Sum_probs=213.5
Q ss_pred HHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
...++...++||+||||.||-+.. .+|+.+|.|++.... .......+|-.+|.+++.|.||.+-..|.+.+.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 334445568999999999999984 579999999874332 222334478899999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||..|.||+|.-+|...+.+ .+++..++.++.+|+.||.+||. .+||.|||||+|||+|+.|+++|+|+|+|..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~~-gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNP-GFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCCC-CCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999988876653 47999999999999999999999 789999999999999999999999999999987
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccCCcccHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVADESEMEEIE 416 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 416 (496)
..... ...+||.+|||||++.++.|+...|||++||++|+|+.|..||....+......+-.. ......+...++
T Consensus 339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 65332 3447999999999999999999999999999999999999999876554333222211 122334466778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
++++|....|..||.+|.....- .-....+|+++++.+|
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~-----ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGE-----GAQEVKEHPFFKDLNW 454 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCc-----CcchhhhCcccccCCH
Confidence 99999999999999999755421 2223355666666665
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=296.08 Aligned_cols=248 Identities=19% Similarity=0.261 Sum_probs=195.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-----------hhhHHHHHHHHhcCCCCceeeEEEEEeeCCe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-----------RITEWEFLGIISQVKHKNVVKILGLCLETKV 255 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 255 (496)
|...+.||.|+||.||+|.. .++..||+|.+...... ......|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 44567899999999999985 46889999987532111 1123467889999999999999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++++||||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999997753 36888899999999999999999 789999999999999999999999999987
Q ss_pred ccCCCCCccceecccccceeecCccccccc--ccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc----cCCc
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTEL--LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ----VADE 409 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~----~~~~ 409 (496)
...............|+..|+|||.+.... ++.++|+||+|++++++++|..|+...........+.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence 654322222223445899999999987754 7889999999999999999998875433222222221111 1111
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.....+..+.+++.+||..+|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 22234678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=303.83 Aligned_cols=248 Identities=20% Similarity=0.166 Sum_probs=201.6
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|... ++..||+|.+...... .....+|+.++..++||||+++++.+...+..|+||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 566688999999999999964 5899999998654322 22344788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+.+++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 83 CPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred cCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999875432 346888999999999999999999 7899999999999999999999999998876532211
Q ss_pred c---------------------------cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc
Q 047375 343 T---------------------------AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395 (496)
Q Consensus 343 ~---------------------------~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~ 395 (496)
. .......||..|+|||++.+..++.++|+||+|+++|+++++..||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 0112346899999999999888899999999999999999999998776655
Q ss_pred chhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047375 396 NSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEV 439 (496)
Q Consensus 396 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 439 (496)
..+..+.......+.....++.+.+++.+||..||.+|||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 55655554443333333356789999999999999999994433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=292.20 Aligned_cols=247 Identities=21% Similarity=0.256 Sum_probs=201.4
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.|.+.+.||+|+||.||+|... ++..|++|.+..... .....+|+.+++.++||||+++++++......|+++||+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 3667788999999999999965 478999999865543 34455889999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
++|.+++..... .+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++........ .
T Consensus 83 ~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 83 GSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 999999975432 46889999999999999999999 7799999999999999999999999999887654321 1
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc-CCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-ADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~l~~li~~ 424 (496)
.....|+..|+|||++.+..++.++|+|++|+++++++++.+||...........+..... ....+...+..+.+++.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 2334588999999999988899999999999999999999998865433322222221111 111223345679999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 047375 425 CLRIRGTERPTMKEVSE 441 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~ 441 (496)
||+.||.+|||+.++++
T Consensus 236 ~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 236 CLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHhcChhhCcCHHHHhc
Confidence 99999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=298.32 Aligned_cols=246 Identities=21% Similarity=0.225 Sum_probs=199.0
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|...+.||+|+||.||+|.. .++..||+|.+.... .......+|+.++++++||||+++++++...+..|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 456668899999999999985 457889999876332 22233458899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|.+++... .+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 999999988642 36788899999999999999999 7899999999999999999999999999877653221
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......|+..|+|||++.+..++.++|+||+|++++++++|.+|+...........+.. ..........+..+.+++.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-CCCCCCCcccCHHHHHHHH
Confidence 12334588999999999998889999999999999999999988765433332222221 1122222345567999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~ 442 (496)
+||+.+|.+|||+.++++.
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHccCCcccCcCHHHHHHh
Confidence 9999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=307.14 Aligned_cols=243 Identities=19% Similarity=0.197 Sum_probs=185.7
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
...|.+.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++...+..++||||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 345777899999999999999964 5678999974322 2246788999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
. |+|.+++..... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 140 ~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 140 S-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred C-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 5 588888865432 37889999999999999999999 789999999999999999999999999987543221
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccch-hhhccc---------chhhhhhhc------ccC
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYF-LDSIEN---------NSFRQILNF------QVA 407 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~-~~~~~~---------~~~~~i~~~------~~~ 407 (496)
......||+.|+|||++.+..++.++|+||+|+++|+++++..++ ...... ..+..+... ...
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 123456999999999999989999999999999999998754333 221100 001111100 000
Q ss_pred C-------------------c-------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 408 D-------------------E-------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 408 ~-------------------~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
. + .....+..+.+||.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 0 0 00012345677999999999999999999853
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.17 Aligned_cols=247 Identities=18% Similarity=0.224 Sum_probs=194.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh------hhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE------IRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~l 258 (496)
|...+.||+|+||.||+|.. .++..||+|++..... ......+|+.+++.++||||+++++++.. ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 55568899999999999985 4688999998753321 11234478999999999999999999875 367889
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
+|||+++++|.+++..... +++...+.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999976442 6788889999999999999998 789999999999999999999999999987654
Q ss_pred CCCC-ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 339 SDDE-TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 339 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
.... ........|+..|+|||++.+..++.++|+||+|++++++++|.+||.....................+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence 3211 111123458899999999998888999999999999999999999987654333333332222222333445567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+++ +||..+|.+|||+.||++
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhc
Confidence 88888 688899999999999953
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=292.97 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=199.4
Q ss_pred hhhhcccCCceEEEEeEeCC-----CcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 190 FHHCLGMGGFGSVYKGVLPD-----NTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.+.||.|+||.||++.... +..||+|.+..... .......|+.++..++||||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999999643 37899999865443 233445889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++++|.+++....... +++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 83 MEGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred cCCCCHHHHHHhhhhcc-CCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999997654321 6889999999999999999999 7899999999999999999999999999887654422
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
... ....+++.|+|||.+.+..++.++|+|++|++++++++ +.+||...........+.... ........+..+.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHH
Confidence 211 12237789999999988889999999999999999987 677766543333333333322 222233356789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L 443 (496)
+.+||..||.+|||+.++++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=294.76 Aligned_cols=245 Identities=21% Similarity=0.290 Sum_probs=191.3
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchh
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALS 269 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 269 (496)
..||+|+||.||+|.. .++..|++|.+....... ....+|+.+++.++||||+++++++..++..++||||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 5799999999999985 467789999886543322 33458899999999999999999999999999999999999999
Q ss_pred hhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCCccccCCCCCccceec
Q 047375 270 HYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 270 ~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
+++.........++..+..++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 168 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTET 168 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cccc
Confidence 999764322112677888999999999999999 78999999999999976 67999999999876543221 1223
Q ss_pred ccccceeecCcccccc--cccCCCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 349 IRGTVGYLDPEYAHTE--LLTGMNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~--~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
..|++.|+|||++.+. .++.++|+||+|+++++++++.+||....... ..............+...++.+.+++.+|
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRC 248 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHH
Confidence 4589999999998663 37789999999999999999998876432211 11111111112223344567799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 047375 426 LRIRGTERPTMKEVSE 441 (496)
Q Consensus 426 l~~dP~~RPs~~eil~ 441 (496)
|+.+|.+|||+.+++.
T Consensus 249 l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 249 FEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCCCchhCCCHHHHHh
Confidence 9999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=292.68 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=202.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|.+.+.||.|+||.||+|.. .++..+++|++..... ......+|+.+++.++||||+++++.+...+..++||||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 66778899999999999995 4678899998854322 22344588899999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++........+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||++..........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999765433347889999999999999999999 789999999999999999999999999988766543221
Q ss_pred --ceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-cc---cHHHHHH
Q 047375 345 --MSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD-ES---EMEEIEV 417 (496)
Q Consensus 345 --~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~---~~~~~~~ 417 (496)
......|+..|+|||++... ..+.++|+||+|++++++++|..||........+.......... .. ....++.
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence 22344689999999998876 78899999999999999999999987654444344333321111 11 1245678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+++.+||..||.+|||+.+|++
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhh
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=300.28 Aligned_cols=251 Identities=18% Similarity=0.144 Sum_probs=198.8
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||++... .+..|++|.+..... ......+|+.+++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 556788999999999999953 578999998865432 122334788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++.... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999997653 36888899999999999999999 7899999999999999999999999998864211100
Q ss_pred -------------ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc
Q 047375 343 -------------TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE 409 (496)
Q Consensus 343 -------------~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 409 (496)
........|+..|+|||++.+..++.++|+||+|+++++++++..||.+......+..+.......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 0011224578899999999888899999999999999999999998876544444444443322211
Q ss_pred c-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 410 S-EMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 410 ~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
. ....+..+.+++.+||+.||.+||++.++.+.|+
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 1 1245577999999999999999999766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.99 Aligned_cols=250 Identities=22% Similarity=0.228 Sum_probs=203.2
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||++... ++..||+|.+..... ......+|++++++++||||+++++++...+..|+||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 566788999999999999954 688999998865332 223344789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++++|.+++.... .++...+..++.|++.||.|||+ ++|+|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 83 VPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 99999999997653 36888999999999999999999 78999999999999999999999999998876543
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.....|++.|+|||.+.+...+.++|+||+|++++++++|..||...........+...... .+...+..+.+++
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 229 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR--FPSFFSPDAKDLI 229 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc--CCccCCHHHHHHH
Confidence 23345899999999998888889999999999999999999998765544444444433222 2223357799999
Q ss_pred HHhcccCCCCCC-----CHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 423 SKCLRIRGTERP-----TMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 423 ~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
.+||..||.+|| ++.|+ ..++|.+...+
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~l----------~~~~~~~~~~~ 262 (290)
T cd05580 230 RNLLQVDLTKRLGNLKNGVNDI----------KNHPWFAGIDW 262 (290)
T ss_pred HHHccCCHHHccCcccCCHHHH----------HcCcccccCCH
Confidence 999999999998 44444 34566655554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=301.20 Aligned_cols=246 Identities=22% Similarity=0.246 Sum_probs=192.3
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||.|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++...+..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3667788999999999999854 678999998864322 2234457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
+ ++|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 87 D-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred c-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 7 589888876433 36788899999999999999999 78999999999999999999999999998765432211
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc------------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF------------------ 404 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------------ 404 (496)
.....+++.|+|||++.+ ..++.++|+||+|+++++|++|.+||...........+...
T Consensus 161 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 161 --YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred --ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 223347899999998865 44678899999999999999999988754432222111100
Q ss_pred ---ccCC-------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 405 ---QVAD-------ESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 405 ---~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
..+. ......++.+.+||.+||+.||.+|||+.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil 284 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 0000 00112346789999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.97 Aligned_cols=251 Identities=22% Similarity=0.254 Sum_probs=199.2
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCC------eee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLETK------VTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~------~~~ 257 (496)
..|.+.+.||+|+||.||+|... ++..+++|.+...........+|+.+++++ +||||+++++++.... ..|
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 34777889999999999999964 578899998876554445556889999998 6999999999997644 489
Q ss_pred EEEeeccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 258 LVYEFVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 9999999999999987532 12346889999999999999999999 7899999999999999999999999999876
Q ss_pred cCCCCCccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-cc
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD-ES 410 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~ 410 (496)
..... .......|++.|+|||++.. ..++.++|+|++|+++++++++.+||...........+....... ..
T Consensus 163 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 163 LDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred cccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 54322 12234558999999998764 346778999999999999999999987544433333333322211 12
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....++.+.+|+.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2235578999999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.95 Aligned_cols=253 Identities=22% Similarity=0.203 Sum_probs=200.6
Q ss_pred cccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 194 LGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
||.|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++.+++..|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999964 588999998864322 223345788999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
.+++..... +++..+..++.||+.||.|||+ ++++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDRGL---FDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999976532 6788899999999999999999 789999999999999999999999999988775432 1233
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhc--ccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSI--ENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
..|++.|+|||.+.+..++.++|+|++|+++|++++|..||.... ....+..+.........+...++.+.+++.+||
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 231 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHc
Confidence 458999999999988888999999999999999999999987655 223334444222222333333678999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 427 RIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 427 ~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
+.||.+||++.+.. +..+.+++|.....|
T Consensus 232 ~~~p~~R~~~~~~~-----~~~l~~~~~~~~~~~ 260 (262)
T cd05572 232 RRNPEERLGNLKGG-----IKDIKKHKWFNGFDW 260 (262)
T ss_pred cCChhhCcCCcccC-----HHHHhcChhhhCCCC
Confidence 99999999932211 222255677765544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=291.42 Aligned_cols=247 Identities=18% Similarity=0.199 Sum_probs=195.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh------hhhhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE------IRITEWEFLGIISQVKHKNVVKILGLCLET--KVTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~l 258 (496)
|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.++++++||||+++++++.+. ..+++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 55568899999999999985 4688999998753221 112334789999999999999999998763 56789
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++|+|.+++..... +++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999999876432 5778889999999999999999 789999999999999999999999999987654
Q ss_pred CCCCc-cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 339 SDDET-AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 339 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
..... .......|+..|+|||++.+..++.++|+||+|+++|++++|.+||.....................+...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence 32111 11223458999999999988888999999999999999999999986543333333333222233344455677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+++.+|+. +|.+||++.+|++
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhc
Confidence 8999999995 9999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=291.59 Aligned_cols=247 Identities=21% Similarity=0.227 Sum_probs=201.8
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|+||.||++.. .++..||+|.+.... .......+|+.++++++||||+++++++...+..|+||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 56678899999999999985 468899999886432 22234457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|.+++..... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 82 EGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999876432 235788899999999999999999 7899999999999999999999999999876644221
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......|++.|+|||++.+...+.++|+||+|+++++++++..|+...........+..... .+.+...+..+.++|.
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 234 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVS 234 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CCCcccCCHHHHHHHH
Confidence 12234588999999999988889999999999999999999988865544444444443322 2223345677999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~ 441 (496)
+||+.+|.+||++.+|++
T Consensus 235 ~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 235 QLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHhhCChhhCcCHHHHhh
Confidence 999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.96 Aligned_cols=254 Identities=21% Similarity=0.285 Sum_probs=196.9
Q ss_pred chhhhcccCCceEEEEeEeC----CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------e
Q 047375 189 NFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETK------V 255 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~ 255 (496)
.+.+.||+|+||.||+|.+. ++..||||.+..... ......+|+.+++.++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45678999999999999852 467899998865321 2223447899999999999999999986532 3
Q ss_pred eeEEEeeccCCchhhhhhhc---CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCC
Q 047375 256 TLLVYEFVSNGALSHYIHDK---SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
.++++||+++|+|..++... .....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 47899999999999887532 112236888899999999999999999 789999999999999999999999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCccc
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESE 411 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~ 411 (496)
+++...............+++.|++||.+....++.++|+||+|+++|++++ +.+||...........+.... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCC
Confidence 9887643322222223346778999999998889999999999999999988 777776544333333333221 11122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 33456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=304.04 Aligned_cols=244 Identities=21% Similarity=0.211 Sum_probs=209.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+...||+|.|+.|.+|.+ .++..||+|.+.... .......+|+++|..++|||||+++.+......+|+||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 356678999999999999995 479999999886432 2234466999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+.+|.+.+++..++. +....+..++.|+..|++|||+ ++|||||||.+||||+.+.++||+|||++..+...
T Consensus 137 a~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 137 ASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred ccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc--
Confidence 999999999988765 4458889999999999999999 88999999999999999999999999999988743
Q ss_pred ccceecccccceeecCccccccccc-CCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLT-GMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t-~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
....+.+|++.|.|||++.+..|. +..|+|++|+++|.++.|..||.+..-...-..++.+.+..+... +.++.++
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~m--s~dce~l 285 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYM--SCDCEDL 285 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccccee--echhHHH
Confidence 335678899999999999997775 579999999999999999999988766666666665555544433 3468899
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~ 441 (496)
|+++|..+|.+|++++++.+
T Consensus 286 Lrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred HHHhhccCccccCCHHHhhh
Confidence 99999999999999998854
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=281.24 Aligned_cols=243 Identities=23% Similarity=0.213 Sum_probs=200.4
Q ss_pred cch-hhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEee----CCeeeEEE
Q 047375 188 KNF-HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLE----TKVTLLVY 260 (496)
Q Consensus 188 ~~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~----~~~~~lv~ 260 (496)
|.+ .++||-|-.|.|..+.. .+++.+|+|++..... ..+|+++.-.. .|||||.++++|.+ ...+.+||
T Consensus 63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred heehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 444 37899999999999985 4788999998865443 33566654444 59999999999864 34567999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCcccc
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVPI 337 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~~ 337 (496)
|.++||.|.+.+.+++.. .+++.++..|+.||+.|+.|||+ .+|.||||||+|+|... +..+||+|||+|+..
T Consensus 139 E~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred ecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999999999999987754 47899999999999999999999 67999999999999953 557999999999876
Q ss_pred CCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc----hhhhhhhc--ccCCccc
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN----SFRQILNF--QVADESE 411 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~----~~~~i~~~--~~~~~~~ 411 (496)
... ....+.+-||.|.|||++..+.|+...|+||+|+++|.+++|.|||+...... .-.+|..+ .++.+.+
T Consensus 215 ~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 215 QEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred CCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 542 22355678999999999999999999999999999999999999999875532 23344443 4456677
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...++..+++|+.+|..+|.+|.|+.++++
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 788999999999999999999999999854
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=294.79 Aligned_cols=250 Identities=22% Similarity=0.211 Sum_probs=195.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeC-----CeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLET-----KVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~-----~~~~lv 259 (496)
.|.+...||+|+||.||++.. .++..+|+|.+...........+|+.++.++ +||||+++++++... +..|+|
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 366678899999999999995 4688999998865433334445778888888 799999999998753 358999
Q ss_pred EeeccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 260 YEFVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 99999999999886421 12346889999999999999999999 789999999999999999999999999988764
Q ss_pred CCCCccceecccccceeecCcccccc-----cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-CcccH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTE-----LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEM 412 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~ 412 (496)
..... .....|+..|+|||++... .++.++|+||+|++++++++|.+||...........+...... .....
T Consensus 180 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 180 STRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred ccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 32211 2234589999999988653 3678999999999999999999888765443333333222111 11122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.....+.++|.+||+.+|++|||+.++++
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 34467999999999999999999999964
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=300.95 Aligned_cols=245 Identities=22% Similarity=0.270 Sum_probs=183.2
Q ss_pred hhcccCCceEEEEeEeC---CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeEEEeeccCC
Q 047375 192 HCLGMGGFGSVYKGVLP---DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLLVYEFVSNG 266 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~g 266 (496)
..||+|+||.||+|... ++..||+|.+.... ......+|+.+++.++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 57999999999999853 45789999886432 22345588999999999999999999864 5678999999975
Q ss_pred chhhhhhhc------CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee----CCCCceEEccCCCccc
Q 047375 267 ALSHYIHDK------SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL----DDNYTAKVSDFESLVP 336 (496)
Q Consensus 267 ~L~~~l~~~------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll----~~~~~~kL~DFGla~~ 336 (496)
+|.+++... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 787777532 112246888899999999999999999 789999999999999 5667999999999987
Q ss_pred cCCCCCc-cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccch---------hhhhhhc-
Q 047375 337 ISSDDET-AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNS---------FRQILNF- 404 (496)
Q Consensus 337 ~~~~~~~-~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~---------~~~i~~~- 404 (496)
....... .......||+.|+|||++.+ ..++.++|+||+|++++++++|.+||........ ...+...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 6543211 11234568999999999876 4578899999999999999999999864322100 0000000
Q ss_pred ---------------------------ccCC--------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ---------------------------QVAD--------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ---------------------------~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 000011245888999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=292.63 Aligned_cols=247 Identities=22% Similarity=0.269 Sum_probs=202.2
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
|.+...||+|++|.||+|... ++..|++|.+...........+|+.+++.++||||+++++++...+..|+|+||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 566678999999999999975 6889999998755443334558899999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.+++.... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........ ..
T Consensus 101 ~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 173 (286)
T cd06614 101 SLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KR 173 (286)
T ss_pred cHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hh
Confidence 9999998764 247889999999999999999999 7899999999999999999999999998776543321 12
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-cccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD-ESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~l~~li~~c 425 (496)
....+++.|+|||++.+..++.++|+|++|++++++++|..|+...........+....... ......+..+.+++.+|
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence 33458899999999988888999999999999999999998876544333333333222221 12222567899999999
Q ss_pred cccCCCCCCCHHHHHH
Q 047375 426 LRIRGTERPTMKEVSE 441 (496)
Q Consensus 426 l~~dP~~RPs~~eil~ 441 (496)
|+.+|.+|||+.++++
T Consensus 254 l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 254 LVKDPEKRPSAEELLQ 269 (286)
T ss_pred hccChhhCcCHHHHhh
Confidence 9999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=298.67 Aligned_cols=243 Identities=22% Similarity=0.250 Sum_probs=195.8
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
...||+|+||.||++.. .++..||+|.+...... .....+|+.++..++||||+++++++..++..|+||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34699999999999985 46889999998643322 23344788999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
..++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ....
T Consensus 106 ~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 176 (297)
T cd06659 106 TDIVSQT----RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 176 (297)
T ss_pred HHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence 9887542 26788999999999999999999 7899999999999999999999999999876543321 1234
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-CcccHHHHHHHHHHHHHhcc
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVAELASKCLR 427 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~l~~li~~cl~ 427 (496)
..|+..|+|||++.+..++.++|+||+|++++++++|.+||...........+...... .......+..+.+++.+||+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 56899999999998888899999999999999999999988654433333333221111 11122344678999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 047375 428 IRGTERPTMKEVSEE 442 (496)
Q Consensus 428 ~dP~~RPs~~eil~~ 442 (496)
.+|.+||++.++++.
T Consensus 257 ~~P~~Rps~~~ll~~ 271 (297)
T cd06659 257 REPQERATAQELLDH 271 (297)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=310.79 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=200.4
Q ss_pred hhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhhh--HHHHHHHHhcCCCCceeeEEEEEeeC------CeeeEEEe
Q 047375 191 HHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT--EWEFLGIISQVKHKNVVKILGLCLET------KVTLLVYE 261 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~--~~~e~~~l~~l~hpnIv~l~~~~~~~------~~~~lv~E 261 (496)
.+.||+|+||.||+|+ ..+|..||||.+......+.. ..+|+++|++++|||||+++++-.+. ..+.+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4679999999999999 468999999998764443333 34899999999999999999987654 35789999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC--C--CCceEEccCCCcccc
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD--D--NYTAKVSDFESLVPI 337 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~--~--~~~~kL~DFGla~~~ 337 (496)
||.||||...|++-.+...+++...+.++.+++.||.|||+ ++||||||||.||++- . .-..||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999987777779999999999999999999998 8899999999999993 2 335799999999998
Q ss_pred CCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccch-----hhhhhhc-------
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNS-----FRQILNF------- 404 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~-----~~~i~~~------- 404 (496)
..+. ....++||+.|.+||.+.. ..|+.-.|.||+|+++|+.++|..||.+...... +..+...
T Consensus 175 ~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 175 DDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 7653 4577889999999999994 8889999999999999999999999987655432 1111110
Q ss_pred -------cc----CCccc----HHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhHh
Q 047375 405 -------QV----ADESE----MEEIEVVAELASKCLRIRGTERP--TMKEVSEELDRLRR 448 (496)
Q Consensus 405 -------~~----~~~~~----~~~~~~l~~li~~cl~~dP~~RP--s~~eil~~L~~l~~ 448 (496)
.+ ..|.+ ......+...+..+|..+|.+|. .+.+....+..+.+
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00 01111 12224567778888899999998 77777766666654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=294.34 Aligned_cols=247 Identities=20% Similarity=0.238 Sum_probs=194.6
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+...||+|+||.||+|... ++..||+|++..... ......+|+.+++.++||||+++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 3667788999999999999964 688999998864322 223345789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++++|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 82 CDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred cCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99988888765433 36889999999999999999999 7899999999999999999999999999887654321
Q ss_pred ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-----------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF----------------- 404 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------------- 404 (496)
......++..|+|||++.+ ..++.++|+||+|++++++++|.+||.+.........+...
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1223457899999999876 45788999999999999999999888654432222111100
Q ss_pred ----ccCCc---c-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ----QVADE---S-----EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ----~~~~~---~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+.+ . ....+..+.+|+.+||+.+|++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000 0 0123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=288.11 Aligned_cols=246 Identities=22% Similarity=0.288 Sum_probs=199.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|+||.||++.. .++..+|+|.+.... .......+|+.+++.++||||+++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 56678899999999999985 468899999886432 12233447899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-CceEEccCCCccccCCCCC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-YTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-~~~kL~DFGla~~~~~~~~ 342 (496)
++++|.+++..... ..+++..+..++.+++.||.|||+ ++|+|+||||+||+++.+ +.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999976542 236888999999999999999999 789999999999999854 4689999999887654321
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.....|+..|+|||.+.+..++.++|+||+|+++++++++..+|...........+..... .+.+...++.+.+++
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 233 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYSPDLRQLI 233 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcCHHHHHHH
Confidence 2234589999999999988889999999999999999999888866544333333332221 222334567799999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+||+.+|.+|||+.++++
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHccCChhhCCCHHHHhh
Confidence 9999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=297.18 Aligned_cols=241 Identities=23% Similarity=0.248 Sum_probs=193.9
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchh
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALS 269 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 269 (496)
..||+|+||.||++.. .++..||||.+...... .....+|+.+++.++||||+++++.+...+..|+||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5699999999999985 46889999988643332 233448889999999999999999999999999999999999999
Q ss_pred hhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecc
Q 047375 270 HYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMI 349 (496)
Q Consensus 270 ~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 349 (496)
+++... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++........ .....
T Consensus 108 ~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 178 (292)
T cd06658 108 DIVTHT----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSL 178 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCcee
Confidence 988542 26788999999999999999999 7899999999999999999999999999876543221 12334
Q ss_pred cccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc-cCCcccHHHHHHHHHHHHHhccc
Q 047375 350 RGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ-VADESEMEEIEVVAELASKCLRI 428 (496)
Q Consensus 350 ~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~l~~li~~cl~~ 428 (496)
.|++.|+|||.+.+..++.++|+||+|++++++++|..||........+..+.... .........+..+.+++.+||..
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 258 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR 258 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccC
Confidence 58999999999988888999999999999999999998886544333333222111 11111223456789999999999
Q ss_pred CCCCCCCHHHHHH
Q 047375 429 RGTERPTMKEVSE 441 (496)
Q Consensus 429 dP~~RPs~~eil~ 441 (496)
||.+|||+.++++
T Consensus 259 ~P~~Rpt~~~il~ 271 (292)
T cd06658 259 EPSQRATAQELLQ 271 (292)
T ss_pred ChhHCcCHHHHhh
Confidence 9999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=289.67 Aligned_cols=248 Identities=20% Similarity=0.308 Sum_probs=198.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh-------hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE-------IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
|...+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++||||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 44557899999999999984 5788999998864321 123445789999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-ceEEccCCCccccC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPIS 338 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~ 338 (496)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .+||+|||.+....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 82 VEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999997643 36788999999999999999999 7899999999999998775 59999999987765
Q ss_pred CCCCc--cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhh---hcccCCcccHH
Q 047375 339 SDDET--AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL---NFQVADESEME 413 (496)
Q Consensus 339 ~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~---~~~~~~~~~~~ 413 (496)
..... .......||..|+|||.+.+..++.++|+|++|++++++++|..||...........+. ........+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence 43111 11233468999999999988888999999999999999999998885433222222221 12223334445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.++.+.+++.+||..+|.+|||+.++++
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 6678999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=294.98 Aligned_cols=243 Identities=22% Similarity=0.269 Sum_probs=194.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++||||++++++|...+..|+||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 66678899999999999985 4688999998853322 122344789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
++ |+|.+++..... .+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++......
T Consensus 97 ~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 97 CL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred hC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 97 577777754332 36889999999999999999999 78999999999999999999999999988765432
Q ss_pred ccceecccccceeecCcccc---cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAH---TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~---~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
....|++.|+|||++. ...++.++|+|++|+++|++++|.+||...........+.............+..+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 2345889999999874 356788999999999999999999888654433322222222222222334567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~ 442 (496)
+++.+||+.||.+||++.+|+..
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=288.41 Aligned_cols=248 Identities=21% Similarity=0.256 Sum_probs=197.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|...+.||+|+||.||+|.. .++..|++|.+..... ......+|+.+++.++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 55668899999999999985 4688999999875543 2334458899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 82 SGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999997643 26788899999999999999999 78999999999999999999999999998876543221
Q ss_pred cc--eecccccceeecCccccccc---ccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--cCCcccHHHHH
Q 047375 344 AM--STMIRGTVGYLDPEYAHTEL---LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--VADESEMEEIE 416 (496)
Q Consensus 344 ~~--~~~~~gt~~Y~aPE~l~~~~---~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 416 (496)
.. .....+++.|+|||++.+.. ++.++|+|++|++++++++|..||................ ...+.....++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 11 11345889999999998765 7889999999999999999999986543222211111111 11122223367
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.+++.+||+.+|.+|||+.+++.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc
Confidence 7899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=292.56 Aligned_cols=247 Identities=20% Similarity=0.197 Sum_probs=190.2
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHH-HHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLG-IISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|+||.||+|... +|..||+|.+..... .......|+. .++.++||||+++++++...+..|+||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 556678999999999999964 689999998865422 2223334444 466678999999999999999999999999
Q ss_pred cCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCC-CcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 264 SNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASP-SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 264 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~-~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
+ |+|.+++... .....+++..++.++.||+.||.|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 7 5888888653 222457899999999999999999998 5 79999999999999999999999999987654321
Q ss_pred CccceecccccceeecCccccc----ccccCCCCCchhhhhcccccccccchhhhcc-cchhhhhhhcccCCcccHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT----ELLTGMNPNSYVALASNEKISMVPYFLDSIE-NNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
..+...|+..|+|||++.+ ..++.++|+|++|+++++++++..||..... ...+..+.............+.
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd06617 159 ---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSP 235 (283)
T ss_pred ---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCH
Confidence 1123458899999998865 4567899999999999999999988754221 1222233222111111223567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.+++.+||..+|.+|||+.++++
T Consensus 236 ~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 7999999999999999999998854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=289.04 Aligned_cols=251 Identities=20% Similarity=0.242 Sum_probs=200.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E 261 (496)
|.+.+.||.|+||.||++.. .++..||+|.+.... ........|+.+++.++||||+++++++.. ....|++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 55667899999999999985 467889999885432 122334478899999999999999998864 456799999
Q ss_pred eccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcC--CCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 262 FVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLA--SPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 262 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|+++++|.+++... .....+++..++.++.||+.||.|||..+ ..+|+|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999999763 22234788999999999999999999332 2789999999999999999999999999988775
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
.... ......|++.|+|||++.+..++.+.|+|++|++++++++|..|+...........+... .....+...+..+
T Consensus 162 ~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (265)
T cd08217 162 HDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-KFRRIPYRYSSEL 238 (265)
T ss_pred CCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-CCCCCccccCHHH
Confidence 4322 123446899999999999888899999999999999999999888765433333333322 2223344556789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+++.+||+.+|.+|||+.+|++
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhh
Confidence 99999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=290.27 Aligned_cols=246 Identities=21% Similarity=0.237 Sum_probs=198.9
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||.|+||.||+|.. .++..||+|.+..... ......+|+.++..++||||+++++++..++..|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 356677899999999999985 4678999998753322 2233447889999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|.+++... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 999999998643 36889999999999999999999 7899999999999999999999999999876643211
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......|+..|+|||++.+...+.++|+||+|++++++++|.+|+...........+.. ..........+..+.+++.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVE 234 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccCHHHHHHHH
Confidence 12334588999999999888888899999999999999999988865443333332222 1122223345577999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~ 442 (496)
+||+.+|.+||++.++++.
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHccCChhhCcCHHHHHhC
Confidence 9999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=290.81 Aligned_cols=245 Identities=20% Similarity=0.263 Sum_probs=194.7
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCC---CCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVK---HKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E 261 (496)
|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++ ||||+++++++......|+|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 55667899999999999995 5788999998754322 2223447788888886 9999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++++|.+++... .+++..++.++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 83 YAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred cCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999998653 36889999999999999999999 789999999999999999999999999988765432
Q ss_pred CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
. ......|+..|+|||.+.+ ..++.+.|+||+|+++|++++|.+||...........+.....+.......+..+.+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence 2 1234468999999998865 456889999999999999999999986543332222221111111111124567999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~ 441 (496)
++.+||+.||.+||++.+++.
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhh
Confidence 999999999999999999964
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=288.46 Aligned_cols=249 Identities=21% Similarity=0.179 Sum_probs=194.4
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHH-HHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLG-IISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||.|+||.||+|.. .+++.||+|.+...... ......|.. .....+||||+++++++...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 46889999988643211 111223333 34456899999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999997643 36788899999999999999999 7899999999999999999999999998876432
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--CcccHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--DESEMEEIEVVAELAS 423 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~l~~li~ 423 (496)
.....|++.|+|||.+.+..++.++|+|++|++++++++|.+||........+..+...... .......++.+.+++.
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 229 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHH
Confidence 12345889999999998888899999999999999999999998765544444444332221 1122235678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 424 KCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
+||+.||++|||+.++.+. ..++|.++..
T Consensus 230 ~~l~~~p~~R~~~~~~~~~-------l~~~~~~~~~ 258 (260)
T cd05611 230 RLLCMDPAKRLGANGYQEI-------KSHPFFKSIN 258 (260)
T ss_pred HHccCCHHHccCCCcHHHH-------HcChHhhcCC
Confidence 9999999999988766443 3345655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=293.49 Aligned_cols=245 Identities=20% Similarity=0.283 Sum_probs=197.4
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||++.. .++..||+|.+...... .....+|+.+++.++||||+++++++...+..|+|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 466778899999999999984 46788999988543322 2334578899999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++.... +++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 100 GGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999986532 5778889999999999999999 7899999999999999999999999998876544322
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh-cccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN-FQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~l~~li~ 423 (496)
......|++.|+|||.+....++.++|+|++|++++++++|.+||...........+.. ...........+..+.+++.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 12334589999999999888889999999999999999999999865433322222211 11111122334567999999
Q ss_pred HhcccCCCCCCCHHHHH
Q 047375 424 KCLRIRGTERPTMKEVS 440 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil 440 (496)
+||..+|.+||++.+++
T Consensus 251 ~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 251 RCLEMDVEKRGSAKELL 267 (293)
T ss_pred HHccCChhhCcCHHHHh
Confidence 99999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=294.23 Aligned_cols=246 Identities=22% Similarity=0.236 Sum_probs=193.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh------hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI------RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
|.+.+.||+|+||.||+|.. .++..||+|.+...... ......|+.+++.++||||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 55667899999999999995 46889999998654322 223347889999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+ +|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+|+||||+||+++.++.+||+|||++......
T Consensus 82 e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 889999997654 247889999999999999999999 78999999999999999999999999998876543
Q ss_pred CCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--------------
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ-------------- 405 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-------------- 405 (496)
... .....+++.|+|||.+.+ ..++.+.|+|++|+++++++++.++|........+..+....
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 156 NRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred Ccc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 211 223347889999998854 467889999999999999999988776544322222221100
Q ss_pred -------cCCc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 -------VADE-----SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 -------~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.... .....+..+.++|.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000 01123467899999999999999999999953
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=273.95 Aligned_cols=244 Identities=18% Similarity=0.203 Sum_probs=194.6
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh--hhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR--ITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
...||+|+.|.|+++++ .+|...|||.+....... .+....+.++.+. .+|.||+.+|+|..+...+|.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 35699999999999996 468899999986544332 2223445555444 489999999999999999999999853
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
.+..++..-.. ++++..+-++...+++||.||.+. ++|+|||+||+|||+|..|++||||||++..+..... .
T Consensus 176 C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---h 248 (391)
T KOG0983|consen 176 CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---H 248 (391)
T ss_pred HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc---c
Confidence 66666665433 367888889999999999999984 7899999999999999999999999999988764322 3
Q ss_pred ecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcc-cchhhhhhhcccCC-cccHHHHHHHHHH
Q 047375 347 TMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIE-NNSFRQILNFQVAD-ESEMEEIEVVAEL 421 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~-~~~~~~~~~l~~l 421 (496)
+...|.+.|||||.+.. ..|+-++|+||+|+.++++.+|..|+.+... -+.+..+++...+. +.....++.+.+|
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f 328 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF 328 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence 44569999999999876 4678899999999999999999999887543 45667777643322 2233478999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~ 442 (496)
+..||..|+.+||...++++.
T Consensus 329 v~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 329 VKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHhhcCcccCcchHHHhcC
Confidence 999999999999999998764
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=290.99 Aligned_cols=241 Identities=21% Similarity=0.236 Sum_probs=195.3
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
.+.||+|++|.||++.. .++..+++|++....... ....+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 35799999999999985 468899999875433322 2345788999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
.+++... .+++..+..++.|++.||.|||+ ++|+||||+|+||+++.++.++|+|||.+........ ....
T Consensus 104 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 174 (285)
T cd06648 104 TDIVTHT----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKS 174 (285)
T ss_pred HHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccc
Confidence 9998762 26788899999999999999999 7899999999999999999999999998776543221 1233
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-cccHHHHHHHHHHHHHhcc
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD-ESEMEEIEVVAELASKCLR 427 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~l~~li~~cl~ 427 (496)
..|++.|+|||.+.+..++.++|+||+|++++++++|..||...........+....... ......+..+.+++.+||+
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 458999999999988889999999999999999999999886644333333333221111 1112245679999999999
Q ss_pred cCCCCCCCHHHHH
Q 047375 428 IRGTERPTMKEVS 440 (496)
Q Consensus 428 ~dP~~RPs~~eil 440 (496)
.+|.+|||+.+++
T Consensus 255 ~~p~~Rpt~~~il 267 (285)
T cd06648 255 RDPAQRATAAELL 267 (285)
T ss_pred cChhhCcCHHHHc
Confidence 9999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=321.37 Aligned_cols=243 Identities=23% Similarity=0.278 Sum_probs=189.7
Q ss_pred hhhcccCCceEEEEeEeC-CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC--------------
Q 047375 191 HHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLET-------------- 253 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-------------- 253 (496)
...||+||||.||+++.+ +|..||||++.... .......+|+..+++|+|||||++|..+.+.
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 478999999999999953 89999999997653 3334556899999999999999998765321
Q ss_pred --------------------------------------------------------------------------------
Q 047375 254 -------------------------------------------------------------------------------- 253 (496)
Q Consensus 254 -------------------------------------------------------------------------------- 253 (496)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred -------------------------CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCc
Q 047375 254 -------------------------KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308 (496)
Q Consensus 254 -------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 308 (496)
..+||-||||+..+|.++++++.... .....++++++|+.||.|+|+ .+|
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~---~gi 718 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD---QGI 718 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh---Cce
Confidence 01378899999988888887765321 346789999999999999999 779
Q ss_pred ccCCCCcCceeeCCCCceEEccCCCccccC----------------CCCCccceecccccceeecCccccccc---ccCC
Q 047375 309 IHSDVKSANILLDDNYTAKVSDFESLVPIS----------------SDDETAMSTMIRGTVGYLDPEYAHTEL---LTGM 369 (496)
Q Consensus 309 vHrDlKp~NIll~~~~~~kL~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y~aPE~l~~~~---~t~~ 369 (496)
|||||||.||++++++.|||+|||+|+... ........+..+||..|+|||++.+.. |+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998722 011112345678999999999998854 9999
Q ss_pred CCCchhhhhcccccccccchhhhccc-chhhhhhhcccCCc--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 370 NPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQVADE--SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 370 ~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.|+||+|++++||+.- |....+. ..+..+.++.++.+ ...+..+.-..+|.+|++.||++|||+.|+|+
T Consensus 799 iDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 9999999999999754 4333332 33444445555444 12334456789999999999999999999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=293.71 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=194.9
Q ss_pred hhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC----eeeEEEeeccC
Q 047375 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETK----VTLLVYEFVSN 265 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~E~~~~ 265 (496)
+..+||+|.||.||+|.+ +++.||||++...........+.+--+-.++|+||++++++-.... .++||++|.+.
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 346799999999999998 6799999999654443333333344444678999999999987555 78999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC------CCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA------SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|+|.++|..+- .+|....+|+.-+++||+|||+.- .++|+|||||+.||||..++++.|+|||+|..+..
T Consensus 293 GsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 293 GSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred CcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 99999998753 699999999999999999999743 25799999999999999999999999999998876
Q ss_pred CCCccceecccccceeecCccccccc------ccCCCCCchhhhhcccccccccchhh--------hcc-----cc---h
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTEL------LTGMNPNSYVALASNEKISMVPYFLD--------SIE-----NN---S 397 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~------~t~~~d~~s~g~~~~~~~~~~~~~~~--------~~~-----~~---~ 397 (496)
..........+||..|||||++.+.. .-.+.|+||+|+++||+++....+.. ..+ .. .
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence 55544445578999999999998721 11368999999999999876433321 011 01 1
Q ss_pred hhh-hhhcccCCcccH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 398 FRQ-ILNFQVADESEM-----EEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 398 ~~~-i~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
++. ++..+.++..+. .....+++.+..||..||+.|.|+.=+.+.+..+...
T Consensus 449 mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 449 MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111 112222222221 2346799999999999999999999998888877654
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=294.50 Aligned_cols=246 Identities=22% Similarity=0.254 Sum_probs=198.3
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|...+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++|||++++++++...+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 356678899999999999995 4688999998864322 12234478999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++ +|.+++..... .+++..+..++.|++.||.|||+ ++|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 78777754332 37889999999999999999999 78999999999999999999999999987654322
Q ss_pred CccceecccccceeecCcccc---cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAH---TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~---~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
....|++.|+|||++. ...++.++|+||+|++++++++|.+||...........+.............++.+
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 253 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF 253 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHH
Confidence 2345899999999974 35678899999999999999999998876544444444444333333334456779
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
.+++.+||+.+|.+||++.++++.+-
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChh
Confidence 99999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.83 Aligned_cols=255 Identities=19% Similarity=0.179 Sum_probs=182.7
Q ss_pred HHHHHhcchhhhcccCCceEEEEeEeCC--CcEEEE------------------EEeecchhhhhhHHHHHHHHhcCCCC
Q 047375 182 ELLKATKNFHHCLGMGGFGSVYKGVLPD--NTQVAV------------------KKYMCADEIRITEWEFLGIISQVKHK 241 (496)
Q Consensus 182 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vav------------------K~~~~~~~~~~~~~~e~~~l~~l~hp 241 (496)
+.....|.+.+.||+|+||.||+|.... +..+++ |.+...........+|+.++..++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3445668888999999999999987421 111221 22222222233345889999999999
Q ss_pred ceeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCc--ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCcee
Q 047375 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSS--QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANIL 319 (496)
Q Consensus 242 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIl 319 (496)
|||++++++...+..|+|||++. ++|..++..... ........+..|+.||+.||.|||+ ++||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 99999999999999999999995 477777654321 1112345677899999999999999 78999999999999
Q ss_pred eCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc---c
Q 047375 320 LDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN---N 396 (496)
Q Consensus 320 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---~ 396 (496)
++.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|+||+||++|+|+++..++...... .
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999987654322 1223456999999999999989999999999999999999875433221111 1
Q ss_pred hhhhhhh------cccCCc------------------cc------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 397 SFRQILN------FQVADE------------------SE------MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 397 ~~~~i~~------~~~~~~------------------~~------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+..+.. ..++.. .. ...+..+.+++.+||+.||.+|||+.|++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111111 000000 00 011245778899999999999999999953
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=280.99 Aligned_cols=237 Identities=21% Similarity=0.158 Sum_probs=204.8
Q ss_pred cchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhh----hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIR----ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.|.++||+|.||+|-+++ ..+++.+|+|+++...... .....|-++|...+||.+..+-..|...+.+|+||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 5677999999999999998 4578999999886543322 2233677899999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+.||.|.-+|.+.. .+++...+.+...|+.||.|||+ ++||.||||.+|.|+|.+|++||+|||+++.--...
T Consensus 250 anGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g- 322 (516)
T KOG0690|consen 250 ANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG- 322 (516)
T ss_pred ccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccccc-
Confidence 99999998887643 36788888899999999999999 889999999999999999999999999998754432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
....++||||.|.|||++....|....|||.+|+++|+|++|..||++......+..|+...+..+ ...+++.+.|+
T Consensus 323 -~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP--r~ls~eAktLL 399 (516)
T KOG0690|consen 323 -DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP--RTLSPEAKTLL 399 (516)
T ss_pred -ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC--ccCCHHHHHHH
Confidence 235678999999999999999999999999999999999999999999888888888876655443 34557899999
Q ss_pred HHhcccCCCCCC
Q 047375 423 SKCLRIRGTERP 434 (496)
Q Consensus 423 ~~cl~~dP~~RP 434 (496)
..+|..||.+|.
T Consensus 400 sGLL~kdP~kRL 411 (516)
T KOG0690|consen 400 SGLLKKDPKKRL 411 (516)
T ss_pred HHHhhcChHhhc
Confidence 999999999994
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=291.17 Aligned_cols=247 Identities=19% Similarity=0.182 Sum_probs=195.7
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|+||.||+|.. .++..||+|++..... ......+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 56678899999999999996 4688999999865432 2234458899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
+++|.+++.... ..+++..++.++.||+.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 82 -PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred -CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 999999987644 237889999999999999999999 7899999999999999999999999999887654322
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc-----------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ----------------- 405 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~----------------- 405 (496)
.......|+..|+|||++.+ ..++.++|+|++|+++++++++.++|........+..+....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 11233458999999999865 346889999999999999999988776544332222221100
Q ss_pred ----cCC-------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 ----VAD-------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ----~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... ....+.+..+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 000123477999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=289.92 Aligned_cols=254 Identities=20% Similarity=0.166 Sum_probs=196.8
Q ss_pred cccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 194 LGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 194 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
||+|+||+||+|.. .++..||+|.+..... .......|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 4688999998864321 122334789999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
.+++..... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.+||+|||.+....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 999976543 236889999999999999999999 789999999999999999999999999987654321 1223
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccCCcccHHHHHHHHHHHHHhc
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~l~~li~~cl 426 (496)
..++..|+|||++.+..++.++|+||+|++++++++|..||...........+... ......+...++.+.+++.+||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 45788999999998888899999999999999999999988654332222222111 1111222334677999999999
Q ss_pred ccCCCCCCCHHH-HHHHHHhhHhhhhhhhhccCcc
Q 047375 427 RIRGTERPTMKE-VSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 427 ~~dP~~RPs~~e-il~~L~~l~~~~~~~~~~~~~~ 460 (496)
+.||.+||++.+ ....| ..++|....++
T Consensus 234 ~~~p~~R~~~~~~~~~~l------l~h~~~~~~~~ 262 (277)
T cd05577 234 QKDPEKRLGCRGGSADEV------REHPLFKDLNW 262 (277)
T ss_pred cCChhHccCCCcccHHHH------HhChhhhcCCh
Confidence 999999996555 33333 23555554443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=288.57 Aligned_cols=237 Identities=18% Similarity=0.162 Sum_probs=183.3
Q ss_pred hcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHH---HHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 193 CLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFL---GIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~---~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.||+|+||.||++.. .++..+|+|.+...... .....++. .++...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 46889999988543211 11122333 34444579999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999987654 37889999999999999999999 789999999999999999999999999987553321
Q ss_pred ceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccc--hhhhhhhcccCCcccHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENN--SFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.....||+.|+|||.+.+ ..++.++|+||+|++++++++|..||....... ..... ........+...+..+.++
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 229 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSL 229 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHH
Confidence 123458999999998864 567889999999999999999999886543211 11111 1111222333456789999
Q ss_pred HHHhcccCCCCCCC-----HHHHH
Q 047375 422 ASKCLRIRGTERPT-----MKEVS 440 (496)
Q Consensus 422 i~~cl~~dP~~RPs-----~~eil 440 (496)
+.+||..||.+||+ +.+++
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~ 253 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVK 253 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHH
Confidence 99999999999994 66653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=293.68 Aligned_cols=246 Identities=17% Similarity=0.212 Sum_probs=189.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|+||.||+|.. .+|..||+|.+...... .....+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 56678899999999999996 46889999988643221 233457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++ +|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 82 DQ-DLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 75 78887765432 36889999999999999999999 78999999999999999999999999998765432211
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcc-cchhhhhhh------------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIE-NNSFRQILN------------------ 403 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-~~~~~~i~~------------------ 403 (496)
.....+++.|+|||++.+ ..++.++|+||+|+++++|+++..|+..... ...+..+..
T Consensus 156 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred --cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 223457899999998876 4468899999999999999987666433221 111111110
Q ss_pred cccCC---------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 404 FQVAD---------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 404 ~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..... ......++.+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 001123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=293.48 Aligned_cols=240 Identities=21% Similarity=0.230 Sum_probs=199.5
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecc---hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCA---DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
+.||+|.||+||-|.+ ++|+.||||.+.+. ........+|+.||.++.||.||.+-..|+..+..++|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 7899999999999995 58999999988543 2233445589999999999999999999999999999999997644
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCccccCCCCCcc
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~~~~~~~~~ 344 (496)
|.-+|..... .+++.....++.||+.||.|||. ++|+|+||||+|||+.+ --++||||||+|+.+... +
T Consensus 650 LEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---s 721 (888)
T KOG4236|consen 650 LEMILSSEKG--RLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---S 721 (888)
T ss_pred HHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh---h
Confidence 5545544332 36778888899999999999999 88999999999999954 347999999999998753 3
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh--cccCCcccHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN--FQVADESEMEEIEVVAELA 422 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~l~~li 422 (496)
....++|||.|.|||++.+..|...-|+||.|+++|--++|..||.... ..-.+|.+ ..++...+.+.++...+||
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHH
Confidence 4567889999999999999999999999999999999999999886432 23333433 3556677788899999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
..+|+..-.+|-|.+..+.
T Consensus 800 n~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHHHHhcchHhhcc
Confidence 9999999999999877653
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=288.57 Aligned_cols=245 Identities=20% Similarity=0.208 Sum_probs=196.8
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
+.+.+.||.|+||.||++... ++..||+|.+.... .......+|+.+++.++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 556678999999999999964 68899999886543 223344588999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++.... ..++...+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 83 GGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999997653 246788889999999999999998 24699999999999999999999999998876543211
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc-----cchhhhhhhcccCCcccHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE-----NNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
....|+..|+|||++.+..++.++|+||+|+++++++++..||..... ......+.............+..+.
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 125689999999999998899999999999999999999888754321 1112222222211111122567899
Q ss_pred HHHHHhcccCCCCCCCHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil 440 (496)
++|.+||..||.+|||+.+++
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHh
Confidence 999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=288.41 Aligned_cols=244 Identities=25% Similarity=0.231 Sum_probs=197.3
Q ss_pred cccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 194 LGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
||.|+||.||++... ++..+++|.+..... ......+|+.++.+++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 589999998864432 223344788999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC------
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE------ 342 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~------ 342 (496)
.+++.... .+++..+..++.||+.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997654 36889999999999999999999 7899999999999999999999999998876543311
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
........++..|+|||.+.....+.++|+|++|++++++++|..||........+..+.......+.....+..+.+++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHH
Confidence 11223445888999999998888889999999999999999999988765555444444433332222222367899999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~~L 443 (496)
.+||+.+|.+|||+.++.+.|
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHh
Confidence 999999999999996554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.98 Aligned_cols=247 Identities=21% Similarity=0.239 Sum_probs=190.5
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|++|.||+|... ++..||+|.+...... .....+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 3667789999999999999964 6889999988643322 233457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++ +|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 86 DT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred CC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 85 99998876543 36788999999999999999999 78999999999999999999999999998765322111
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcc-cchhhhhhhc-----------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIE-NNSFRQILNF----------------- 404 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-~~~~~~i~~~----------------- 404 (496)
.....++..|+|||++.+ ..++.+.|+||+|++++++++|.++|..... ...+..+.+.
T Consensus 160 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 --YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred --ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 122347889999998875 4578899999999999999999988854431 1111111000
Q ss_pred ----cc--CCccc-----HHH--HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ----QV--ADESE-----MEE--IEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ----~~--~~~~~-----~~~--~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.. ..... ... ...+.+++.+||+.+|.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000 011 156789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=286.09 Aligned_cols=247 Identities=20% Similarity=0.259 Sum_probs=198.8
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|+||.||+|... ++..||+|.+.... .......+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 556678999999999999964 57889999886432 12233447899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-ceEEccCCCccccCCCCC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPISSDDE 342 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~~~~~ 342 (496)
++++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 82 DGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999976543 236889999999999999999999 7899999999999998875 469999999877654321
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
......|++.|+|||++.+..++.++|+||+|+++++++++..||...........+...... +.....+..+.+++
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i 234 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLI 234 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-CCCCCCCHHHHHHH
Confidence 123345899999999998888899999999999999999999888654433333333332221 22223456799999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+||..+|++|||+.++++
T Consensus 235 ~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 235 SQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHhccChhhCcCHHHHhh
Confidence 9999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=290.56 Aligned_cols=248 Identities=21% Similarity=0.224 Sum_probs=194.8
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|... ++..||+|.+.... .......+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 3667788999999999999964 57899999876432 2233455889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
++++.+..+..... .+++..+..++.||+.||.|||+ ++++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99877766654432 26888999999999999999999 7899999999999999999999999999887655432
Q ss_pred ccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhh----------------c-
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN----------------F- 404 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~----------------~- 404 (496)
.......++..|+|||++.+. .++.++|+||+|+++++++++.++|...........+.. .
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 122345688999999999887 888999999999999999999988764322211111100 0
Q ss_pred ----ccCC---------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ----QVAD---------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ----~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.... ..+...+..+.+||.+||..+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 011123577999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=293.20 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=193.0
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|... ++..||+|.+...... .....+|+.+++.++||||+++++++...+..|+||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 3566789999999999999964 5889999987543222 23345789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++++|..+..... .+++..+..++.||+.||.|||+ .+|+|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 82 VDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99999988765432 26889999999999999999999 7899999999999999999999999999887644321
Q ss_pred ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh------------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN------------------ 403 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~------------------ 403 (496)
......++..|+|||++.+ ..++.++|+||+|++++++++|.++|...........+..
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 1233458999999998875 4467889999999999999999888754332111111110
Q ss_pred ------cccCCc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 404 ------FQVADE-----SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 404 ------~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...... .....+..+.+|+.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 01123467999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=278.06 Aligned_cols=244 Identities=22% Similarity=0.271 Sum_probs=202.4
Q ss_pred hhcccCCceEEEEeE-eCCCcEEEEEEeecc-hhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKYMCA-DEIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
+.||+|+|+.|-.+. ..+|..+|||++... ...+.+.++|++++..++ |+||++|+++|.++..+|||||-+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999988 568999999998654 345667779999999986 99999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC---ceEEccCCCccccCCCCC---
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY---TAKVSDFESLVPISSDDE--- 342 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~---~~kL~DFGla~~~~~~~~--- 342 (496)
...+.++.. +++.++.++..+|+.||.|||. +||.||||||+|||-.... -+|||||.+..-+.....
T Consensus 164 LshI~~~~~---F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRKH---FNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999987654 7889999999999999999999 8899999999999996543 489999987654432211
Q ss_pred --ccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhccc---------------chhhh
Q 047375 343 --TAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIEN---------------NSFRQ 400 (496)
Q Consensus 343 --~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---------------~~~~~ 400 (496)
+....+.+|+..|||||+..- ..|+.+.|.||+|+++|.|++|.+||.+.... ..+..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 222346789999999997643 57889999999999999999999999876432 23445
Q ss_pred hhhccc--CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 401 ILNFQV--ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 401 i~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
|.++.+ +...+...+.+.+++|..++..|+.+|-++.++++
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 555433 44456678899999999999999999999888854
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=281.13 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=199.9
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh-hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE-IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
|...+.||+|++|.||++... ++..+++|++..... ......+|+..++.++||||+++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 445678999999999999964 688999999866543 334455889999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
++|.+++.... ..+++..+..++.|++.||.|||. ++++||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999997753 236889999999999999999999 7899999999999999999999999999887754321
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-CcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~l~~li~~ 424 (496)
.....|+..|+|||++.+..++.+.|+|++|+++++++++.+|+...........+...... .......+..+.+++.+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 23455899999999998888899999999999999999999887654332222222211111 11112225679999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 047375 425 CLRIRGTERPTMKEVSE 441 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~ 441 (496)
||+.||.+|||+.++++
T Consensus 234 ~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 234 CLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=287.36 Aligned_cols=242 Identities=19% Similarity=0.188 Sum_probs=197.2
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||.|+||.||+|... ++..||+|.+..... ......+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 566788999999999999964 688999998864321 223445789999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 82 LLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999997652 36788999999999999999999 789999999999999999999999999987765432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc--chhhhhhhcccCCcccHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN--NSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
......|+..|+|||.+.+..++.++|+|++|++++++++|..|+...... ..+...... .....+...+..+.+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 231 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAID 231 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHH
Confidence 123345889999999999888999999999999999999999888765431 111111111 222333345578999
Q ss_pred HHHHhcccCCCCCCCH--HHH
Q 047375 421 LASKCLRIRGTERPTM--KEV 439 (496)
Q Consensus 421 li~~cl~~dP~~RPs~--~ei 439 (496)
++.+||+.||.+||++ .|+
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l 252 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDL 252 (258)
T ss_pred HHHHHccCChhHcCCccHHHH
Confidence 9999999999999999 554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=290.45 Aligned_cols=247 Identities=19% Similarity=0.183 Sum_probs=191.9
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|...+.||.|++|.||+|.. .++..||||++...... .....+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 45567899999999999985 46889999988643221 234558899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
. ++|..++..... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.+||+|||++.........
T Consensus 82 ~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 82 H-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred c-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 6 589888876433 236889999999999999999999 78999999999999999999999999998765432111
Q ss_pred cceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC---------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--------------- 407 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--------------- 407 (496)
.....+++.|+|||++.+. .++.++|+|++|+++++++++..||...........+......
T Consensus 157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 157 --YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred --cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233478899999988763 3578899999999999999999888654433222222110000
Q ss_pred --------Cc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 408 --------DE----SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 408 --------~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.. .....++.+.++|.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 00123466889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.54 Aligned_cols=244 Identities=20% Similarity=0.198 Sum_probs=188.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCC-CCceeeEEEEEeeC--CeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVK-HKNVVKILGLCLET--KVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~E 261 (496)
|.+.+.||+|+||.||+|.. .++..||+|++..... ......+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 34567899999999999985 4688999998864322 2223346788888885 99999999999987 88999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++ +|.+.+..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++. +.+||+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 88888765432 37889999999999999999999 78999999999999999 999999999988764332
Q ss_pred CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc----------------
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF---------------- 404 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~---------------- 404 (496)
. .....++..|+|||++.. ..++.++|+||+|+++++++++.+||........+..+...
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1 123458899999997654 55688999999999999999999888654332222211110
Q ss_pred ----ccCCc-------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ----QVADE-------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ----~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+.. .....+..+.++|.+||+.+|.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000 01134578999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=282.74 Aligned_cols=247 Identities=19% Similarity=0.204 Sum_probs=197.2
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch------hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD------EIRITEWEFLGIISQVKHKNVVKILGLCLET--KVTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~l 258 (496)
|.+.+.||+|+||.||+|.. .++..||+|.+.... .......+|+.++++++||||+++++++.+. +..++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 56678999999999999985 468899999874321 1122344789999999999999999998764 56889
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++++|.+++..... +++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999876432 5778889999999999999999 789999999999999999999999999988654
Q ss_pred CCCC-ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 339 SDDE-TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 339 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
.... ........|+..|+|||++.+...+.++|+||+|++++++++|.+||...........+.........+...++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence 3111 111123458999999999998888899999999999999999999987654444444443333333345556678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+++.+||. +|..|||+.+++.
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhc
Confidence 9999999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=282.61 Aligned_cols=246 Identities=22% Similarity=0.240 Sum_probs=200.7
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
+.+.+.||+|++|.||+|... ++..|++|++..... ......+|+..+..++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 456688999999999999965 589999998865543 23344588999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+++|.+++.... .+++..+..++.|++.||.|||+. .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 83 GGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 999999997653 368899999999999999999982 46999999999999999999999999998876543222
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc---cchhhhhhhcccCCcccHH-HHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE---NNSFRQILNFQVADESEME-EIEVVAE 420 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~---~~~~~~i~~~~~~~~~~~~-~~~~l~~ 420 (496)
.....++..|+|||.+.+..++.+.|+|++|+++++++++.+|+..... ......+... ........ .+..+.+
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PPPSLPAEEFSPEFRD 234 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-CCCCCCcccCCHHHHH
Confidence 2244588999999999998889999999999999999999988866531 1122222222 12222233 5678999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~ 441 (496)
++.+||..+|++|||+.++++
T Consensus 235 li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHHHHccCChhhCCCHHHHHh
Confidence 999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=288.28 Aligned_cols=247 Identities=19% Similarity=0.213 Sum_probs=193.4
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh---hhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR---ITEWEFLGIISQVKHKNVVKILGLCLET--KVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 260 (496)
.|.+.+.||.|+||.||+|... ++..+++|.+....... ....+|+.++.+++||||+++++++... +..|+||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3667789999999999999964 57899999886443221 2335789999999999999999999877 8899999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++ +|.+++..... .+++..+..++.||+.||.|||+ ++|+|+||||+||+++.++.+||+|||++......
T Consensus 86 e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 86 EYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99975 99998876443 47889999999999999999999 78999999999999999999999999998876543
Q ss_pred CCccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc---------------
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--------------- 404 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------------- 404 (496)
.. ......+++.|+|||.+.+. .++.++|+||+|++++++++|.++|...........+...
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 21 12234478999999988753 4678999999999999999999888654333222221110
Q ss_pred --------------ccCCcccHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 --------------QVADESEME-EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 --------------~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
......+.. .++.+.++|.+||+.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000111 3567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=284.86 Aligned_cols=249 Identities=18% Similarity=0.164 Sum_probs=191.2
Q ss_pred hcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHH---HHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 193 CLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWE---FLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~---e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.||+|+||.||+|.. .+++.||+|.+...... ...... .+..++...||||+++++++...+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 46889999987543211 111122 2345556689999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
||+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999886543 37899999999999999999999 789999999999999999999999999987654321
Q ss_pred ceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccc--hhhhhhhcccCCcccHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENN--SFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.....|+..|+|||++.+ ..++.++|+||+|++++++++|..||....... ...... .......+...+..+.++
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~l 229 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSL 229 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHH
Confidence 123459999999999875 358899999999999999999998886542211 111111 111122223346789999
Q ss_pred HHHhcccCCCCCC-----CHHHHHHHHHhhHhhhhhhhhccCcccc
Q 047375 422 ASKCLRIRGTERP-----TMKEVSEELDRLRRLQENYWARKNNEES 462 (496)
Q Consensus 422 i~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~~~ 462 (496)
+.+||..+|.+|| ++.+++ +++|.+...+..
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~ll----------~~~~~~~~~~~~ 265 (278)
T cd05606 230 LEGLLQRDVNRRLGCLGRGAQEVK----------EHPFFRSLDWQM 265 (278)
T ss_pred HHHHhhcCHHhccCCCCCCHHHHH----------hCccccCCCchH
Confidence 9999999999999 888874 456666555433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=287.68 Aligned_cols=247 Identities=24% Similarity=0.233 Sum_probs=193.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~ 262 (496)
+.+.+.||.|++|.||+|.. .++..+|+|.+..... ......+|+++++.++||||++++++|.. .+.+|+||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 45567899999999999996 4678899998864332 23345588999999999999999999865 3468999999
Q ss_pred ccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 263 VSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
+++++|.+++.... ....++...+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999998876421 22346788899999999999999999 789999999999999999999999999987654321
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc-----cchhhhhhhcc---cCCcc--c
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE-----NNSFRQILNFQ---VADES--E 411 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-----~~~~~~i~~~~---~~~~~--~ 411 (496)
.....++..|+|||.+.+..++.+.|+|++|+++|++++|..||..... ......+.... ..... .
T Consensus 160 ----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 160 ----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred ----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 1234578899999999988899999999999999999999888765421 11111111111 11111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...++.+.+++.+||..+|.+|||+.|+++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 234567999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.73 Aligned_cols=250 Identities=20% Similarity=0.227 Sum_probs=210.9
Q ss_pred hcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEee-----CCeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLE-----TKVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~-----~~~~~lv 259 (496)
++.|...||.|.+|.||++. ..+++..|||+.............|.++++.. .|||++.+||+|.. ++.+|||
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 35667889999999999999 45788899998877666665556677888776 59999999999873 5689999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||||.+|+..++++... ...+.|..+..|++.++.||.+||. +.++|||||-.|||++.++.|||+|||.+..+..
T Consensus 100 MEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred eeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999998766 4458999999999999999999999 7799999999999999999999999999988866
Q ss_pred CCCccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccchhhhhh-hcccCCcccHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL-NFQVADESEME 413 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~ 413 (496)
... ...+.+|||.|||||++.. -.|+.++|+||+|++..||..|.||+.+......+-.|- ++......+..
T Consensus 176 T~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 176 TVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 433 3456779999999999976 457789999999999999999999998876665544443 33444445677
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
.++++.++|..||..|-.+||++.++++.
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 88999999999999999999999998753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=299.27 Aligned_cols=248 Identities=18% Similarity=0.267 Sum_probs=207.0
Q ss_pred hhhhcccCCceEEEEeEeC--CC--cEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 190 FHHCLGMGGFGSVYKGVLP--DN--TQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
+.++||+|.||.|++|.|. +| -.||||.+..... ....+.+|+.+|.+|+|||+|+|||+..+ ....+|||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4578999999999999974 33 3689999875543 34566799999999999999999999987 5678999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+.|++. ....+.......++.|||.||.||.+ +++|||||-..|+|+-..-.|||||||+.+.+......
T Consensus 193 plGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999983 33446677888999999999999999 88999999999999998889999999999998766443
Q ss_pred ccee-cccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 344 AMST-MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 344 ~~~~-~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.... ...-...|+|||.+....++.++|+|++|+++|||+++ ..||.+......++.+- .....+.+..|++.+.++
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~i 347 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQI 347 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHH
Confidence 3222 22245689999999999999999999999999999875 56777766666666655 555666778889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L 443 (496)
+..||..+|.+|||+..|.+.+
T Consensus 348 mk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 348 MKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHhccCCccccccHHHHHHhH
Confidence 9999999999999999997544
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=280.52 Aligned_cols=248 Identities=23% Similarity=0.266 Sum_probs=201.5
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLET--KVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~E 261 (496)
|...+.||+|++|.||+|... ++..|++|.+..... ......+|+.++++++||||+++++.+... +..++|||
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 345578999999999999965 688999998865442 233445889999999999999999999988 88999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 82 YVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999999998754 47889999999999999999999 789999999999999999999999999988776543
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc-cchhhhhhhcccCCcccHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE-NNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
.........++..|+|||.+.+...+.++|+|++|++++++++|..||..... ......+.........+...+..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence 21112345589999999999888899999999999999999999888765441 11222222212223333444678999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~ 441 (496)
++.+||+.||.+||++.++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhh
Confidence 999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.02 Aligned_cols=250 Identities=22% Similarity=0.271 Sum_probs=190.4
Q ss_pred cchhhhcccCCceEEEEeEeC---CCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP---DNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLET--KVTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~l 258 (496)
|.+.+.||+|+||.||+|... .+..||+|.+.... .......+|+.++..++||||+++++++.+. ...|+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 566778999999999999964 47899999987532 2223445789999999999999999999987 78999
Q ss_pred EEeeccCCchhhhhhhcCc--ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC----CCceEEccCC
Q 047375 259 VYEFVSNGALSHYIHDKSS--QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD----NYTAKVSDFE 332 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~----~~~~kL~DFG 332 (496)
||||+++ +|.+++..... ...++...+..++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 67776654321 2246888999999999999999999 78999999999999999 8999999999
Q ss_pred CccccCCCCC-ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccc---------hhhhh
Q 047375 333 SLVPISSDDE-TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENN---------SFRQI 401 (496)
Q Consensus 333 la~~~~~~~~-~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~---------~~~~i 401 (496)
++........ ........+|+.|+|||++.+ ..++.++|+||+|+++++++++.++|....... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9887644322 111233458899999998766 457889999999999999999998886543321 00000
Q ss_pred hh------------------------cccCCccc----H-------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 402 LN------------------------FQVADESE----M-------EEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 402 ~~------------------------~~~~~~~~----~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.. ........ . ..+..+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00000000 0 22356889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=287.36 Aligned_cols=248 Identities=18% Similarity=0.221 Sum_probs=195.0
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|.+.+.||.|++|.||+|... ++..||+|.+...... .....+|+.+++.++||||+++++++...+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 556788999999999999964 6889999988654322 2334478999999999999999999999999999999998
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+ +|.+++........+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++........
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 5 898888765533457899999999999999999999 7899999999999999999999999999876543211
Q ss_pred ceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc------------------
Q 047375 345 MSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ------------------ 405 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------------ 405 (496)
......+|+.|+|||++.+ ..++.++|+|++|++++++++|.+||.+.........+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1123447899999998866 356788999999999999999999887554333322222100
Q ss_pred --cCC-------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 --VAD-------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 --~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+. ......++.+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 001123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=287.81 Aligned_cols=244 Identities=21% Similarity=0.255 Sum_probs=193.9
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+|...+.||+|+||.||+|.. .++..+|+|.+.... .......+|+.+++.++|||++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 355567899999999999995 467889999875321 112234478999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+. |+|.+++..... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 997 588877754432 36788899999999999999999 78999999999999999999999999988765432
Q ss_pred CccceecccccceeecCcccc---cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAH---TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~---~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
....|++.|+|||++. ...++.++|+||+|++++++++|..|+...........+.............+..+
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHH
Confidence 2345889999999874 34678899999999999999999988765443333333333222222233456779
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
.+||.+||+.+|.+||++.++++.
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhC
Confidence 999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=286.77 Aligned_cols=241 Identities=21% Similarity=0.241 Sum_probs=193.4
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecchh-hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE-IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
...||+|+||.||++.. .++..||+|++..... ......+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 4788999998754332 223344788999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
.+++... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........ ....
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 9987543 26788899999999999999999 7899999999999999999999999998876543221 1233
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC--cccHHHHHHHHHHHHHhc
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD--ESEMEEIEVVAELASKCL 426 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~l~~li~~cl 426 (496)
..|++.|+|||++.+..++.++|+||+|++++++++|.+||...........+.. ..+. ......+..+.+++.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-hCCcccCCcccCCHHHHHHHHHHH
Confidence 4589999999999888888999999999999999999988765433322222211 1111 111234567899999999
Q ss_pred ccCCCCCCCHHHHHH
Q 047375 427 RIRGTERPTMKEVSE 441 (496)
Q Consensus 427 ~~dP~~RPs~~eil~ 441 (496)
+.||.+||++.++++
T Consensus 255 ~~~P~~R~~~~~ll~ 269 (292)
T cd06657 255 VRDPAQRATAAELLK 269 (292)
T ss_pred hCCcccCcCHHHHhc
Confidence 999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.59 Aligned_cols=245 Identities=20% Similarity=0.179 Sum_probs=190.4
Q ss_pred HHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC------C
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET------K 254 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~ 254 (496)
...|...+.||+|+||.||+|.. .++..||+|.+.... .......+|+.+++.++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 34577778999999999999995 478899999885321 1223344789999999999999999998643 3
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
..|+||||+.+ +|.+.+... ++...+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 57999999964 888877542 5778889999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc----------
Q 047375 335 VPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF---------- 404 (496)
Q Consensus 335 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~---------- 404 (496)
........ .....||+.|+|||++.+..++.+.|+||+|++++++++|..||........+..+...
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 87643211 23345889999999999989999999999999999999998887644322222111110
Q ss_pred ------------ccC-------------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ------------QVA-------------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ------------~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... .......++.+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0001123456899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=287.14 Aligned_cols=247 Identities=22% Similarity=0.225 Sum_probs=189.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
+.+...||+|+||.||++.. .++..||+|.+.... .......+|+.++.++. ||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 33456899999999999995 468899999886432 22334457888888886 999999999999999999999998
Q ss_pred cCCchhhhhh---hcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 264 SNGALSHYIH---DKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 264 ~~g~L~~~l~---~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
+. +|.++.. ... ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~-~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 86 DI-SLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cC-CHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 64 6655432 221 13478889999999999999999972 37999999999999999999999999998765432
Q ss_pred CCccceecccccceeecCcccccc---cccCCCCCchhhhhcccccccccchhhhccc-chhhhhhhc---ccCCcccHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTE---LLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNF---QVADESEME 413 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~---~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~---~~~~~~~~~ 413 (496)
.. .....|++.|+|||++.+. .++.++|+||+|++++++++|.+||...... .....+... .........
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 11 1233589999999998875 6888999999999999999999988654311 111222111 111122234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+..+.+|+.+||+.||.+|||+.+|++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 5678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.25 Aligned_cols=248 Identities=19% Similarity=0.165 Sum_probs=189.6
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCC-CCceeeEEEEEeeCCe-----ee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVK-HKNVVKILGLCLETKV-----TL 257 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~-----~~ 257 (496)
|.+.+.||+|+||.||+|.. .++..||+|.+...... .....+|+.+++.++ ||||+++++++..... .|
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 55667899999999999995 46889999987543221 234457899999995 6999999999987655 89
Q ss_pred EEEeeccCCchhhhhhhcCc--ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCCc
Q 047375 258 LVYEFVSNGALSHYIHDKSS--QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFESL 334 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla 334 (496)
+||||+++ +|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999986 88888865422 2346889999999999999999999 78999999999999998 889999999998
Q ss_pred cccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--------
Q 047375 335 VPISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ-------- 405 (496)
Q Consensus 335 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-------- 405 (496)
......... .....+++.|+|||++.+ ..++.++|+|++|++++++++|.+||...........+....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 765432111 122347889999998865 457889999999999999999998886543322222211100
Q ss_pred -----------c---CCc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 -----------V---ADE----SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 -----------~---~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
. ... .....++.+.++|.+||..||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000 00124567999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=289.89 Aligned_cols=245 Identities=20% Similarity=0.211 Sum_probs=192.0
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLET--KVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~E 261 (496)
|.+.+.||.|+||.||+|.. .++..||+|.+...... .....+|+.++++++||||+++++++... +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 66678899999999999996 46899999988643222 22334789999999999999999998754 56899999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 89 YCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred cCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 9975 8888887543 247889999999999999999999 789999999999999999999999999988765432
Q ss_pred CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc---------------
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--------------- 405 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--------------- 405 (496)
.. .....+++.|+|||.+.+ ..++.++|+||+|+++|+++++.++|........+..+.+..
T Consensus 163 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 KP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred CC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 11 122346888999999865 567889999999999999999999887654443333332210
Q ss_pred ----c--CCc---c----cHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 406 ----V--ADE---S----EMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 406 ----~--~~~---~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
. ... . ....++.+.++|.+||+.||.+|||+.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 0 000 0 011356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=285.35 Aligned_cols=247 Identities=18% Similarity=0.185 Sum_probs=188.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|.. .++..||+|.+...... .....+|+.+++.++|+||+++++++...+..|+||||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 366678899999999999985 46889999998644322 223457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
. ++|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 86 ~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 86 H-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred c-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 6 577777654332 25677888899999999999999 78999999999999999999999999998765432221
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhccc-chhhhhhh------------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILN------------------ 403 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~------------------ 403 (496)
.....+++.|+|||++.+ ..++.++|+||+|++++++++|.+||...... ..+..+..
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 --YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred --CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 223347899999999875 34778899999999999999999888543221 11111100
Q ss_pred -------cccCCcc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 404 -------FQVADES-----EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 404 -------~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....... ....+..+.+++.+|+..||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 0011357889999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=290.09 Aligned_cols=249 Identities=16% Similarity=0.210 Sum_probs=183.2
Q ss_pred HHhcchhhhcccCCceEEEEeEeCC----CcEEEEEEeecchhhh------------hhHHHHHHHHhcCCCCceeeEEE
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLPD----NTQVAVKKYMCADEIR------------ITEWEFLGIISQVKHKNVVKILG 248 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~------------~~~~~e~~~l~~l~hpnIv~l~~ 248 (496)
...|.+.+.||+|+||.||+|.... +..+|+|......... .....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3457888999999999999999643 3456666432211110 01112234456678999999999
Q ss_pred EEeeCC----eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC
Q 047375 249 LCLETK----VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY 324 (496)
Q Consensus 249 ~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~ 324 (496)
++.... ..+++||++.. ++.+.+.... ..++..+..++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence 876543 34788888754 6766665432 14677788999999999999999 7899999999999999999
Q ss_pred ceEEccCCCccccCCCCCc-----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchh-
Q 047375 325 TAKVSDFESLVPISSDDET-----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSF- 398 (496)
Q Consensus 325 ~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~- 398 (496)
.+||+|||+|+........ .......||+.|+|||++.+..++.++|+||+|+++++++++.+||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999876432111 1122346999999999999999999999999999999999999998765332211
Q ss_pred --------hhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047375 399 --------RQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 399 --------~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 443 (496)
..+...... ...+++.+.+++..|+..+|.+||++.++++.|
T Consensus 244 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 112211111 123357799999999999999999999998876
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=329.52 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=195.2
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+...+.||+|+||.||+|.. .++..||||++..... ....|+.++++++|||||+++|+|.+.+..|+||||+++|
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 34456899999999999995 5789999998864332 2234588899999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.++++. ++|..+.+|+.|++.||.|||+.+.++|+||||||+||+++.++.+++. ||........
T Consensus 769 ~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------ 835 (968)
T PLN00113 769 NLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------ 835 (968)
T ss_pred cHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------
Confidence 99999953 6889999999999999999996545789999999999999999888876 6654433211
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-ch-------------hhhhhhcccC--Ccc
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NS-------------FRQILNFQVA--DES 410 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~-------------~~~i~~~~~~--~~~ 410 (496)
....||+.|+|||++.+..++.++|+||+|+++||++++..|+...... .. ...+.++... ...
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 2235899999999999999999999999999999999999887432111 00 1111122221 122
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
......++.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 334556788999999999999999999999999987653
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=289.57 Aligned_cols=245 Identities=16% Similarity=0.188 Sum_probs=187.2
Q ss_pred hcccC--CceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 193 CLGMG--GFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 193 ~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.||.| +||+||++.. .+++.||+|.+..... ......+|+.+++.++||||++++++|..++..++||||+++|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999996 4789999998864322 1233347788888999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc--
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA-- 344 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~-- 344 (496)
+|.+++...... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||.+..........
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999998875432 36888889999999999999999 789999999999999999999999998654332211110
Q ss_pred ---ceecccccceeecCcccccc--cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc---------------
Q 047375 345 ---MSTMIRGTVGYLDPEYAHTE--LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--------------- 404 (496)
Q Consensus 345 ---~~~~~~gt~~Y~aPE~l~~~--~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------------- 404 (496)
......++..|+|||++.+. .++.+.|+||+|++++++++|.+||...............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 01112356779999999763 4678999999999999999999988654332222111110
Q ss_pred ------------------------------ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ------------------------------QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ------------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....+....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0111122345678999999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=276.12 Aligned_cols=250 Identities=21% Similarity=0.268 Sum_probs=195.5
Q ss_pred cchhhhcccCCceEEEEeEeC-C----CcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEee-CCeeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-D----NTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLE-TKVTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~l 258 (496)
|+....||+|+||.||+|... + +..+|+|+++...+ ......+|+.+++.++|||||.+..++.. +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 677788999999999999632 2 34789999975532 34556699999999999999999999987 778999
Q ss_pred EEeeccCCchhhhhhhcC--cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC----CceEEccCC
Q 047375 259 VYEFVSNGALSHYIHDKS--SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN----YTAKVSDFE 332 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~----~~~kL~DFG 332 (496)
++||.+. +|.++++-+. ....++...+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |.|||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999988 9999997542 22346778899999999999999999 669999999999999877 899999999
Q ss_pred CccccCCCCCcc-ceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhccc---------chhhhh
Q 047375 333 SLVPISSDDETA-MSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIEN---------NSFRQI 401 (496)
Q Consensus 333 la~~~~~~~~~~-~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---------~~~~~i 401 (496)
+++.+...-... ....++-|..|.|||.+.+ .-||...|+|+.||++.|+++..|.|.+.... ..+.+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999886543222 2345678999999999988 67999999999999999999999988764322 112222
Q ss_pred hh---cccCCccc--------------------HH------------HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 402 LN---FQVADESE--------------------ME------------EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 402 ~~---~~~~~~~~--------------------~~------------~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+. ..-...++ .+ .++...+|+.++|.+||-+|.|+.+.++
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 21 00000000 00 1134789999999999999999998864
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=278.35 Aligned_cols=245 Identities=20% Similarity=0.267 Sum_probs=200.3
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|++|.||++... ++..|++|.+..... ......+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 556678999999999999854 678999999865542 3334458899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999987653 37889999999999999999999 78999999999999999999999999998877543221
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
.....|+..|+|||.+.+..++.+.|+|++|+++++++++.+|+............... .....+...++.+.+++.
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGISPELKDFLM 232 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-CCCCCCCCCCHHHHHHHH
Confidence 23345899999999998877889999999999999999999887654433222222211 122223344578999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~ 441 (496)
+||..+|++|||+.+++.
T Consensus 233 ~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHhCChhhCcCHHHHhc
Confidence 999999999999999863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=290.98 Aligned_cols=249 Identities=24% Similarity=0.277 Sum_probs=192.1
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecc---hhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeC--Ceee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCA---DEIRITEWEFLGIISQV-KHKNVVKILGLCLET--KVTL 257 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~--~~~~ 257 (496)
...|.+.+.||+|+||.||+|... ++..+|+|++... ........+|+.+++++ +||||++++++|... ...|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 345777889999999999999964 6889999987532 12223344789999999 999999999998643 4689
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+||||++ ++|..++... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 5999888654 36788889999999999999999 78999999999999999999999999998876
Q ss_pred CCCCCc---cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--------
Q 047375 338 SSDDET---AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ-------- 405 (496)
Q Consensus 338 ~~~~~~---~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-------- 405 (496)
...... .......||+.|+|||++.+ ..++.++|+||+|+++++++++.++|...........+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543221 12234568999999998765 567889999999999999999998885433222221111100
Q ss_pred --------------cC-------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 --------------VA-------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 --------------~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.. .......+..+.++|.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00 0001113567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=287.30 Aligned_cols=247 Identities=17% Similarity=0.142 Sum_probs=189.1
Q ss_pred hhhhcccCCceEEEEeEeCCCcEEEEEEeecc---hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCA---DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+.+.+|.|+++.||++.. ++..||||++... ........+|+.+++.++||||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445566677777777766 7899999998654 222234458899999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC----
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE---- 342 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~---- 342 (496)
+|.+++...... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999999865332 36788889999999999999999 7899999999999999999999999998875543211
Q ss_pred -ccceecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc---------------
Q 047375 343 -TAMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--------------- 404 (496)
Q Consensus 343 -~~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------------- 404 (496)
........++..|+|||++.. ..++.++|+||+|++++++++|.+||...............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 111223457889999999876 35788999999999999999999988654322111110000
Q ss_pred -----------------ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 -----------------QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 -----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..........+..+.+|+.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0011112234467899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=277.51 Aligned_cols=248 Identities=23% Similarity=0.238 Sum_probs=201.8
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||.|+||.||++... ++..|++|++..... ......+|+++++.++|||++++++.+......++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 455678999999999999964 688999999865432 2333457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 264 SNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 264 ~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
++++|.+++.... ....+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999997642 12347889999999999999999999 789999999999999999999999999988765432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.......|++.|+|||.+.+..++.+.|+|++|+++++++++..|+................ ..+.+...+..+.+++
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i 235 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPSQYSSELRNLV 235 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCCHHHHHHH
Confidence 12234468999999999988889999999999999999999988876544333333333222 2222334557799999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+||..+|++|||+.++++
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHcCCChhhCcCHHHHhc
Confidence 9999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=280.31 Aligned_cols=246 Identities=22% Similarity=0.234 Sum_probs=200.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||.|+||.||++.. .++..+++|.+.... .......+|+.+++.++||||+++++++......|+||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 45667899999999999985 467899999886432 22233447889999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCc-ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 264 SNGALSHYIHDKSS-QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 264 ~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
++++|.+++..... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999999876321 2346888999999999999999999 78999999999999999999999999998876543
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
......|++.|+|||.+.+..++.++|+|++|+++++++++..||...........+.... ..+.....+..+.+++
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 233 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFI 233 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCchhhCHHHHHHH
Confidence 1223458899999999998888999999999999999999999886654333333333222 2223335667899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+||+.+|.+|||+.++++
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 234 RSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHcCCCcccCCCHHHHhc
Confidence 9999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=285.89 Aligned_cols=247 Identities=22% Similarity=0.246 Sum_probs=190.2
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||.|++|.||+|... +++.||+|.+..... ......+|+.+++.++||||+++++++...+..|+||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 566788999999999999964 688999998754322 1233457899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCCccccCCCCC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~~~~~~ 342 (496)
+ ++|.+++..... ...++..+..++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||++........
T Consensus 84 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 84 D-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred c-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 6 488887765433 225778888999999999999999 78999999999999985 56799999999876543211
Q ss_pred ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-----------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF----------------- 404 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------------- 404 (496)
......|++.|+|||++.+ ..++.+.|+||+|++++++++|.+||...........+...
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 159 --TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred --ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1123457899999998866 45788999999999999999999988654333222222110
Q ss_pred ------ccCCc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ------QVADE----SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ------~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..... .....++.+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 01123467899999999999999999999974
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=285.63 Aligned_cols=246 Identities=22% Similarity=0.208 Sum_probs=191.6
Q ss_pred chhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 189 NFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.+.+.||.|++|.||+|.. .+|..||+|++...... .....+|+.+++.++||||+++++++.+.+..|++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 4567899999999999985 47899999988644321 2334578999999999999999999999999999999995
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
++|.+++..... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 82 -~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 -LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 689999876542 236889999999999999999999 78999999999999999999999999998765432111
Q ss_pred ceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc------------------
Q 047375 345 MSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ------------------ 405 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------------ 405 (496)
.....+++.|+|||++.+. .++.++|+||+|+++++++++.+||...........+....
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 1223478899999988663 56888999999999999999998886543322222211100
Q ss_pred -----cCC----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 -----VAD----ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 -----~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... ......++.+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 001123367899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=285.44 Aligned_cols=245 Identities=23% Similarity=0.270 Sum_probs=200.0
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 261 (496)
|.+.+.||+|+||.||+|.. .++..||+|.+.... .......+|..++.+++ ||||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 56678899999999999995 478899999886432 11233447788999998 9999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 83 YAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999999998754 37889999999999999999999 789999999999999999999999999988765432
Q ss_pred Cc------------------cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh
Q 047375 342 ET------------------AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN 403 (496)
Q Consensus 342 ~~------------------~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~ 403 (496)
.. .......|+..|+|||.+....++.+.|+|++|+++++++++..||........+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 11 112334588999999999888889999999999999999999999876654444444442
Q ss_pred cccCCcccHHHHHHHHHHHHHhcccCCCCCCCH----HHHH
Q 047375 404 FQVADESEMEEIEVVAELASKCLRIRGTERPTM----KEVS 440 (496)
Q Consensus 404 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil 440 (496)
... ..+...++.+.+++.+||+.+|.+|||+ .+++
T Consensus 237 ~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 237 LEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred cCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 222 2223345779999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=286.00 Aligned_cols=249 Identities=22% Similarity=0.249 Sum_probs=188.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCC--------
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETK-------- 254 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-------- 254 (496)
.|.+.+.||+|+||.||+|.. .++..||||.+...... .....+|+.++++++||||++++++|....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 377778999999999999995 46889999988543221 223347899999999999999999987654
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
..++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 88888765432 36889999999999999999999 78999999999999999999999999998
Q ss_pred cccCCCCCc--cceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhh--cc----
Q 047375 335 VPISSDDET--AMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN--FQ---- 405 (496)
Q Consensus 335 ~~~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~---- 405 (496)
......... .......++..|+|||.+.+. .++.++|+||+|+++++++++.++|...........+.. ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 866433221 112234578899999988664 467889999999999999999888765433221111110 00
Q ss_pred ---------------cCCccc---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 ---------------VADESE---------MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ---------------~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...... ...+..+.+||.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000 011245789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=283.83 Aligned_cols=242 Identities=24% Similarity=0.273 Sum_probs=191.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+...+.||+|+||.||+|.. .++..|++|++..... ......+|+.+++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 33446799999999999985 4688999998864322 112344788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+. |+|.+++..... .+++..+..++.||+.||.|||+ ++|+|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 578777765432 36889999999999999999999 7899999999999999999999999998764322
Q ss_pred ccceecccccceeecCcccc---cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAH---TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~---~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
.....|+..|+|||++. ...++.++|+||+|++++++++|.+|+...........+.....+.......+..+.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR 250 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHH
Confidence 12345899999999984 356788999999999999999999887665433333333322222222223446699
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~ 441 (496)
+|+.+||+.+|.+||++.+++.
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=280.64 Aligned_cols=245 Identities=22% Similarity=0.250 Sum_probs=190.6
Q ss_pred chhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh---hhhHHHHHHHHhc---CCCCceeeEEEEEeeCCe-----e
Q 047375 189 NFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI---RITEWEFLGIISQ---VKHKNVVKILGLCLETKV-----T 256 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~---l~hpnIv~l~~~~~~~~~-----~ 256 (496)
.+.+.||+|+||.||+|... ++..||+|.+...... .....+|+.++.+ ++||||+++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45678999999999999975 4889999998643221 1223355555544 469999999999988776 8
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
+++|||+++ +|.+++..... ..+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999975 89888876433 237889999999999999999999 7899999999999999999999999999877
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc----------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV---------- 406 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 406 (496)
...... .....++..|+|||++.+..++.+.|+|++|+++++++++.++|........+..+.....
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 644321 1233478999999999988899999999999999999999988876544433333322100
Q ss_pred ------------C---CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 407 ------------A---DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 407 ------------~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
. .......++.+.+++.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0001134567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=282.78 Aligned_cols=240 Identities=18% Similarity=0.156 Sum_probs=187.9
Q ss_pred cchhhhcccCCceEEEEeEe----CCCcEEEEEEeecchh-----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL----PDNTQVAVKKYMCADE-----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~ 257 (496)
|.+.+.||.|+||.||++.. .+|..||+|.+..... ......+|+.++..+ +||||+++++++..+...|
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45667899999999999985 3688999999864322 122334788999999 5999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999997653 36788889999999999999999 78999999999999999999999999998776
Q ss_pred CCCCCccceecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccCCcccHH
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVADESEME 413 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~ 413 (496)
..... .......|+..|+|||.+.. ..++.+.|+|++|+++++++++..||...........+... ....+.+..
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T cd05613 156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234 (290)
T ss_pred ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc
Confidence 43321 11233558999999999875 34678899999999999999999887543222222222211 011222334
Q ss_pred HHHHHHHHHHHhcccCCCCCC
Q 047375 414 EIEVVAELASKCLRIRGTERP 434 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RP 434 (496)
.++.+.+++.+||+.||.+||
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhc
Confidence 557799999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=290.73 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=187.9
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----CeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLET-----KVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~~l 258 (496)
.|.+.+.||+|+||.||+|.. .++..||+|.+.... .......+|+.+++.++||||+++++++... ...|+
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 467778999999999999985 468899999885422 2223345789999999999999999987644 35799
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++ +|..++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 86 VQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred Eehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 9999975 888777543 36888999999999999999999 789999999999999999999999999987654
Q ss_pred CCCCc-cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhh--------------
Q 047375 339 SDDET-AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL-------------- 402 (496)
Q Consensus 339 ~~~~~-~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~-------------- 402 (496)
..... .......||+.|+|||.+.+ ..++.++|+||+|++++++++|.++|........+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 32211 11233468999999998654 567889999999999999999998885432211111110
Q ss_pred -hcc-------cC--Ccc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 403 -NFQ-------VA--DES-----EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 403 -~~~-------~~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... .. ... ....++.+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00 000 0123467899999999999999999998853
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=289.26 Aligned_cols=246 Identities=20% Similarity=0.205 Sum_probs=195.4
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC-----eeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETK-----VTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~l 258 (496)
|.+.+.||.|+||.||+|... ++..||+|++.... .......+|+.+++.++||||+++++++.... ..|+
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 566788999999999999964 58899999886543 22334558899999999999999999998765 7899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++ +|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++....
T Consensus 82 v~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999984 8988886543 47889999999999999999999 789999999999999999999999999988765
Q ss_pred CCCCc-cceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC--------
Q 047375 339 SDDET-AMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD-------- 408 (496)
Q Consensus 339 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-------- 408 (496)
..... .......+|+.|+|||++.+. .++.++|+||+|+++++++++.++|........+..+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 43210 112334588999999999887 78899999999999999999999987654433332222210000
Q ss_pred ----------------c-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 409 ----------------E-----SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 409 ----------------~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
. .....+..+.+++.+||+.+|.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 0 0011346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=289.66 Aligned_cols=248 Identities=21% Similarity=0.240 Sum_probs=190.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEee----CCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLE----TKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~l 258 (496)
.|.+.+.||.|+||.||+|.. .++..||+|++..... ......+|+.+++.++||||+++++++.. ....|+
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 466678899999999999985 4689999998865322 22334478999999999999999998763 356899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+. |+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 86 VMDLME-SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEehhh-hhHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 999996 589888865432 7889999999999999999999 789999999999999999999999999987654
Q ss_pred CCCCc--cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh------------
Q 047375 339 SDDET--AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN------------ 403 (496)
Q Consensus 339 ~~~~~--~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~------------ 403 (496)
..... .......|+..|+|||.+.+ ..++.++|+|++|+++++++++.+||........+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 33221 11234468999999998765 4578899999999999999999999865432111111110
Q ss_pred ------------cccCCcc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 404 ------------FQVADES-----EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 404 ------------~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....... ....++.+.++|.+||+.+|.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000 1123577999999999999999999998854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=283.96 Aligned_cols=247 Identities=19% Similarity=0.198 Sum_probs=190.0
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
+.+.+.||+|+||.||+|.+. ++..||||.+..... ......+++.++.+. .||||++++++|.+....|+||||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 566789999999999999975 488999999865422 222333556555555 4999999999999999999999998
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++ +|.+++..... .+++..+..++.|++.||.|||+. ++|+||||+|+||+++.++.+||+|||++........
T Consensus 97 ~~-~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 97 ST-CLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred Cc-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 54 77777765332 478889999999999999999972 4799999999999999999999999999876543221
Q ss_pred cceecccccceeecCccccccc----ccCCCCCchhhhhcccccccccchhhhcc-cchhhhhhhcccC-CcccHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTEL----LTGMNPNSYVALASNEKISMVPYFLDSIE-NNSFRQILNFQVA-DESEMEEIEV 417 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~----~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~-~~~~~~~~~~ 417 (496)
.....+++.|+|||++.+.. ++.++|+||+|++++++++|..||..... ...+..+...... .+.....+..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 12234788999999987653 78899999999999999999998865322 1223333322211 1111234577
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
+.+|+.+||+.||.+|||+.++++.
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=291.61 Aligned_cols=246 Identities=21% Similarity=0.214 Sum_probs=189.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----Ceee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET-----KVTL 257 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 257 (496)
.|.+.+.||+|+||.||+|.. .++..||||.+.... .......+|+.+++.++||||+++++++... ...|
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 466678899999999999985 468999999886431 1223344789999999999999999988654 3479
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+||||+. ++|.+++.... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9999996 68988886543 37889999999999999999999 78999999999999999999999999998876
Q ss_pred CCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhh--------------
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL-------------- 402 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~-------------- 402 (496)
.... .......||..|+|||.+.. ..++.++|+|++|+++++++++.+||...........+.
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 4432 12234458899999998765 468889999999999999999998885432211111110
Q ss_pred ---------hc--ccC-C---cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 403 ---------NF--QVA-D---ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 403 ---------~~--~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.. ... . ......++.+.+++.+||+.+|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 00 000 0 011234577899999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=282.92 Aligned_cols=248 Identities=19% Similarity=0.156 Sum_probs=193.7
Q ss_pred cchhhhcccCCceEEEEeEe----CCCcEEEEEEeecchh-----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL----PDNTQVAVKKYMCADE-----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~ 257 (496)
|.+.+.||+|+||.||++.. .++..||||.+..... ......+|+.++.++ +||||+++++.+......|
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 45667899999999999874 2568899998864322 122344788999999 5999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999987543 36788889999999999999999 78999999999999999999999999998775
Q ss_pred CCCCCccceecccccceeecCccccccc--ccCCCCCchhhhhcccccccccchhhhcccchh----hhhhhcccCCccc
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTEL--LTGMNPNSYVALASNEKISMVPYFLDSIENNSF----RQILNFQVADESE 411 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~----~~i~~~~~~~~~~ 411 (496)
..... .......|+..|+|||.+.+.. .+.+.|+|++|+++++++++..||......... ..+.... .+.+
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 232 (288)
T cd05583 156 LAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFP 232 (288)
T ss_pred ccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCC
Confidence 44321 1123345899999999987654 678999999999999999999887533221111 1121111 2223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
...+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred cccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 334567999999999999999999887766544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=247.33 Aligned_cols=242 Identities=18% Similarity=0.233 Sum_probs=193.6
Q ss_pred hhhcccCCceEEEEeE-eCCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 191 HHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.++||+|.||+||+|+ ..+++.||+|.+...+. ......+|+.+++.++|.|||+++++...++..-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 3679999999999999 56789999998865433 234556999999999999999999999999999999999976
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|..+...... .++.+.+..++.|+++||.|+|+ ++++|||+||.|.||+.+|.+||+|||+++.+.-... ..
T Consensus 86 dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr--cy 158 (292)
T KOG0662|consen 86 DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CY 158 (292)
T ss_pred HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--ee
Confidence 89888876543 36788999999999999999999 8899999999999999999999999999998764321 12
Q ss_pred ecccccceeecCccccc-ccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcc--c----------------
Q 047375 347 TMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQ--V---------------- 406 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~--~---------------- 406 (496)
+.-+-|..|.+|.++.+ ..|+...|+||.||++.|+.. |.|.|.+......+.+|...- .
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 33457999999999988 778999999999999999864 667777666555555554210 0
Q ss_pred CCccc-----H----HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 407 ADESE-----M----EEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 407 ~~~~~-----~----~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.+..+ . .....-++++.+.+.-+|.+|.++++.+
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 00000 0 1113457899999999999999999874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=289.21 Aligned_cols=244 Identities=20% Similarity=0.195 Sum_probs=189.4
Q ss_pred hhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh---------------hhHHHHHHHHhcCCCCceeeEEEEEeeC
Q 047375 190 FHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR---------------ITEWEFLGIISQVKHKNVVKILGLCLET 253 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~hpnIv~l~~~~~~~ 253 (496)
+.+.||.|+||.||+|.. .++..||||++....... ....+|+.+++.++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 346799999999999995 468899999885432221 1244789999999999999999999999
Q ss_pred CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 254 KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 254 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
+..++||||++ |+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999997 58999886543 36788999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCC------------CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhh
Q 047375 334 LVPISSDD------------ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQ 400 (496)
Q Consensus 334 a~~~~~~~------------~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
+....... .........+++.|+|||.+.+ ..++.++|+||+|+++++++++.+||........+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 87654110 0111122347889999999876 3468899999999999999999998876544333322
Q ss_pred hhhccc---C-------------------Cc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 401 ILNFQV---A-------------------DE----SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 401 i~~~~~---~-------------------~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
+..... . .. .....+..+.+++.+||+.+|.+|||+.+++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 221000 0 00 0012246789999999999999999999985
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=284.03 Aligned_cols=250 Identities=21% Similarity=0.233 Sum_probs=191.8
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETK------ 254 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------ 254 (496)
...|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 345777789999999999999964 588999998864322 2223447899999999999999999987654
Q ss_pred ----eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEcc
Q 047375 255 ----VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSD 330 (496)
Q Consensus 255 ----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~D 330 (496)
..++||||+++ +|..++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 7777766542 236889999999999999999999 7899999999999999999999999
Q ss_pred CCCccccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc---cc
Q 047375 331 FESLVPISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF---QV 406 (496)
Q Consensus 331 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~---~~ 406 (496)
||++......... ......++..|+|||.+.+ ..++.++|+|++|+++++++++.++|........+..+... ..
T Consensus 160 fg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9998876543221 1122346888999998865 45688999999999999999999888654332222221110 00
Q ss_pred CC-------------------------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 407 AD-------------------------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 407 ~~-------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.. ......+..+.+++.+||+.||.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 001123567999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.34 Aligned_cols=246 Identities=21% Similarity=0.225 Sum_probs=191.4
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+.+.||+|++|.||+|... ++..|++|++..... ......+|+..+.+++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 345678999999999999964 578899998764322 1223346788899999 999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
+|+|.+++..... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 7799998876542 246889999999999999999999 7899999999999999999999999999876643221
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc------------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF------------------ 404 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------------ 404 (496)
.....|+..|+|||++.. ..++.++|+||+|+++++++++.++|........+..+...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123458899999998754 45788999999999999999998887554332222211110
Q ss_pred ---ccCC--cc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ---QVAD--ES-----EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ---~~~~--~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.... .. ....+..+.+++.+||+.||.+|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 00 0011367999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.98 Aligned_cols=247 Identities=20% Similarity=0.237 Sum_probs=192.7
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET--KVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~E 261 (496)
|.+.+.||.|+||.||+|... ++..+|+|.+.... .......+|+.+++.++||||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 345678999999999999964 57899999987552 2223345789999999999999999999987 88999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++ +|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8988886643 247889999999999999999999 789999999999999999999999999988765432
Q ss_pred CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc---------------
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--------------- 405 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--------------- 405 (496)
.. ......++..|+|||.+.+ ..++.++|+|++|+++++++++.+||...........+....
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 11 1223347889999998765 457889999999999999999998886544332222222100
Q ss_pred ------cCCcc-------cHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 ------VADES-------EME-EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ------~~~~~-------~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..... ... +++.+.+++.+||+.+|.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 001 2567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=277.01 Aligned_cols=237 Identities=17% Similarity=0.150 Sum_probs=184.9
Q ss_pred cchhhh--cccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHh-cCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFHHC--LGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIIS-QVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~~~--lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~-~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
+.+.+. ||+|+||.||++.. .++..+|+|.+....... . |+.... ..+||||+++++.+...+..|+||||+
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~---e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-I---EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-h---hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 344444 59999999999985 467889999875432111 1 111111 127999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-ceEEccCCCccccCCCCC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPISSDDE 342 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~~~~~ 342 (496)
++|+|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++......
T Consensus 92 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 92 KDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999999997654 47899999999999999999999 7899999999999999888 9999999998766432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch-hhhhhhc-ccCCcccHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS-FRQILNF-QVADESEMEEIEVVAE 420 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~-~~~i~~~-~~~~~~~~~~~~~l~~ 420 (496)
....|+..|+|||++.+..++.++|+||+|++++++++|..||........ ...+... ..........++.+.+
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 223589999999999988899999999999999999999988864432211 1111111 1112223356678999
Q ss_pred HHHHhcccCCCCCCC-HHHHH
Q 047375 421 LASKCLRIRGTERPT-MKEVS 440 (496)
Q Consensus 421 li~~cl~~dP~~RPs-~~eil 440 (496)
++.+||+.+|.+||+ +++++
T Consensus 240 li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred HHHHHhccChhhCCchHHHHh
Confidence 999999999999996 58875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.22 Aligned_cols=260 Identities=21% Similarity=0.199 Sum_probs=221.4
Q ss_pred hhhcccCCceEEEEeEeCCCc-EEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 191 HHCLGMGGFGSVYKGVLPDNT-QVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
...||-||||.|-++...+.. .+|+|.++...- .....+.|-++|..++.|.||++|..|.+....|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 356999999999999864332 488887764432 222334778899999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|.|...|++++. ++..++..++..+++|+.|||+ ++||.|||||+|.|++.+|-+||.|||+|+.+.....
T Consensus 505 GElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--- 575 (732)
T KOG0614|consen 505 GELWTILRDRGS---FDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--- 575 (732)
T ss_pred chhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCc---
Confidence 999999998765 6777888999999999999999 8899999999999999999999999999999976533
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
+.++||||.|.|||++.+...+...|+|++|+++||+++|.|||.+......+..|+.+.-....+........+||.++
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence 57889999999999999999999999999999999999999999999999999999887666666677778899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcccccc
Q 047375 426 LRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEESEH 464 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~~~ 464 (496)
+..+|.+|... .-..+..+..|.|+..-+|+--.
T Consensus 656 Cr~~P~ERLG~-----~~~gI~DIkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 656 CRDNPTERLGY-----QKGGINDIKKHRWFEGFDWEGLR 689 (732)
T ss_pred HhcCcHhhhcc-----ccCChHHHHhhhhhhcCChhhhh
Confidence 99999999642 12334455778899888886443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=279.12 Aligned_cols=247 Identities=17% Similarity=0.186 Sum_probs=192.9
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch------hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD------EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
|.+.+.||+|+||.||++... .+..+++|.+.... ........|+.+++.++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 667788999999999999863 34445555543211 12223446788999999999999999999999999999
Q ss_pred eeccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 261 EFVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 261 E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||+++++|.+++... .....+++..++.++.|++.||.|||+ ++++|+||||+||+++. +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988652 222347889999999999999999999 78999999999999985 5799999999877643
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
... ......|++.|+|||.+.+..++.+.|+|++|+++++++++..+|...........+.... ....+...+..+.
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETYSRQLN 234 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC-CCCCcchhcHHHH
Confidence 322 1233458899999999988888899999999999999999998886543333333333221 2223345567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~ 441 (496)
++|.+||..||++||++.++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 235 SIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHhcCChhhCcCHHHHhh
Confidence 9999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.18 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=197.6
Q ss_pred HHHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC----eeeEE
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETK----VTLLV 259 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~lv 259 (496)
+..+..+.+.||+|.||.||+|.| .|+.||||+|...++.......|+---..++|+||+.+++.-...+ ++|||
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 344556678999999999999999 7999999999766554433334444445679999999998876443 67999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHh-----cCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS-----LASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-----~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
.+|-+.|||++||.+.. ++....++++..+|.||+|||. .+.+.|.|||||+.|||+..++.+.|+|+|+|
T Consensus 288 TdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999998743 6778899999999999999995 34467999999999999999999999999999
Q ss_pred cccCCCCC--ccceecccccceeecCcccccccc------cCCCCCchhhhhccccccc----------ccchhhhccc-
Q 047375 335 VPISSDDE--TAMSTMIRGTVGYLDPEYAHTELL------TGMNPNSYVALASNEKISM----------VPYFLDSIEN- 395 (496)
Q Consensus 335 ~~~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~------t~~~d~~s~g~~~~~~~~~----------~~~~~~~~~~- 395 (496)
........ ....+..+||..|||||++....- -...||||+|+++||+... .+||.+..+.
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 87665422 122345679999999999876221 1468999999999998642 3555544322
Q ss_pred chhhhhh----hcccCCc----c-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 396 NSFRQIL----NFQVADE----S-EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 396 ~~~~~i~----~~~~~~~----~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
..+..+. ..++.+. + ..+....+.+|++.||..||.-|-|+--|-+.|.++.+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2233222 1222222 1 12456789999999999999999999988888887764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=277.43 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=200.6
Q ss_pred HHhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhh--------hhhHHHHHHHHhcCCCCceeeEEEEEe-eCC
Q 047375 185 KATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEI--------RITEWEFLGIISQVKHKNVVKILGLCL-ETK 254 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~ 254 (496)
..+|-+.++||+|||+.||++. +...+-||||+-...... .....+|.+|.+.|.||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3345566889999999999999 446778899975433222 223347889999999999999999997 567
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC---CCCceEEccC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD---DNYTAKVSDF 331 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~---~~~~~kL~DF 331 (496)
.+|-|+|||+|.+|.-+|..+. .+++.+++.|+.||+.||.||.+.. .+|||=||||.|||+- ..|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 7899999999999999998765 3789999999999999999999977 7899999999999994 4578999999
Q ss_pred CCccccCCCCCc-----cceecccccceeecCccccc----ccccCCCCCchhhhhcccccccccchhhhcccchh---h
Q 047375 332 ESLVPISSDDET-----AMSTMIRGTVGYLDPEYAHT----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSF---R 399 (496)
Q Consensus 332 Gla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~---~ 399 (496)
|+++.+..+... ..++...||..|++||.+.- ..++.+.|+||.|+++|..+.|..||........+ .
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999988765332 23455779999999998754 45678999999999999999999999765443222 1
Q ss_pred hhhh-cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 400 QILN-FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 400 ~i~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
-|++ ..+..+..+..+.+..++|++||++.-++|....++.
T Consensus 698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 2222 2334445556678899999999999999998877764
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.86 Aligned_cols=245 Identities=21% Similarity=0.194 Sum_probs=193.9
Q ss_pred chhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 189 NFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.+.+.||.|++|.||+|.. .++..+++|.+...... .....+|+.+++.++||||+++++++..++..++||||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 4456899999999999986 46889999988644322 2344578899999999999999999999999999999997
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||.+........
T Consensus 82 ~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-- 153 (283)
T cd05118 82 T-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-- 153 (283)
T ss_pred C-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--
Confidence 5 8888887643 247889999999999999999999 7899999999999999999999999999877754421
Q ss_pred ceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-------------------
Q 047375 345 MSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF------------------- 404 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------------- 404 (496)
......++..|+|||.+.+. .++.+.|+|++|++++++++|.++|........+..+...
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 12234588899999998876 7889999999999999999998887554332222111110
Q ss_pred --ccC-------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 --QVA-------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 --~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... .......+..+.++|.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 0011234578999999999999999999999964
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=277.58 Aligned_cols=240 Identities=21% Similarity=0.189 Sum_probs=202.5
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhh----HHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRIT----EWEFLGIISQV-KHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~----~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 259 (496)
..++|...||+|+||+|.+|.. .+.+.+|||+++........ ...|-++|... +-|.+++++.+|..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4478899999999999999985 35678999988654322211 12445555544 468899999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+.||+|.-.++.-+. +.+..+..++.+||-||-|||+ ++||.||||.+|||+|.+|++||+|||+++..-.
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999988887654 4556788899999999999999 8899999999999999999999999999987654
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
... .+.+++|||.|+|||++.-++|..+.|||++|+++|||+.|.+||.+..+++.++.|.+..... +...+.+..
T Consensus 503 ~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsy--PKslSkEAv 578 (683)
T KOG0696|consen 503 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSY--PKSLSKEAV 578 (683)
T ss_pred CCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcC--cccccHHHH
Confidence 332 3567899999999999999999999999999999999999999999999999999998765543 345667889
Q ss_pred HHHHHhcccCCCCCCC
Q 047375 420 ELASKCLRIRGTERPT 435 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs 435 (496)
+++...|...|.+|..
T Consensus 579 ~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHhhcCCccccC
Confidence 9999999999999953
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=288.32 Aligned_cols=243 Identities=19% Similarity=0.208 Sum_probs=189.0
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------e
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETK------V 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~ 255 (496)
.+|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+.+++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 3466778999999999999984 4788999998854221 2233458899999999999999999987543 3
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.++||||+ +++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 58999999 67998887642 36889999999999999999999 789999999999999999999999999987
Q ss_pred ccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA------- 407 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~------- 407 (496)
..... .....+++.|+|||.+.+ ..++.++|+||+|++++++++|.+||........+..+......
T Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 65432 123457899999998876 45788999999999999999999988654332222222110000
Q ss_pred ---------------Cc-------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 408 ---------------DE-------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 408 ---------------~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.. .....++.+.+++.+|++.||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00123456899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=272.83 Aligned_cols=235 Identities=24% Similarity=0.203 Sum_probs=192.8
Q ss_pred cccCCceEEEEeEeC-CCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 194 LGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
||.|+||.||++... ++..+|+|.+...... ......|+.+++.++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 5889999988654322 22344788999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 99997654 36889999999999999999999 789999999999999999999999999987764432 11234
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhccc
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRI 428 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~ 428 (496)
..|+..|+|||...+...+.+.|+|++|+++++++++..||...........+.... ...+...+..+.+++.+||..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~ 230 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQK 230 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcC
Confidence 558999999999988888899999999999999999998886554433344443322 222233357799999999999
Q ss_pred CCCCCCCHHH
Q 047375 429 RGTERPTMKE 438 (496)
Q Consensus 429 dP~~RPs~~e 438 (496)
||++|||+.+
T Consensus 231 ~p~~R~~~~~ 240 (250)
T cd05123 231 DPTKRLGSGG 240 (250)
T ss_pred CHhhCCCccc
Confidence 9999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=284.41 Aligned_cols=246 Identities=20% Similarity=0.220 Sum_probs=185.8
Q ss_pred cchhhhcccCCceEEEEeEeC-C--CcEEEEEEeecchh---hhhhHHHHHHHHhcC-CCCceeeEEEEEeeC----Cee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-D--NTQVAVKKYMCADE---IRITEWEFLGIISQV-KHKNVVKILGLCLET----KVT 256 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~----~~~ 256 (496)
|.+.+.||+|+||.||++... . +..||+|++..... ......+|+.++.++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 556788999999999999963 3 67899998764221 123345788899888 599999999976532 457
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|++|||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 89999986 58998886543 36889999999999999999999 7899999999999999999999999999986
Q ss_pred cCCCCCc--cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc---------
Q 047375 337 ISSDDET--AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--------- 404 (496)
Q Consensus 337 ~~~~~~~--~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------- 404 (496)
....... .......||+.|+|||++.+ ..++.++|+||+|+++++++++.+||........+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6532211 11233468999999998765 56788999999999999999999888654322211111110
Q ss_pred ----------------ccCCc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 405 ----------------QVADE----SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 405 ----------------~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
..... .....+..+.+++.+||+.||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000 0011246799999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=286.87 Aligned_cols=247 Identities=19% Similarity=0.195 Sum_probs=186.6
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeC----------
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLET---------- 253 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~---------- 253 (496)
.+|.+.+.||.|+||.||+|.. .++..||+|++....... ....+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 3467778999999999999985 468899999886544322 3344789999999999999999876543
Q ss_pred ----CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC-CCCceEE
Q 047375 254 ----KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAKV 328 (496)
Q Consensus 254 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~-~~~~~kL 328 (496)
...|+||||++ ++|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+||+++ .++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 5898887543 26788999999999999999999 7899999999999997 4567899
Q ss_pred ccCCCccccCCCCC-ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc-
Q 047375 329 SDFESLVPISSDDE-TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ- 405 (496)
Q Consensus 329 ~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~- 405 (496)
+|||++........ ........|+..|+|||.+.. ..++.++|+||+|+++++++++..||...........+....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999876543211 111122357889999997654 567789999999999999999999986543322222221100
Q ss_pred ----------------------cCCcc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 406 ----------------------VADES-----EMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 406 ----------------------~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
..... ....+..+.+|+.+||+.||.+|||+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 00000 012346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=266.12 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=193.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeec---chhhhhhHHHHHHHHhcCCCCceeeEEEEEeeC--------Ce
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMC---ADEIRITEWEFLGIISQVKHKNVVKILGLCLET--------KV 255 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--------~~ 255 (496)
|.-..+||+|.||.||+|+. .+|+.||+|++.- .........+|+++|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 33346799999999999995 4677889987643 223445667999999999999999999888532 34
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
+|+||.+|+. +|.-+|..... .++..++.+++.++..||.|+|. ..|+|||+||.|+||+.+|.+||+|||+++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 7999999987 89988876532 36778999999999999999999 679999999999999999999999999998
Q ss_pred ccCCCCCcc--ceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh--cccCCc-
Q 047375 336 PISSDDETA--MSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN--FQVADE- 409 (496)
Q Consensus 336 ~~~~~~~~~--~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~- 409 (496)
.+....... .-+..+-|..|.+||.+.+ ..|+.+.|+|..||++.+|+++.|.+.+..+...+..|.. +....+
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 765432221 1234456999999999988 5678899999999999999999999887766554433321 111000
Q ss_pred -----------------ccH-------HH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 410 -----------------SEM-------EE------IEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 410 -----------------~~~-------~~------~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
.+. +. .+...+|+.+++..||.+||+++++++.
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 000 00 1468899999999999999999998753
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=284.87 Aligned_cols=241 Identities=20% Similarity=0.211 Sum_probs=185.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------ee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETK------VT 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~ 256 (496)
.|.....||+|+||.||+|.. .++..||+|++.... .......+|+.+++.++||||+++++++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 355668999999999999995 468999999886432 12233457899999999999999999987543 46
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+||||+.. +|..++.. .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 96 YLVMPYMQT-DLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEeccccc-CHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 899999964 77766521 26788899999999999999999 7899999999999999999999999999876
Q ss_pred cCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc----------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ---------- 405 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~---------- 405 (496)
.... .....||+.|+|||++.+ ..++.++|+||+|++++++++|..||........+..+....
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 5322 123457899999999876 467889999999999999999999887543322222221100
Q ss_pred ---------------cCCcc----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 ---------------VADES----EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ---------------~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..... ....++.+.+|+.+||+.||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 0112356889999999999999999999964
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=283.92 Aligned_cols=243 Identities=19% Similarity=0.206 Sum_probs=187.1
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeC------Ce
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLET------KV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~ 255 (496)
..|.+.+.||+|+||.||+|.. .++..||+|++..... ......+|+.++.+++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 3466678899999999999984 5788999998864321 123344789999999999999999988643 34
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.|++++++ +++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 68888887 77998887643 26888999999999999999999 789999999999999999999999999987
Q ss_pred ccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc--------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-------- 406 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-------- 406 (496)
..... .....||..|+|||.+.+ ..++.+.|+||+|++++++++|.+||...........+.....
T Consensus 169 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 169 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred ccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 65322 123458899999998866 5678899999999999999999988864433222222211000
Q ss_pred -----------------CCcc----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 407 -----------------ADES----EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 407 -----------------~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.... ....++.+.++|.+||+.||.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000 0012456899999999999999999998853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=281.66 Aligned_cols=243 Identities=19% Similarity=0.215 Sum_probs=187.2
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEee-CCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLE-TKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~ 260 (496)
..|.+.+.||.|+||.||+|.. .++..||+|++.... .......+|+.++..++||||++++++|.. ....|+||
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 3467778999999999999984 478899999875321 122344578999999999999999999875 56789999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+ +++|..++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 90 e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 90 ELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred ehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 999 56898888643 25677788899999999999999 78999999999999999999999999998754322
Q ss_pred CCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh----------------
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN---------------- 403 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~---------------- 403 (496)
.....+++.|+|||++.+ ..++.++|+|++|++++++++|.++|........+..+.+
T Consensus 162 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 162 -----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred -----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 123457889999998766 5688899999999999999999988854332111110000
Q ss_pred --------cccCCccc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 404 --------FQVADESE-----MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 404 --------~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.......+ ...++.+.++|.+||+.+|.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000001 123467999999999999999999998853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=279.93 Aligned_cols=249 Identities=24% Similarity=0.257 Sum_probs=188.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCC--------
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETK-------- 254 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-------- 254 (496)
.|.+.+.||+|+||.||+|.. .++..||+|++...... .....+|+.+++.++||||+++++++....
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 467778999999999999995 46889999988543221 223457899999999999999999876433
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
..++||||+.+ +|...+.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred eEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999975 7777765432 237889999999999999999999 78999999999999999999999999998
Q ss_pred cccCCCCCc---------cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc
Q 047375 335 VPISSDDET---------AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF 404 (496)
Q Consensus 335 ~~~~~~~~~---------~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 404 (496)
......... ...+...|++.|+|||.+.+ ..++.++|+||+|++++++++|.++|.+.........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 765432211 11123457889999998765 45788999999999999999999988654433222222110
Q ss_pred c---------------------cCCcc-------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 Q---------------------VADES-------EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ~---------------------~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
. ..... .....+.+.+++.+||+.||.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00000 0112256889999999999999999999863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=275.60 Aligned_cols=245 Identities=23% Similarity=0.240 Sum_probs=192.9
Q ss_pred chhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 189 NFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.+.+.||+|++|.||+|... ++..||+|.+.... ........|+.+++.++||||+++++++...+..++||||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34567999999999999964 58999999887542 222334578899999999999999999999999999999998
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||+|+||+++.++.+||+|||++........
T Consensus 82 -~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 82 -MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred -cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 59999998753 237889999999999999999999 7899999999999999999999999999887654321
Q ss_pred ceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-------------------
Q 047375 345 MSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF------------------- 404 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------------- 404 (496)
......++..|+|||.+.+. .++.+.|+|++|+++++++++.++|........+..+...
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 12233467889999998776 7888999999999999999998888654332222211110
Q ss_pred -ccC---C----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 -QVA---D----ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 -~~~---~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... . ......+..+.+++.+||..||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 0 000112467999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=266.78 Aligned_cols=255 Identities=17% Similarity=0.164 Sum_probs=206.4
Q ss_pred cccCHHHHHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCC--Cc----eeeEEE
Q 047375 176 KIFSKSELLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKH--KN----VVKILG 248 (496)
Q Consensus 176 ~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--pn----Iv~l~~ 248 (496)
..+...+.+..+|.+...+|+|.||.|-.+.. ..+..||||+++.....+....-|+++|.++.+ |+ +|.+.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 45667777788899999999999999999985 357899999998888888777788999999842 33 888999
Q ss_pred EEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC------
Q 047375 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD------ 322 (496)
Q Consensus 249 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~------ 322 (496)
+|...++.|||+|.+ |.|+.++|..++. .+++...++.|+.|+++++.|||+ .+++|-||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEE
Confidence 999999999999998 5699999988664 347889999999999999999999 77999999999999931
Q ss_pred --------------CCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccc
Q 047375 323 --------------NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPY 388 (496)
Q Consensus 323 --------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~ 388 (496)
+..+||+|||.|+..... .+.++.|..|.|||++.+-.++..+|+||.||+++|+++|...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 235899999999876543 2556789999999999999999999999999999999999988
Q ss_pred hhhhcccc---hhhhhhhccc----------------CC-----------------cc--------cHHHHHHHHHHHHH
Q 047375 389 FLDSIENN---SFRQILNFQV----------------AD-----------------ES--------EMEEIEVVAELASK 424 (496)
Q Consensus 389 ~~~~~~~~---~~~~i~~~~~----------------~~-----------------~~--------~~~~~~~l~~li~~ 424 (496)
|+...+.+ .++.|+.+.. .. .. ......+|.+|+.+
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 87655333 1222221100 00 00 00122469999999
Q ss_pred hcccCCCCCCCHHHHH
Q 047375 425 CLRIRGTERPTMKEVS 440 (496)
Q Consensus 425 cl~~dP~~RPs~~eil 440 (496)
||.+||.+|+|+.|++
T Consensus 389 mL~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 389 MLEFDPARRITLREAL 404 (415)
T ss_pred HHccCccccccHHHHh
Confidence 9999999999999995
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=267.54 Aligned_cols=222 Identities=18% Similarity=0.042 Sum_probs=176.5
Q ss_pred CCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchhhhhhhc
Q 047375 197 GGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDK 275 (496)
Q Consensus 197 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~ 275 (496)
|.+|.||++.. .+++.||+|++...... .++...+....||||+++++++...+..|+||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY----SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh----hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 89999999995 47889999998654322 23344445567999999999999999999999999999999998765
Q ss_pred CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceeccccccee
Q 047375 276 SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGY 355 (496)
Q Consensus 276 ~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y 355 (496)
. .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||.+...... .....++..|
T Consensus 80 ~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y 148 (237)
T cd05576 80 L---NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY 148 (237)
T ss_pred c---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence 3 27889999999999999999999 78999999999999999999999999987665432 1223467889
Q ss_pred ecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCC
Q 047375 356 LDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPT 435 (496)
Q Consensus 356 ~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 435 (496)
+|||++.+..++.+.|+||+|++++++++|.+++....... . .......+...++.+.+++.+||+.||.+||+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--N----THTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--c----cccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 99999988888999999999999999999987764322110 0 00111122234567999999999999999999
Q ss_pred HHHH
Q 047375 436 MKEV 439 (496)
Q Consensus 436 ~~ei 439 (496)
+.+.
T Consensus 223 ~~~~ 226 (237)
T cd05576 223 AGVA 226 (237)
T ss_pred CCcc
Confidence 7443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.62 Aligned_cols=143 Identities=24% Similarity=0.281 Sum_probs=124.8
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||||++..... .......|+.++..++||||+++++++...+..|||||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 3667789999999999999964 688999999864322 12334478889999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
|+++++|.+++.... .+++..++.|+.||+.||.|||. ++||||||||+||||+.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999997643 26778899999999999999999 789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=261.19 Aligned_cols=257 Identities=19% Similarity=0.196 Sum_probs=193.3
Q ss_pred cccccCHHHHHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHH-HHhcCCCCceeeEEEE
Q 047375 174 RMKIFSKSELLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLG-IISQVKHKNVVKILGL 249 (496)
Q Consensus 174 ~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~-~l~~l~hpnIv~l~~~ 249 (496)
....|+...+.. ...||.|+||+|++-.+ +.|+..|||++..... ...+...|.+ +++.-+.||||++||.
T Consensus 57 ~~~~F~~~~Lqd-----lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 57 HLHTFTSDNLQD-----LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccccchHHH-----HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 344555555443 24699999999999985 5799999999976543 2233335554 4555579999999999
Q ss_pred EeeCCeeeEEEeeccCCchhhhhhhc--CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceE
Q 047375 250 CLETKVTLLVYEFVSNGALSHYIHDK--SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAK 327 (496)
Q Consensus 250 ~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~k 327 (496)
+..++..||.||+|.- +|..+...- -....+++...-.|....+.||.||... ..|||||+||+|||++..|.+|
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEe
Confidence 9999999999999964 776555421 1122367788888999999999999974 5799999999999999999999
Q ss_pred EccCCCccccCCCCCccceecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcc-cchhhhhhhc
Q 047375 328 VSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIE-NNSFRQILNF 404 (496)
Q Consensus 328 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-~~~~~~i~~~ 404 (496)
|||||++..+... ...+.-+|...|||||.+.. ..|+-++|+||+|++++|+.+|..|+..... -+.+..+..+
T Consensus 209 LCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 209 LCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred eecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 9999998776432 12244569999999999876 4578899999999999999999888765433 1233333333
Q ss_pred ccCC----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 QVAD----ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+. ......+..+..+|.-||..|.++||...++.+
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2221 112346678999999999999999999998854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=287.06 Aligned_cols=235 Identities=22% Similarity=0.221 Sum_probs=193.0
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhc-CCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQ-VKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+...+|.|+|+.|-.+.. .++...+||++.... ....+|+.++.. -+||||+++.+.+.++.+.|+|||++.
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 466777899999999999984 578899999986551 122244544443 379999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee-CCCCceEEccCCCccccCCCCCc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL-DDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll-~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
||-|.+.+..... .. ..+..|+.+|+.|+.|||+ +|||||||||+|||+ +..++++|+|||.++.....
T Consensus 400 g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 9988887766543 22 6677899999999999999 889999999999999 68999999999999877654
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-chhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
..+.+-|..|.|||++....||..+||||+|+++|+|++|..||...... .....+. .++.....+..+++|+
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~----~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ----MPKFSECVSDEAKDLL 543 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc----CCccccccCHHHHHHH
Confidence 23345789999999999999999999999999999999999999877665 2333332 2333366778899999
Q ss_pred HHhcccCCCCCCCHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil 440 (496)
.+||+.||.+||++.++.
T Consensus 544 ~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIG 561 (612)
T ss_pred HHhccCChhhCcChhhhc
Confidence 999999999999999983
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=283.10 Aligned_cols=241 Identities=19% Similarity=0.204 Sum_probs=189.1
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCe------e
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKV------T 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~------~ 256 (496)
.|.+...||+|+||.||+|... ++..||+|++.... .......+|+.+++.++||||+++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 4667789999999999999964 67899999876431 122334478999999999999999998876544 8
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
++|+||+ +++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 96 ~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 96 YLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9999999 56999988652 36889999999999999999999 7899999999999999999999999999876
Q ss_pred cCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD------- 408 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~------- 408 (496)
.... .....+|..|+|||.+.+ ..++.+.|+||+|++++++++|.+||........+..+.+.....
T Consensus 168 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 168 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 6432 233458899999998865 357789999999999999999998886544333332222110000
Q ss_pred ------------------c----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 409 ------------------E----SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 409 ------------------~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
. .....++.+.+++.+||+.||.+|||+.+|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 0 0011256799999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.31 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=203.5
Q ss_pred chhhhcccCCceEEEEeEeC----C----CcEEEEEEeecchhh--hhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeee
Q 047375 189 NFHHCLGMGGFGSVYKGVLP----D----NTQVAVKKYMCADEI--RITEWEFLGIISQVK-HKNVVKILGLCLETKVTL 257 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~ 257 (496)
.+.+.||+|.||.|++|... . ...||||.++..... ......|+.+|..+. ||||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 44568999999999999832 1 457999998754433 334458889998884 999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcC------cc-------cccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC
Q 047375 258 LVYEFVSNGALSHYIHDKS------SQ-------VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY 324 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~------~~-------~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~ 324 (496)
+|+|||..|+|.++++... .. ..++....+.++.|||.|+.||++ .++|||||-..|||+..+.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCC
Confidence 9999999999999998765 00 126778899999999999999999 7799999999999999999
Q ss_pred ceEEccCCCccccCCCCCccceecccc--cceeecCcccccccccCCCCCchhhhhcccccccc-cchhhhcccchhhhh
Q 047375 325 TAKVSDFESLVPISSDDETAMSTMIRG--TVGYLDPEYAHTELLTGMNPNSYVALASNEKISMV-PYFLDSIENNSFRQI 401 (496)
Q Consensus 325 ~~kL~DFGla~~~~~~~~~~~~~~~~g--t~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~-~~~~~~~~~~~~~~i 401 (496)
.+||+|||+|+.......... ..-.| ...|||||.+....|+.++|+||+|+++||+++.. .|+.+......+-..
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 999999999997655433221 11123 34599999999999999999999999999998764 444332212333335
Q ss_pred hhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 402 LNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 402 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
+........+..+.+++.+++..||+.+|.+||++.++.+.|+.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 555556666677788999999999999999999999999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=282.78 Aligned_cols=237 Identities=19% Similarity=0.213 Sum_probs=191.2
Q ss_pred hhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhhhH----HHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 191 HHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITE----WEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~----~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.+.||-|+||.|.+++ .++...||+|.+...+...... ..|..||..-..+.||+||-.|.+++.+|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 4679999999999998 4567789999887655433222 2677899999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC----
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD---- 341 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~---- 341 (496)
|++..+|-+.+ .+++..++.++.++..|+.+.|. -|+|||||||+|||||.+|++||+|||+|+-+....
T Consensus 714 GDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 714 GDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99999997754 37888899999999999999999 569999999999999999999999999987543100
Q ss_pred -----Cc-------------------------------cceecccccceeecCcccccccccCCCCCchhhhhccccccc
Q 047375 342 -----ET-------------------------------AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM 385 (496)
Q Consensus 342 -----~~-------------------------------~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~ 385 (496)
.. ......+||+.|+|||++....|+..+|||+.|+++|+|+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 00 001125699999999999999999999999999999999999
Q ss_pred ccchhhhcccchhhhhhhccc--CCcccHHHHHHHHHHHHHhcccCCCCCC
Q 047375 386 VPYFLDSIENNSFRQILNFQV--ADESEMEEIEVVAELASKCLRIRGTERP 434 (496)
Q Consensus 386 ~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RP 434 (496)
.+||......+.-.++.++.- ..+...+.+.++.++|.+++. +++.|.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999998877766666655432 233344556777788877554 566774
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=288.18 Aligned_cols=260 Identities=21% Similarity=0.330 Sum_probs=213.6
Q ss_pred hhhcccCCceEEEEeEe-CCC----cEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 191 HHCLGMGGFGSVYKGVL-PDN----TQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.++||+|+||+||+|.| +.| -+||+|++...... .....+|.-+|.+++|||+++++|+|.... +-||++|+
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 35799999999999985 333 46899988654433 344558889999999999999999998766 78999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
|+|+|.++++.+... +..+..+.|..|||+||.|||. +++|||||-..|||+.....+||.|||+++.+..+...
T Consensus 780 P~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 999999999986543 5668889999999999999998 88999999999999999999999999999998776544
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.......-.+.|||=|.+....||.++|+|++|+++||+++. ..|+.+ .....+..++......+.+..++-.+..++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 333333456789999999999999999999999999998765 444433 344455556655555677777888899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhcc
Q 047375 423 SKCLRIRGTERPTMKEVSEELDRLRRLQENYWARK 457 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~ 457 (496)
.+||..|+..||+++++...+.++.+-.+++..-.
T Consensus 934 vkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~ 968 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ 968 (1177)
T ss_pred HHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence 99999999999999999999999887666554433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=283.62 Aligned_cols=239 Identities=23% Similarity=0.257 Sum_probs=183.4
Q ss_pred hhcccCCceE-EEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccCCchh
Q 047375 192 HCLGMGGFGS-VYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSNGALS 269 (496)
Q Consensus 192 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 269 (496)
+.+|.|+.|+ ||+|.+ .|+.||||++... ......+|+..|..- .|||||++|+.-.+..+.||..|.|.. +|.
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHH
Confidence 6789998876 799999 7899999987432 222334788888766 599999999999999999999999976 999
Q ss_pred hhhhhcCccccc-CHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-----CCceEEccCCCccccCCCCCc
Q 047375 270 HYIHDKSSQVLK-NWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-----NYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 270 ~~l~~~~~~~~l-~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-----~~~~kL~DFGla~~~~~~~~~ 343 (496)
+++......... .-...+.+..|++.||++||+ -+||||||||.||||+. ...++|+|||+++.+..+...
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999874111111 113346788999999999999 46999999999999965 257999999999998765432
Q ss_pred c-ceecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccC---CcccHHHHHHH
Q 047375 344 A-MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVA---DESEMEEIEVV 418 (496)
Q Consensus 344 ~-~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~l 418 (496)
- ......||.+|+|||++....-+...|++|+||++|..+++ ..||......+ ..|+..... .....++ +.
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~--eA 743 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDC--EA 743 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchH--HH
Confidence 2 23456799999999999998888899999999999998776 67776554332 122222111 1111112 78
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+||.+|++++|..||++.+|+.
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhC
Confidence 99999999999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=286.22 Aligned_cols=246 Identities=18% Similarity=0.148 Sum_probs=161.7
Q ss_pred hcchhhhcccCCceEEEEeEeC-C----CcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEE------EeeCCe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-D----NTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGL------CLETKV 255 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~------~~~~~~ 255 (496)
.|.+.+.||+|+||.||+|.+. + +..||+|++.......... ...+....+.+++.++.. +.....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~---~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWM---NERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHH---HHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 4667789999999999999964 4 6899999875432211111 111222223333322221 235567
Q ss_pred eeEEEeeccCCchhhhhhhcCccc-----------------ccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCce
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQV-----------------LKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANI 318 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~-----------------~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NI 318 (496)
.++||||+++++|.+++....... ......+..++.||+.||.|||+ ++|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHE
Confidence 899999999999999987543110 01223456799999999999999 7899999999999
Q ss_pred eeCC-CCceEEccCCCccccCCCCCccceecccccceeecCcccccc----------------------cccCCCCCchh
Q 047375 319 LLDD-NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE----------------------LLTGMNPNSYV 375 (496)
Q Consensus 319 ll~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~----------------------~~t~~~d~~s~ 375 (496)
|++. ++.+||+|||+|+.+.... ........||+.|||||.+... .++.+.|+||+
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9985 5799999999998764332 2223456799999999966432 23345699999
Q ss_pred hhhcccccccccchhhhcccchhhhhhhc-c---------cCCcccHH----------HHHHHHHHHHHhcccCCCCCCC
Q 047375 376 ALASNEKISMVPYFLDSIENNSFRQILNF-Q---------VADESEME----------EIEVVAELASKCLRIRGTERPT 435 (496)
Q Consensus 376 g~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~---------~~~~~~~~----------~~~~l~~li~~cl~~dP~~RPs 435 (496)
||++|+|+++..++.. ....+...+.. . .......+ ......+|+.+||+.||.+|||
T Consensus 366 GviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 366 GLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 9999999875433221 11111111100 0 00000000 1123568999999999999999
Q ss_pred HHHHHH
Q 047375 436 MKEVSE 441 (496)
Q Consensus 436 ~~eil~ 441 (496)
+.++++
T Consensus 444 a~e~L~ 449 (566)
T PLN03225 444 AKAALA 449 (566)
T ss_pred HHHHhC
Confidence 999953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=253.03 Aligned_cols=235 Identities=23% Similarity=0.234 Sum_probs=190.7
Q ss_pred CceEEEEeEeC-CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchhhhhhh
Q 047375 198 GFGSVYKGVLP-DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHD 274 (496)
Q Consensus 198 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 274 (496)
+||.||+|... ++..+++|.+...... .....+|+..+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 5889999998654433 24455889999999999999999999999999999999999999999876
Q ss_pred cCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccce
Q 047375 275 KSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVG 354 (496)
Q Consensus 275 ~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 354 (496)
... +++..++.++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 543 6788999999999999999999 789999999999999999999999999988765432 2234458899
Q ss_pred eecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhh-hcccCCcccHH-HHHHHHHHHHHhcccCCCC
Q 047375 355 YLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL-NFQVADESEME-EIEVVAELASKCLRIRGTE 432 (496)
Q Consensus 355 Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~ 432 (496)
|+|||.+.+..++.+.|+|++|+++++++++..|+............. ........... .+..+.+++.+||..+|++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 231 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEK 231 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchh
Confidence 999999988888999999999999999999988876532222222222 22221111111 5567999999999999999
Q ss_pred CCCHHHHHH
Q 047375 433 RPTMKEVSE 441 (496)
Q Consensus 433 RPs~~eil~ 441 (496)
||++.++++
T Consensus 232 Rp~~~~~~~ 240 (244)
T smart00220 232 RLTAEEALQ 240 (244)
T ss_pred ccCHHHHhh
Confidence 999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=263.37 Aligned_cols=258 Identities=19% Similarity=0.171 Sum_probs=212.3
Q ss_pred cccCHHHHHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC------CCceeeEEE
Q 047375 176 KIFSKSELLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK------HKNVVKILG 248 (496)
Q Consensus 176 ~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~------hpnIv~l~~ 248 (496)
-.....+++...|.+....|+|-||+|.+|.. ..|..||||++.........-..|+++|++|+ --|+++|+.
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 34567889999999999999999999999995 45789999999888777777789999999996 358999999
Q ss_pred EEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-CceE
Q 047375 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-YTAK 327 (496)
Q Consensus 249 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-~~~k 327 (496)
.|...+++|||+|-+.- +|.++|...+....+....+..++.|+..||..|.. -+|+|.||||.|||+++. ..+|
T Consensus 502 ~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceee
Confidence 99999999999999854 999999998877778889999999999999999999 469999999999999864 5789
Q ss_pred EccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh--cc
Q 047375 328 VSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN--FQ 405 (496)
Q Consensus 328 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~ 405 (496)
|||||.|........ +.+.-+..|.|||++.|..|+...|+||.||++||+++|...|.+......+...++ +.
T Consensus 578 LCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 578 LCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 999999988765433 233357789999999999999999999999999999999888876554332221111 00
Q ss_pred c--------------------------------------------------------CCcccHHHHHHHHHHHHHhcccC
Q 047375 406 V--------------------------------------------------------ADESEMEEIEVVAELASKCLRIR 429 (496)
Q Consensus 406 ~--------------------------------------------------------~~~~~~~~~~~l~~li~~cl~~d 429 (496)
+ .+.........+.+|+.+|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 0 00111233468999999999999
Q ss_pred CCCCCCHHHHHH
Q 047375 430 GTERPTMKEVSE 441 (496)
Q Consensus 430 P~~RPs~~eil~ 441 (496)
|++|.|..++|.
T Consensus 734 P~KRit~nqAL~ 745 (752)
T KOG0670|consen 734 PEKRITVNQALK 745 (752)
T ss_pred hhhcCCHHHHhc
Confidence 999999998864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=271.37 Aligned_cols=250 Identities=17% Similarity=0.148 Sum_probs=173.2
Q ss_pred hcchhhhcccCCceEEEEeEe-----------------CCCcEEEEEEeecchhhh---------------hhHHHHHHH
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-----------------PDNTQVAVKKYMCADEIR---------------ITEWEFLGI 234 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~---------------~~~~~e~~~ 234 (496)
.|.+.++||+|+||.||+|.. ..++.||||++....... .....|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 366678999999999999963 234679999986432211 111234556
Q ss_pred HhcCCCCce-----eeEEEEEee--------CCeeeEEEeeccCCchhhhhhhcCc---------------------ccc
Q 047375 235 ISQVKHKNV-----VKILGLCLE--------TKVTLLVYEFVSNGALSHYIHDKSS---------------------QVL 280 (496)
Q Consensus 235 l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~~ 280 (496)
+.+++|.|+ ++++++|.. .+..++||||+++|+|.+++..... ...
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 666766554 677787753 3567999999999999999874311 112
Q ss_pred cCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcc
Q 047375 281 KNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEY 360 (496)
Q Consensus 281 l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~ 360 (496)
+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......... ......+|+.|+|||.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEE 381 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhh
Confidence 3567888999999999999999 78999999999999999999999999998765432111 1122235899999998
Q ss_pred ccccc--------------------cc--CCCCCchhhhhccccccccc-chhhhccc-----------chhhhhhhccc
Q 047375 361 AHTEL--------------------LT--GMNPNSYVALASNEKISMVP-YFLDSIEN-----------NSFRQILNFQV 406 (496)
Q Consensus 361 l~~~~--------------------~t--~~~d~~s~g~~~~~~~~~~~-~~~~~~~~-----------~~~~~i~~~~~ 406 (496)
+.... +. .+.|+||+||++++|+.+.. ++...... ..+..+.....
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 75421 11 23699999999999988753 44321100 01111111122
Q ss_pred CCcccHHHHHHHHHHHHHhcccCC---CCCCCHHHHH
Q 047375 407 ADESEMEEIEVVAELASKCLRIRG---TERPTMKEVS 440 (496)
Q Consensus 407 ~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil 440 (496)
........++..++|+.+||..+| .+|+|+.|++
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 222233456789999999999766 6899999995
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=248.96 Aligned_cols=260 Identities=18% Similarity=0.130 Sum_probs=202.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhc-CCCCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQ-VKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+.+...||+|+|.+|..+++ .+.+.+|+|+++..- +.-.-...|-.+..+ -+||.+|.+..+|.....+++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 34457899999999999995 467889999875421 111111233333333 369999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|++||+|.-.+++... ++++.++.+...|+.||.|||+ +|||.||||.+|||+|..|++||+|+|+++..-.+.
T Consensus 332 yv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 9999999888876543 7889999999999999999999 889999999999999999999999999998765443
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhh--------cccchhhhhhhcccCCcccHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDS--------IENNSFRQILNFQVADESEME 413 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~--------~~~~~~~~i~~~~~~~~~~~~ 413 (496)
. .+++++|||.|.|||++.++.|....|||++|+++++|+.|..||.-. .++..++-|+...+..+. .
T Consensus 406 d--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--s 481 (593)
T KOG0695|consen 406 D--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--S 481 (593)
T ss_pred c--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--e
Confidence 3 357789999999999999999999999999999999999999998521 122345555555554443 3
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHhhHhhhhhhhhccCcccc
Q 047375 414 EIEVVAELASKCLRIRGTERPTMK-EVSEELDRLRRLQENYWARKNNEES 462 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~-eil~~L~~l~~~~~~~~~~~~~~~~ 462 (496)
.+-....+++.-|+.||.+|.... ++ .+..++.+.++|..+|+.
T Consensus 482 lsvkas~vlkgflnkdp~erlgc~~~~-----g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERLGCRPQT-----GFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhcCCCccc-----chhhhhcchhhhhCCHHH
Confidence 344577888899999999995432 11 445556777777777653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=243.75 Aligned_cols=244 Identities=19% Similarity=0.223 Sum_probs=189.3
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC-----eeeEEEe
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETK-----VTLLVYE 261 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv~E 261 (496)
.+.||-|+||.||.+.. ++|+.||+|++.... ......++|+++|..++|.|++..+++..-.+ ..|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 47899999999999985 479999999986432 23456679999999999999999998876543 4578899
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
++. .+|..++-.- ..++...+.-+.+||++||.|||+ .+|+||||||.|.|++.+..+||||||+++.-..+.
T Consensus 138 LmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 885 4888877543 236778888899999999999999 789999999999999999999999999999766553
Q ss_pred CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc----------------
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF---------------- 404 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~---------------- 404 (496)
.. ..+.-+-|..|.|||++.+ ..|++..|+||.||++.|++.....|.....-..+..|.+-
T Consensus 211 ~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 211 RL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 33 3344457899999999988 67899999999999999999988877765554443333221
Q ss_pred -------ccCCcc---------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 405 -------QVADES---------EMEEIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 405 -------~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
....+. +.....+...+..+++..||++|.+..+.+..
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 111110 00112456788889999999999998887643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=268.48 Aligned_cols=246 Identities=22% Similarity=0.265 Sum_probs=199.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhh-hHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRI-TEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
|.....+|+|+||.||+++. .+++..|+|.++-...... ...+|+-+++.++|||||.++|.+......||.||||.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 55567899999999999994 5788999998865433332 223678889999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+.-+..+ ++++.++..+++..++||+|||+ .+-+|||||-.|||+++.|.+|++|||.+..+... ...
T Consensus 97 gslQdiy~~Tg---plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K 168 (829)
T KOG0576|consen 97 GSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK 168 (829)
T ss_pred Ccccceeeecc---cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence 99999876543 47888889999999999999999 67899999999999999999999999998777543 223
Q ss_pred eecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc---ccHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE---SEMEEIEVVA 419 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~l~ 419 (496)
...+.||+.|||||+..- ..|...+|+|+.|+...++-...+|.........+..+....+.++ .....++.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 445779999999998753 5677899999999999999888888766555444444333333222 2334567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~ 441 (496)
+|++.|+..+|.+|||++.++.
T Consensus 249 ~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHhcCCCccCCChhhhee
Confidence 9999999999999999987764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=246.43 Aligned_cols=263 Identities=17% Similarity=0.214 Sum_probs=210.0
Q ss_pred hcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEee-CCeee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLE-TKVTL 257 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~ 257 (496)
+......+-+|.||.||+|.|. +.+.|.+|.++.... .......|--.+..+.|||+..+.+++.. ...++
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 3445578999999999999753 344567776654322 22333467777888899999999999975 56788
Q ss_pred EEEeeccCCchhhhhh-----hcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCC
Q 047375 258 LVYEFVSNGALSHYIH-----DKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
+++.+..-|+|..+|. +......++-.+...++.|++.|+.|||. ++|||.||-..|.+||+..++||+|=.
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccch
Confidence 9999999999999998 32333335566778899999999999999 889999999999999999999999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccH
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEM 412 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 412 (496)
+++.+-+.+.......-.....||+||.+.++.|+..+|+||+|+++||+++...-.....+...+...+..++....+.
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~ 521 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF 521 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCC
Confidence 99987665444333333356789999999999999999999999999999876544444455555666666677777888
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhh
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~ 452 (496)
+|++++..++.-||...|++||+++++..-|.++......
T Consensus 522 NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~ 561 (563)
T KOG1024|consen 522 NCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR 561 (563)
T ss_pred CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999999988655443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=227.77 Aligned_cols=206 Identities=21% Similarity=0.206 Sum_probs=160.5
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhc-CCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQ-VKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
...||+|++|.|-+-++ .+|...|+|.+...-. ...+...++.+..+ ..+|.+|++||........||.||.|.-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 35699999999988874 5789999999864433 23334466665544 4699999999999999999999999965
Q ss_pred chhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 267 ALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 267 ~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
+|..+.++- ......++...-+|+..+..||.|||+. -.+||||+||+||||+.+|++|+||||++..+...-.
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--- 204 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--- 204 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH---
Confidence 887776542 1223368888899999999999999995 4799999999999999999999999999887754321
Q ss_pred eecccccceeecCccccc----ccccCCCCCchhhhhcccccccccchhhh-cccchhhhhh
Q 047375 346 STMIRGTVGYLDPEYAHT----ELLTGMNPNSYVALASNEKISMVPYFLDS-IENNSFRQIL 402 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~-~~~~~~~~i~ 402 (496)
.+...|...|||||.+.. ..|+-++|+||+|+.+.||..+..|+... .+-+.+.+++
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 233458899999998876 46788999999999999999987766443 2333444444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=229.11 Aligned_cols=209 Identities=29% Similarity=0.409 Sum_probs=180.0
Q ss_pred cccCCceEEEEeEeC-CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchhh
Q 047375 194 LGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSH 270 (496)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~ 270 (496)
||+|++|.||++... ++..+++|.+...... .....+|+..++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999974 4899999998765442 3455688999999999999999999999899999999999999999
Q ss_pred hhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCCccccCCCCCccceecc
Q 047375 271 YIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPISSDDETAMSTMI 349 (496)
Q Consensus 271 ~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~~ 349 (496)
++.... ..+++..+..++.+++.+|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 997653 236788999999999999999999 78999999999999998 89999999999887654321 12234
Q ss_pred cccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhccc
Q 047375 350 RGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRI 428 (496)
Q Consensus 350 ~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~ 428 (496)
.++..|++||.+... ..+.+.|+|++|++++++ ..+.+++.+|++.
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhC
Confidence 478899999998876 788999999999999987 4589999999999
Q ss_pred CCCCCCCHHHHHHH
Q 047375 429 RGTERPTMKEVSEE 442 (496)
Q Consensus 429 dP~~RPs~~eil~~ 442 (496)
||.+||++.++++.
T Consensus 201 ~p~~R~~~~~l~~~ 214 (215)
T cd00180 201 DPEKRPSAKEILEH 214 (215)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=227.19 Aligned_cols=241 Identities=18% Similarity=0.217 Sum_probs=186.1
Q ss_pred hcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeC--CeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLET--KVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~E~ 262 (496)
.|.+.+++|+|.|+.||.|. ..++..++||.+++... ....+|+.||..+. ||||++++++..++ ..+.+|+||
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 36777899999999999998 45788999999875433 33458999999997 99999999998764 457899999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-CceEEccCCCccccCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-YTAKVSDFESLVPISSDD 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-~~~kL~DFGla~~~~~~~ 341 (496)
+.+.+...+... ++-..+..++.+++.||.|||+ .||+|||+||.|++||.. -.++|+|+|+|.+.....
T Consensus 117 v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 117 VNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 998877766532 4556778899999999999999 779999999999999864 469999999999987654
Q ss_pred CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchh-hhcccchhhhhh-----------------
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFL-DSIENNSFRQIL----------------- 402 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~-~~~~~~~~~~i~----------------- 402 (496)
.. +..+.+..|..||.+.. ..|+.+-|+||+||++..|+....||. +......+-+|.
T Consensus 188 eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 EY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 43 33457888999999876 678899999999999999987766654 333222222111
Q ss_pred --hcc--------cCCc--------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 403 --NFQ--------VADE--------SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 403 --~~~--------~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
++. ...+ ...-.++++.+|+.+.|.+|..+|||+.|.+.
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000 0000 00112378999999999999999999999853
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=248.74 Aligned_cols=193 Identities=22% Similarity=0.253 Sum_probs=162.1
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh-----hhhh----HHHHHHHHhcCC---CCceeeEEEEEeeCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE-----IRIT----EWEFLGIISQVK---HKNVVKILGLCLETK 254 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~----~~~e~~~l~~l~---hpnIv~l~~~~~~~~ 254 (496)
|.-.+.+|+|+||.|+.|.++ ++..|+||.+.+..- .+.+ .--|++||..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 444578999999999999975 566789998754321 1111 125788999887 999999999999999
Q ss_pred eeeEEEeec-cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 255 VTLLVYEFV-SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 255 ~~~lv~E~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
++||+||-- ++-+|.+++..+.. +++.++..|+.||+.|+++||+ .+|||||||-+||.++.+|.+||+|||.
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 999999964 56689999977654 7889999999999999999999 7899999999999999999999999998
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCC-CCCchhhhhcccccccccchh
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGM-NPNSYVALASNEKISMVPYFL 390 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~-~d~~s~g~~~~~~~~~~~~~~ 390 (496)
|....+. ....++||..|.|||++.++.|-|+ .|||++|+++|.++....|++
T Consensus 717 aa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8776543 2456789999999999999988765 799999999999988777765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=232.76 Aligned_cols=237 Identities=23% Similarity=0.195 Sum_probs=183.9
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------eeeEEE
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETK------VTLLVY 260 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~~lv~ 260 (496)
...+|.|.- .|-.+.. -.+.+||+|+..... ....+..+|..++..+.|+||++++.+|.-.. ..|+||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 356788877 5555542 368899999875432 22234558899999999999999999997543 569999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+.. +|.+.+.-. ++-.++..|+.|++.|+.|||+ .+|+||||||+||++..++.+||.|||+|+.....
T Consensus 101 e~m~~-nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 101 ELMDA-NLCQVILME-----LDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred Hhhhh-HHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence 99965 999888732 4667889999999999999999 78999999999999999999999999999875433
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-------------
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA------------- 407 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~------------- 407 (496)
-..+.++.|..|.|||++.+-.|....|+||.||++.+|+.+...|.+...-..+.++.+....
T Consensus 172 ---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred ---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 2346677999999999999988999999999999999999998887765443333333211000
Q ss_pred ---------------------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 408 ---------------------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 408 ---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.+........+++++.+||..||++|.|++++|
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 000011124689999999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=219.71 Aligned_cols=244 Identities=17% Similarity=0.189 Sum_probs=182.9
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEE-EeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGL-CLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~-~~~~~~~~lv~E~ 262 (496)
..|++.+.||+|.||.+.+++++ +.+.+++|-+.........+.+|..---.| .|.||+..|++ |...+.++++|||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 45888899999999999999964 577899998877666666666776543334 48999998864 6777888899999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC--CCCceEEccCCCccccCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD--DNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~--~~~~~kL~DFGla~~~~~~ 340 (496)
||.|+|..-+...+ +.+....+++.|++.|+.|+|+ +++||||||.+||||- +...+||||||..+.....
T Consensus 104 aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 104 APRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred CccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999998876543 4667788999999999999999 8899999999999992 3458999999987765432
Q ss_pred CCccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhh-cccchhhhhhhc---cc--CCc
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDS-IENNSFRQILNF---QV--ADE 409 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~-~~~~~~~~i~~~---~~--~~~ 409 (496)
. ....-+..|.+||.+.. -...+..|+|.+|++++.+++|.+|+... ..+..+...... .. .+.
T Consensus 177 V-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 177 V-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred e-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 1 12235678999997754 23457899999999999999998877643 333444333321 11 111
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.....++.+..+.++-+..+|.+|--..++.+
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 22345577889999999999999954444443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=232.67 Aligned_cols=143 Identities=22% Similarity=0.310 Sum_probs=119.8
Q ss_pred ccccCHHHHHH-HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-----C---Ccee
Q 047375 175 MKIFSKSELLK-ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK-----H---KNVV 244 (496)
Q Consensus 175 ~~~~~~~~l~~-~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h---pnIv 244 (496)
.+-...++... .+|.+.++||.|.|++||+|.. .+.+-||+|+.+...........|+++|++++ | .+||
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 44445556655 6788889999999999999995 46778999999888777777788999998874 3 4699
Q ss_pred eEEEEEee----CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee
Q 047375 245 KILGLCLE----TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL 320 (496)
Q Consensus 245 ~l~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll 320 (496)
+|++.|.. +.+.|+|+|++ |.+|..+|.....+. ++...+..|++||+.||.|||..+ +|||-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 99999974 55899999999 669999998765544 788999999999999999999965 79999999999999
Q ss_pred C
Q 047375 321 D 321 (496)
Q Consensus 321 ~ 321 (496)
.
T Consensus 222 ~ 222 (590)
T KOG1290|consen 222 C 222 (590)
T ss_pred e
Confidence 3
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=215.63 Aligned_cols=197 Identities=26% Similarity=0.302 Sum_probs=166.5
Q ss_pred chhhhcccCCceEEEEeEeCC-CcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 189 NFHHCLGMGGFGSVYKGVLPD-NTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.+.+.||.|++|.||++.... +..+++|.+..... ......+|+..+..++|+|++++++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 455789999999999999754 88999999875443 233445788999999999999999999998999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
++|.+++...... +++..+..++.+++.+|.+||. ++++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 82 ~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 82 GDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 9999999765421 5788899999999999999999 78999999999999999999999999998877543211 1
Q ss_pred eecccccceeecCccc-ccccccCCCCCchhhhhcccccccccchhh
Q 047375 346 STMIRGTVGYLDPEYA-HTELLTGMNPNSYVALASNEKISMVPYFLD 391 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l-~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~ 391 (496)
.....++..|++||.+ ....++.+.|+|++|+++++++++.+||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334588899999998 666777899999999999999999999865
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=221.79 Aligned_cols=244 Identities=17% Similarity=0.197 Sum_probs=182.5
Q ss_pred cchhhhcccCCceEEEEeEeC----CCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|...++||+|+|++||++... ....||+|.+....... +...|+++|..+. +.||+++.+++..++...+||||
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~-ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS-RILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch-HHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 556789999999999999842 46789999886543332 3457788888874 99999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCCccccCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~~~~~ 341 (496)
++.....++... ++...+..+++.+..||.++|. +|||||||||+|+|.+. .+.-.|+|||+|.......
T Consensus 117 ~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 117 FEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred cCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 999888888865 4567888999999999999999 88999999999999974 4567899999987211000
Q ss_pred -----------------C-------------------------ccceecccccceeecCccccc-ccccCCCCCchhhhh
Q 047375 342 -----------------E-------------------------TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALA 378 (496)
Q Consensus 342 -----------------~-------------------------~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~ 378 (496)
. ........||++|.|||++.. ...|.+.|+||.|++
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 000112459999999999876 556789999999999
Q ss_pred cccccccccchhhhccc-chhhhhh--------------hcc---------------------c-------------CCc
Q 047375 379 SNEKISMVPYFLDSIEN-NSFRQIL--------------NFQ---------------------V-------------ADE 409 (496)
Q Consensus 379 ~~~~~~~~~~~~~~~~~-~~~~~i~--------------~~~---------------------~-------------~~~ 409 (496)
+..+++...||....++ ..+..+. .+. + ...
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999887776533221 1111110 000 0 000
Q ss_pred ccH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 410 SEM-EEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 410 ~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... ..+..+.+|+.+|+..||.+|.|+++.|+
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000 11236899999999999999999999974
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-27 Score=259.12 Aligned_cols=196 Identities=14% Similarity=0.128 Sum_probs=140.9
Q ss_pred cCCC-CceeeEEEEE-------eeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCc
Q 047375 237 QVKH-KNVVKILGLC-------LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308 (496)
Q Consensus 237 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 308 (496)
.++| +||.+++++| .....++++|||+ +++|.++|.... ..+++..+..++.||+.||.|||+ ++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 3456 6888888887 2234567788987 559999997542 237889999999999999999999 789
Q ss_pred ccCCCCcCceeeCC-------------------CCceEEccCCCccccCCCCC--------------ccceeccccccee
Q 047375 309 IHSDVKSANILLDD-------------------NYTAKVSDFESLVPISSDDE--------------TAMSTMIRGTVGY 355 (496)
Q Consensus 309 vHrDlKp~NIll~~-------------------~~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~Y 355 (496)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566777777654321000 0001124589999
Q ss_pred ecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCC
Q 047375 356 LDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPT 435 (496)
Q Consensus 356 ~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 435 (496)
||||++.+..++.+.|+||+||++|||+++.+++..... .+..+.... .++......+....++.+||+.||.+|||
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence 999999998999999999999999999998877653211 111111111 11111122345678999999999999999
Q ss_pred HHHHHH
Q 047375 436 MKEVSE 441 (496)
Q Consensus 436 ~~eil~ 441 (496)
+.|+++
T Consensus 259 ~~eil~ 264 (793)
T PLN00181 259 MSELLQ 264 (793)
T ss_pred hHHHhh
Confidence 999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=220.39 Aligned_cols=163 Identities=18% Similarity=0.129 Sum_probs=126.0
Q ss_pred HHhcchhhhcccCCceEEEEeEeC--CCcEEEEEEeecc------hhhhhhHHHHHHHHhcCCCCceee-EEEEEeeCCe
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP--DNTQVAVKKYMCA------DEIRITEWEFLGIISQVKHKNVVK-ILGLCLETKV 255 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~hpnIv~-l~~~~~~~~~ 255 (496)
...|.+.+.||+|+||+||+|.+. ++..||||++... ........+|+++|+.++|+||+. ++++ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 345788899999999999999864 5677899986422 112334558999999999999985 4432 45
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCC-CcCceeeCCCCceEEccCCCc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDV-KSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDl-Kp~NIll~~~~~~kL~DFGla 334 (496)
.|+|||||+|++|... .. .. ...++.|++.||.|||+ ++|+|||| ||+|||++.++.+||+|||+|
T Consensus 93 ~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 7999999999999632 11 01 14578899999999999 78999999 999999999999999999999
Q ss_pred cccCCCCCccc------eecccccceeecCcccccc
Q 047375 335 VPISSDDETAM------STMIRGTVGYLDPEYAHTE 364 (496)
Q Consensus 335 ~~~~~~~~~~~------~~~~~gt~~Y~aPE~l~~~ 364 (496)
+.+........ .+...+++.|+|||++..+
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 97755432211 1356689999999998774
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=197.65 Aligned_cols=162 Identities=17% Similarity=0.102 Sum_probs=127.6
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..+.. .+++..++.|+.||+.||.|||+ ++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999976432 47999999999999999999999 44 999999999999999 99987764321
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-chhhhhhhcccCC-----cccHHHHH--H
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQVAD-----ESEMEEIE--V 417 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~-----~~~~~~~~--~ 417 (496)
..||+.|||||++.+..++.++|+||+|+++|+++++.+||...... ..+..+....... ........ .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARS 140 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhh
Confidence 24899999999999999999999999999999999999988654332 2222222211111 11223333 6
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
+.+++.+||..||.+|||+.++++.+..+.
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 999999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=187.48 Aligned_cols=276 Identities=16% Similarity=0.121 Sum_probs=211.0
Q ss_pred HHHHhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCC-CceeeEEEEEeeCCeeeEEE
Q 047375 183 LLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVKH-KNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 183 l~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~ 260 (496)
+....|.+.++||+|+||.+|.|. ..+|..||||.-.... .......|..+...+++ ..|..+..+..+...-.+||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 344568888999999999999999 5689999999754332 22233355556666654 66777788888888889999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCcccc
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVPI 337 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~~ 337 (496)
+.+ |.+|.+++.-... .++..+++-++-|++.-++|+|. +++|||||||+|+|..- ...+.|+|||+|+..
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 7899998875443 26788999999999999999999 78999999999999953 346899999999987
Q ss_pred CCCCCc-----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc---cchhhhhhhcccCCc
Q 047375 338 SSDDET-----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE---NNSFRQILNFQVADE 409 (496)
Q Consensus 338 ~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~---~~~~~~i~~~~~~~~ 409 (496)
.+.... .......||..|.+--...+...+.++|+-|+|.++.....|..||.+... ...+.+|.......+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 543221 123456799999998888877778899999999999888888888876543 345566665555444
Q ss_pred ccH---HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccccccc
Q 047375 410 SEM---EEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEESEHL 465 (496)
Q Consensus 410 ~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~~~~ 465 (496)
... ..+.++...+.-|-..--++-|...-+-+.+.-+.+.+.+...--.+|.+...
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkq 303 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQ 303 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHH
Confidence 332 33567889999999999999999998888888887777776666666654443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-25 Score=200.55 Aligned_cols=249 Identities=17% Similarity=0.199 Sum_probs=198.0
Q ss_pred chhhhcccCCceEEEEeEeCCCcEEEEEEeecc---hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 189 NFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCA---DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
++.-+|.+...|..|+|+| .|..+++|++... ......+.+|.-.|+-+.||||+.++|.|..+.++.++..|++.
T Consensus 193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 4556789999999999999 4666777876433 22334455777778888999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|+.+|+..... ..+..++.+++.++++|+.|||+.. +-|.---|.+..|+||++.+++|+= +-+++.-.
T Consensus 272 gslynvlhe~t~v-vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfsfq------ 342 (448)
T KOG0195|consen 272 GSLYNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ------ 342 (448)
T ss_pred hHHHHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceeeee------
Confidence 9999999987643 3577889999999999999999986 4455557899999999999888751 11111100
Q ss_pred eecccccceeecCcccccccc---cCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELL---TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~---t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.....-+|.||+||.++...- -...|+||+.+++||+.+...||......+.-.++.-..+....++..+..+..|+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 111225789999999987433 35789999999999999999999887766666666666666777778888999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 423 SKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
.-|++.||.+||.++.|+-.|+++.
T Consensus 423 ~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHhcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999999998864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=205.81 Aligned_cols=259 Identities=17% Similarity=0.127 Sum_probs=190.8
Q ss_pred hcchhhhcccCCceEEEEeEeCCC--cEEEEEEeecchhhhh-hHHHHHHHHhcCC----CCceeeEEEEE-eeCCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDN--TQVAVKKYMCADEIRI-TEWEFLGIISQVK----HKNVVKILGLC-LETKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~-~~~~e~~~l~~l~----hpnIv~l~~~~-~~~~~~~l 258 (496)
.|.+.+.||+|+||.||.|..... ..+|+|.......... ....|..++..+. .+++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 477789999999999999996443 4788887654332221 3345677777765 36899999998 47778899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-----CceEEccCCC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-----YTAKVSDFES 333 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-----~~~kL~DFGl 333 (496)
||+.+ |.+|.++..... ...++..++.+|+.|++.+|.+||+ .|++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 779999886655 3447889999999999999999999 789999999999999754 4699999999
Q ss_pred cc--ccCCCCCc---cc---eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh--
Q 047375 334 LV--PISSDDET---AM---STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN-- 403 (496)
Q Consensus 334 a~--~~~~~~~~---~~---~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~-- 403 (496)
++ ........ .. .....||..|+++.+..+...+.++|+||++.++.++..+..||...........+..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 43222111 11 2345699999999999999999999999999999999988655544332222222211
Q ss_pred -cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 404 -FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 404 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
...........+..+..+...+-..+...+|....+...|.......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111223355777777777789999999999999987776544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-24 Score=224.25 Aligned_cols=244 Identities=18% Similarity=0.128 Sum_probs=180.6
Q ss_pred hhhhcccCCceEEEEeEe-CCCcEEEEEEee----cchhhh---hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 190 FHHCLGMGGFGSVYKGVL-PDNTQVAVKKYM----CADEIR---ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
....+|.|.+|.|+.... ......+.|.+. ...... .....|+.+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998877763 234445555432 111111 112245556677899999888877776665556699
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++ +|..++..... +....+..++.|++.|+.|||+ .||.||||||+|++++.+|.+||+|||.+....-..
T Consensus 402 ~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99999977532 5667788899999999999999 779999999999999999999999999988765544
Q ss_pred Cc--cceecccccceeecCcccccccccC-CCCCchhhhhcccccccccchhhhcccchh-hhhh-hc-----ccCCccc
Q 047375 342 ET--AMSTMIRGTVGYLDPEYAHTELLTG-MNPNSYVALASNEKISMVPYFLDSIENNSF-RQIL-NF-----QVADESE 411 (496)
Q Consensus 342 ~~--~~~~~~~gt~~Y~aPE~l~~~~~t~-~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~-~~i~-~~-----~~~~~~~ 411 (496)
.. ......+|+..|+|||.+.+..|.+ ..|+||.|+++..|..+..+|......... .... .. ..+....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 43 4456778999999999999988876 579999999999999997777654433221 1111 11 1111222
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
...+...+.++.++|+.||.+|.|+.+|+
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHh
Confidence 34556789999999999999999999984
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=185.04 Aligned_cols=138 Identities=14% Similarity=0.171 Sum_probs=105.4
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhh---------------------------hhHHHHHHHHhcCCCCcee
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIR---------------------------ITEWEFLGIISQVKHKNVV 244 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------~~~~~e~~~l~~l~hpnIv 244 (496)
..||+|+||.||+|...+|+.||||++....... .....|+..+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 5799999999999998789999999986532110 0112478888888877764
Q ss_pred eEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHh-HhcCCCCcccCCCCcCceeeCCC
Q 047375 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL-HSLASPSIIHSDVKSANILLDDN 323 (496)
Q Consensus 245 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~~~~ivHrDlKp~NIll~~~ 323 (496)
....+... ..+|||||++++++........ .++...+..++.|++.+|.|+ |+ .+|+||||||+|||++ +
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-C
Confidence 43333222 2389999999887765432222 367888999999999999999 57 6899999999999998 4
Q ss_pred CceEEccCCCccccC
Q 047375 324 YTAKVSDFESLVPIS 338 (496)
Q Consensus 324 ~~~kL~DFGla~~~~ 338 (496)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=195.24 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=191.9
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCC-ceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHK-NVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+...||.|+||.||++... ..+++|.+...... .....+|..++..+.|+ +|+++++.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 345577999999999999985 78899988654433 33445788899999988 799999999877778999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-ceEEccCCCccccCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPISSDD 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~~~~ 341 (496)
+.++++.+++........++......++.|++.++.|+|. .+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999999777654311236778889999999999999999 7799999999999999888 79999999988655433
Q ss_pred Ccc----ceecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcc----cchhhhhhhcccC---
Q 047375 342 ETA----MSTMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIE----NNSFRQILNFQVA--- 407 (496)
Q Consensus 342 ~~~----~~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~----~~~~~~i~~~~~~--- 407 (496)
... ......||..|+|||.+.+ ..+....|+|++|+++++++.+..|+..... ......+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 2355679999999999987 5788899999999999999988888655442 1222222221111
Q ss_pred CcccHH----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 408 DESEME----EIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 408 ~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
...... ....+.+++..|+..+|..|.+..+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111 12568899999999999999988876654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=183.70 Aligned_cols=256 Identities=16% Similarity=0.153 Sum_probs=197.4
Q ss_pred HhcchhhhcccCCceEEEEeE-eCCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|.+.++||+|+||.++.|. +-++.+||||.-....+ ....+.+..++|. ..++|..+|-+...+.+-.||||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~--g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLG--GTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHc--CCCCCCceeeeccccchhhhhhhh
Confidence 347888999999999999998 45899999996543322 2233445566665 679999999888888888899999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-----CceEEccCCCcccc
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-----YTAKVSDFESLVPI 337 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-----~~~kL~DFGla~~~ 337 (496)
+ |.+|.++..-.+. .++..++..++.|++.-++|+|+ +.+|.|||||+|+||... ..+.|+|||+|+..
T Consensus 106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7899998876544 36889999999999999999999 889999999999999643 35899999999987
Q ss_pred CCCCCcc-----ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc---chhhhhhhcccCCc
Q 047375 338 SSDDETA-----MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN---NSFRQILNFQVADE 409 (496)
Q Consensus 338 ~~~~~~~-----~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~ 409 (496)
....... ......||..||+--...+..-+.++|.-++|-++...+.|..||.+.... ..+++|-+..-..+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 6543221 123456999999988888888889999999999999889998888765433 44555554333222
Q ss_pred cc---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 410 SE---MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 410 ~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.. ...+.++..-+.-.-..+-.+-|..+-+...+.++...
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 22 23456777777777778888899998888877777653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=176.66 Aligned_cols=139 Identities=18% Similarity=0.224 Sum_probs=107.2
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhh---------------------------hhhHHHHHHHHhcCCCCcee
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI---------------------------RITEWEFLGIISQVKHKNVV 244 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~hpnIv 244 (496)
..||+|+||.||+|...+|..||||.+...... ......|...+.++.|++|.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999768999999998654210 01113677888889999875
Q ss_pred eEEEEEeeCCeeeEEEeeccCCchhhh-hhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC
Q 047375 245 KILGLCLETKVTLLVYEFVSNGALSHY-IHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN 323 (496)
Q Consensus 245 ~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~ 323 (496)
....+.... .||||||++|+++... +.. ..++......++.|++.+|.++|+. .+|+||||||+|||++ +
T Consensus 83 ~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~ 153 (190)
T cd05145 83 VPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-C
Confidence 544443332 4899999998855433 322 1256678889999999999999982 4699999999999999 7
Q ss_pred CceEEccCCCccccCC
Q 047375 324 YTAKVSDFESLVPISS 339 (496)
Q Consensus 324 ~~~kL~DFGla~~~~~ 339 (496)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=179.10 Aligned_cols=172 Identities=10% Similarity=0.042 Sum_probs=129.8
Q ss_pred HHHHHHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhh----------HHHHHHHHhcCCCCceeeEEEEE
Q 047375 181 SELLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRIT----------EWEFLGIISQVKHKNVVKILGLC 250 (496)
Q Consensus 181 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~hpnIv~l~~~~ 250 (496)
.+++...|...++||.|+||.||+... ++..+|+|.+......... ..+|+..+.++.||+|..+.+++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 345667788889999999999999766 5778999998644322222 24778889999999999999886
Q ss_pred eeC--------CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC
Q 047375 251 LET--------KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD 322 (496)
Q Consensus 251 ~~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~ 322 (496)
... +..+|||||++|.+|.++.. .+. ....+++.+|..+|. .+++|||+||+||+++.
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK 170 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence 643 35789999999999988732 222 245699999999999 88999999999999998
Q ss_pred CCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccc
Q 047375 323 NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEK 382 (496)
Q Consensus 323 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~ 382 (496)
++ ++|+|||........... . .++....+.-+.|+|++|+++...
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~---d-----------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK---D-----------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CC-EEEEECCCcccccchhhH---H-----------HHHHHhHhcccccccceeEeehHH
Confidence 88 999999987655322111 0 022333455689999999887653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=171.10 Aligned_cols=132 Identities=15% Similarity=0.180 Sum_probs=101.0
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchh-hhhhHHHHHHHHhcC-----CCCceeeEEEEEeeCC---eee-EEEe
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE-IRITEWEFLGIISQV-----KHKNVVKILGLCLETK---VTL-LVYE 261 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l-----~hpnIv~l~~~~~~~~---~~~-lv~E 261 (496)
..||+|+||.||. ++.....+||++..... ......+|+.+++.+ .||||++++|++.++. ..+ +|||
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5799999999996 43334447898765322 233455899999999 5799999999998763 333 7899
Q ss_pred e--ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHH-HHhHhcCCCCcccCCCCcCceeeCC----CCceEEccCCCc
Q 047375 262 F--VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAI-HYLHSLASPSIIHSDVKSANILLDD----NYTAKVSDFESL 334 (496)
Q Consensus 262 ~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL-~~LH~~~~~~ivHrDlKp~NIll~~----~~~~kL~DFGla 334 (496)
| +++|+|.+++.+.. +++. ..++.+++.++ .|||+ ++|+||||||+|||++. ++.++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 66899999996532 3433 35678888888 99999 88999999999999973 347999996543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.2e-22 Score=197.73 Aligned_cols=242 Identities=20% Similarity=0.130 Sum_probs=185.2
Q ss_pred cccCCceEEEEeEe----CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 194 LGMGGFGSVYKGVL----PDNTQVAVKKYMCADE---IRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 194 lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+|+|+||.|+++.. ..+.-+|+|....... .+.....|..++..++ ||.+|++...+..+...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998762 3466788887643321 1112224566777776 99999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|.|...+..... ........+...++-|+.++|+ .+|+|||+|++||+++.+|++|+.|||+++.......
T Consensus 82 g~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEVM---FDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred chhhhccccCCc---hHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999888765443 4556667778899999999999 6799999999999999999999999999887654321
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
.|||..|||||++. ......|+|++|+++++++++..||.. .....|+.. ....+...+..+.+++..+
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~~~~~~l 221 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEARSLFRQL 221 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHHHHHHHH
Confidence 17999999999998 467789999999999999999999987 344444432 2344556677899999999
Q ss_pred cccCCCCCCCHH-HHHHHHHhhHhhhhhhhh
Q 047375 426 LRIRGTERPTMK-EVSEELDRLRRLQENYWA 455 (496)
Q Consensus 426 l~~dP~~RPs~~-eil~~L~~l~~~~~~~~~ 455 (496)
+..+|.+|--.. +.+..+..-...+...|.
T Consensus 222 ~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 222 FKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 999999996542 343333333333444444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=169.39 Aligned_cols=185 Identities=13% Similarity=0.005 Sum_probs=134.5
Q ss_pred hhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhh-----hHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeecc
Q 047375 191 HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRI-----TEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
...|++|+||+||.+.. .+.+++.+.+........ .+.+|+++|++++ |++|++++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999998776 678888887765444222 3458999999995 5889999886 34689999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCC-CcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDV-KSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDl-Kp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
|.+|.+.+.. . ...++.|++.+|.++|+ +||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 82 G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR---------G-DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh---------h-hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9998754321 1 13477899999999999 78999999 799999999999999999999865433210
Q ss_pred ----cc-------eecccccceeecCcccccc--cccCCCCCchhhhhcccccccccchhhhc
Q 047375 344 ----AM-------STMIRGTVGYLDPEYAHTE--LLTGMNPNSYVALASNEKISMVPYFLDSI 393 (496)
Q Consensus 344 ----~~-------~~~~~gt~~Y~aPE~l~~~--~~t~~~d~~s~g~~~~~~~~~~~~~~~~~ 393 (496)
.. ..-...++.|++|+..... .--...+|++.|.-+|.++++..+..+..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00 0012256777777743321 11134567889999999998877766544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=176.80 Aligned_cols=198 Identities=21% Similarity=0.207 Sum_probs=143.9
Q ss_pred CCCceeeEEEEEeeC---------------------------CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHH
Q 047375 239 KHKNVVKILGLCLET---------------------------KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA 291 (496)
Q Consensus 239 ~hpnIv~l~~~~~~~---------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 291 (496)
+|||||+++++|.+. ..+|+||.-++. +|.+++..+.. +.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~----s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR----SYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC----chHHHHHHHH
Confidence 599999999988653 245899999876 99999987653 4456677899
Q ss_pred HHHHHHHHhHhcCCCCcccCCCCcCceee--CCCC--ceEEccCCCccccCCCC----CccceecccccceeecCccccc
Q 047375 292 ETASAIHYLHSLASPSIIHSDVKSANILL--DDNY--TAKVSDFESLVPISSDD----ETAMSTMIRGTVGYLDPEYAHT 363 (496)
Q Consensus 292 qi~~gL~~LH~~~~~~ivHrDlKp~NIll--~~~~--~~kL~DFGla~~~~~~~----~~~~~~~~~gt~~Y~aPE~l~~ 363 (496)
|+++|+.|||. ++|.|||+|++|||| |+++ .+.|+|||++-.-.... ..+..-...|...-||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 889999999999999 4444 47899999875432210 0111112347888999998765
Q ss_pred ------ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047375 364 ------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMK 437 (496)
Q Consensus 364 ------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 437 (496)
..--++.|.|+.|.+.||+++...||+...+...-..-.....-+..+..+++.+++++...|+.||++|||..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 22346899999999999999999999873322111111111222334455667799999999999999999987
Q ss_pred HHHHHHH
Q 047375 438 EVSEELD 444 (496)
Q Consensus 438 eil~~L~ 444 (496)
-..+.|+
T Consensus 506 iAANvl~ 512 (598)
T KOG4158|consen 506 IAANVLN 512 (598)
T ss_pred HHHhHHH
Confidence 6665553
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.2e-20 Score=184.86 Aligned_cols=211 Identities=18% Similarity=0.266 Sum_probs=161.3
Q ss_pred HhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCC
Q 047375 235 ISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVK 314 (496)
Q Consensus 235 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlK 314 (496)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.... ..+++.....+.++|+.||.|||+. .-..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence 456889999999999999999999999999999999998743 3478888999999999999999993 223999999
Q ss_pred cCceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccc-------cccCCCCCchhhhhccccccccc
Q 047375 315 SANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE-------LLTGMNPNSYVALASNEKISMVP 387 (496)
Q Consensus 315 p~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-------~~t~~~d~~s~g~~~~~~~~~~~ 387 (496)
++|.++|..+.+||+|||+.................-...|.|||.+.+. ..+.+.|+||+|++++++++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999987776431111112222345679999999873 24667999999999999999888
Q ss_pred chhhhcccc----hhhhhhh-cc--cCCccc-H-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 388 YFLDSIENN----SFRQILN-FQ--VADESE-M-EEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 388 ~~~~~~~~~----~~~~i~~-~~--~~~~~~-~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
||....... ....+.+ .. ..+... . +..+.+..++.+||..+|..||++..|-..++.+...
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 876543322 2222222 11 111111 1 3445799999999999999999999998877766553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.8e-20 Score=195.80 Aligned_cols=255 Identities=16% Similarity=0.135 Sum_probs=183.4
Q ss_pred HHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC---CCceeeEEEEEeeCCeeeEEEe
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVK---HKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E 261 (496)
...+.+.+.||+|+||+||+|...+|+.||+|.-.+....... --.+++.+|+ -+-|..+..++...+.-+||+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY--I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY--ICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee--ehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 3446677899999999999999878999999986654433211 1134445555 2445666666667777889999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC-------CCCceEEccCCCc
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-------DNYTAKVSDFESL 334 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~-------~~~~~kL~DFGla 334 (496)
|.+.|+|.+++...+ .++|..++.+..|++.-+.+||. .+|||+||||+|+||. ....++|+|||.+
T Consensus 775 y~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 775 YSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 999999999998433 47899999999999999999999 6799999999999994 2346899999988
Q ss_pred cccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHH
Q 047375 335 VPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEE 414 (496)
Q Consensus 335 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 414 (496)
-.+..-.........++|-.+-.+|+..|..++...|.|-+..+++.|+.|...- ......+ .+ ...++.-+..
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~~~-~~-~~~~~Ry~~~-- 922 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGSSW-MV-KTNFPRYWKR-- 922 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCcce-ec-cccchhhhhH--
Confidence 7665433333456677999999999999999999999999999999998886543 1111111 00 1111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhh
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYW 454 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~ 454 (496)
.-..+++..+|+.|-..=|...++...|+.+...+...|
T Consensus 923 -~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~~ 961 (974)
T KOG1166|consen 923 -DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTGL 961 (974)
T ss_pred -HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHHH
Confidence 224567777777444444888888888888765544443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=168.65 Aligned_cols=140 Identities=17% Similarity=0.223 Sum_probs=106.6
Q ss_pred cchhhhcccCCceEEEEeE--eCCCcEEEEEEeecchhh-------------------------hhhHHHHHHHHhcCCC
Q 047375 188 KNFHHCLGMGGFGSVYKGV--LPDNTQVAVKKYMCADEI-------------------------RITEWEFLGIISQVKH 240 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~h 240 (496)
|.+.+.||+|+||.||+|. ..+|..||+|.+...... ......|...+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5567899999999999998 568999999988643210 0112367888888875
Q ss_pred C--ceeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCC-cccCCCCcCc
Q 047375 241 K--NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS-IIHSDVKSAN 317 (496)
Q Consensus 241 p--nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~-ivHrDlKp~N 317 (496)
. .+.+++++ ...++||||+++++|........ .........++.|++.+|.+||+ ++ |+||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 3 34445543 23489999999988876553222 23445667899999999999999 78 9999999999
Q ss_pred eeeCCCCceEEccCCCccccC
Q 047375 318 ILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 318 Ill~~~~~~kL~DFGla~~~~ 338 (496)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 7899999999877543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.6e-21 Score=199.12 Aligned_cols=242 Identities=21% Similarity=0.231 Sum_probs=174.6
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh-hhh----hHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE-IRI----TEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~----~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.+.+.||++.|=+|.+|.++.|. |+||++...+. ... +..++++ ...++|||++.+.-+-....-.|+|=+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 455688999999999999987666 99999865542 221 2224444 5556899999998887778888999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc--CCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI--SSD 340 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~--~~~ 340 (496)
..+ +|++.+..+. .+..-+...|+.|++.||.-+|. .+|+|+|||.+||||+.=+=+.|+||..-+.. +.+
T Consensus 103 vkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 976 9999987643 36667778899999999999999 78999999999999998777899999754432 221
Q ss_pred CCccc---eecccccceeecCccccc----------c-cccCCCCCchhhhhccccccc-ccchhhhc-------ccchh
Q 047375 341 DETAM---STMIRGTVGYLDPEYAHT----------E-LLTGMNPNSYVALASNEKISM-VPYFLDSI-------ENNSF 398 (496)
Q Consensus 341 ~~~~~---~~~~~gt~~Y~aPE~l~~----------~-~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~-------~~~~~ 398 (496)
..... ..+...-..|.|||.+.. . .++++-||+|+||++.|++.- .|+|.-.. .....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 11111 111123357999998765 2 277888999999999998664 66663210 01111
Q ss_pred hhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 399 RQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 399 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
+..+. .+ ....++.+|..|++.||++|.|+++.|+.-..+
T Consensus 256 e~~Le-~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 256 EQLLE-KI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHHHH-hC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11111 00 113589999999999999999999999875444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.7e-19 Score=162.84 Aligned_cols=133 Identities=19% Similarity=0.236 Sum_probs=110.5
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchh---------hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE---------IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.||+|++|.||+|.+ .+..|++|+...... ......+|+.++..+.|+||.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999998 678899997653221 112334788899999999988877777777888999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
++|++|.+++.... + .+..++.+++.+|.++|+ .+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 1 678899999999999999 7899999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=159.45 Aligned_cols=136 Identities=21% Similarity=0.252 Sum_probs=105.8
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh-----------------------hhhhHHHHHHHHhcCCCC--c
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE-----------------------IRITEWEFLGIISQVKHK--N 242 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~e~~~l~~l~hp--n 242 (496)
|.+.+.||+|+||.||++...+|+.||||++..... .......|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 566788999999999999987899999998653220 001133567778888777 4
Q ss_pred eeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC
Q 047375 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD 322 (496)
Q Consensus 243 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~ 322 (496)
++..++. ...++||||++|++|..+... .....++.+++.++.++|+ .+|+||||||+||+++.
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 4555542 345899999999999765421 2235688999999999999 78999999999999999
Q ss_pred CCceEEccCCCccccCC
Q 047375 323 NYTAKVSDFESLVPISS 339 (496)
Q Consensus 323 ~~~~kL~DFGla~~~~~ 339 (496)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999866544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=159.71 Aligned_cols=129 Identities=16% Similarity=0.245 Sum_probs=103.9
Q ss_pred hcccCCceEEEEeEeCCCcEEEEEEeecchh----h-----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 193 CLGMGGFGSVYKGVLPDNTQVAVKKYMCADE----I-----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~-----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.||+|+||.||+|.+ ++..|++|....... . .....+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 678899998643211 0 122347888999998887666555566667779999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
+|++|.+++..... .++.+++.+|.+||+ .+++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754210 688999999999999 7899999999999999 78999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=164.93 Aligned_cols=229 Identities=19% Similarity=0.176 Sum_probs=139.4
Q ss_pred hhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhH---H-HHHHHHhcCC----------CCceeeEEEEEee--
Q 047375 190 FHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITE---W-EFLGIISQVK----------HKNVVKILGLCLE-- 252 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~-~e~~~l~~l~----------hpnIv~l~~~~~~-- 252 (496)
....||.|+++.||.+.+. +++++|||.+.......... . +|.-....+. |-.++-.++...-
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3578999999999999964 68999999886443222111 1 2221111111 1112222222211
Q ss_pred -------C---C-----eeeEEEeeccCCchhhhhhh---cCc-ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCC
Q 047375 253 -------T---K-----VTLLVYEFVSNGALSHYIHD---KSS-QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDV 313 (496)
Q Consensus 253 -------~---~-----~~~lv~E~~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDl 313 (496)
. . +.+++|+-+. ++|.+++.. ... ...+....+..+..|+++.+++||+ .|+||+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEeccc
Confidence 1 1 2367788774 488887643 211 1234445667778999999999999 78999999
Q ss_pred CcCceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCccccc--------ccccCCCCCchhhhhccccccc
Q 047375 314 KSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT--------ELLTGMNPNSYVALASNEKISM 385 (496)
Q Consensus 314 Kp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~t~~~d~~s~g~~~~~~~~~ 385 (496)
||+|++++.+|.++|+||+........ ... ...+..|.|||.... -.+|.+.|.|.+|+++|.++++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999866554321 111 235678999997644 2578889999999999999999
Q ss_pred ccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCC
Q 047375 386 VPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTER 433 (496)
Q Consensus 386 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 433 (496)
..||........... .-.... +.++.++.||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 888765433322211 111222 566789999999999999988
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.4e-18 Score=178.14 Aligned_cols=133 Identities=15% Similarity=0.203 Sum_probs=106.8
Q ss_pred chhhhcccCCceEEEEeEeCCCcEEEEEEeecch----h-----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 189 NFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD----E-----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~-----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
...+.||+|+||.||+|.+. +..+++|+..... . ......+|+.++..++|++|+....++......++|
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 34578999999999999874 3445555432111 0 112344789999999999999888888877788999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
|||+++++|.+++. ....++.+++.+|.|||+ ++|+||||||+|||+ .++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999998874 235689999999999999 789999999999999 5779999999988764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.4e-19 Score=175.75 Aligned_cols=174 Identities=20% Similarity=0.253 Sum_probs=135.1
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
.+||.|++|.-.+|.++|.++......++.....++.|++.|+.| ++.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999876555556888999999999999999 35999999999999999989999999998
Q ss_pred cccCCCC----CccceecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCc
Q 047375 335 VPISSDD----ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADE 409 (496)
Q Consensus 335 ~~~~~~~----~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~ 409 (496)
....... .....+..+||..||+||.+.++.|+.+.|||++|++++|++.. ...+. ....+..+.+..+++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChH
Confidence 8776543 12234566799999999999999999999999999999998762 22221 1123333434444433
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKE 438 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 438 (496)
...+. +.-..|+.+++...|.+||++.+
T Consensus 481 ~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 481 FLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 32222 34568999999999999995444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-18 Score=182.85 Aligned_cols=205 Identities=20% Similarity=0.178 Sum_probs=148.6
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
++-++.|..|+||.||.+++. +.+.+|+| +....-... .++.....|.+| |
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR------nilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR------NILTFAGNPFVV---------------------G 136 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh------ccccccCCccee---------------------c
Confidence 344578999999999999864 46778884 322211110 033333344433 3
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc---
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET--- 343 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~--- 343 (496)
+-...+..-+. ++. +++.+++|||+ .+|+|||+||+|.+|+.-|++|+.|||+++........
T Consensus 137 Dc~tllk~~g~---lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 137 DCATLLKNIGP---LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhhhcccCCC---Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 44444433222 222 22789999999 77999999999999999999999999987754321100
Q ss_pred ----------cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-cccH
Q 047375 344 ----------AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD-ESEM 412 (496)
Q Consensus 344 ----------~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~ 412 (496)
-....++|||.|+|||++..+.|....|||++|+++|+.+-+..||.+...++.+..++...+.. +...
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de 282 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE 282 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc
Confidence 11234689999999999999999999999999999999999999999988888887777543332 2234
Q ss_pred HHHHHHHHHHHHhcccCCCCCC
Q 047375 413 EEIEVVAELASKCLRIRGTERP 434 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RP 434 (496)
...+++++++.++|+.+|..|-
T Consensus 283 a~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 283 ALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CCCHHHHHHHHHHHHhChHhhc
Confidence 4557899999999999999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.5e-17 Score=140.93 Aligned_cols=134 Identities=20% Similarity=0.167 Sum_probs=110.4
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCC--CceeeEEEEEeeCCeeeEEEeeccCCchh
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKH--KNVVKILGLCLETKVTLLVYEFVSNGALS 269 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 269 (496)
+.||.|.++.||++... +..+++|....... .....+|...+..++| ++++++++++...+..+++|||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK-DEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEec-CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 56999999999999984 47899998765433 3345577888888876 58999999988888899999999988776
Q ss_pred hhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 270 HYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 270 ~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
.+ +......++.+++.+|.++|.....+++|+|++|.||+++..+.++++|||.+...
T Consensus 82 ~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 54 33455678899999999999865457999999999999998889999999987654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.2e-17 Score=146.22 Aligned_cols=137 Identities=20% Similarity=0.222 Sum_probs=95.2
Q ss_pred hhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhH-------------------------HHHHHHHhcCCCC--ce
Q 047375 191 HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITE-------------------------WEFLGIISQVKHK--NV 243 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------------------------~~e~~~l~~l~hp--nI 243 (496)
.+.||+|+||.||+|...++..||||.+.......... ..|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999998789999999876432111000 1233444444332 24
Q ss_pred eeEEEEEeeCCeeeEEEeeccCCchhhh-hhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC
Q 047375 244 VKILGLCLETKVTLLVYEFVSNGALSHY-IHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD 322 (496)
Q Consensus 244 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~ 322 (496)
.+.+++ ...++||||++++++... +.... .. ..+..++.+++.++.++|.. ++|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-
Confidence 444443 235899999999554321 11111 11 45678999999999999982 4699999999999999
Q ss_pred CCceEEccCCCccccCC
Q 047375 323 NYTAKVSDFESLVPISS 339 (496)
Q Consensus 323 ~~~~kL~DFGla~~~~~ 339 (496)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999998866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.1e-16 Score=146.68 Aligned_cols=134 Identities=14% Similarity=0.181 Sum_probs=102.6
Q ss_pred hhcc-cCCceEEEEeEeCCCcEEEEEEeecch--------------hhhhhHHHHHHHHhcCCCCce--eeEEEEEeeCC
Q 047375 192 HCLG-MGGFGSVYKGVLPDNTQVAVKKYMCAD--------------EIRITEWEFLGIISQVKHKNV--VKILGLCLETK 254 (496)
Q Consensus 192 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~hpnI--v~l~~~~~~~~ 254 (496)
..|| .||.|+||.+.. .+..++||.+.... .......+|+.++..+.|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 899999999987 47889999875321 111234578999999998775 67777654322
Q ss_pred ----eeeEEEeeccC-CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEc
Q 047375 255 ----VTLLVYEFVSN-GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 255 ----~~~lv~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
..++||||++| .+|.+++.... ++.. .+.+|+.+|.+||+ +||+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 68988886431 3332 36789999999999 889999999999999988899999
Q ss_pred cCCCcccc
Q 047375 330 DFESLVPI 337 (496)
Q Consensus 330 DFGla~~~ 337 (496)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.6e-18 Score=176.72 Aligned_cols=247 Identities=17% Similarity=0.171 Sum_probs=184.4
Q ss_pred cchhhhcccCCceEEEEeEeC--CCcEEEEEEeecchhhhhhH---HHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP--DNTQVAVKKYMCADEIRITE---WEFLGIISQVK-HKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~---~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 261 (496)
|.+.+.||+|+|+.|-..... ....+|+|.+.......... ..|..+-..+. |+|++++++........+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 566677999999999888753 34556777665443211111 13555555665 9999999999999999999999
Q ss_pred eccCCchhhhh-hhcCcccccCHHHHHHHHHHHHHHHHHhH-hcCCCCcccCCCCcCceeeCCCC-ceEEccCCCccccC
Q 047375 262 FVSNGALSHYI-HDKSSQVLKNWKTCLRIAAETASAIHYLH-SLASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPIS 338 (496)
Q Consensus 262 ~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~ 338 (496)
|..||++...+ ..... ..+......++.|+..|+.|+| . .++.||||||+|.+++..+ ..|++|||+|....
T Consensus 102 ~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999888 33321 1344566789999999999999 6 7899999999999999999 99999999999887
Q ss_pred C-CCCccceecccc-cceeecCcccccc-cccCCCCCchhhhhcccccccccchhhh-cccchhhhhhhcc--cCCcccH
Q 047375 339 S-DDETAMSTMIRG-TVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDS-IENNSFRQILNFQ--VADESEM 412 (496)
Q Consensus 339 ~-~~~~~~~~~~~g-t~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~--~~~~~~~ 412 (496)
. ..........+| ++.|+|||...+. ...+..|+||.|+++..++.+..|+... .....+....... .......
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 6 444444455678 9999999999884 4556789999999999998886655433 2333333333221 1223334
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEV 439 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~ei 439 (496)
.......+++.+++..+|..|.+..++
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred cCChhhhhcccccccCCchhccccccc
Confidence 455678899999999999999998877
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=4e-14 Score=144.59 Aligned_cols=140 Identities=19% Similarity=0.157 Sum_probs=95.5
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhh-----------------------------------------hhHHH
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIR-----------------------------------------ITEWE 230 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------------------------~~~~~ 230 (496)
+.||+|++|.||+|++.+|+.||||+..+..... ....+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999899999999875431100 00112
Q ss_pred HHHHHhcC----CCCceeeEEEEEe-eCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHH-HHHHhHhcC
Q 047375 231 FLGIISQV----KHKNVVKILGLCL-ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETAS-AIHYLHSLA 304 (496)
Q Consensus 231 e~~~l~~l----~hpnIv~l~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~-gL~~LH~~~ 304 (496)
|...+.++ +|.+-+.+-.++. ..+..+|||||++|++|.++....... .+ ...++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHh--
Confidence 33333332 2333233323332 234468999999999999887542211 11 2346666665 4678888
Q ss_pred CCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 305 ~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
.|++|+|++|.||+++.++.++|+|||++..+..
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7899999999999999999999999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.3e-13 Score=119.64 Aligned_cols=130 Identities=18% Similarity=0.091 Sum_probs=94.1
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCce-eeEEEEEeeCCeeeEEEeeccCCchhh
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNV-VKILGLCLETKVTLLVYEFVSNGALSH 270 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~g~L~~ 270 (496)
+.|+.|.++.||++.. .+..|++|..............|..++..+.+.++ .+++++.. ...++||||++|.++..
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence 4689999999999987 47889999875543222334567777777765444 45555443 34579999999988764
Q ss_pred hhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC--CCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 271 YIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA--SPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 271 ~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
.. .. ...++.+++.+|..||... +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~--------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED--------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc--------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 00 1235679999999999843 12369999999999999 66899999997654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-13 Score=139.56 Aligned_cols=251 Identities=20% Similarity=0.134 Sum_probs=178.2
Q ss_pred HHHHHhcchhhhccc--CCceEEEEeEe---CCCcEEEEEEeecch---hhhhhHHHHHHHHhcC-CCCceeeEEEEEee
Q 047375 182 ELLKATKNFHHCLGM--GGFGSVYKGVL---PDNTQVAVKKYMCAD---EIRITEWEFLGIISQV-KHKNVVKILGLCLE 252 (496)
Q Consensus 182 ~l~~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~ 252 (496)
+....+..+...+|. |.+|.||.+.. .++..+|+|+-+... .......++.....++ .|+|.++.+..+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 344455666788999 99999999986 357789998733221 1222233445444455 49999999999999
Q ss_pred CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHH----HHHHhHhcCCCCcccCCCCcCceeeCCC-CceE
Q 047375 253 TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETAS----AIHYLHSLASPSIIHSDVKSANILLDDN-YTAK 327 (496)
Q Consensus 253 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~----gL~~LH~~~~~~ivHrDlKp~NIll~~~-~~~k 327 (496)
.+..|+-+|+|. .+|..+...... .++....+.++.+... ||.++|. ++|+|-|+||.||++..+ ...+
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccceee
Confidence 999999999995 688888765433 2455677888888888 9999999 789999999999999988 8899
Q ss_pred EccCCCccccCCCCCccc---eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc
Q 047375 328 VSDFESLVPISSDDETAM---STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF 404 (496)
Q Consensus 328 L~DFGla~~~~~~~~~~~---~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 404 (496)
++|||+...+........ .....|...|++||...+ .++..+|++++|.+..+...+...+.... ...+..+-..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~-~~~W~~~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK-NSSWSQLRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC-CCCccccccc
Confidence 999999888876542211 112247888999998776 78889999999998888766644433220 0112222211
Q ss_pred ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 405 QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 405 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.++.+.....+..+...+..+++.+|..|+++..+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 222222223344566699999999999999877654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=2e-13 Score=141.13 Aligned_cols=138 Identities=15% Similarity=0.097 Sum_probs=88.1
Q ss_pred hhcccCCceEEEEeEeCC-CcEEEEEEeecchhh-----------------------------------hhh------HH
Q 047375 192 HCLGMGGFGSVYKGVLPD-NTQVAVKKYMCADEI-----------------------------------RIT------EW 229 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----------------------------------~~~------~~ 229 (496)
+.||+|++|.||+|++.+ |+.||||+..+.-.. ... ..
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999866 999999998643110 000 11
Q ss_pred HHHHHHhcC----CCCceeeEEEEEee-CCeeeEEEeeccCCchhhhh--hhcCc-ccccCHHHHHHHHHHHHHHHHHhH
Q 047375 230 EFLGIISQV----KHKNVVKILGLCLE-TKVTLLVYEFVSNGALSHYI--HDKSS-QVLKNWKTCLRIAAETASAIHYLH 301 (496)
Q Consensus 230 ~e~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l--~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH 301 (496)
+|...+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++- ...+. ...+....+..++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 222222222 24444444343332 34567999999999998753 22211 1112222233333343 2
Q ss_pred hcCCCCcccCCCCcCceeeCCCC----ceEEccCCCccccCC
Q 047375 302 SLASPSIIHSDVKSANILLDDNY----TAKVSDFESLVPISS 339 (496)
Q Consensus 302 ~~~~~~ivHrDlKp~NIll~~~~----~~kL~DFGla~~~~~ 339 (496)
. .|++|+|+||.||+++.++ .++++|||++..++.
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 6799999999999999887 999999999887754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-13 Score=128.23 Aligned_cols=202 Identities=21% Similarity=0.253 Sum_probs=136.0
Q ss_pred HHhcCCCCceeeEEEEEeeCC-----eeeEEEeeccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCC
Q 047375 234 IISQVKHKNVVKILGLCLETK-----VTLLVYEFVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPS 307 (496)
Q Consensus 234 ~l~~l~hpnIv~l~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ 307 (496)
-|-.+-|.|||+++.|+.+.. ...++.||+..|+|.++|++.. ....+....-.+++.||..||.|||++. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 344567999999999987543 4678999999999999998742 2333555666789999999999999976 78
Q ss_pred cccCCCCcCceeeCCCCceEEccCCCccccCC--CCCccceecccccceeecCcccccccccCCCCCchhhhhccccccc
Q 047375 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISS--DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM 385 (496)
Q Consensus 308 ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~--~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~ 385 (496)
|+|+++...-|++..+|-+|+.----...... ...........|-++|.+||+=..-..++..|||++|+...+|..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999888742111000000 0000111223467899999987777888999999999888777655
Q ss_pred ccchhhhcc-cchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 386 VPYFLDSIE-NNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 386 ~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..-...... ...-..+.+..+.... ..-++++.+|++..|..||+|.+++-
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~len-----~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLEN-----GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceeehhhhhhhheeeccC-----ccccCcCcccccCCCCCCcchhhhhc
Confidence 332111110 0000111111111111 11357899999999999999998764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-11 Score=111.24 Aligned_cols=135 Identities=16% Similarity=0.173 Sum_probs=94.6
Q ss_pred hhcccCCceEEEEeEeCC-------CcEEEEEEeecch-----------------------hhhhhH----HHHHHHHhc
Q 047375 192 HCLGMGGFGSVYKGVLPD-------NTQVAVKKYMCAD-----------------------EIRITE----WEFLGIISQ 237 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-----------------------~~~~~~----~~e~~~l~~ 237 (496)
..||.|--+.||.|...+ +..+|||.+.... ...... .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4789999774210 001111 167777777
Q ss_pred CCC--CceeeEEEEEeeCCeeeEEEeeccCCchhh-hhhhcCcccccCHHHHHHHHHHHHHHHHHh-HhcCCCCcccCCC
Q 047375 238 VKH--KNVVKILGLCLETKVTLLVYEFVSNGALSH-YIHDKSSQVLKNWKTCLRIAAETASAIHYL-HSLASPSIIHSDV 313 (496)
Q Consensus 238 l~h--pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~~~~ivHrDl 313 (496)
+.. -++.+++++ ..-+|||||+.++.+.. .+... .++......+..+++.+|..| |. .+|||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 753 456666654 34579999997654422 22221 133445667889999999999 77 68999999
Q ss_pred CcCceeeCCCCceEEccCCCccccC
Q 047375 314 KSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 314 Kp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
+|.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.6e-11 Score=103.94 Aligned_cols=130 Identities=18% Similarity=0.210 Sum_probs=95.8
Q ss_pred hcccCCceEEEEeEeCCCcEEEEEEeecch----h-----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 193 CLGMGGFGSVYKGVLPDNTQVAVKKYMCAD----E-----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~-----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.+++|+-+.+|.+.+ -|.++++|.-.+.. . ...+..+|..++.+++--.|...+=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 588999999999987 45567777432221 1 1123347788888776544444444555667778999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+|-.|.+.+.... ..++..+-.-+.-||. .+|||+||.++||++..+ .+.++|||++...
T Consensus 82 ~G~~lkd~l~~~~----------~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEAR----------PDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhcc----------hHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCC-cEEEEECCccccc
Confidence 9999988886541 3466777778888999 889999999999999876 4999999997653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.9e-12 Score=128.49 Aligned_cols=242 Identities=17% Similarity=0.137 Sum_probs=169.2
Q ss_pred cchhhhcccCCceEEEEeEe--CCCcEEEEEEeecchhh---hhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL--PDNTQVAVKKYMCADEI---RITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+.....||.|.|+.|+.... .++..|++|.+...-.. ......|+-+...+ .|.++++++..+....+.||--|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 34457899999999999874 46788999976543221 22222444444444 59999999988888888889999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-CceEEccCCCccccCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-YTAKVSDFESLVPISSD 340 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-~~~kL~DFGla~~~~~~ 340 (496)
||+++++...+.- ...++...++++..|++.++.++|+ ..++|+|+||+||++..+ +..++.|||+.+.+...
T Consensus 347 ~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 347 FCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred hhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee
Confidence 9999988766522 1225667788999999999999998 779999999999999875 78899999987653322
Q ss_pred CCccceecccccceee--cCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYL--DPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~--aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
.. ...+.-.++ +|.......+..+.|++++|..+.+..++.+.-..... ...+........ + .....+
T Consensus 421 ~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~-~-~~~~~~ 490 (524)
T KOG0601|consen 421 SG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNL-P-GLKLQL 490 (524)
T ss_pred cc-----cccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCC-C-chHHhh
Confidence 11 111233344 55666667778899999999999998887665433221 111221111111 1 122668
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDR 445 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~ 445 (496)
..+...++..++..||++.++....+.
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchh
Confidence 889999999999999998887655443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.7e-11 Score=111.25 Aligned_cols=141 Identities=18% Similarity=0.175 Sum_probs=105.8
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCC--CceeeEEEEEeeC---CeeeEEEeecc
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE--IRITEWEFLGIISQVKH--KNVVKILGLCLET---KVTLLVYEFVS 264 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~---~~~~lv~E~~~ 264 (496)
+.|+.|.++.||++...+|..+++|....... .......|..++..+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999986668999998754432 23344577888888765 4567788877654 25689999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC----------------------------------------
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA---------------------------------------- 304 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~---------------------------------------- 304 (496)
|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988876532 12455667778888888888888531
Q ss_pred -------------CCCcccCCCCcCceeeCC--CCceEEccCCCccc
Q 047375 305 -------------SPSIIHSDVKSANILLDD--NYTAKVSDFESLVP 336 (496)
Q Consensus 305 -------------~~~ivHrDlKp~NIll~~--~~~~kL~DFGla~~ 336 (496)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56789999987654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-10 Score=99.51 Aligned_cols=140 Identities=17% Similarity=0.226 Sum_probs=100.4
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecch---------hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD---------EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.+|-+|+-+.|+++.+ .|+...||.-.... -.+.+..+|.+.|.++.--.|.-..=++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4688999999999998 68888888532211 1223344778888887644444444455566666799999
Q ss_pred ccC-CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC---ceEEccCCCccc
Q 047375 263 VSN-GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY---TAKVSDFESLVP 336 (496)
Q Consensus 263 ~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~---~~kL~DFGla~~ 336 (496)
++| .++.+++.........+ .....++..|-..+.-||. ++|||+||..+||++..++ .+.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 987 47888887654332222 2226788899999999999 8899999999999996544 458999998654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-10 Score=118.63 Aligned_cols=165 Identities=15% Similarity=0.096 Sum_probs=121.7
Q ss_pred eCCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHH
Q 047375 207 LPDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKT 285 (496)
Q Consensus 207 ~~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~ 285 (496)
..++.+|.|.......... ....+.++-|+.++||||++++..+...+..|||+|-+. .|..++.... ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHH
Confidence 3468888888876655411 123366888999999999999999999999999999985 6877776543 344
Q ss_pred HHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCccccccc
Q 047375 286 CLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTEL 365 (496)
Q Consensus 286 ~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~ 365 (496)
....+.||+.||.|||+. .+++|++|.-+-|+++..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 556789999999999974 4799999999999999999999999987655432211 001111123456666443211
Q ss_pred ccCCCCCchhhhhccccccc
Q 047375 366 LTGMNPNSYVALASNEKISM 385 (496)
Q Consensus 366 ~t~~~d~~s~g~~~~~~~~~ 385 (496)
-..|.|-+||++++++.+
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 235889999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.9e-12 Score=133.63 Aligned_cols=240 Identities=19% Similarity=0.171 Sum_probs=172.9
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHH----HHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEW----EFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~----~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+.+-+|.++.++.+.- ..+...+.|............. .+-.++-...||.+++.+-.+......++||+|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 4678889999887763 2343344443322222221111 1112222335677776666655667789999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC------C
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS------D 340 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~------~ 340 (496)
+|...|+.... .+..-.......+..+++|||. ..++|||++|.|+++..++..+++|||+...... .
T Consensus 890 ~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 890 DLPSKLHNSGC---LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred CchhhhhcCCC---cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 99999876542 3334445667788899999998 5599999999999999999999999984332110 0
Q ss_pred ---------------C--------CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch
Q 047375 341 ---------------D--------ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS 397 (496)
Q Consensus 341 ---------------~--------~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~ 397 (496)
. .........||+.|.+||.+.+.......|||+.|+++++.++|.+||........
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~ 1043 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI 1043 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh
Confidence 0 00112235699999999999998888889999999999999999999999888888
Q ss_pred hhhhhhcccCCcc-cHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047375 398 FRQILNFQVADES-EMEEIEVVAELASKCLRIRGTERPTMK 437 (496)
Q Consensus 398 ~~~i~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ 437 (496)
+..+.+...+.+. +...+....+++.+.+..+|.+|-.+.
T Consensus 1044 f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 8888876655443 344567899999999999999997665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-09 Score=96.68 Aligned_cols=125 Identities=25% Similarity=0.307 Sum_probs=79.8
Q ss_pred EEEEeEeCCCcEEEEEEeecch--------------h-------------hhhhHHHHHHHHhcCCCC--ceeeEEEEEe
Q 047375 201 SVYKGVLPDNTQVAVKKYMCAD--------------E-------------IRITEWEFLGIISQVKHK--NVVKILGLCL 251 (496)
Q Consensus 201 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------------~~~~~~~e~~~l~~l~hp--nIv~l~~~~~ 251 (496)
.||.|...+|..+|||...... . ......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999773210 0 011223778889888755 566776552
Q ss_pred eCCeeeEEEeecc--CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHh-HhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 252 ETKVTLLVYEFVS--NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL-HSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 252 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
.-+|||||++ |..+..+.... ++......++.+++..+..+ |. .+|+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 2469999998 55554433221 11233456777888866664 56 689999999999999977 9999
Q ss_pred ccCCCccccC
Q 047375 329 SDFESLVPIS 338 (496)
Q Consensus 329 ~DFGla~~~~ 338 (496)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999876654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.1e-09 Score=100.37 Aligned_cols=138 Identities=12% Similarity=0.043 Sum_probs=93.2
Q ss_pred cccCCceEEEEeEeCCCcEEEEEEeecchhh------------hhhHHHHHHHHhcCCC--CceeeEEEEEee-----CC
Q 047375 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEI------------RITEWEFLGIISQVKH--KNVVKILGLCLE-----TK 254 (496)
Q Consensus 194 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h--pnIv~l~~~~~~-----~~ 254 (496)
+-......|+++.+ +|+.|.||........ .....+|...+..+.. -.++.++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667766 6788999977433211 0123466666655532 223344444432 23
Q ss_pred eeeEEEeeccCC-chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-------CCce
Q 047375 255 VTLLVYEFVSNG-ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-------NYTA 326 (496)
Q Consensus 255 ~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-------~~~~ 326 (496)
..+||||++++. +|.+++..... ...+......++.+++..+.-||. .||+|+|++++|||++. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence 568999999886 79988864221 123445677899999999999999 88999999999999975 4689
Q ss_pred EEccCCCccc
Q 047375 327 KVSDFESLVP 336 (496)
Q Consensus 327 kL~DFGla~~ 336 (496)
.|+||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999997753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.6e-08 Score=98.13 Aligned_cols=212 Identities=12% Similarity=0.109 Sum_probs=145.3
Q ss_pred ceEEEEeEe-CCCcEEEEEEeecchhhhh-hHHHHHHHHhcCCCCceeeEEEEEee----CCeeeEEEeeccC-Cchhhh
Q 047375 199 FGSVYKGVL-PDNTQVAVKKYMCADEIRI-TEWEFLGIISQVKHKNVVKILGLCLE----TKVTLLVYEFVSN-GALSHY 271 (496)
Q Consensus 199 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~E~~~~-g~L~~~ 271 (496)
..+.|++.. .+|..|++|+++....... ..-.-++.++++.|+|||++..++.. ...+++|++|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788884 4789999999854332222 22245788999999999999998873 4467899999985 577766
Q ss_pred hhhcC------------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 272 IHDKS------------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 272 l~~~~------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
-.... .....++...|.++.|+..||.++|+ .|..-+-|.|.+||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 12235778999999999999999999 6788899999999999999999998887665543
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccc--hhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPY--FLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~--~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
+.. |-+. -..+.|.-.+|.++..+.++..- -.......... ......+.+
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~---------~I~~~yS~D 497 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT---------RITTTYSTD 497 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHH---------HhhhhhhHH
Confidence 320 1111 12356777889888888777432 11111111111 122344566
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
+++++.-....++++ -++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 888888888888876 567777665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.2e-08 Score=90.74 Aligned_cols=134 Identities=19% Similarity=0.236 Sum_probs=91.1
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecc----------h-------------hhhhhHHHHHHHHhcCCCC--c
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCA----------D-------------EIRITEWEFLGIISQVKHK--N 242 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----------~-------------~~~~~~~~e~~~l~~l~hp--n 242 (496)
+.+...||-|.-|.||.|..+.|.++|||.-... . ..+....+|...|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3456889999999999999999999999953210 0 1122334778888887644 5
Q ss_pred eeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC
Q 047375 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD 322 (496)
Q Consensus 243 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~ 322 (496)
|.+.+++ +.-.+||||++|-.|...-- +....-.++..|+.-+.-+-. .||||+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 6666654 34569999999876654321 111122333444444433334 57999999999999999
Q ss_pred CCceEEccCCCccc
Q 047375 323 NYTAKVSDFESLVP 336 (496)
Q Consensus 323 ~~~~kL~DFGla~~ 336 (496)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999964433
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=7.4e-09 Score=106.52 Aligned_cols=149 Identities=15% Similarity=0.135 Sum_probs=105.6
Q ss_pred HHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc-------eecccccceeecCccccc
Q 047375 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM-------STMIRGTVGYLDPEYAHT 363 (496)
Q Consensus 291 ~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~gt~~Y~aPE~l~~ 363 (496)
.+++.||.|+|.. .++||++|.|++|.++.++.+||+.|+.+........... .....-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999984 6799999999999999999999999998776654222110 111124567999999999
Q ss_pred ccccCCCCCchhhhhcccccccccchhhhcccchhhhh---hhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 364 ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQI---LNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 364 ~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
...+...|++|+|+.+|.+..+..+............. .......-...+.++++++-+.+++..++.-||++.++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 88899999999999999999554443333222211111 111111112245567899999999999999999887765
Q ss_pred H
Q 047375 441 E 441 (496)
Q Consensus 441 ~ 441 (496)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.2e-07 Score=85.53 Aligned_cols=104 Identities=14% Similarity=0.128 Sum_probs=76.9
Q ss_pred HHHHHHHHhcCC--CCceeeEEEEEeeC----CeeeEEEeeccCC-chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHh
Q 047375 228 EWEFLGIISQVK--HKNVVKILGLCLET----KVTLLVYEFVSNG-ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300 (496)
Q Consensus 228 ~~~e~~~l~~l~--hpnIv~l~~~~~~~----~~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~L 300 (496)
..+|...+..+. .=.+.+.+++.... ...+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHHH
Confidence 345555555443 22345556665542 2458999999874 79999876332 34456678999999999999
Q ss_pred HhcCCCCcccCCCCcCceeeCCCC---ceEEccCCCcccc
Q 047375 301 HSLASPSIIHSDVKSANILLDDNY---TAKVSDFESLVPI 337 (496)
Q Consensus 301 H~~~~~~ivHrDlKp~NIll~~~~---~~kL~DFGla~~~ 337 (496)
|. +||+|+|++|.|||++.+. .+.|+||+.++..
T Consensus 135 H~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 8899999999999998876 8999999876653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.8e-07 Score=86.03 Aligned_cols=251 Identities=19% Similarity=0.121 Sum_probs=155.0
Q ss_pred hhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceee--------EEEEEeeCCeeeEEEe
Q 047375 191 HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVK--------ILGLCLETKVTLLVYE 261 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~--------l~~~~~~~~~~~lv~E 261 (496)
.+.||+|+-+.+|-.-- -+. .+.|+++.......... +..|... .||-+-. ++|-- .....-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e-~~d-~VAKIYh~Pppa~~aqk--~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE-VRD-QVAKIYHAPPPAAQAQK--VAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch-hhc-hhheeecCCCchHHHHH--HHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEecc
Confidence 46799999999996542 122 34577765443332221 2233332 4554333 11111 1122456777
Q ss_pred eccCC-chhhhhh---hcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 262 FVSNG-ALSHYIH---DKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 262 ~~~~g-~L~~~l~---~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
.+++. .+..+++ ++.......|...++.++.++.+..-||. .|.+-+|+.++|+|+.+++.|.|.|=..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 77653 1222222 22333456899999999999999999999 77899999999999999999999875422211
Q ss_pred CCCCCccceecccccceeecCccccc-----ccccCCCCCchhhhhccccccc-ccchhhhccc----chhh-hhhhccc
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISM-VPYFLDSIEN----NSFR-QILNFQV 406 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~----~~~~-~i~~~~~ 406 (496)
. ........+|.+.|.+||.-.- ..-+...|.+-+++++++++.+ ..||.+-... ..+. .|..+.+
T Consensus 168 -~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 168 -A--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred -c--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 1 1122345669999999996552 3445678999999999988665 6666543211 1111 1211110
Q ss_pred -----------C--Ccc-cHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHhhHhhhhh
Q 047375 407 -----------A--DES-EMEEIEVVAELASKCLRI--RGTERPTMKEVSEELDRLRRLQEN 452 (496)
Q Consensus 407 -----------~--~~~-~~~~~~~l~~li~~cl~~--dP~~RPs~~eil~~L~~l~~~~~~ 452 (496)
+ ..+ ..-.++.+..|..+|+.. ++.-|||++.-+..|..+......
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 1 111 123347789999999964 467899999888888887765443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.9e-07 Score=80.17 Aligned_cols=138 Identities=17% Similarity=0.046 Sum_probs=97.5
Q ss_pred cccCCceEEEEeEeCCCcEEEEEEeecc-------hhhhhhHHHHHHHHhcCCC--CceeeEEEEEee----CCeeeEEE
Q 047375 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCA-------DEIRITEWEFLGIISQVKH--KNVVKILGLCLE----TKVTLLVY 260 (496)
Q Consensus 194 lg~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~----~~~~~lv~ 260 (496)
-|.||-+.|++..+ .|..+-+|+-... +.....+.+|...+..+.. -.+.++...... .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46699999999887 4557888965311 2244556678777776642 224454422222 12457999
Q ss_pred eeccC-CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc--eEEccCCCccc
Q 047375 261 EFVSN-GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT--AKVSDFESLVP 336 (496)
Q Consensus 261 E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~--~kL~DFGla~~ 336 (496)
|-++| -+|.+++...... ..+......+..+++..+.-||+ .|+.|+|+-+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97763 4888888654322 24556678899999999999999 78999999999999986666 99999975544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.1e-08 Score=100.88 Aligned_cols=182 Identities=16% Similarity=0.129 Sum_probs=129.3
Q ss_pred hhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCc-eeeEEEEEeeCCeeeEEEeeccCC-ch
Q 047375 191 HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKN-VVKILGLCLETKVTLLVYEFVSNG-AL 268 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~~~g-~L 268 (496)
-+-+++|+++++||.+-...+....+.+... ....-++++|.+++||| .+..++-+..+...+++|++|.+| +-
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 3557899999999988533333445554333 12224578999999999 888888888888999999999887 22
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceec
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
....... ...+.......+.+.-.++|+++|+ -.-+||| ||+..+ +..|..||+....+.... ..+.
T Consensus 323 ~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t 389 (829)
T KOG0576|consen 323 ALEMTVS--EIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRT 389 (829)
T ss_pred cccCChh--hHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cccc
Confidence 2221111 1112233445567777889999998 2248999 888775 589999999887776542 3455
Q ss_pred ccccceeecCcccccccccCCCCCchhhhhcccccccccch
Q 047375 349 IRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYF 389 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~ 389 (496)
..+|+.++|||+.....+.+..+.|+.+.-..++.-+.+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 66999999999999999999999999987555665555543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.2e-07 Score=93.82 Aligned_cols=139 Identities=19% Similarity=0.156 Sum_probs=88.1
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhh-----------------------------------hhhH------HH
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI-----------------------------------RITE------WE 230 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------------------~~~~------~~ 230 (496)
..|+.++-|.||+|++.+|+.||||+..+.-.. .... .+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999989999999987433100 0000 12
Q ss_pred HHHHHhcC----C-CCceeeEEEEEe-eCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHH-HHHhHhc
Q 047375 231 FLGIISQV----K-HKNVVKILGLCL-ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASA-IHYLHSL 303 (496)
Q Consensus 231 e~~~l~~l----~-hpnIv~l~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~g-L~~LH~~ 303 (496)
|..-+.++ + .|+| ++=.+|. ..+...|+|||++|-.+.+...-.... .+... ++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~---ia~~~~~~f~~q~~~- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKE---LAELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHH---HHHHHHHHHHHHHHh-
Confidence 22222222 2 3443 2223332 344567999999999998885332211 23222 23232222 122222
Q ss_pred CCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 304 ~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
.|++|.|..|.||+++.+|.+.+.|||+...+..
T Consensus 284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5699999999999999999999999999887764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.5e-06 Score=81.10 Aligned_cols=140 Identities=16% Similarity=0.166 Sum_probs=81.4
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCC--ceeeEEEEEeeCCeeeEEEeeccCCc-h
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHK--NVVKILGLCLETKVTLLVYEFVSNGA-L 268 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~~~~~~~~~lv~E~~~~g~-L 268 (496)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..- .+.+.++++...+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 25567888775432 222335677777776532 25677888877777889999999863 2
Q ss_pred hhhhh--------------h-----cCc-ccccCHHHH-HHHHH----------HHHH-HHHHhHhc-CCCCcccCCCCc
Q 047375 269 SHYIH--------------D-----KSS-QVLKNWKTC-LRIAA----------ETAS-AIHYLHSL-ASPSIIHSDVKS 315 (496)
Q Consensus 269 ~~~l~--------------~-----~~~-~~~l~~~~~-~~i~~----------qi~~-gL~~LH~~-~~~~ivHrDlKp 315 (496)
...+. . +.- ....+.... ..+.. .+.. ...+|... ....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 21111 0 000 000010000 00000 0001 11222211 124578999999
Q ss_pred CceeeCCCCceEEccCCCccc
Q 047375 316 ANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 316 ~NIll~~~~~~kL~DFGla~~ 336 (496)
.||++++++ +.|+||+.+..
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CcEEEcCCC-cEEEechhcCc
Confidence 999999887 99999987653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.3e-06 Score=77.82 Aligned_cols=138 Identities=14% Similarity=0.138 Sum_probs=86.2
Q ss_pred HHHHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHH----------HHHHHHhcCC---CCceeeEEEE
Q 047375 183 LLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEW----------EFLGIISQVK---HKNVVKILGL 249 (496)
Q Consensus 183 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~----------~e~~~l~~l~---hpnIv~l~~~ 249 (496)
++...+...+.+-......|.+-.. +|..+++|..........+.+ +.+..+.++. -...+.++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3444455556677777777777777 678899997654332211111 1122222222 2222333333
Q ss_pred Ee-----eCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC
Q 047375 250 CL-----ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY 324 (496)
Q Consensus 250 ~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~ 324 (496)
.. .....+++|||++|-.|.++.. ++. .+...+..++.-||. .|++|+|..|+|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence 22 1234568999999988876542 121 244567788999999 789999999999999965
Q ss_pred ceEEccCCCccc
Q 047375 325 TAKVSDFESLVP 336 (496)
Q Consensus 325 ~~kL~DFGla~~ 336 (496)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 599999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.8e-06 Score=78.09 Aligned_cols=137 Identities=18% Similarity=0.215 Sum_probs=89.1
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhh-------------------h----h--HHHHHHHHhcCC--CCcee
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIR-------------------I----T--EWEFLGIISQVK--HKNVV 244 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~----~--~~~e~~~l~~l~--hpnIv 244 (496)
-.|++|.-+.||+|...++..+|||++....... . . ..+|+.-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3688899999999998789999999885332110 0 0 013444444442 33344
Q ss_pred eEEEEEeeCCeeeEEEeeccCC-chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC
Q 047375 245 KILGLCLETKVTLLVYEFVSNG-ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN 323 (496)
Q Consensus 245 ~l~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~ 323 (496)
+.+++.. -.|||||+... .-.-.|..- .+.......+..++++++.-|-.. .++||+||+.-|||+. +
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-C
Confidence 4444432 35999999643 111122211 122235667778888888877763 4699999999999999 7
Q ss_pred CceEEccCCCccccCC
Q 047375 324 YTAKVSDFESLVPISS 339 (496)
Q Consensus 324 ~~~kL~DFGla~~~~~ 339 (496)
+.+.|+|||-|.....
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 7999999998776643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.33 E-value=4e-06 Score=78.46 Aligned_cols=142 Identities=19% Similarity=0.206 Sum_probs=78.8
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCC--ceeeEEEEEee---CCeeeEEEeeccCC
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHK--NVVKILGLCLE---TKVTLLVYEFVSNG 266 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~~~~---~~~~~lv~E~~~~g 266 (496)
+.|+.|..+.||+....+ ..+++|..... .......+|..++..+... .+.+++.++.. ....+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 458899999999999865 69999987655 2333334566666655422 35667765433 34578999999998
Q ss_pred chhh----------------hhhh---c-CcccccCHH---------HHHHH------------HHHHHH-HHHHhHhc-
Q 047375 267 ALSH----------------YIHD---K-SSQVLKNWK---------TCLRI------------AAETAS-AIHYLHSL- 303 (496)
Q Consensus 267 ~L~~----------------~l~~---~-~~~~~l~~~---------~~~~i------------~~qi~~-gL~~LH~~- 303 (496)
.+.. .+.. . ......... ..... ...+.. .+..++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 1111 0 000000000 00000 111222 23333321
Q ss_pred ---CCCCcccCCCCcCceeeC-CCCceEEccCCCcc
Q 047375 304 ---ASPSIIHSDVKSANILLD-DNYTAKVSDFESLV 335 (496)
Q Consensus 304 ---~~~~ivHrDlKp~NIll~-~~~~~kL~DFGla~ 335 (496)
.+..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 236699999999999999 66666899998653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.5e-06 Score=77.52 Aligned_cols=75 Identities=11% Similarity=-0.020 Sum_probs=50.0
Q ss_pred cccCCc-eEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeeccCCchhhh
Q 047375 194 LGMGGF-GSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFVSNGALSHY 271 (496)
Q Consensus 194 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 271 (496)
|..|.+ +.||+.... +..+.||...... .....+|+.++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444544 789999764 4678888765432 222335666666553 34466788887776778999999999877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.3e-06 Score=84.50 Aligned_cols=139 Identities=18% Similarity=0.114 Sum_probs=87.3
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhh--------------------------------hh------hHHHHH-
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI--------------------------------RI------TEWEFL- 232 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------------~~------~~~~e~- 232 (496)
+.||.-+.|.||+|+.++|+.||||+-++.-.. .. .+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 679999999999999989999999976432110 00 011121
Q ss_pred ---HHHhcCCCCc------eeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhc
Q 047375 233 ---GIISQVKHKN------VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303 (496)
Q Consensus 233 ---~~l~~l~hpn------Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~ 303 (496)
+....+.|-+ |.++|-.+. ....|+||||+|..+.+.-.-.... ++.. .++..+.++ |++..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g--i~~~---~i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG--ISPH---DILNKLVEA--YLEQI 317 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC--CCHH---HHHHHHHHH--HHHHH
Confidence 1222334544 444443332 3467999999998887654322211 2323 333333333 22222
Q ss_pred CCCCcccCCCCcCceeeC----CCCceEEccCCCccccCC
Q 047375 304 ASPSIIHSDVKSANILLD----DNYTAKVSDFESLVPISS 339 (496)
Q Consensus 304 ~~~~ivHrDlKp~NIll~----~~~~~kL~DFGla~~~~~ 339 (496)
-..|++|+|-.|.||++. .++.+.+-|||+...+..
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 225799999999999998 367899999999887754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.3e-06 Score=75.48 Aligned_cols=104 Identities=19% Similarity=0.233 Sum_probs=79.8
Q ss_pred HHHHHHhcCCC-CceeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCc
Q 047375 230 EFLGIISQVKH-KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308 (496)
Q Consensus 230 ~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 308 (496)
.|.-++..+++ +++++++|+|- .++|.||.+.+++...-..-......+|..+.+|+.+++..+.++++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 45667777765 69999999993 35789999877664321000011125899999999999999999998665567
Q ss_pred ccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 309 IHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 309 vHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
.-.|++|+|+-+++++.+|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 78999999999999999999999865544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.5e-05 Score=86.93 Aligned_cols=77 Identities=12% Similarity=0.199 Sum_probs=54.2
Q ss_pred hhcccCCceEEEEeEeCCC---cEEEEEEeecchh--hhhhHHHHHHHHhcCC-CCce--eeEEEEEeeC---CeeeEEE
Q 047375 192 HCLGMGGFGSVYKGVLPDN---TQVAVKKYMCADE--IRITEWEFLGIISQVK-HKNV--VKILGLCLET---KVTLLVY 260 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpnI--v~l~~~~~~~---~~~~lv~ 260 (496)
..++.|.++.+|+.....+ ..+++|+...... ......+|..+++.+. |++| .+++++|.+. +..|+||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688999999999876443 4677777543221 1233457888888885 6654 7888888764 4678999
Q ss_pred eeccCCch
Q 047375 261 EFVSNGAL 268 (496)
Q Consensus 261 E~~~~g~L 268 (496)
||++|..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99998653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.02 E-value=3e-05 Score=73.00 Aligned_cols=31 Identities=32% Similarity=0.503 Sum_probs=25.8
Q ss_pred CCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
..++|+|+.|.|||++.+...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4589999999999998776567999997644
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.8e-05 Score=70.92 Aligned_cols=73 Identities=21% Similarity=0.169 Sum_probs=46.0
Q ss_pred hhcccCCceEEEEeEeCC--CcEEEEEEeecchhhhhhHHHHHHHHhcCCC-CceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 192 HCLGMGGFGSVYKGVLPD--NTQVAVKKYMCADEIRITEWEFLGIISQVKH-KNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
+.|..|-...+|+....+ +..|++|.............+|..++..+.. ...+++++.+. -.++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 357778888999998653 6789999765432222222356667776643 23445555432 2489999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00016 Score=65.69 Aligned_cols=126 Identities=17% Similarity=0.224 Sum_probs=82.5
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecch-----------------hhhhhHHHHHHHHh------cCCCCceeeEEE
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD-----------------EIRITEWEFLGIIS------QVKHKNVVKILG 248 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~e~~~l~------~l~hpnIv~l~~ 248 (496)
..||+|+.=.||.- +.+...+||+..... .......+|+.... ...+.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 46999999988864 456667888876544 11122224433322 234889999999
Q ss_pred EEeeCCeeeEEEeeccC------CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC
Q 047375 249 LCLETKVTLLVYEFVSN------GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD 322 (496)
Q Consensus 249 ~~~~~~~~~lv~E~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~ 322 (496)
+..++..+-+|+|.+.+ -+|.+++.... ++. .....+.+ -..||-. +.|+.+|++|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~~---f~~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALDE---FKRYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHHH---HHHHHHH---cCCeecCCCcccEEEEe
Confidence 99999889999998643 36777775432 333 23333333 3455655 66999999999999953
Q ss_pred C---C-ceEEcc
Q 047375 323 N---Y-TAKVSD 330 (496)
Q Consensus 323 ~---~-~~kL~D 330 (496)
. . .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 2 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00017 Score=70.21 Aligned_cols=75 Identities=7% Similarity=0.014 Sum_probs=51.8
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCC---CceeeEEEEEee---CCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKH---KNVVKILGLCLE---TKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h---pnIv~l~~~~~~---~~~~~lv~E~~~~ 265 (496)
+.||.|..+.||+....++ .+.+|..+. .........|...|+.+.. ..+.+++++|.. .+..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 5699999999999876444 566676432 1122344466666666642 467888888754 3668999999998
Q ss_pred Cch
Q 047375 266 GAL 268 (496)
Q Consensus 266 g~L 268 (496)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00012 Score=63.87 Aligned_cols=129 Identities=17% Similarity=0.133 Sum_probs=83.6
Q ss_pred hhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCcee-eEEEEEeeCCeeeEEEeeccCCch
Q 047375 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVV-KILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
..+.|++|++|.||+|.+ .|..+|+|+-.. +..+.....|.++|..+...++. ++|.+.. .++.|||+.|-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence 346799999999999999 567899987543 34444556778888877765543 3554433 3466999999888
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCC-cCceeeCCCCceEEccCCCcccc
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVK-SANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlK-p~NIll~~~~~~kL~DFGla~~~ 337 (496)
.+.-... +.... ..++..-.-|-. .||-|..|. |..++|..++.+.|+||..|+..
T Consensus 100 ~~~~~~~------~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 100 GKLEIGG------DRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcc------cHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 7665321 11222 233344223333 568888876 44444444558999999887743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00016 Score=65.09 Aligned_cols=124 Identities=24% Similarity=0.273 Sum_probs=84.9
Q ss_pred HhcchhhhcccCCc-eEEEEeEeCCCcEEEEEEeecc----h------------------hhhhhHHHHHHH---HhcCC
Q 047375 186 ATKNFHHCLGMGGF-GSVYKGVLPDNTQVAVKKYMCA----D------------------EIRITEWEFLGI---ISQVK 239 (496)
Q Consensus 186 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~----~------------------~~~~~~~~e~~~---l~~l~ 239 (496)
....|.+.||.|.- |.||++.. +|..+|+|.+..- . .....+..|.+. |+...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 45677899999999 99999999 6889999984210 0 001122244444 44445
Q ss_pred CCce--eeEEEEEeeC------------------CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHH
Q 047375 240 HKNV--VKILGLCLET------------------KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299 (496)
Q Consensus 240 hpnI--v~l~~~~~~~------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~ 299 (496)
+.++ |+.+||..-. ....||.||++... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 6677 9999998422 12357888876543 011 2235577778889
Q ss_pred hHhcCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 300 LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
+|. .+|+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 999 67999999999987 3489999854
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00022 Score=68.02 Aligned_cols=137 Identities=12% Similarity=0.051 Sum_probs=74.2
Q ss_pred cccCCceEEEEeEeCCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCc-eeeEEEEEeeCCeeeEEEeeccCCchhhh
Q 047375 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKN-VVKILGLCLETKVTLLVYEFVSNGALSHY 271 (496)
Q Consensus 194 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 271 (496)
+..|-.+.+|+... ++..+++|........- ....+|..+++.+.... ..++++.+. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 56677888998875 57788888754332211 22345666666664322 234444432 3689999998765421
Q ss_pred --------------hhh---cC-cccccCHH-HHHHHHHHH---------HHHHHHhHhc-----CCCCcccCCCCcCce
Q 047375 272 --------------IHD---KS-SQVLKNWK-TCLRIAAET---------ASAIHYLHSL-----ASPSIIHSDVKSANI 318 (496)
Q Consensus 272 --------------l~~---~~-~~~~l~~~-~~~~i~~qi---------~~gL~~LH~~-----~~~~ivHrDlKp~NI 318 (496)
+.+ .. ...+++.. ....+..++ ..-+..+-.. .+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111 00 00111111 111111111 1111112111 123589999999999
Q ss_pred eeCCCCceEEccCCCccc
Q 047375 319 LLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 319 ll~~~~~~kL~DFGla~~ 336 (496)
+++.++ +.|+||+.|..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999986654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00039 Score=67.81 Aligned_cols=142 Identities=15% Similarity=0.121 Sum_probs=79.3
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCC--ceeeEEEE------EeeCCeeeEEEeec
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHK--NVVKILGL------CLETKVTLLVYEFV 263 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~------~~~~~~~~lv~E~~ 263 (496)
+.|..|....+|+... ++..+++|..... .......|+.++..+.+. .+.+++.. ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~-~~~~~vLr~~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTT-DSGRYVLTLFEKV--SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEe-CCCcEEEEEcCCC--ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 4577787789999876 3457888987541 122222455555555321 24454432 12345678999999
Q ss_pred cCCchhh----hhh----------hc----Ccc----cccCHHHHH----------HHHHHHHHHHHHhHh----cCCCC
Q 047375 264 SNGALSH----YIH----------DK----SSQ----VLKNWKTCL----------RIAAETASAIHYLHS----LASPS 307 (496)
Q Consensus 264 ~~g~L~~----~l~----------~~----~~~----~~l~~~~~~----------~i~~qi~~gL~~LH~----~~~~~ 307 (496)
+|..+.. ... .. ... ....|.... .....+..++.++.. ..+.+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9876532 010 00 000 001111110 011112333444442 12357
Q ss_pred cccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 308 IIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 308 ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999887778999986543
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0012 Score=66.37 Aligned_cols=73 Identities=15% Similarity=0.068 Sum_probs=48.6
Q ss_pred hhcccCCceEEEEeEeCCC-cEEEEEEeecc-----h---hhhhhHHHHHHHHhcC---CCCceeeEEEEEeeCCeeeEE
Q 047375 192 HCLGMGGFGSVYKGVLPDN-TQVAVKKYMCA-----D---EIRITEWEFLGIISQV---KHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~---~~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~~~~~~lv 259 (496)
+.||.|.+..||++...+| +.|+||.-.+. . -...+...|...|..+ ...++.+++.+. ....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 4689999999999998666 48999974311 1 1112233455555544 335678888774 3557899
Q ss_pred EeeccCC
Q 047375 260 YEFVSNG 266 (496)
Q Consensus 260 ~E~~~~g 266 (496)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0003 Score=68.82 Aligned_cols=74 Identities=24% Similarity=0.312 Sum_probs=45.2
Q ss_pred hcccCCceEEEEeEeCC-------CcEEEEEEeecchhhhhhHHHHHHHHhcCCCCc-eeeEEEEEeeCCeeeEEEeecc
Q 047375 193 CLGMGGFGSVYKGVLPD-------NTQVAVKKYMCADEIRITEWEFLGIISQVKHKN-VVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.+..|-...+|+....+ +..+++|.............+|..++..+.... ..++++++.. .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 45566667899888644 578999987554333233345666666554222 3456665542 36899999
Q ss_pred CCchhh
Q 047375 265 NGALSH 270 (496)
Q Consensus 265 ~g~L~~ 270 (496)
|..+..
T Consensus 81 G~~l~~ 86 (302)
T cd05156 81 SRTLTT 86 (302)
T ss_pred CCcCCH
Confidence 877643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0038 Score=61.58 Aligned_cols=32 Identities=22% Similarity=0.355 Sum_probs=26.8
Q ss_pred CCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 305 ~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
+.++||+|+.|.||+++.+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 36899999999999999765568999987643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00053 Score=75.40 Aligned_cols=193 Identities=17% Similarity=0.105 Sum_probs=129.7
Q ss_pred HHHHHHhcCCCCceeeEEEEEeeCCe----eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCC
Q 047375 230 EFLGIISQVKHKNVVKILGLCLETKV----TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305 (496)
Q Consensus 230 ~e~~~l~~l~hpnIv~l~~~~~~~~~----~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~ 305 (496)
.|...+.++.|+|++.++.|...... ..+..++|..-++...+..... .+..+.+.+..++..||.|+|+
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~--- 304 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHS--- 304 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHH---
Confidence 45677888899999999999765432 2345678888888888876543 5667888899999999999999
Q ss_pred CCcccCCCCcC---ceeeCCCCceEEc--cCCCccccCCCCCccceecccccceeecCcccccccccCC--CCCchhhhh
Q 047375 306 PSIIHSDVKSA---NILLDDNYTAKVS--DFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGM--NPNSYVALA 378 (496)
Q Consensus 306 ~~ivHrDlKp~---NIll~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~--~d~~s~g~~ 378 (496)
....|.-+..+ +.-.+..+.+.++ ||+.++........ ....-+..|.+||......++.+ .|+|.+|..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 44555444444 4444566677777 89887776543221 12224566888888777666554 699999988
Q ss_pred cccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 379 SNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
...+..+........ ....++... ......+...+|+..++++|+++.+++..
T Consensus 382 ~~~~~~~~~i~~~~~---~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA---VPVSLLDVL--------STSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCccccccc---chhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 877766544321111 111111100 00147788999999999999999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.002 Score=62.75 Aligned_cols=139 Identities=17% Similarity=0.204 Sum_probs=88.9
Q ss_pred hhhhcccCCceEEEEeEeCCCcEEEEEEeecch-----------------------hhh----hhHHHHHHHHhcCCCCc
Q 047375 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD-----------------------EIR----ITEWEFLGIISQVKHKN 242 (496)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------------~~~----~~~~~e~~~l~~l~hpn 242 (496)
+.-+|..|.-+.||.+.-.+|..+|||+++.+- ..+ .-...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346788899999999998899999999874320 001 11124455555554333
Q ss_pred eeeEEEEEeeCCeeeEEEeeccCCchh--hhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee
Q 047375 243 VVKILGLCLETKVTLLVYEFVSNGALS--HYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL 320 (496)
Q Consensus 243 Iv~l~~~~~~~~~~~lv~E~~~~g~L~--~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll 320 (496)
|...--+.. ..-.|||+|+.. +=. -.|.. ..++...+..+-.+++.-+.-|.+.| ++||.||.--|+|+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCceee--ecceEeeeeccC-CCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 322111111 123589999953 221 11211 22455567777788888888888754 69999999999998
Q ss_pred CCCCceEEccCCCccccC
Q 047375 321 DDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 321 ~~~~~~kL~DFGla~~~~ 338 (496)
- +|.+.|+|-+-+....
T Consensus 299 h-dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 H-DGKLYIIDVSQSVEHD 315 (520)
T ss_pred E-CCEEEEEEccccccCC
Confidence 7 5689999998665543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0043 Score=60.87 Aligned_cols=143 Identities=18% Similarity=0.180 Sum_probs=77.9
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC--CCceeeEEEEE------eeCCeeeEEEeec
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVK--HKNVVKILGLC------LETKVTLLVYEFV 263 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--hpnIv~l~~~~------~~~~~~~lv~E~~ 263 (496)
..++.|....+|+.... +..+++|........ .....+..++..+. .-.+.+++... ...+..+++|+|+
T Consensus 28 ~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~~~~-~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTD-VGRYILTLYEKRVKA-EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeC-CCcEEEEEecCCCCH-HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 45777777899998764 446888876542111 11223444444442 11244444321 1245678999999
Q ss_pred cCCchhh-----------hh---hhcCcc---------cccCHHHHH------------HHHHHHHHHHHHhHh----cC
Q 047375 264 SNGALSH-----------YI---HDKSSQ---------VLKNWKTCL------------RIAAETASAIHYLHS----LA 304 (496)
Q Consensus 264 ~~g~L~~-----------~l---~~~~~~---------~~l~~~~~~------------~i~~qi~~gL~~LH~----~~ 304 (496)
+|..+.. .+ +..... ....|.... .....+...+.++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 8855421 11 100000 001121110 001123334555532 22
Q ss_pred CCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 305 ~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
+.+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 46899999999999999887778999986543
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.25 E-value=1.7e-05 Score=88.40 Aligned_cols=160 Identities=11% Similarity=-0.077 Sum_probs=115.8
Q ss_pred HHHHHhcCCCCceeeEEEEEee--CCeeeEEEeeccCCchhhhhhhcCc-ccccCHHHHHHHHHHHHHHHHHhHhcCC--
Q 047375 231 FLGIISQVKHKNVVKILGLCLE--TKVTLLVYEFVSNGALSHYIHDKSS-QVLKNWKTCLRIAAETASAIHYLHSLAS-- 305 (496)
Q Consensus 231 e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~-- 305 (496)
|...++...|+++...+.-... ....|.+++||.+|.+.+.+-+... ..++...-+.....+...+..-+|+...
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 3445666789998887766543 3456899999999999999876432 2223333333333343666666665432
Q ss_pred CCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhccccccc
Q 047375 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM 385 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~ 385 (496)
+-.+|+++|+-|.+|..+..+|++++|+.+.... .........+++.|++|++...-.++.++|+|..++.+|....+
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 3479999999999999999999999999884332 22223445688999999998888888889999999999998888
Q ss_pred ccchhhh
Q 047375 386 VPYFLDS 392 (496)
Q Consensus 386 ~~~~~~~ 392 (496)
.++|...
T Consensus 1437 n~~fi~f 1443 (2724)
T KOG1826|consen 1437 NAYFIFF 1443 (2724)
T ss_pred cHHHHHH
Confidence 8777543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0019 Score=64.40 Aligned_cols=141 Identities=18% Similarity=0.203 Sum_probs=76.2
Q ss_pred hcccCCceEEEEeEeCC-----CcEEEEEEeecchhhhhhHHHHHHHHhcCCCCce-eeEEEEEeeCCeeeEEEeeccCC
Q 047375 193 CLGMGGFGSVYKGVLPD-----NTQVAVKKYMCADEIRITEWEFLGIISQVKHKNV-VKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.|-.|-...+|++...+ +..|++|........-....+|..++..+..-++ .++++.+... .|++|+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 34456777888886432 3578888775433322222456666665543222 3455665332 589999876
Q ss_pred chhhh-------h----------hhcC---cccccCHHHHHHHHHHH-----------------HHHHHHh----Hh-cC
Q 047375 267 ALSHY-------I----------HDKS---SQVLKNWKTCLRIAAET-----------------ASAIHYL----HS-LA 304 (496)
Q Consensus 267 ~L~~~-------l----------~~~~---~~~~l~~~~~~~i~~qi-----------------~~gL~~L----H~-~~ 304 (496)
+|... + +... ......+..+..+..++ ...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 66421 0 1100 00011233333332211 1111122 11 11
Q ss_pred CCCcccCCCCcCceeeCC-CCceEEccCCCcccc
Q 047375 305 SPSIIHSDVKSANILLDD-NYTAKVSDFESLVPI 337 (496)
Q Consensus 305 ~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~ 337 (496)
+..++|+|+++.|||+++ ++.+.|+||..+...
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 246899999999999976 468999999876543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00045 Score=66.03 Aligned_cols=133 Identities=19% Similarity=0.227 Sum_probs=87.1
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeec----------chh-------------hhhhHHHHHHHHhcCC-C-Cc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMC----------ADE-------------IRITEWEFLGIISQVK-H-KN 242 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~----------~~~-------------~~~~~~~e~~~l~~l~-h-pn 242 (496)
+.+.+.||-|.-+.||.+....|.+.++|.-.. ... .+....+|...|+.+. | =-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 566789999999999999998899999984310 000 0112225566666553 2 12
Q ss_pred eeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC
Q 047375 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD 322 (496)
Q Consensus 243 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~ 322 (496)
|.+.+++ +.-++|||++.|-.|.+.-+-.. ... +...+..-+--|-. +|+||+|..-=||++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d------~~~---ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVED------PPT---LYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeecCC------hHH---HHHHHHHHHHHHHH---cCceecccchheeEEec
Confidence 3444433 44679999999988876543221 112 22333333344444 78999999999999999
Q ss_pred CCceEEccCCCccc
Q 047375 323 NYTAKVSDFESLVP 336 (496)
Q Consensus 323 ~~~~kL~DFGla~~ 336 (496)
++.++++||--+..
T Consensus 238 d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVS 251 (465)
T ss_pred CCCEEEeechHhhc
Confidence 99999999965443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0065 Score=59.64 Aligned_cols=31 Identities=16% Similarity=0.298 Sum_probs=27.6
Q ss_pred CCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
.+++|+|+.+.|||++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 5799999999999999998999999986654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.014 Score=58.68 Aligned_cols=71 Identities=11% Similarity=0.138 Sum_probs=47.3
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeec-----ch---hhhhhHHHHHHHHhcCC---CCceeeEEEEEeeCCeeeEEE
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMC-----AD---EIRITEWEFLGIISQVK---HKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~-----~~---~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+.||.|....||+... .+..++||.-.. .. ....+...|...|..+. ..++.+++.++.+. .+++|
T Consensus 38 ~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEE
Confidence 4689999999999887 456799996531 11 12223334455554432 35788899988744 57899
Q ss_pred eeccC
Q 047375 261 EFVSN 265 (496)
Q Consensus 261 E~~~~ 265 (496)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.016 Score=57.34 Aligned_cols=71 Identities=15% Similarity=0.069 Sum_probs=43.1
Q ss_pred hcccCCceEEEEeEeCCC-cEEEEEEeecch--------hhhhhHHHHHHHHhcCC--CC-ceeeEEEEEeeCCeeeEEE
Q 047375 193 CLGMGGFGSVYKGVLPDN-TQVAVKKYMCAD--------EIRITEWEFLGIISQVK--HK-NVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~--hp-nIv~l~~~~~~~~~~~lv~ 260 (496)
.||.|....||++..+.| +.|+||.-.+.. -...+..-|...|.... -| .+.++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997544 589999642111 11122234445554432 23 45666655 344556999
Q ss_pred eeccC
Q 047375 261 EFVSN 265 (496)
Q Consensus 261 E~~~~ 265 (496)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.021 Score=56.05 Aligned_cols=30 Identities=33% Similarity=0.375 Sum_probs=25.6
Q ss_pred CCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 57999999999999987 5789999986543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.013 Score=57.10 Aligned_cols=33 Identities=24% Similarity=0.446 Sum_probs=28.7
Q ss_pred CCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
..++|+|+.+.||+++.+.-+=+.||+++..-.
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 469999999999999988889999999876543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.009 Score=59.17 Aligned_cols=141 Identities=17% Similarity=0.213 Sum_probs=74.3
Q ss_pred hcccCCceEEEEeEeCC----CcEEEEEEeecchhhhhhHHHHHHHHhcCCCCce-eeEEEEEeeCCeeeEEEeeccCCc
Q 047375 193 CLGMGGFGSVYKGVLPD----NTQVAVKKYMCADEIRITEWEFLGIISQVKHKNV-VKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
.|..|=...+|+....+ +..|++|.............+|..+++.+..-++ .++++++. .+ +|.+|+++.+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence 34446667788886432 2378888775443322223356666666654333 35566553 22 5899997765
Q ss_pred hhh-------hh-------hh-cCc-----ccccCHHHHHHHHHHH----------------------HHHHHHhHhc--
Q 047375 268 LSH-------YI-------HD-KSS-----QVLKNWKTCLRIAAET----------------------ASAIHYLHSL-- 303 (496)
Q Consensus 268 L~~-------~l-------~~-~~~-----~~~l~~~~~~~i~~qi----------------------~~gL~~LH~~-- 303 (496)
|.. .+ +. +.. ..+..|..+..+..++ ..-+..+...
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 532 01 11 000 0011233332222221 1111111110
Q ss_pred ---CCCCcccCCCCcCceeeCC-CCceEEccCCCcccc
Q 047375 304 ---ASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPI 337 (496)
Q Consensus 304 ---~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~ 337 (496)
.+.-.+|.|+.|.|||+++ ++.++++||..|...
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 1123799999999999974 568999999876543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.015 Score=56.00 Aligned_cols=32 Identities=19% Similarity=0.390 Sum_probs=25.7
Q ss_pred CCcccCCCCcCceeeCCCCc-eEEccCCCcccc
Q 047375 306 PSIIHSDVKSANILLDDNYT-AKVSDFESLVPI 337 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~-~kL~DFGla~~~ 337 (496)
..++|+|+.|.|||++.++. .-|.||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 34899999999999997555 569999976553
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.016 Score=55.87 Aligned_cols=72 Identities=17% Similarity=0.087 Sum_probs=43.1
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcC---CCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQV---KHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
..++-|....+|+.. .+++.+.||.-. ......+..|..-|+.| .--.+.+++++....+..||||||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 458888889999988 478889999765 22233334455444444 4566888999988877889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.005 Score=56.74 Aligned_cols=31 Identities=29% Similarity=0.390 Sum_probs=21.4
Q ss_pred CCcccCCCCcCceee-CCCCceEEccCCCccc
Q 047375 306 PSIIHSDVKSANILL-DDNYTAKVSDFESLVP 336 (496)
Q Consensus 306 ~~ivHrDlKp~NIll-~~~~~~kL~DFGla~~ 336 (496)
..++|.|+.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 7888999999987654
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.028 Score=56.32 Aligned_cols=72 Identities=19% Similarity=0.104 Sum_probs=43.7
Q ss_pred hhcccCCceEEEEeEeCC-CcEEEEEEeecc----hh---hhhhHHHHHHHHhcC---CCCceeeEEEEEeeCCeeeEEE
Q 047375 192 HCLGMGGFGSVYKGVLPD-NTQVAVKKYMCA----DE---IRITEWEFLGIISQV---KHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~----~~---~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+.||.|.-..||++...+ ++.|+||.-.+. .. ...+..-|...|+.. --.++.++|.+ +.....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 468999999999999743 568999964211 11 112223444455443 22356667665 344456889
Q ss_pred eeccC
Q 047375 261 EFVSN 265 (496)
Q Consensus 261 E~~~~ 265 (496)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 99854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.031 Score=50.89 Aligned_cols=115 Identities=14% Similarity=0.086 Sum_probs=69.9
Q ss_pred CCceEEEEeEeCCCcEEEEEEeecchhh-h-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchhhhhhh
Q 047375 197 GGFGSVYKGVLPDNTQVAVKKYMCADEI-R-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHD 274 (496)
Q Consensus 197 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 274 (496)
|+.++.-.+...- .+..+|++...+-. . ..++.+.+++.+++ .|+++..- +...+-++.|+|-....
T Consensus 73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 3444444444322 34566666544332 2 22346677777654 46776622 33345689999953211
Q ss_pred cCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 275 KSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 275 ~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
.. .-.|..+ +++|.-.|+.. .+.+|+|-.|+|||-|..|.+||.|=+.
T Consensus 142 ------~~---~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ------NF---SNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ------ch---hHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 11 1112222 46788889755 6899999999999999999999999764
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.16 Score=58.01 Aligned_cols=154 Identities=15% Similarity=0.144 Sum_probs=81.8
Q ss_pred HHHHHHHhcchh---hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhc-------CCCCceeeEE-E
Q 047375 180 KSELLKATKNFH---HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQ-------VKHKNVVKIL-G 248 (496)
Q Consensus 180 ~~~l~~~~~~~~---~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~-------l~hpnIv~l~-~ 248 (496)
..++....|.+. ..|+ |..-.+|+....+|..+++|+.......... ..+...|.. +.-|.+++.. |
T Consensus 16 ~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~~~~-~~q~~~L~hL~~~~~glpvP~~i~t~~G 93 (1013)
T PRK06148 16 AEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPRVES-DFQTAALDHLAAVAPDLPVPRLIPSLSG 93 (1013)
T ss_pred HHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccchhHH-HHHHHHHHHHHhhCCCCCcCeeeecCCC
Confidence 344555556653 4564 3457789988777888999998754322111 122333322 2334444322 1
Q ss_pred ----EEee-CC--eeeEEEeeccCCchhhhh-------h--------------hcCc---ccccCHHH------------
Q 047375 249 ----LCLE-TK--VTLLVYEFVSNGALSHYI-------H--------------DKSS---QVLKNWKT------------ 285 (496)
Q Consensus 249 ----~~~~-~~--~~~lv~E~~~~g~L~~~l-------~--------------~~~~---~~~l~~~~------------ 285 (496)
.... .+ ..+-+++|++|..+.+.. . .... ...+.|..
T Consensus 94 ~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~ 173 (1013)
T PRK06148 94 ASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHF 173 (1013)
T ss_pred CeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhh
Confidence 1111 22 456789999997775511 0 0000 01112211
Q ss_pred -----HHHHHHHHHHHHH-----HhHhcCCCCcccCCCCcCceeeCCCC--ceE-EccCCCccc
Q 047375 286 -----CLRIAAETASAIH-----YLHSLASPSIIHSDVKSANILLDDNY--TAK-VSDFESLVP 336 (496)
Q Consensus 286 -----~~~i~~qi~~gL~-----~LH~~~~~~ivHrDlKp~NIll~~~~--~~k-L~DFGla~~ 336 (496)
...++.++..... .+... +.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 174 i~d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 174 IDDPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 1122222322221 22232 36799999999999998775 455 999997654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.15 Score=50.32 Aligned_cols=28 Identities=21% Similarity=0.325 Sum_probs=23.8
Q ss_pred CCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 306 PSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.++||+|+.+.|||++ + .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 5789999999999995 4 57899998654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.1 Score=51.45 Aligned_cols=140 Identities=18% Similarity=0.167 Sum_probs=75.2
Q ss_pred hcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC---CCc---eeeEEEEE----eeCCeeeEEEee
Q 047375 193 CLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVK---HKN---VVKILGLC----LETKVTLLVYEF 262 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpn---Iv~l~~~~----~~~~~~~lv~E~ 262 (496)
.|.+ .-..||+....+|.. ++|..... ........|...|..+. .|= |..+=|-. ..+...+-+.+|
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 456789988755555 88887665 33333334454444432 211 22222222 112367788999
Q ss_pred ccCCchhh-hh--------------h----hcC--c---ccccCHHH-------------HHHHHHHHHHHHHHhHh---
Q 047375 263 VSNGALSH-YI--------------H----DKS--S---QVLKNWKT-------------CLRIAAETASAIHYLHS--- 302 (496)
Q Consensus 263 ~~~g~L~~-~l--------------~----~~~--~---~~~l~~~~-------------~~~i~~qi~~gL~~LH~--- 302 (496)
++|..+.. .. + ... . .....|.. ......++...+..+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987773 11 0 000 0 00122320 01122233333333332
Q ss_pred -cCCCC---cccCCCCcCceeeCCCCc-eEEccCCCcc
Q 047375 303 -LASPS---IIHSDVKSANILLDDNYT-AKVSDFESLV 335 (496)
Q Consensus 303 -~~~~~---ivHrDlKp~NIll~~~~~-~kL~DFGla~ 335 (496)
.-+.. +||+|+.|.||+++.+.. +.+.|||-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22233 999999999999998874 8899998654
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.079 Score=50.05 Aligned_cols=77 Identities=17% Similarity=0.014 Sum_probs=54.5
Q ss_pred hcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec-cCCchhhh
Q 047375 193 CLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV-SNGALSHY 271 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~~g~L~~~ 271 (496)
.+..|..+.|+.++..+|.++++|...+...... +......|+..+-...|++++.-.. .-.+.+|.+ ++.+|.++
T Consensus 9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-E~~g~~~L~~w~G~GaVrll~~d~~--~~AlLLErl~~g~~L~~~ 85 (253)
T PF04655_consen 9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-EARGEAALRWWNGRGAVRLLAADPE--RGALLLERLDPGRSLASL 85 (253)
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-hhhHHhHhheeCCCCceeeeccccc--cchhhhhhccCCCchhhc
Confidence 4667899999999988999999998765443222 1212245777777888999987643 345889998 55577666
Q ss_pred h
Q 047375 272 I 272 (496)
Q Consensus 272 l 272 (496)
.
T Consensus 86 ~ 86 (253)
T PF04655_consen 86 P 86 (253)
T ss_pred c
Confidence 5
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.041 Score=61.29 Aligned_cols=76 Identities=16% Similarity=0.175 Sum_probs=63.9
Q ss_pred HHHhHHHHHHHHhHHhHHHHHHhHHHHHHHHHHHhhhHHhhccchhHHHHHHHHhhhhhcchhhhhhhhhhHHHHh
Q 047375 32 KKLTKDWLGQFAREEQVQADLIGWKKILVKINEVVDDAVEKQTKEESVKRWLGKLRNLACDVDYLLDEFQTEAFQR 107 (496)
Q Consensus 32 ~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~i~~~l~dae~~~~~~~~~~~w~~~l~~~~~~~~d~ld~~~~~~~~~ 107 (496)
.|+...+-..+....+..+.+.+|++.|..++..+.||+.++-+..-+..|.+..++.+|+++|+++.+..+....
T Consensus 10 ~~~~~~l~~~~~~~~~~~~~i~~Lk~~L~~l~~~l~d~~a~~~~~~~~~~~~e~~~~~~~~~e~~~~~~~v~~~~~ 85 (889)
T KOG4658|consen 10 EKLDQLLNRESECLDGKDNYILELKENLKALQSALEDLDAKRDDLERRVNWEEDVGDLVYLAEDIIWLFLVEEIER 85 (889)
T ss_pred hhHHHHHHHHHHHHhchHHHHHHHHHHHHHHHHHHHHHHhhcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3333333444455567777999999999999999999999999999999999999999999999999998887655
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.23 Score=51.15 Aligned_cols=30 Identities=23% Similarity=0.308 Sum_probs=24.8
Q ss_pred CCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
..++|.|+-+.|||.+.+ .++|+||..|..
T Consensus 284 ~VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~ 313 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNK-CLRLIDFEYSGY 313 (442)
T ss_pred eeEEeCCCCccceeecCC-CEEEEeeccccc
Confidence 458999999999998755 499999986654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.11 Score=50.89 Aligned_cols=87 Identities=16% Similarity=0.055 Sum_probs=61.1
Q ss_pred CCceeeEEEEE-eeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCce
Q 047375 240 HKNVVKILGLC-LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANI 318 (496)
Q Consensus 240 hpnIv~l~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NI 318 (496)
.++..+.+-+- .+....|++|++- |++|.-.- ...+.++..|+.+.+.-+.-+... -+.=|||+.-.||
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~ik-------~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~ni 353 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISIIK-------ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNI 353 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeeeee-------cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccce
Confidence 34444433333 2234557788875 55554221 136788889999988877777763 4589999999999
Q ss_pred eeCCCCceEEccCCCcccc
Q 047375 319 LLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 319 ll~~~~~~kL~DFGla~~~ 337 (496)
||+ +|++-|+||-+++..
T Consensus 354 LId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 354 LID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred eee-cCceEEEEeeeeecc
Confidence 999 899999999998843
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.29 Score=49.40 Aligned_cols=73 Identities=22% Similarity=0.281 Sum_probs=41.8
Q ss_pred hcccCCceEEEEeEeCCC--cE-----EEEEEeecchhhhhhHHHHHHHHhcCCCCce-eeEEEEEeeCCeeeEEEeecc
Q 047375 193 CLGMGGFGSVYKGVLPDN--TQ-----VAVKKYMCADEIRITEWEFLGIISQVKHKNV-VKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|..|-.+.+|++....+ .. |.+..............+|+.+++.+...++ .++++.+.. +++.||++
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIe 132 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVE 132 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEec
Confidence 455577788999875332 22 3333322222222222356777777764443 456666642 58999999
Q ss_pred CCchh
Q 047375 265 NGALS 269 (496)
Q Consensus 265 ~g~L~ 269 (496)
|.+|.
T Consensus 133 Gr~l~ 137 (383)
T PTZ00384 133 GNTMG 137 (383)
T ss_pred cccCC
Confidence 87664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 496 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-32 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-09 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 9e-83
Identities = 92/300 (30%), Positives = 152/300 (50%), Gaps = 30/300 (10%)
Query: 176 KIFSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF-L 232
+L +AT NF +G G FG VYKGVL D +VA+K+ I E+E +
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 233 GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLK-NWKTCLRIAA 291
+S +H ++V ++G C E +L+Y+++ NG L +++ + +W+ L I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF--ESLVPISSDDETAMSTMI 349
A +HYLH+ +IIH DVKS NILLD+N+ K++DF D+T +ST++
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGT--ELDQTHLSTVV 201
Query: 350 RGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLDS 392
+GT+GY+DPEY E+L + E +++ + ++S
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS--LPREMVNLAEWAVES 259
Query: 393 IENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452
N QI++ +AD+ E + + A KCL + +RP+M +V +L+ RLQE+
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 9e-79
Identities = 93/295 (31%), Positives = 153/295 (51%), Gaps = 25/295 (8%)
Query: 168 PGLAFSRMKIFSKSELLKATKNFHH--CLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIR 225
P + ++K FS EL A+ NF + LG GGFG VYKG L D T VAVK+ + + +
Sbjct: 10 PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR-LKEERTQ 68
Query: 226 ITEWEFL---GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLK- 281
E +F +IS H+N++++ G C+ LLVY +++NG+++ + ++
Sbjct: 69 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 282 NWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341
+W RIA +A + YLH P IIH DVK+ANILLD+ + A V DF L +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF-GLAKLMDYK 187
Query: 342 ETAMSTMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKIS 384
+T ++T +RGT+G++ PEY T EL+TG LA+++ +
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 385 MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEV 439
++ + ++ +++ + + EE+E + ++A C + ERP M EV
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 6e-72
Identities = 85/313 (27%), Positives = 139/313 (44%), Gaps = 57/313 (18%)
Query: 173 SRMKIFSKSELLKATKNFH--------HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI 224
+R FS EL T NF + +G GGFG VYKG + +NT VAVKK +I
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68
Query: 225 RIT--EWEFL---GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV 279
+ +F ++++ +H+N+V++LG + LVY ++ NG+L +
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 280 LKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF--ESLVPI 337
+W +IA A+ I++LH IH D+KSANILLD+ +TAK+SDF
Sbjct: 129 PLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE- 184
Query: 338 SSDDETAMSTMIRGTVGYLDPEYAHT----------------ELLTGMNPNSYVALASNE 381
+T M++ I GT Y+ PE E++TG+ E
Sbjct: 185 -KFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE----HRE 239
Query: 382 KISMV----PYFLDSIENNSFRQILNFQVAD----ESEMEEIEVVAELASKCLRIRGTER 433
++ E + D +++ +E + +AS+CL + +R
Sbjct: 240 PQLLLDIKEEIE---DEEKTIEDY-----IDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 434 PTMKEVSEELDRL 446
P +K+V + L +
Sbjct: 292 PDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-50
Identities = 62/320 (19%), Positives = 111/320 (34%), Gaps = 60/320 (18%)
Query: 178 FSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF---L 232
L + G FG V+K N VAVK + D+ W+ +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDK---QSWQNEYEV 69
Query: 233 GIISQVKHKNVVKILGLCLETKVT----LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR 288
+ +KH+N+++ +G L+ F G+LS ++ + V+ +W
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVV-SWNELCH 125
Query: 289 IAAETASAIHYLHS-------LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341
IA A + YLH P+I H D+KS N+LL +N TA ++DF + +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 342 ETAMSTMIRGTVGYLDPEYAHT----------------------ELLTGMNPNSYVALAS 379
+ GT Y+ PE EL +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV--- 242
Query: 380 NEKISMVPYFLDSIENNSFRQILNFQVADE---------SEMEEIEVVAELASKCLRIRG 430
M+P+ + ++ S + V + + + ++ E +C
Sbjct: 243 --DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 431 TERPTMKEVSEELDRLRRLQ 450
R + V E + +++RL
Sbjct: 301 EARLSAGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-43
Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 51/284 (17%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKI 246
+G G FG+V++ + VAVK M D EFL I+ +++H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+G + +V E++S G+L +H ++ + + L +A + A ++YLH+ +P
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE------Y 360
I+H ++KS N+L+D YT KV DF L + + + + GT ++ PE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDF-GLSRLKASTFLSSKSA-AGTPEWMAPEVLRDEPS 216
Query: 361 AHT-----------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE 409
EL T P+ N + Q++ V +
Sbjct: 217 NEKSDVYSFGVILWELATL----------------QQPW-----GNLNPAQVV-AAVGFK 254
Query: 410 SEMEEI-----EVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448
+ EI VA + C +RP+ + + L L +
Sbjct: 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-41
Identities = 60/331 (18%), Positives = 110/331 (33%), Gaps = 67/331 (20%)
Query: 178 FSKSELLKATKNFH--HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF---L 232
+ SE N +G G +G+VYKG L D VAVK + A+ + +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 233 GIISQVKHKNVVKILGLCLETKVT-----LLVYEFVSNGALSHYIHDKSSQVLKNWKTCL 287
+ ++H N+ + + LLV E+ NG+L Y+ +S +W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSC 114
Query: 288 RIAAETASAIHYLHS------LASPSIIHSDVKSANILLDDNYTAKVSDF------ESLV 335
R+A + YLH+ P+I H D+ S N+L+ ++ T +SDF
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 336 PISSDDETAMSTMIRGTVGYLDPEYAHT------------------------ELLTGMNP 371
+ +E + GT+ Y+ PE E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 372 NSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD----------ESEMEEIEVVAEL 421
+ + + + + +F + + + + + E
Sbjct: 235 LFP---GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 422 ASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452
C R T + E + L + E
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-40
Identities = 52/288 (18%), Positives = 102/288 (35%), Gaps = 55/288 (19%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVK 245
NF L G ++KG + VK D +F + H NV+
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 246 ILGLCLETKVTLL--VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+LG C + ++ G+L + +H+ ++ V+ + ++ A + A + +LH+L
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTL 130
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF-ESLVPISSDDETAMSTMIRGTVGYLDPEYAH 362
P I + S ++++D++ TA++S S ++ P
Sbjct: 131 -EPLIPRHALNSRSVMIDEDMTARISMADVKFS--------FQSPGRMYAPAWVAP---- 177
Query: 363 TELLTGMNPNSYVALASNEKISM--------------VPYFLDSIENNSFRQILNFQVAD 408
E L ++ M VP+ + S +I +VA
Sbjct: 178 -EALQKKPEDTN-----RRSADMWSFAVLLWELVTREVPF-----ADLSNMEIG-MKVAL 225
Query: 409 ESEMEEI-----EVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451
E I V++L C+ +RP + + L ++Q+
Sbjct: 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMI---VPILEKMQD 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-39
Identities = 58/282 (20%), Positives = 103/282 (36%), Gaps = 53/282 (18%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGL 249
+G G FG V K VA+K+ E + E +S+V H N+VK+ G
Sbjct: 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVEL-RQLSRVNHPNIVKLYGA 69
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
C LV E+ G+L + +H + + + + YLHS+ ++I
Sbjct: 70 C--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 310 HSDVKSANILLDDNYT-AKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE------YAH 362
H D+K N+LL T K+ DF + D +T M+ G+ ++ PE Y+
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFG----TACDIQTHMTNNK-GSAAWMAPEVFEGSNYSE 182
Query: 363 T-----------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESE 411
E++T P+ +
Sbjct: 183 KCDVFSWGIILWEVITR----------------RKPF-----DEIGGPAFRIMWAVHNGT 221
Query: 412 MEEI-----EVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448
+ + + L ++C ++RP+M+E+ + + L R
Sbjct: 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 57/302 (18%), Positives = 108/302 (35%), Gaps = 51/302 (16%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKI 246
+G G FG VY G + +VA++ + F Q +H+NVV
Sbjct: 37 IGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+G C+ ++ L + D + + +IA E + YLH +
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL--DVNKTRQIAQEIVKGMGYLH---AK 149
Query: 307 SIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVGYLDPE-YA 361
I+H D+KS N+ D+ ++DF S V + E + + G + +L PE
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKL-RIQNGWLCHLAPEIIR 207
Query: 362 HTELLTGMNPNSYVALASNEKI--------------SMVPYFLDSIENNSFRQILNFQVA 407
T + + ++ P+ + I+ +Q+
Sbjct: 208 QLSPDTEEDKLPF-----SKHSDVFALGTIWYELHAREWPF-----KTQPAEAII-WQMG 256
Query: 408 DESEMEEIEV-----VAELASKCLRIRGTERPTMKEVSEELDRL----RRLQENYWARKN 458
+ ++ ++++ C ERPT ++ + L++L RRL K+
Sbjct: 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316
Query: 459 NE 460
E
Sbjct: 317 AE 318
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 66/293 (22%), Positives = 106/293 (36%), Gaps = 68/293 (23%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCA--DEIRITEWEFL---GIISQVKHKNVV 244
+G+GGFG VY+ +VAVK ++I T + + +KH N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ G+CL+ LV EF G L+ + K + A + A ++YLH A
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEA 125
Query: 305 SPSIIHSDVKSANILLD--------DNYTAKVSDF-ESLVPISSDDETAMSTMIRGTVGY 355
IIH D+KS+NIL+ N K++DF + T + G +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAA-GAYAW 180
Query: 356 LDPE------YAH-----------TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSF 398
+ PE ++ ELLTG VP+
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTG----------------EVPF-----RGIDG 219
Query: 399 RQILNFQVADESEMEEI-----EVVAELASKCLRIRGTERPTMKEVSEELDRL 446
+ + VA I E A+L C RP+ + ++L +
Sbjct: 220 LAVA-YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 71/291 (24%), Positives = 112/291 (38%), Gaps = 60/291 (20%)
Query: 190 FHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEW-----EFL---GIISQVKH 240
+ +G GGFG V+KG + D + VA+K + D TE EF I+S + H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
N+VK+ GL +V EFV G L H + DK+ + W LR+ + A I Y+
Sbjct: 83 PNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIALGIEYM 138
Query: 301 HSLASPSIIHSDVKSANILLD-----DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGY 355
+ +P I+H D++S NI L AKV+DF L S + + G +
Sbjct: 139 QNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF-GL----SQQSVHSVSGLLGNFQW 192
Query: 356 LDPEYAHTELLTGMNPNSYVALASNEKI--------------SMVPYFLDSIENNSFRQI 401
+ P E + + EK P+ + S+ +I
Sbjct: 193 MAP-----ETIGAEEE------SYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKI 236
Query: 402 -LNFQVADESEMEEI-----EVVAELASKCLRIRGTERPTMKEVSEELDRL 446
+ +E I + + C +RP + +EL L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 55/308 (17%), Positives = 109/308 (35%), Gaps = 60/308 (19%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF---LGIISQVKHKNVVKI 246
+G G +G V+ G +VAVK + +E W + ++H+N++
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGF 96
Query: 247 LGLCLETKVT----LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+ ++ + L+ ++ NG+L Y+ + + K+ L++A + S + +LH+
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL----DAKSMLKLAYSSVSGLCHLHT 152
Query: 303 LAS-----PSIIHSDVKSANILLDDNYTAKVSDF--ESLVPISSDDETAMSTMIRGTVGY 355
P+I H D+KS NIL+ N T ++D +++ GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 356 LDPE------------YAHT-----------ELLTGMNPNSYVALASNEKISMVPYFLDS 392
+ PE E+ V + +PY
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV------EEYQLPYHDLV 266
Query: 393 IENNSFRQILNFQVAD---------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEEL 443
+ S+ + S E + + +L ++C R T V + L
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 444 DRLRRLQE 451
++ Q+
Sbjct: 327 AKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 60/303 (19%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF---LGIISQVKHKNVVKI 246
C+G G +G V++G VAVK + DE W L ++H+N++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGF 67
Query: 247 LGLCLETKVT----LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+ + ++ + L+ + G+L Y+ + + +CLRI AS + +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL----DTVSCLRIVLSIASGLAHLHI 123
Query: 303 LAS-----PSIIHSDVKSANILLDDNYTAKVSDF-ESLVPISSDDETAMSTMIR-GTVGY 355
P+I H D+KS NIL+ N ++D +++ S ++ + R GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 356 LDPE-YAHT----------------------ELLTGMNPNSYVALASNEKISMVPYFLDS 392
+ PE T E+ M N V + P++
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV------EDYKPPFYDVV 237
Query: 393 IENNSFRQILNFQV---------ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEEL 443
+ SF + + +A+L +C + R T + + L
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 444 DRL 446
++
Sbjct: 298 TKI 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-36
Identities = 66/278 (23%), Positives = 122/278 (43%), Gaps = 44/278 (15%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGLC 250
+G G FG+VYKG + VAVK F G++ + +H N++ +G
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
++ + V ++ +L H++H ++ K + IA +TA + YLH+ SIIH
Sbjct: 90 TAPQLAI-VTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE---------YA 361
D+KS NI L ++ T K+ DF S + + G++ ++ PE Y+
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 362 H-----------TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADES 410
EL+TG P Y + + ++I ++ + S L+ ++
Sbjct: 204 FQSDVYAFGIVLYELMTGQLP--YSNINNRDQI------IEMVGRGSLSPDLSKVRSNCP 255
Query: 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448
+ + L ++CL+ + ERP+ + E++ L R
Sbjct: 256 -----KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-35
Identities = 59/304 (19%), Positives = 113/304 (37%), Gaps = 58/304 (19%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILG 248
+G G FG V++G +VAVK + +E E E ++H+N++ +
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIY-QTVMLRHENILGFIA 103
Query: 249 LCLETKVT----LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS-- 302
+ T LV ++ +G+L Y++ + + +++A TAS + +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV----TVEGMIKLALSTASGLAHLHMEI 159
Query: 303 ---LASPSIIHSDVKSANILLDDNYTAKVSDF---ESLVPISSDDETAMSTMIRGTVGYL 356
P+I H D+KS NIL+ N T ++D + + A + + GT Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYM 218
Query: 357 DPE-------YAHT----------------ELLTGMNPNSYVALASNEKISMVPYFLDSI 393
PE H E+ + + +PY+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG------IHEDYQLPYYDLVP 272
Query: 394 ENNSFRQILNFQVADE---------SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444
+ S ++ + E + V+A++ +C G R T + + L
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 445 RLRR 448
+L +
Sbjct: 333 QLSQ 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 66/313 (21%), Positives = 119/313 (38%), Gaps = 75/313 (23%)
Query: 176 KIFSKSELLKATKNFHHCLGMGGFGSVYKGVLPDNTQ-VAVKKYMCADEIRITEWEFL-- 232
+IF S+L+ LG G FG K + + + +K+ + DE T+ FL
Sbjct: 5 RIFRPSDLIHGEV-----LGKGCFGQAIKVTHRETGEVMVMKELIRFDEE--TQRTFLKE 57
Query: 233 -GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA 291
++ ++H NV+K +G+ + K + E++ G L I SQ W + A
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY--PWSQRVSFAK 115
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF-------------ESLVPIS 338
+ AS + YLHS+ +IIH D+ S N L+ +N V+DF E L +
Sbjct: 116 DIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 339 SDDETAMSTMIRGTVGYLDPE------YAH-----------TELLTGMNPNSYVALASNE 381
D T++ G ++ PE Y E++ +N +
Sbjct: 173 KPDRKKRYTVV-GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD------- 224
Query: 382 KISMVPYFLDSIENNSFRQILNFQVADESEME-EI-----EVVAELASKCLRIRGTERPT 435
+P R + +F + ++ + +C + +RP+
Sbjct: 225 ---YLP-----------RTM-DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPS 269
Query: 436 MKEVSEELDRLRR 448
++ L+ LR
Sbjct: 270 FVKLEHWLETLRM 282
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 63/289 (21%), Positives = 113/289 (39%), Gaps = 62/289 (21%)
Query: 190 FHHCLGMGGFGSVYKGVL-PDNTQVAVK--KYMCADEIRITEWEFLG---IISQVKHKNV 243
+G G FG V+ G L DNT VAVK + +++ +FL I+ Q H N+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNI 174
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
V+++G+C + + +V E V G ++ + +++ KT L++ + A+ + YL S
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL--RVKTLLQMVGDAAAGMEYLESK 232
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTM----IRGTVGYLDPE 359
IH D+ + N L+ + K+SDF + A + ++ T PE
Sbjct: 233 ---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PE 285
Query: 360 YAH-----------------TELLT-GMNPNSYVALASNEKISMVP--YFLDSIENNSFR 399
+ E + G +P Y L++ + V L E
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASP--YPNLSNQQTREFVEKGGRLPCPELCP-- 341
Query: 400 QILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448
+ V L +C +RP+ + +EL +R+
Sbjct: 342 ----------------DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 13/146 (8%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKI 246
+G G FG V G +VAVK ++ T FL +++Q++H N+V++
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDA--TAQAFLAEASVMTQLRHSNLVQL 251
Query: 247 LGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
LG+ +E K L +V E+++ G+L Y+ + VL L+ + + A+ YL
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG-GDCLLKFSLDVCEAMEYL---EG 307
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
+ +H D+ + N+L+ ++ AKVSDF
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDF 333
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKK----YMCADEIRITEWEFLG---IISQVKHKN 242
F LG G FG V G VA+K M DE F+ ++ + H+
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-------FIEEAKVMMNLSHEK 80
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+V++ G+C + + ++ E+++NG L +Y+ + + + L + + A+ Y
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEY--- 135
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
L S +H D+ + N L++D KVSDF
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDF 164
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 41/176 (23%), Positives = 78/176 (44%), Gaps = 23/176 (13%)
Query: 164 GRDPPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGVL-----PDNTQVAVKKY 218
G P + ++I ++E K LG G FG+VYKG+ VA+K+
Sbjct: 1 GEAP---NQALLRILKETEFKKIKV-----LGSGAFGTVYKGLWIPEGEKVKIPVAIKE- 51
Query: 219 MCADEIRITEWEFLG---IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDK 275
+ E L +++ V + +V ++LG+CL + V L+ + + G L Y+ +
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH 110
Query: 276 SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ + L + A ++YL ++H D+ + N+L+ K++DF
Sbjct: 111 KDNI--GSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDF 161
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 41/149 (27%), Positives = 61/149 (40%), Gaps = 19/149 (12%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKK----YMCADEIRITEWEFLG---IISQVKHKN 242
LG G FG V G VAVK M DE F + ++ H
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE-------FFQEAQTMMKLSHPK 64
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+VK G+C + +V E++SNG L +Y+ + L + + + +
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL--EPSQLLEMCYDVCEGMAF--- 119
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
L S IH D+ + N L+D + KVSDF
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDF 148
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-24
Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 19/149 (12%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKK----YMCADEIRITEWEFLG---IISQVKHKN 242
F +G G FG V+ G + +VA+K M ++ F+ ++ ++ H
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-------FIEEAEVMMKLSHPK 64
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+V++ G+CLE LV EF+ +G LS Y+ + +T L + + + Y
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAY--- 119
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
L +IH D+ + N L+ +N KVSDF
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDF 148
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 7e-24
Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 13/146 (8%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKI 246
+G G FG V G +VAVK ++ T FL +++Q++H N+V++
Sbjct: 25 LLQTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDA--TAQAFLAEASVMTQLRHSNLVQL 79
Query: 247 LGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
LG+ +E K L +V E+++ G+L Y+ + VL L+ + + A+ YL
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG-GDCLLKFSLDVCEAMEYL---EG 135
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
+ +H D+ + N+L+ ++ AKVSDF
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDF 161
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 52/286 (18%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKI 246
LG G FG V+ G T+VA+K ++ FL ++ +++H+ +V++
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL 327
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+ E + +V E++S G+L ++ ++ + L+ + +AA+ AS + Y+ +
Sbjct: 328 YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMAYVERM--- 382
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAH---- 362
+ +H D+++ANIL+ +N KV+DF L + D+E + + + PE A
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADF-GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 363 -------------TELLT-GMNPNSYVALASNEKISMVP--YFLDSIENNSFRQILNFQV 406
TEL T G P Y + + E + V Y +
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMPCPPECP--------- 490
Query: 407 ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452
E + +L +C R ERPT + + L+ E
Sbjct: 491 ---------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 13/144 (9%)
Query: 194 LGMGGFGSVYKGVL---PDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKIL 247
LG G FGSV +GV VA+K + + E + I+ Q+ + +V+++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
G+C + +LV E G L ++ K ++ + + + + YL +
Sbjct: 77 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYL---EEKN 130
Query: 308 IIHSDVKSANILLDDNYTAKVSDF 331
+H D+ + N+LL + + AK+SDF
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDF 154
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 52/286 (18%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKI 246
LG G FG V+ G T+VA+K ++ FL ++ +++H+ +V++
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+ E + +V E++S G+L ++ ++ + L+ + +AA+ AS + Y+ +
Sbjct: 245 YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMAYVERM--- 299
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAH---- 362
+ +H D+++ANIL+ +N KV+DF L + D+E + + + PE A
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADF-GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 363 -------------TELLT-GMNPNSYVALASNEKISMVP--YFLDSIENNSFRQILNFQV 406
TEL T G P Y + + E + V Y +
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMPCPPECP--------- 407
Query: 407 ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452
E + +L +C R ERPT + + L+ E
Sbjct: 408 ---------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 69/306 (22%), Positives = 128/306 (41%), Gaps = 58/306 (18%)
Query: 190 FHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVK 245
H LG G +G VY+GV + VAVK ++ + EFL ++ ++KH N+V+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+LG+C ++ EF++ G L Y+ + + Q + L +A + +SA+ YL
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-AVVLLYMATQISSAMEYLEKK-- 337
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAH--- 362
+ IH ++ + N L+ +N+ KV+DF L + + D + + + PE
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADF-GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 363 --------------TELLT-GMNPNSYVALASNEKISMVP--YFLDSIENNSFRQILNFQ 405
E+ T GM+P Y + ++ ++ Y ++ E
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYELLEKDYRMERPEGCP-------- 445
Query: 406 VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEESEHL 465
E V EL C + ++RP+ E+ + + + + +E E
Sbjct: 446 ----------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS------DEVEKE 489
Query: 466 LGESST 471
LG+ T
Sbjct: 490 LGKRGT 495
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 190 FHHCLGMGGFGSVYKGVLP----DNTQVAVK--KYMCADEIRITEWEFLG---IISQVKH 240
+G G G V G L + VA+K K + R +FL I+ Q H
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR---DFLSEASIMGQFDH 109
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
N++++ G+ ++ ++V E++ NG+L ++ Q + + + + YL
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGAGMRYL 167
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L +H D+ + N+L+D N KVSDF
Sbjct: 168 SDL---GYVHRDLAARNVLVDSNLVCKVSDF 195
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 38/145 (26%), Positives = 73/145 (50%), Gaps = 11/145 (7%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKI 246
LG G FG V+ G +T+VAVK + FL ++ Q++H+ +V++
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+ + + ++ E++ NG+L ++ S L L +AA+ A + + +
Sbjct: 74 YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLT-INKLLDMAAQIAEGMAF---IEER 128
Query: 307 SIIHSDVKSANILLDDNYTAKVSDF 331
+ IH D+++ANIL+ D + K++DF
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADF 153
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 46/146 (31%), Positives = 78/146 (53%), Gaps = 11/146 (7%)
Query: 190 FHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVK 245
H LG G +G VY+GV + VAVK ++ E EFL ++ ++KH N+V+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+LG+C ++ EF++ G L Y+ + + Q + L +A + +SA+ Y L
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-AVVLLYMATQISSAMEY---LEK 129
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
+ IH D+ + N L+ +N+ KV+DF
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADF 155
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-23
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 26/157 (16%)
Query: 194 LGMGGFGSVYKGVL--------PDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKN 242
LG G F ++KGV T+V +K + R F ++S++ HK+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLK--VLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+V G+C+ +LV EFV G+L Y+ + + WK L +A + A+A+H+
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHF--- 128
Query: 303 LASPSIIHSDVKSANILLD--------DNYTAKVSDF 331
L ++IH +V + NILL + K+SD
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 32/145 (22%), Positives = 67/145 (46%), Gaps = 11/145 (7%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKI 246
LG G FG V+ +T+VAVK ++ FL ++ ++H +VK+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVK--TMKPG-SMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+ + + ++ EF++ G+L ++ + +A+ A + ++
Sbjct: 249 HAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQP-LPKLIDFSAQIAEGMAFI---EQR 303
Query: 307 SIIHSDVKSANILLDDNYTAKVSDF 331
+ IH D+++ANIL+ + K++DF
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADF 328
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 22/159 (13%)
Query: 190 FHHCLGMGGFGSVYKGVLPD------NTQVAVKKYMCADEIRITEW-EFLG---IISQVK 239
LG G FG VY+GV T+VA+K + + E EFL ++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK--TVNEAASMRERIEFLNEASVMKEFN 86
Query: 240 HKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNW-------KTCLRIAAE 292
+VV++LG+ + + TL++ E ++ G L Y+ + N +++A E
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
A + Y L + +H D+ + N ++ +++T K+ DF
Sbjct: 147 IADGMAY---LNANKFVHRDLAARNCMVAEDFTVKIGDF 182
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 16/147 (10%)
Query: 194 LGMGGFGSVYKGVLPD----NTQVAVKKYMCADEIRITEW-EFLG---IISQVKHKNVVK 245
+G G FG VY G D Q A+K + + + FL ++ + H NV+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIK--SLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 246 ILGLCLETK-VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
++G+ L + + ++ ++ +G L +I K + + A + YL A
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP--TVKDLISFGLQVARGMEYL---A 141
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
+H D+ + N +LD+++T KV+DF
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADF 168
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 17/151 (11%)
Query: 190 FHHCLGMGGFGSVYKGVLP----DNTQVAVK--KYMCADEIRITEWEFLG---IISQVKH 240
+G G FG V G L VA+K K ++ R +FLG I+ Q H
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR---DFLGEASIMGQFDH 105
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
N++++ G+ ++K ++V E++ NG+L ++ +Q + + AS + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYL 163
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ +H D+ + NIL++ N KVSDF
Sbjct: 164 SDM---GYVHRDLAARNILINSNLVCKVSDF 191
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDN----TQVAVKKYMCADEIRITE-WEFLG---IISQVKH 240
+F+ +G G FG VY G L DN AVK I E +FL I+ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 241 KNVVKILGLCLETKVTLL-VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
NV+ +LG+CL ++ + L V ++ +G L ++I +++ K + + A + Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKY 143
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L AS +H D+ + N +LD+ +T KV+DF
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADF 172
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 2e-22
Identities = 39/172 (22%), Positives = 77/172 (44%), Gaps = 18/172 (10%)
Query: 166 DPPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGVLP---DNTQVAVKKYMCAD 222
DP L ++ + + L+ + LG G FGSV +GV VA+K +
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIE-----LGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQG 374
Query: 223 EIRITEWEFLG---IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV 279
+ E + I+ Q+ + +V+++G+C + +LV E G L ++ K ++
Sbjct: 375 TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI 433
Query: 280 LKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ + + + YL + +H ++ + N+LL + + AK+SDF
Sbjct: 434 --PVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDF 480
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 15/146 (10%)
Query: 194 LGMGGFGSVYKGVLPD-----NTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVK 245
LG G FG+VYKG+ VA+K+ + E L +++ V + +V +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+LG+CL + V L+ + + G L Y+ + + + L + A ++YL
Sbjct: 82 LLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL---ED 135
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
++H D+ + N+L+ K++DF
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDF 161
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 22/166 (13%)
Query: 176 KIFSKSELLKATKNFHHCLGMGGFGSVYKGV---LPDN--TQVAVKKYMCADEIRITEWE 230
IF + L ++ LG G FGSV L DN VAVK + +
Sbjct: 18 TIFEERHLKYISQ-----LGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRD 70
Query: 231 FLG---IISQVKHKNVVKILGLCLETKV--TLLVYEFVSNGALSHYIHDKSSQVLKNWKT 285
F I+ + +VK G+ LV E++ +G L ++ +++ +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL--DASR 128
Query: 286 CLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L +++ + YL S +H D+ + NIL++ K++DF
Sbjct: 129 LLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF 171
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 18/148 (12%)
Query: 194 LGMGGFGSVYKGVL-----PDNTQVAVK--KYMCADEIRITEWEFLG---IISQVKHKNV 243
+G G FG VYKG+L VA+K K ++ R+ +FLG I+ Q H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV---DFLGEAGIMGQFSHHNI 108
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+++ G+ + K +++ E++ NGAL ++ +K + + + + A+ + YL ++
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKYLANM 166
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ +H D+ + NIL++ N KVSDF
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDF 191
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 20/154 (12%)
Query: 190 FHHCLGMGGFGSVYKGVLP-----DNTQVAVK--KYMCADEIRITEWEFLG---IISQVK 239
LG G FG V QVAVK K + I+ +
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLY 81
Query: 240 HKNVVKILGLCLETKVT--LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAI 297
H+N+VK G+C E L+ EF+ +G+L Y+ +++ N K L+ A + +
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYAVQICKGM 139
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
YL S +H D+ + N+L++ + K+ DF
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDF 170
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 24/160 (15%)
Query: 190 FHHCLGMGGFGSVYKGVLPD----NTQVAVK--KYMCADEIRITEWEFLG---IISQVKH 240
LG G FGSV +G L + +VAVK K + + EFL + H
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSH 95
Query: 241 KNVVKILGLCLETK-----VTLLVYEFVSNGALSHYI----HDKSSQVLKNWKTCLRIAA 291
NV+++LG+C+E +++ F+ G L Y+ + + + +T L+
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL-QTLLKFMV 154
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ A + YL ++ + +H D+ + N +L D+ T V+DF
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADF 191
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 38/149 (25%), Positives = 60/149 (40%), Gaps = 20/149 (13%)
Query: 194 LGMGGFGSVYKGVL----PDNTQVAVK----KYMCADEIRITEWEFLG---IISQVKHKN 242
LG G FG V +G VAVK + E +F+ + + H+N
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DDFIREVNAMHSLDHRN 82
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
++++ G+ L + +V E G+L + L T R A + A + YL S
Sbjct: 83 LIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLES 139
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
IH D+ + N+LL K+ DF
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDF 165
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 18/153 (11%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDN----TQVAVK--KYMCADEIRITEWEFLG---IISQVK 239
+F+ +G G FG VY G L DN AVK + +FL I+
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFS 148
Query: 240 HKNVVKILGLCLETKV-TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIH 298
H NV+ +LG+CL ++ L+V ++ +G L ++I +++ K + + A +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMK 206
Query: 299 YLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+L AS +H D+ + N +LD+ +T KV+DF
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADF 236
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 51/291 (17%), Positives = 100/291 (34%), Gaps = 59/291 (20%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD---------EIRITEWEFLGIISQVKHKNV 243
LG GGF V L D A+K+ +C + E + H N+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADM--------HRLFNHPNI 88
Query: 244 VKILGLCLETKVT----LLVYEFVSNGALSHYIHDKSSQVLKNW--KTCLRIAAETASAI 297
++++ CL + L+ F G L + I ++ L + +
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMI-------R 350
+H+ H D+K NILL D + D S+ E + + R
Sbjct: 148 EAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 351 GTVGYLDPEYAHTELLTGMNPNSYVALASNEKI----------SMV----PYFLDSIENN 396
T+ Y PE + S+ + +E+ +M+ PY + + +
Sbjct: 205 CTISYRAPEL--------FSVQSHCVI--DERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 397 SFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447
S + Q++ + +L + + + +RP + + +L+ L+
Sbjct: 255 SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 25/161 (15%)
Query: 190 FHHCLGMGGFGSVYKGVLPDN----TQVAVK--KYMCADEIRITEWEFLG---IISQVKH 240
LG G FGSV + L +VAVK K I EFL + + H
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI--EEFLREAACMKEFDH 84
Query: 241 KNVVKILGLCLE------TKVTLLVYEFVSNGALSHYI----HDKSSQVLKNWKTCLRIA 290
+V K++G+ L + +++ F+ +G L ++ ++ L +T +R
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL-QTLVRFM 143
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ A + YL +S + IH D+ + N +L ++ T V+DF
Sbjct: 144 VDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADF 181
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 16/146 (10%)
Query: 194 LGMGGFGSVYKGVL----PDNTQVAVKKYMC-ADEIRITEWEFLG---IISQVKHKNVVK 245
LG G FG VY+GV + VAVK C D + +F+ I+ + H ++VK
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
++G+ E ++ E G L HY+ + + T + + + A+ YL S
Sbjct: 78 LIGIIEEEPT-WIIMELYPYGELGHYLERNKNSL--KVLTLVLYSLQICKAMAYL---ES 131
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
+ +H D+ NIL+ K+ DF
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDF 157
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 39/165 (23%), Positives = 73/165 (44%), Gaps = 22/165 (13%)
Query: 176 KIFSKSELLKATKNFHHCLGMGGFGSVYKGVLPD-----NTQVAVKKYMC-ADEIRITEW 229
+IF ++EL K LG G FG+V+KGV V +K + R +
Sbjct: 8 RIFKETELRKLKV-----LGSGVFGTVHKGVWIPEGESIKIPVCIK--VIEDKSGRQSFQ 60
Query: 230 EFLG---IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC 286
I + H ++V++LGLC + + LV +++ G+L ++ + +
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGAL--GPQLL 117
Query: 287 LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L + A ++YL ++H ++ + N+LL +V+DF
Sbjct: 118 LNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADF 159
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 37/147 (25%), Positives = 71/147 (48%), Gaps = 18/147 (12%)
Query: 194 LGMGGFGSVYKGVLPD----NTQVAVK--KYMCADEIRITEWEFLG---IISQVKHKNVV 244
+G G FG V++G+ VA+K K +D +R +FL + Q H ++V
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE---KFLQEALTMRQFDHPHIV 79
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
K++G+ E V ++ E + G L ++ + + + + + A + ++A+ YL
Sbjct: 80 KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYL---E 133
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
S +H D+ + N+L+ N K+ DF
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDF 160
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 40/166 (24%), Positives = 72/166 (43%), Gaps = 30/166 (18%)
Query: 190 FHHCLGMGGFGSVYKGVL------PDNTQVAVK--KYMCADEIRITEWEFLG---IISQV 238
F LG FG VYKG L VA+K K +R EF + +++
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE---EFRHEAMLRARL 69
Query: 239 KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC------------ 286
+H NVV +LG+ + + +++ + S+G L ++ +S
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 287 -LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ + A+ A+ + Y L+S ++H D+ + N+L+ D K+SD
Sbjct: 130 FVHLVAQIAAGMEY---LSSHHVVHKDLATRNVLVYDKLNVKISDL 172
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 27/160 (16%)
Query: 194 LGMGGFGSVYKGVL------PDNTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVV 244
LG G FG V+ D VAVK D +F +++ ++H+++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC-------------LRIAA 291
K G+C + ++V+E++ +G L+ ++ + L IA+
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ AS + Y LAS +H D+ + N L+ N K+ DF
Sbjct: 141 QIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDF 177
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 38/187 (20%), Positives = 81/187 (43%), Gaps = 31/187 (16%)
Query: 166 DPPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYM 219
+P + + + + ++ LG G FG V+ D VAVK
Sbjct: 26 NPQYFSDACVHHIKRRDI-----VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK--A 78
Query: 220 CADEIRITEWEFLG---IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYI--HD 274
+ +F +++ ++H+++V+ G+C E + L+V+E++ +G L+ ++ H
Sbjct: 79 LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
Query: 275 KSSQVLKNWKTC----------LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY 324
+++L + L +A++ A+ + Y LA +H D+ + N L+
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY---LAGLHFVHRDLATRNCLVGQGL 195
Query: 325 TAKVSDF 331
K+ DF
Sbjct: 196 VVKIGDF 202
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 40/152 (26%), Positives = 65/152 (42%), Gaps = 17/152 (11%)
Query: 190 FHHCLGMGGFGSVYKGV---LPDN--TQVAVKKYMCADEIRITEWEFLG---IISQVKHK 241
F LG G FGSV L DN VAVK +F I+ ++H
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 242 NVVKILGLCLETKVT--LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
N+VK G+C L+ E++ G+L Y+ ++ + L+ ++ + Y
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEY 129
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L + IH D+ + NIL+++ K+ DF
Sbjct: 130 LGTK---RYIHRDLATRNILVENENRVKIGDF 158
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 40/150 (26%), Positives = 62/150 (41%), Gaps = 22/150 (14%)
Query: 194 LGMGGFGSVYKGVL-----PDNTQVAVK--KYMCADEIRITEWEFLG---IISQVKHKNV 243
LG G FG V VAVK K + R + I+ + H+++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS---GWKQEIDILRTLYHEHI 95
Query: 244 VKILGLCLETKV--TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
+K G C + LV E+V G+L Y+ S + L A + + YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL----AQLLLFAQQICEGMAYLH 151
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ IH D+ + N+LLD++ K+ DF
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDF 178
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 40/152 (26%), Positives = 65/152 (42%), Gaps = 17/152 (11%)
Query: 190 FHHCLGMGGFGSVYKGV---LPDN--TQVAVKKYMCADEIRITEWEFLG---IISQVKHK 241
F LG G FGSV L DN VAVK +F I+ ++H
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSLQHD 102
Query: 242 NVVKILGLCLETKVT--LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
N+VK G+C L+ E++ G+L Y+ ++ + L+ ++ + Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEY 160
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L + IH D+ + NIL+++ K+ DF
Sbjct: 161 LGTK---RYIHRDLATRNILVENENRVKIGDF 189
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 40/198 (20%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT--EWEF------LGIISQVKHKNV 243
CLG GGFG V++ D+ A+K+ IR+ E + +++++H +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKR------IRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 244 VKILGLCLE---------TKVTLLVY---EFVSNGALSHYIHDKSSQVLKNWKTCLRIAA 291
V+ LE + + +Y + L +++ + + + CL I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF----------ESLVPISSDD 341
+ A A+ +LHS ++H D+K +NI + KV DF E ++
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 342 ETAMSTMIRGTVGYLDPE 359
A T GT Y+ PE
Sbjct: 183 AYARHTGQVGTKLYMSPE 200
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 48/297 (16%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVKK-----YMCADEIRITEWEFLGIISQVKHKNVVK 245
+G G F VY+ L D VA+KK M A E + ++ Q+ H NV+K
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKE-IDLLKQLNHPNVIK 96
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYI-HDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+E +V E G LS I H K + L +T + + SA+ ++HS
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE----- 359
++H D+K AN+ + K+ D L S TA +++ GT Y+ PE
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDL-GLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 211
Query: 360 -YAHT-----------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA 407
Y E+ +P + N + IE + + + +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSP--FYGDKMN-----LYSLCKKIEQCDYPPLPSDHYS 264
Query: 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEESEH 464
+E + +L + C+ +RP + V + R+ + H
Sbjct: 265 EE--------LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH---HHHHH 310
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 35/195 (17%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKK-YMCADEIRITEWEFLGIISQVKHKNVVKILG-- 248
LG G FG V K D+ A+KK +++ E + +++ + H+ VV+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSE-VMLLASLNHQYVVRYYAAW 71
Query: 249 ----------LCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAI 297
++ K TL + E+ NG L IH + + + R+ + A+
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEAL 129
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF-------------ESLVPISSDDETA 344
Y+HS IIH D+K NI +D++ K+ DF +
Sbjct: 130 SYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 345 MSTMIRGTVGYLDPE 359
+++ I GT Y+ E
Sbjct: 187 LTSAI-GTAMYVATE 200
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 37/144 (25%), Positives = 63/144 (43%), Gaps = 13/144 (9%)
Query: 194 LGMGGFGSVYKGVLPDN---TQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKIL 247
LG G FG+V KG VAVK + E L ++ Q+ + +V+++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
G+C +LV E G L+ Y+ K + + + + + YL +
Sbjct: 85 GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK---NIIELVHQVSMGMKYL---EESN 137
Query: 308 IIHSDVKSANILLDDNYTAKVSDF 331
+H D+ + N+LL + AK+SDF
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDF 161
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 24/156 (15%)
Query: 194 LGMGGFGSVYKGVL------PDNTQVAVK--KYMCADEIRITEWEFLG---IISQVKHKN 242
LG G FG VY+G + P QVAVK +C+++ + +FL IIS+ H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQN 94
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKN----WKTCLRIAAETASAIH 298
+V+ +G+ L++ ++ E ++ G L ++ + + + L +A + A
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 299 YLHSLASPSIIHSDVKSANILLD---DNYTAKVSDF 331
Y L IH D+ + N LL AK+ DF
Sbjct: 155 Y---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 44/194 (22%), Positives = 83/194 (42%), Gaps = 14/194 (7%)
Query: 173 SRMKIFSKSELLKATKNFH--HCLGMGGFGSVYKGV-LPDNTQVAVKK----YMCADEIR 225
S + + +++ ++ + + +G G FG D Q +K+ M + E
Sbjct: 9 SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 226 ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKT 285
+ E + +++ +KH N+V+ E +V ++ G L I+ + + +
Sbjct: 69 ESRRE-VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-DQ 126
Query: 286 CLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345
L + A+ ++H I+H D+KS NI L + T ++ DF ++S E A
Sbjct: 127 ILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA- 182
Query: 346 STMIRGTVGYLDPE 359
I GT YL PE
Sbjct: 183 RACI-GTPYYLSPE 195
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 24/156 (15%)
Query: 194 LGMGGFGSVYKGVL------PDNTQVAVK--KYMCADEIRITEWEFLG---IISQVKHKN 242
LG G FG VY+G + P QVAVK +C+++ + +FL IIS+ H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQN 135
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKN----WKTCLRIAAETASAIH 298
+V+ +G+ L++ ++ E ++ G L ++ + + + L +A + A
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 299 YLHSLASPSIIHSDVKSANILLD---DNYTAKVSDF 331
Y L IH D+ + N LL AK+ DF
Sbjct: 196 Y---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 27/160 (16%)
Query: 194 LGMGGFGSVYKGVLPD------NTQVAVKKYMCADEIRITE-WEFLG---IISQV-KHKN 242
LG G FG V + +VAVK M E + I+S + +H+N
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC-----------LRIAA 291
+V +LG C L++ E+ G L +++ KS + + L ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ A + + LAS + IH DV + N+LL + + AK+ DF
Sbjct: 172 QVAQGMAF---LASKNCIHRDVAARNVLLTNGHVAKIGDF 208
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 27/184 (14%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVK------ 245
+G GGFG V+K D +K+ +E E + ++++ H N+V
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE---VKALAKLDHVNIVHYNGCWD 74
Query: 246 -------ILGLCLETKVTLLVY---EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETAS 295
T ++ EF G L +I + + L L + +
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK-VLALELFEQITK 133
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGY 355
+ Y+HS +I+ D+K +NI L D K+ DF LV +D + GT+ Y
Sbjct: 134 GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDF-GLVTSLKNDGKRTRSK--GTLRY 187
Query: 356 LDPE 359
+ PE
Sbjct: 188 MSPE 191
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 35/146 (23%), Positives = 69/146 (47%), Gaps = 16/146 (10%)
Query: 194 LGMGGFGSVYKGVLPD----NTQVAVKKYMCADEIRITEW-EFLG---IISQVKHKNVVK 245
+G G FG V++G+ VA+K C + + +FL + Q H ++VK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
++G+ E V ++ E + G L ++ + + + + + A + ++A+ YL S
Sbjct: 456 LIGVITENPV-WIIMELCTLGELRSFLQVRKFSL--DLASLILYAYQLSTALAYL---ES 509
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDF 331
+H D+ + N+L+ N K+ DF
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDF 535
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 38/163 (23%), Positives = 64/163 (39%), Gaps = 26/163 (15%)
Query: 190 FHHCLGMGGFGSVYKGVL---PDNTQVAVKKYMCADEIRITEW-EFLG---IISQV-KHK 241
F +G G FG V K + A+K + + +F G ++ ++ H
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC-------------LR 288
N++ +LG C L E+ +G L ++ L
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 289 IAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
AA+ A + Y L+ IH D+ + NIL+ +NY AK++DF
Sbjct: 147 FAADVARGMDY---LSQKQFIHRDLAARNILVGENYVAKIADF 186
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 40/169 (23%), Positives = 67/169 (39%), Gaps = 36/169 (21%)
Query: 194 LGMGGFGSVYKGVLPD------NTQVAVKKYMCADEIRITE-WEFLG---IISQVKHKNV 243
LG G FG V K T VAVK M + +E + L ++ QV H +V
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVK--MLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC----------------- 286
+K+ G C + LL+ E+ G+L ++ + +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 287 ----LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ A + + + Y LA ++H D+ + NIL+ + K+SDF
Sbjct: 149 MGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDF 194
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 39/198 (19%), Positives = 76/198 (38%), Gaps = 28/198 (14%)
Query: 189 NFHHCLGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFLGIISQVKHKNVV 244
LG G +V++G A+K + + EF ++ ++ HKN+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF-EVLKKLNHKNIV 70
Query: 245 KILGL--CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
K+ + T+ +L+ EF G+L + + S+ L + + +++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 303 LASPSIIHSDVKSANILL----DDNYTAKVSDF---ESLVPISSDDETAMSTMIRGTVGY 355
I+H ++K NI+ D K++DF L +D+ ++ GT
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-----EDDEQFVSLY-GT--- 178
Query: 356 LDPEYAHTELLTGMNPNS 373
EY H ++
Sbjct: 179 --EEYLHPDMYERAVLRK 194
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 71/338 (21%), Positives = 124/338 (36%), Gaps = 44/338 (13%)
Query: 161 GGGGRDPPGLAFSRMKIFSKS-ELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKY 218
G GRD +++ + + L GGF VY+ + + A+K+
Sbjct: 9 GASGRDQSDFVGQTVELGELRLRVRR-------VLAEGGFAFVYEAQDVGSGREYALKRL 61
Query: 219 MCADEIR----ITEWEFLGIISQVKHKNVVKILGLCLETKVT-------LLVYEFVSNGA 267
+ +E + I E F+ +S H N+V+ K L+ + G
Sbjct: 62 LSNEEEKNRAIIQEVCFMKKLS--GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ 119
Query: 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAK 327
L ++ S+ + T L+I +T A+ ++H P IIH D+K N+LL + T K
Sbjct: 120 LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIK 178
Query: 328 VSDFESLVPISSDDETAMSTMIRGTVGYLD-----PEYAHTELLTGMNPNSYVALASNEK 382
+ DF S IS + + S R V P Y E++ + Y EK
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII-----DLYSNFPIGEK 233
Query: 383 I----------SMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTE 432
+ + E+ + +I+N + + + V L L++ E
Sbjct: 234 QDIWALGCILYLLC-FRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEE 292
Query: 433 RPTMKEVSEELDRLRRLQENYWARKNNEESEHLLGESS 470
R ++ EV +L + + E E G S
Sbjct: 293 RLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGS 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 50/276 (18%), Positives = 100/276 (36%), Gaps = 59/276 (21%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRITEWEFLGIISQVKHKNVVKIL 247
+G G F +VYKG+ +VA + + E + + E ++ ++H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE-MLKGLQHPNIVRFY 91
Query: 248 GLCLET---KVTLLVY-EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
T K +++ E +++G L Y+ +K + + + +LH+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQFLHT- 147
Query: 304 ASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAH 362
+P IIH D+K NI + + K+ D +++ + + + GT ++ PE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLG----LATLKRASFAKAVIGTPEFMAPEMYE 203
Query: 363 T----------------ELLTGMNPNS-YVALASNEKISM---VPYFLDSIENNSFRQIL 402
E+ T P S A + P D + ++I+
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263
Query: 403 NFQVADESEMEEIEVVAELASKCLRIRGTERPTMKE 438
C+R ER ++K+
Sbjct: 264 --------------------EGCIRQNKDERYSIKD 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 29/180 (16%)
Query: 193 CLGMGGFGSVYKGVLPDNTQVAVKK-----------YMCADEIRITEWEFLGIISQVKHK 241
+G GG V++ + A+K +EI +++++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA--------YLNKLQQH 86
Query: 242 N--VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+ ++++ + + +V E N L+ ++ K S + A+H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHT 142
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+H I+HSD+K AN L+ D K+ DF + D + + GTV Y+ PE
Sbjct: 143 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 39/174 (22%), Positives = 77/174 (44%), Gaps = 38/174 (21%)
Query: 190 FHHCLGMGGFGSVYKGVLPD------NTQVAVK--KYMCADEIRITEWEFLG---IISQV 238
+ +G G FG V++ P T VAVK K + +++ +F ++++
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQREAALMAEF 107
Query: 239 KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC------------ 286
+ N+VK+LG+C K L++E+++ G L+ ++ S + +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 287 ---------LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L IA + A+ + Y L+ +H D+ + N L+ +N K++DF
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADF 218
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 38/164 (23%), Positives = 66/164 (40%), Gaps = 31/164 (18%)
Query: 194 LGMGGFGSVYKGVLPD--------NTQVAVKKYMCADEIRITEW-EFLG---IISQV-KH 240
LG G FG V VAVK M D+ + + + ++ + KH
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC-------------L 287
KN++ +LG C + ++ E+ S G L Y+ + ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ A + YL AS IH D+ + N+L+ +N K++DF
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 31/168 (18%)
Query: 190 FHHCLGMGGFGSVYKGVLPD------NTQVAVKKYMCADEIRITE-WEFLG---IISQV- 238
F LG G FG V + VAVK M +TE + ++S +
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTEREALMSELKVLSYLG 84
Query: 239 KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC------------ 286
H N+V +LG C TL++ E+ G L +++ K + + +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 287 ---LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L + + A + +L AS + IH D+ + NILL K+ DF
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDF 189
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 37/181 (20%), Positives = 69/181 (38%), Gaps = 31/181 (17%)
Query: 193 CLGMGGFGSVYKGVLPDNTQVAVKK-----------YMCADEIRITEWEFLGIISQVKHK 241
+G GG V++ + A+K +EI +++++
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA--------YLNKLQQH 67
Query: 242 N--VVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIH 298
+ ++++ T + +V E N L+ ++ K S + A+H
Sbjct: 68 SDKIIRLYD-YEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVH 122
Query: 299 YLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDP 358
+H I+HSD+K AN L+ D K+ DF + D + + GTV Y+ P
Sbjct: 123 TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 359 E 359
E
Sbjct: 179 E 179
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKK----YMCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G +G K D + K+ M E ++ E ++ ++KH N+V+
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV-NLLRELKHPNIVRYYD 72
Query: 249 LCLETKVTLL--VYEFVSNGALSHYI-HDKSSQVLKNWKTCLRIAAETASAIHYLHS--L 303
++ T L V E+ G L+ I + + + LR+ + A+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+++H D+K AN+ LD K+ DF L I + D + T + GT Y+ PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDF-GLARILNHDTSFAKTFV-GTPYYMSPE 186
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 41/167 (24%), Positives = 65/167 (38%), Gaps = 30/167 (17%)
Query: 190 FHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADEIRITE-WEFLG---IISQV- 238
LG G FG V + VAVK M + +E + I+ +
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSELKILIHIG 88
Query: 239 KHKNVVKILGLCLETKV-TLLVYEFVSNGALSHYIHDKSSQVLKNWKTC----------- 286
H NVV +LG C + +++ EF G LS Y+ K ++ +
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 287 --LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ + + A + +L AS IH D+ + NILL + K+ DF
Sbjct: 149 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 39/168 (23%), Positives = 68/168 (40%), Gaps = 31/168 (18%)
Query: 190 FHHCLGMGGFGSVYKGVLPD--------NTQVAVKKYMCADEIRITE-WEFLG---IISQ 237
LG G FG V T+VAVK M + + + + ++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATEKDLSDLISEMEMMKM 130
Query: 238 V-KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC---------- 286
+ KHKN++ +LG C + ++ E+ S G L Y+ + L+
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 287 ---LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ A + A + Y LAS IH D+ + N+L+ ++ K++DF
Sbjct: 191 KDLVSCAYQVARGMEY---LASKKCIHRDLAARNVLVTEDNVMKIADF 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 39/205 (19%), Positives = 82/205 (40%), Gaps = 32/205 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRITEWEFLGIISQVKHKNVVKIL 247
LG G +V++G A+K ++ ++++ E+E ++ ++ HKN+VK+
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE---VLKKLNHKNIVKLF 73
Query: 248 GL--CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+ T+ +L+ EF G+L + + S+ L + + +++L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 306 PSIIHSDVKSANILL----DDNYTAKVSDF---ESLVPISSDDETAMSTMIRGTVGYLDP 358
I+H ++K NI+ D K++DF L +D+ ++ GT
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-----EDDEQFVSLY-GT-----E 179
Query: 359 EYAHTELLTGMNPNSYVALASNEKI 383
EY H ++ +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATV 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 38/164 (23%), Positives = 67/164 (40%), Gaps = 31/164 (18%)
Query: 194 LGMGGFGSVYKGVL--------PDNTQVAVKKYMCADEIRITEW-EFLG---IISQV-KH 240
LG G FG V + VAVK M D+ + + + ++ + KH
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC-------------L 287
KN++ +LG C + ++ E+ S G L Y+ + ++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ A + YL AS IH D+ + N+L+ +N K++DF
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 247
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 41/180 (22%), Positives = 67/180 (37%), Gaps = 29/180 (16%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEF--LGIISQVKHKNVVKILG 248
+G G FG V++ Q AVK ++R+ + L + + +V + G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVACAGLSSPRIVPLYG 117
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKT-----CLRIAAETASAIHYLHSL 303
E + E + G+L Q++K L + + YLH+
Sbjct: 118 AVREGPWVNIFMELLEGGSLG--------QLIKQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 304 ASPSIIHSDVKSANILLDDN-YTAKVSDF---ESLVPISSDDETAMSTMIRGTVGYLDPE 359
I+H DVK+ N+LL + A + DF L P I GT ++ PE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 36/173 (20%)
Query: 190 FHHCLGMGGFGSVYKGVLPD------NTQVAVKKYMCADEIRITE-WEFLG---IISQV- 238
F LG G FG V + QVAVK M ++ +E + +++Q+
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSEREALMSELKMMTQLG 106
Query: 239 KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC------------ 286
H+N+V +LG C + L++E+ G L +Y+ K + ++
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 287 --------LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
L A + A + +L S +H D+ + N+L+ K+ DF
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDF 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 35/180 (19%), Positives = 68/180 (37%), Gaps = 29/180 (16%)
Query: 193 CLGMGGFGSVYKGVLPDNTQVAVKK-----------YMCADEIRITEWEFLGIISQVKHK 241
+G GG V++ + A+K +EI +++++
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA--------YLNKLQQH 114
Query: 242 N--VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+ ++++ + + +V E N L+ ++ K S + A+H
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHT 170
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+H I+HSD+K AN L+ D K+ DF + D + + G V Y+ PE
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 48/380 (12%), Positives = 108/380 (28%), Gaps = 86/380 (22%)
Query: 124 DARMQDIASQIDPLDLRKKSAGKSRNVGRVILSAVRLGGGGRDPPGLAFSRMKIFSKSEL 183
D ++++ ++I ++R S ++ +++ G R + + +
Sbjct: 26 DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTV 85
Query: 184 LKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRITEWE------- 230
L G + + V + ++ I+ + E
Sbjct: 86 L----------GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 231 --------------FLGIISQVKHKNVVKILGLCLETKVTLLVYEFV-------SNGALS 269
F+ VK K++ + L+ + ++ F +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 270 HYIHDKSS-QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328
+ SS L++ + + LH ++H+ ++ +I+LD +
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFL 252
Query: 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNS--------------- 373
+ FE LV + + G+ PE +L +
Sbjct: 253 TGFEHLVRDGASAVS------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 374 -YVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI-EVVAELASKCLRIRGT 431
Y ++ +P D I + I + V L LR
Sbjct: 307 IYWIWCAD-----LP-NTDDAALGGSEWIF-------RSCKNIPQPVRALLEGFLRYPKE 353
Query: 432 ERPTMKEVSE--ELDRLRRL 449
+R + E E ++LR
Sbjct: 354 DRLLPLQAMETPEYEQLRTE 373
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 53/326 (16%), Positives = 99/326 (30%), Gaps = 60/326 (18%)
Query: 172 FSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGVLPDNT------QVAVKKYMCADEIR 225
+K ++ +L HH LG G F VY+ D + +K +
Sbjct: 51 LPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV-----QKP 105
Query: 226 ITEWEF------LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV 279
WEF + + +K L ++LV E S G L + I+ +
Sbjct: 106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTP 165
Query: 280 LKNW--KTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTA----------- 326
K + A I +H IIH D+K N +L + +
Sbjct: 166 EKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222
Query: 327 KVSDF-ESLVPISSDDETAMSTMIRGTVGYLDPE------YAHT-----------ELLTG 368
+ D +S+ T + T G+ E + + +L G
Sbjct: 223 ALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 369 MNPNSYVALASNE-KISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLR 427
+ + + N F +LN + D + ++++ + K +
Sbjct: 282 TYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN--IPDCHHLPSLDLLRQKLKKVFQ 339
Query: 428 IRGTERP-----TMKEVSEELDRLRR 448
T + + + E R R+
Sbjct: 340 QHYTNKIRALRNRLIVLLLECKRSRK 365
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 20/176 (11%)
Query: 193 CLGMGGFGSVYKGVLPDNTQ-VAVKKYMCADEIRITEWEFL-------GIISQVKHKNVV 244
LG G +G VY G N +A+K EI + + + +KHKN+V
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIK------EIPERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ LG E + E V G+LS + K + N +T + + YLH
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--- 139
Query: 305 SPSIIHSDVKSANILLD-DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I+H D+K N+L++ + K+SDF + ++ + + GT+ Y+ PE
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 193
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 54/269 (20%), Positives = 103/269 (38%), Gaps = 32/269 (11%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKIL 247
LG G G++ + DN VAVK+ + + + E + ++ + +H NV++
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKR-ILPECFSFADRE-VQLLRESDEHPNVIRYF 84
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
+ + + E + L Y+ K + + +T S + +LHSL +
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSL---N 138
Query: 308 IIHSDVKSANILL-----DDNYTAKVSDFESLVPISSDDETAMSTM--IRGTVGYLDPEY 360
I+H D+K NIL+ A +SDF L + + S + GT G++ PE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDF-GLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 361 AHTELLTGMNPNS---------YVALASNEKISMVPYFLDSIENNSFRQILNFQVADESE 411
+ Y ++ F S++ + + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQANILLGACSLDCLHP 252
Query: 412 MEEIEVVA-ELASKCLRIRGTERPTMKEV 439
+ +V+A EL K + + +RP+ K V
Sbjct: 253 EKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 42/179 (23%), Positives = 62/179 (34%), Gaps = 28/179 (15%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKK----YMCADEIRITEWEFLGIISQVKHKNVVKIL 247
LG G +G V+K D AVK+ + + E +H V++
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 248 GLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCL------RIAAETASAIHYL 300
E L L E +L + + W L +T A+ +L
Sbjct: 124 Q-AWEEGGILYLQTELCG-PSLQQHC--------EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
HS ++H DVK ANI L K+ DF LV + + G Y+ PE
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPRYMAPE 226
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 22/176 (12%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK--------KYMCADEIRITEWEFLGIISQVKHKNVV 244
LG G F VY+ + +VA+K K ++ E + I Q+KH +++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ-NEVK---IHCQLKHPSIL 74
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
++ E + LV E NG ++ Y+ ++ + + + + + YLHS
Sbjct: 75 ELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEAR-HFMHQIITGMLYLHSH 131
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I+H D+ +N+LL N K++DF + E T+ GT Y+ PE
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-TLC-GTPNYISPE 182
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 32/148 (21%), Positives = 53/148 (35%), Gaps = 21/148 (14%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK--------KYMCADEIRITEWEFLGIISQVKHKNVV 244
LG GGF ++ A K K +++ E I + H++VV
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-MEIS---IHRSLAHQHVV 104
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
G E + +V E +L K + L + + YLH
Sbjct: 105 GFHG-FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLHRN 160
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
+IH D+K N+ L+++ K+ DF
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDF 185
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 27/177 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK--------KYMCADEIRITEWEFLGIISQVKHKNVV 244
LG G FG+VY +A+K K ++R E E I S ++H N++
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR-REVE---IQSHLRHPNIL 72
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
++ G + L+ E+ G + + + +T E A+A+ Y HS
Sbjct: 73 RLYG-YFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSYCHSK 128
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFE-SLVPISSDDETAMSTMIRGTVGYLDPE 359
+IH D+K N+LL K++DF S+ SS GT+ YL PE
Sbjct: 129 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPE 177
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 32/148 (21%), Positives = 53/148 (35%), Gaps = 21/148 (14%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK--------KYMCADEIRITEWEFLGIISQVKHKNVV 244
LG GGF ++ A K K +++ E I + H++VV
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-MEIS---IHRSLAHQHVV 78
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
G E + +V E +L K + L + + YLH
Sbjct: 79 GFHG-FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLHRN 134
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
+IH D+K N+ L+++ K+ DF
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDF 159
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 35/298 (11%), Positives = 78/298 (26%), Gaps = 73/298 (24%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRITEWE----------------- 230
LG + + V + ++ I+ + E
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 231 ----FLGIISQVKHKNVVKILGLCLETKVTLLVYEFV-------SNGALSHYIHDKSS-Q 278
F+ VK K++ + L+ + ++ F + + SS
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 279 VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338
L++ + + LH ++H+ ++ +I+LD ++ FE LV
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNS-----------------YVALASNE 381
+ + + G+ PE + + Y ++
Sbjct: 258 AR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310
Query: 382 KISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEV 439
+P I + + V L LR +R +
Sbjct: 311 ----LP-ITKDAALGGSEWIFRS-CKNIPQP-----VRALLEGFLRYPKEDRLLPLQA 357
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 36/148 (24%), Positives = 59/148 (39%), Gaps = 13/148 (8%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKKY---MCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G V P +VA+K+ C + E + +SQ H N+V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE-IQAMSQCHHPNIVSYYT 80
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC--LRIAA---ETASAIHYLHSL 303
+ LV + +S G++ I ++ IA E + YLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
IH DVK+ NILL ++ + +++DF
Sbjct: 141 ---GQIHRDVKAGNILLGEDGSVQIADF 165
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 41/147 (27%), Positives = 65/147 (44%), Gaps = 19/147 (12%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLC 250
LG G +GSVYK + VA+K+ +++ E I+ Q +VVK G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS-IMQQCDSPHVVKYYGSY 93
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR---IAA---ETASAIHYLHSLA 304
+ +V E+ G++S +++ L IA T + YLH +
Sbjct: 94 FKNTDLWIVMEYCGAGSVS--------DIIRLRNKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
IH D+K+ NILL+ AK++DF
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADF 169
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 55/208 (26%), Positives = 80/208 (38%), Gaps = 45/208 (21%)
Query: 194 LGMGGFGSVYKGVLPD---NTQVAVK---KYMCADEIRITEWEFLG-------IISQVKH 240
LG GG +VY D N +VA+K E E L SQ+ H
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKE------ETLKRFEREVHNSSQLSH 70
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
+N+V ++ + E LV E++ LS YI + T + + I +
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL---SVDTAINFTNQILDGIKHA 127
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEY 360
H + I+H D+K NIL+D N T K+ DF + S+ + + GTV Y PE
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDF-GIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 361 AHT-----------------ELLTGMNP 371
A E+L G P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 62/288 (21%), Positives = 94/288 (32%), Gaps = 59/288 (20%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVK-----KYMCAD-EIRITEWEFLGIISQVKHKNVVKIL 247
LG G G+V VAVK A EI++ + H NV++
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL-------LTESDDHPNVIRYY 75
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE----TASAIHYLHSL 303
+ + E N L + K+ AS + +LHSL
Sbjct: 76 CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 304 ASPSIIHSDVKSANILLD-------------DNYTAKVSDF---ESLVPISSDDETAMST 347
IIH D+K NIL+ +N +SDF + L S T ++
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 348 MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNE----KISMVPYFL-----------DS 392
GT G+ P ELL N + + V Y++ S
Sbjct: 192 PS-GTSGWRAP-----ELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 393 IENNSFRQILNFQVADESEMEEIEVVA-ELASKCLRIRGTERPTMKEV 439
E+N R I + + A +L S+ + +RPT +V
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 37/148 (25%), Positives = 59/148 (39%), Gaps = 21/148 (14%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKK--YMCADEIRITEWEFLGIISQVKHKNVVKILGL 249
LG G FG VYK A K +E+ E I++ H +VK+LG
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE-ILATCDHPYIVKLLGA 84
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR---IAA---ETASAIHYLHSL 303
++ EF GA+ ++ L I + A+++LHS
Sbjct: 85 YYHDGKLWIMIEFCPGGAVD--------AIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
IIH D+K+ N+L+ +++DF
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 12/144 (8%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKY---MCADEIRITEWEFLGIISQVKHKNVVKIL 247
+G G FG V+KG+ VA+K DEI + E ++SQ V K
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDSPYVTKYY 86
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
G L+ ++ E++ G+ + L + I E + YLHS
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIAT-ILREILKGLDYLHSE---K 139
Query: 308 IIHSDVKSANILLDDNYTAKVSDF 331
IH D+K+AN+LL ++ K++DF
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADF 163
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 39/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVKK--YMCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G G+VY + + +VA+++ + + E + ++ + K+ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE-ILVMRENKNPNIVNYLD 84
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR---IAA---ETASAIHYLHS 302
L +V E+++ G+L+ + +TC+ IAA E A+ +LHS
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
+IH D+KS NILL + + K++DF
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDF 160
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 4e-16
Identities = 45/176 (25%), Positives = 73/176 (41%), Gaps = 25/176 (14%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK--------KYMCADEIRITEWEFLGIISQVKHKNVV 244
LG G FG+VY + +A+K K ++R E E I S ++H N++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR-REIE---IQSHLRHPNIL 77
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
++ + + L+ EF G L + + ++ E A A+HY H
Sbjct: 78 RMYN-YFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSA-TFMEELADALHYCHER 133
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+IH D+K N+L+ K++DF + TM GT+ YL PE
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADF-GWSVHAPSLRR--RTMC-GTLDYLPPE 182
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 23/151 (15%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKI 246
+G G FG+VY + ++ VA+KK + + +W+ + + +++H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR---IAA---ETASAIHYL 300
G L LV E+ A +L+ K L+ IAA + YL
Sbjct: 120 RGCYLREHTAWLVMEYCLGSAS---------DLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
HS ++IH DVK+ NILL + K+ DF
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 57/275 (20%), Positives = 97/275 (35%), Gaps = 49/275 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRITEWEFL----GIISQVKHKNV 243
LG G G V +VA++ K+ + I+ ++ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+KI + + +V E + G L + LK TC + A+ YLH
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR--LKE-ATCKLYFYQMLLAVQYLHEN 258
Query: 304 ASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEY 360
IIH D+K N+LL +++ K++DF + + + M T+ GT YL P
Sbjct: 259 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC-GTPTYLAP-- 310
Query: 361 AHTELLTGMNPNSYVALASNEKISM--------------VPYFLDSIENNSFRQILNFQV 406
E+L + Y N + P+ + + QI + +
Sbjct: 311 ---EVLVSVGTAGY-----NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 407 A-DESEMEEIEVVA-ELASKCLRIRGTERPTMKEV 439
E+ A +L K L + R T +E
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 80.3 bits (197), Expect = 6e-16
Identities = 76/546 (13%), Positives = 158/546 (28%), Gaps = 175/546 (32%)
Query: 21 NFHSESIEKIIKKLTKDWLGQFAREEQVQ--ADLIGWKKILVKINEVVDDAVEKQTKEES 78
+F + + K + + F + D+ K IL K E +D + +
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMP--KSILSK--EEIDHIIMSKDAVSG 63
Query: 79 VKRWLGKLRN-------------LACDVDYLLDEFQTEAFQRML-----------LQDDD 114
R L + L + +L+ +TE Q + L +D+
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 115 DVMSKVKVVDARMQDIASQIDPLDLRKKSAGKSRNVGRVILSAVRLGGGGRDPPGLAFSR 174
V +K V R+Q L LR+ + R V++
Sbjct: 124 QVFAKYNVS--RLQPY------LKLRQA-LLELRPAKNVLI------------------- 155
Query: 175 MKIFSKSELLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGI 234
G+ G G K + + C + +F I
Sbjct: 156 -----------------D--GVLGSG---KTWVALDV--------CLSYKVQCKMDF-KI 184
Query: 235 --ISQVKHKNVVKILGLCLETKVTL-----LVYEFVSNGALSHYIHDKSSQVLKNWKTCL 287
++ L C + L L+Y+ N + + + L
Sbjct: 185 FWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV---SDFESLVPISSDDETA 344
R ++ Y + L ++ +V++A N + K+ + F+ + S T
Sbjct: 235 RRLLKSKP---YENCL----LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 345 MSTMIRGTVGYLDPE-------YAHT-------ELLTGMNP-----------------NS 373
++ ++ E Y E+LT NP ++
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT-NPRRLSIIAESIRDGLATWDN 346
Query: 374 YVALASNEKISMVPYFLDSIENNSFRQ------ILNFQV-----------ADESEMEEIE 416
+ + ++ +++ L+ +E +R+ + D + + +
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 417 VVAELASKCLRIRGTERPT---------MKEVSEELDRL-RRLQENYWARKNNEESEHLL 466
VV +L L + + T +K E L R + ++Y K + + +
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466
Query: 467 GESSTY 472
Y
Sbjct: 467 PYLDQY 472
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 26/145 (17%), Positives = 49/145 (33%), Gaps = 16/145 (11%)
Query: 195 GMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILGL 249
G +V P V V++ + + FL + H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRR-INLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA---ETASAIHYLHSLASP 306
+ +V F++ G+ I + L IA A+ Y+H +
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNE----LAIAYILQGVLKALDYIHHM--- 147
Query: 307 SIIHSDVKSANILLDDNYTAKVSDF 331
+H VK+++IL+ + +S
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGL 172
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 38/196 (19%), Positives = 72/196 (36%), Gaps = 28/196 (14%)
Query: 187 TKNFH--HCLGMGGFGSVYKGV-LPDNTQVAVKK----YMCADEIRITEWEFLGIISQVK 239
T FH +G G FGSV+K V D A+K+ + + + E +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 240 HKNVVKILGLCLETKVTLLVYEFVSNGALSHYI--HDKSSQVLKNWKTCLRIAAETASAI 297
H +VV+ E L+ E+ + G+L+ I + + K + + +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE-AELKDLLLQVGRGL 128
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE--------------T 343
Y+HS+ S++H D+K +NI + + E + ++ +
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 344 AMSTMIRGTVGYLDPE 359
+ G +L E
Sbjct: 186 SPQVEE-GDSRFLANE 200
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 8e-16
Identities = 46/191 (24%), Positives = 71/191 (37%), Gaps = 31/191 (16%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFLGIISQVKHKNVVKIL-- 247
LG GGFG V + + QVA+K + + E I+ ++ H NVV
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI-QIMKKLNHPNVVSAREV 80
Query: 248 ----GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+ LL E+ G L Y++ + + ++ +SA+ YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 304 ASPSIIHSDVKSANILLD---DNYTAKVSDF---ESLVPISSDDETAMSTMIRGTVGYLD 357
IIH D+K NI+L K+ D + L D + + GT
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-----DQGELCTEFV-GT----- 186
Query: 358 PEYAHTELLTG 368
+Y ELL
Sbjct: 187 LQYLAPELLEQ 197
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 38/191 (19%), Positives = 70/191 (36%), Gaps = 34/191 (17%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVK--------KYMCADEIRITEWEFLGIISQVK------ 239
L G F + DN A+K K + + K
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 240 ----HKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIH-----DKSSQVLKNWKTCLRI 289
++ + G+ + + ++YE++ N ++ + DK+ + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 290 AAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF-ESLVPISSDDETAMSTM 348
++ Y+H+ +I H DVK +NIL+D N K+SDF ES + + +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--- 211
Query: 349 IRGTVGYLDPE 359
GT ++ PE
Sbjct: 212 --GTYEFMPPE 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 42/208 (20%), Positives = 76/208 (36%), Gaps = 48/208 (23%)
Query: 193 CLGMGGFGSVYKG---VLPDNTQVAVK--KYMCADEIR---ITEWEFLGIISQVKHKNVV 244
C+ GG G +Y + + V +K + E + + E +FL ++V H ++V
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFL---AEVVHPSIV 142
Query: 245 KIL-----GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+I V +V E+V +L K + E A+ Y
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP-----VAEAIAYLLEILPALSY 197
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
LHS+ ++++D+K NI+L + K+ D ++ I + + GT G+ PE
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI-----NSFGYLY-GTPGFQAPE 247
Query: 360 YAHT----------------ELLTGMNP 371
T L +
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 40/147 (27%), Positives = 61/147 (41%), Gaps = 21/147 (14%)
Query: 193 CLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEF-LGIISQVKHKNVVKILGLC 250
+G G G V QVAVK + R + I+ +H NVV++
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLR---IAA---ETASAIHYLHSLA 304
L + ++ EF+ GAL+ + + L IA A+ YLH+
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVS----------QVRLNEEQIATVCEAVLQALAYLHA-- 159
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
+IH D+KS +ILL + K+SDF
Sbjct: 160 -QGVIHRDIKSDSILLTLDGRVKLSDF 185
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 39/151 (25%), Positives = 61/151 (40%), Gaps = 18/151 (11%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKY-MCADEIRITEWEFLGIISQVKHKNVVKILGL 249
+G G +G VYKG + A+K + DE + E + H+N+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 250 CLETKVTL------LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA---ETASAIHYL 300
++ LV EF G+++ I + LK IA E + +L
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE----EWIAYICREILRGLSHL 145
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
H +IH D+K N+LL +N K+ DF
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDF 173
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 44/195 (22%), Positives = 72/195 (36%), Gaps = 18/195 (9%)
Query: 173 SRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRIT 227
S + N LG G FG V K + AVK +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 228 EWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL 287
E + ++ ++ H N++K+ + ++ +V E + G L I + + +
Sbjct: 69 LRE-VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETA 344
+ S I Y+H +I+H D+K NILL + + K+ DF T
Sbjct: 128 KQV---FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTK 179
Query: 345 MSTMIRGTVGYLDPE 359
M I GT Y+ PE
Sbjct: 180 MKDRI-GTAYYIAPE 193
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 57/305 (18%), Positives = 103/305 (33%), Gaps = 60/305 (19%)
Query: 168 PGLAFSRMKIFSKSELLKATKNFHHC------LGMGGFGSVYKGV-LPDNTQVAVK---- 216
PG + + +T F LG G FG V + AVK
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61
Query: 217 -KYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDK 275
+ + E + ++ Q+ H N++K+ + LV E + G L I +
Sbjct: 62 RQVKQKTDKESLLRE-VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120
Query: 276 SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFE 332
+ +R + S I Y+H I+H D+K N+LL + ++ DF
Sbjct: 121 KRFSEVDAARIIR---QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 333 SLVPISSDDETAMSTMIRGTVGYLDPE-----YAHT-----------ELLTGMNPNSYVA 376
+ + M I GT Y+ PE Y LL+G P
Sbjct: 175 LSTHFEASKK--MKDKI-GTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP----- 226
Query: 377 LASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVA-ELASKCLRIRGTERP 434
F + E + +++ + + + +++ A +L K L + R
Sbjct: 227 ------------FNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
Query: 435 TMKEV 439
+ ++
Sbjct: 275 SARDA 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 52/213 (24%), Positives = 74/213 (34%), Gaps = 49/213 (23%)
Query: 194 LGMGGFGSVYKGVLPDNT---QVAVK---KYMCADEIRITEWEFLG-------IISQVKH 240
LG GG V+ D VAVK + D F + + H
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDP------SFYLRFRREAQNAAALNH 71
Query: 241 KNVVKIL--GLCLETKVTL--LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASA 296
+V + G L +V E+V L +H + K + + A+ A
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQA 128
Query: 297 IHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST-MIRGTVGY 355
+++ H IIH DVK ANI++ KV DF I+ + T + GT Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 356 LDPEYAHT-----------------ELLTGMNP 371
L PE A E+LTG P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 56/293 (19%), Positives = 95/293 (32%), Gaps = 51/293 (17%)
Query: 173 SRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITE 228
S + + F LG G FG V+ + +K K + E
Sbjct: 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68
Query: 229 WEFLGIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLK-NWKTC 286
E + ++ + H N++KI + E + +V E G L I ++ +
Sbjct: 69 AE-IEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 287 LRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDET 343
+ + +A+ Y HS ++H D+K NIL + K+ DF SD+
Sbjct: 127 AELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH- 182
Query: 344 AMSTMIRGTVGYLDPE---YAHTE-------------LLTGMNPNSYVALASNEKISMVP 387
+ GT Y+ PE T LLTG P
Sbjct: 183 -STNAA-GTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLP---------------- 224
Query: 388 YFLDSIENNSFRQILNFQVADESEMEEIEVVA-ELASKCLRIRGTERPTMKEV 439
F + ++ + E + A +L + L RP+ +V
Sbjct: 225 -FTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 180 KSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFLGII 235
++ ++ T F LG G F V+ A+K K + + E E + ++
Sbjct: 3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL-ENE-IAVL 60
Query: 236 SQVKHKNVVKILGLCLETKVTL-LVYEFVSNGAL-------SHYIHDKSSQVLKNWKTCL 287
++KH+N+V + + E+ LV + VS G L Y +S V++
Sbjct: 61 KKIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----- 114
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISS-DDET 343
SA+ YLH I+H D+K N+L ++N ++DF +S +
Sbjct: 115 -----VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFG----LSKMEQNG 162
Query: 344 AMSTMIRGTVGYLDPE 359
MST GT GY+ PE
Sbjct: 163 IMSTAC-GTPGYVAPE 177
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 36/217 (16%), Positives = 72/217 (33%), Gaps = 57/217 (26%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-------KYMCADEIRITEWEFLGIISQVKHKNVVK 245
+G G +G V + A+K + + ++ + E ++ ++ H N+ +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV-RLMKKLHHPNIAR 92
Query: 246 ILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETA---------- 294
+ E + + LV E G L ++ +
Sbjct: 93 LYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 295 ---------------------------SAIHYLHSLASPSIIHSDVKSANILL--DDNYT 325
SA+HYLH+ I H D+K N L + ++
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFE 208
Query: 326 AKVSDF---ESLVPISSDDETAMSTMIRGTVGYLDPE 359
K+ DF + +++ + M+T GT ++ PE
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE 244
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 32/300 (10%), Positives = 67/300 (22%), Gaps = 73/300 (24%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
L +G V+ + A+K + E +E E L +++ ++ +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 249 LCLETKVT--------------------------LLVYEFVSNGALSHYIHDKSSQVLKN 282
+ LL+ S L +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 283 ----WKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338
+ A+ L S ++H N+ + + + D +L +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 339 SDDETAMSTMIRGTVGYLDPEYAHT-------------------ELLTGMNPNSYVALAS 379
+ V Y E+ + + P V
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 380 NEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEV 439
+ ++ +F + D V L + L R E
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTP--LPDF--------VKTLIGRFLNFDRRRRLLPLEA 350
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 28/181 (15%)
Query: 164 GRDPPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCAD 222
+ GLA + K + LG G FG V+ V N +V VK ++ +
Sbjct: 9 AVELEGLAACEGEYSQKYSTMS-------PLGSGAFGFVWTAVDKEKNKEVVVK-FIKKE 60
Query: 223 EIRITEWEFLG----------IISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGA-LSH 270
++ W I+S+V+H N++K+L + E + LV E +G L
Sbjct: 61 KVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFA 119
Query: 271 YIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSD 330
+I L I + SA+ YL IIH D+K NI++ +++T K+ D
Sbjct: 120 FIDRH--PRLDE-PLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID 173
Query: 331 F 331
F
Sbjct: 174 F 174
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 22/148 (14%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRIT-EWEFLGIISQVKHKNVVKI 246
+G G F V + +VA+K + ++ E + I+ + H N+VK+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE---VRIMKILNHPNIVKL 79
Query: 247 LGLCLETKVTL-LVYEFVSNGALSHYI--HDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+ET+ TL L+ E+ S G + Y+ H + + K + SA+ Y H
Sbjct: 80 FE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-----KEARSKFRQIVSAVQYCHQK 133
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
I+H D+K+ N+LLD + K++DF
Sbjct: 134 ---RIVHRDLKAENLLLDADMNIKIADF 158
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 18/193 (9%)
Query: 175 MKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRITEW 229
+ + S + LG G F V + V + A K K + A + + E
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 230 EFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRI 289
E I +++H N+V++ E LV++ V+ G L I + + C++
Sbjct: 78 E-ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ 136
Query: 290 AAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETAMS 346
+I Y HS I+H ++K N+LL K++DF + + +D A
Sbjct: 137 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWH 188
Query: 347 TMIRGTVGYLDPE 359
GT GYL PE
Sbjct: 189 GFA-GTPGYLSPE 200
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 18/174 (10%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRITEWEFLGIISQVKHKNVVKILG 248
LG G F V + V + A K K + A + + E E I +++H N+V++
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE-ARICRKLQHPNIVRLHD 72
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
E LV++ V+ G L I + + C++ +I Y HS I
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---ILESIAYCHSN---GI 126
Query: 309 IHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+H ++K N+LL K++DF + + +D A GT GYL PE
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFA-GTPGYLSPE 177
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 17/174 (9%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRITEWEFLGIISQVKHKNVVKILG 248
LG G F V + V + + A K + A + + E E I +KH N+V++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE-ARICRLLKHPNIVRLHD 77
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
E L+++ V+ G L I + + C++ E A+ + H + +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE---AVLHCHQM---GV 131
Query: 309 IHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+H ++K N+LL K++DF L ++ A GT GYL PE
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADF-GLAIEVEGEQQAWFGFA-GTPGYLSPE 183
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 59/296 (19%), Positives = 99/296 (33%), Gaps = 59/296 (19%)
Query: 173 SRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRIT 227
S + N LG G FG V K + AVK +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 228 EWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL 287
E + ++ ++ H N++K+ + ++ +V E + G L I + + +
Sbjct: 69 LRE-VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETA 344
+ S I Y+H +I+H D+K NILL + + K+ DF + +
Sbjct: 128 KQV---FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179
Query: 345 MSTMIRGTVGYLDPE-------------------YAHTELLTGMNPNSYVALASNEKISM 385
M I GT Y+ PE Y LL+G P
Sbjct: 180 MKDRI-GTAYYIAPEVLRGTYDEKCDVWSAGVILY---ILLSGTPP-------------- 221
Query: 386 VPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVA-ELASKCLRIRGTERPTMKEV 439
F E + +++ + A D + I A +L K L + R T +
Sbjct: 222 ---FYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 45/156 (28%), Positives = 62/156 (39%), Gaps = 28/156 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVK------------- 239
LG GGFG+V+ G L D QVA+K R+ W L
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIK---VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 240 -HKNVVKILGLCLETKVTL-LVYEFVSNGA-LSHYIHDKSSQVLKNWKTCLRIAAETASA 296
H V+++L ET+ LV E L YI +K L + +A
Sbjct: 96 GHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGP--LGE-GPSRCFFGQVVAA 151
Query: 297 IHYLHSLASPSIIHSDVKSANILLD-DNYTAKVSDF 331
I + HS ++H D+K NIL+D AK+ DF
Sbjct: 152 IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDF 184
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 55/198 (27%), Positives = 80/198 (40%), Gaps = 19/198 (9%)
Query: 172 FSRMKIFSKSELLKATKN---FHHCLGMGGFGSVYKGVLPDNTQV-AVKKY-----MCAD 222
F+R + E TKN + LG GGFG V + ++ A KK
Sbjct: 167 FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226
Query: 223 EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLK 281
+ E I+ +V + VV L ETK L LV ++ G L +I+
Sbjct: 227 GEAMALNE-KQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 282 NWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341
+ AAE + LH I++ D+K NILLDD+ ++SD V +
Sbjct: 285 EARAVF-YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340
Query: 342 ETAMSTMIRGTVGYLDPE 359
+ GTVGY+ PE
Sbjct: 341 TI--KGRV-GTVGYMAPE 355
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 26/154 (16%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLG----------IISQVKHK- 241
LG GGFGSVY G+ + DN VA+K ++ RI++W L ++ +V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIK---HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 242 -NVVKILGLCLETKVTL-LVYEFVSN-GALSHYIHDKSSQVLKNWKTCLRIAAETASAIH 298
V+++L E + L+ E L +I ++ L+ + + A+
Sbjct: 108 SGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITER--GALQE-ELARSFFWQVLEAVR 163
Query: 299 YLHSLASPSIIHSDVKSANILLDDNY-TAKVSDF 331
+ H+ ++H D+K NIL+D N K+ DF
Sbjct: 164 HCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 41/208 (19%), Positives = 70/208 (33%), Gaps = 45/208 (21%)
Query: 194 LGMGGFGSVYKGVLPDNT---QVAVK---KYMCADEIRITEWEFLG-------IISQVKH 240
+G GG G VY+ D VA+K + + +D F +++
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDP------VFRTRMQREARTAGRLQE 93
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
+VV I + ++ L+ + + + I + SA+
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPL---APPRAVAIVRQIGSALDAA 150
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEY 360
H+ H DVK NIL+ + A + DF + + T + + GT+ Y+ PE
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPER 206
Query: 361 AHT-----------------ELLTGMNP 371
E LTG P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 55/293 (18%), Positives = 98/293 (33%), Gaps = 53/293 (18%)
Query: 173 SRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRIT 227
M I SK L LG G +G V + + A+K +
Sbjct: 24 PGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKL 83
Query: 228 EWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL 287
E + ++ + H N++K+ + + LV E G L I + + +
Sbjct: 84 LEE-VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETA 344
+ + S + YLH +I+H D+K N+LL + + K+ DF + +
Sbjct: 143 K---QVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-- 194
Query: 345 MSTMIRGTVGYLDPE-----YAHT-----------ELLTGMNPNSYVALASNEKISMVPY 388
M + GT Y+ PE Y LL G P
Sbjct: 195 MKERL-GTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPP----------------- 236
Query: 389 FLDSIENNSFRQILNFQVA-DESEMEEIEVVA-ELASKCLRIRGTERPTMKEV 439
F + R++ + D E + + A +L + L+ R + ++
Sbjct: 237 FGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 36/183 (19%), Positives = 68/183 (37%), Gaps = 39/183 (21%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRITEWEFLGIISQVKHKNVVKIL 247
+G+G + + + N + AVK K +EI I ++ +H N++ +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI-------LLRYGQHPNIITLK 82
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKS-------SQVLKNWKTCLRIAAETASAIHYL 300
+ + K +V E + G L I + S VL + YL
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT----------ITKTVEYL 132
Query: 301 HSLASPSIIHSDVKSANILL----DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYL 356
H+ ++H D+K +NIL + + ++ DF + + T T ++
Sbjct: 133 HAQ---GVVHRDLKPSNILYVDESGNPESIRICDF-GFAKQLRAENGLLMTPC-YTANFV 187
Query: 357 DPE 359
PE
Sbjct: 188 APE 190
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRITEWEFLGIISQVKHKNVVKIL 247
LG+G FG V G +VAVK K D + + E + + +H +++K+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE-IQNLKLFRHPHIIKLY 77
Query: 248 GLCLETKVTL-LVYEFVSNGALSHYI--HDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ + T +V E+VS G L YI H + + R+ + SA+ Y H
Sbjct: 78 QV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEE-----MEARRLFQQILSAVDYCHRH- 130
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
++H D+K N+LLD + AK++DF
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADF 155
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 21/178 (11%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-------KYMCADEIRITEWEFL---GIISQVK-HK 241
LG G V + + P + AVK A+E++ L I+ +V H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
N++++ LV++ + G L Y+ +K + K + +R I LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA---LLEVICALH 141
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
L +I+H D+K NILLDD+ K++DF + D + + GT YL PE
Sbjct: 142 KL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVC-GTPSYLAPE 193
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 55/275 (20%), Positives = 95/275 (34%), Gaps = 49/275 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRITEWEFL----GIISQVKHKNV 243
LG G G V +VA+K K+ + I+ ++ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+KI + + +V E + G L + TC + A+ YLH
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL---KEATCKLYFYQMLLAVQYLHEN 133
Query: 304 ASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEY 360
IIH D+K N+LL +++ K++DF + + + M T+ GT YL P
Sbjct: 134 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC-GTPTYLAP-- 185
Query: 361 AHTELLTGMNPNSYVALASNEKISM-----VPYFL---------DSIENNSFRQILNFQV 406
E+L + Y N + + + + + QI + +
Sbjct: 186 ---EVLVSVGTAGY-----NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 407 A-DESEMEEI-EVVAELASKCLRIRGTERPTMKEV 439
E+ E +L K L + R T +E
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 44/202 (21%), Positives = 74/202 (36%), Gaps = 41/202 (20%)
Query: 175 MKIFSKSELLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGI 234
MK+ SK +L++ G + + P V + EI I
Sbjct: 43 MKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ-----EIAI-------- 89
Query: 235 ISQVKHKNVVK---ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA 291
+ ++ H NVVK +L E + +V+E V+ G + K L
Sbjct: 90 LKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKP---LSE-DQARFYFQ 144
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRG 351
+ I YLH IIH D+K +N+L+ ++ K++DF +S +G
Sbjct: 145 DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF------------GVSNEFKG 189
Query: 352 TVGYLD-----PEYAHTELLTG 368
+ L P + E L+
Sbjct: 190 SDALLSNTVGTPAFMAPESLSE 211
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 37/159 (23%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-------KYMCADEIRIT-EWEFLGIISQVKHKNVV 244
LG G +G V + + + AVK + + E + E + ++ +++HKNV+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE---IQLLRRLRHKNVI 69
Query: 245 KILG-LCLETKVTL-LVYEFVSNGA--LSHYIHDKSSQVLKNWKTCLRIAAETA------ 294
+++ L E K + +V E+ G + + +K R A
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK------------RFPVCQAHGYFCQ 117
Query: 295 --SAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ YLHS I+H D+K N+LL T K+S
Sbjct: 118 LIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISAL 153
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 41/151 (27%), Positives = 55/151 (36%), Gaps = 29/151 (19%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFLGIISQVKHKNVVKILGL 249
LG G +G V V VAVK D + E + I + H+NVVK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYGH 73
Query: 250 CLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETA--------SAIHYL 300
L E+ S G L I + A + + YL
Sbjct: 74 -RREGNIQYLFLEYCSGGELFDRIEPDI-----------GMPEPDAQRFFHQLMAGVVYL 121
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
H + I H D+K N+LLD+ K+SDF
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDF 149
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 36/178 (20%), Positives = 67/178 (37%), Gaps = 18/178 (10%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFL---GIISQVKHKNVVKI 246
+G G F V + + Q AVK ++ + I +KH ++V++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 247 LGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLK-NWKTCLRIAAETASAIHYLHSLA 304
L + L +V+EF+ L I ++ + + A+ Y H
Sbjct: 92 LETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149
Query: 305 SPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+IIH DVK +LL +++ K+ F + + + GT ++ PE
Sbjct: 150 --NIIHRDVKPHCVLLASKENSAPVKLGGF-GVAIQLGESGLVAGGRV-GTPHFMAPE 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 41/151 (27%), Positives = 55/151 (36%), Gaps = 29/151 (19%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFLGIISQVKHKNVVKILGL 249
LG G +G V V VAVK D + E + I + H+NVVK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYGH 73
Query: 250 CLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETA--------SAIHYL 300
L E+ S G L I + A + + YL
Sbjct: 74 -RREGNIQYLFLEYCSGGELFDRIEPDI-----------GMPEPDAQRFFHQLMAGVVYL 121
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
H + I H D+K N+LLD+ K+SDF
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDF 149
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 45/183 (24%), Positives = 70/183 (38%), Gaps = 39/183 (21%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK------KYMCADEIRITEWEFLGIISQVKHKNVVKI 246
LG G F K V N AVK + EI L + H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITA-----LKLCEG--HPNIVKL 71
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKS-------SQVLKNWKTCLRIAAETASAIHY 299
+ + T LV E ++ G L I K S +++ + SA+ +
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR----------KLVSAVSH 121
Query: 300 LHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYL 356
+H + ++H D+K N+L +DN K+ DF + D + T T+ Y
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDF-GFARLKPPDNQPLKTPC-FTLHYA 176
Query: 357 DPE 359
PE
Sbjct: 177 APE 179
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 28/213 (13%)
Query: 165 RDPPGLAFSRMKIFSKSELLKATKNFH------HCLGMGGFGSVYKGV-LPDNTQVAVK- 216
+ L F M + A K F+ +G G V + V + AVK
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 217 --KYMCADEIRITEWEFLGIISQVK-------HKNVVKILGLCLETKVTL-LVYEFVSNG 266
E + H +++ ++ E+ + LV++ + G
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG 185
Query: 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTA 326
L Y+ +K + K ++ +R A+ +LH+ +I+H D+K NILLDDN
Sbjct: 186 ELFDYLTEKVALSEKETRSIMRS---LLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239
Query: 327 KVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
++SDF E + + GT GYL PE
Sbjct: 240 RLSDF-GFSCHLEPGEK-LRELC-GTPGYLAPE 269
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 57/299 (19%), Positives = 99/299 (33%), Gaps = 62/299 (20%)
Query: 177 IFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRITEWEF 231
+ K + + LG G +G V +++ A+K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 232 LG----------IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLK 281
++ + H N++K+ + + K LV EF G L I ++
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 282 NWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPIS 338
+ ++ S I YLH +I+H D+K NILL + K+ DF S
Sbjct: 147 DAANIMKQI---LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 339 SDDETAMSTMIRGTVGYLDPE---YAHTE-------------LLTGMNPNSYVALASNEK 382
D + + + GT Y+ PE + E LL G P
Sbjct: 201 KDYK--LRDRL-GTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP----------- 246
Query: 383 ISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVA-ELASKCLRIRGTERPTMKEV 439
F + + +++ + D ++ + I A EL L +R T +E
Sbjct: 247 ------FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 49/300 (16%), Positives = 90/300 (30%), Gaps = 56/300 (18%)
Query: 173 SRMKIFSKSELLKA------TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRI 226
+R K+ + + L + F+ L + + + +
Sbjct: 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106
Query: 227 TEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC 286
+ + KN V L + + L +++ + S + C
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 287 LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF----------ESLVP 336
L I + A A+ +LHS ++H D+K +NI + KV DF E
Sbjct: 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 337 ISSDDETAMSTMIRGTVGYLDPEYAHT-----------------ELLTGMNPNSYVALAS 379
++ A T GT Y+ PE H ELL +
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------ 277
Query: 380 NEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEV 439
E++ + + + N F + + E + L TERP ++
Sbjct: 278 -ERVRI----ITDVRNLKFPLLFTQKYPQE---------HMMVQDMLSPSPTERPEATDI 323
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 39/195 (20%), Positives = 65/195 (33%), Gaps = 32/195 (16%)
Query: 179 SKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK---------KYMCADEIRITE 228
S + + +G G +G V V + A K EI I
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEI-- 59
Query: 229 WEFLGIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCL 287
+ + H N++++ E + LV E + G L + K + +
Sbjct: 60 ------MKSLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM 112
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETA 344
+ SA+ Y H L ++ H D+K N L + K+ DF
Sbjct: 113 KDV---LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKM 164
Query: 345 MSTMIRGTVGYLDPE 359
M T + GT Y+ P+
Sbjct: 165 MRTKV-GTPYYVSPQ 178
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRITEWEFLGIISQVKHKNVVKIL 247
LG+G FG V G +VAVK K D + E + + +H +++K+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE-IQNLKLFRHPHIIKLY 82
Query: 248 GLCLETKVTL-LVYEFVSNGALSHYI--HDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ + T + +V E+VS G L YI + + + K R+ + S + Y H
Sbjct: 83 QV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDE-----KESRRLFQQILSGVDYCHRH- 135
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
++H D+K N+LLD + AK++DF
Sbjct: 136 --MVVHRDLKPENVLLDAHMNAKIADF 160
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 18/199 (9%)
Query: 172 FSRMKIFSKSELLKATKN---FHHCLGMGGFGSVYKGVLPDNTQV-AVKKY-----MCAD 222
F R + E ++ LG GGFG V+ + ++ A KK
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 223 EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLK 281
+ E I+++V + +V L ETK L LV ++ G + ++I++
Sbjct: 228 GYQGAMVE-KKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 282 NWKTCLRI-AAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340
+ A+ S + +LH +II+ D+K N+LLDD+ ++SD L
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL-GLAVELKA 341
Query: 341 DETAMSTMIRGTVGYLDPE 359
+T GT G++ PE
Sbjct: 342 GQTKTKGYA-GTPGFMAPE 359
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 39/188 (20%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRI-TEWEFLGIISQVK-HKNVVKIL 247
LG G V + L + + AVK K R+ E E ++ Q + H+NV++++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVE---MLYQCQGHRNVLELI 77
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKS-------SQVLKNWKTCLRIAAETASAIHYL 300
E LV+E + G++ +IH + S V++ + ASA+ +L
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ----------DVASALDFL 127
Query: 301 HSLASPSIIHSDVKSANILL---DDNYTAKVSDF------ESLVPISSDDETAMSTMIRG 351
H+ I H D+K NIL + K+ DF + S + T G
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-G 183
Query: 352 TVGYLDPE 359
+ Y+ PE
Sbjct: 184 SAEYMAPE 191
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 22/181 (12%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV-AVKKYMCADEIR--------ITEWEFLGIISQVK 239
+ H +G GGFG VY D ++ A+K + I+ + E L ++S
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKC-LDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 240 HKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIH 298
+V + T L + + ++ G L +++ V AAE +
Sbjct: 251 CPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRF-YAAEIILGLE 306
Query: 299 YLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDP 358
++H+ +++ D+K ANILLD++ ++SD L S + + GT GY+ P
Sbjct: 307 HMHNR---FVVYRDLKPANILLDEHGHVRISDL-GLACDFSKKKP--HASV-GTHGYMAP 359
Query: 359 E 359
E
Sbjct: 360 E 360
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 38/175 (21%), Positives = 63/175 (36%), Gaps = 20/175 (11%)
Query: 192 HCLGMGGFGSVYKGVL-PDNTQVAVKK---YMCADEIRITEWEFLGIISQVKHKNVVKIL 247
LG G G V+K P +A K + E L ++ + +V
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE-LQVLHECNSPYIVGFY 97
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSS---QVLKNWKTCLRIAAETASAIHYLHSLA 304
G + E + G+L + Q+L +++ + YL
Sbjct: 98 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYLRE-- 149
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I+H DVK +NIL++ K+ DF +S +M+ GT Y+ PE
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPE 200
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 41/178 (23%), Positives = 69/178 (38%), Gaps = 27/178 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRITEWEFLGIISQVKHKNVVKILG 248
LG+G G V + + A+K E+ W+ G ++V IL
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDH-HWQASG------GPHIVCILD 89
Query: 249 LC----LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ + L++ E + G L I ++ Q + I + +AI +LHS
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF-TEREAAEIMRDIGTAIQFLHSH- 147
Query: 305 SPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+I H DVK N+L + + K++DF + A+ T T Y+ PE
Sbjct: 148 --NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQTPC-YTPYYVAPE 199
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 49/180 (27%), Positives = 71/180 (39%), Gaps = 28/180 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT--EWEFLGII-------SQVKHKNV 243
+G G +GSV K V P +AVK IR T E E ++ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVK------RIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 244 VKILGLCL-ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL-RIAAETASAIHYLH 301
V+ G E + E +S Y + S + L +I T A+++L
Sbjct: 84 VQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS--DDETAMSTMIRGTVGYLDPE 359
+ IIH D+K +NILLD + K+ DF IS D A + G Y+ PE
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFG----ISGQLVDSIAKTRDA-GCRPYMAPE 195
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 37/176 (21%), Positives = 70/176 (39%), Gaps = 19/176 (10%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRITEWEFLGIISQVKH-KNVVKIL 247
LG G F V + + + A K + D E + ++ K V+ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE-IAVLELAKSCPRVINLH 95
Query: 248 GLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+ E + L+ E+ + G + + ++++ + +R+ + ++YLH
Sbjct: 96 EVY-ENTSEIILILEYAAGGEIFSLCLPELAEMV-SENDVIRLIKQILEGVYYLHQN--- 150
Query: 307 SIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+I+H D+K NILL K+ DF I + ++ GT YL PE
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIM-GTPEYLAPE 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 47/216 (21%), Positives = 76/216 (35%), Gaps = 44/216 (20%)
Query: 163 GGRDPPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK----- 216
L S + L LG G VY+ A+K
Sbjct: 30 AAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT 89
Query: 217 --KYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGAL----- 268
K + EI + + ++ H N++K+ + ET + LV E V+ G L
Sbjct: 90 VDKKIVRTEIGV--------LLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIV 140
Query: 269 --SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDN 323
+Y ++ +K A+ YLH I+H D+K N+L +
Sbjct: 141 EKGYYSERDAADAVKQ----------ILEAVAYLHEN---GIVHRDLKPENLLYATPAPD 187
Query: 324 YTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
K++DF + + + M T+ GT GY PE
Sbjct: 188 APLKIADFGLSKIV--EHQVLMKTVC-GTPGYCAPE 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 46/193 (23%), Positives = 76/193 (39%), Gaps = 23/193 (11%)
Query: 180 KSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFL--- 232
K + ++ + LG G F V K + A K K R E +
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 233 -GIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIA 290
I+ QV H NV+ + + E + + L+ E VS G L ++ K S + + ++
Sbjct: 66 VSILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILL----DDNYTAKVSDFESLVPISSDDETAMS 346
+ ++YLH+ I H D+K NI+L K+ DF I +D
Sbjct: 125 LD---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK 176
Query: 347 TMIRGTVGYLDPE 359
+ GT ++ PE
Sbjct: 177 NIF-GTPEFVAPE 188
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 49/212 (23%), Positives = 78/212 (36%), Gaps = 34/212 (16%)
Query: 164 GRDPPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK----KY 218
+ P K+ ++ K LG+G G V + + A+K
Sbjct: 40 PQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP 99
Query: 219 MCADEIRITEWEFLGIISQVKHKNVVKILGLC----LETKVTLLVYEFVSNGALSHYIHD 274
E+ + W ++V+I+ + K L+V E + G L I D
Sbjct: 100 KARREVEL-HWRASQ------CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 152
Query: 275 KSSQVLKNWKTCLRIAAET----ASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAK 327
+ Q R A+E AI YLHS+ +I H DVK N+L N K
Sbjct: 153 RGDQAFTE-----REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK 204
Query: 328 VSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
++DF +S + ++T T Y+ PE
Sbjct: 205 LTDFGFAKETTSHNS--LTTPC-YTPYYVAPE 233
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 38/177 (21%), Positives = 65/177 (36%), Gaps = 26/177 (14%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYM----CADEIR--ITEWEFLGIISQVKHKNVVKIL 247
+G G G V+K V K M +E + + + + + + +V+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV--LKSHDCPYIVQCF 90
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSS---QVLKNWKTCLRIAAETASAIHYLHSLA 304
G + + E + A + ++L ++ A++YL
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG------KMTVAIVKALYYLKE-- 142
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS--DDETAMSTMIRGTVGYLDPE 359
+IH DVK +NILLD+ K+ DF IS D+ A G Y+ PE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFG----ISGRLVDDKAKDRSA-GCAAYMAPE 194
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 23/179 (12%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFL----GIISQVKHKNVVK 245
LG G F V K + A K K + R E + I+ +++H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 246 ILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ + E K + L+ E VS G L ++ +K S L+ + +HYLHS
Sbjct: 73 LHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSK- 127
Query: 305 SPSIIHSDVKSANILL----DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I H D+K NI+L N K+ DF I + +E + GT ++ PE
Sbjct: 128 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIF-GTPEFVAPE 181
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 63/303 (20%), Positives = 112/303 (36%), Gaps = 60/303 (19%)
Query: 167 PPGLAFSRMKIFSKSELLKATKNFHHC--LGMGGFGSVYKGV-LPDNTQVAVK-----KY 218
P F + +K + + LG G FG V+K ++A K
Sbjct: 68 APPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM 127
Query: 219 MCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSS 277
+E++ E + +++Q+ H N++++ E+K + LV E+V G L I D+S
Sbjct: 128 KDKEEVK-NE---ISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESY 182
Query: 278 QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL--DDNYTAKVSDFESLV 335
+ + + I ++H + I+H D+K NIL D K+ DF
Sbjct: 183 NL--TELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
Query: 336 PISSDDETAMSTMIRGTVGYLDPE-----YAHTE------------LLTGMNPNSYVALA 378
++ + GT +L PE + LL+G++P
Sbjct: 238 RYKPREK--LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP------- 287
Query: 379 SNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVA-ELASKCLRIRGTERPTM 436
FL + + IL + ++ E ++I A E SK L + R +
Sbjct: 288 ----------FLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISA 337
Query: 437 KEV 439
E
Sbjct: 338 SEA 340
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 23/179 (12%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFL----GIISQVKHKNVVK 245
LG G F V K + A K K R E + I+ QV H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 246 ILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ + E + + L+ E VS G L ++ K S + + ++ + ++YLH+
Sbjct: 80 LHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLHTK- 134
Query: 305 SPSIIHSDVKSANILL----DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I H D+K NI+L K+ DF I +D + GT ++ PE
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTPEFVAPE 188
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 50/300 (16%), Positives = 101/300 (33%), Gaps = 52/300 (17%)
Query: 165 RDPPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCA-- 221
+ + K + + + H LG G FG V++ A K M
Sbjct: 136 VFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195
Query: 222 DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVL 280
+ E + +S ++H +V + E + ++YEF+S G L + D+ +++
Sbjct: 196 SDKETVRKE-IQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKM- 252
Query: 281 KNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTA--KVSDFESLVPIS 338
+ + + + ++H + +H D+K NI+ + K+ DF +
Sbjct: 253 -SEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 339 SDDETAMSTMIRGTVGYLDPEYAHTE-----------------LLTGMNPNSYVALASNE 381
+ GT + PE A + LL+G++P
Sbjct: 309 PKQS--VKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---------- 355
Query: 382 KISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVA-ELASKCLRIRGTERPTMKEV 439
F ++ + R + + D+S I + K L R T+ +
Sbjct: 356 -------FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 51/300 (17%), Positives = 99/300 (33%), Gaps = 66/300 (22%)
Query: 172 FSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK---------KYMCA 221
+ + K + + LG G FG V++ V K KY
Sbjct: 37 YVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK 96
Query: 222 DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVL 280
+EI I++Q+ H ++ + E K + L+ EF+S G L I + ++
Sbjct: 97 NEIS--------IMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKM- 146
Query: 281 KNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL--DDNYTAKVSDFESLVPIS 338
+ + + + ++H SI+H D+K NI+ + K+ DF +
Sbjct: 147 -SEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL- 201
Query: 339 SDDETAMSTMIRGTVGYLDPEYAHTE-----------------LLTGMNPNSYVALASNE 381
+ + + T + PE E LL+G++P
Sbjct: 202 -NPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---------- 249
Query: 382 KISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVA-ELASKCLRIRGTERPTMKEV 439
F + + + + DE + A + L+ +R T+ +
Sbjct: 250 -------FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 44/178 (24%), Positives = 62/178 (34%), Gaps = 25/178 (14%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT--EWEFLGII-------SQVKHKNV 243
LG G +G V K +P +AVK IR T E ++ V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVK------RIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
V G + E + Y +IA A+ +LHS
Sbjct: 69 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS- 127
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS--DDETAMSTMIRGTVGYLDPE 359
S+IH DVK +N+L++ K+ DF IS D+ A G Y+ PE
Sbjct: 128 -KLSVIHRDVKPSNVLINALGQVKMCDFG----ISGYLVDDVAKDIDA-GCKPYMAPE 179
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 18/178 (10%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV-AVK---KYMCA--DEIRITEWEFLGIISQVKHKN 242
+G G FG V D ++ A+K K C +E+R E L I+ ++H
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE-LQIMQGLEHPF 76
Query: 243 VVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
+V L + + + +V + + G L + H + + K L E A+ YL
Sbjct: 77 LVN-LWYSFQDEEDMFMVVDLLLGGDLRY--HLQQNVHFKEETVKL-FICELVMALDYLQ 132
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+ IIH D+K NILLD++ ++DF ++ + + + + GT Y+ PE
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDF-NIAAMLPRETQITT--MAGTKPYMAPE 184
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADEIRITEWEFLGI-------IS---QVKHKN 242
+G G +G V+K D Q VA+KK +E + I I Q+KH N
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKK------FLESE-DDPVIKKIALREIRMLKQLKHPN 63
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+V +L + + LV+E+ + + H + Q I +T A+++ H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDHT-VLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ IH DVK NIL+ + K+ DF
Sbjct: 121 H---NCIHRDVKPENILITKHSVIKLCDF 146
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 42/173 (24%), Positives = 68/173 (39%), Gaps = 15/173 (8%)
Query: 194 LGMGGFGSVYKGVLPDNTQV-AVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
+G G F V + QV A+K D ++ E ++ + + + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ-LH 127
Query: 249 LCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRI-AAETASAIHYLHSLASP 306
+ + L LV E+ G L + ++ R AE AI +H L
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLAEIVMAIDSVHRL--- 181
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+H D+K NILLD +++DF S + + +D + GT YL PE
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPE 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 43/172 (25%), Positives = 68/172 (39%), Gaps = 13/172 (7%)
Query: 194 LGMGGFGSVYKGVLPDNTQV-AVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
+G G FG V L + +V A+K + ++ E ++ K + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT-LH 140
Query: 249 LCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
+ L LV ++ G L + K L AE AI +H L
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMARF-YLAEMVIAIDSVHQL---H 195
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+H D+K NIL+D N +++DF S + + D S + GT Y+ PE
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPE 246
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 20/147 (13%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK-----KYMCADEIRITEWEFLGIISQVKHKNVVKIL 247
LG G FG V +VA+K +D E E + + ++H +++K+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE-ISYLKLLRHPHIIKLY 75
Query: 248 GLCLETKVTL-LVYEFVSNGALSHYI--HDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ + T + +V E+ G L YI + ++ R + AI Y H
Sbjct: 76 DV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTE-----DEGRRFFQQIICAIEYCHRH- 127
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDF 331
I+H D+K N+LLDDN K++DF
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADF 152
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 24/211 (11%)
Query: 162 GGGRDPPGLAFSRMKIFSKSELLKATKN---FHHCLGMGGFGSVYKGVLPDNTQV-AVK- 216
G +P A S + K F LG G F +V ++ A+K
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI 62
Query: 217 ----KYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL-LVYEFVSNGALSHY 271
+ +++ E ++S++ H VK+ + L + NG L Y
Sbjct: 63 LEKRHIIKENKVPYVTRERD-VMSRLDHPFFVKLYF-TFQDDEKLYFGLSYAKNGELLKY 120
Query: 272 IHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
I + T AE SA+ YLH IIH D+K NILL+++ +++DF
Sbjct: 121 I--RKIGSFDETCTRF-YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF 174
Query: 332 ---ESLVPISSDDETAMSTMIRGTVGYLDPE 359
+ L P S ++ + GT Y+ PE
Sbjct: 175 GTAKVLSPESKQARA--NSFV-GTAQYVSPE 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 47/179 (26%), Positives = 72/179 (40%), Gaps = 23/179 (12%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWEFL----GIISQVKHKNVVK 245
LG G F V K Q A K K R E + I+ +++H NV+
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 246 ILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ + E K + L+ E V+ G L ++ +K S + L+ ++YLHSL
Sbjct: 79 LHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHSL- 133
Query: 305 SPSIIHSDVKSANILL----DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
I H D+K NI+L K+ DF I +E + GT ++ PE
Sbjct: 134 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF-GTPEFVAPE 187
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 42/179 (23%), Positives = 66/179 (36%), Gaps = 31/179 (17%)
Query: 169 GLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK----KYMCADE 223
G K+ ++ K LG+G G V + + A+K E
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE 60
Query: 224 IRITEWEFLGIISQVKHKNVVKILGLC----LETKVTLLVYEFVSNGALSHYIHDKSSQV 279
+ + + ++V+I+ + K L+V E + G L I D+ Q
Sbjct: 61 VEL-------HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 113
Query: 280 LKNWKTCLRIAAET----ASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDF 331
R A+E AI YLHS+ +I H DVK N+L N K++DF
Sbjct: 114 FTE-----REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 54/273 (19%), Positives = 99/273 (36%), Gaps = 57/273 (20%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRITEWEFLGIISQVKHKNVVKILG 248
LG G FG V++ V K K ++ E + I++ +H+N++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK-KE---ISILNIARHRNILHLHE 68
Query: 249 LCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
E+ L +++EF+S + I+ + ++ N + + + A+ +LHS +
Sbjct: 69 SF-ESMEELVMIFEFISGLDIFERINTSAFEL--NEREIVSYVHQVCEALQFLHSH---N 122
Query: 308 IIHSDVKSANILL--DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE- 364
I H D++ NI+ + T K+ +F + D + Y PE +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLF-TAPEYYAPEVHQHDV 179
Query: 365 ----------------LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA- 407
LL+G+NP FL I+N +
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINP-----------------FLAETNQQIIENIMNAEYTF 222
Query: 408 DESEMEEIEVVA-ELASKCLRIRGTERPTMKEV 439
DE +EI + A + + L R T E
Sbjct: 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 38/158 (24%), Positives = 56/158 (35%), Gaps = 43/158 (27%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK---KYMCAD-----EIRITEWEFLGIISQVKHKNVV 244
+G G FG VAVK + D EI ++H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN--------HRSLRHPNIV 79
Query: 245 KILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETA--------S 295
+ + T L ++ E+ S G L I + R + + A S
Sbjct: 80 R-FKEVILTPTHLAIIMEYASGGELYERICNAG-----------RFSEDEARFFFQQLLS 127
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTA--KVSDF 331
+ Y HS+ I H D+K N LLD + K+ DF
Sbjct: 128 GVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDF 162
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 16/178 (8%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV----AVKKYMCA--DEIRITEWEFLGIISQVKHKN 242
+ LG G FG V + +KK + DE+ T E ++ +H
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNSRHPF 209
Query: 243 VVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
+ L +T L V E+ + G L ++ +V + AE SA+ YLH
Sbjct: 210 LTA-LKYSFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARF-YGAEIVSALDYLH 265
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
S ++++ D+K N++LD + K++DF L D M T GT YL PE
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDF-GLCKEGIKDGATMKTFC-GTPEYLAPE 319
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 49/225 (21%), Positives = 87/225 (38%), Gaps = 34/225 (15%)
Query: 117 MSKVKVVDARMQDIASQIDPLDLRKKSAGKSRNVGRVILSAVRLGGGGRDPPGLAFSRMK 176
MS + + P + ++ +V G G P ++++ K
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60
Query: 177 IFSKSELLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGII 235
+ +G G FG VY+ L VA+KK + + R E L I+
Sbjct: 61 V----------------IGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRE-LQIM 101
Query: 236 SQVKHKNVVKILGLCLET-----KVTL-LVYEFVSNGALSHYI--HDKSSQVLKNWKTCL 287
++ H N+V++ + +V L LV ++V + + ++ Q L L
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKL 160
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAKVSDF 331
+ + ++ Y+HS I H D+K N+LLD D K+ DF
Sbjct: 161 YMY-QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRIT-EWEFLGIISQVKHKNVVKIL----- 247
+G G FG V++ L ++ +VA+KK + D+ E L I+ VKH NVV +
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKK-VLQDKRFKNRE---LQIMRIVKHPNVVDLKAFFYS 103
Query: 248 GLCLETKVTL-LVYEFVSNGALSHYI--HDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ +V L LV E+V + + K Q + L + + ++ Y+HS+
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYM-YQLLRSLAYIHSI- 160
Query: 305 SPSIIHSDVKSANILLD-DNYTAKVSDF 331
I H D+K N+LLD + K+ DF
Sbjct: 161 --GICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 35/152 (23%), Positives = 65/152 (42%), Gaps = 26/152 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGI-------IS---QVKHKN 242
LG G + +VYKG+ VA+K+ +++ E G IS ++KH+N
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKE------VKLDSEE--GTPSTAIREISLMKELKHEN 64
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAA---ETASAIHY 299
+V++ + LV+EF+ N L Y+ ++ + + + +
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
H I+H D+K N+L++ K+ DF
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDF 152
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 43/209 (20%), Positives = 73/209 (34%), Gaps = 51/209 (24%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKYMCA-----D------EIRITEWEFLGIISQVK 239
H +G G +G VY VA+KK D EI I ++++K
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI--------LNRLK 83
Query: 240 HKNVVKILGLCLETKVTL-----LVYEFV-SNGALSHYIHDKSSQVLKNWKTC------L 287
++++ L + + +V E S+ L K+ L L
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADSD--LKKLF--KTPIFLTEEHIKTILYNLL 139
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347
+++H IIH D+K AN LL+ + + KV DF I+S+ +T +
Sbjct: 140 L-------GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 348 MIRGTVGYLDPEYAHTELLTGMNPNSYVA 376
+ + LT +V
Sbjct: 190 DLEENEEPGPHNKNLKKQLTS-----HVV 213
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 36/149 (24%), Positives = 66/149 (44%), Gaps = 25/149 (16%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGI-------IS---QVKHKNV 243
+G G +G VYK VA+K+ IR+ + E GI IS ++ H N+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKR------IRL-DAEDEGIPSTAIREISLLKELHHPNI 81
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV-LKNWKTCLRIAAETASAIHYLHS 302
V ++ + + LV+EF+ L + + + + K L + + + H
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLY---QLLRGVAHCHQ 137
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDF 331
I+H D+K N+L++ + K++DF
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADF 163
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 2e-09
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 27/151 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGI-------IS---QVKHKN 242
+G G +G VYK VA+KK IR+ + E G+ IS ++ H N
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKK------IRL-DTETEGVPSTAIREISLLKELNHPN 63
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVL--KNWKTCLRIAAETASAIHYL 300
+VK+L + LV+EF+ L ++ + + K+ L + + +
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF---QLLQGLAFC 119
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
HS ++H D+K N+L++ K++DF
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADF 147
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 15/172 (8%)
Query: 194 LGMGGFGSVYKGVLPDNTQV-AVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
+G G FG V +V A+K + I+ ++ F I++ VV+ L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ-LF 135
Query: 249 LCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
+ L +V E++ G L + + S+ + AE A+ +HS+
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARF-YTAEVVLALDAIHSM---G 188
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
IH DVK N+LLD + K++DF + + ++ + T + GT Y+ PE
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 3e-09
Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 29/151 (19%)
Query: 194 LGMGGFGSVYKGVLPDNTQ--VAVKKYMCADEIRITEWEFLGI-------IS---QVKHK 241
+G G +G VYK +N A+KK IR+ E E GI IS ++KH
Sbjct: 10 IGEGTYGVVYKAQ--NNYGETFALKK------IRL-EKEDEGIPSTTIREISILKELKHS 60
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV-LKNWKTCLRIAAETASAIHYL 300
N+VK+ + K +LV+E + L + + K+ L + + I Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLL---QLLNGIAYC 116
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
H ++H D+K N+L++ K++DF
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADF 144
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 27/150 (18%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADEIRITEWEFLGI-------IS---QVKHKN 242
LG G + +VYKG VA+K+ IR+ E G +S +KH N
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKE------IRLEHEE--GAPCTAIREVSLLKDLKHAN 61
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV-LKNWKTCLRIAAETASAIHYLH 301
+V + + K LV+E++ L Y+ D + + + N K L + + Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFLF---QLLRGLAYCH 117
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
++H D+K N+L+++ K++DF
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADF 144
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 39/148 (26%), Positives = 74/148 (50%), Gaps = 22/148 (14%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-VAVKKYMCADE---IRIT---EWEFLGIIS---QVKHKNV 243
+G G +G V K D + VA+KK++ +D+ ++ E I Q++H+N+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE------IKLLKQLRHENL 86
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
V +L +C + K LV+EFV + + + + + +++ + + + I + HS
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNGL--DYQVVQKYLFQIINGIGFCHSH 143
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDF 331
+IIH D+K NIL+ + K+ DF
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDF 168
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 33/271 (12%), Positives = 82/271 (30%), Gaps = 52/271 (19%)
Query: 193 CLGMGGFGSVYKGVLPDNT---QVAVK---KYMCADEIRITEWEFLG---IISQVKHKNV 243
G ++ + D QVA+ + + E L +S++ V
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQE--TLSRTLRLSRIDKPGV 93
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
++L + L+V E++ G+L S V +R A+A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV-----GAIRAMQSLAAAADAAHRA 148
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS-SDDETAMSTMIRGTVGYLDPEYAH 362
+ S + + + + ++ ++ + DD + G Y
Sbjct: 149 G---VALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIRGI-----GASLY------- 193
Query: 363 TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI--EVVAE 420
LL P ++ + Q + ++++ ++
Sbjct: 194 -ALLVNRWP--LPEAGVRSGLAPAE------------RDTAGQPIEPADIDRDIPFQISA 238
Query: 421 LASKCLRIRGTERPTMKEVSEELDRLRRLQE 451
+A++ ++ G R + + + + +
Sbjct: 239 VAARSVQGDGGIRSAS-TLLNLMQQATAVAD 268
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 30/154 (19%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGI-------IS---QVKHKN 242
LG G +G VYK + N VA+K+ IR+ E E G+ +S +++H+N
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKR------IRL-EHEEEGVPGTAIREVSLLKELQHRN 94
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
++++ + L++E+ N L Y+ ++ K+ L + + +++ HS
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLY---QLINGVNFCHS 150
Query: 303 LASPSIIHSDVKSANILLDDNYTA-----KVSDF 331
+H D+K N+LL + + K+ DF
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 36/154 (23%), Positives = 67/154 (43%), Gaps = 22/154 (14%)
Query: 194 LGMGGFGSVYKGV---LPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLC 250
+G G +G VYK D+ A+K+ I ++ + ++ ++KH NV+ + +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 251 L---ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL------RIAAETASAIHYLH 301
L + KV L ++++ + L H I + L + + IHYLH
Sbjct: 88 LSHADRKVWL-LFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 302 SLASPSIIHSDVKSANILLDDNYTA----KVSDF 331
+ ++H D+K ANIL+ K++D
Sbjct: 146 A---NWVLHRDLKPANILVMGEGPERGRVKIADM 176
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 6e-09
Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 35/156 (22%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRI--TEWEFLGI-------IS---QVKH 240
LG G F +VYK N VA+KK I++ GI I ++ H
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKK------IKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKS-----SQVLKNWKTCLRIAAETAS 295
N++ +L LV++F+ L I D S S + K + T
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHI----KAYML---MTLQ 123
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ YLH I+H D+K N+LLD+N K++DF
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADF 156
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 7e-09
Identities = 35/150 (23%), Positives = 71/150 (47%), Gaps = 26/150 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGI-------IS---QVKHKN 242
+G G +G+V+K + VA+K+ +R+ + + G+ I ++KHKN
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKR------VRL-DDDDEGVPSSALREICLLKELKHKN 62
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV-LKNWKTCLRIAAETASAIHYLH 301
+V++ + K LV+EF L Y + + + K+ L + + + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLF---QLLKGLGFCH 118
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
S +++H D+K N+L++ N K+++F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANF 145
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 30/167 (17%), Positives = 55/167 (32%), Gaps = 47/167 (28%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEF------------LGIISQVKHK 241
+ G +G+V GV + VA+K+ T + +++ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 242 NVVKILGLCLETKVTL-----LVYEFV----------SNGALSHYIHDKS--SQVLKNWK 284
N++ + + + + LV E + +S H + +L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP-QHIQYFMYHILL--- 145
Query: 285 TCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+H LH ++H D+ NILL DN + DF
Sbjct: 146 -----------GLHVLHE---AGVVHRDLHPGNILLADNNDITICDF 178
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 42/158 (26%), Positives = 67/158 (42%), Gaps = 30/158 (18%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKY-MCADE----------IRITEWEFLGIISQVKHK 241
+G+G +G+VYK VA+K + +R E L + +H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR--EVALLRRLEAFEHP 74
Query: 242 NVVKIL------GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVL--KNWKTCLRIAAET 293
NVV+++ E KVTL V+E V L Y+ L + K +R +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTL-VFEHVDQD-LRTYLDKAPPPGLPAETIKDLMR---QF 129
Query: 294 ASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ +LH+ I+H D+K NIL+ T K++DF
Sbjct: 130 LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADF 164
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 28/156 (17%)
Query: 194 LGMGGFGSVYKGVLPDNTQ--VAVKKY-MCADE-------IRITEWEFLGIISQVKHKNV 243
+G G +G V+K N VA+K+ + E IR E L + +H NV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR--EVAVLRHLETFEHPNV 76
Query: 244 VKIL------GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVL--KNWKTCLRIAAETAS 295
V++ ETK+TL V+E V L+ Y+ + + K + +
Sbjct: 77 VRLFDVCTVSRTDRETKLTL-VFEHVDQD-LTTYLDKVPEPGVPTETIKDMMF---QLLR 131
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ +LHS ++H D+K NIL+ + K++DF
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 40/211 (18%), Positives = 69/211 (32%), Gaps = 54/211 (25%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCA-----D------EIRITEWEFLGIISQVKHK 241
+G G +G V + + VA+KK + D EI I ++++ H
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI--------LNRLNHD 112
Query: 242 NVVKILGLCLETKVTL-----LVYEFVSNGALSHYIHDKSSQVLKNWKTC------LRIA 290
+VVK+L + + V +V E + ++ L L
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF--RTPVYLTELHIKTLLYNLLV-- 167
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF-----ESLVPISSDDETAM 345
+ Y+HS I+H D+K AN L++ + + KV DF +
Sbjct: 168 -----GVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVA 376
+ LTG +V
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTG-----HVV 245
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 36/150 (24%), Positives = 70/150 (46%), Gaps = 18/150 (12%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGL 249
+G G FG V+K +VA+KK + +E IT + I+ +KH+NVV ++ +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 250 CLETKVTL--------LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
C LV++F + L+ + + + + + + ++Y+H
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIH 141
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF 331
I+H D+K+AN+L+ + K++DF
Sbjct: 142 RN---KILHRDMKAANVLITRDGVLKLADF 168
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 34/154 (22%), Positives = 64/154 (41%), Gaps = 24/154 (15%)
Query: 194 LGMGGFGSVYKGVL-PDNTQVAVKKYM-----CADEIRITEWEFLGIISQVKHKNVVKIL 247
G G FG+V G VA+KK + E++I + ++ + H N+V++
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-----MQDLAVLHHPNIVQLQ 85
Query: 248 ------GLCLETKVTL-LVYEFVSNGALSHYI--HDKSSQVLKNWKTCLRIAAETASAIH 298
G + L +V E+V + L + + + + + +I
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF-QLIRSIG 143
Query: 299 YLHSLASPSIIHSDVKSANILLD-DNYTAKVSDF 331
LH S ++ H D+K N+L++ + T K+ DF
Sbjct: 144 CLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 50/182 (27%), Positives = 74/182 (40%), Gaps = 24/182 (13%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV----AVKKYMCA--DEIRITEWEFLGIISQVKHKN 242
NF LG G FG V ++ +KK + D++ T E + K
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 243 VVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
+ + L C +T L V E+V+ G L ++I K AAE A + +L
Sbjct: 404 LTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVF-YAAEIAIGLFFLQ 459
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVGYLD 357
S II+ D+K N++LD K++DF E+ I T T GT Y+
Sbjct: 460 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN---IWDGVTT--KTFC-GTPDYIA 510
Query: 358 PE 359
PE
Sbjct: 511 PE 512
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 7e-08
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 29/186 (15%)
Query: 189 NFHHCLGMGGFGSVY---KGVLPDNTQV-AVK---KYMC---ADEIRITEWEFLGIISQV 238
LG GG+G V+ K + ++ A+K K M A + T+ E I+ +V
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE-RNILEEV 78
Query: 239 KHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAI 297
KH +V L +T L L+ E++S G L + + C AE + A+
Sbjct: 79 KHPFIVD-LIYAFQTGGKLYLILEYLSGGELFMQLE--REGIFMEDTACF-YLAEISMAL 134
Query: 298 HYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTV 353
+LH II+ D+K NI+L+ K++DF ES+ D T GT+
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI----HDGTVT-HTFC-GTI 185
Query: 354 GYLDPE 359
Y+ PE
Sbjct: 186 EYMAPE 191
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 39/184 (21%), Positives = 61/184 (33%), Gaps = 17/184 (9%)
Query: 190 FHHCLGMGGFGSVYKGVL------PDNTQVAVK---KYMCADEIRITEWEFLGIISQVKH 240
LG G FG V + VAVK + E R E +I H
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 241 KNVVKILGLCLETKV-TLLVYEFVSNGALSHYIHDKSSQVLKNW--KTCLRIAAETASAI 297
NVV +LG C + +++ EF G LS Y+ K ++ + R + AI
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 298 H-----YLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
L S+ S S L D + + ++ + S +
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 353 VGYL 356
+ +L
Sbjct: 206 MEFL 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 14/48 (29%), Positives = 24/48 (50%), Gaps = 3/48 (6%)
Query: 284 KTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ + + + A + +L AS IH D+ + NILL + K+ DF
Sbjct: 193 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 237
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 46/182 (25%), Positives = 75/182 (41%), Gaps = 25/182 (13%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV----AVKKYMCA--DEIRITEWEFLGIISQVKHKN 242
++ LG G FG V + ++K + DE+ T E ++ +H
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE-SRVLQNTRHPF 66
Query: 243 VVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
+ L +T L V E+ + G L ++ +V + AE SA+ YLH
Sbjct: 67 LTA-LKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARF-YGAEIVSALEYLH 122
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVGYLD 357
S +++ D+K N++LD + K++DF E + D M T GT YL
Sbjct: 123 SR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-----SDGATMKTFC-GTPEYLA 173
Query: 358 PE 359
PE
Sbjct: 174 PE 175
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 33/187 (17%)
Query: 189 NFHHCLGMGGFGSVY---KGVLPDNTQV-AVK---KYMCA--DEIR-ITEWEFLGIISQV 238
LG G FG V+ K D Q+ A+K K D +R E + I+ +V
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD---ILVEV 83
Query: 239 KHKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRI-AAETASA 296
H +VK L +T+ L L+ +F+ G L + K + ++ AE A A
Sbjct: 84 NHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEED---VKFYLAELALA 138
Query: 297 IHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGT 352
+ +LHSL II+ D+K NILLD+ K++DF ES+ ++ A + GT
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI----DHEKKA-YSFC-GT 189
Query: 353 VGYLDPE 359
V Y+ PE
Sbjct: 190 VEYMAPE 196
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 44/216 (20%)
Query: 189 NFHHCLGMGGFGSVY---KGVLPDNTQV-AVK---KYMCADEIRITEWEFL--GIISQVK 239
LG G +G V+ K D ++ A+K K + + TE ++ ++
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 240 HKNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIH 298
+ L +T+ L L+ ++++ G L ++ + + + E A+
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQI-YVGEIVLALE 173
Query: 299 YLHSLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVG 354
+LH L II+ D+K NILLD N ++DF E ++ + E A GT+
Sbjct: 174 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF---VADETERA-YDFC-GTIE 225
Query: 355 YLDPE------YAHT-------------ELLTGMNP 371
Y+ P+ H ELLTG +P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 18/172 (10%)
Query: 194 LGMGGFGSVYKGVLPDNTQV-AVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
LG G FG V ++ A+K +++ + E I+ V +VK+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 249 LCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
+ L +V E+V+ G + ++ AA+ YLHSL
Sbjct: 109 -SFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYLHSL---D 161
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+I+ D+K N+L+D +V+DF + + T+ GT L PE
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF----GFAKRVKGRTWTL-CGTPEALAPE 208
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 53/184 (28%), Positives = 79/184 (42%), Gaps = 28/184 (15%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV----AVKKYMCA--DEIR--ITEWEFLGIISQVKH 240
F LG G FG V + + + +KK + D++ +TE L + H
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NH 83
Query: 241 KNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+ + L C +T L V EFV+ G L +I S+ + AAE SA+ +
Sbjct: 84 PFLTQ-LFCCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARF-YAAEIISALMF 139
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVGY 355
LH II+ D+K N+LLD K++DF E I + T +T GT Y
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG---ICNGVTT--ATFC-GTPDY 190
Query: 356 LDPE 359
+ PE
Sbjct: 191 IAPE 194
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 50/184 (27%), Positives = 75/184 (40%), Gaps = 28/184 (15%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV----AVKKYMCA--DEIR--ITEWEFLGIISQVKH 240
NF LG G FG V ++ +KK + D++ + E L + K
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KP 80
Query: 241 KNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+ + L C +T L V E+V+ G L ++I K AAE A + +
Sbjct: 81 PFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVF-YAAEIAIGLFF 136
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVGY 355
L S II+ D+K N++LD K++DF E+ I T T GT Y
Sbjct: 137 LQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN---IWDGVTT--KTFC-GTPDY 187
Query: 356 LDPE 359
+ PE
Sbjct: 188 IAPE 191
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 40/161 (24%), Positives = 64/161 (39%), Gaps = 46/161 (28%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD----------EIRITEWEFLGIISQVKHKN 242
LG G +G V P VA+KK D EI+I + KH+N
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI--------LKHFKHEN 70
Query: 243 VVKILGLCLETKVTL-----LVYEFV-SNGALSHYIHDKSSQVLKNWKTC------LRIA 290
++ I + ++ E + ++ L I S+Q+L + LR
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVI---STQMLSDDHIQYFIYQTLR-- 123
Query: 291 AETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
A+ LH ++IH D+K +N+L++ N KV DF
Sbjct: 124 -----AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDF 156
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 28/184 (15%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV----AVKKYMCA--DEIR--ITEWEFLGIISQVKH 240
+ +G G + V L ++ VKK + ++I TE S H
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS--NH 69
Query: 241 KNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+V L C +T+ L V E+V+ G L ++ + + L +AE + A++Y
Sbjct: 70 PFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARF-YSAEISLALNY 125
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVGY 355
LH II+ D+K N+LLD K++D+ E + D T ST GT Y
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG---LRPGDTT--STFC-GTPNY 176
Query: 356 LDPE 359
+ PE
Sbjct: 177 IAPE 180
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 60/252 (23%), Positives = 91/252 (36%), Gaps = 76/252 (30%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV----AVKKYMCA--DEIRITEWEFLGIISQVKHKN 242
H LG G FG V+ Q A+KK + D++ T E K
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE----------KR 69
Query: 243 VVK-------ILGL--CLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAE 292
V+ + + +TK L V E+++ G L ++I + AAE
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATF-YAAE 126
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTM 348
+ +LHS I++ D+K NILLD + K++DF E+ + D +T +T
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN---MLGDAKT--NTF 178
Query: 349 IRGTVGYLDPE------YAHT-----------ELLTGMNPNSYVALASNEKISMVPYFLD 391
GT Y+ PE Y H+ E+L G +P F
Sbjct: 179 C-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP-----------------FHG 220
Query: 392 SIENNSFRQILN 403
E F I
Sbjct: 221 QDEEELFHSIRM 232
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 53/182 (29%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV-AVK---KYMCA--DEIRITEWEFLGIISQVKHKN 242
+F +G G FG V AVK K E + E ++ VKH
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 243 VVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
+V L +T L V ++++ G L +++ + + AAE ASA+ YLH
Sbjct: 101 LVG-LHFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARF-YAAEIASALGYLH 156
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVGYLD 357
SL +I++ D+K NILLD ++DF E++ + T ST GT YL
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI----EHNSTT-STFC-GTPEYLA 207
Query: 358 PE 359
PE
Sbjct: 208 PE 209
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 34/160 (21%), Positives = 64/160 (40%), Gaps = 44/160 (27%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD----------EIRITEWEFLGIISQVKHKN 242
+G G +G V + +VA+KK + EI+I + + +H+N
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI--------LLRFRHEN 86
Query: 243 VVKILGLCLETKVTL-----LVYEFVSNGALSHYIHDKSSQVLKNWKTC------LRIAA 291
++ I + + +V + + L + +Q L N C LR
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLK---TQHLSNDHICYFLYQILR--- 139
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ Y+HS +++H D+K +N+LL+ K+ DF
Sbjct: 140 ----GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDF 172
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 33/156 (21%), Positives = 63/156 (40%), Gaps = 42/156 (26%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD------EIRITEWEFLGIISQVKHKNVVKI 246
LG G + V++ + + +N +V VK EI+I E G N++ +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE-NLRG------GPNIITL 96
Query: 247 LGLCL--ETKVTLLVYEFVSNGALSHYIHDKSS--------QVLKNWKTCLRIAAETASA 296
+ ++ LV+E V+N + ++LK A
Sbjct: 97 ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK--------------A 142
Query: 297 IHYLHSLASPSIIHSDVKSANILLD-DNYTAKVSDF 331
+ Y HS+ I+H DVK N+++D ++ ++ D+
Sbjct: 143 LDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW 175
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 28/184 (15%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQV----AVKKYMCA--DEIR--ITEWEFLGIISQVKH 240
+ +G G + V L ++ VKK + ++I TE S H
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS--NH 112
Query: 241 KNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+V L C +T+ L V E+V+ G L ++ + + L +AE + A++Y
Sbjct: 113 PFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARF-YSAEISLALNY 168
Query: 300 LHSLASPSIIHSDVKSANILLDDNYTAKVSDF----ESLVPISSDDETAMSTMIRGTVGY 355
LH II+ D+K N+LLD K++D+ E + D T ST GT Y
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG---LRPGDTT--STFC-GTPNY 219
Query: 356 LDPE 359
+ PE
Sbjct: 220 IAPE 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 49/204 (24%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCA-----D------EIRITEWEFLGIISQVKHK 241
LG G +G V+K + VAVKK A D EI I E G H+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT-ELSG------HE 69
Query: 242 NVVKILGLCL--ETKVTLLVYEFV-SNGALSHYIHDKSSQVLKNWKTC------LRIAAE 292
N+V +L + + LV++++ ++ L I + +L+ ++
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIR---ANILEPVHKQYVVYQLIK---- 120
Query: 293 TASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
I YLHS ++H D+K +NILL+ KV+DF L + + +
Sbjct: 121 ---VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADF-GLSRSFVNIRRVTNNIPLSI 173
Query: 353 VGYLDPEYAHTELLTGMNPNSYVA 376
+ +LT YVA
Sbjct: 174 NENTENFDDDQPILTD-----YVA 192
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 5e-06
Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 20/173 (11%)
Query: 194 LGMGGFGSVYKGVLPDNTQV-AVK-----KYMCADEIRITEWEFLGIISQVKHKNVVKIL 247
LG G FG V+ N + A+K + ++ T E L ++S V H ++++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL-MLSIVTHPFIIRMW 72
Query: 248 GLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
G + + ++ +++ G L + + SQ N AAE A+ YLHS
Sbjct: 73 G-TFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKF-YAAEVCLALEYLHSK--- 125
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
II+ D+K NILLD N K++DF + T+ GT Y+ PE
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFG----FAKYVPDVTYTLC-GTPDYIAPE 173
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 33/157 (21%), Positives = 60/157 (38%), Gaps = 36/157 (22%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCA-----DEIRIT-EWEFLGIISQVKHKNVVKI 246
+G G +G+V V +VA+KK R E L ++H+NV+ +
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL---KHMRHENVIGL 89
Query: 247 LGLCLETKVTL------LVYEFVSNGALSHYIHDKSSQVLKNWKTC------LRIAAETA 294
L + + LV F+ L + + L + L+
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTD-LGKLMK---HEKLGEDRIQFLVYQMLK------ 139
Query: 295 SAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ Y+H+ IIH D+K N+ ++++ K+ DF
Sbjct: 140 -GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 172
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 5e-06
Identities = 44/250 (17%), Positives = 73/250 (29%), Gaps = 70/250 (28%)
Query: 176 KIFSKSELLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD------------- 222
+L + K +G G FG V++ + D+T VA+K
Sbjct: 15 HCLPTEKLQRCEK-----IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 223 ----EIRIT-EWEFLGIISQVKHKNVVKILGLCL-----------------ETKVTL--- 257
EI I+ E L + + + + + TK +
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 258 ----------LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
+V EF G + K L + T I + +++ + S
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLR 182
Query: 308 IIHSDVKSANILLDDNYTAKVSDF----ESLVPISS-----DDETAMSTMIRGTVGYLDP 358
H D+ N+LL K+ S +P D T G V + D
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV 242
Query: 359 EYAHTELLTG 368
+L TG
Sbjct: 243 SMDE-DLFTG 251
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 36/160 (22%)
Query: 191 HHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT------EWEFLGIISQVKHKNV 243
+G G +GSV +VAVKK + I E L +KH+NV
Sbjct: 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL---KHMKHENV 90
Query: 244 VKILGLCLETKVTL------LVYEFVSNGALSHYIHDKSSQVLKNWKTC------LRIAA 291
+ +L + + LV + L++ + Q L + LR
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVK---CQKLTDDHVQFLIYQILR--- 143
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ Y+HS IIH D+K +N+ ++++ K+ DF
Sbjct: 144 ----GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 35/160 (21%), Positives = 61/160 (38%), Gaps = 43/160 (26%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT------EWEFLGIISQVKHKNVVKI 246
+G G +GSV + +VA+KK + I E L ++H+NV+ +
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL---KHMQHENVIGL 88
Query: 247 LGLCLETKVTL------LVYEFVSNGALSHYIHDKSS---------QVLKNWKTCLRIAA 291
L + LV F+ L + K S Q+LK
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQTD-LQKIMGLKFSEEKIQYLVYQMLK---------- 137
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
+ Y+HS ++H D+K N+ ++++ K+ DF
Sbjct: 138 ----GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 170
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 14/144 (9%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIR--ITEWEFLGIISQVKHKNVVKILGLC 250
+G G FG +Y G + +VA+K + E + ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG--IPTIRWCG 74
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
E ++V E + +L + S + + KT L +A + S I Y+HS + IH
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHSK---NFIH 128
Query: 311 SDVKSANILLDDNYTAK---VSDF 331
DVK N L+ + DF
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDF 152
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 61/173 (35%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCAD---------EIRITEWEFLGIISQVKHKNV 243
LG GG G V+ V + +VA+KK + D EI+I I ++ H N+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKI--------IRRLDHDNI 70
Query: 244 VKIL-------GLCLETKVTL-------LVYEF--------VSNGALSHYIHDKS--SQV 279
VK+ + +L +V E+ + G L H + Q+
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE-EHARLFMYQL 129
Query: 280 LKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAKVSDF 331
L+ + Y+HS +++H D+K AN+ ++ ++ K+ DF
Sbjct: 130 LR--------------GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF 165
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 39/160 (24%), Positives = 57/160 (35%), Gaps = 43/160 (26%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT------EWEFLGIISQVKHKNVVKI 246
+G G G V + VA+KK + + E + V HKN++ +
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM---KCVNHKNIISL 126
Query: 247 L-----GLCLETKVTL-LVYEF-------VSNGALSHYIHDKS--SQVLKNWKTCLRIAA 291
L LE + LV E V L H Q+L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH-ERMSYLLYQMLC---------- 175
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
I +LHS IIH D+K +NI++ + T K+ DF
Sbjct: 176 ----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 208
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 36/160 (22%), Positives = 56/160 (35%), Gaps = 43/160 (26%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT------EWEFLGIISQVKHKNVVKI 246
+G G G V VA+KK + + E + V HKN++ +
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM---KCVNHKNIIGL 89
Query: 247 LGLCLETKVTL------LVYEFVSNGALSHYIHDKSS---------QVLKNWKTCLRIAA 291
L + K +V E + L I + Q+L
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC---------- 138
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331
I +LHS IIH D+K +NI++ + T K+ DF
Sbjct: 139 ----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 171
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 32/139 (23%), Positives = 58/139 (41%), Gaps = 15/139 (10%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIR--ITEWEFLGIISQVKHKNVVKILGLC 250
+G G FG +Y G + N +VA+K + + E + I+ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG--IPNVRWFG 72
Query: 251 LETKVTLLVYEFV--SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+E +LV + + S L ++ K S KT L +A + + + ++HS S
Sbjct: 73 VEGDYNVLVMDLLGPSLEDLFNFCSRKLSL-----KTVLMLADQMINRVEFVHSK---SF 124
Query: 309 IHSDVKSANILLDDNYTAK 327
+H D+K N L+ A
Sbjct: 125 LHRDIKPDNFLMGLGRRAN 143
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 28/132 (21%), Positives = 53/132 (40%), Gaps = 15/132 (11%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIR--ITEWEFLGIISQVKHKNVVKILGLC 250
+G G FG +++G L +N QVA+K + E+ +++ + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG--IPNVYYFG 75
Query: 251 LETKVTLLVYEFV--SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
E +LV + + S L K S KT A + + + +H S+
Sbjct: 76 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSV-----KTVAMAAKQMLARVQSIHEK---SL 127
Query: 309 IHSDVKSANILL 320
++ D+K N L+
Sbjct: 128 VYRDIKPDNFLI 139
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 23/157 (14%), Positives = 50/157 (31%), Gaps = 28/157 (17%)
Query: 194 LGMGGFGSVYKGV---------LPDNTQVAVK-----------KYMCADEIRITEWEFLG 233
G +Y+ P + ++K + + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 234 IISQVKHKNVVKILGL-CLETKVTLLVYEFVSNGA-LSHYIHDKSSQVLKNWKTCLRIAA 291
+ + +G + K LV + G L + VL + ++ L++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVL-SERSVLQVAC 166
Query: 292 ETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328
A+ +LH +H +V + NI +D ++V
Sbjct: 167 RLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQV 200
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 40/166 (24%), Positives = 60/166 (36%), Gaps = 48/166 (28%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK------KYMCA--DEIRITEWEFLGIISQVKHKNVV 244
+G G FG V K + VA+K ++ +EIRI E L + NV+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILE--HLRKQDKDNTMNVI 162
Query: 245 KILG-------LCLETKVT-LL---VYEFVSNGALS----HYIHDKSSQVLKNWKTCLRI 289
+L +C+ LL +YE + + + +L+
Sbjct: 163 HMLENFTFRNHICM---TFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ-------- 211
Query: 290 AAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTA--KVSDFES 333
+ LH IIH D+K NILL + KV DF S
Sbjct: 212 ------CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 33/133 (24%), Positives = 52/133 (39%), Gaps = 13/133 (9%)
Query: 192 HCLGMGGFGSVYKGV-LPDNTQVAVK--KYMCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G FG + G L N VA+K E+ F + + ++
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG--IPQVYY 72
Query: 249 LCLETKVTLLVYEFVSNGA-LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
K +V E + G L D + + KT L IA + S + Y+HS +
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDL-FDLCDRTF-SLKTVLMIAIQLISRMEYVHSK---N 125
Query: 308 IIHSDVKSANILL 320
+I+ DVK N L+
Sbjct: 126 LIYRDVKPENFLI 138
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 36/180 (20%), Positives = 68/180 (37%), Gaps = 50/180 (27%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKIL----- 247
LG G FG V + + + A+KK + + R E L I+ + H N++K++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVL--QDPRYKNRE-LDIMKVLDHVNIIKLVDYFYT 71
Query: 248 --------------------------------GLCLETKVTL-LVYEFVSNGALSHYI-- 272
+ L ++ E+V + L +
Sbjct: 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKS 130
Query: 273 HDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAKVSDF 331
+S + + + I + A+ ++HSL I H D+K N+L++ + T K+ DF
Sbjct: 131 FIRSGRSIPMNLISIYI-YQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDF 186
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 28/159 (17%), Positives = 52/159 (32%), Gaps = 24/159 (15%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRI------TEWEFLGIISQVKHKNVVKIL 247
+G GGFG +Y + + V TE +F ++ +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 248 GLCLETKVTLLVYEFVSNGALSHY---IHD---KSSQVLKNW-------KTCLRIAAETA 294
V + + Y I D Q + KT L+++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRIL 162
Query: 295 SAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV--SDF 331
+ Y+H +H D+K++N+LL+ +V D+
Sbjct: 163 DILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDY 198
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 32/171 (18%), Positives = 56/171 (32%), Gaps = 59/171 (34%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAV------------------------KKYMCADEIRITE 228
+G GGFG +Y + A KK I +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 229 WEFLGI-------ISQVKHKN----VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSS 277
++LGI +++ K ++ V++ LG+ L+ NG
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKI-------SGQNGTFKK------- 150
Query: 278 QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328
T L++ + Y+H +H D+K+AN+LL +V
Sbjct: 151 ------STVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV 192
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 33/176 (18%), Positives = 60/176 (34%), Gaps = 47/176 (26%)
Query: 194 LGMGGFGSVYKGV--LPDNTQVAVK------KYMCA--DEIRITEWEFLGIISQVKHKNV 243
LG G FG V + + +QVA+K KY A EI + + + +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLK--KIKEKDKENKFLC 84
Query: 244 VKILG-------LCLETKVT-LL---VYEFVSNGALS----HYIHDKSSQVLKNWKTCLR 288
V + +C+ LL +EF+ ++ + Q+
Sbjct: 85 VLMSDWFNFHGHMCI---AFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH------- 134
Query: 289 IAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344
A+ +LH + H+D+K NIL ++ + + S T+
Sbjct: 135 -------ALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 46/186 (24%), Positives = 65/186 (34%), Gaps = 55/186 (29%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK------KYMCA--DEIRITEWEFLGIISQVKH--KN 242
+G G FG V + + AVK KY + E I L I N
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADI-----LKKIQNDDINNNN 97
Query: 243 VVKILG-------LCLETKVT-LL---VYEFV-SNG----ALSHYIHDKSSQVLKNWKTC 286
+VK G +CL + L +YE + N + I ++LK
Sbjct: 98 IVKYHGKFMYYDHMCL---IFEPLGPSLYEIITRNNYNGFHIED-IKLYCIEILK----- 148
Query: 287 LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV--PISSDDETA 344
A++YL + S+ H+D+K NILLDD Y K V
Sbjct: 149 ---------ALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 345 MSTMIR 350
ST I+
Sbjct: 197 KSTGIK 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 496 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3qfl_A | 115 | MLA10; coiled-coil, (CC) domain, NLRS, nucleotide- | 99.52 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.6 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.55 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.54 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.4 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.38 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.35 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.84 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.5 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.77 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.34 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.11 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=438.22 Aligned_cols=259 Identities=21% Similarity=0.283 Sum_probs=217.8
Q ss_pred hcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
.+.+.+.||+|+||+||+|.+. ++..||||++...... ...+.+|+.+|++++|||||+++|+|.+++..|||
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3667789999999999999863 4678999999754333 34455999999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcC----------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEc
Q 047375 260 YEFVSNGALSHYIHDKS----------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
||||++|+|.++|+... ....++|..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEEC
Confidence 99999999999997643 22358999999999999999999999 789999999999999999999999
Q ss_pred cCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCC
Q 047375 330 DFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVAD 408 (496)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~ 408 (496)
|||+|+...............||+.|||||++.+..|+.++|+||+|+++|||++ |.+||.+......+..+..... .
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-~ 249 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-L 249 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-C
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C
Confidence 9999987655433333344569999999999999999999999999999999998 7999887766666666655432 3
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 409 ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 409 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
+.+..+++.+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 34456778899999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-57 Score=442.72 Aligned_cols=258 Identities=20% Similarity=0.270 Sum_probs=210.0
Q ss_pred cchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+.+.+.||+|+||+||+|.+. ++..||||++...... ...+.+|+.+|++++|||||+++|+|.+.+..||||
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 122 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456688999999999999863 4778999999754433 344559999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCc------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 261 EFVSNGALSHYIHDKSS------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
|||++|+|.++++.... ..+++|..++.|+.|||.||.|||+ ++||||||||+||||+.++.+||
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEE
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEE
Confidence 99999999999976432 2357999999999999999999999 78999999999999999999999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccC
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
+|||+|+...........+..+||+.|||||++.+..++.++|+||+||++|||++ |.+||........+..+.... .
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~ 278 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-E 278 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-C
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-C
Confidence 99999987755443334455679999999999999999999999999999999998 788888766655565555432 3
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+.+..+++.+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 279 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 279 LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 344556778899999999999999999999999999988654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-57 Score=440.33 Aligned_cols=258 Identities=21% Similarity=0.256 Sum_probs=217.7
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..+.|.+.||+|+||+||+|.+. ++..||||++..... ....+.+|+.++++++|||||+++|+|.+.+..|
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34677889999999999999862 467899999865432 2345568999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC
Q 047375 258 LVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY 324 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~ 324 (496)
||||||++|+|.++|..... ...++|..+..|+.|||.||.|||+ ++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 99999999999999975421 2347899999999999999999999 7899999999999999999
Q ss_pred ceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhh
Q 047375 325 TAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILN 403 (496)
Q Consensus 325 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~ 403 (496)
.+||+|||+|+...........+..+||+.|||||++.+..|+.++|+||+|+++||+++ |.+||.+.........+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987755433333455679999999999999999999999999999999998 7888887666555655554
Q ss_pred cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 404 FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 404 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
.. ..+.+..+++.+.+|+.+||+.||.+|||+.||++.|+.+.
T Consensus 263 ~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 263 RQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 33 33445567788999999999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=434.09 Aligned_cols=264 Identities=21% Similarity=0.242 Sum_probs=228.5
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||+||+|.. .+++.||||++.... .......+|+++|++++|||||++++++.+.+..|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 388889999999999999995 578999999986432 122345589999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||+||+|.+++...+. +++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+....
T Consensus 113 y~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred cCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999987543 7889999999999999999999 889999999999999999999999999999876544
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
......+.+||+.|||||++.+..|+.++|+||+||++|+|++|.+||.+......+..+....+.. +...++++.+|
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--p~~~s~~~~dl 264 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF--PEKFFPKARDL 264 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTCCHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CcccCHHHHHH
Confidence 4444567789999999999999999999999999999999999999998877777777777655433 33456789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcccc
Q 047375 422 ASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEES 462 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~ 462 (496)
|.+||+.||.+|||+.|++.. ..+.+|+|++..+|+.
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~----~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGY----GPLKAHPFFESVTWEN 301 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCH----HHHHTSGGGTTCCCTT
T ss_pred HHHHccCCHhHCcChHHHcCC----HHHHCCCCcCCCCHHH
Confidence 999999999999999987532 3356789999888754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-56 Score=433.73 Aligned_cols=261 Identities=18% Similarity=0.183 Sum_probs=217.8
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+.+.+.||+|+||.||+|.+ .+|..||||++.... ...+|+.+|+.++|||||++++++.+.+.+|||||||+||
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 55667899999999999996 468999999986432 2236899999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-ceEEccCCCccccCCCCCcc-
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPISSDDETA- 344 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~~~~~~~- 344 (496)
+|.+++..... +++..+..|+.||+.||.|||+ ++||||||||+||||+.+| .+||+|||+|+.+.......
T Consensus 136 ~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 136 SLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp BHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred cHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999987543 7899999999999999999999 7899999999999999887 69999999999875432211
Q ss_pred --ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-CcccHHHHHHHHHH
Q 047375 345 --MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVAEL 421 (496)
Q Consensus 345 --~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~l~~l 421 (496)
....++||+.|||||++.+..|+.++|+||+||++|+|++|.+||.+......+..+.....+ ...+..+++.+.+|
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 289 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHH
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHH
Confidence 123467999999999999999999999999999999999999999887777777777654332 12344567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhHhh---hhhhhhccC
Q 047375 422 ASKCLRIRGTERPTMKEVSEELDRLRRL---QENYWARKN 458 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L~~l~~~---~~~~~~~~~ 458 (496)
|.+||+.||.+|||+.|+++.|...... ..++|....
T Consensus 290 i~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 290 IQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9999999999999999999998877643 346676543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=427.22 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=202.5
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
+.+.+.||+|+||+||+|.+. ..||||+++... .....+.+|+.+|++++|||||+++|+|.. +.+|||||||+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 456788999999999999974 369999886432 223445589999999999999999998865 56899999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
||+|.++|..... .+++..+..|+.|||.||.|||+ ++||||||||+||||++++.+||+|||+|+.........
T Consensus 115 gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 115 GSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp SCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999976543 37899999999999999999999 789999999999999999999999999998775543333
Q ss_pred ceecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC----CcccHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA----DESEMEEIEV 417 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~----~~~~~~~~~~ 417 (496)
.....+||+.|||||++.+ ..|+.++|+||+||++|||++|.+||.+......+..++..... ...+..+++.
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 4456789999999999964 35889999999999999999999999775544444444332222 1234456788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
+.+|+.+||+.||.+|||+.||++.|+.++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 999999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=430.61 Aligned_cols=252 Identities=20% Similarity=0.215 Sum_probs=216.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
|.+.+.||+|+||+||+|.. .+|+.||||++...... .....+|+.+|+.++|||||+++++|.+.+.+|||||||+|
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 66678899999999999996 47899999998654332 33455899999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+..... .
T Consensus 156 g~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 226 (346)
T 4fih_A 156 GALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 226 (346)
T ss_dssp EEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence 9999999753 27889999999999999999999 7899999999999999999999999999988754322 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc-CCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-ADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~l~~li~~ 424 (496)
....+||+.|||||++.+..|+.+.||||+||++|+|++|.+||.+......+..+..... ..+.....++.+.+||.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999988766666666655322 223345567889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccC
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
||+.||.+|||+.|+ .+++|..+.
T Consensus 307 ~L~~dP~~R~ta~e~----------l~Hp~~~~~ 330 (346)
T 4fih_A 307 LLVRDPAQRATAAEL----------LKHPFLAKA 330 (346)
T ss_dssp HSCSSTTTSCCHHHH----------TTCGGGGGC
T ss_pred HcCCChhHCcCHHHH----------hcCHhhcCC
Confidence 999999999999988 457777654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=434.29 Aligned_cols=248 Identities=20% Similarity=0.234 Sum_probs=208.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||+||+|.. .+|+.||||++.... .......+|+.+|++++|||||++++++.+++.+||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 478889999999999999995 478999999986432 2234455899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|+||+|.+++..... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 105 ~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 105 CEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999976543 336888999999999999999999 88999999999999999999999999999876432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
....+..+||+.|||||++.+..|+.++|+||+||++|+|++|.+||.+......+..+.....+ +.+...++.+.+||
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li 257 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHH
Confidence 12234567999999999999999999999999999999999999999887777777777765543 33445678899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+||+.||.+|||+.|+++
T Consensus 258 ~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=417.04 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=202.8
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEee----CCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLE----TKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv 259 (496)
+.|.+.||+|+||+||+|.+ .++..||+|++.... .....+.+|+.+|++++|||||+++++|.+ .+.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35667899999999999996 468899999986432 223345589999999999999999999875 3568999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCCccccC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPIS 338 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~~ 338 (496)
||||+||+|.+++.... .+++..+..|+.||+.||.|||+.+ .+||||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999998754 3788999999999999999999932 23999999999999974 7899999999998643
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccCCcccHHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 417 (496)
.. .....+||+.|||||++.+ .|+.++|+||+||++|+|++|.+||.+..... .+..+.....+...+...+++
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHH
Confidence 22 2355689999999999876 59999999999999999999999997654333 333343333333334445678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhcc
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARK 457 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~ 457 (496)
+.+||.+||+.||.+|||+.|++ +|+|.++
T Consensus 259 ~~~li~~~L~~dP~~R~s~~e~l----------~Hp~~~~ 288 (290)
T 3fpq_A 259 VKEIIEGCIRQNKDERYSIKDLL----------NHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHH----------TSGGGC-
T ss_pred HHHHHHHHccCChhHCcCHHHHh----------cCccccC
Confidence 99999999999999999999984 4667654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=427.86 Aligned_cols=262 Identities=22% Similarity=0.254 Sum_probs=218.5
Q ss_pred HHhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCC-CceeeEEEEEeeC-C
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKH-KNVVKILGLCLET-K 254 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~-~ 254 (496)
...+.+.+.||+|+||+||+|.+. .++.||||.+..... ....+.+|+.+|.+++| ||||+++|+|... +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 455778899999999999999853 235799999865432 23345589999999965 9999999999764 5
Q ss_pred eeeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
.+|||||||++|+|.++|+.... ...+++..+..|+.|||.||.|||+ ++||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeC
Confidence 68999999999999999976432 2347899999999999999999999 7899999999999999
Q ss_pred CCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhh
Q 047375 322 DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQ 400 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 400 (496)
.++.+||+|||+|+.+............+||+.|||||++.+..|+.++|+||+||++|||++ |.+||.+......+..
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999998765544444456779999999999999999999999999999999997 7888877655555555
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+......+.+..+++++.+|+.+||+.||.+|||+.||++.|+.+.+.
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 5544444455556678899999999999999999999999999988653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=431.54 Aligned_cols=253 Identities=20% Similarity=0.215 Sum_probs=216.1
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .+|+.||||++...... .....+|+.+|+.++|||||+++++|.+.+.+|||||||+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 366778999999999999996 47899999998654332 3445699999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
||+|.+++.... +++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 232 gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 302 (423)
T 4fie_A 232 GGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 302 (423)
T ss_dssp TEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred CCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence 999999997532 7889999999999999999999 789999999999999999999999999998875432 2
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc-CCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-ADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~l~~li~ 423 (496)
.....+||+.|||||++.+..|+.+.||||+||++|+|++|.+||.+......+..+..... ........++.+.+||.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 24567899999999999999999999999999999999999999988766666666654322 22233456678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccC
Q 047375 424 KCLRIRGTERPTMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
+||+.||.+|||+.|+ ..++|....
T Consensus 383 ~~L~~dP~~R~ta~el----------l~Hp~~~~~ 407 (423)
T 4fie_A 383 RLLVRDPAQRATAAEL----------LKHPFLAKA 407 (423)
T ss_dssp HHSCSSTTTSCCHHHH----------TTCGGGGGC
T ss_pred HHcCCChhHCcCHHHH----------hcCHHhcCC
Confidence 9999999999999988 456777654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-54 Score=408.96 Aligned_cols=250 Identities=19% Similarity=0.240 Sum_probs=199.9
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||+||+|.. .+|+.||||++.... .......+|+.+|+.++|||||++++++.+.+..|||||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 488889999999999999995 478999999986432 223345689999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|| +|+|.+++..+.. +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CC-CEEHHHHHHHSCS---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CC-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99 6799999987543 7899999999999999999999 889999999999999999999999999998765432
Q ss_pred CccceecccccceeecCccccccccc-CCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLT-GMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t-~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
.....+||+.|||||++.+..+. .++|+||+||++|+|++|.+||.+......+..+....... +...++.+.+
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 241 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL--PKFLSPGAAG 241 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTSCHHHHH
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHH
Confidence 23456799999999999988765 68999999999999999999998776666666666554432 3345678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccC
Q 047375 421 LASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
||.+||+.||.+|||+.|++ +++|.+..
T Consensus 242 li~~~L~~dP~~R~s~~eil----------~hpw~k~~ 269 (275)
T 3hyh_A 242 LIKRMLIVNPLNRISIHEIM----------QDDWFKVD 269 (275)
T ss_dssp HHHHHSCSSGGGSCCHHHHH----------HCHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHH----------cCcccccC
Confidence 99999999999999999984 46677543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=417.36 Aligned_cols=260 Identities=20% Similarity=0.163 Sum_probs=212.0
Q ss_pred hcchhhhcccCCceEEEEeEe----CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL----PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
.|.+.+.||+|+||+||+|+. .+++.||||++.... .......+|+.+|++++|||||++++++.+.+..|||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 488889999999999999985 246789999986432 2223455789999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||||+||+|.+++.... .+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 105 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp ECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999998754 37889999999999999999999 7899999999999999999999999999987644
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
... .....+||+.|||||++.+..|+.++|+||+||++|+|++|.+||.+......+..+....... +...++.+.
T Consensus 179 ~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--p~~~s~~~~ 254 (304)
T 3ubd_A 179 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM--PQFLSPEAQ 254 (304)
T ss_dssp --C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHH
T ss_pred CCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--CCcCCHHHH
Confidence 322 2345679999999999999999999999999999999999999998877777777777654433 344668899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
+||.+||+.||.+|||+... .+.++..|+|.+..+|+
T Consensus 255 ~li~~~L~~dP~~R~ta~~~-----~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPD-----GVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTT-----THHHHHTSGGGTTCCHH
T ss_pred HHHHHHcccCHHHCCCCCcC-----CHHHHHcCccccCCCHH
Confidence 99999999999999996420 11223568888877664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=414.52 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=200.9
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC----eeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETK----VTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~E~ 262 (496)
.+.+.+.||+|+||+||+|.+ +|+.||||++............|+..+.+++|||||+++|+|...+ .+||||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 356678999999999999998 6899999998755443333335667777899999999999998654 57999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC-----CCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA-----SPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-----~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
|++|+|.++++... ++|..+.+++.|++.||.|||+.+ .++||||||||+||||+.++++||+|||+|+..
T Consensus 83 ~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 83 HEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999997642 789999999999999999999731 238999999999999999999999999999877
Q ss_pred CCCCCcc--ceecccccceeecCcccccc------cccCCCCCchhhhhcccccccccchhhhccc--------------
Q 047375 338 SSDDETA--MSTMIRGTVGYLDPEYAHTE------LLTGMNPNSYVALASNEKISMVPYFLDSIEN-------------- 395 (496)
Q Consensus 338 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~------~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-------------- 395 (496)
....... .....+||+.|||||++.+. .++.++|+||+||++|||+++.+|+......
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5443221 22346799999999998764 4778999999999999999998765432211
Q ss_pred -chhhhhhhcccCCcc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 396 -NSFRQILNFQVADES-----EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 396 -~~~~~i~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.....+......+.. ..+.++.+.+|+.+||+.||.+|||+.||++.|+.+.+.
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 011112222222221 235667899999999999999999999999999988653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=409.54 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=188.8
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCC----------
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETK---------- 254 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~---------- 254 (496)
|.+.+.||+|+||+||+|.. .+|..||||++..... ......+|+.+|++++|||||+++++|.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 77789999999999999995 4789999999864332 2334558999999999999999999997644
Q ss_pred --eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCC
Q 047375 255 --VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 255 --~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
..|||||||++|+|.+++.........++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCc
Confidence 369999999999999999876654455677889999999999999999 789999999999999999999999999
Q ss_pred CccccCCCCCc----------cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-chhhhh
Q 047375 333 SLVPISSDDET----------AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQI 401 (496)
Q Consensus 333 la~~~~~~~~~----------~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i 401 (496)
+|+........ ...+..+||+.|||||++.+..|+.++|+||+||++|+|++ ||....+. ..+..+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 99887543221 11234679999999999999999999999999999999985 44432221 222222
Q ss_pred hhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 402 LNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 402 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
..... ++.....++.+.+||.+||+.||.+|||+.|++
T Consensus 241 ~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 278 (299)
T 4g31_A 241 RNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278 (299)
T ss_dssp HTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 22222 223344556788999999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=398.88 Aligned_cols=256 Identities=19% Similarity=0.199 Sum_probs=205.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEee------CCee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLE------TKVT 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------~~~~ 256 (496)
.|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+|+.+|+.++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 477889999999999999995 4799999999864322 22344589999999999999999999864 3578
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|||||||+ |+|.+++.... .+++..+..|+.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999996 68999997654 37899999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCC--CccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc----
Q 047375 337 ISSDD--ETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE---- 409 (496)
Q Consensus 337 ~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---- 409 (496)
+.... ........+||+.|||||++.+. .++.+.|+||+||++|+|++|.+||.+......+..|......++
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 64432 12234567899999999998874 568899999999999999999999987766655555543211110
Q ss_pred --------------------c-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 410 --------------------S-----EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 410 --------------------~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
. ....++.+.+||.+||..||.+|||+.|+ .+|+|.....
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~----------L~Hp~f~~~~ 352 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA----------LRHPFLAKYH 352 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH----------TTSGGGTTTC
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH----------hcCHhhCcCC
Confidence 0 01234678999999999999999999988 4567776543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=409.69 Aligned_cols=253 Identities=19% Similarity=0.168 Sum_probs=208.7
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----h---hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----R---ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
|.+.+.||+|+||+||+|.. .+|..||||++...... . ..+..++.+++.++|||||+++++|.+.+.+|||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 77789999999999999995 47899999998643211 1 1222446778888999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||||+||+|.++|..... +++..+..++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 271 mEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp ECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999987543 7899999999999999999999 8899999999999999999999999999988754
Q ss_pred CCCccceecccccceeecCcccc-cccccCCCCCchhhhhcccccccccchhhhcccc---hhhhhhhcccCCcccHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAH-TELLTGMNPNSYVALASNEKISMVPYFLDSIENN---SFRQILNFQVADESEMEEI 415 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~-~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~ 415 (496)
.. ..+.+||+.|||||++. +..|+.+.||||+||++|+|++|.+||.+..... ....+..... ..+...+
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~--~~p~~~S 418 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFS 418 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC--CCCTTSC
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC--CCCccCC
Confidence 32 34568999999999996 4679999999999999999999999998654432 2233333332 2334567
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHHHHHHhhHhhhhhhhhccCcccc
Q 047375 416 EVVAELASKCLRIRGTERPT-----MKEVSEELDRLRRLQENYWARKNNEES 462 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~l~~~~~~~~~~~~~~~~ 462 (496)
+.+.+||.+||+.||.+|++ +.|| ..|+|.+..+|+.
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei----------~~HpfF~~idW~~ 460 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEV----------KESPFFRSLDWQM 460 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSSSTHHHH----------TTSGGGTTCCHHH
T ss_pred HHHHHHHHHHccCCHhHCCCCCCCCHHHH----------hcCccccCCCHHH
Confidence 88999999999999999998 4554 6788888877754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=387.83 Aligned_cols=252 Identities=17% Similarity=0.167 Sum_probs=195.8
Q ss_pred HhcchhhhcccCCceEEEEeEe----CCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL----PDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
..|.+.+.||+|+||+||+|.. .+++.||+|++..... .....+|+++|..+ +|||||++++++.+.+..||||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 4588889999999999999974 2467899998865432 23455889999988 6999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-CceEEccCCCccccCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-YTAKVSDFESLVPISS 339 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-~~~kL~DFGla~~~~~ 339 (496)
|||++|+|.+++.. +++..+..++.||+.||.|||+ ++||||||||+|||++.+ +.+||+|||+|+....
T Consensus 100 E~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 100 PYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp ECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred eCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999842 6788999999999999999999 889999999999999876 7999999999986543
Q ss_pred CCC--------------------------ccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhh
Q 047375 340 DDE--------------------------TAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDS 392 (496)
Q Consensus 340 ~~~--------------------------~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~ 392 (496)
... ....+..+||+.|||||++.+. .|+.+.|+||+||++|+|++|.+||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 0112345799999999999875 5888999999999999999999887543
Q ss_pred ccc-chhhhhhhc---------------------cc-------------------------------CCcccHHHHHHHH
Q 047375 393 IEN-NSFRQILNF---------------------QV-------------------------------ADESEMEEIEVVA 419 (496)
Q Consensus 393 ~~~-~~~~~i~~~---------------------~~-------------------------------~~~~~~~~~~~l~ 419 (496)
... ..+..+... .. ..+.....++++.
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 221 111111100 00 0001112346789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhcc
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARK 457 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~ 457 (496)
+||.+||+.||.+|||+.|++ +|+|.+.
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL----------~Hp~f~~ 358 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEAL----------LHPFFKD 358 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHH----------TSGGGTT
T ss_pred HHHHHHCcCChhHCcCHHHHh----------cCcccCC
Confidence 999999999999999999984 5667654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=408.16 Aligned_cols=247 Identities=19% Similarity=0.247 Sum_probs=213.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .+|+.||+|.+...... .....+|+.+|+.++|||||+++++|.+.+.+|||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 578889999999999999995 47899999998654433 3344589999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC--CceEEccCCCccccCCCCC
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN--YTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~--~~~kL~DFGla~~~~~~~~ 342 (496)
||+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 238 gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 238 GGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred CCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999965432 37889999999999999999999 789999999999999854 899999999999876432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc--CCcccHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV--ADESEMEEIEVVAE 420 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~l~~ 420 (496)
.....+||+.|||||++.+..|+.+.|+||+||++|+|++|.+||.+......+..+..... ........++.+.+
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 23456799999999999999999999999999999999999999988877777777765443 33334456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~ 441 (496)
||.+||+.||.+|||+.|+++
T Consensus 390 li~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=362.75 Aligned_cols=258 Identities=22% Similarity=0.262 Sum_probs=207.9
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|.+.+.||+|+||.||+|.. ++..||||++..... ......+|+.++++++||||+++++++...+..++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 3477789999999999999988 688999999865432 223445899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCC--cccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS--IIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|++|+|.+++........+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999876544457889999999999999999999 66 999999999999999999999999999765432
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
. .......||+.|+|||++.+..++.++|+||+|+++|+++++..||...........+.........+...++.+.+
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 1 12234569999999999999999999999999999999999999998765555444443333333444556678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 421 LASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
||.+||+.||.+|||+.++++.|+.+.+.
T Consensus 271 li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999988654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=362.14 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=208.0
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC----eeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETK----VTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|.+ .+..||||++............|+.++.+++||||+++++++.... ..|+||||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hchhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 477789999999999999998 4899999999765555555557888999999999999999998744 46999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCC----------CcccCCCCcCceeeCCCCceEEccCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP----------SIIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~----------~ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
|++|+|.+++.... +++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 104 HEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp CTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999999997642 7889999999999999999998 5 89999999999999999999999999
Q ss_pred CccccCCCCCccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhcccch----------
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIENNS---------- 397 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~---------- 397 (496)
+++...............||+.|+|||++.+ ..++.++|+||+|+++|+++++.+||.+......
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987765433333344679999999999986 4667788999999999999999988865432111
Q ss_pred -----hhh-hhhcccCCc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 398 -----FRQ-ILNFQVADE-----SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 398 -----~~~-i~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
... +........ .....++.+.+|+.+||+.||.+|||+.||++.|+.+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111 111111111 12245677999999999999999999999999999997753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=361.68 Aligned_cols=262 Identities=32% Similarity=0.506 Sum_probs=217.8
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.|.+.+.||+|+||.||+|.+.++..||||++...... .....+|+.+++.++||||+++++++...+..++|||||++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 36667899999999999999878999999988654332 23445889999999999999999999999999999999999
Q ss_pred CchhhhhhhcCc-ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 266 GALSHYIHDKSS-QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 266 g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
|+|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999976432 2247899999999999999999999 789999999999999999999999999998765433333
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch---------------hhhhhhcccCCc
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS---------------FRQILNFQVADE 409 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~---------------~~~i~~~~~~~~ 409 (496)
......||+.|+|||++.+..++.++|+||+|+++++++++.+||........ +..+.+......
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence 33455699999999999988999999999999999999999988865433221 112222333344
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhh
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 451 (496)
.....+..+.+++.+||+.||.+|||+.++++.|+.+.+.++
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 556788899999999999999999999999999999877643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=366.62 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=215.0
Q ss_pred HhcchhhhcccCCceEEEEeEe--------CCCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL--------PDNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETK 254 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~ 254 (496)
..|.+.+.||+|+||.||+|.+ .++..||||.+..... ......+|+.+++.+ +||||++++++|...+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 4577789999999999999985 2345799999865432 223455899999999 8999999999999999
Q ss_pred eeeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
..|+|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 99999999999999999987532 1236889999999999999999999 7899999999999999
Q ss_pred CCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhh
Q 047375 322 DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQ 400 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 400 (496)
.++.+||+|||+++...............||+.|+|||++.+..++.++|+||+|+++|+|++ +.+||........+..
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999987654433333344558899999999999999999999999999999998 8888876554444444
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
+... .....+..+++.+.+|+.+||+.||.+|||+.|+++.|+.+....
T Consensus 318 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 318 LKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 3332 233344456678999999999999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.27 Aligned_cols=245 Identities=20% Similarity=0.278 Sum_probs=206.6
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .++..||||++....... ....+|+.+++.++||||+++++++...+..|+|||||+
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 477778999999999999984 578999999986544333 334588999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++.... +++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 101 GGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp TCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 999999997642 6888999999999999999999 7899999999999999999999999999887654322
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-ccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF-QVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~l~~li~ 423 (496)
......||+.|+|||++.+..++.++|+||+|+++|++++|..||...........+... ......+...++.+.+|+.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 234456999999999999999999999999999999999999999776554444433322 2223334456678999999
Q ss_pred HhcccCCCCCCCHHHHH
Q 047375 424 KCLRIRGTERPTMKEVS 440 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil 440 (496)
+||+.||.+|||+.|++
T Consensus 252 ~~l~~dp~~Rps~~ell 268 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELL 268 (297)
T ss_dssp HHSCSSTTTSCCHHHHT
T ss_pred HHccCChhHCcCHHHHh
Confidence 99999999999999984
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.92 Aligned_cols=252 Identities=18% Similarity=0.215 Sum_probs=212.4
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|.. .+|+.||||++..... ......+|+.+++.++||||+++++++...+..|+||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 377789999999999999996 5789999999865422 223445899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999977543 7889999999999999999999 789999999999999999999999999998765432
Q ss_pred ccceecccccceeecCccccccccc-CCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLT-GMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t-~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.....+||+.|+|||++.+..++ .++|+||+|+++++|++|.+||.+.........+.......+ ...++.+.+|
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~l 244 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMSTDCENL 244 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHHHH
Confidence 23456799999999999887765 689999999999999999999987766666666665544332 2345779999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 422 ASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
+.+||+.||.+|||+.|++ +++|.+...
T Consensus 245 i~~~L~~dP~~R~t~~eil----------~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIM----------KDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHT----------TCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHHh----------cCHhhcCCC
Confidence 9999999999999999984 466766544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=354.52 Aligned_cols=245 Identities=20% Similarity=0.155 Sum_probs=207.0
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .+++.||+|.+..... ......+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 477788999999999999996 4689999999865421 22344588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 86 YANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999997654 36889999999999999999999 789999999999999999999999999998644322
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
. .....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||........+..+....... +...++.+.+|
T Consensus 160 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~l 235 (337)
T 1o6l_A 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSL 235 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHH
T ss_pred C--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHH
Confidence 2 2345679999999999999999999999999999999999999998766666666665543332 23456789999
Q ss_pred HHHhcccCCCCCC-----CHHHHHH
Q 047375 422 ASKCLRIRGTERP-----TMKEVSE 441 (496)
Q Consensus 422 i~~cl~~dP~~RP-----s~~eil~ 441 (496)
|.+||+.||.+|| ++.||++
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 9999999999999 7887753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=349.23 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=215.0
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.|.+.+.||+|+||.||+|...++..||+|++...........+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 47778899999999999999878899999999766555555668999999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ...
T Consensus 91 ~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 164 (269)
T 4hcu_A 91 CLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 164 (269)
T ss_dssp BHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HST
T ss_pred cHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-ccc
Confidence 99999976443 36889999999999999999999 7899999999999999999999999999987643211 112
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....||+.|+|||++.+..++.++|+||+|++++++++ +.+||...........+... .....+...++.+.+++.+|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 243 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHC 243 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHH
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccCCCCCcCCHHHHHHHHHH
Confidence 33447889999999998899999999999999999998 88888766555554444432 22223334467799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhHh
Q 047375 426 LRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l~~ 448 (496)
|+.||.+|||+.++++.|+.+.+
T Consensus 244 l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 244 WRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999998865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.52 Aligned_cols=257 Identities=20% Similarity=0.221 Sum_probs=215.2
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..|.+.+.||+|+||.||+|...++..||+|.+...........+|+.++..++||||+++++++.+.+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 45778899999999999999988888999999976655555566899999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......... .
T Consensus 88 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~ 161 (268)
T 3sxs_A 88 GCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-S 161 (268)
T ss_dssp CBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-E
T ss_pred CcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-c
Confidence 999999977532 37889999999999999999999 78999999999999999999999999999876543222 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....||+.|+|||++.+..++.++|+||+|++++++++ +..||...........+.... ....+...++.+.+++.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRPHLASDTIYQIMYS 240 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CCCCCCcChHHHHHHHHH
Confidence 233447788999999999899999999999999999998 888887655544444443322 222223345679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
||+.||.+|||+.++++.|+.+++.
T Consensus 241 ~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HcCCChhhCcCHHHHHHHHHHhhhc
Confidence 9999999999999999999988654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=358.34 Aligned_cols=273 Identities=32% Similarity=0.476 Sum_probs=220.0
Q ss_pred ccccccCHHHHHHH--hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEE
Q 047375 173 SRMKIFSKSELLKA--TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILG 248 (496)
Q Consensus 173 ~~~~~~~~~~l~~~--~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~ 248 (496)
...+.++..++... .|.+.+.||+|+||.||+|...++..||||++...... .....+|+.+++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 33455666666544 45556899999999999999878999999998654322 224558899999999999999999
Q ss_pred EEeeCCeeeEEEeeccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceE
Q 047375 249 LCLETKVTLLVYEFVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAK 327 (496)
Q Consensus 249 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~k 327 (496)
++...+..++|||||++|+|.+++.... ....+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999998753 233478999999999999999999994222899999999999999999999
Q ss_pred EccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc-------------
Q 047375 328 VSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE------------- 394 (496)
Q Consensus 328 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~------------- 394 (496)
|+|||++....... ........||+.|+|||++.+..++.++|+||+|++++++++|.+||.....
T Consensus 175 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999998765432 2223445699999999999988899999999999999999999998853211
Q ss_pred ----cchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 395 ----NNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 395 ----~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
......+.+...........++.+.+++.+||+.||.+|||+.||++.|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 1112222233334455667788999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=356.46 Aligned_cols=259 Identities=19% Similarity=0.277 Sum_probs=212.1
Q ss_pred HHhcchhhhcccCCceEEEEeEeC----CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
...|.+.+.||+|+||.||+|.+. .+..||||.+.... .......+|+.+++.++||||+++++++.+.+..|+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 355788899999999999999963 34569999987532 233445589999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||||++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999976532 37889999999999999999999 789999999999999999999999999998775
Q ss_pred CCCCcc-ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHH
Q 047375 339 SDDETA-MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 339 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
...... ......+|+.|+|||++.+..++.++|+||+|++++++++ +..||...........+... ...+.+..+++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 281 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCPH 281 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcCH
Confidence 432221 1223346889999999999899999999999999999998 88888776555554444432 23334445667
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=354.84 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=207.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh-hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE-IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .++..||+|++..... ......+|+.+++.++||||+++++++.+.+..++|||||+
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 467788999999999999996 4688999998865433 33445589999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 91 GGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999987433 37889999999999999999999 789999999999999999999999999998765432211
Q ss_pred ------------ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch-----hhhhhhcccC
Q 047375 345 ------------MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS-----FRQILNFQVA 407 (496)
Q Consensus 345 ------------~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~-----~~~i~~~~~~ 407 (496)
......||+.|+|||++.+..++.++|+||+|+++++++++..++........ ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-- 243 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT--
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc--
Confidence 01145699999999999999999999999999999999999887765433211 11111111
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhh
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 451 (496)
.+..+++.+.+++.+||+.||.+|||+.++++.|+.++....
T Consensus 244 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 244 --CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp --CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 122334568999999999999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=359.77 Aligned_cols=241 Identities=23% Similarity=0.191 Sum_probs=201.9
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 259 (496)
..|.+.+.||+|+||.||+|.. .++..||||++..... ......+|..++..+ +||||+++++++.+.+..|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 4577889999999999999996 4688999999875421 223344778888887 699999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999987543 7889999999999999999999 7899999999999999999999999999986433
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
.. ......+||+.|+|||++.+..++.+.|+||+|+++|+|++|.+||........+..+.......+ ...++.+.
T Consensus 177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~ 252 (353)
T 3txo_A 177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLHEDAT 252 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHH
Confidence 22 223456799999999999999999999999999999999999999988777777777776554433 23456799
Q ss_pred HHHHHhcccCCCCCCCH
Q 047375 420 ELASKCLRIRGTERPTM 436 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~ 436 (496)
+||.+||+.||.+||++
T Consensus 253 ~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGS 269 (353)
T ss_dssp HHHHHHTCSSGGGSTTS
T ss_pred HHHHHHhhhCHHHccCC
Confidence 99999999999999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.16 Aligned_cols=268 Identities=31% Similarity=0.461 Sum_probs=220.9
Q ss_pred ccccCHHHHHHHhcchh--------hhcccCCceEEEEeEeCCCcEEEEEEeecch-----hhhhhHHHHHHHHhcCCCC
Q 047375 175 MKIFSKSELLKATKNFH--------HCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD-----EIRITEWEFLGIISQVKHK 241 (496)
Q Consensus 175 ~~~~~~~~l~~~~~~~~--------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~hp 241 (496)
...|+..++...+.+|. +.||+|+||.||+|.. ++..||||++.... .......+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 46678888888887775 5699999999999998 68899999986432 2233455889999999999
Q ss_pred ceeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 242 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
||+++++++.+.+..++||||+++|+|.+++........+++..++.++.||+.||.|||+ ++|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999999865444457899999999999999999999 7899999999999999
Q ss_pred CCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhh
Q 047375 322 DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQI 401 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i 401 (496)
.++.+||+|||++................||+.|+|||++.+ .++.++|+||+|+++++++++.+||...........+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999987655433333344569999999998876 4788999999999999999999998765443322222
Q ss_pred hhc-------------ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 402 LNF-------------QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 402 ~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
... ..........++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 110 1112334567788999999999999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=362.69 Aligned_cols=262 Identities=22% Similarity=0.262 Sum_probs=214.2
Q ss_pred HHhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchhh--hhhHHHHHHHHhcC-CCCceeeEEEEEeeCC-
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADEI--RITEWEFLGIISQV-KHKNVVKILGLCLETK- 254 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~- 254 (496)
...|.+.+.||+|+||.||+|.+ .+++.||||++...... .....+|+.++.++ +||||++++++|...+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 34577789999999999999973 24678999998654322 23455899999999 7899999999998755
Q ss_pred eeeEEEeeccCCchhhhhhhcCc---------------------------------------------------------
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSS--------------------------------------------------------- 277 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------------------- 277 (496)
..++|||||++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 48999999999999999976532
Q ss_pred ------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccc
Q 047375 278 ------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRG 351 (496)
Q Consensus 278 ------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 351 (496)
...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...............|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 1127889999999999999999999 7899999999999999999999999999987755433333445668
Q ss_pred cceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCC
Q 047375 352 TVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRG 430 (496)
Q Consensus 352 t~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP 430 (496)
|+.|+|||++.+..++.++|+||+|+++|++++ +.+||........+............+...++.+.+++.+||+.||
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 337 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 337 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999999999998 8888877655544444444333344444556789999999999999
Q ss_pred CCCCCHHHHHHHHHhhHhh
Q 047375 431 TERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 431 ~~RPs~~eil~~L~~l~~~ 449 (496)
.+|||+.|+++.|+.+.+.
T Consensus 338 ~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 338 SQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp GGSCCHHHHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHHHH
Confidence 9999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=355.04 Aligned_cols=247 Identities=17% Similarity=0.207 Sum_probs=211.5
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.|.+.+.||+|+||.||+|... ++..||+|.+...........+|+.+++.++||||+++++++.+.+..|+|||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 4778899999999999999964 688999999876555555556899999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC--CCceEEccCCCccccCCCCCc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD--NYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~--~~~~kL~DFGla~~~~~~~~~ 343 (496)
|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 86 LDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 999999976432 37889999999999999999999 78999999999999987 7899999999998775432
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcc--cHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADES--EMEEIEVVAEL 421 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~l~~l 421 (496)
......||+.|+|||++.+..++.++|+||+|+++|++++|.+||........+..+.......+. ....++.+.+|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 234456999999999999988999999999999999999999999887666666666655443322 12446789999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~ 441 (496)
+.+||..||.+|||+.|+++
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=358.48 Aligned_cols=247 Identities=22% Similarity=0.221 Sum_probs=209.5
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh-------hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI-------RITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..|.+.+.||+|+||.||+|... +|..||+|.+...... .....+|+.++..++||||+++++++.+.+..|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 44788899999999999999964 6889999998654322 234458999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC----ceEEccCCC
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY----TAKVSDFES 333 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~----~~kL~DFGl 333 (496)
+|||||++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 92 lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999997643 37889999999999999999999 7899999999999998776 799999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc--cc
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE--SE 411 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~ 411 (496)
+........ ....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||.+......+..+.......+ ..
T Consensus 166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 987654321 2445699999999999998999999999999999999999999988766666666665443322 22
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...++.+.+||.+||..||.+|||+.|+++
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 344578999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=364.57 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=210.5
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.+.+.+.||+|+||.||+|.+. ++..||||.+.... .....+.+|+.+++.++||||++++++|...+..|+|||||
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 4677789999999999999975 78899999986432 22234458999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 195 ~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 195 QGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp TTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999986532 36889999999999999999999 78999999999999999999999999998865432111
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.......+|+.|+|||++.+..++.++|+||+|+++|++++ +.+||...........+. .....+.+..+++.+.+|+
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 348 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDAVFRLM 348 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHH
Confidence 11122336788999999998899999999999999999997 888877654443333332 2233334445567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 423 SKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 349 ~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=353.78 Aligned_cols=248 Identities=20% Similarity=0.206 Sum_probs=202.8
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|... +++.||||++..... ......+|+.+++.++||||+++++++.+.+..|+|||||
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4777899999999999999964 788999999864432 2244558899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 88 ~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 88 SGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999997643 37889999999999999999999 78999999999999999999999999999876543333
Q ss_pred cceecccccceeecCcccccccc-cCCCCCchhhhhcccccccccchhhhccc-chhhhhhhcccCCcccHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELL-TGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~-t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
......+||+.|+|||++.+..+ +.++|+||+|++++++++|..||...... ..+................++.+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 33345679999999999987665 77899999999999999999998765433 22233333333333334556789999
Q ss_pred HHHhcccCCCCCCCHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil 440 (496)
+.+||+.||.+|||+.|++
T Consensus 242 i~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 242 LHKILVENPSARITIPDIK 260 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHT
T ss_pred HHHHccCChhhCcCHHHHh
Confidence 9999999999999999884
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=358.34 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=215.9
Q ss_pred HHhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCe
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETKV 255 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~ 255 (496)
...|.+.+.||+|+||.||+|.. .++..||||.+..... ......+|+.++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 34577889999999999999985 2456899999864322 234455899999999 89999999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcCcc--------------------cccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQ--------------------VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKS 315 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp 315 (496)
.|+|||||++|+|.+++...... ..+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 99999999999999999865421 236889999999999999999999 7899999999
Q ss_pred CceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcc
Q 047375 316 ANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIE 394 (496)
Q Consensus 316 ~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~ 394 (496)
+|||++.++.+||+|||++................||+.|+|||++.+..++.++|+||+|++++++++ +.+||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987755433333445568899999999998899999999999999999997 8888877665
Q ss_pred cchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 395 NNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 395 ~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
...+..+.......+.+...++.+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 5555555544444444455667899999999999999999999999999987553
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=362.51 Aligned_cols=256 Identities=19% Similarity=0.216 Sum_probs=212.9
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||+|++..... ......+|+.++..++|||||+++++|.+.+..|+|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3677789999999999999964 688999999865322 22335588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||+||+|.+++.... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 150 ~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 150 YMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999999997542 6888999999999999999999 789999999999999999999999999998765432
Q ss_pred CccceecccccceeecCccccccc----ccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--cCCcccHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTEL----LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--VADESEMEEI 415 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~----~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~ 415 (496)
.......+||+.|+|||++.+.. ++.++|+||+|+++|+|++|.+||.+......+..+.... ...+.....+
T Consensus 223 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 223 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp -EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred -cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 22234567999999999998755 8889999999999999999999998877777777776542 2333333456
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 416 EVVAELASKCLRIRGTE--RPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~--RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
+.+.+||.+||..+|.+ ||++.|| ..++|.+..+|
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei----------~~Hp~f~~~~w 338 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEI----------KRHLFFKNDQW 338 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHH----------HTSGGGCCSSC
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHH----------hcCccccCCCH
Confidence 78999999999999988 9999988 45666665544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=345.08 Aligned_cols=256 Identities=20% Similarity=0.241 Sum_probs=211.8
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..|.+.+.||+|+||.||+|.+.++..||+|++...........+|+.++..++||||+++++++.+.+..|+||||+++
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 34777899999999999999988888999999976655555566899999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 104 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 177 (283)
T 3gen_A 104 GCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 177 (283)
T ss_dssp CBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HS
T ss_pred CcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-cc
Confidence 999999976432 37889999999999999999999 7899999999999999999999999999987643211 11
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....||+.|+|||++.+..++.++|+||+|++++++++ +..||...........+... .....+...++.+.+|+.+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 256 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYS 256 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-cCCCCCCcCCHHHHHHHHH
Confidence 223347889999999998889999999999999999998 88888766555554444432 2222233345679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHh
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
||+.||.+|||+.++++.|..+..
T Consensus 257 ~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 257 CWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HccCChhHCcCHHHHHHHHHHHhh
Confidence 999999999999999999998864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=350.82 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=217.8
Q ss_pred HhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 256 (496)
..|.+.+.||+|+||.||+|.+ .++..||||.+..... ......+|+.++.++ +||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4578889999999999999984 3567899999875432 233445889999999 899999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCcc---------------cccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQ---------------VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
++|||||++|+|.+++...... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence 9999999999999999875421 237889999999999999999999 7899999999999999
Q ss_pred CCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhh
Q 047375 322 DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQ 400 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 400 (496)
.++.+||+|||++................||+.|+|||++.+..++.++|+||+|++++++++ +.+||...........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 999999999999987765543333344558899999999999899999999999999999998 8888877655555555
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
..........+...++.+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 5444444444445567899999999999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.83 Aligned_cols=252 Identities=22% Similarity=0.228 Sum_probs=212.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .+|+.||+|.+..... ......+|..+++.++||||+++++++.+.+..|+|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 367788999999999999996 4789999999865432 12234478899999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999987543 6888999999999999999999 78999999999999999999999999999876432
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||........+..+....... +...++.+.++
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~l 233 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNEDVKDL 233 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHH
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCHHHHHH
Confidence 234579999999999999999999999999999999999999998776666667776654332 23345779999
Q ss_pred HHHhcccCCCCCC-----CHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 422 ASKCLRIRGTERP-----TMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 422 i~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
+.+||..||.+|| ++.++ ..++|.+...++
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i----------~~hp~f~~~~~~ 268 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDV----------KNHPWFKEVVWE 268 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHH----------HTSGGGSSCCHH
T ss_pred HHHHhccCHHHcCCCcCCCHHHH----------hcCccccCCCHH
Confidence 9999999999999 66666 456666655543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=355.02 Aligned_cols=243 Identities=20% Similarity=0.169 Sum_probs=204.4
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|... +++.||+|.+..... .......|..++..+ +||||+++++++.+.+..|+||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4777899999999999999964 688999999875421 223344677788766 8999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999986543 7889999999999999999999 78999999999999999999999999999865432
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
.. .....+||+.|+|||++.+..++.+.|+||+|+++|+|++|.+||.+......+..+....... +...++.+.+
T Consensus 172 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 247 (345)
T 1xjd_A 172 DA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRWLEKEAKD 247 (345)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHH
T ss_pred CC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC--CcccCHHHHH
Confidence 21 2345679999999999999999999999999999999999999998776666666665543322 2335577999
Q ss_pred HHHHhcccCCCCCCCHH-HH
Q 047375 421 LASKCLRIRGTERPTMK-EV 439 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~-ei 439 (496)
||.+||+.||.+||++. +|
T Consensus 248 li~~lL~~dp~~R~~~~~~i 267 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDI 267 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCG
T ss_pred HHHHHhcCCHhHcCCChHHH
Confidence 99999999999999987 44
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=363.32 Aligned_cols=249 Identities=19% Similarity=0.173 Sum_probs=209.8
Q ss_pred HHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
...|.+.+.||+|+||.||+|.. .+|..||+|++..... ......+|+.+++.++||||+++++++.+.+..|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45688889999999999999985 4788999999865432 2233458999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC---CCCceEEccCCCcccc
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD---DNYTAKVSDFESLVPI 337 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~---~~~~~kL~DFGla~~~ 337 (496)
|||++|+|.+.+..... +++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999987543 7889999999999999999999 7899999999999998 4678999999999876
Q ss_pred CCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC--cccHHHH
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD--ESEMEEI 415 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~ 415 (496)
..... .....+||+.|+|||++.+..++.++|+||+|+++|++++|.+||.+......+..+....... +.....+
T Consensus 164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence 54322 2234579999999999999899999999999999999999999998776666666666544332 2234566
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 416 EVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 242 PEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 78999999999999999999999976
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=345.81 Aligned_cols=256 Identities=22% Similarity=0.272 Sum_probs=205.6
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
..|.+.+.||+|+||.||+|.. .++..||+|.+.... .......+|+.++..++||||+++++++...+..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 4578889999999999999995 468899999885432 22234458899999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999997754 37889999999999999999999 78999999999999999999999999999876543
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC---cccHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD---ESEMEEIEV 417 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~ 417 (496)
.. .......||+.|+|||++.+..++.++|+||+|+++|++++|.+||.................+. ......++.
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 21 22334569999999999999999999999999999999999999997655444333333222221 112334577
Q ss_pred HHHHHHHhcccCCCCCC-CHHHHHHHHHhhHh
Q 047375 418 VAELASKCLRIRGTERP-TMKEVSEELDRLRR 448 (496)
Q Consensus 418 l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~ 448 (496)
+.+++.+||+.||.+|| ++.++.+.|+.+..
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 99999999999999998 89999988887643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=347.35 Aligned_cols=245 Identities=22% Similarity=0.244 Sum_probs=204.5
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+...+.||+|+||.||+|... +|+.||||++....... ....+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 344578999999999999964 78999999987544333 3445899999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........ .
T Consensus 127 ~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (321)
T 2c30_A 127 GALTDIVSQV----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 197 (321)
T ss_dssp CBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence 9999998653 37889999999999999999999 7899999999999999999999999999987654322 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-CcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~l~~li~~ 424 (496)
.....||+.|+|||++.+..++.++|+||+|++++++++|.+||...........+...... .......++.+.+++.+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence 24456999999999999989999999999999999999999998766554444444433221 12233455779999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 047375 425 CLRIRGTERPTMKEVSE 441 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~ 441 (496)
||+.||.+|||+.++++
T Consensus 278 ~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 278 MLVRDPQERATAQELLD 294 (321)
T ss_dssp HSCSSTTTSCCHHHHHT
T ss_pred HccCChhhCcCHHHHhc
Confidence 99999999999999853
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=371.75 Aligned_cols=257 Identities=18% Similarity=0.252 Sum_probs=213.7
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..+.+.+.||+|+||.||+|.+.++..||||++.........+.+|+.+++.++|||||++++++. .+..|+|||||++
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 456777899999999999999888889999999765555556669999999999999999999986 5678999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 267 g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~ 341 (454)
T 1qcf_A 267 GSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTA 341 (454)
T ss_dssp CBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHT
T ss_pred CcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eec
Confidence 999999976432 236788899999999999999999 789999999999999999999999999998764321 111
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....+|+.|+|||++....++.++|+||+|++++++++ +..||.+.........+.. ....+.+..+++.+.+|+.+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYNIMMR 420 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Confidence 223347889999999998899999999999999999998 8888876555444444433 23333445567789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
||+.||.+|||+.+|++.|+.+...
T Consensus 421 cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HccCChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=351.08 Aligned_cols=251 Identities=18% Similarity=0.162 Sum_probs=211.8
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3677789999999999999964 689999999865432 22344578999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999987543 7889999999999999999999 78999999999999999999999999999876432
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||........+..+....... +...++.+.+|
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~l 268 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHFSSDLKDL 268 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTCCHHHHHH
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHH
Confidence 234569999999999999999999999999999999999999998776666666776654332 23456779999
Q ss_pred HHHhcccCCCCCCC-----HHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 422 ASKCLRIRGTERPT-----MKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 422 i~~cl~~dP~~RPs-----~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
|.+||+.||.+||+ +.+| ..++|....+|
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei----------~~h~~f~~~~w 302 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDI----------KNHKWFATTDW 302 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHH----------HTSGGGTTCCH
T ss_pred HHHHhhcCHHhccCCccCCHHHH----------HhCcCcCCCCH
Confidence 99999999999998 5655 44556655544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=360.54 Aligned_cols=260 Identities=20% Similarity=0.250 Sum_probs=212.4
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecc--hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCA--DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..|.+.+.||+|+||.||+|.+. ++..||||++... ........+|+.+++.++||||+++++++......|
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 45778899999999999999842 4568999998643 222334558899999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCc----ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC---ceEEcc
Q 047375 258 LVYEFVSNGALSHYIHDKSS----QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY---TAKVSD 330 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~---~~kL~D 330 (496)
+|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999987532 2347889999999999999999999 7899999999999998554 599999
Q ss_pred CCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCc
Q 047375 331 FESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADE 409 (496)
Q Consensus 331 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~ 409 (496)
||+++...............||+.|+|||++.+..++.++|+||+|++++++++ +.+||...........+.... ...
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~ 306 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMD 306 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC
Confidence 999986543322233345568999999999999899999999999999999997 888887765555554444332 223
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+..+++.+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 3345567799999999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=348.64 Aligned_cols=259 Identities=20% Similarity=0.263 Sum_probs=213.7
Q ss_pred HhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..|.+.+.||+|+||.||+|.. .++..||||.+..... ......+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 3477789999999999999985 2457899999865332 2234458999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCc---------------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcC
Q 047375 258 LVYEFVSNGALSHYIHDKSS---------------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSA 316 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~ 316 (496)
+|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchh
Confidence 99999999999999986532 1237889999999999999999999 78999999999
Q ss_pred ceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhccc
Q 047375 317 NILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIEN 395 (496)
Q Consensus 317 NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~ 395 (496)
|||++.++.+||+|||++................||+.|+|||++.+..++.++|+||+|++++++++ +..||......
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987755433323334457899999999999899999999999999999998 88888766554
Q ss_pred chhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 396 NSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 396 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
.....+.. ......+...++.+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 260 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 260 RLFNLLKT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhhc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 44443333 22333344556789999999999999999999999999998854
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=349.24 Aligned_cols=248 Identities=21% Similarity=0.214 Sum_probs=207.3
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh-------hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE-------IRITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
...|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888899999999999999964 688999999865432 123455899999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC----ceEEccCC
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY----TAKVSDFE 332 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~----~~kL~DFG 332 (496)
|+|||||++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997643 37889999999999999999999 7899999999999998877 79999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc--c
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE--S 410 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~ 410 (496)
+++....... .....||+.|+|||++.+..++.++|+||+|+++|+++++.+||.+......+..+.......+ .
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc
Confidence 9987754322 2345699999999999988999999999999999999999999977655555555443332222 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....++.+.+|+.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2234577999999999999999999999964
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=346.53 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=196.9
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhc--CCCCceeeEEEEEee----CCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQ--VKHKNVVKILGLCLE----TKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~l~~~~~~----~~~~~lv 259 (496)
..|.+.+.||+|+||.||+|.+ ++..||||++...... ....|.+++.. ++||||+++++++.. ....|+|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK--SWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHH--HHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccch--hhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 4577889999999999999998 7899999998654332 22344444444 899999999999765 3468999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhH--------hcCCCCcccCCCCcCceeeCCCCceEEccC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH--------SLASPSIIHSDVKSANILLDDNYTAKVSDF 331 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~~~~ivHrDlKp~NIll~~~~~~kL~DF 331 (496)
|||+++|+|.+++... .+++..++.++.||+.||.||| + ++|+||||||+|||++.++.+||+||
T Consensus 85 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 85 THYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp ECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999999643 3788999999999999999999 6 78999999999999999999999999
Q ss_pred CCccccCCCCCcc--ceecccccceeecCcccccc------cccCCCCCchhhhhccccccc----------ccchhhhc
Q 047375 332 ESLVPISSDDETA--MSTMIRGTVGYLDPEYAHTE------LLTGMNPNSYVALASNEKISM----------VPYFLDSI 393 (496)
Q Consensus 332 Gla~~~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~------~~t~~~d~~s~g~~~~~~~~~----------~~~~~~~~ 393 (496)
|+++......... ......||+.|+|||++.+. .++.++|+||+|+++|+++++ .+||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998765432221 12234699999999999876 566789999999999999998 66665443
Q ss_pred ccc----hhhhhhh-cccCCc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 394 ENN----SFRQILN-FQVADE-----SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 394 ~~~----~~~~i~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
... ....... ...... .....++.+.+|+.+||+.||.+|||+.+|++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 221 1111111 111111 1235678899999999999999999999999999876
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=355.81 Aligned_cols=261 Identities=18% Similarity=0.119 Sum_probs=206.7
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh----hhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI----RITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|... ++..||+|++...... ......|..++.++ +|||||++++++.+.+..|+||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 4777899999999999999964 6788999998754221 22344778888776 8999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|..++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 133 E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999987543 7889999999999999999999 78999999999999999999999999999864332
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc---------cchhhhhhhcccCCccc
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE---------NNSFRQILNFQVADESE 411 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~---------~~~~~~i~~~~~~~~~~ 411 (496)
. ......+||+.|+|||++.+..++.+.|+||+|+++|+|++|.+||..... ......+...... .+
T Consensus 207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p 282 (396)
T 4dc2_A 207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IP 282 (396)
T ss_dssp T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--CC
T ss_pred C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--CC
Confidence 2 223556799999999999999999999999999999999999999964321 1123334333322 23
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
...++.+.+||.+||+.||.+||++... ..+..+..++|.+..+|+
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~----~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQ----TGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTT----THHHHHHHSTTTTTCCHH
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCC----CCHHHHhcCccccCCCHH
Confidence 3456779999999999999999997311 111223456677666553
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.82 Aligned_cols=262 Identities=22% Similarity=0.276 Sum_probs=215.6
Q ss_pred HHhcchhhhcccCCceEEEEeEeC--------CCcEEEEEEeecchhh--hhhHHHHHHHHhcC-CCCceeeEEEEEeeC
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP--------DNTQVAVKKYMCADEI--RITEWEFLGIISQV-KHKNVVKILGLCLET 253 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~ 253 (496)
...|.+.+.||+|+||.||+|... .+..||||++...... .....+|+.+++.+ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 346788899999999999999852 2357999998654322 23455889999999 899999999999999
Q ss_pred CeeeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee
Q 047375 254 KVTLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL 320 (496)
Q Consensus 254 ~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll 320 (496)
+..|+|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 999999999999999999987542 1247899999999999999999999 789999999999999
Q ss_pred CCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhh
Q 047375 321 DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFR 399 (496)
Q Consensus 321 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~ 399 (496)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|+||+|++++++++ +..||..........
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987755433333344568899999999999999999999999999999998 888887655444444
Q ss_pred hhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 400 QILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 400 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
.+... .....+..+++.+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus 305 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 305 LLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 44332 223333445678999999999999999999999999999997653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=348.54 Aligned_cols=260 Identities=19% Similarity=0.273 Sum_probs=204.3
Q ss_pred HHhcchhhhcccCCceEEEEeEe-----CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEee--CCee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL-----PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLE--TKVT 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~ 256 (496)
...|.+.+.||+|+||.||+|.+ .++..||||++....... ....+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 34578889999999999999984 368899999987544333 344589999999999999999999965 3568
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
++|||||++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999987543 36889999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCc-cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc---------------hhhh
Q 047375 337 ISSDDET-AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN---------------SFRQ 400 (496)
Q Consensus 337 ~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~---------------~~~~ 400 (496)
....... .......||+.|+|||++.+..++.++|+||+|+++++++++..|+....... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 11233457888999999999999999999999999999999877664332110 1111
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
........+.+..+++.+.+|+.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1122223334445667899999999999999999999999999998653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=354.31 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=212.4
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..|.+.+.||+|+||.||+|... ++..||||.+..... ......+|+.+++.++||||+++++++.+.+..|
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 45677789999999999999963 347899999865432 2334558999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCc---------------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcC
Q 047375 258 LVYEFVSNGALSHYIHDKSS---------------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSA 316 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~ 316 (496)
+|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcc
Confidence 99999999999999986431 1347889999999999999999999 78999999999
Q ss_pred ceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhccc
Q 047375 317 NILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIEN 395 (496)
Q Consensus 317 NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~ 395 (496)
|||++.++.+||+|||++................||+.|+|||++.+..++.++|+||+|+++|++++ +..||......
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 99999999999999999987644322222344568999999999998889999999999999999998 88888766555
Q ss_pred chhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 396 NSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 396 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
.....+..... ...+..+++.+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 284 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 284 EVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 55554444332 22334456789999999999999999999999999998854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=347.39 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=199.4
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCC--------
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETK-------- 254 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-------- 254 (496)
..|.+.+.||+|+||.||+|... ++..||||++..... ......+|+.++++++||||++++++|.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45788899999999999999964 789999999864332 3344558999999999999999999986543
Q ss_pred -------------------------------------------------eeeEEEeeccCCchhhhhhhcCcccccCHHH
Q 047375 255 -------------------------------------------------VTLLVYEFVSNGALSHYIHDKSSQVLKNWKT 285 (496)
Q Consensus 255 -------------------------------------------------~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~ 285 (496)
..++|||||++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3799999999999999998876655567778
Q ss_pred HHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc----------cceeccccccee
Q 047375 286 CLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET----------AMSTMIRGTVGY 355 (496)
Q Consensus 286 ~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~Y 355 (496)
++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999999 78999999999999999999999999999877654211 112345699999
Q ss_pred ecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCC
Q 047375 356 LDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPT 435 (496)
Q Consensus 356 ~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 435 (496)
+|||++.+..++.++|+||+|+++++++++..++..... ....+.. ..........++.+.+|+.+||+.||.+|||
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--IITDVRN-LKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH--HHHHHHT-TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH--HHHHhhc-cCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 999999999999999999999999999998776543221 1112211 1122233445577899999999999999999
Q ss_pred HHHHHH
Q 047375 436 MKEVSE 441 (496)
Q Consensus 436 ~~eil~ 441 (496)
+.|+++
T Consensus 320 ~~~~l~ 325 (332)
T 3qd2_B 320 ATDIIE 325 (332)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=341.65 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=198.6
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh-----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI-----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.+ .+..||||.+...... .....+|+.+++.++||||+++++++...+..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 467778999999999999998 5899999988644222 2334578999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC--------CCceEEccCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD--------NYTAKVSDFES 333 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~--------~~~~kL~DFGl 333 (496)
|+++|+|.+++... .+++..++.++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 87 FARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp CCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred cCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999998643 3688999999999999999999932112999999999999985 67899999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHH
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEME 413 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 413 (496)
+....... .....||+.|+|||++.+..++.++|+||+|+++++++++..||...........+.......+.+..
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 163 AREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 98664332 22346999999999999988999999999999999999999999876555555555444444445556
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
+++.+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 667899999999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.07 Aligned_cols=253 Identities=19% Similarity=0.197 Sum_probs=206.3
Q ss_pred HHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh------hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCe
Q 047375 183 LLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE------IRITEWEFLGIISQVKHKNVVKILGLCLETKV 255 (496)
Q Consensus 183 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 255 (496)
+....|.+.+.||+|+||.||+|.. .+++.||||++..... ......+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456789999999999999999985 4689999999864321 12345589999999999999999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc---eEEccC
Q 047375 256 TLLVYEFVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT---AKVSDF 331 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~---~kL~DF 331 (496)
.|+|||||++|+|.+++.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999999998886532 22346889999999999999999999 78999999999999976554 999999
Q ss_pred CCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcc-
Q 047375 332 ESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADES- 410 (496)
Q Consensus 332 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~- 410 (496)
|++........ .....+||+.|+|||++.+..++.++|+||+|+++|+++++.+||.... ...+..+.........
T Consensus 178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 178 GVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp TTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred cceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence 99987754322 2334569999999999999899999999999999999999999987643 2334444433322221
Q ss_pred -cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 411 -EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 411 -~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....++.+.+||.+||+.||.+|||+.++++
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1234578999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=353.52 Aligned_cols=251 Identities=19% Similarity=0.204 Sum_probs=210.2
Q ss_pred HHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 183 LLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 183 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
.....|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3456688899999999999999996 4688999999865432 22334589999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC---CceEEccCCCcc
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN---YTAKVSDFESLV 335 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~---~~~kL~DFGla~ 335 (496)
|||||++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999987653 37889999999999999999999 789999999999999764 459999999998
Q ss_pred ccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--CcccHH
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--DESEME 413 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~ 413 (496)
....... ....+||+.|+|||++.+..++.++|+||+|+++|++++|.+||........+..+...... .+....
T Consensus 180 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (362)
T 2bdw_A 180 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256 (362)
T ss_dssp CCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGG
T ss_pred EecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 7654321 23456999999999999989999999999999999999999999876665556666554333 223345
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
.++.+.+||.+||+.||.+|||+.++++.
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 56789999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=344.26 Aligned_cols=245 Identities=20% Similarity=0.211 Sum_probs=197.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---------------------------hhhHHHHHHHHhcC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---------------------------RITEWEFLGIISQV 238 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l 238 (496)
.|.+.+.||+|+||.||+|.. .++..||||++...... .....+|+.+++.+
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 477789999999999999985 46889999998644211 12345899999999
Q ss_pred CCCceeeEEEEEee--CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcC
Q 047375 239 KHKNVVKILGLCLE--TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSA 316 (496)
Q Consensus 239 ~hpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~ 316 (496)
+||||+++++++.+ .+..|+||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 99999999999986 56889999999999999876432 37889999999999999999999 78999999999
Q ss_pred ceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCccccccc---ccCCCCCchhhhhcccccccccchhhhc
Q 047375 317 NILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTEL---LTGMNPNSYVALASNEKISMVPYFLDSI 393 (496)
Q Consensus 317 NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~---~t~~~d~~s~g~~~~~~~~~~~~~~~~~ 393 (496)
|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|+||+|+++|+++++..||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999987654322 233456999999999997754 4677899999999999999999987654
Q ss_pred ccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 394 ENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 394 ~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.......+.......+.....++.+.+|+.+||+.||.+|||+.|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 44444444443333333334567799999999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.51 Aligned_cols=246 Identities=20% Similarity=0.203 Sum_probs=195.1
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.|.+.+.||+|+||.||++... +++.||||++...........+|+.+++.++||||+++++++.+.+..|+|||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 4788899999999999999964 788999999976655555666899999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc--eEEccCCCccccCCCCCc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT--AKVSDFESLVPISSDDET 343 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~--~kL~DFGla~~~~~~~~~ 343 (496)
|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++......
T Consensus 101 ~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 101 GELYERICNAGR---FSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp CBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 999999976543 7889999999999999999999 78999999999999987665 9999999987543221
Q ss_pred cceecccccceeecCcccccccccCC-CCCchhhhhcccccccccchhhhcccchhhh----hhhcccCCcccHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGM-NPNSYVALASNEKISMVPYFLDSIENNSFRQ----ILNFQVADESEMEEIEVV 418 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~-~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~----i~~~~~~~~~~~~~~~~l 418 (496)
......||+.|+|||++.+..++++ +|+||+|+++|++++|.+||........+.. +.......+.....++.+
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence 1234569999999999988777665 8999999999999999999977654433333 333333333333455779
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+||.+||+.||.+|||+.|+++
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 252 CHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHHh
Confidence 99999999999999999999854
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.08 Aligned_cols=255 Identities=22% Similarity=0.281 Sum_probs=213.5
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.|.+.+.||+|+||.||+|...++..||+|.+...........+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 47778899999999999999878889999999766555555668999999999999999999999999999999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 89 ~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (267)
T 3t9t_A 89 CLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 162 (267)
T ss_dssp BHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred cHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence 99999976532 36889999999999999999999 789999999999999999999999999988764321 1112
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....||+.|+|||++.+..++.++|+||+|++++++++ +.+||...........+... .....+...++.+.+++.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~ 241 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHC 241 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcCCCCccCcHHHHHHHHHH
Confidence 23447889999999998889999999999999999998 78888765544444444432 12222334457799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhHh
Q 047375 426 LRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l~~ 448 (496)
|+.||.+|||+.++++.|+.+.+
T Consensus 242 l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 242 WRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.51 Aligned_cols=249 Identities=17% Similarity=0.210 Sum_probs=209.2
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC--CeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET--KVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.+ .+..||||.+.... .......+|+.+++.++||||+++++++.+. +..++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 477788999999999999998 58999999986543 2223455889999999999999999999876 78899999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCC--cccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS--IIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp CCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999987543 247899999999999999999999 66 99999999999999999999998887655332
Q ss_pred CCCccceecccccceeecCcccccccccC---CCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTG---MNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~---~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
....||+.|+|||++.+..++. ++|+||+|+++|+++++..||...........+.........+...++
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 2235899999999998765555 699999999999999999999876655555555554444455556677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 8999999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.04 Aligned_cols=261 Identities=19% Similarity=0.271 Sum_probs=206.1
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCc----EEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNT----QVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
..|.+.+.||+|+||.||+|.+. ++. +||+|.+.... .......+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 34777899999999999999953 344 36888775432 22334558999999999999999999998765 788
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999987543 36889999999999999999999 789999999999999999999999999998776
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
............||+.|+|||++.+..++.++|+||+|+++|++++ +..||......... ..+......+.+..++..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCccCCHH
Confidence 5443333344557889999999999999999999999999999998 88888765444333 333333333344455678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRRLQENY 453 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~ 453 (496)
+.+++.+||+.||.+|||+.++++.|+.+.+....+
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 283 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 283 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhhh
Confidence 999999999999999999999999999987654443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=353.50 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=215.2
Q ss_pred HhcchhhhcccCCceEEEEeEeCC-C-----cEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPD-N-----TQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 256 (496)
..|.+.+.||+|+||.||+|.... + ..||+|.+..... ......+|+.+++.+ +||||+++++++...+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 457778999999999999998532 2 4799999865432 233445889999999 899999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc-----------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc
Q 047375 257 LLVYEFVSNGALSHYIHDKSS-----------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT 325 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~ 325 (496)
|+|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCe
Confidence 999999999999999976421 1236889999999999999999999 78999999999999999999
Q ss_pred eEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhc
Q 047375 326 AKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNF 404 (496)
Q Consensus 326 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~ 404 (496)
+||+|||++................||+.|+|||++.+..++.++|+||+|++++++++ +.+||........+..+...
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 99999999987654433333344558899999999999889999999999999999998 88888766555555555544
Q ss_pred ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 405 QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 405 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
......+...++.+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 4444444445678999999999999999999999999999886543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=361.88 Aligned_cols=259 Identities=17% Similarity=0.165 Sum_probs=211.7
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||+||+|... +++.||+|++...... .....+|..++..++||||++++++|.+.+..|+|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 3667789999999999999964 5788999998653221 2235578999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++..... .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 155 y~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp CCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 9999999999976432 37889999999999999999999 789999999999999999999999999998765432
Q ss_pred CccceecccccceeecCcccc-----cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--cCCc-ccHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAH-----TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--VADE-SEME 413 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~-----~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~-~~~~ 413 (496)
. ......+||+.|+|||++. ...++.++|+||+|+++|+|++|.+||.+......+..+.... ...+ ....
T Consensus 230 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 230 T-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp C-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred C-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 2 2234467999999999997 4578899999999999999999999998877666777766432 1211 1123
Q ss_pred HHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 414 EIEVVAELASKCLRIRGTE--RPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
.++.+.+||.+||..+|.+ ||++.|++ .++|.+..+|+
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil----------~Hpff~~i~w~ 348 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFK----------KHPFFSGIDWD 348 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHH----------TSGGGTTCCTT
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHh----------CCCccCCCCHH
Confidence 5678999999999888888 99998884 46666655543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=342.18 Aligned_cols=254 Identities=16% Similarity=0.198 Sum_probs=207.2
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCC--eeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETK--VTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||||++...... .....+|+.+++.++||||+++++++.... ..|+|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 4777899999999999999964 5889999998754332 234458999999999999999999998655 7899999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee----CCCCceEEccCCCcccc
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL----DDNYTAKVSDFESLVPI 337 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll----~~~~~~kL~DFGla~~~ 337 (496)
||++|+|.+++........+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999876544447899999999999999999999 789999999999999 78888999999999877
Q ss_pred CCCCCccceecccccceeecCcccc--------cccccCCCCCchhhhhcccccccccchhhhccc----chhhhhhhcc
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAH--------TELLTGMNPNSYVALASNEKISMVPYFLDSIEN----NSFRQILNFQ 405 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~--------~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~----~~~~~i~~~~ 405 (496)
..... .....||+.|+|||++. +..++.++|+||+|+++|++++|..||...... ..+..+....
T Consensus 167 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 167 EDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred CCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 54322 23456999999999986 467889999999999999999999998643322 2222222211
Q ss_pred c-----------------------CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 406 V-----------------------ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 406 ~-----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
. ........++.+.+++.+||+.||.+|||+.|+++...+-
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1 1123356778899999999999999999999999887754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=348.55 Aligned_cols=259 Identities=20% Similarity=0.259 Sum_probs=197.2
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCc----EEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCee--
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNT----QVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVT-- 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~-- 256 (496)
..|.+.+.||+|+||.||+|...... .||||.+.... .......+|+.+++.++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 35778899999999999999964332 79999986532 2233455899999999999999999999876654
Q ss_pred ----eEEEeeccCCchhhhhhhcC---cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEc
Q 047375 257 ----LLVYEFVSNGALSHYIHDKS---SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 257 ----~lv~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEe
Confidence 99999999999999997542 12247889999999999999999999 789999999999999999999999
Q ss_pred cCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCC
Q 047375 330 DFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVAD 408 (496)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~ 408 (496)
|||+++...............+|+.|+|||++.+..++.++|+||+|++++++++ +.+||...........+.... ..
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~ 258 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RL 258 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CC
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CC
Confidence 9999987655433333334457889999999999999999999999999999998 888887766555555554332 22
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 409 ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 409 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
..+...++.+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 3334556789999999999999999999999999988743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=350.86 Aligned_cols=241 Identities=20% Similarity=0.155 Sum_probs=204.1
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 259 (496)
..|.+.+.||+|+||.||+|... +++.||+|++..... .......|..++..+ +||||+++++++.+.+..|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 34777899999999999999964 578899999875432 223344778888887 799999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||||+||+|.+++..... +++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999986543 7889999999999999999999 7899999999999999999999999999986433
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
... .....+||+.|+|||++.+..++.+.|+||+|+++|+|++|.+||.+......+..+....... +...++.+.
T Consensus 174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~ 249 (353)
T 2i0e_A 174 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--PKSMSKEAV 249 (353)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHH
T ss_pred CCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCHHHH
Confidence 221 2345679999999999999999999999999999999999999998877666677776654432 234567899
Q ss_pred HHHHHhcccCCCCCCCH
Q 047375 420 ELASKCLRIRGTERPTM 436 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~ 436 (496)
+||.+||+.||.+||++
T Consensus 250 ~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGC 266 (353)
T ss_dssp HHHHHHTCSCTTSCTTC
T ss_pred HHHHHHhhcCHHHcCCC
Confidence 99999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=356.40 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=199.8
Q ss_pred HhcchhhhcccCCceEEEEeEeC----CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
..|.+.+.||+|+||.||+|... ++..||||.+.... .......+|+.++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 45777899999999999999864 56789999986532 2233455899999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||||++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999976532 37889999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCcc-ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 340 DDETA-MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 340 ~~~~~-~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
..... ......+|+.|+|||++.+..++.++|+||+|+++|++++ |..||...........+.. ....+.+..++..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 278 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAA 278 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TEECCCCTTCBHH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCccccHH
Confidence 32211 1122336788999999999899999999999999999887 8888876554444433332 2233334455678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 279 l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=349.16 Aligned_cols=261 Identities=20% Similarity=0.227 Sum_probs=207.3
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcE----EEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQ----VAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
.|.+.+.||+|+||.||+|.+. ++.. ||+|.+..... ......+|+.++..++||||+++++++. .+..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 3677789999999999999953 4444 77887654322 1233447899999999999999999986 4568899
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999997653 246888999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
...........||+.|+|||++.+..++.++|+||+|+++|++++ +..||...........+... .....+..++..+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQPQICTIDV 246 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCCTTBCTTT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCCCcCcHHH
Confidence 544433455668889999999998899999999999999999999 88888765544443333322 2222233345668
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRRLQENYW 454 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~ 454 (496)
.+++.+||+.||.+|||+.++++.|+.+.+....++
T Consensus 247 ~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~~ 282 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYL 282 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHHB
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 999999999999999999999999999876554443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=361.96 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=208.9
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC-eeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETK-VTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~E~~~~ 265 (496)
.+.+.+.||+|+||.||+|.+ .+..||||.+.... ....+.+|+.++++++||||+++++++.... ..|+|||||++
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred HeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 356678999999999999998 57899999987544 3445668999999999999999999987665 78999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 272 g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 342 (450)
T 1k9a_A 272 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 342 (450)
T ss_dssp CBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----
Confidence 999999987643 236888999999999999999999 78999999999999999999999999999865332
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....+|+.|+|||++.+..++.++|+||+|+++|++++ |..||...........+.. ....+.+..+++.+.+||.+
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-TCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHH
Confidence 122357889999999999999999999999999999998 8888876655544444433 23334445567889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHh
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
||+.||.+|||+.++++.|+.+..
T Consensus 422 cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=343.80 Aligned_cols=255 Identities=17% Similarity=0.189 Sum_probs=203.4
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|...+++.||+|++...... .....+|+.+++.++||||+++++++.+.+..++|||||
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 47788999999999999999878999999998644322 234558999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++ +|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 102 EK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp SE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 85 88888876543 36889999999999999999999 7899999999999999999999999999987653322
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc---CCc----------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV---ADE---------- 409 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~---~~~---------- 409 (496)
......||+.|+|||++.+ ..++.++|+||+|++++++++|.+||.+......+..+..... ...
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 1234468999999999876 5688999999999999999999999977665554444432100 000
Q ss_pred ---------------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 410 ---------------SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 410 ---------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
.....++++.+|+.+||+.||.+|||+.|++ +++|.+..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell----------~hp~f~~~~ 308 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM----------NHPYFKDLD 308 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH----------TSGGGTTSC
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh----------cCcccccCC
Confidence 0012346789999999999999999999984 566766543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=346.37 Aligned_cols=260 Identities=19% Similarity=0.124 Sum_probs=206.0
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|... +++.||+|++..... ......+|..++.++ +||||+++++++.+.+..|+||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 3777889999999999999964 688999999875432 122344788888887 8999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|.+++..... +++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred eCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999976543 7889999999999999999999 78999999999999999999999999999864332
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhc---------ccchhhhhhhcccCCccc
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSI---------ENNSFRQILNFQVADESE 411 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~---------~~~~~~~i~~~~~~~~~~ 411 (496)
.. .....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||.... ....+..+...... .+
T Consensus 164 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p 239 (345)
T 3a8x_A 164 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IP 239 (345)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--CC
T ss_pred CC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--CC
Confidence 21 2345679999999999999999999999999999999999999986421 11223333333322 22
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
...++.+.+||.+||+.||.+||++... ..+.....++|.+..+|
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~----~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQ----TGFADIQGHPFFRNVDW 284 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTT----THHHHHHTSGGGTTCCH
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCc----CCHHHHhcCCccCCCCH
Confidence 3456779999999999999999997310 01122345667666554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=368.53 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=214.7
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
...+.+.+.||+|+||.||+|.+. ++..||||.+.........+.+|+.+|++++|||||+++++|...+..|||||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 344677789999999999999975 4789999999765555556668999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 299 ~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 299 TYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp TTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred CCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence 99999999986543 236889999999999999999999 7899999999999999999999999999987654321
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.......+|+.|+|||++.+..++.++|+||+|+++|++++ +.+||...........+ ......+.+..+++.+.+||
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li 452 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELM 452 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHH
Confidence 11223446789999999999899999999999999999998 88888765444433333 33333444455667899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 423 SKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
.+||+.||.+|||+.+|++.|+.+.
T Consensus 453 ~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 453 RACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHcCcChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999998874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=351.46 Aligned_cols=253 Identities=18% Similarity=0.162 Sum_probs=204.3
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++|||||+++++|.+.+..|+|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 477889999999999999995 4688999999865432 12344588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999997643 37889999999999999999999 789999999999999999999999999998765432
Q ss_pred CccceecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccc---hhhhhhhcccCCcccHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENN---SFRQILNFQVADESEMEEI 415 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~ 415 (496)
.....+||+.|+|||++.+ ..++.++|+||+|+++|+|++|.+||....... ....+.... ...+...+
T Consensus 170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s 244 (384)
T 4fr4_A 170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWS 244 (384)
T ss_dssp ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSC
T ss_pred ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCC
Confidence 2345679999999999874 458899999999999999999999986543222 122222222 22233456
Q ss_pred HHHHHHHHHhcccCCCCCCC-HHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 416 EVVAELASKCLRIRGTERPT-MKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs-~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
+.+.+||.+||+.||.+||+ +.++ ..++|....+|
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l----------~~hp~f~~~~w 280 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDV----------QNFPYMNDINW 280 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHH----------HTSGGGTTCCH
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHH----------HcChhhhcCCH
Confidence 77999999999999999998 4444 45556655554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=366.61 Aligned_cols=257 Identities=20% Similarity=0.273 Sum_probs=207.9
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..+.+.+.||+|+||.||+|.+..+..||||.+.........+.+|+.++++++||||+++++++.. +..|+|||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 4467778999999999999998777889999997655444556689999999999999999999876 678999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 263 gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 337 (452)
T 1fmk_A 263 GSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 337 (452)
T ss_dssp CBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ec
Confidence 999999975422 236889999999999999999999 7899999999999999999999999999987654321 11
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....+|+.|+|||++.+..++.++|+||+|++++++++ +..||.+.........+.. ....+.+..+++.+.+|+.+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQ 416 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Confidence 233447889999999998889999999999999999998 8888876555444444433 22333445567789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
||+.||.+|||+.+|++.|+.+...
T Consensus 417 cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 417 CWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HccCChhhCcCHHHHHHHHHHHhcc
Confidence 9999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=357.83 Aligned_cols=258 Identities=17% Similarity=0.143 Sum_probs=209.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .+++.||+|++..... ......+|..++..++||||+++++++.+.+..|+|||
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 367778999999999999996 4789999999865322 22334578999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 142 ~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp CCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999986532 36889999999999999999999 789999999999999999999999999998775432
Q ss_pred CccceecccccceeecCcccc-------cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--cCCc-cc
Q 047375 342 ETAMSTMIRGTVGYLDPEYAH-------TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ--VADE-SE 411 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~-------~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~-~~ 411 (496)
. ......+||+.|+|||++. ...++.++|+||+|+++|+|++|.+||........+..+.... ...+ ..
T Consensus 217 ~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 217 T-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp C-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred c-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 2 1223457999999999997 3578999999999999999999999998877666666666432 1111 12
Q ss_pred HHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 412 MEEIEVVAELASKCLRIRGTER---PTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
...++.+.+||.+||. +|.+| |++.|| ..++|.+..+|+
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei----------~~Hpff~~i~w~ 337 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDF----------RTHPFFFGLDWD 337 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH----------HTSGGGTTCCST
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH----------hcCCCcCCCCHH
Confidence 3456789999999999 99998 577777 345666555543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=348.47 Aligned_cols=242 Identities=20% Similarity=0.234 Sum_probs=201.4
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .++..||+|++..... ......+|+.+++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 477789999999999999995 5789999999864321 22345589999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+ +|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred CC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99 6799998876543 7889999999999999999999 789999999999999999999999999998765432
Q ss_pred CccceecccccceeecCcccccccc-cCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELL-TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~-t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
. ....+||+.|+|||++.+..+ +.++|+||+|+++|++++|..||...........+...... .+...++.+.+
T Consensus 163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~ 237 (336)
T 3h4j_B 163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV--MPDFLSPGAQS 237 (336)
T ss_dssp T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCC--CCTTSCHHHHH
T ss_pred c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC--CcccCCHHHHH
Confidence 2 244569999999999998776 57899999999999999999999765544444443332221 22334577999
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil 440 (496)
|+.+||+.||.+|||+.|++
T Consensus 238 li~~~L~~dP~~Rpt~~eil 257 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIR 257 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999884
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=347.25 Aligned_cols=267 Identities=16% Similarity=0.101 Sum_probs=213.7
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .++..||||.+..... .....+|+.+++.+ +||||+++++++...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 477788999999999999995 5789999998865432 33456889999999 8999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc-----eEEccCCCccccCC
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT-----AKVSDFESLVPISS 339 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~-----~kL~DFGla~~~~~ 339 (496)
+|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++....
T Consensus 88 ~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 88 GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 8999999986532 47899999999999999999999 78999999999999998887 99999999987654
Q ss_pred CCCcc-----ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch---hhhhhhcccCCccc
Q 047375 340 DDETA-----MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS---FRQILNFQVADESE 411 (496)
Q Consensus 340 ~~~~~-----~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~---~~~i~~~~~~~~~~ 411 (496)
..... ......||+.|+|||++.+..++.++|+||+|+++|++++|..||........ +..+.......+..
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 32211 12356799999999999999999999999999999999999999987543322 23332222211111
Q ss_pred ---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 412 ---MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 412 ---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
... +.+.+++..||+.||.+||++.+|++.|+.+.+.....+....+|+
T Consensus 243 ~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 243 VLCENF-PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 112 3799999999999999999999999999988766544444444444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=348.72 Aligned_cols=265 Identities=22% Similarity=0.346 Sum_probs=197.5
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEee-----CCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE-----TKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-----~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. ++..||||++............++..+..++||||+++++.+.. ....|+|||
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 367788999999999999987 78999999987544333333344555566899999999986643 336789999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC------CCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA------SPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
||++|+|.+++.... .++..+..++.||+.||.|||+.. .++|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 93 YYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 999999999997653 377889999999999999999830 0189999999999999999999999999998
Q ss_pred ccCCCCC------ccceecccccceeecCccccc-------ccccCCCCCchhhhhcccccccccchhhhcccchhh---
Q 047375 336 PISSDDE------TAMSTMIRGTVGYLDPEYAHT-------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFR--- 399 (496)
Q Consensus 336 ~~~~~~~------~~~~~~~~gt~~Y~aPE~l~~-------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~--- 399 (496)
....... ........||+.|+|||++.+ ..++.++|+||+|+++|+++++..|+........+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 7654321 111234569999999999987 567788999999999999999866554332211110
Q ss_pred --------------hhh-hc----ccCC--cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccC
Q 047375 400 --------------QIL-NF----QVAD--ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 400 --------------~i~-~~----~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
... .. ..+. ......++.+.+||.+||+.||.+|||+.|+++.|+.+.. .|.+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~----~~~~~~ 324 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM----IWERNK 324 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH----CCCC--
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH----HHHhcc
Confidence 000 00 1111 1123466789999999999999999999999999998864 355555
Q ss_pred cc
Q 047375 459 NE 460 (496)
Q Consensus 459 ~~ 460 (496)
..
T Consensus 325 ~~ 326 (336)
T 3g2f_A 325 SV 326 (336)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=342.32 Aligned_cols=259 Identities=21% Similarity=0.274 Sum_probs=217.0
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
...|.+.+.||+|+||.||+|.+. ++..||+|.+...........+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 345778899999999999999964 5888999999766555556668999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 166 (288)
T 3kfa_A 92 TYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 166 (288)
T ss_dssp TTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-
T ss_pred CCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-
Confidence 99999999987543 337889999999999999999999 7899999999999999999999999999987654322
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.......||+.|+|||++.+..++.++|+||+|++++++++ +.+||...........+. .......+...++.+.+|+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 245 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELM 245 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCHHHHHHH
Confidence 22334457889999999998899999999999999999998 888887654444333332 2333334445567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 423 SKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+||+.||.+|||+.++++.|+.+...
T Consensus 246 ~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 246 RACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999988654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=347.21 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=212.7
Q ss_pred HhcchhhhcccCCceEEEEeEeC--------CCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP--------DNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETK 254 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~ 254 (496)
..|.+.+.||+|+||.||+|... ++..||||.+..... ......+|+.+++.+ +||||+++++++...+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 45788899999999999999852 467899999865432 223445889999999 8999999999999999
Q ss_pred eeeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
..|+|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEc
Confidence 99999999999999999986542 1236889999999999999999999 7899999999999999
Q ss_pred CCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhh
Q 047375 322 DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQ 400 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 400 (496)
.++.+||+|||++................+|+.|+|||++.+..++.++|+||+|++++++++ +..||...........
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 999999999999987755433222334457899999999998889999999999999999998 8888876544444433
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
+... .....+..+++.+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 272 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 272 LKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 3332 222333455678999999999999999999999999999997653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=344.13 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=201.0
Q ss_pred HHHHHHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHh--cCCCCceeeEEEEEeeC----C
Q 047375 181 SELLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIIS--QVKHKNVVKILGLCLET----K 254 (496)
Q Consensus 181 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~--~l~hpnIv~l~~~~~~~----~ 254 (496)
.......|.+.+.||+|+||.||+|.+ .+..||||++....... ...+..++. .++||||+++++++... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~--~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEAS--WFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccccch--hhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334556788999999999999999998 58999999986544332 233444444 45899999999999877 7
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC-----CCCcccCCCCcCceeeCCCCceEEc
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA-----SPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-----~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
..|+|||||++|+|.+++... .+++..++.++.|++.||.|||+.. .++|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 889999999999999999754 2688999999999999999999830 1289999999999999999999999
Q ss_pred cCCCccccCCCCCcc--ceecccccceeecCcccccccccCC------CCCchhhhhccccccc----------ccchhh
Q 047375 330 DFESLVPISSDDETA--MSTMIRGTVGYLDPEYAHTELLTGM------NPNSYVALASNEKISM----------VPYFLD 391 (496)
Q Consensus 330 DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~t~~------~d~~s~g~~~~~~~~~----------~~~~~~ 391 (496)
|||++.......... ......||+.|+|||++.+...+.. +|+||+|+++|+|+++ ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999997765432211 1224569999999999988766665 8999999999999999 444433
Q ss_pred hcccc----hhhhhh-hcccCCcc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 392 SIENN----SFRQIL-NFQVADES-----EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 392 ~~~~~----~~~~i~-~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
..... ...... ........ ...+++.+.+|+.+||+.||.+|||+.+|++.|+.+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 22211 111111 11111111 2367788999999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=339.11 Aligned_cols=256 Identities=19% Similarity=0.268 Sum_probs=199.4
Q ss_pred HhcchhhhcccCCceEEEEeEeCC----CcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPD----NTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
..|.+.+.||+|+||.||+|.+.. +..||+|.+..... ......+|+.+++.++||||+++++++. .+..|+|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 457888999999999999998632 45699998764322 2334558899999999999999999985 5568999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999976532 36889999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
.... ......+|+.|+|||++.+..++.++|+||+|++++++++ +.+||...........+.... ..+.+..+++.+
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l 246 (281)
T 1mp8_A 169 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTL 246 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHH
T ss_pred cccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCCCHHH
Confidence 3221 2233457889999999998889999999999999999985 888887765555555554332 223334556789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 247 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 247 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=345.37 Aligned_cols=261 Identities=22% Similarity=0.265 Sum_probs=212.2
Q ss_pred HHhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCC-
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETK- 254 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~- 254 (496)
...|.+.+.||+|+||.||+|.+ .++..||||.+..... ......+|+.++..+ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 34577889999999999999973 3567899999865432 223445889999999 6999999999998754
Q ss_pred eeeEEEeeccCCchhhhhhhcCcc-------------cccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQ-------------VLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
..++|||||++|+|.+++...... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEEC
Confidence 589999999999999999875431 126889999999999999999999 7899999999999999
Q ss_pred CCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhh
Q 047375 322 DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQ 400 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 400 (496)
.++.+||+|||+++...............||+.|+|||++.+..++.++|+||+|++++++++ +..||........+..
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 999999999999987755433333345568999999999999899999999999999999997 8888876554444433
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
..........+...++.+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 333332333334456779999999999999999999999999998865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=338.88 Aligned_cols=257 Identities=19% Similarity=0.266 Sum_probs=212.1
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..|.+.+.||+|+||.||+|...++..||+|.+...........+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 4577889999999999999998778899999987655445556689999999999999999999874 458999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 92 ~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 166 (279)
T 1qpc_A 92 GSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TA 166 (279)
T ss_dssp CBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-EC
T ss_pred CCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-cc
Confidence 999999975432 237889999999999999999999 7899999999999999999999999999987754321 11
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....+|+.|+|||++.+..++.++|+||+|++++++++ +..||...........+... .....+...++.+.+++.+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 245 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQLMRL 245 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHHHHHHHHH
Confidence 223447889999999998889999999999999999998 88888765544444443322 2223334456789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
||+.||.+|||+.++++.|+.+...
T Consensus 246 ~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 246 CWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhccChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999999999999988654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=342.46 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=200.9
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.|.+.+.||+|+||.||+|.+ .+..||||++.... ......+|+.++++++||||+++++++.+ ..++||||+++|
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred HeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 367778999999999999998 57899999986432 33445688999999999999999998874 478999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc-eEEccCCCccccCCCCCccc
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT-AKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~-~kL~DFGla~~~~~~~~~~~ 345 (496)
+|.+++........+++..++.++.|++.||.|||+.+.++|+||||||+|||++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----- 159 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----- 159 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence 99999987655445688899999999999999999965568999999999999988876 799999998765432
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....||+.|+|||++.+..++.++|+||+|+++++++++..||....... ............+.....++.+.+|+.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 239 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHH
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHH
Confidence 123459999999999999899999999999999999999999986543221 1111111122233334456779999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
||+.||.+|||+.++++.|+.+.+.
T Consensus 240 ~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 240 CWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred HhcCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999988654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=351.48 Aligned_cols=270 Identities=13% Similarity=0.148 Sum_probs=208.0
Q ss_pred HhcchhhhcccCCceEEEEeEeCC------CcEEEEEEeecchhhhh------------hHHHHHHHHhcCCCCceeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPD------NTQVAVKKYMCADEIRI------------TEWEFLGIISQVKHKNVVKIL 247 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~------------~~~~e~~~l~~l~hpnIv~l~ 247 (496)
..|.+.+.||+|+||.||+|.+.. +..||||.+........ ....++..+..++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 357888999999999999998643 47899999865432111 112345567788999999999
Q ss_pred EEEeeC----CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC--
Q 047375 248 GLCLET----KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-- 321 (496)
Q Consensus 248 ~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~-- 321 (496)
+++... ...||||||| +|+|.+++..... .+++..++.|+.||+.||.|||+ ++|+||||||+|||++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 999864 5589999999 9999999987532 37899999999999999999999 7899999999999998
Q ss_pred CCCceEEccCCCccccCCCCCc-----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc
Q 047375 322 DNYTAKVSDFESLVPISSDDET-----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN 396 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~ 396 (496)
.++.+||+|||+++........ ......+||+.|+|||++.+..++.++|+||+|+++|+|++|..||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999876533211 11134559999999999999889999999999999999999999998654433
Q ss_pred hhhhhhhcccCCccc---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 397 SFRQILNFQVADESE---------MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 397 ~~~~i~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
............... ...++.+.+++..||+.||.+|||+.+|++.|+.+.+.....+....+|+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS 342 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence 322221111100000 12256799999999999999999999999999999876655555545443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=351.91 Aligned_cols=247 Identities=22% Similarity=0.217 Sum_probs=201.8
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh----hhHHHHHHH-HhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR----ITEWEFLGI-ISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|... ++..||+|++....... .....|..+ ++.++||||+++++++.+.+..|+||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 4778899999999999999964 67889999986543221 122344554 56789999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||+||+|.+++..... +++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 119 E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 119 DYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred eCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999977543 6788899999999999999999 78999999999999999999999999999864332
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
.. .....+||+.|+|||++.+..++.+.|+||+|+++|+|++|.+||........+..+.......+ ...++.+.+
T Consensus 193 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ 268 (373)
T 2r5t_A 193 NS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARH 268 (373)
T ss_dssp CC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC--SSSCHHHHH
T ss_pred CC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC--CCCCHHHHH
Confidence 21 23456799999999999999999999999999999999999999988777777777776543322 234577999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~~L 443 (496)
||.+||+.||.+||++.+.++.+
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHH
T ss_pred HHHHHcccCHHhCCCCCCCHHHH
Confidence 99999999999999987544433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=339.56 Aligned_cols=268 Identities=12% Similarity=0.053 Sum_probs=214.3
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeec
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
..|.+.+.||+|+||.||+|.. .++..||||.+.... ......+|+.++..+ +||||+++++++......++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 4577889999999999999995 578999999886443 333456788899988 7999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc-----eEEccCCCccccC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT-----AKVSDFESLVPIS 338 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~-----~kL~DFGla~~~~ 338 (496)
+++|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++....
T Consensus 89 -~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 -GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp -CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 8999999986543 37889999999999999999999 78999999999999987765 9999999998775
Q ss_pred CCCCc-----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc---chhhhhhhcccCCcc
Q 047375 339 SDDET-----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN---NSFRQILNFQVADES 410 (496)
Q Consensus 339 ~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~ 410 (496)
..... .......||+.|+|||++.+..++.++|+||+|++++++++|..||...... ..+..+.......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 1134556999999999999988999999999999999999999998764322 222222222111111
Q ss_pred ---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 411 ---EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 411 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
....++.+.+|+.+||+.||.+|||+.+|++.|+.+.+.....+....+|
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 11345779999999999999999999999999999977655444444333
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=345.64 Aligned_cols=256 Identities=21% Similarity=0.207 Sum_probs=203.9
Q ss_pred HhcchhhhcccCCceEEEEeEe----CCCcEEEEEEeecchh-----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL----PDNTQVAVKKYMCADE-----IRITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
..|.+.+.||+|+||.||+|.. .++..||+|++..... ......+|+.+++.++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 3478889999999999999986 4788999999865421 222344789999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+|||||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999976543 6788999999999999999999 7899999999999999999999999999876
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHH
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
..... ......+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||........+..+....... +...++
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~--p~~~~~ 246 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL--PPYLTQ 246 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CTTSCH
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCH
Confidence 54321 12344579999999999999889999999999999999999999998766666666665543322 233457
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 417 VVAELASKCLRIRGTERP-----TMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
.+.+|+.+||+.||.+|| ++.++ ..++|.+...++
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~----------l~hp~f~~~~~~ 286 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEV----------QAHPFFRHINWE 286 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHH----------HHSGGGSSCCHH
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHH----------HcCCcccCCCHH
Confidence 799999999999999999 45555 456676665543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=336.37 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=203.7
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh--------hhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR--------ITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
..|.+.+.||+|+||.||+|.. .++..||+|.+....... ....+|+.+++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 3477789999999999999996 478899999985433221 34458899999999999999999997654
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCC--cccCCCCcCceeeCCCCc-----eEEc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS--IIHSDVKSANILLDDNYT-----AKVS 329 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivHrDlKp~NIll~~~~~-----~kL~ 329 (496)
++||||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998876543 47889999999999999999999 67 999999999999987776 9999
Q ss_pred cCCCccccCCCCCccceecccccceeecCccc--ccccccCCCCCchhhhhcccccccccchhhhcccch--hhhhhhcc
Q 047375 330 DFESLVPISSDDETAMSTMIRGTVGYLDPEYA--HTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS--FRQILNFQ 405 (496)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l--~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~--~~~i~~~~ 405 (496)
|||+++..... .....||+.|+|||++ ....++.++|+||+|+++|+++++..||........ ...+....
T Consensus 172 Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 99998754332 3445699999999998 445678899999999999999999999876543322 23333334
Q ss_pred cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 406 VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 406 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
.....+..+++.+.+|+.+||+.||.+|||+.++++.|+++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 44445556678899999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=352.57 Aligned_cols=250 Identities=16% Similarity=0.151 Sum_probs=199.9
Q ss_pred hcchhhhcccC--CceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMG--GFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+| +||.||+|... ++..||||++..... ......+|+.+++.++|||||++++++.+.+..|+||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 47888999999 99999999964 789999999875432 2233447999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|.+++...... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||.+......
T Consensus 106 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp ECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999875322 37889999999999999999999 78999999999999999999999999987654322
Q ss_pred CC-----ccceecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC------
Q 047375 341 DE-----TAMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA------ 407 (496)
Q Consensus 341 ~~-----~~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 407 (496)
.. .......+||+.|+|||++.+ ..++.++|+||+||++++|++|.+||.+......+..+......
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 11 111223469999999999987 67899999999999999999999999765444433332221110
Q ss_pred --------------------------------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 408 --------------------------------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 408 --------------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.+.....++.+.+||.+||+.||.+|||+.|++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 011223346799999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=351.13 Aligned_cols=248 Identities=17% Similarity=0.208 Sum_probs=207.1
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh-hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE-IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
..|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++||||+++++++.+....|+|||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 3477889999999999999996 4688999999865433 2334458999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC--CCceEEccCCCccccCCCC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD--NYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~--~~~~kL~DFGla~~~~~~~ 341 (496)
++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 131 ~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 131 SGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999976432 37889999999999999999999 78999999999999974 5789999999998775432
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc--CCcccHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV--ADESEMEEIEVVA 419 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~l~ 419 (496)
. .....||+.|+|||++.+..++.++|+||+|+++|+|++|.+||.+......+..+..... ........++.+.
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 2 2344699999999999998999999999999999999999999987665555555544332 2222334567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 047375 420 ELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~ 441 (496)
+||.+||+.||.+|||+.++++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHhh
Confidence 9999999999999999999964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=347.55 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=211.9
Q ss_pred HHhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
...|.+.+.||+|+||.||+|... ++..||+|.+...... .....+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345788899999999999999853 3678999998654322 23345899999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc-------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEc
Q 047375 257 LLVYEFVSNGALSHYIHDKSS-------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
++|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEEC
Confidence 999999999999999976421 1235888999999999999999999 789999999999999999999999
Q ss_pred cCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCC
Q 047375 330 DFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVAD 408 (496)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~ 408 (496)
|||++................||+.|+|||++.+..++.++|+||+|++++++++ +.+||...........+..... .
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~ 259 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-L 259 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-C
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-C
Confidence 9999987654322222334457899999999998889999999999999999998 7888876554444444443322 2
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 409 ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 409 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
..+...++.+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2334456779999999999999999999999999987743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=339.05 Aligned_cols=246 Identities=21% Similarity=0.213 Sum_probs=195.9
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|...++..||+|++...... .....+|+.+++.++||||+++++++...+..++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 36778899999999999999878999999998644322 234558999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++ +|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 83 DQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp SE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred CC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 86 99998876432 36888999999999999999999 7899999999999999999999999999887643211
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc-----------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ----------------- 405 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~----------------- 405 (496)
......||+.|+|||++.+ ..++.++|+||+|++++++++|.+||........+..+....
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 1234468999999999876 458899999999999999999999987654443333332100
Q ss_pred ---cC--C-----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 406 ---VA--D-----ESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 406 ---~~--~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.. . ......++.+.+|+.+||+.||.+|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00 0 00112456789999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.76 Aligned_cols=250 Identities=21% Similarity=0.255 Sum_probs=197.3
Q ss_pred HHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh------hhhhHHHHHHHHhcC---CCCceeeEEEEEee
Q 047375 183 LLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE------IRITEWEFLGIISQV---KHKNVVKILGLCLE 252 (496)
Q Consensus 183 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~ 252 (496)
+....|.+.+.||+|+||.||+|.. .+++.||||++..... ......+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4455688889999999999999995 5788999999864321 122334555555554 59999999999987
Q ss_pred CC-----eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceE
Q 047375 253 TK-----VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAK 327 (496)
Q Consensus 253 ~~-----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~k 327 (496)
.. ..++||||++ |+|.+++...... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 54 5799999997 5999999875533 37899999999999999999999 7899999999999999999999
Q ss_pred EccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC
Q 047375 328 VSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 328 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
|+|||+++....... .....||+.|+|||++.+..++.++|+||+|+++++++++.+||...........+......
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999987653322 24556999999999999989999999999999999999999999776655555444321100
Q ss_pred C--------------------c-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 408 D--------------------E-----SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 408 ~--------------------~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
. + .....++.+.+||.+||+.||.+|||+.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 0 0 0012346789999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.91 Aligned_cols=247 Identities=17% Similarity=0.162 Sum_probs=206.3
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
...|.+.+.||+|+||.||+|... ++..||+|++...... .....+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456888899999999999999964 5778999998754332 33445899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee---CCCCceEEccCCCccccCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll---~~~~~~kL~DFGla~~~~~ 339 (496)
+++++|.+++..... +++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999876543 6889999999999999999999 789999999999999 7889999999999987654
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCccc--HHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESE--MEEIEV 417 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~ 417 (496)
... .....||+.|+|||++.+. ++.++|+||+|+++++++++..||...........+.......+.. ...++.
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred ccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 322 2345699999999998764 8999999999999999999999998766655555555543333221 134678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999999853
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.56 Aligned_cols=257 Identities=21% Similarity=0.255 Sum_probs=205.1
Q ss_pred HhcchhhhcccCCceEEEEeEe-----CCCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeC--Cee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-----PDNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLET--KVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~ 256 (496)
..|.+.+.||+|+||.||+|.+ .++..||+|++...... .....+|+.+++.++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477789999999999999983 36889999998654322 23445899999999999999999999876 668
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
++||||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999966543 36889999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCc-cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc--------------cchhhhh
Q 047375 337 ISSDDET-AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE--------------NNSFRQI 401 (496)
Q Consensus 337 ~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~--------------~~~~~~i 401 (496)
....... .......||..|+|||++.+..++.++|+||+|+++++++++..|+..... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7554321 123345688999999999998999999999999999999998776543211 1111112
Q ss_pred hhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 402 LNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 402 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
.......+.+...++.+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222233344455678999999999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.56 Aligned_cols=255 Identities=19% Similarity=0.180 Sum_probs=204.9
Q ss_pred HHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch------hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD------EIRITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
+...|.+.+.||+|+||.||+|.. .++..||+|.+.... .......+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 345688899999999999999996 468899999986432 2223445899999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcC-------------------------------------cccccCHHHHHHHHHHHHHHHHH
Q 047375 257 LLVYEFVSNGALSHYIHDKS-------------------------------------SQVLKNWKTCLRIAAETASAIHY 299 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~gL~~ 299 (496)
|+|||||++|+|.+++.... ....+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999999985210 01224677888999999999999
Q ss_pred hHhcCCCCcccCCCCcCceeeCCCC--ceEEccCCCccccCCCCCc--cceecccccceeecCccccc--ccccCCCCCc
Q 047375 300 LHSLASPSIIHSDVKSANILLDDNY--TAKVSDFESLVPISSDDET--AMSTMIRGTVGYLDPEYAHT--ELLTGMNPNS 373 (496)
Q Consensus 300 LH~~~~~~ivHrDlKp~NIll~~~~--~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~ 373 (496)
||+ ++|+||||||+|||++.++ .+||+|||++......... .......||+.|+|||++.+ ..++.++|+|
T Consensus 184 LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 184 LHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 999 7899999999999998766 8999999999876432211 12344569999999999875 6788999999
Q ss_pred hhhhhcccccccccchhhhcccchhhhhhhcccCCc--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 374 YVALASNEKISMVPYFLDSIENNSFRQILNFQVADE--SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 374 s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
|+|+++++++++..||...........+.......+ .....++.+.+||.+||+.||.+|||+.++++
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999987766666666665443332 22345678999999999999999999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.63 Aligned_cols=243 Identities=22% Similarity=0.231 Sum_probs=200.2
Q ss_pred hhhcccCCceEEEEeEe-CCCcEEEEEEeecchh-hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 191 HHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE-IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
.+.||+|+||.||+|.. .++..||+|++..... ......+|+.++.+++||||+++++++...+..|+|||||++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999985 4689999999876433 233445899999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee--CCCCceEEccCCCccccCCCCCccce
Q 047375 269 SHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL--DDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 269 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll--~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 99887643 237889999999999999999999 789999999999999 6678999999999987754322 2
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--CcccHHHHHHHHHHHHH
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--DESEMEEIEVVAELASK 424 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~l~~li~~ 424 (496)
...+||+.|+|||++.+..++.++|+||+|+++++|+++.+||........+..+...... .......++.+.+||.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 3446999999999999888999999999999999999999999877666666666654332 22223456789999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 047375 425 CLRIRGTERPTMKEVSE 441 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~ 441 (496)
||+.||.+|||+.|+++
T Consensus 326 ~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 326 LLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCSSGGGSCCHHHHHH
T ss_pred HcCCChhhCCCHHHHhc
Confidence 99999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.25 Aligned_cols=247 Identities=19% Similarity=0.168 Sum_probs=194.5
Q ss_pred HHHHHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhc-CCCCceeeEEEEEeeCCe
Q 047375 181 SELLKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQ-VKHKNVVKILGLCLETKV 255 (496)
Q Consensus 181 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~ 255 (496)
.+.....|.+.+.||+|+||+||+|... ++..||||++..... .......++..+.. .+||||++++++|.+.+.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 3455667888999999999999999964 789999998754322 22233344444444 489999999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.|+||||| +|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEEEEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeee
Confidence 99999999 6699998876543 37899999999999999999999 789999999999999999999999999988
Q ss_pred ccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHH
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI 415 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 415 (496)
...... ......||+.|+|||++.+ .++.++|+||+|+++++++++..++.... ....+.............+
T Consensus 206 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 278 (311)
T 3p1a_A 206 ELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLS 278 (311)
T ss_dssp ECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSC
T ss_pred ecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCC
Confidence 765432 2234569999999999887 68899999999999999999966554432 2223332222222233445
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 416 EVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
+.+.+|+.+||+.||.+|||+.|++
T Consensus 279 ~~l~~li~~~L~~dP~~Rpt~~ell 303 (311)
T 3p1a_A 279 SELRSVLVMMLEPDPKLRATAEALL 303 (311)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHH
Confidence 7899999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.53 Aligned_cols=258 Identities=17% Similarity=0.227 Sum_probs=193.6
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++||||+++++++...+..|+|||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 367778999999999999985 4688999999865432 2234558999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcC---cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 264 SNGALSHYIHDKS---SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 264 ~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
+ |+|.+++.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 59999987542 12237889999999999999999999 78999999999999999999999999999876533
Q ss_pred CCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC------------
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA------------ 407 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~------------ 407 (496)
.. ......||+.|+|||++.+ ..++.++|+||+|+++++|++|.+||.+......+..+......
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 162 VN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred cc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 22 1234468999999999876 46889999999999999999999998766554443333221000
Q ss_pred --------------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 408 --------------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 408 --------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
.......++.+.+|+.+||+.||.+|||+.|++ .++|.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l----------~hp~f~~~~~ 302 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL----------HHPWFAEYYH 302 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT----------TSGGGGGGCC
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh----------CChhhhcccc
Confidence 000012346799999999999999999999884 4666665543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=347.40 Aligned_cols=252 Identities=21% Similarity=0.160 Sum_probs=203.4
Q ss_pred CHHHHHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-----CCceeeEEEEEee
Q 047375 179 SKSELLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK-----HKNVVKILGLCLE 252 (496)
Q Consensus 179 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~l~~~~~~ 252 (496)
...++....|.+.+.||+|+||.||+|.. .++..||||++............|+.+++.+. ||||+++++++..
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 33444556788889999999999999996 57889999999765555555567888888886 9999999999999
Q ss_pred CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC----------
Q 047375 253 TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---------- 322 (496)
Q Consensus 253 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---------- 322 (496)
.+..|+||||| +++|.+++...... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccch
Confidence 99999999999 88999999875432 36889999999999999999999 78999999999999975
Q ss_pred ---------------CCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhccccccccc
Q 047375 323 ---------------NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVP 387 (496)
Q Consensus 323 ---------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~ 387 (496)
++.+||+|||++...... .....||+.|+|||++.+..++.++|+||+|+++|+++++.+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999865432 234569999999999999999999999999999999999999
Q ss_pred chhhhcccchhhhhhhcccCCcc--------------------------------------------cHHHHHHHHHHHH
Q 047375 388 YFLDSIENNSFRQILNFQVADES--------------------------------------------EMEEIEVVAELAS 423 (496)
Q Consensus 388 ~~~~~~~~~~~~~i~~~~~~~~~--------------------------------------------~~~~~~~l~~li~ 423 (496)
||........+..+.......+. .....+.+.+|+.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 98765443333222211000000 0001156889999
Q ss_pred HhcccCCCCCCCHHHHH
Q 047375 424 KCLRIRGTERPTMKEVS 440 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil 440 (496)
+||+.||.+|||+.|++
T Consensus 338 ~~L~~dP~~Rpta~elL 354 (360)
T 3llt_A 338 SILQIDPTLRPSPAELL 354 (360)
T ss_dssp HHCCSSGGGSCCHHHHT
T ss_pred HHhcCChhhCCCHHHHh
Confidence 99999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.48 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=195.1
Q ss_pred HHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
...|.+.+.||+|+||.||+|.+. ..||+|.+..... ......+|+.+++.++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 445788899999999999999873 3599998864322 223445899999999999999999966 4556899999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++++|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999965432 37889999999999999999999 789999999999999999999999999998665433
Q ss_pred CccceecccccceeecCcccc---cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-ccCC---cccHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAH---TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF-QVAD---ESEMEE 414 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~---~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~---~~~~~~ 414 (496)
.........||+.|+|||++. +..++.++|+||+|+++++++++..||............... .... .....+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 333334556999999999986 566788999999999999999999998765544443333322 1111 122345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
++.+.+|+.+||+.||.+|||+.++++.|+.+.+
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 6789999999999999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=341.08 Aligned_cols=253 Identities=20% Similarity=0.201 Sum_probs=186.3
Q ss_pred hcchh---hhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFH---HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~---~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+. +.||+|+||.||+|.. .++..||||++... ......+|+.++..+. ||||+++++++.+....|+|||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 35553 6799999999999996 46889999998643 2334457889999997 9999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC---ceEEccCCCccccC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY---TAKVSDFESLVPIS 338 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~---~~kL~DFGla~~~~ 338 (496)
||++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 87 LLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp CCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999998754 37889999999999999999999 7899999999999997655 89999999998665
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-------chhhhhhhcccCCc--
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-------NSFRQILNFQVADE-- 409 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-------~~~~~i~~~~~~~~-- 409 (496)
.... .....+||+.|+|||++.+..++.++|+||+|++++++++|.+||...... ..+..+.......+
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 161 PDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 4322 234456899999999999999999999999999999999999998764332 22333333332222
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
.....++.+.+||.+||+.||.+|||+.++ ..++|.+...
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~el----------l~h~w~~~~~ 278 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGL----------RYNEWLQDGS 278 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTS----------TTCGGGCTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHH----------hcChhhccCc
Confidence 223456789999999999999999999988 4567776543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=344.25 Aligned_cols=263 Identities=18% Similarity=0.258 Sum_probs=204.9
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcE----EEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQ----VAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
.|.+.+.||+|+||.||+|.+. ++.. ||+|.+.... .......+|+.+++.++||||++++++|.... .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 4777899999999999999953 4444 5777664332 22344558999999999999999999998765 7889
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp ECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999987543 36889999999999999999999 7899999999999999999999999999987754
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
...........||+.|+|||++.+..++.++|+||+|+++|++++ +.+||...........+ ......+.+...+..+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 248 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDV 248 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTBCHHH
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHH
Confidence 433333344457889999999999999999999999999999998 88888765544433333 3333333444556779
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhc
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWAR 456 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~ 456 (496)
.+|+.+||+.||.+|||+.|+++.|+.+.+....++.-
T Consensus 249 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 286 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 286 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHBCC
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceEEe
Confidence 99999999999999999999999999998766555444
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.94 Aligned_cols=259 Identities=18% Similarity=0.212 Sum_probs=208.9
Q ss_pred HhcchhhhcccCCceEEEEeEe-----CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEe--eCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-----PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCL--ETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~--~~~~~~ 257 (496)
..|.+.+.||+|+||.||+|.+ .++..||||++...... .....+|+.+++.++||||+++++++. +.+..|
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 3478889999999999999983 36789999998755433 234558999999999999999999987 456789
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+|||||++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999976432 37889999999999999999999 78999999999999999999999999999876
Q ss_pred CCCCCcc-ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc--------------hhhhhh
Q 047375 338 SSDDETA-MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN--------------SFRQIL 402 (496)
Q Consensus 338 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~--------------~~~~i~ 402 (496)
....... ......||+.|+|||++.+..++.++|+||+|+++++++++..||....... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 5432211 1233458899999999999999999999999999999999988876543221 111122
Q ss_pred hcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 403 NFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 403 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
......+.+..+++.+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 22233334455667899999999999999999999999999988553
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.80 Aligned_cols=247 Identities=16% Similarity=0.189 Sum_probs=196.7
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecch---hhhhhHHHHHHHHhcCC--CCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD---EIRITEWEFLGIISQVK--HKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|....+..||||++.... .......+|+.++..++ ||||+++++++...+..|+|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 377789999999999999998779999999986432 22234458899999996 5999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
+.+|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++......
T Consensus 137 -~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 -CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp -CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred -cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 56789999998754 36788899999999999999999 7899999999999996 5799999999998775443
Q ss_pred CccceecccccceeecCccccc-----------ccccCCCCCchhhhhcccccccccchhhhccc-chhhhhhhcccCCc
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-----------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQVADE 409 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-----------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~ 409 (496)
........+||+.|+|||++.+ ..++.++|+||+|+++|+|++|.+||...... ..+..+........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 3323345679999999999875 36788999999999999999999998764332 33444444433333
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+...+..+.+||.+||+.||.+|||+.|+++
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 33333567999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=339.07 Aligned_cols=248 Identities=22% Similarity=0.223 Sum_probs=207.3
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh-------hhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI-------RITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
...|.+.+.||+|+||.||+|... ++..||+|.+...... .....+|+.++..++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888999999999999999964 6889999998654321 23455889999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC----ceEEccCC
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY----TAKVSDFE 332 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~----~~kL~DFG 332 (496)
++||||+++|+|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997643 37889999999999999999999 7899999999999999887 79999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc--c
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE--S 410 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~ 410 (496)
++........ .....||+.|+|||++.+..++.++|+||+|+++++++++..||...........+.......+ .
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence 9987654322 2345699999999999998999999999999999999999999977655555555544332221 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....++.+.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1234567999999999999999999999965
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=345.10 Aligned_cols=244 Identities=20% Similarity=0.252 Sum_probs=202.4
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
..|...+.||+|+||.||+|.. .++..||||++..... ......+|+.++++++||||+++++++...+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4477778999999999999995 5789999999864321 2234458999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||+ |+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 588888865432 37889999999999999999999 78999999999999999999999999998776432
Q ss_pred CCccceecccccceeecCcccc---cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAH---TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~---~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
....||+.|+|||++. ...++.++|+||+|+++++++++.+||...........+.....+.......++.
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 281 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2346999999999984 4678899999999999999999999987765544444454433333333445677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+||.+||+.||.+|||+.++++
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHcccChhhCcCHHHHhh
Confidence 999999999999999999999965
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=336.63 Aligned_cols=256 Identities=18% Similarity=0.245 Sum_probs=203.4
Q ss_pred cchhhhcccCCceEEEEeEeC-C---CcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCee-eEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-D---NTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVT-LLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~-~lv~ 260 (496)
+...+.||+|+||.||+|.+. + +..||+|.+...... .....+|+.+++.++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 444588999999999999852 2 236999988653332 23445889999999999999999999866554 9999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+.+|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 103 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999976432 36889999999999999999999 78999999999999999999999999999866432
Q ss_pred CC--ccceecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 341 DE--TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 341 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
.. ........||+.|+|||.+.+..++.++|+||+|+++++++++ .+|+.... ..............+.+...++.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRLPQPEYCPDS 256 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCCCCCCccchHH
Confidence 21 1112345589999999999998999999999999999999995 55554433 33333333323333334445678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.31 Aligned_cols=247 Identities=16% Similarity=0.191 Sum_probs=195.1
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCC--CceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKH--KNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|...++..||||++..... ......+|+.++..++| |||+++++++...+..|+|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 4777899999999999999988899999999864322 22344588999999986 999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
+.+|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++......
T Consensus 90 -~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 90 -CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp -CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred -CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 45789999998754 36888999999999999999999 7899999999999997 5789999999998775543
Q ss_pred CccceecccccceeecCccccc-----------ccccCCCCCchhhhhcccccccccchhhhccc-chhhhhhhcccCCc
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHT-----------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQVADE 409 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~-----------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~ 409 (496)
........+||+.|+|||++.+ ..++.++|+||+|++++++++|.+||...... ..+..+........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 3333345679999999999865 67788999999999999999999998754332 23333443333333
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+...++.+.+|+.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 33334467999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=338.23 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=199.9
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CC-------cEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DN-------TQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 256 (496)
..|.+.+.||+|+||.||+|... ++ ..||+|.+...... .....+|+.+++.++||||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 45778899999999999999853 23 46999998654433 34455899999999999999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc--------eEE
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT--------AKV 328 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~--------~kL 328 (496)
++|||||++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999987542 36888999999999999999999 78999999999999988876 999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
+|||++...... ....||+.|+|||++.+ ..++.++|+||+|+++++++++..++..................
T Consensus 163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 999998765321 23458999999999987 77899999999999999999954444333332222222221111
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
.+...++.+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 237 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 237 --LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp --CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred --CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111224568999999999999999999999999998743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=356.57 Aligned_cols=244 Identities=22% Similarity=0.255 Sum_probs=206.9
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... +|..||||++..... ......+|+.+++.++||||+++++++...+..|+|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3777889999999999999964 789999999865432 12344589999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 97 YVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999997643 37889999999999999999999 789999999999999999999999999998765432
Q ss_pred CccceecccccceeecCcccccccc-cCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELL-TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~-t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
.....+||+.|+|||++.+..+ +.++|+||+|+++|++++|.+||........+..+.......+ ...++.+.+
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~ 245 (476)
T 2y94_A 171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--QYLNPSVIS 245 (476)
T ss_dssp ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC--TTCCHHHHH
T ss_pred ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC--ccCCHHHHH
Confidence 2244579999999999988766 5789999999999999999999987666556666655443322 234567999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~ 441 (496)
||.+||+.||.+|||+.++++
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCchhCcCHHHHHh
Confidence 999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=345.42 Aligned_cols=246 Identities=21% Similarity=0.222 Sum_probs=191.0
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
..|.+.+.||+|+||.||+|... ++..||||.+.... ......+|+.++.+++||||+++++++...+..++||||++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 45778899999999999999964 57889999987543 22334578999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCccccCCCC
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~~~~~~ 341 (496)
+|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 132 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 132 GGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp SCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999999997654 37889999999999999999999 78999999999999975 8899999999988764321
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccC--CcccHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVA--DESEMEEIEVV 418 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~--~~~~~~~~~~l 418 (496)
......||+.|+|||++.+..++.++|+||+|+++|++++|..||....... .+..+...... .+.....+..+
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 282 (349)
T 2w4o_A 206 ---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred ---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence 1234569999999999999889999999999999999999998886654433 34444443322 22234456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+||.+||+.||.+|||+.++++
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=355.66 Aligned_cols=256 Identities=18% Similarity=0.123 Sum_probs=205.6
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+.+++.++||||++++++|...+..|+|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 477789999999999999995 4688999999865321 12233478889999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++.... .+++..+..++.||+.||.|||+. ++|+||||||+|||++.++.+||+|||+++......
T Consensus 229 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 229 YANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred eCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999999997654 378899999999999999999962 569999999999999999999999999998654322
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
. .....+||+.|+|||++.+..++.++|+||+|+++++|++|.+||........+..+....... +...++.+.+|
T Consensus 304 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~l 379 (446)
T 4ejn_A 304 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLGPEAKSL 379 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHH
T ss_pred c--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--CccCCHHHHHH
Confidence 2 2345679999999999999999999999999999999999999998776666666665544332 23345779999
Q ss_pred HHHhcccCCCCCC-----CHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 422 ASKCLRIRGTERP-----TMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 422 i~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
|.+||+.||.+|| |+.|++ +++|....+++
T Consensus 380 i~~~L~~dP~~R~~~~~~t~~ell----------~hp~f~~~~~~ 414 (446)
T 4ejn_A 380 LSGLLKKDPKQRLGGGSEDAKEIM----------QHRFFAGIVWQ 414 (446)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHH----------TSGGGTTCCHH
T ss_pred HHHHcccCHHHhCCCCCCCHHHHH----------hCccccCCCHH
Confidence 9999999999999 888873 56676666553
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=339.12 Aligned_cols=260 Identities=21% Similarity=0.293 Sum_probs=200.2
Q ss_pred HhcchhhhcccCCceEEEEeEeC----CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCC----
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETK---- 254 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~---- 254 (496)
..|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.++++++||||+++++++...+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 45777899999999999999853 345799999864322 2234458899999999999999999998654
Q ss_pred -eeeEEEeeccCCchhhhhhhc---CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEcc
Q 047375 255 -VTLLVYEFVSNGALSHYIHDK---SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSD 330 (496)
Q Consensus 255 -~~~lv~E~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~D 330 (496)
..++||||+++|+|.+++... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEee
Confidence 359999999999999998542 122347899999999999999999999 7899999999999999999999999
Q ss_pred CCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCc
Q 047375 331 FESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADE 409 (496)
Q Consensus 331 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~ 409 (496)
||++................+|+.|+|||.+.+..++.++|+||+|++++++++ +.+||...........+.... ...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 269 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLK 269 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCC
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCC
Confidence 999987654432222344558899999999999889999999999999999999 888887665555444444332 233
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+...++.+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 3445567899999999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=338.05 Aligned_cols=256 Identities=20% Similarity=0.227 Sum_probs=207.8
Q ss_pred cchhhhcccCCceEEEEeEeC-----CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-----DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLL 258 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~l 258 (496)
+.+.+.||+|+||.||++.+. ++..||||++..... ......+|+.+++.++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377789999999999988642 678899999875432 23345589999999999999999999987 467899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||||++|+|.+++.... +++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999997643 6889999999999999999999 789999999999999999999999999998775
Q ss_pred CCCCc-cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc--------------chhhhhhh
Q 047375 339 SDDET-AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN--------------NSFRQILN 403 (496)
Q Consensus 339 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~--------------~~~~~i~~ 403 (496)
..... .......||+.|+|||++.+..++.++|+||+|+++++++++..||...... ........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 54221 1223445889999999999988999999999999999999998887653221 11122222
Q ss_pred cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 404 FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 404 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
.....+.+..+++.+.+|+.+||+.||.+|||+.++++.|+.+.+..
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 33333444556678999999999999999999999999999887653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=336.83 Aligned_cols=256 Identities=22% Similarity=0.301 Sum_probs=202.9
Q ss_pred cchhhhcccCCceEEEEeEeCC----CcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEe-eCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPD----NTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCL-ETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~ 260 (496)
|.+.+.||+|+||.||+|.... ...||+|.+..... ......+|+.++++++||||+++++++. ..+..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 6677899999999999998532 23589998865332 2234458899999999999999999965 456789999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 107 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp ECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999976432 36888999999999999999999 78999999999999999999999999999876543
Q ss_pred CCc--cceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 341 DET--AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 341 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
... .......||+.|+|||.+.+..++.++|+||+|++++++++ +.+||...........+.... ....+...++.
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-CCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-CCCCCccCCHH
Confidence 211 11234458889999999999899999999999999999998 566666554444443333322 22223334567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999999988653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=334.99 Aligned_cols=246 Identities=17% Similarity=0.185 Sum_probs=193.5
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|.. .++..||+|++...... .....+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 367788999999999999996 46889999998644322 23455899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++ +|.+.+..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 986 66666654332 37889999999999999999999 7899999999999999999999999999987653322
Q ss_pred ccceecccccceeecCccccccc-ccCCCCCchhhhhcccccccccc-hhhhcccchhhhhhhcccC-------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTEL-LTGMNPNSYVALASNEKISMVPY-FLDSIENNSFRQILNFQVA------------- 407 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~-~t~~~d~~s~g~~~~~~~~~~~~-~~~~~~~~~~~~i~~~~~~------------- 407 (496)
......||+.|+|||++.+.. ++.++|+||+|+++++++++..| |........+..+......
T Consensus 157 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 223456899999999997755 79999999999999999976555 4433333333332211000
Q ss_pred --------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 408 --------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 408 --------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.......++.+.+|+.+||+.||.+|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 001123456789999999999999999999984
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=342.89 Aligned_cols=255 Identities=20% Similarity=0.227 Sum_probs=196.2
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCC----ee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETK----VT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~ 256 (496)
..|.+.+.||+|+||.||+|.. .+++.||||++...... .....+|+.++..++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 3578889999999999999995 57889999998654222 233458899999999999999999987654 34
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+|||||++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999997654 37889999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCc-cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcc--cHH
Q 047375 337 ISSDDET-AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADES--EME 413 (496)
Q Consensus 337 ~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~ 413 (496)
....... .......||+.|+|||++.+..++.++|+||+|+++|+++++..||...................+. ...
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 6543221 1223456999999999999999999999999999999999999998766554444444333222211 123
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHhh
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVS-EELDRL 446 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil-~~L~~l 446 (496)
.++.+.+|+.+||+.||.+||++.+++ ..|..+
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 457799999999999999999766554 445444
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=339.67 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=203.6
Q ss_pred HhcchhhhcccCCceEEEEeEeCC-----CcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPD-----NTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
..|.+.+.||+|+||.||+|.... +..||||.+..... ......+|+.++..++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 346667899999999999998532 23599999865422 23344589999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||||++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 124 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999976532 36889999999999999999999 789999999999999999999999999998765
Q ss_pred CCCCcc-ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHH
Q 047375 339 SDDETA-MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 339 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
...... ......+|+.|+|||++.+..++.++|+||+|++++++++ +..||...........+... ...+.+..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCcccCCH
Confidence 432211 1223346889999999998889999999999999999988 88888765554444444332 22233345567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 899999999999999999999999999988754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=368.04 Aligned_cols=256 Identities=20% Similarity=0.278 Sum_probs=211.3
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..+.+.+.||+|+||.||+|.+..+..||||++.........+.+|+.+|++++||||+++++++.+ +..|||||||++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 3456678899999999999998777889999997655444556689999999999999999999876 678999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 346 gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 420 (535)
T 2h8h_A 346 GSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 420 (535)
T ss_dssp EEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHT
T ss_pred CcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eec
Confidence 999999975422 236889999999999999999999 789999999999999999999999999998764321 111
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....+|..|+|||++.+..++.++|+||+|+++|++++ +..||...........+.. ....+.+..+++.+.+||.+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~ 499 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQ 499 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Confidence 223347889999999998889999999999999999998 8888876555444444433 22333344566789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHh
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
||+.||.+|||+.+|++.|+.+..
T Consensus 500 cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 500 CWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HcCCChhHCcCHHHHHHHHHHHhh
Confidence 999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=330.22 Aligned_cols=247 Identities=19% Similarity=0.206 Sum_probs=205.4
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
..|.+.+.||+|+||.||+|.. .++..||+|++...... .....+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 3477789999999999999985 46889999998654322 2334488999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc---eEEccCCCccccC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT---AKVSDFESLVPIS 338 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~---~kL~DFGla~~~~ 338 (496)
|+++|+|.+++..... +++..+..++.|++.||.|||+ ++|+||||||+||+++.++. +||+|||++....
T Consensus 86 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 86 LVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999998876543 7889999999999999999999 78999999999999976654 9999999997765
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--CcccHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--DESEMEEIE 416 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~ 416 (496)
.... .....||+.|+|||++.+..++.++|+||+|+++++++++.+||...........+...... .+.....++
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 160 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp SSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 4322 23456999999999999999999999999999999999999999776655555555543332 222234567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHcccChhhCCCHHHHhc
Confidence 8999999999999999999999953
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.15 Aligned_cols=246 Identities=16% Similarity=0.201 Sum_probs=200.4
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
...|.+.+.||+|+||.||+|... ++..||||.+..... ...+|+.++.++ +||||+++++++.+.+..|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 456888899999999999999964 688999999865432 234567777777 799999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC----CceEEccCCCccccC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN----YTAKVSDFESLVPIS 338 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~----~~~kL~DFGla~~~~ 338 (496)
|++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+..+ +.+||+|||+++...
T Consensus 98 ~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 98 MKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999997654 37889999999999999999999 789999999999998433 359999999998765
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcc---cchhhhhhhcccCC--cccHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIE---NNSFRQILNFQVAD--ESEME 413 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~---~~~~~~i~~~~~~~--~~~~~ 413 (496)
.... .....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||..... ...+..+....... .....
T Consensus 172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 4322 23445799999999999988899999999999999999999999875322 22334444333322 22344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.++.+.+||.+||..||.+|||+.++++
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 5678999999999999999999998854
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=331.93 Aligned_cols=257 Identities=19% Similarity=0.244 Sum_probs=208.9
Q ss_pred cchhh-hcccCCceEEEEeEeC---CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHH-CLGMGGFGSVYKGVLP---DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+.+.. .||+|+||.||+|.+. ++..||||.+.... .......+|+.+++.++||||+++++++ ..+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 44444 8999999999999853 57789999987542 2233455899999999999999999999 4566899999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 90 MAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp CCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred eCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999975432 37889999999999999999999 789999999999999999999999999998775432
Q ss_pred Cc-cceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 342 ET-AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 342 ~~-~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
.. .......||+.|+|||++.+..++.++|+||+|++++++++ +..||...........+... .....+..+++.+.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~ 243 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELY 243 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTTCCHHHH
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-CcCCCCCCcCHHHH
Confidence 21 11223447899999999998889999999999999999998 88888765544444444332 22333445667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHhhhh
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 451 (496)
+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 244 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 244 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999976543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=350.07 Aligned_cols=256 Identities=16% Similarity=0.191 Sum_probs=208.3
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCC--eeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETK--VTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||||++...... .....+|+.+++.++||||+++++++...+ ..|+|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4777899999999999999964 5899999998754332 234458999999999999999999998755 7799999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee----CCCCceEEccCCCcccc
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL----DDNYTAKVSDFESLVPI 337 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll----~~~~~~kL~DFGla~~~ 337 (496)
||++|+|.+++........+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999876544447899999999999999999999 789999999999999 77888999999999876
Q ss_pred CCCCCccceecccccceeecCccccc--------ccccCCCCCchhhhhcccccccccchhhhccc----chhhhhhhcc
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHT--------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN----NSFRQILNFQ 405 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~----~~~~~i~~~~ 405 (496)
.... ......||+.|+|||++.+ ..++.++|+||+|+++|++++|..||...... ..+..+....
T Consensus 167 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 167 EDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred cCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 5432 1234569999999999875 56788999999999999999999998753322 1222222211
Q ss_pred c-----------------------CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 406 V-----------------------ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 406 ~-----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
. ........++.+.+++.+||+.||.+|||+.++++.++.+..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1 112235677889999999999999999999999999988764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=333.54 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=206.4
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+...|.+.+.||+|+||.||+|... +++.||+|.+....... ....+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3456888899999999999999964 78999999987544322 334588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee---CCCCceEEccCCCccccC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll---~~~~~~kL~DFGla~~~~ 338 (496)
|+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999997654 36889999999999999999999 789999999999999 788899999999987653
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--CcccHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--DESEMEEIE 416 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~ 416 (496)
.. ......||+.|+|||++.+..++.++|+||+|+++++++++.+||...........+...... .+.....++
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 22 123456999999999999988999999999999999999999999876655555555543322 222334567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 8999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=328.81 Aligned_cols=249 Identities=20% Similarity=0.202 Sum_probs=203.2
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|.+.+.||+|+||.||+|... ++..||||.+..... ......+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45788899999999999999964 688999999865432 223445889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999997543 37889999999999999999999 7899999999999999999999999999987644322
Q ss_pred ccceecccccceeecCcccccccc-cCCCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccCCcccHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELL-TGMNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~-t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
........||+.|+|||++.+..+ +.++|+||+|+++++++++..||....... .+..+.............++.+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence 222345569999999999987655 778999999999999999999987654332 223333222222223345677999
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil 440 (496)
|+.+||+.||.+|||+.+++
T Consensus 241 li~~~l~~~p~~Rps~~~il 260 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIK 260 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHT
T ss_pred HHHHHCCCCchhCCCHHHHh
Confidence 99999999999999999884
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=360.41 Aligned_cols=256 Identities=24% Similarity=0.193 Sum_probs=209.4
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .+|..||+|++..... ......+|+.+|..++|||||++++++.+.+..|+|||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 466778999999999999996 4789999999865422 22334588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||+||+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 265 y~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 265 LMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999976543 237889999999999999999999 789999999999999999999999999998775432
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch----hhhhhhcccCCcccHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS----FRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~----~~~i~~~~~~~~~~~~~~~~ 417 (496)
. ....+||+.|+|||++.+..++.+.|+||+|+++|+|++|.+||........ ...+... ....+...++.
T Consensus 341 ~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~ 415 (576)
T 2acx_A 341 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQ 415 (576)
T ss_dssp C---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred c---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHH
Confidence 1 2345799999999999999999999999999999999999999976543222 2222222 22233445678
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 418 VAELASKCLRIRGTERP-----TMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 418 l~~li~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
+.+||.+||+.||.+|| ++.|| ..++|.+..+|.
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~ei----------l~HpfF~~i~w~ 454 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREV----------KEHPLFKKLNFK 454 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHH----------HTSGGGTTCCHH
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHH----------HhChhhccCCHH
Confidence 99999999999999999 56666 456777766553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=355.38 Aligned_cols=248 Identities=22% Similarity=0.223 Sum_probs=208.0
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
....|.+.+.||+|+||.||+|... ++..||||++..... ......+|+.+++.++||||+++++++.+.+..|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3456899999999999999999964 788999999864322 233455899999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC---CCCceEEccCCCccc
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD---DNYTAKVSDFESLVP 336 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~---~~~~~kL~DFGla~~ 336 (496)
||||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999999876543 7889999999999999999999 7899999999999995 456799999999987
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--CcccHHH
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--DESEMEE 414 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~ 414 (496)
..... .....+||+.|+|||++.+ .++.++|+||+|+++|++++|.+||.+......+..+...... .+.....
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC
Confidence 65432 1234569999999999886 4889999999999999999999999887666666666654433 2333456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
++.+.+||.+||+.||.+|||+.++++
T Consensus 250 s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 788999999999999999999999965
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=349.56 Aligned_cols=249 Identities=22% Similarity=0.255 Sum_probs=189.6
Q ss_pred HHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecc---hhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCC--ee
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCA---DEIRITEWEFLGIISQVK-HKNVVKILGLCLETK--VT 256 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~--~~ 256 (496)
....|.+.+.||+|+||.||+|.. .++..||||++... ........+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 445688889999999999999985 47899999998543 222334458899999997 999999999997544 68
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+|||||+ |+|..++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 5999998763 36788899999999999999999 7899999999999999999999999999986
Q ss_pred cCCCC-------------------CccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccc
Q 047375 337 ISSDD-------------------ETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENN 396 (496)
Q Consensus 337 ~~~~~-------------------~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~ 396 (496)
..... .....+..+||+.|+|||++.+ ..++.+.|+||+||++++|++|.+||.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 54311 1112344679999999999986 678999999999999999999999998765555
Q ss_pred hhhhhhhcccCCcc---------------------------------------------cHHHHHHHHHHHHHhcccCCC
Q 047375 397 SFRQILNFQVADES---------------------------------------------EMEEIEVVAELASKCLRIRGT 431 (496)
Q Consensus 397 ~~~~i~~~~~~~~~---------------------------------------------~~~~~~~l~~li~~cl~~dP~ 431 (496)
.+..+......+.. ....++.+.+|+.+||+.||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 44444321100000 002246789999999999999
Q ss_pred CCCCHHHHH
Q 047375 432 ERPTMKEVS 440 (496)
Q Consensus 432 ~RPs~~eil 440 (496)
+|||+.|++
T Consensus 319 ~R~t~~e~l 327 (388)
T 3oz6_A 319 KRISANDAL 327 (388)
T ss_dssp GSCCHHHHT
T ss_pred cCCCHHHHh
Confidence 999999884
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=339.20 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=208.0
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcE--EEEEEeecch--hhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQ--VAVKKYMCAD--EIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|... ++.. ||+|.+.... .......+|+.++.++ +||||+++++++.+.+..|+||
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 4777899999999999999953 4554 4999886432 2233455889999999 8999999999999999999999
Q ss_pred eeccCCchhhhhhhcC-------------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceE
Q 047375 261 EFVSNGALSHYIHDKS-------------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAK 327 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~k 327 (496)
||+++|+|.+++.... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEE
Confidence 9999999999997653 12347889999999999999999999 7899999999999999999999
Q ss_pred EccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhccc
Q 047375 328 VSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQV 406 (496)
Q Consensus 328 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~ 406 (496)
|+|||+++..... .......+|+.|+|||++.+..++.++|+||+|++++++++ +.+||...........+... .
T Consensus 183 L~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~ 258 (327)
T 1fvr_A 183 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-Y 258 (327)
T ss_dssp ECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-C
T ss_pred EcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-C
Confidence 9999998754321 11233447889999999998889999999999999999998 88888766554444444332 2
Q ss_pred CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhh
Q 047375 407 ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452 (496)
Q Consensus 407 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~ 452 (496)
....+...++.+.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 2233344567899999999999999999999999999998765443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=332.95 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=202.1
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeC-CeeeEEEeecc
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLET-KVTLLVYEFVS 264 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~ 264 (496)
..|.+.+.||+|+||.||+|.. .+..||||.+.... ......+|+.+++.++||||+++++++... +..|+||||++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 3477889999999999999998 58899999986543 334456889999999999999999997654 47899999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 99 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 9999999976532 236888999999999999999999 789999999999999999999999999987654321
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
....+|+.|+|||++.+..++.++|+||+|++++++++ +.+||...........+... .....+...++.+.+++.
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 248 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMK 248 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHH
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCcccCCHHHHHHHH
Confidence 22347899999999998889999999999999999998 88888765544444444332 223334455678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 424 KCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
+||+.||.+|||+.++++.|+.+...
T Consensus 249 ~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 249 NCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=347.81 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=195.4
Q ss_pred cchhhhcccCCceEEEEeEeC--CC--cEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEee-CCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP--DN--TQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLE-TKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~ 260 (496)
|.+.+.||+|+||.||+|.+. ++ ..||+|.+..... ....+.+|+.++++++||||++++++|.. .+..|+||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 556688999999999999853 22 3689998864322 23345588999999999999999999764 56789999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999976433 36788999999999999999999 78999999999999999999999999999876433
Q ss_pred CCcc--ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 341 DETA--MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 341 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
.... ......||+.|+|||++.+..++.++|+||+|+++|++++ +.+||...........+.... ....+..+++.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHH
Confidence 2111 1233457889999999999999999999999999999998 677776654444444443322 22233345677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999998865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=331.06 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=205.0
Q ss_pred hcchhhhcccCCceEEEEeEeCC----CcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPD----NTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|.+.. +..||+|.+.... .......+|+.+++.++||||+++++++.+. ..|+||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 47778899999999999998532 3359999986542 2233455889999999999999999998754 568999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 92 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp ECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred ecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999976542 36888999999999999999999 78999999999999999999999999999876543
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
... ......||+.|+|||++.+..++.++|+||+|++++++++ +..||...........+... ...+.+...++.+.
T Consensus 167 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 244 (281)
T 3cc6_A 167 DYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPKPDLCPPVLY 244 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCCCTTCCHHHH
T ss_pred ccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CCCCCCCCCCHHHH
Confidence 221 1233457889999999998889999999999999999998 88888765444444333332 22223334567799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHhhhh
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 451 (496)
+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus 245 ~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 245 TLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999876543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=336.69 Aligned_cols=261 Identities=22% Similarity=0.305 Sum_probs=206.8
Q ss_pred CHHHHHHHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhc--CCCCceeeEEEEEeeCC--
Q 047375 179 SKSELLKATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQ--VKHKNVVKILGLCLETK-- 254 (496)
Q Consensus 179 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~l~~~~~~~~-- 254 (496)
...+.+...|.+.+.||+|+||.||+|.. +++.||||.+.... .....+|.+++.. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 34556677899999999999999999998 68999999986433 2334466777766 78999999999998765
Q ss_pred --eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhH--------hcCCCCcccCCCCcCceeeCCCC
Q 047375 255 --VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH--------SLASPSIIHSDVKSANILLDDNY 324 (496)
Q Consensus 255 --~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~~~~ivHrDlKp~NIll~~~~ 324 (496)
..|+||||+++|+|.+++... .+++..++.++.|++.||.||| + ++|+||||||+|||++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCC
Confidence 789999999999999999764 2688999999999999999999 6 7899999999999999999
Q ss_pred ceEEccCCCccccCCCCCcc--ceecccccceeecCcccccc------cccCCCCCchhhhhccccccc----------c
Q 047375 325 TAKVSDFESLVPISSDDETA--MSTMIRGTVGYLDPEYAHTE------LLTGMNPNSYVALASNEKISM----------V 386 (496)
Q Consensus 325 ~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~------~~t~~~d~~s~g~~~~~~~~~----------~ 386 (496)
.+||+|||++.......... ......||+.|+|||++.+. .++.++|+||+|+++|+++++ .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998765443211 12345699999999998775 344689999999999999998 4
Q ss_pred cchhhhcccc----h-hhhhhhcccCCcc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 387 PYFLDSIENN----S-FRQILNFQVADES-----EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 387 ~~~~~~~~~~----~-~~~i~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.||....... . ...+......... ....++.+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 5554432211 1 1122222222221 235677899999999999999999999999999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=344.61 Aligned_cols=255 Identities=14% Similarity=0.141 Sum_probs=196.0
Q ss_pred HhcchhhhcccCCceEEEEeEeC----CCcEEEEEEeecchhh------------hhhHHHHHHHHhcCCCCceeeEEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCADEI------------RITEWEFLGIISQVKHKNVVKILGL 249 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~hpnIv~l~~~ 249 (496)
..|.+.+.||+|+||.||+|... ++..||+|.+...... .....+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 45788899999999999999964 5778999988654321 1123366788899999999999999
Q ss_pred Eee----CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-
Q 047375 250 CLE----TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY- 324 (496)
Q Consensus 250 ~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~- 324 (496)
+.. ....|+||||| +++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence 988 77899999999 899999997654 47899999999999999999999 7899999999999998777
Q ss_pred -ceEEccCCCccccCCCCCc-----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchh
Q 047375 325 -TAKVSDFESLVPISSDDET-----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSF 398 (496)
Q Consensus 325 -~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|+||+|+++|++++|..||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876432111 1113456999999999999988999999999999999999999998654332221
Q ss_pred hhhhhcccCCcccH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 399 RQILNFQVADESEM---------EEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 399 ~~i~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
............+. ..++.+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111001111 34467999999999999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=334.32 Aligned_cols=260 Identities=21% Similarity=0.255 Sum_probs=198.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecc----hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCA----DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .++..||||++... ........+|+.+++.++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 477889999999999999995 57899999998642 2223344588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 262 FVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|+++|+|.+++.... ....+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999997521 12346889999999999999999999 78999999999999999999999999998876543
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc--chhhhhhhcccCCcccHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN--NSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
.. ......||+.|+|||++.+..++.++|+||+|+++++++++..||...... .....+.............++.+
T Consensus 190 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 190 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred Cc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 21 123446999999999999988999999999999999999999888654322 12222222222222223456779
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 451 (496)
.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999976543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.94 Aligned_cols=247 Identities=21% Similarity=0.233 Sum_probs=192.7
Q ss_pred cchh-hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeec
Q 047375 188 KNFH-HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 188 ~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
|.+. +.||+|+||.||+|.. .++..||||++...... .....+|+.++.++ +||||+++++++.+.+..|+|||||
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 5553 6899999999999995 47899999998654332 34455889999884 7999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc---eEEccCCCccccCCC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT---AKVSDFESLVPISSD 340 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~---~kL~DFGla~~~~~~ 340 (496)
++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++......
T Consensus 94 ~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 94 RGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred CCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999998754 36889999999999999999999 78999999999999987765 999999998766432
Q ss_pred CC-----ccceecccccceeecCccccc-----ccccCCCCCchhhhhcccccccccchhhhccc---------------
Q 047375 341 DE-----TAMSTMIRGTVGYLDPEYAHT-----ELLTGMNPNSYVALASNEKISMVPYFLDSIEN--------------- 395 (496)
Q Consensus 341 ~~-----~~~~~~~~gt~~Y~aPE~l~~-----~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~--------------- 395 (496)
.. .......+||+.|+|||++.+ ..++.++|+||+|+++++++++.+||......
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 111223459999999999875 56889999999999999999999998764321
Q ss_pred chhhhhhhcccCCccc--HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 396 NSFRQILNFQVADESE--MEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 396 ~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
..+..+.......+.. ...++.+.+|+.+||+.||.+|||+.|++
T Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 1223333332222211 23457799999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=347.39 Aligned_cols=244 Identities=23% Similarity=0.196 Sum_probs=190.2
Q ss_pred cchh-hhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHH-hcCCCCceeeEEEEEee----CCeeeEEE
Q 047375 188 KNFH-HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGII-SQVKHKNVVKILGLCLE----TKVTLLVY 260 (496)
Q Consensus 188 ~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~l~~~~~~----~~~~~lv~ 260 (496)
|.+. +.||+|+||.||+|.. .++..||||++.... ...+|+.++ +..+||||+++++++.. ....||||
T Consensus 63 y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch----hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 4443 6899999999999996 468899999986432 334666665 45589999999999875 56789999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCcccc
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVPI 337 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~~ 337 (496)
|||++|+|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 139 E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 139 ECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp ECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999999986542 237899999999999999999999 78999999999999987 789999999999876
Q ss_pred CCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc----hhhhhhhcccC--Cccc
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN----SFRQILNFQVA--DESE 411 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~----~~~~i~~~~~~--~~~~ 411 (496)
.... .....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||....... ....+...... .+..
T Consensus 215 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 291 (400)
T 1nxk_A 215 TSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291 (400)
T ss_dssp C--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred CCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence 4322 2345679999999999999999999999999999999999999987654322 22333332222 2222
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
...++.+.+||.+||+.||.+|||+.|+++.
T Consensus 292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3456789999999999999999999999753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=340.12 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=206.2
Q ss_pred HhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecc--hhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCA--DEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..|.+.+.||+|+||.||+|.+ .++..||||.+... ........+|+.+++.++||||+++++++...+..|
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 4578889999999999999984 24678999998543 223334558899999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCc----ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEcc
Q 047375 258 LVYEFVSNGALSHYIHDKSS----QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSD 330 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~D 330 (496)
+|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999987532 1336888999999999999999999 78999999999999984 45699999
Q ss_pred CCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCc
Q 047375 331 FESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADE 409 (496)
Q Consensus 331 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~ 409 (496)
||++................||+.|+|||++.+..++.++|+||+|++++++++ +..||...........+.... ...
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~ 265 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMD 265 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCC
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCC
Confidence 999876544333223344568999999999998889999999999999999997 888887654444444443322 222
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+..+++.+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 3344567799999999999999999999999999988653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.35 Aligned_cols=248 Identities=19% Similarity=0.205 Sum_probs=205.0
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
+...|.+.+.||+|+||.||+|... ++..||+|++.... .......+|+.+++.++|||||+++++|.+.+..|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456888999999999999999964 68899999986542 2234455899999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCccc
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVP 336 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~ 336 (496)
||||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999998876543 6888999999999999999999 78999999999999976 45599999999987
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC--cccHHH
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD--ESEMEE 414 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~ 414 (496)
...... ....+||+.|+|||++.+ .++.++|+||+|+++|++++|.+||.+......+..+....... +.....
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTS
T ss_pred CCCCcc---ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccC
Confidence 654322 234569999999999875 68999999999999999999999998877666666666544332 333456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
++.+.+||.+||+.||.+|||+.++++
T Consensus 265 s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 265 SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 678999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.41 Aligned_cols=252 Identities=20% Similarity=0.295 Sum_probs=206.6
Q ss_pred HHHHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEee--------
Q 047375 182 ELLKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE-------- 252 (496)
Q Consensus 182 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-------- 252 (496)
......|.+.+.||+|+||.||+|... ++..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 345566888899999999999999974 78999999986543 234578999999999999999999864
Q ss_pred --------CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC
Q 047375 253 --------TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY 324 (496)
Q Consensus 253 --------~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~ 324 (496)
....++|||||++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCC
Confidence 4457999999999999999976532 247889999999999999999999 7899999999999999999
Q ss_pred ceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc
Q 047375 325 TAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF 404 (496)
Q Consensus 325 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 404 (496)
.+||+|||++........ .....||+.|+|||++.+..++.++|+||+|+++++++++..++..... ....+...
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~~~ 234 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDLRDG 234 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHHHTT
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHhhcc
Confidence 999999999987754322 2344599999999999998899999999999999999999887754321 22222222
Q ss_pred ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 405 QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 405 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
... ...++.+.+++.+||+.||.+|||+.|+++.|..+.+.
T Consensus 235 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 235 IIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 222 22345689999999999999999999999999887654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=357.32 Aligned_cols=248 Identities=20% Similarity=0.208 Sum_probs=210.6
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
....|.+.+.||+|+||.||+|... ++..||||++.... .......+|+.+++.++||||+++++++.+.+..|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4566888999999999999999964 78999999986432 223345589999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee---CCCCceEEccCCCcc
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLV 335 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll---~~~~~~kL~DFGla~ 335 (496)
|||||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999999876543 7889999999999999999999 789999999999999 567899999999998
Q ss_pred ccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC--cccHH
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD--ESEME 413 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~ 413 (496)
....... ....+||+.|+|||++.+ .++.++|+||+|+++|++++|.+||.+......+..+....... +....
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 253 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGG
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccccc
Confidence 7654322 234569999999999877 68899999999999999999999998877666666666554332 33345
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.++.+.+||.+||+.||.+|||+.|+++
T Consensus 254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 254 VSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 6788999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=358.34 Aligned_cols=263 Identities=19% Similarity=0.148 Sum_probs=210.7
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .+|+.||+|++...... .....+|+.++..++||||+++++++.+.+..|+|||
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 265 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 366678899999999999996 46899999998654322 2334578999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCc-ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 262 FVSNGALSHYIHDKSS-QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+||+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 9999999999876431 2347889999999999999999999 78999999999999999999999999999876543
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc----chhhhhhhcccCCcccHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN----NSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~----~~~~~i~~~~~~~~~~~~~~~ 416 (496)
.. .....+||+.|+|||++.+..++.++|+||+|+++|+|++|.+||...... .....+..... ..+...++
T Consensus 343 ~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~ 418 (543)
T 3c4z_A 343 QT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDKFSP 418 (543)
T ss_dssp CC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTTSCH
T ss_pred Cc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCcccCH
Confidence 22 123457999999999999999999999999999999999999999765332 22333333322 22344567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
.+.+||.+||+.||.+||++.+. ....+..++|.+..+|.
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~-----~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDG-----SCDGLRTHPLFRDISWR 458 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTT-----BSHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHhccCCHhHCCCCccc-----CHHHHHcCccccCCCHH
Confidence 89999999999999999986431 11223466777766553
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.59 Aligned_cols=247 Identities=20% Similarity=0.203 Sum_probs=204.9
Q ss_pred HHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--------------hhhhHHHHHHHHhcCCCCceeeEEEE
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--------------IRITEWEFLGIISQVKHKNVVKILGL 249 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~e~~~l~~l~hpnIv~l~~~ 249 (496)
...|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34588889999999999999996 4678999999865431 22344589999999999999999999
Q ss_pred EeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC---ce
Q 047375 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY---TA 326 (496)
Q Consensus 250 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~---~~ 326 (496)
+.+....|+|||||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999976543 7889999999999999999999 7899999999999998765 69
Q ss_pred EEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc
Q 047375 327 KVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV 406 (496)
Q Consensus 327 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 406 (496)
||+|||++........ ....+||+.|+|||++.+ .++.++|+||+|+++|++++|.+||.+......+..+.....
T Consensus 189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999987754322 234569999999999875 589999999999999999999999988776666666665544
Q ss_pred CCcc--cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 407 ADES--EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 407 ~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+. ....++.+.+||.+||+.||.+|||+.|+++
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 3322 2345678999999999999999999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=337.40 Aligned_cols=268 Identities=19% Similarity=0.241 Sum_probs=214.3
Q ss_pred ccCHHHHHHHhcchh-hhcccCCceEEEEeEeC-CCcEEEEEEeecchhh---hhhHHHHHHHHhcCC-CCceeeEEEEE
Q 047375 177 IFSKSELLKATKNFH-HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI---RITEWEFLGIISQVK-HKNVVKILGLC 250 (496)
Q Consensus 177 ~~~~~~l~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hpnIv~l~~~~ 250 (496)
.|...+.....|.+. +.||+|+||.||+|... ++..||+|++...... .....+|+.++..+. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 355566667778776 88999999999999964 6899999998654322 234558888998885 69999999999
Q ss_pred eeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceE
Q 047375 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAK 327 (496)
Q Consensus 251 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~k 327 (496)
.+.+..|+|||||++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999999865432 247889999999999999999999 78999999999999987 78999
Q ss_pred EccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc--
Q 047375 328 VSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ-- 405 (496)
Q Consensus 328 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-- 405 (496)
|+|||++........ .....||+.|+|||++.+..++.++|+||+|+++++++++..||........+..+....
T Consensus 175 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence 999999987654321 234569999999999999999999999999999999999999997766555554444322
Q ss_pred cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 406 VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 406 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
...+.....++.+.+||.+||+.||.+|||+.+++ .++|.+...++
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll----------~h~~~~~~~~~ 297 (327)
T 3lm5_A 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL----------SHSWLQQWDFE 297 (327)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT----------TCGGGCCCCTT
T ss_pred cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh----------CCHhhcccccc
Confidence 22233345567899999999999999999999984 56777665543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=327.77 Aligned_cols=245 Identities=20% Similarity=0.242 Sum_probs=180.7
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .++..||||.+...... .....+|+.++..++||||+++++++.+.+..|+|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 367778999999999999995 57899999998654322 2344588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++++|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred cCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999976532 36889999999999999999999 789999999999999999999999999988765332
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.. .....||+.|+|||++.+..++.++|+||+|+++++++++.+||...........+...... .+...+..+.+|
T Consensus 167 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 242 (278)
T 3cok_A 167 EK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--MPSFLSIEAKDL 242 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC--CCTTSCHHHHHH
T ss_pred Cc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC--CccccCHHHHHH
Confidence 21 23456999999999999988999999999999999999999998765444443333322221 222345679999
Q ss_pred HHHhcccCCCCCCCHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil 440 (496)
+.+||+.||.+|||+.+++
T Consensus 243 i~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHT
T ss_pred HHHHcccCHhhCCCHHHHh
Confidence 9999999999999999984
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.75 Aligned_cols=270 Identities=17% Similarity=0.145 Sum_probs=212.7
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEE-eeCCeeeEEEeec
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLC-LETKVTLLVYEFV 263 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~E~~ 263 (496)
..|.+.+.||+|+||.||+|.. .++..||||.+..... .....+|+.++..++|+|++..++.+ ...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 4588889999999999999995 5788999998654432 23456788999999988877776665 5677889999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee---CCCCceEEccCCCccccCCC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll---~~~~~~kL~DFGla~~~~~~ 340 (496)
+|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 -~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 88 -GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp -CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 8999999975433 37889999999999999999999 789999999999999 78899999999999876543
Q ss_pred CCc-----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc---chhhhhhhcccCCccc-
Q 047375 341 DET-----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN---NSFRQILNFQVADESE- 411 (496)
Q Consensus 341 ~~~-----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~- 411 (496)
... .......||+.|+|||++.+..++.++|+||+|+++++++++..||...... ..+..+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 221 1123456999999999999988999999999999999999999998764332 2222222222222211
Q ss_pred --HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcccc
Q 047375 412 --MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEES 462 (496)
Q Consensus 412 --~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~ 462 (496)
...++.+.+|+.+||+.||.+|||+.++++.|+.+.......|....+|+.
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 223567999999999999999999999999999998877666666665553
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=333.46 Aligned_cols=256 Identities=16% Similarity=0.121 Sum_probs=198.8
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
..|.+.+.||+|+||.||+|... ++..||+|.+...... .....+|+.++..++||||+++++++...+..|+||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 34778899999999999999964 6889999998654322 234458899999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 114 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 114 RLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp ECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999998654 37889999999999999999999 78999999999999999999999999998776543
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC--cccHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD--ESEMEEIEVV 418 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~l 418 (496)
.. .......||+.|+|||++.+..++.++|+||+|+++++++++..||...... ............ ......++.+
T Consensus 188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHH
Confidence 21 1223456999999999999999999999999999999999999998765433 222222222111 1223445679
Q ss_pred HHHHHHhcccCCCCCC-CHHHHHHHHHhhHhh
Q 047375 419 AELASKCLRIRGTERP-TMKEVSEELDRLRRL 449 (496)
Q Consensus 419 ~~li~~cl~~dP~~RP-s~~eil~~L~~l~~~ 449 (496)
.+++.+||+.||.+|| |+.++++.|+.+...
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 9999999999999999 999999999877543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.82 Aligned_cols=255 Identities=19% Similarity=0.228 Sum_probs=204.8
Q ss_pred hcchhh-hcccCCceEEEEeEe---CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 187 TKNFHH-CLGMGGFGSVYKGVL---PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 187 ~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
.|.+.+ .||+|+||.||+|.+ ..+..||||.+...... .....+|+.+++.++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 366666 899999999999964 34678999998654322 33455899999999999999999999 56678999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|||+++|+|.+++..... +++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEeCCCCCHHHHHHhCcC---CCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999987542 6889999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCcc-ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 340 DDETA-MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 340 ~~~~~-~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
..... ......||+.|+|||++.+..++.++|+||+|++++++++ +..||...........+... .....+..+++.
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 248 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPRE 248 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHH
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHH
Confidence 32221 1223346789999999998889999999999999999998 88888765544444333332 223334455678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 249 l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 249 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999988653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=328.23 Aligned_cols=242 Identities=20% Similarity=0.270 Sum_probs=195.6
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEee----CCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLE----TKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv 259 (496)
|.+.+.||+|+||.||+|.. .++..||+|.+.... .......+|+.+++.++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 56677899999999999985 467889999886432 223344588999999999999999999875 4568999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCC--cccCCCCcCceeeC-CCCceEEccCCCccc
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS--IIHSDVKSANILLD-DNYTAKVSDFESLVP 336 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivHrDlKp~NIll~-~~~~~kL~DFGla~~ 336 (496)
|||+++|+|.+++..... +++..++.++.||+.||.|||+ ++ |+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHHccC---CCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999976543 6889999999999999999999 56 99999999999997 788999999999876
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchh-hhhhhcccCCcccHHHH
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSF-RQILNFQVADESEMEEI 415 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~~~~~~~~~~~ 415 (496)
.... ......||+.|+|||++.+ .++.++|+||+|+++++++++..||......... ..+.............+
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred cccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence 5432 1234569999999998875 5889999999999999999999998764433322 22322222222333344
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 416 EVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
+.+.+|+.+||+.||.+|||+.+++
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHh
Confidence 6799999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.69 Aligned_cols=249 Identities=21% Similarity=0.242 Sum_probs=204.0
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh-------hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCe
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE-------IRITEWEFLGIISQVKHKNVVKILGLCLETKV 255 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 255 (496)
+...|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4456888999999999999999964 689999998865422 12345588999999999999999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC----ceEEccC
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY----TAKVSDF 331 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~----~~kL~DF 331 (496)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++ .+||+||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999997643 37889999999999999999999 7899999999999998877 8999999
Q ss_pred CCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc--
Q 047375 332 ESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE-- 409 (496)
Q Consensus 332 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-- 409 (496)
|++........ .....||+.|+|||++.+..++.++|+||+|+++++++++..||...........+.......+
T Consensus 157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T 3bhy_A 157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE 233 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred ccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence 99987654321 2344699999999999988899999999999999999999999877655544444443322211
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.....++.+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 11234567999999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=337.77 Aligned_cols=257 Identities=21% Similarity=0.224 Sum_probs=187.1
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCC-CCceeeEEEEEe--------eCC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVK-HKNVVKILGLCL--------ETK 254 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~-hpnIv~l~~~~~--------~~~ 254 (496)
..|.+.+.||+|+||.||+|.. .++..||||++...... .....+|+.++.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 3577889999999999999995 47889999988654333 334458899999996 999999999994 344
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCC--cccCCCCcCceeeCCCCceEEccCC
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS--IIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
..++||||+. |+|.+++........+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 5799999996 6999998764333457899999999999999999999 66 9999999999999999999999999
Q ss_pred CccccCCCCCcc----------ceecccccceeecCccc---ccccccCCCCCchhhhhcccccccccchhhhcccchhh
Q 047375 333 SLVPISSDDETA----------MSTMIRGTVGYLDPEYA---HTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFR 399 (496)
Q Consensus 333 la~~~~~~~~~~----------~~~~~~gt~~Y~aPE~l---~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
++.......... ......||+.|+|||++ .+..++.++|+||+|+++++++++..||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~- 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV- 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh-
Confidence 998765432211 11234599999999998 5667888999999999999999999998654333222
Q ss_pred hhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 400 QILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 400 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
......+.....+..+.+|+.+||+.||.+|||+.|+++.|+.+....
T Consensus 263 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 263 ---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 222222222233355889999999999999999999999999887643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.25 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=200.5
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++.+.+..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 3777889999999999999854 577899999864322 12334588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 90 YAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred cCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999976543 6889999999999999999999 789999999999999999999999999886554321
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.....||+.|+|||++.+..++.++|+||+|+++++++++..||...........+...... .+...++.+.+|
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 237 (279)
T 3fdn_A 164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDL 237 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCTTSCHHHHHH
T ss_pred ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC--CCCcCCHHHHHH
Confidence 23456999999999999999999999999999999999999998766555555554433222 223345679999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~ 441 (496)
+.+||+.||.+|||+.|+++
T Consensus 238 i~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHhh
Confidence 99999999999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=341.93 Aligned_cols=258 Identities=19% Similarity=0.176 Sum_probs=203.3
Q ss_pred hcchhhhcccCCceEEEEeEe----CCCcEEEEEEeecch-----hhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL----PDNTQVAVKKYMCAD-----EIRITEWEFLGIISQV-KHKNVVKILGLCLETKVT 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 256 (496)
.|.+.+.||+|+||.||+|.. .++..||||++.... .......+|+.++..+ +||||+++++++...+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 477889999999999999986 378999999986432 1223334678888888 699999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+|||||++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999998754 37889999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCccceecccccceeecCccccc--ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccCCcccH
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVADESEM 412 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~ 412 (496)
..... .......+||+.|+|||++.+ ..++.++|+||+|+++|+++++..||...........+... ....+.+.
T Consensus 209 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (355)
T 1vzo_A 209 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287 (355)
T ss_dssp CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred cccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc
Confidence 64322 222345679999999999985 45788999999999999999999998754433322222211 11222334
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 413 EEIEVVAELASKCLRIRGTERP-----TMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
..+..+.+||.+||+.||.+|| |+.|++ ++.|....++.
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell----------~h~~f~~~~~~ 331 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK----------EHLFFQKINWD 331 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH----------TSGGGTTCCHH
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH----------cCcchhcCChh
Confidence 4557799999999999999999 777774 45666655543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=337.65 Aligned_cols=241 Identities=22% Similarity=0.218 Sum_probs=199.0
Q ss_pred HHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---------hhhhHHHHHHHHhcCCCCceeeEEEEEeeC
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---------IRITEWEFLGIISQVKHKNVVKILGLCLET 253 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~ 253 (496)
....|.+.+.||+|+||.||+|.. .++..||||.+..... ......+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 345688889999999999999984 5788999999875432 112334789999999999999999999999
Q ss_pred CeeeEEEeeccCC-chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCC
Q 047375 254 KVTLLVYEFVSNG-ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 254 ~~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
+..++||||+.+| +|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999976543 7889999999999999999999 789999999999999999999999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccccc-cCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCccc
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTELL-TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESE 411 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 411 (496)
++........ ....+||+.|+|||++.+..+ +.++|+||+|+++|+++++..||..... ....... .+
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~--~~ 244 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIH--PP 244 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCC--CS
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccC--CC
Confidence 9987754322 234569999999999988776 7789999999999999999999865322 1111111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...++.+.+|+.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 224567999999999999999999999964
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.69 Aligned_cols=248 Identities=19% Similarity=0.161 Sum_probs=195.9
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|.+.+.||+|+||.||+|.. .++..||+|++...... .....+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4588889999999999999995 46889999998754322 23445899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee---CCCCceEEccCCCccccC
Q 047375 263 VSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 263 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll---~~~~~~kL~DFGla~~~~ 338 (496)
|++|+|.+++.... ....+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986531 12347889999999999999999999 789999999999999 456789999999998765
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc-ccHHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE-SEMEEIEV 417 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~ 417 (496)
.... .....||+.|+|||++.+ .++.++|+||+|+++++++++..||...........+........ .....++.
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp -----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred Cccc---CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence 4321 234569999999998864 578899999999999999999999876554443333322211111 11123567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil 440 (496)
+.+|+.+||+.||.+|||+.|++
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l 277 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVL 277 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHh
Confidence 89999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=339.18 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=204.9
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---------hhhhHHHHHHHHhcC-CCCceeeEEEEEee
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---------IRITEWEFLGIISQV-KHKNVVKILGLCLE 252 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~ 252 (496)
....|.+.+.||+|+||.||+|... +|..||||++..... ......+|+.++..+ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 3456778899999999999999974 789999998864321 123344788999998 79999999999999
Q ss_pred CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCC
Q 047375 253 TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 253 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecC
Confidence 999999999999999999997653 37889999999999999999999 789999999999999999999999999
Q ss_pred CccccCCCCCccceecccccceeecCccccc------ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHT------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV 406 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 406 (496)
++..+..... .....||+.|+|||++.+ ..++.++|+||+|+++|++++|.+||...........+.....
T Consensus 246 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 246 FSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 9987754322 234569999999999864 3578899999999999999999999876555444455544333
Q ss_pred CCccc--HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 407 ADESE--MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 407 ~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....+ ...++.+.+|+.+||+.||.+|||+.++++
T Consensus 323 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 32211 234567999999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=337.87 Aligned_cols=259 Identities=19% Similarity=0.265 Sum_probs=207.1
Q ss_pred HhcchhhhcccCCceEEEEeEe-----CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCC--eee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-----PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETK--VTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~ 257 (496)
..|.+.+.||+|+||.||+|.+ .++..||||++...... .....+|+.+++.++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4477789999999999999983 36889999998754333 234558999999999999999999987644 789
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+||||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 121 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999987543 36889999999999999999999 78999999999999999999999999999877
Q ss_pred CCCCCcc-ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc---------------chhhhh
Q 047375 338 SSDDETA-MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN---------------NSFRQI 401 (496)
Q Consensus 338 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---------------~~~~~i 401 (496)
....... ......+|..|+|||++.+..++.++|+||+|+++++++++..|+...... ..+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 5442211 122345788899999999988999999999999999999998776533110 011112
Q ss_pred hhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 402 LNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 402 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
+......+.+..+++.+.+||.+||+.||.+|||+.++++.|+.++..
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 222222333445567899999999999999999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=338.35 Aligned_cols=262 Identities=20% Similarity=0.222 Sum_probs=200.5
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh--hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR--ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|... ++..||+|++....... ....+|+.+++.++||||+++++++.+.+..++|||||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 3677789999999999999964 78899999986443222 12236899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
+ |+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 83 D-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp S-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred c-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 7 499998876543 36889999999999999999999 7899999999999999999999999999876543321
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc---CC-----------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV---AD----------- 408 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~---~~----------- 408 (496)
......||+.|+|||++.+ ..++.++|+||+|++++++++|.+||.+.........+..... ..
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 2234468999999999876 5688999999999999999999999977654444333322100 00
Q ss_pred --------------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcccccccc
Q 047375 409 --------------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEESEHLL 466 (496)
Q Consensus 409 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~~~~~ 466 (496)
......++.+.+|+.+||+.||.+|||+.|++ +++|.....+......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l----------~hp~f~~~~~~~~~~~ 296 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM----------KHPFFLSLGERIHKLP 296 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT----------TSGGGGGGCSTTSSSC
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh----------cChhhhhcccccccCC
Confidence 00012346789999999999999999999984 5777776655444433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.02 Aligned_cols=240 Identities=20% Similarity=0.160 Sum_probs=205.5
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|.. .+++.||||++.... ........|..++..+ +||||+++++++.+.+..||||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 466778999999999999995 467889999987532 2223345778888877 7999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
||+++|+|.+++..... +++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.....
T Consensus 422 E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred eCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999987543 7889999999999999999999 78999999999999999999999999999865433
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
.. .....+||+.|+|||++.+..++.+.|+||+|+++|+|++|.+||.+......+..+.......+ ...++.+.+
T Consensus 496 ~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~ 571 (674)
T 3pfq_A 496 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVA 571 (674)
T ss_dssp TC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC--TTSCHHHHH
T ss_pred Cc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHHHHH
Confidence 22 23456799999999999999999999999999999999999999988777777777776544333 345678999
Q ss_pred HHHHhcccCCCCCCCH
Q 047375 421 LASKCLRIRGTERPTM 436 (496)
Q Consensus 421 li~~cl~~dP~~RPs~ 436 (496)
||.+||+.||.+||++
T Consensus 572 li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HHHHHSCSSSTTCTTC
T ss_pred HHHHHccCCHHHCCCC
Confidence 9999999999999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=333.44 Aligned_cols=246 Identities=21% Similarity=0.233 Sum_probs=193.4
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|... ++..||+|++...... .....+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 4777889999999999999964 5899999988654322 23345889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++++|.+++..... +++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 84 CDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999998865432 6889999999999999999999 7899999999999999999999999999987654322
Q ss_pred ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-----------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF----------------- 404 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------------- 404 (496)
......||+.|+|||++.+ ..++.++|+||+|++++++++|.+||.+.........+...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 1234569999999999876 66789999999999999999999998765443333222110
Q ss_pred ----ccCCc--------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 405 ----QVADE--------SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 405 ----~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
..+.+ .....++.+.+|+.+||+.||.+|||+.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 00000 0012346789999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=339.04 Aligned_cols=257 Identities=19% Similarity=0.222 Sum_probs=198.1
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
..|.+.+.||+|+||.||+|.. .++..||||++...... .....+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 3478889999999999999985 47889999998644322 2234488999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee-----CCCCceEEccCCCccc
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL-----DDNYTAKVSDFESLVP 336 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll-----~~~~~~kL~DFGla~~ 336 (496)
||++ +|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++..
T Consensus 114 ~~~~-~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 114 YAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp CCSE-EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred cCCC-CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9985 99999987543 7889999999999999999999 789999999999999 4555699999999987
Q ss_pred cCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD------- 408 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~------- 408 (496)
...... ......||+.|+|||++.+ ..++.++|+||+|+++++++++.+||........+..+.......
T Consensus 187 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 187 FGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 653321 2234568999999999987 458999999999999999999999987665544444333210000
Q ss_pred ----------------c-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 409 ----------------E-----SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 409 ----------------~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
. .....++.+.+||.+||+.||.+|||+.|++ +++|.+...++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l----------~hp~f~~~~~~ 328 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL----------EHPYFSHNDFD 328 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH----------TSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh----------CCcccCCCCCC
Confidence 0 0011346789999999999999999999984 57787776543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=346.95 Aligned_cols=254 Identities=19% Similarity=0.160 Sum_probs=202.0
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcC------CCCceeeEEEEEeeCCeeeE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQV------KHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l------~hpnIv~l~~~~~~~~~~~l 258 (496)
..|.+.+.||+|+||.||+|.. .++..||||++...........+|+.++..+ +|+||+++++++...+..|+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 4578889999999999999985 4688999999976555444555677776665 57899999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc--eEEccCCCccc
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT--AKVSDFESLVP 336 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~--~kL~DFGla~~ 336 (496)
||||+. |+|.+++...... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 177 v~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 999996 5999999875433 37889999999999999999999 78999999999999999887 99999999976
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC--------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD-------- 408 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-------- 408 (496)
.... ....+||+.|+|||++.+..++.++|+||+||++|+|++|.+||........+..+.......
T Consensus 252 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 252 EHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred cCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 5432 234569999999999999999999999999999999999999987655443333322110000
Q ss_pred -----------------------------------------c---cc-----HHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047375 409 -----------------------------------------E---SE-----MEEIEVVAELASKCLRIRGTERPTMKEV 439 (496)
Q Consensus 409 -----------------------------------------~---~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ei 439 (496)
+ .. ...++.+.+||.+||+.||.+|||+.|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 0 00 0114668999999999999999999999
Q ss_pred HHHHHhhHhhhhhhhhccCc
Q 047375 440 SEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 440 l~~L~~l~~~~~~~~~~~~~ 459 (496)
+ +++|.+...
T Consensus 407 L----------~Hpw~~~~~ 416 (429)
T 3kvw_A 407 L----------RHPWLRRRL 416 (429)
T ss_dssp H----------TSTTTC---
T ss_pred h----------CChhhccCC
Confidence 4 567776654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.88 Aligned_cols=243 Identities=21% Similarity=0.174 Sum_probs=190.9
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC------Cee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET------KVT 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~~ 256 (496)
.|.+.+.||+|+||.||+|.. .+++.||||++.... .......+|+.+++.++|||||++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 477789999999999999985 468899999986532 2233455899999999999999999999754 357
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+|||||++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 143 ~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999976 56666643 26788999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC---------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--------- 407 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--------- 407 (496)
..... ..+..+||+.|+|||++.+..++.+.|+||+||++++|++|.+||.+......+..+......
T Consensus 214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 214 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ---CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred cCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 65431 234567999999999999999999999999999999999999999775544433333221000
Q ss_pred -------------------------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 408 -------------------------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 408 -------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.......++.+.+|+.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0001122577999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=327.61 Aligned_cols=243 Identities=23% Similarity=0.296 Sum_probs=204.1
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4777899999999999999964 678899999865322 12344588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++|+|.+++..... +++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999987543 6889999999999999999999 789999999999999999999999999987654321
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.....||+.|+|||++.+..++.++|+||+|+++++++++.+||...........+...... .+...+..+.++
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 242 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDL 242 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCTTSCHHHHHH
T ss_pred ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC--CCCcCCHHHHHH
Confidence 23456999999999999989999999999999999999999998766555555555443322 223345679999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~ 441 (496)
|.+||+.||.+|||+.++++
T Consensus 243 i~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhcCHhhCCCHHHHhh
Confidence 99999999999999999853
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.54 Aligned_cols=259 Identities=18% Similarity=0.210 Sum_probs=202.5
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh-hhhhHHHHHHHHhcCCCCceeeEEEEEee----CCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE-IRITEWEFLGIISQVKHKNVVKILGLCLE----TKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv 259 (496)
..|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+.+++.++||||+++++++.. ....|+|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 3578889999999999999995 5789999998865433 33344589999999999999999999973 4578999
Q ss_pred EeeccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 260 YEFVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||+++|+|.+++... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 9999999999999763 112347889999999999999999999 789999999999999999999999999887653
Q ss_pred CCCCcc-------ceecccccceeecCcccccc---cccCCCCCchhhhhcccccccccchhhhccc-chhhhhhhcccC
Q 047375 339 SDDETA-------MSTMIRGTVGYLDPEYAHTE---LLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQVA 407 (496)
Q Consensus 339 ~~~~~~-------~~~~~~gt~~Y~aPE~l~~~---~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~ 407 (496)
...... ......||+.|+|||++.+. .++.++|+||+|+++++++++..||...... ............
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence 211110 01234579999999998754 3688999999999999999999988653222 122222222233
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
.+.....++.+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 3333445678999999999999999999999999998774
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=329.46 Aligned_cols=268 Identities=16% Similarity=0.141 Sum_probs=210.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEE-eeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLC-LETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .+++.||||.+..... .....+|+.++..++|+|++..++++ ...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 477789999999999999995 5789999998865433 23456889999999998877666655 5677889999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee---CCCCceEEccCCCccccCCCC
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll---~~~~~~kL~DFGla~~~~~~~ 341 (496)
+++|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++.......
T Consensus 88 ~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 88 GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 8899999975432 37889999999999999999999 789999999999999 478899999999998765542
Q ss_pred Ccc-----ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc---chhhhhhhcccCCcc---
Q 047375 342 ETA-----MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN---NSFRQILNFQVADES--- 410 (496)
Q Consensus 342 ~~~-----~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~--- 410 (496)
... ......||+.|+|||++.+..++.++|+||+|+++++++++..||...... ..+..+.......+.
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 211 123456999999999999988999999999999999999999998764322 223333322222211
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
....++.+.+++.+||+.||.+|||+.++++.|+.+.......+....+|+
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 123356799999999999999999999999999998766554444434443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.30 Aligned_cols=250 Identities=20% Similarity=0.199 Sum_probs=193.0
Q ss_pred HHHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---------hhhhHHHHHHHHhcCCCCceeeEEEEEe
Q 047375 182 ELLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---------IRITEWEFLGIISQVKHKNVVKILGLCL 251 (496)
Q Consensus 182 ~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~l~~~~~ 251 (496)
......|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34556788889999999999999985 4688999999865321 1123458899999999999999999985
Q ss_pred eCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC---CceEE
Q 047375 252 ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN---YTAKV 328 (496)
Q Consensus 252 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~---~~~kL 328 (496)
.+..|+|||||++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.+ +.+||
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence 455799999999999999987643 37889999999999999999999 789999999999999654 45999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccchhhhh-hhc
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQI-LNF 404 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i-~~~ 404 (496)
+|||+++..... ......+||+.|+|||++.+ ..++.++|+||+|+++|++++|.+||............ ...
T Consensus 284 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~ 360 (419)
T 3i6u_A 284 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred eecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence 999999876532 22345679999999999864 56788999999999999999999999765444333322 222
Q ss_pred ccCCc--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 QVADE--SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..... .....++.+.+|+.+||+.||.+|||+.|+++
T Consensus 361 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 22211 11234578999999999999999999999853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.54 Aligned_cols=257 Identities=19% Similarity=0.226 Sum_probs=202.0
Q ss_pred HhcchhhhcccCCceEEEEeEeC--CCc--EEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP--DNT--QVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..|.+.+.||+|+||.||+|.+. ++. .||||.+.... .......+|+.+++.++||||+++++++...+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 34788899999999999999852 233 68999886432 22334458899999999999999999998765 88
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+||||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999986532 36889999999999999999999 78999999999999999999999999999877
Q ss_pred CCCCCcc-ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHH
Q 047375 338 SSDDETA-MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEI 415 (496)
Q Consensus 338 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 415 (496)
....... ......+|+.|+|||++.+..++.++|+||+|++++++++ +..||...........+.......+.....+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 5432221 1233457889999999999889999999999999999998 8988877665555555554444444445566
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 416 EVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
+.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 789999999999999999999999999987753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=340.29 Aligned_cols=252 Identities=17% Similarity=0.140 Sum_probs=201.0
Q ss_pred HhcchhhhcccCCceEEEEeE------eCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC---CCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGV------LPDNTQVAVKKYMCADEIRITEWEFLGIISQVK---HKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~ 256 (496)
..|.+.+.||+|+||.||+|. ..++..||||++.... ......|+.++..++ |+||+++++++...+..
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 447778899999999999994 3468899999986543 223345666666666 99999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcC--cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-----------C
Q 047375 257 LLVYEFVSNGALSHYIHDKS--SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-----------N 323 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-----------~ 323 (496)
|+|||||++|+|.+++.... ....+++..++.|+.||+.||.|||+ ++||||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999997532 22347999999999999999999999 78999999999999998 8
Q ss_pred CceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh
Q 047375 324 YTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN 403 (496)
Q Consensus 324 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~ 403 (496)
+.+||+|||+|+..............+||+.|+|||++.+..++.++|+||+|+++|+|++|..||......... ..
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~ 296 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PE 296 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---EC
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---ec
Confidence 999999999997664333333345667999999999999999999999999999999999999888654332111 01
Q ss_pred cccCCcccHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhHh
Q 047375 404 FQVADESEMEEIEVVAELASKCLRIRGTER-PTMKEVSEELDRLRR 448 (496)
Q Consensus 404 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~l~~ 448 (496)
...... ...+.+.+++..|++.+|.+| |++.++.+.|+.+..
T Consensus 297 ~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 297 GLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp SCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred hhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 111111 124568899999999999999 678888888887654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=334.40 Aligned_cols=249 Identities=18% Similarity=0.236 Sum_probs=197.5
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEee------CCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLE------TKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~------~~~~~l 258 (496)
.|.+.+.||+|+||.||+|.. .++..||||.+...........+|+.++.++ +||||+++++++.. .+..|+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 477789999999999999996 4788999999876555555566889999998 79999999999987 467899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 105 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 9999999999999986532 347888999999999999999999 789999999999999999999999999988764
Q ss_pred CCCCccceecccccceeecCcccc-----cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAH-----TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEME 413 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 413 (496)
.... ......||+.|+|||++. +..++.++|+||+|+++++++++.+||...........+............
T Consensus 181 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 2x7f_A 181 RTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSC
T ss_pred cCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccc
Confidence 3211 123456999999999987 467888999999999999999999998765544444333333222222334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.++.+.+||.+||..||.+|||+.++++
T Consensus 259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 259 WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 4567999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=337.71 Aligned_cols=259 Identities=20% Similarity=0.208 Sum_probs=193.6
Q ss_pred HHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCe-------e
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKV-------T 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-------~ 256 (496)
-..|.+.+.||+|+||.||+|.. .++..||||++.........+.+++..+..++||||+++++++...+. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 34578889999999999999996 468899999987665555666788888899999999999999976433 7
Q ss_pred eEEEeeccCCchhhhhhh-cCcccccCHHHHHHHHHHHHHHHHHhH--hcCCCCcccCCCCcCceeeCC-CCceEEccCC
Q 047375 257 LLVYEFVSNGALSHYIHD-KSSQVLKNWKTCLRIAAETASAIHYLH--SLASPSIIHSDVKSANILLDD-NYTAKVSDFE 332 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~qi~~gL~~LH--~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFG 332 (496)
++|||||++ +|...+.. ......+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 899999986 55544432 222334688899999999999999999 6 78999999999999986 8999999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC----
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA---- 407 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 407 (496)
++........ .....||+.|+|||++.+. .++.++|+||+|++++++++|.+||........+..+......
T Consensus 178 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 178 SAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp TCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 9987754322 2345689999999998664 4899999999999999999999999876555444444321100
Q ss_pred --------------------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 408 --------------------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 408 --------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
.......++.+.+|+.+||+.||.+|||+.|++ +++|.+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l----------~hp~f~~~~~ 323 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL----------CHPYFDELHD 323 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT----------TSGGGGGGGC
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh----------cCccccccCC
Confidence 001112457899999999999999999999984 5677766543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=327.80 Aligned_cols=249 Identities=16% Similarity=0.161 Sum_probs=199.0
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh-----hhhhHHHHHHHHhcCCCCceeeEEEEEe--eCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE-----IRITEWEFLGIISQVKHKNVVKILGLCL--ETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~hpnIv~l~~~~~--~~~~~~ 257 (496)
..|.+.+.||+|+||.||+|.. .++..||+|.+..... ......+|+.+++.++||||+++++++. +.+..|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 3577889999999999999996 4688999999865432 2334558999999999999999999984 456789
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+|||||++| |.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999875 7777765433 247889999999999999999999 78999999999999999999999999999876
Q ss_pred CCCCCccceecccccceeecCcccccc--cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHH
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTE--LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI 415 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 415 (496)
.............||+.|+|||++.+. .++.++|+||+|+++++++++..||...........+...... .+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~ 237 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA--IPGDCG 237 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--CCSSSC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC--CCCccC
Confidence 543333333455699999999998763 3467899999999999999999998766554444444443322 223345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 416 EVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 67999999999999999999999853
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.95 Aligned_cols=249 Identities=19% Similarity=0.231 Sum_probs=201.6
Q ss_pred hhcccCCceEEEEeEe---CCCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVL---PDNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.+ ..+..||||++...... .....+|+.++.+++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 34678999998754322 2445589999999999999999999964 457899999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc-c
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET-A 344 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~-~ 344 (496)
|+|.+++.... .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997654 37889999999999999999999 78999999999999999999999999999877543221 1
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......||+.|+|||++.+..++.++|+||+|++++++++ |..||.+.........+... .....+..+++.+.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHH
Confidence 2233457889999999999899999999999999999998 89998776555544444432 233344556678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 424 KCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
+||+.||.+|||+.+|++.|+.+..
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999988753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=325.38 Aligned_cols=243 Identities=19% Similarity=0.199 Sum_probs=196.0
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEE
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 259 (496)
...|.+.+.||+|+||.||+|... ++..||+|.+.... .......+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 355888899999999999999964 78999999987532 2233445788888888 899999999999999999999
Q ss_pred EeeccCCchhhhhhhcCc-ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC----------------
Q 047375 260 YEFVSNGALSHYIHDKSS-QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---------------- 322 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---------------- 322 (496)
||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976422 1347889999999999999999999 78999999999999984
Q ss_pred ---CCceEEccCCCccccCCCCCccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchh
Q 047375 323 ---NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSF 398 (496)
Q Consensus 323 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
...+||+|||++....... ...||+.|+|||++.+. .++.++|+||+|+++++++++.+++.... ..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QW 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HH
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HH
Confidence 4479999999988765432 23499999999999875 56679999999999999999988764432 22
Q ss_pred hhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 399 RQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 399 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
..+..... ...+...++.+.+|+.+||+.||.+|||+.+++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 238 HEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp HHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 33332222 222334457799999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=332.58 Aligned_cols=245 Identities=20% Similarity=0.212 Sum_probs=204.6
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
..|.+.+.||+|+||.||++... ++..||+|.+.... .......+|+.+++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 45777899999999999999964 57889999886542 22334458899999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 121 e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999987654 37889999999999999999999 78999999999999999999999999999876533
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
... .....||+.|+|||++.+..++.++|+||+|+++|+++++..||........+..+...... .+...++.+.+
T Consensus 195 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 270 (335)
T 2owb_A 195 GER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINPVAAS 270 (335)
T ss_dssp TCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCTTSCHHHHH
T ss_pred ccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC--CCccCCHHHHH
Confidence 221 23456999999999999988999999999999999999999998765554444444433322 22234567899
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil 440 (496)
|+.+||+.||.+|||+.+++
T Consensus 271 li~~~l~~dp~~Rps~~ell 290 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELL 290 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGG
T ss_pred HHHHHccCChhHCcCHHHHh
Confidence 99999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=347.82 Aligned_cols=258 Identities=19% Similarity=0.210 Sum_probs=183.8
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----Cee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET-----KVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~ 256 (496)
..|.+.+.||+|+||.||+|.. .++..||||++.... .......+|+.+|+.++|||||++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 3578889999999999999985 478899999986432 2223455899999999999999999999543 568
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+||||+. |+|.+++.... .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.
T Consensus 133 ~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 99999985 69999987643 37889999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCc-------------------------cceecccccceeecCccc-ccccccCCCCCchhhhhcccccc------
Q 047375 337 ISSDDET-------------------------AMSTMIRGTVGYLDPEYA-HTELLTGMNPNSYVALASNEKIS------ 384 (496)
Q Consensus 337 ~~~~~~~-------------------------~~~~~~~gt~~Y~aPE~l-~~~~~t~~~d~~s~g~~~~~~~~------ 384 (496)
....... ...+..+||+.|+|||++ ....++.+.|+||+||++|+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6532111 123445789999999976 55679999999999999999998
Q ss_pred -----cccchhhhcc--------------------cchhhhhhhcc----------------------cC-------Ccc
Q 047375 385 -----MVPYFLDSIE--------------------NNSFRQILNFQ----------------------VA-------DES 410 (496)
Q Consensus 385 -----~~~~~~~~~~--------------------~~~~~~i~~~~----------------------~~-------~~~ 410 (496)
+.++|.+... ...+..+.+.. .. ...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 4455533211 00111111000 00 000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
....++.+.+||.+||..||.+|||+.|++ .++|.+...+
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L----------~Hp~f~~~~~ 405 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECL----------AHPFFKEVRI 405 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHH----------HSGGGTTTCC
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHh----------cCHhhhhcCC
Confidence 112356799999999999999999999884 4666665543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=327.31 Aligned_cols=244 Identities=20% Similarity=0.214 Sum_probs=203.9
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||+|.+.... .......+|+.+++.++||||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 4777889999999999999964 57889999886542 223344578999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 96 LCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp CCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999987654 37889999999999999999999 789999999999999999999999999998765332
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
.. .....||+.|+|||++.+..++.++|+||+|+++++++++..||........+..+...... .+...++.+.++
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 245 (294)
T 2rku_A 170 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINPVAASL 245 (294)
T ss_dssp CC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCTTSCHHHHHH
T ss_pred cc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC--CccccCHHHHHH
Confidence 22 23456999999999999988999999999999999999999998766554444444433322 222345679999
Q ss_pred HHHhcccCCCCCCCHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil 440 (496)
+.+||+.||.+|||+.+++
T Consensus 246 i~~~l~~~p~~Rps~~~ll 264 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELL 264 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGG
T ss_pred HHHHcccChhhCcCHHHHh
Confidence 9999999999999999984
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=360.59 Aligned_cols=250 Identities=20% Similarity=0.255 Sum_probs=202.0
Q ss_pred hcccCCceEEEEeEeC---CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 193 CLGMGGFGSVYKGVLP---DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
.||+|+||.||+|.+. ++..||||++..... ......+|+.+|+.++|||||+++++|.. +..|+|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999863 456799999875432 23445689999999999999999999976 56899999999999
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc-cce
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET-AMS 346 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~ 346 (496)
|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 422 L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999976432 37889999999999999999999 78999999999999999999999999999876543221 111
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+|+.|+|||++.+..++.++|+||+|+++|+|++ |..||...........+... ...+.+..+++.+.+||.+|
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~c 575 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMSDC 575 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHT
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHH
Confidence 22346789999999998899999999999999999997 89998776555555444432 23334445668899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhHhh
Q 047375 426 LRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
|+.||.+|||+.+|++.|+.+...
T Consensus 576 l~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 576 WIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp TCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred cCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999887543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.24 Aligned_cols=256 Identities=10% Similarity=0.118 Sum_probs=203.5
Q ss_pred hcchhhhcccCCceEEEEeEeCC---------CcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceee------------
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPD---------NTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVK------------ 245 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~------------ 245 (496)
.|.+.+.||+|+||.||+|.... +..||||.+... ....+|+.++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 47788999999999999999653 789999998643 34568899999999999988
Q ss_pred ---EEEEEee-CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 246 ---ILGLCLE-TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 246 ---l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
+++++.. .+..|+||||| +|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEE
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEc
Confidence 6778776 77889999999 9999999986532 347899999999999999999999 7899999999999999
Q ss_pred CCC--ceEEccCCCccccCCCCCc-----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhc-
Q 047375 322 DNY--TAKVSDFESLVPISSDDET-----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSI- 393 (496)
Q Consensus 322 ~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~- 393 (496)
.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|+||+|+++|+++++..||....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 988 8999999999876543211 11234469999999999999889999999999999999999999887654
Q ss_pred ccchhhhhhh---cccCCc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhh
Q 047375 394 ENNSFRQILN---FQVADE-----SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQE 451 (496)
Q Consensus 394 ~~~~~~~i~~---~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 451 (496)
.......... ...... .....++.+.+|+.+||+.||.+|||+.+|++.|+.+.+...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 2222211111 111100 011235779999999999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.33 Aligned_cols=247 Identities=18% Similarity=0.155 Sum_probs=198.1
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|.+.+.||+|+||.||+|... ++..||+|.+.... .......+|+.+++.++||||+++++++...+..|+||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 34777789999999999999964 68899999986542 2234455889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++..... +++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999987543 68899999999999999999982 27999999999999999999999999998765322
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchh------------------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSF------------------------ 398 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~------------------------ 398 (496)
......||+.|+|||++.+..++.++|+||+|+++++++++..||.........
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 123456999999999999988999999999999999999999888653322110
Q ss_pred ------------------hhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 399 ------------------RQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 399 ------------------~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+.............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1111111111111224567999999999999999999999964
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=326.57 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=196.1
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCchh
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALS 269 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 269 (496)
..||+|+||.||+|.. .++..||||.+...... .....+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999995 56889999998654332 334558899999999999999999999999999999999999999
Q ss_pred hhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCCccccCCCCCccceec
Q 047375 270 HYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPISSDDETAMSTM 348 (496)
Q Consensus 270 ~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~ 348 (496)
+++........+++..+..++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 182 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTET 182 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccc
Confidence 999876544456788899999999999999999 78999999999999987 89999999999987654221 1234
Q ss_pred ccccceeecCccccccc--ccCCCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 349 IRGTVGYLDPEYAHTEL--LTGMNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 349 ~~gt~~Y~aPE~l~~~~--~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
..||+.|+|||++.+.. ++.++|+||+|++++++++|..||....... ..............+...++.+.+|+.+|
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 262 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 262 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHT
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHH
Confidence 56999999999987643 7889999999999999999999886543221 11111111222333344567899999999
Q ss_pred cccCCCCCCCHHHHH
Q 047375 426 LRIRGTERPTMKEVS 440 (496)
Q Consensus 426 l~~dP~~RPs~~eil 440 (496)
|+.||.+|||+.+++
T Consensus 263 l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 263 FEPDPDKRACANDLL 277 (295)
T ss_dssp TCSSTTTSCCHHHHH
T ss_pred ccCChhhCCCHHHHh
Confidence 999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=325.63 Aligned_cols=249 Identities=21% Similarity=0.279 Sum_probs=192.6
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEee------------
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE------------ 252 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------------ 252 (496)
..|.+.+.||+|+||.||+|.. .++..||||.+...........+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 4578889999999999999995 478999999997655555556689999999999999999999865
Q ss_pred -CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccC
Q 047375 253 -TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331 (496)
Q Consensus 253 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DF 331 (496)
.+..|+|||||++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence 4567999999999999999986432 36778899999999999999999 78999999999999999999999999
Q ss_pred CCccccCCCCC------------ccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchh
Q 047375 332 ESLVPISSDDE------------TAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSF 398 (496)
Q Consensus 332 Gla~~~~~~~~------------~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|++........ ........||+.|+|||++.+. .++.++|+||+|++++++++ ++..........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--p~~~~~~~~~~~ 238 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--CCSSHHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--ccCCchhHHHHH
Confidence 99887643210 1112345699999999999864 68899999999999999997 222222222222
Q ss_pred hhhhhc--ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 399 RQILNF--QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 399 ~~i~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+... ..+.......++.+.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 333221 2233333445567999999999999999999999953
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.29 Aligned_cols=246 Identities=21% Similarity=0.205 Sum_probs=192.4
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------eeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETK------VTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|....+..||+|++....... .+|+.+++.++||||++++++|...+ ..++||
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~---~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK---NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC---CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH---HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 477889999999999999998777779999886543222 26899999999999999999996543 378999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC-CCCceEEccCCCccccCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAKVSDFESLVPISS 339 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~-~~~~~kL~DFGla~~~~~ 339 (496)
|||+++.+............+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 999875444333222222347889999999999999999999 7899999999999998 799999999999987644
Q ss_pred CCCccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc-------------
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ------------- 405 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------- 405 (496)
... .....||+.|+|||++.+. .++.+.|+||+||++|+|++|.+||.+......+..+....
T Consensus 195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 195 GEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp TCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred CCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 322 2345689999999998764 58999999999999999999999998765444443333210
Q ss_pred ------cC---Cc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 ------VA---DE-----SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ------~~---~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+ .. .....++.+.+|+.+||+.||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 00 01124467999999999999999999999853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=335.70 Aligned_cols=247 Identities=21% Similarity=0.214 Sum_probs=195.9
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh------hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI------RITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
..|.+.+.||+|+||.||+|... +|..||||++...... .....+|+.+++.++||||+++++++...+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 34777899999999999999964 6889999998643221 2344589999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||+++ +|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 90 v~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 9999986 89888876532 36778899999999999999999 789999999999999999999999999998765
Q ss_pred CCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC---------
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD--------- 408 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--------- 408 (496)
.... ......||+.|+|||++.+ ..++.++|+||+|+++++++++.+||.+......+..+.......
T Consensus 164 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 164 SPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp SCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred CCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 4322 2234569999999999876 457889999999999999999999987765554444443211000
Q ss_pred ------------cc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 409 ------------ES-----EMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 409 ------------~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.. ....++.+.+||.+||+.||.+|||+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 00 022346799999999999999999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=325.54 Aligned_cols=255 Identities=21% Similarity=0.253 Sum_probs=207.8
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch----------hhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD----------EIRITEWEFLGIISQVK-HKNVVKILGLCLETK 254 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~ 254 (496)
.|.+.+.||+|+||.||+|... +++.||||.+.... .......+|+.++.++. ||||+++++++...+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4777899999999999999964 68899999986432 11233447899999995 999999999999999
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999998653 37889999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCccceecccccceeecCcccc------cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-
Q 047375 335 VPISSDDETAMSTMIRGTVGYLDPEYAH------TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA- 407 (496)
Q Consensus 335 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~------~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~- 407 (496)
........ .....||+.|+|||++. ...++.++|+||+|+++++++++..||...........+......
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 87654322 23456999999999985 346788999999999999999999998766555444444443322
Q ss_pred -CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 408 -DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 408 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
.+.....++.+.+|+.+||+.||.+|||+.+++ .++|.+....
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll----------~h~~~~~~~~ 292 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL----------AHPFFQQYVV 292 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT----------TSGGGCTTC-
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHH----------hChHhhhccc
Confidence 222245567899999999999999999999984 4666665543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=327.44 Aligned_cols=250 Identities=20% Similarity=0.226 Sum_probs=199.8
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
....|.+.+.||+|+||.||+|... ++..||+|.+.... ......+|+.++..++||||+++++++...+..|+||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3455778899999999999999964 58899999986543 234456889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 106 CGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999975432 36889999999999999999999 7899999999999999999999999999987654322
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc-cCCcccHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ-VADESEMEEIEVVAEL 421 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~l~~l 421 (496)
......||+.|+|||++.+..++.++|+||+|+++++++++..||...........+.... .....+...+..+.+|
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 2234569999999999999889999999999999999999999987654333332222211 1112233345779999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~ 441 (496)
+.+||+.||.+|||+.++++
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHccCChhhCcCHHHHHh
Confidence 99999999999999999954
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=333.90 Aligned_cols=247 Identities=23% Similarity=0.297 Sum_probs=194.5
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh---hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI---RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|... ++..||||++...... .....+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 3777889999999999999964 5889999998644322 23344889999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 106 ~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 106 VDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999988865543 27889999999999999999999 7899999999999999999999999999987654322
Q ss_pred ccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc---------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV--------------- 406 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--------------- 406 (496)
......||+.|+|||++.+. .++.++|+||+|++++++++|.+||...........+.....
T Consensus 180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 12345699999999999875 678899999999999999999999876554433333221100
Q ss_pred ---------CCcc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 407 ---------ADES-----EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 407 ---------~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.... ....++.+.+|+.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0123577999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=336.62 Aligned_cols=242 Identities=20% Similarity=0.222 Sum_probs=191.5
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------ee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETK------VT 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~ 256 (496)
.|.+.+.||+|+||.||+|.. .+|..||||++.... .......+|+.+++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 477788999999999999996 478999999985432 22334458999999999999999999998653 45
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+||||+ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999999 78999999763 26888999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD------- 408 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~------- 408 (496)
.... ....+||+.|+|||++.+ ..++.+.|+||+||++++|++|.+||.+......+..+.......
T Consensus 178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 6432 234569999999999887 678999999999999999999999997665444444333211000
Q ss_pred ----------------------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 409 ----------------------ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 409 ----------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
......++.+.+|+.+||..||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 011223567999999999999999999999854
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.43 Aligned_cols=244 Identities=23% Similarity=0.238 Sum_probs=194.6
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|... ++..||||.+..... ......+|+.+++.++||||+++++++...+..|+|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4777889999999999999964 789999999865432 12344588999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
|+++++|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred ccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999976543 6888999999999999999999 789999999999999999999999999988765432
Q ss_pred CccceecccccceeecCcccccccc-cCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELL-TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~-t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
. .....||+.|+|||++.+..+ +.++|+||+|+++++++++..||...........+...... .+...+..+.+
T Consensus 166 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 240 (276)
T 2h6d_A 166 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY--IPEYLNRSVAT 240 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred c---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--CchhcCHHHHH
Confidence 1 234469999999999988665 67899999999999999999998765444444444433222 12234567999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~ 441 (496)
++.+||+.||.+|||+.++++
T Consensus 241 li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHh
Confidence 999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.43 Aligned_cols=251 Identities=18% Similarity=0.265 Sum_probs=202.0
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 260 (496)
.|.+.+.||+|+||.||+|... ++..||+|.+.... .......+|+.+++.++||||+++++++.. ....|+||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4777889999999999999964 68899999986432 223344588999999999999999998864 56889999
Q ss_pred eeccCCchhhhhhhcCc-ccccCHHHHHHHHHHHHHHHHHhHhcCCCC-----cccCCCCcCceeeCCCCceEEccCCCc
Q 047375 261 EFVSNGALSHYIHDKSS-QVLKNWKTCLRIAAETASAIHYLHSLASPS-----IIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~-----ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999999999976421 2337889999999999999999999 55 999999999999999999999999998
Q ss_pred cccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHH
Q 047375 335 VPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEE 414 (496)
Q Consensus 335 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 414 (496)
....... .......||+.|+|||++.+..++.++|+||+|+++++++++.+||...........+..... ...+...
T Consensus 164 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~ 240 (279)
T 2w5a_A 164 RILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIPYRY 240 (279)
T ss_dssp HHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCCTTS
T ss_pred eeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-ccCCccc
Confidence 8765432 112345699999999999988899999999999999999999999876654444444444332 2233345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSEEL 443 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~~L 443 (496)
++.+.+++.+||+.||.+|||+.||++.+
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 67899999999999999999999997654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=343.56 Aligned_cols=194 Identities=23% Similarity=0.243 Sum_probs=159.8
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----Cee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLET-----KVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~ 256 (496)
..|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+.+++.++||||+++++++... +..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 3588889999999999999995 4688999999864322 223455899999999999999999999866 578
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+||||++ |+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 99999996 59999997643 37889999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCc--------------------cceecccccceeecCccc-ccccccCCCCCchhhhhcccccccc
Q 047375 337 ISSDDET--------------------AMSTMIRGTVGYLDPEYA-HTELLTGMNPNSYVALASNEKISMV 386 (496)
Q Consensus 337 ~~~~~~~--------------------~~~~~~~gt~~Y~aPE~l-~~~~~t~~~d~~s~g~~~~~~~~~~ 386 (496)
....... ...+..+||+.|+|||++ ....++.+.|+||+||++++|++|.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 6543211 123556799999999986 5567899999999999999999743
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.41 Aligned_cols=239 Identities=15% Similarity=0.082 Sum_probs=187.9
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHH---HHHhcCCCCceeeEE-------EEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFL---GIISQVKHKNVVKIL-------GLCL 251 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~---~~l~~l~hpnIv~l~-------~~~~ 251 (496)
.|.+.+.||+|+||.||+|.. .+++.||||++.... .......+|+ .+++.++|||||+++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 366678999999999999995 568999999986332 2223444777 556666899999998 6665
Q ss_pred eCC-----------------eeeEEEeeccCCchhhhhhhcCc----ccccCHHHHHHHHHHHHHHHHHhHhcCCCCccc
Q 047375 252 ETK-----------------VTLLVYEFVSNGALSHYIHDKSS----QVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310 (496)
Q Consensus 252 ~~~-----------------~~~lv~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH 310 (496)
..+ ..|+||||| +|+|.+++..... ...+++..++.|+.||+.||.|||+ ++|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 543 278999999 6799999986421 1234468888999999999999999 78999
Q ss_pred CCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccc-----------cccCCCCCchhhhhc
Q 047375 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE-----------LLTGMNPNSYVALAS 379 (496)
Q Consensus 311 rDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----------~~t~~~d~~s~g~~~ 379 (496)
|||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|+||+|+++
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999986432 2344568 999999999988 899999999999999
Q ss_pred ccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 380 NEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
|+|+++.+||...........+.... ...++.+.+||.+||+.||.+|||+.++++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CCSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccchhhhhhhc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999987765554444443221 123467999999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=326.74 Aligned_cols=246 Identities=21% Similarity=0.231 Sum_probs=204.0
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|.. .++..||||.+..... ......+|+.+++.++||||+++++++...+..|+||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 367778999999999999985 4688999999865432 2334558899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 103 ~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 103 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp TTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 999999998653 36889999999999999999999 7899999999999999999999999999987654321
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......||+.|+|||++.+..++.++|+||+|+++++++++.+||...........+... .........+..+.+|+.
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCCSSCCHHHHHHHH
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-CCCCCccccCHHHHHHHH
Confidence 123456999999999999988999999999999999999999998765444333333222 122223344567999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 047375 424 KCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~ 442 (496)
+||+.||.+|||+.++++.
T Consensus 253 ~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 253 ACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHCCSSGGGSCCHHHHTTC
T ss_pred HHcCCChhhCcCHHHHhhC
Confidence 9999999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.91 Aligned_cols=241 Identities=13% Similarity=0.030 Sum_probs=177.2
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHH---HHHHhcCCCCceeeEE-------EEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEF---LGIISQVKHKNVVKIL-------GLCLE 252 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e---~~~l~~l~hpnIv~l~-------~~~~~ 252 (496)
|.+.+.||+|+||.||+|.+ .++..||||++..... ......+| +.+|+. +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence 66778999999999999995 4789999999976432 22233355 456666 799988865 44443
Q ss_pred C-----------------CeeeEEEeeccCCchhhhhhhcCcccccCHHHH------HHHHHHHHHHHHHhHhcCCCCcc
Q 047375 253 T-----------------KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTC------LRIAAETASAIHYLHSLASPSII 309 (496)
Q Consensus 253 ~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~qi~~gL~~LH~~~~~~iv 309 (496)
. ...|||||||+ |+|.+++...... +++..+ ..++.||+.||.|||+ ++|+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv 216 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQS---KGLV 216 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence 2 34799999998 7999999875322 344455 6788999999999999 7899
Q ss_pred cCCCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCccccc--ccccCCCCCchhhhhccccccccc
Q 047375 310 HSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEKISMVP 387 (496)
Q Consensus 310 HrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~~~~~~ 387 (496)
||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|+||+|+++|+|++|.+
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876422 224457899999999987 789999999999999999999999
Q ss_pred chhhhcccc--hhhh-----hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 388 YFLDSIENN--SFRQ-----ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 388 ~~~~~~~~~--~~~~-----i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
||....... .+.. ........+.....++.+.+||.+||+.||.+|||+.+++
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 987653321 1111 1111222222234567899999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=333.31 Aligned_cols=247 Identities=21% Similarity=0.224 Sum_probs=203.1
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhh------------------hhHHHHHHHHhcCCCCceeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIR------------------ITEWEFLGIISQVKHKNVVKILG 248 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------~~~~~e~~~l~~l~hpnIv~l~~ 248 (496)
.|.+.+.||+|+||.||+|.. ++..||||.+....... ....+|+.++..++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 477789999999999999999 89999999986543221 45568999999999999999999
Q ss_pred EEeeCCeeeEEEeeccCCchhhh------hhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC
Q 047375 249 LCLETKVTLLVYEFVSNGALSHY------IHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD 322 (496)
Q Consensus 249 ~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~ 322 (496)
++.+.+..|+||||+++|+|.++ +.... ...+++..++.++.||+.||.|||+ .++|+||||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence 99999999999999999999999 55422 2347899999999999999999997 156999999999999999
Q ss_pred CCceEEccCCCccccCCCCCccceecccccceeecCcccccc-cccC-CCCCchhhhhcccccccccchhhhcc-cchhh
Q 047375 323 NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE-LLTG-MNPNSYVALASNEKISMVPYFLDSIE-NNSFR 399 (496)
Q Consensus 323 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~-~~d~~s~g~~~~~~~~~~~~~~~~~~-~~~~~ 399 (496)
++.+||+|||++...... ......||+.|+|||++.+. .++. ++|+||+|+++++++++.+||..... .....
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999999999999876433 23445699999999999886 6666 99999999999999999999876655 33344
Q ss_pred hhhhcccCCccc-----------------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 400 QILNFQVADESE-----------------MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 400 ~i~~~~~~~~~~-----------------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.......+.. ...++.+.+|+.+||+.||.+|||+.|+++
T Consensus 264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 443332222210 334578999999999999999999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.00 Aligned_cols=243 Identities=21% Similarity=0.179 Sum_probs=187.5
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------ee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETK------VT 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~ 256 (496)
.|.+.+.||+|+||.||+|.. .++..||||++.... .......+|+.+++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 477789999999999999985 468899999986532 22234458899999999999999999998654 78
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+|||||++ +|.+++.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 999999975 78888753 26788899999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC---------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--------- 407 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--------- 407 (496)
..... ......||+.|+|||++.+..++.++|+||+|++++++++|.+||.+......+..+......
T Consensus 177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 64321 123456999999999999989999999999999999999999998765544333333221000
Q ss_pred -------------------------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 408 -------------------------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 408 -------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.......++.+.+|+.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0011233678999999999999999999999853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=330.65 Aligned_cols=247 Identities=20% Similarity=0.190 Sum_probs=199.3
Q ss_pred HHHhcchhhhcccCCceEEEEeEe--CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCC------ceeeEEEEEeeCCe
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVL--PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHK------NVVKILGLCLETKV 255 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp------nIv~l~~~~~~~~~ 255 (496)
+...|.+.+.||+|+||.||+|.. .++..||||++...........+|+.++..++|+ +|+++++++...+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 345688889999999999999985 3688999999976555455556788888877655 59999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-------------
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD------------- 322 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~------------- 322 (496)
.|+||||| +++|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 7899999987543 236889999999999999999999 78999999999999987
Q ss_pred ------CCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc
Q 047375 323 ------NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN 396 (496)
Q Consensus 323 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~ 396 (496)
++.+||+|||++...... .....||+.|+|||++.+..++.++|+||+|++++++++|.+||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999875432 234569999999999999899999999999999999999999887554333
Q ss_pred hhhhhhhccc------------------------------------------CCcccHHHHHHHHHHHHHhcccCCCCCC
Q 047375 397 SFRQILNFQV------------------------------------------ADESEMEEIEVVAELASKCLRIRGTERP 434 (496)
Q Consensus 397 ~~~~i~~~~~------------------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RP 434 (496)
....+..... ........++.+.+|+.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 2222111000 0011224567899999999999999999
Q ss_pred CHHHHH
Q 047375 435 TMKEVS 440 (496)
Q Consensus 435 s~~eil 440 (496)
|+.|++
T Consensus 322 t~~ell 327 (339)
T 1z57_A 322 TLREAL 327 (339)
T ss_dssp CHHHHT
T ss_pred CHHHHh
Confidence 999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=326.86 Aligned_cols=249 Identities=22% Similarity=0.209 Sum_probs=197.3
Q ss_pred HHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---------hhhhHHHHHHHHhcCCCCceeeEEEEEee
Q 047375 183 LLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---------IRITEWEFLGIISQVKHKNVVKILGLCLE 252 (496)
Q Consensus 183 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~ 252 (496)
.+...|.+.+.||+|+||.||+|.. .++..||||.+..... ......+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 4456788999999999999999996 4678999999864321 12234588999999999999999999876
Q ss_pred CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc---eEEc
Q 047375 253 TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT---AKVS 329 (496)
Q Consensus 253 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~---~kL~ 329 (496)
.+ .|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred Cc-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 55 899999999999999987643 37889999999999999999999 78999999999999987654 9999
Q ss_pred cCCCccccCCCCCccceecccccceeecCcccc---cccccCCCCCchhhhhcccccccccchhhhcccchhhh-hhhcc
Q 047375 330 DFESLVPISSDDETAMSTMIRGTVGYLDPEYAH---TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQ-ILNFQ 405 (496)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~ 405 (496)
|||++...... .......||+.|+|||++. ...++.++|+||+|+++++++++.+||........+.. +....
T Consensus 160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 99999876432 1223456999999999974 46678899999999999999999999876544333322 22222
Q ss_pred cCCc--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 VADE--SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 ~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.... .....++.+.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 2111 11234577999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.67 Aligned_cols=256 Identities=19% Similarity=0.236 Sum_probs=199.6
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|.... .||+|.+..... ......+|+.+++.++||||+++++++...+..++||||+
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 47778999999999999999743 599998864322 1223347888999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC--
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD-- 341 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~-- 341 (496)
++++|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||++.......
T Consensus 112 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 112 KGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999976532 36889999999999999999999 7899999999999998 6799999999987653211
Q ss_pred -CccceecccccceeecCccccc---------ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCccc
Q 047375 342 -ETAMSTMIRGTVGYLDPEYAHT---------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESE 411 (496)
Q Consensus 342 -~~~~~~~~~gt~~Y~aPE~l~~---------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 411 (496)
.........||+.|+|||++.+ ..++.++|+||+|+++++++++..||...........+..........
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ 265 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc
Confidence 1112233459999999999875 346788999999999999999999987665554444444333222222
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhh
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 450 (496)
...+..+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus 266 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 266 IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 234567999999999999999999999999999987653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.72 Aligned_cols=254 Identities=18% Similarity=0.195 Sum_probs=201.7
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----CeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLET-----KVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~~l 258 (496)
.|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+.++.+++||||+++++++... ...|+
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 478889999999999999985 4688899999864332 224455899999999999999999999765 36899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||++ |+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 108 v~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999997 4999998754 26889999999999999999999 789999999999999999999999999998765
Q ss_pred CCCCc-cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc-------
Q 047375 339 SDDET-AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE------- 409 (496)
Q Consensus 339 ~~~~~-~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~------- 409 (496)
..... ......+||+.|+|||++.+ ..++.++|+||+|++++++++|.+||.+......+..+........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 43221 11234579999999998754 4588999999999999999999999977655554444432110000
Q ss_pred ----------------------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccC
Q 047375 410 ----------------------SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 410 ----------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
.....++.+.+|+.+||+.||.+|||+.|++ .++|.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l----------~hp~~~~~ 320 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL----------AHPYLEQY 320 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH----------TSGGGTTT
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh----------cCcchhhc
Confidence 0012346799999999999999999999985 45666654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=331.11 Aligned_cols=248 Identities=21% Similarity=0.250 Sum_probs=195.5
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEee--------CC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLE--------TK 254 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--------~~ 254 (496)
.|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+.+++.++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 478889999999999999996 5789999998854432 22345589999999999999999999987 44
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
..|+|||||++ +|.+.+..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 68999999985 77777765432 37889999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCC--ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccCCc
Q 047375 335 VPISSDDE--TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVADE 409 (496)
Q Consensus 335 ~~~~~~~~--~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~ 409 (496)
+....... ........||+.|+|||++.+ ..++.++|+||+|+++++++++.+||.+.........+... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 87653221 112234568999999999876 45789999999999999999999998776544433333211 00000
Q ss_pred c----------------------cH------HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 410 S----------------------EM------EEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 410 ~----------------------~~------~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
. .. ..++.+.+||.+||+.||.+|||+.|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 0 00 0135689999999999999999999885
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=325.90 Aligned_cols=249 Identities=19% Similarity=0.191 Sum_probs=186.3
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh--hh-HHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR--IT-EWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~-~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
..|.+.+.||+|+||.||+|.. .+++.||+|++....... .. ..++...++.++||||+++++++.+.+..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 4577789999999999999996 578999999986542221 22 2244556788899999999999999999999999
Q ss_pred eccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCC-CcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 262 FVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASP-SIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 262 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~-~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|+++ +|.+++... .....+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9975 888887652 122347899999999999999999999 6 799999999999999999999999999987654
Q ss_pred CCCccceecccccceeecCccc----ccccccCCCCCchhhhhcccccccccchhhh-cccchhhhhhhcccCCcccHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYA----HTELLTGMNPNSYVALASNEKISMVPYFLDS-IENNSFRQILNFQVADESEMEE 414 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l----~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~ 414 (496)
... .....||+.|+|||++ .+..++.++|+||+|+++++++++..||... ......................
T Consensus 163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 322 2334699999999996 4567888999999999999999999988652 2223333333333333333445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
++.+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 678999999999999999999999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=320.08 Aligned_cols=250 Identities=22% Similarity=0.222 Sum_probs=206.1
Q ss_pred HHHHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 182 ELLKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 182 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
......|.+.+.||+|+||.||+|... ++..||+|.+..... ......+|+.++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345567889999999999999999964 688999999865432 2334558899999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC---CceEEccCCCc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN---YTAKVSDFESL 334 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~---~~~kL~DFGla 334 (496)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999887654 37889999999999999999999 789999999999999754 47999999998
Q ss_pred cccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc--ccH
Q 047375 335 VPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE--SEM 412 (496)
Q Consensus 335 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~ 412 (496)
........ .....||+.|+|||++.+. ++.++|+||+|+++++++++.+||...........+.......+ ...
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T 2wei_A 172 TCFQQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (287)
T ss_dssp GTBCCCSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGT
T ss_pred eeecCCCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhh
Confidence 87654321 2334589999999998764 88899999999999999999999877655555555544433222 223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..++.+.+++.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 45678999999999999999999999965
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=327.83 Aligned_cols=249 Identities=18% Similarity=0.168 Sum_probs=197.5
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
..|.+.+.||+|+||.||+|... ++..||+|.+...... .....+|+.++..++||||+++++++...+..++|||||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 44778889999999999999964 5889999998654332 234458899999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++...... .
T Consensus 99 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 171 (302)
T 2j7t_A 99 PGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L 171 (302)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred CCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence 99999999876433 36889999999999999999999 78999999999999999999999999987543211 1
Q ss_pred cceecccccceeecCcccc-----cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-CcccHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAH-----TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEV 417 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~-----~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~ 417 (496)
.......||+.|+|||++. +..++.++|+||+|+++++++++.+||...........+...... ...+...+..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence 1123346999999999984 566788999999999999999999998766554444444433222 1223445677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+++.+||+.||.+|||+.++++
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHcccChhhCCCHHHHhc
Confidence 999999999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=341.07 Aligned_cols=250 Identities=20% Similarity=0.180 Sum_probs=198.0
Q ss_pred HHHHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC--------CCceeeEEEEEe
Q 047375 181 SELLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK--------HKNVVKILGLCL 251 (496)
Q Consensus 181 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------hpnIv~l~~~~~ 251 (496)
.++....|.+.+.||+|+||.||+|.. .++..||||++...........+|+.+++.++ ||||+++++++.
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 334445688889999999999999985 46889999999766555555668888888875 788999999998
Q ss_pred ----eCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCC-CcccCCCCcCceeeCCCC--
Q 047375 252 ----ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP-SIIHSDVKSANILLDDNY-- 324 (496)
Q Consensus 252 ----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~-~ivHrDlKp~NIll~~~~-- 324 (496)
.....|+||||+ +|+|.+.+..... ..+++..++.++.||+.||.|||+ + +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchh
Confidence 556889999999 5567666655432 237889999999999999999999 6 899999999999998775
Q ss_pred -----------------------------------------------ceEEccCCCccccCCCCCccceecccccceeec
Q 047375 325 -----------------------------------------------TAKVSDFESLVPISSDDETAMSTMIRGTVGYLD 357 (496)
Q Consensus 325 -----------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 357 (496)
.+||+|||++...... .....||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 7999999999876432 233469999999
Q ss_pred CcccccccccCCCCCchhhhhcccccccccchhhhcccc------hhhhhhhc--c------------------------
Q 047375 358 PEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN------SFRQILNF--Q------------------------ 405 (496)
Q Consensus 358 PE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~------~~~~i~~~--~------------------------ 405 (496)
||++.+..++.++|+||+|+++|+|++|.+||....... ....+... .
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999999889999999999999999999999986543211 11111100 0
Q ss_pred --------------cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 406 --------------VADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 406 --------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.........++.+.+||.+||+.||.+|||+.|++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 390 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHH
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 00122356677899999999999999999999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.41 Aligned_cols=268 Identities=15% Similarity=0.135 Sum_probs=211.8
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCC-CceeeEEEEEeeCCeeeEEEeec
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKH-KNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
..|.+.+.||+|+||.||+|.. .++..||||++..... .....+|+.++..++| ++|..+..++...+..+||||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 3477889999999999999995 5789999998764433 2345678899999987 55666777777888999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee---CCCCceEEccCCCccccCCC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---DDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll---~~~~~~kL~DFGla~~~~~~ 340 (496)
+++|.+++..... .+++..++.|+.||+.||.|||+ ++||||||||+|||| +.++.+||+|||+++.....
T Consensus 86 -g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 -GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp -CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 8999999975432 37899999999999999999999 789999999999999 58889999999999877543
Q ss_pred CCcc-----ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc---hhhhhhhcccCCcc--
Q 047375 341 DETA-----MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN---SFRQILNFQVADES-- 410 (496)
Q Consensus 341 ~~~~-----~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~---~~~~i~~~~~~~~~-- 410 (496)
.... ......||+.|+|||++.+..++.++|+||+|+++|+|++|..||....... .+..+.........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 2211 1235679999999999999999999999999999999999999987654322 22222222211111
Q ss_pred -cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 411 -EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 411 -~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
...+++.+.+|+.+||+.||.+||++.+|++.|+.+.......|....+|
T Consensus 240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW 290 (483)
T 3sv0_A 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDW 290 (483)
T ss_dssp HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHH
T ss_pred HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCc
Confidence 12334679999999999999999999999999999987665555444443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.28 Aligned_cols=257 Identities=19% Similarity=0.268 Sum_probs=206.6
Q ss_pred HHhcchhhhcccCCceEEEEeEeC----CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP----DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
...|.+.+.||+|+||.||+|.+. .+..||+|.+.... .......+|+.+++.++||||+++++++. .+..|+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 345777889999999999999863 24579999876432 22344558999999999999999999985 456899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||||++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 468 v~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999986532 36889999999999999999999 789999999999999999999999999998765
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
.... .......||+.|+|||++.+..++.++|+||+|++++++++ |.+||.+.........+.... ..+.+..+++.
T Consensus 543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 620 (656)
T 2j0j_A 543 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPT 620 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTCCHH
T ss_pred CCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccccHH
Confidence 4322 12233457889999999998899999999999999999986 888887765555555554432 22334455678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999988643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=338.52 Aligned_cols=246 Identities=20% Similarity=0.209 Sum_probs=194.4
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----------
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLET----------- 253 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~----------- 253 (496)
..|.+.+.||+|+||.||+|.. .++..||||++....... .+|+.+++.++|||||++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~---~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC---CHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH---HHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 3578889999999999999985 578999999986543222 3689999999999999999998543
Q ss_pred ---------------------------CeeeEEEeeccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCC
Q 047375 254 ---------------------------KVTLLVYEFVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLAS 305 (496)
Q Consensus 254 ---------------------------~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~ 305 (496)
...++|||||++ +|.+.+... .....+++..+..++.||+.||.|||+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--- 159 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--- 159 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---
Confidence 347899999985 888877642 112347889999999999999999999
Q ss_pred CCcccCCCCcCceeeC-CCCceEEccCCCccccCCCCCccceecccccceeecCcccccc-cccCCCCCchhhhhccccc
Q 047375 306 PSIIHSDVKSANILLD-DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKI 383 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~ 383 (496)
++|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|+||+|+++++|+
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 7899999999999997 688999999999987654322 2345689999999998774 4899999999999999999
Q ss_pred ccccchhhhcccchhhhhhhcccC----------------------Cc-----ccHHHHHHHHHHHHHhcccCCCCCCCH
Q 047375 384 SMVPYFLDSIENNSFRQILNFQVA----------------------DE-----SEMEEIEVVAELASKCLRIRGTERPTM 436 (496)
Q Consensus 384 ~~~~~~~~~~~~~~~~~i~~~~~~----------------------~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~ 436 (496)
+|.+||.+......+..+...... .. .+...++.+.+|+.+||+.||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999876555444444321000 00 111234679999999999999999999
Q ss_pred HHHHH
Q 047375 437 KEVSE 441 (496)
Q Consensus 437 ~eil~ 441 (496)
.|+++
T Consensus 317 ~e~l~ 321 (383)
T 3eb0_A 317 YEAMA 321 (383)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.19 Aligned_cols=260 Identities=20% Similarity=0.248 Sum_probs=184.6
Q ss_pred Hhcch-hhhcccCCceEEEEeEeC---CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeEE
Q 047375 186 ATKNF-HHCLGMGGFGSVYKGVLP---DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLLV 259 (496)
Q Consensus 186 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv 259 (496)
..|.+ .++||+|+||.||+|.+. ++..||||++.... ......+|+.+|+.++|||||++++++.. ....|+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 34555 468999999999999954 57889999986432 23345689999999999999999999964 6789999
Q ss_pred EeeccCCchhhhhhhcC------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee----CCCCceEEc
Q 047375 260 YEFVSNGALSHYIHDKS------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL----DDNYTAKVS 329 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll----~~~~~~kL~ 329 (496)
|||+++ +|.+++.... ....+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 8888876422 12237889999999999999999999 789999999999999 677899999
Q ss_pred cCCCccccCCCCC-ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhccc---------chh
Q 047375 330 DFESLVPISSDDE-TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIEN---------NSF 398 (496)
Q Consensus 330 DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~---------~~~ 398 (496)
|||+++....... .......+||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||...... ..+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987654311 122344679999999999987 45889999999999999999999998654321 111
Q ss_pred hhhhhcc----------------------------cCCccc--------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047375 399 RQILNFQ----------------------------VADESE--------MEEIEVVAELASKCLRIRGTERPTMKEVSEE 442 (496)
Q Consensus 399 ~~i~~~~----------------------------~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 442 (496)
..+.... ...... ...++.+.+||.+||+.||.+|||+.|++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L-- 332 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM-- 332 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH--
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh--
Confidence 1111100 000000 00135688999999999999999999984
Q ss_pred HHhhHhhhhhhhhccCcc
Q 047375 443 LDRLRRLQENYWARKNNE 460 (496)
Q Consensus 443 L~~l~~~~~~~~~~~~~~ 460 (496)
.++|......
T Consensus 333 --------~hp~f~~~~~ 342 (405)
T 3rgf_A 333 --------QDPYFLEDPL 342 (405)
T ss_dssp --------TSGGGTSSSC
T ss_pred --------cChhhccCCC
Confidence 4566655443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=332.19 Aligned_cols=255 Identities=18% Similarity=0.154 Sum_probs=200.6
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CC-----ceeeEEEEEeeCCeeeE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVK-HK-----NVVKILGLCLETKVTLL 258 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp-----nIv~l~~~~~~~~~~~l 258 (496)
..|.+.+.||+|+||.||+|... ++..||||++............|+.++..++ |+ +|+++++++...+..|+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 45778899999999999999854 6789999999765544444456777777664 44 59999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC--CCCceEEccCCCccc
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD--DNYTAKVSDFESLVP 336 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~--~~~~~kL~DFGla~~ 336 (496)
||||++ |+|.+++...... .+++..+..++.|++.||.|||+.. .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 134 v~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 999996 5999999875432 3788999999999999999999532 6899999999999994 578899999999987
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC--------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD-------- 408 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-------- 408 (496)
.... .....||+.|+|||++.+..++.++|+||+|++++++++|.+||.+......+..+.......
T Consensus 211 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 211 LGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred cccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6432 234569999999999999899999999999999999999999998655444333332210000
Q ss_pred ------------------------------------------------------cccHHHHHHHHHHHHHhcccCCCCCC
Q 047375 409 ------------------------------------------------------ESEMEEIEVVAELASKCLRIRGTERP 434 (496)
Q Consensus 409 ------------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RP 434 (496)
.......+.+.+||.+||+.||.+||
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp 365 (382)
T 2vx3_A 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365 (382)
T ss_dssp TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence 00112335799999999999999999
Q ss_pred CHHHHHHHHHhhHhhhhhhhhccC
Q 047375 435 TMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 435 s~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
|+.|+ .+++|.+..
T Consensus 366 ta~e~----------L~hp~f~~~ 379 (382)
T 2vx3_A 366 QPYYA----------LQHSFFKKT 379 (382)
T ss_dssp CHHHH----------TTSGGGCC-
T ss_pred CHHHH----------hcCcccccC
Confidence 99998 346666554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.82 Aligned_cols=248 Identities=17% Similarity=0.193 Sum_probs=192.8
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecch---hhhhhHHHHHHHHhcCC--CCceeeEEEEEeeCCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD---EIRITEWEFLGIISQVK--HKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~ 260 (496)
..|.+.+.||+|+||.||+|...++..||||.+.... .......+|+.++.+++ ||||+++++++...+..|+||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 4477889999999999999998789999999986432 22334458899999997 599999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
| +.+++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+++ +.+||+|||++......
T Consensus 108 e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp C-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred e-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 9 55789999998754 36888999999999999999999 78999999999999974 79999999999877544
Q ss_pred CCccceecccccceeecCccccc-----------ccccCCCCCchhhhhcccccccccchhhhccc-chhhhhhhcccCC
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHT-----------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQVAD 408 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~-----------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~ 408 (496)
..........||+.|+|||++.+ ..++.++|+||+|+++++++++..||...... ..+..+.......
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 33222344569999999999875 46778999999999999999999988654322 2233333333332
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 409 ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 409 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+...++.+.+++.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 333333567999999999999999999999853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=327.30 Aligned_cols=250 Identities=18% Similarity=0.210 Sum_probs=197.4
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEee--CCeeeEEEe
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLE--TKVTLLVYE 261 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv~E 261 (496)
..|.+.+.||+|+||.||+|.. .++..||||.+.... .....+|+.+++.++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 3477789999999999999985 578899999986432 334558899999997 9999999999987 667899999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-ceEEccCCCccccCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPISSD 340 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~~~ 340 (496)
|+++++|.+++.. +++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 114 ~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 114 HVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999998853 5778899999999999999999 7899999999999999766 8999999999876543
Q ss_pred CCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhccc-chhhhhh-------------hcc
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQIL-------------NFQ 405 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~-------------~~~ 405 (496)
.. .....||+.|+|||++.+ ..++.++|+||+|+++++|+++..||...... ..+..+. ...
T Consensus 185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 22 234469999999999887 67899999999999999999998887432211 1111100 000
Q ss_pred ----------------------cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 406 ----------------------VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 406 ----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
.........++.+.+||.+||+.||.+|||+.|++ +++|.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l----------~hp~f~~~~ 327 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM----------EHPYFYTVV 327 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH----------TSGGGTTCC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh----------cCccHhhhc
Confidence 00111122457899999999999999999999984 456665543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.65 Aligned_cols=245 Identities=20% Similarity=0.199 Sum_probs=191.4
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeC------CeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLET------KVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~~~lv 259 (496)
.|.+.+.||+|+||.||+|.+. ++..||||++..... ...+|+.+++.++|||||+++++|... ...++|
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 3677789999999999999964 689999999865432 223689999999999999999998642 236799
Q ss_pred EeeccCCchhhhhhhc-CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-CceEEccCCCcccc
Q 047375 260 YEFVSNGALSHYIHDK-SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-YTAKVSDFESLVPI 337 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-~~~kL~DFGla~~~ 337 (496)
|||+++ +|.+++... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999986 676666531 112347889999999999999999999 789999999999999955 57899999999876
Q ss_pred CCCCCccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc-----------
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ----------- 405 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~----------- 405 (496)
..... ....+||+.|+|||++.+. .++.+.|+||+||++|+|++|.+||.+......+..+....
T Consensus 208 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 208 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred ccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 54322 2345699999999998764 78999999999999999999999997765444443333210
Q ss_pred --------cC---Cc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 406 --------VA---DE-----SEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 406 --------~~---~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
++ .. .....++.+.+||.+||+.||.+|||+.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00 00 01123467999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=327.19 Aligned_cols=252 Identities=19% Similarity=0.213 Sum_probs=184.7
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|.+.+.||+|+||.||+|.. .++..||||.+..... ......+|+.++..++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 3477788999999999999985 4688999998864322 223344788999999999999999999999999999999
Q ss_pred ccCCchhhhhhhc-----CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 263 VSNGALSHYIHDK-----SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 263 ~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+++|+|.+++... .....+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999999752 112347889999999999999999999 78999999999999999999999999998766
Q ss_pred CCCCC---ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-----
Q 047375 338 SSDDE---TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD----- 408 (496)
Q Consensus 338 ~~~~~---~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~----- 408 (496)
..... ........||+.|+|||++.+ ..++.++|+||+|+++++++++..||...................
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence 43221 111234569999999999876 568899999999999999999999987654443333222211111
Q ss_pred ---cccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 409 ---ESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 409 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
......++.+.+|+.+||+.||.+|||+.+++
T Consensus 252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 286 (303)
T 2vwi_A 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286 (303)
T ss_dssp ---CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11122346799999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=332.11 Aligned_cols=246 Identities=19% Similarity=0.231 Sum_probs=189.0
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh------------hhhHHHHHHHHhcCCCCceeeEEEEEee-
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI------------RITEWEFLGIISQVKHKNVVKILGLCLE- 252 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~hpnIv~l~~~~~~- 252 (496)
..|.+.+.||+|+||.||+|...++..||||++...... .....+|+.+++.++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 457778999999999999999878999999988543211 1345589999999999999999999854
Q ss_pred ----CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 253 ----TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 253 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
....|+|||||+ |+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEE
Confidence 336799999998 58888887543 247889999999999999999999 78999999999999999999999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 407 (496)
+|||++....... ......||+.|+|||++.+ ..++.++|+||+|+++++++++.+||.+.........+......
T Consensus 176 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999997654332 1234569999999999877 67889999999999999999999998765544433333221100
Q ss_pred C--------------------------c----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 408 D--------------------------E----SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 408 ~--------------------------~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
. . .....++.+.+|+.+||+.||.+|||+.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 0 0 0012246799999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=323.98 Aligned_cols=246 Identities=21% Similarity=0.248 Sum_probs=195.7
Q ss_pred hcchhhhcccCCceEEEEeEe--CCCcEEEEEEeecchhh---hhhHHHHHHHHhcC---CCCceeeEEEEEe-----eC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL--PDNTQVAVKKYMCADEI---RITEWEFLGIISQV---KHKNVVKILGLCL-----ET 253 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~hpnIv~l~~~~~-----~~ 253 (496)
.|.+.+.||+|+||.||+|.. .++..||+|++...... .....+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 477889999999999999996 46788999988643221 22334566555554 8999999999997 55
Q ss_pred CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 254 KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 254 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
...++||||++ |+|.+++...... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 67899999998 5999999875432 36889999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC------
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA------ 407 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 407 (496)
+....... ......||+.|+|||++.+..++.++|+||+|+++++++++.+||........+..+......
T Consensus 167 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 167 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred cccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 88764321 223456899999999999988999999999999999999999998766554444433321000
Q ss_pred -------------------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 408 -------------------DESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 408 -------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.......++.+.+|+.+||+.||.+|||+.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 001123456789999999999999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=330.63 Aligned_cols=249 Identities=18% Similarity=0.186 Sum_probs=196.1
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCee------
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVT------ 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~------ 256 (496)
.|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 477778999999999999985 4689999999865322 233445889999999999999999999876654
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+||||+. |+|.+++.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 123 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 588888743 26889999999999999999999 7899999999999999999999999999986
Q ss_pred cCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC-------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD------- 408 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~------- 408 (496)
.... .....||+.|+|||++.+ ..++.++|+||+|++++++++|.+||.+......+..+.......
T Consensus 194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 5432 234568999999999887 778999999999999999999999997655444333332210000
Q ss_pred ------------------c----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 409 ------------------E----SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 409 ------------------~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
. .....++.+.+||.+||+.||.+|||+.|++ .++|.+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell----------~hp~f~~~~ 331 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL----------THPFFEPFR 331 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH----------TSGGGTTTC
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh----------cCcccccCC
Confidence 0 0012357799999999999999999999884 466766543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.24 Aligned_cols=242 Identities=19% Similarity=0.201 Sum_probs=178.6
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeC------Ce
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLET------KV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~ 255 (496)
..|.+.+.||+|+||.||+|.. .+|..||||++.... .......+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 3477789999999999999984 578899999986432 2233445899999999999999999999754 56
Q ss_pred eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 256 TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
.|+||||+ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 79999999 67999988652 37889999999999999999999 789999999999999999999999999998
Q ss_pred ccCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc--------
Q 047375 336 PISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-------- 406 (496)
Q Consensus 336 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-------- 406 (496)
..... .....||+.|+|||++.+ ..++.+.|+||+||++++|++|.+||.+......+..+.....
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 75432 234569999999999887 6789999999999999999999999976654444433332100
Q ss_pred -----------------CCccc----HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 407 -----------------ADESE----MEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 407 -----------------~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
..... ...++.+.+|+.+||+.||.+|||+.|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 00000 11246789999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=329.04 Aligned_cols=255 Identities=18% Similarity=0.192 Sum_probs=200.1
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-----------CCceeeEEEEEeeC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK-----------HKNVVKILGLCLET 253 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~l~~~~~~~ 253 (496)
..|.+.+.||+|+||.||+|.. .++..||||.+...........+|+.++.+++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 4588889999999999999995 57889999999765544555557888887775 89999999999865
Q ss_pred C----eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCC-CcccCCCCcCceeeC------C
Q 047375 254 K----VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP-SIIHSDVKSANILLD------D 322 (496)
Q Consensus 254 ~----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~-~ivHrDlKp~NIll~------~ 322 (496)
+ ..++||||+ +++|.+++...... .+++..+..++.||+.||.|||+ + +|+||||||+|||++ .
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 4 789999999 88999999875432 36889999999999999999999 6 899999999999994 4
Q ss_pred CCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc------c
Q 047375 323 NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN------N 396 (496)
Q Consensus 323 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~------~ 396 (496)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|+||+|+++|++++|.+||...... .
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 458999999999876432 23346999999999999989999999999999999999999998754311 1
Q ss_pred hhhhhhhc----------------------------------------ccCCcccHHHHHHHHHHHHHhcccCCCCCCCH
Q 047375 397 SFRQILNF----------------------------------------QVADESEMEEIEVVAELASKCLRIRGTERPTM 436 (496)
Q Consensus 397 ~~~~i~~~----------------------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 436 (496)
.+..+... ......+...++.+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11111110 00112234667889999999999999999999
Q ss_pred HHHHHHHHhhHhhhhhhhhccCcc
Q 047375 437 KEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 437 ~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
.|++ +++|......
T Consensus 329 ~ell----------~hp~f~~~~~ 342 (373)
T 1q8y_A 329 GGLV----------NHPWLKDTLG 342 (373)
T ss_dssp HHHH----------TCGGGTTCTT
T ss_pred HHHh----------hChhhhcccC
Confidence 9984 4667765543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=324.58 Aligned_cols=244 Identities=20% Similarity=0.211 Sum_probs=172.2
Q ss_pred hcchh-hhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEee----CCeeeEEE
Q 047375 187 TKNFH-HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE----TKVTLLVY 260 (496)
Q Consensus 187 ~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 260 (496)
.|.+. +.||+|+||.||+|... +++.||||++....... .+....+..++||||+++++++.. ....++||
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 36664 56999999999999964 68999999986543222 223345667799999999999976 45689999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCcccc
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVPI 337 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~~ 337 (496)
|||++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++...
T Consensus 106 e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp ECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred eccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999987543 247899999999999999999999 78999999999999975 456999999999866
Q ss_pred CCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchh----hhhhh--cccCCccc
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSF----RQILN--FQVADESE 411 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~----~~i~~--~~~~~~~~ 411 (496)
.... .....||+.|+|||++.+..++.++|+||+|+++++++++.+||......... ..+.. .....+..
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 182 TQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred cccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 4321 23456899999999999889999999999999999999999998765443221 11111 11222222
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...++.+.+|+.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 345678999999999999999999999964
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.76 Aligned_cols=240 Identities=19% Similarity=0.197 Sum_probs=190.3
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCe------e
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKV------T 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~------~ 256 (496)
.|.+.+.||+|+||.||+|.. .+|..||||++..... ......+|+.+++.++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 477778999999999999995 4689999999865322 22344588999999999999999999987654 4
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+||||++ |+|.+++.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 105 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 99999997 599888743 26889999999999999999999 7899999999999999999999999999886
Q ss_pred cCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc---------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV--------- 406 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--------- 406 (496)
.... .....||+.|+|||++.+ ..++.++|+||+|++++++++|.+||.+......+..+.....
T Consensus 176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 5432 234568999999999877 6788999999999999999999999876544333332221000
Q ss_pred -----------------C---CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 407 -----------------A---DESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 407 -----------------~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
. .......++.+.+|+.+||+.||.+|||+.+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 304 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 011123457899999999999999999999884
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.41 Aligned_cols=255 Identities=20% Similarity=0.205 Sum_probs=198.0
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----CeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLET-----KVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~~l 258 (496)
.|.+.+.||+|+||.||+|... ++..||||++..... ......+|+.+++.++||||+++++++... ...|+
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 4777889999999999999964 688999999864322 233445899999999999999999998754 67899
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||||++ |+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 92 v~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 92 IQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999997 5999998763 36889999999999999999999 789999999999999999999999999998765
Q ss_pred CCCCcc--------ceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-----
Q 047375 339 SDDETA--------MSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF----- 404 (496)
Q Consensus 339 ~~~~~~--------~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~----- 404 (496)
...... ......||+.|+|||++.+ ..++.++|+||+|+++++++++.+||.+......+..+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 322111 1223468999999998764 67888999999999999999999998765433222222110
Q ss_pred ---------------------ccCCc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 405 ---------------------QVADE----SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 405 ---------------------~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
..... .....++.+.+|+.+||+.||.+|||+.|++ +++|.+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell----------~hp~~~~~~ 313 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL----------EHPYLQTYH 313 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH----------TSGGGTTTC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh----------cCccccccC
Confidence 00000 0113456789999999999999999999984 466766544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.99 Aligned_cols=256 Identities=17% Similarity=0.145 Sum_probs=202.3
Q ss_pred HHhcchhhhcccCCceEEEEeEeC-CC-cEEEEEEeecchhhhhhHHHHHHHHhcCCCCc------eeeEEEEEeeCCee
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLP-DN-TQVAVKKYMCADEIRITEWEFLGIISQVKHKN------VVKILGLCLETKVT 256 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn------Iv~l~~~~~~~~~~ 256 (496)
...|.+.+.||+|+||.||+|... ++ ..||+|.+...........+|+.+++.++|+| ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 456888899999999999999863 34 68999999765555555567888888887665 99999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceee----------------
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL---------------- 320 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll---------------- 320 (496)
|+||||+ +++|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 9999999 5677777766442 237889999999999999999999 789999999999999
Q ss_pred ---CCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch
Q 047375 321 ---DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS 397 (496)
Q Consensus 321 ---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~ 397 (496)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|+||+|+++|++++|.+||........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999865432 2345699999999999998999999999999999999999999876544332
Q ss_pred hhhhhhcccC------------------------------------------CcccHHHHHHHHHHHHHhcccCCCCCCC
Q 047375 398 FRQILNFQVA------------------------------------------DESEMEEIEVVAELASKCLRIRGTERPT 435 (496)
Q Consensus 398 ~~~i~~~~~~------------------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs 435 (496)
...+...... .......+..+.+|+.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 2222110000 0111234567999999999999999999
Q ss_pred HHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 436 MKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 436 ~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
+.|+ .+++|.....+
T Consensus 328 ~~e~----------l~hp~f~~~~~ 342 (355)
T 2eu9_A 328 LAEA----------LLHPFFAGLTP 342 (355)
T ss_dssp HHHH----------TTSGGGGGCCH
T ss_pred HHHH----------hcChhhcCCCh
Confidence 9988 45667665544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.58 Aligned_cols=247 Identities=19% Similarity=0.190 Sum_probs=188.3
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEe------------
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCL------------ 251 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~------------ 251 (496)
..|.+.+.||+|+||.||+|... +++.||+|++...... .....+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 34777889999999999999964 5899999988654332 334458999999999999999999874
Q ss_pred --eCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC-CCCceEE
Q 047375 252 --ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAKV 328 (496)
Q Consensus 252 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~-~~~~~kL 328 (496)
..+..|+||||++ |+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999998 5999998643 36788999999999999999999 7899999999999997 5679999
Q ss_pred ccCCCccccCCCCC-ccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc
Q 047375 329 SDFESLVPISSDDE-TAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV 406 (496)
Q Consensus 329 ~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 406 (496)
+|||++........ ........||+.|+|||.+.+ ..++.++|+||+|++++++++|.+||...........+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999987643211 111234458999999998865 6788899999999999999999999876654444333332110
Q ss_pred C-----------------------C-c----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 407 A-----------------------D-E----SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 407 ~-----------------------~-~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
. . . .....++.+.+|+.+||+.||.+|||+.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHh
Confidence 0 0 0 0112357799999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.97 Aligned_cols=246 Identities=20% Similarity=0.171 Sum_probs=184.4
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
+...+.||+|+||+||.+...+|..||||++.... .....+|+.++..+ +|||||++++++.+.+..|+|||||. |
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 44457899999999987665689999999986432 23345788888876 89999999999999999999999996 5
Q ss_pred chhhhhhhcCcccc----cCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCC-------------CceEEc
Q 047375 267 ALSHYIHDKSSQVL----KNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDN-------------YTAKVS 329 (496)
Q Consensus 267 ~L~~~l~~~~~~~~----l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~-------------~~~kL~ 329 (496)
+|.+++........ .++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 99999986532111 1223457799999999999999 789999999999999653 489999
Q ss_pred cCCCccccCCCCCcc--ceecccccceeecCccccc-------ccccCCCCCchhhhhcccccc-cccchhhhcccchhh
Q 047375 330 DFESLVPISSDDETA--MSTMIRGTVGYLDPEYAHT-------ELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFR 399 (496)
Q Consensus 330 DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~l~~-------~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~ 399 (496)
|||+++......... .....+||+.|+|||++.+ ..++.++|+||+||+++++++ |.+||....... .
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~ 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--S 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--H
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--H
Confidence 999998875432211 1234569999999999876 668899999999999999998 888886543221 2
Q ss_pred hhhhcc-----cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 400 QILNFQ-----VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 400 ~i~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.... .........++.+.+||.+||+.||.+|||+.++++
T Consensus 249 ~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 222211 112223466788999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=323.36 Aligned_cols=240 Identities=23% Similarity=0.262 Sum_probs=195.0
Q ss_pred HHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-------hhhHHHHHHHHhcCC--CCceeeEEEEEee
Q 047375 183 LLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-------RITEWEFLGIISQVK--HKNVVKILGLCLE 252 (496)
Q Consensus 183 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~--hpnIv~l~~~~~~ 252 (496)
.....|.+.+.||+|+||.||+|.. .++..||||.+...... .....+|+.+++.++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3445688889999999999999985 57889999998654322 123347788899886 5999999999999
Q ss_pred CCeeeEEEeeccC-CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC-CCCceEEcc
Q 047375 253 TKVTLLVYEFVSN-GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAKVSD 330 (496)
Q Consensus 253 ~~~~~lv~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~-~~~~~kL~D 330 (496)
.+..++||||+.+ ++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999976 89999998754 36889999999999999999999 7899999999999998 788999999
Q ss_pred CCCccccCCCCCccceecccccceeecCcccccccc-cCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc
Q 047375 331 FESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELL-TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE 409 (496)
Q Consensus 331 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 409 (496)
||++....... .....||+.|+|||++.+..+ +.++|+||+|+++++++++..||..... +......
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~-- 261 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVF-- 261 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCC--
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccccc--
Confidence 99998765431 234569999999999887665 6788999999999999999988865321 1111111
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 410 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.....++.+.+|+.+||+.||.+|||+.+++
T Consensus 262 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 292 (320)
T 3a99_A 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292 (320)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1123346799999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=318.59 Aligned_cols=248 Identities=19% Similarity=0.200 Sum_probs=174.3
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHH-HHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLG-IISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|.. .+++.||||++..... .......|+. +++.++||||+++++++...+..++||||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 366778899999999999996 4689999999865422 2223334444 77888999999999999999999999999
Q ss_pred ccCCchhhhhhhc--CcccccCHHHHHHHHHHHHHHHHHhHhcCCC-CcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 263 VSNGALSHYIHDK--SSQVLKNWKTCLRIAAETASAIHYLHSLASP-SIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 263 ~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~-~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
+++ +|.+++... .....+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 985 888877641 112347889999999999999999999 6 899999999999999999999999999987654
Q ss_pred CCCccceecccccceeecCccc----ccccccCCCCCchhhhhcccccccccchhhhccc-chhhhhhhcc---cCCccc
Q 047375 340 DDETAMSTMIRGTVGYLDPEYA----HTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQ---VADESE 411 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l----~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~---~~~~~~ 411 (496)
... .....||+.|+|||++ .+..++.++|+||+|+++++++++..||...... ..+..+.... ......
T Consensus 179 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3aln_A 179 SIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSS
T ss_pred ccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccc
Confidence 321 2334699999999998 4567889999999999999999999888653221 2222222211 111112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...++.+.+|+.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 256 REFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 234577999999999999999999999965
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=328.81 Aligned_cols=246 Identities=22% Similarity=0.221 Sum_probs=183.4
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
|...+.||+|+||+||.....+++.||||++..... ....+|+.+++.+ +|||||++++++.+....|||||||+ |
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 666789999999996554445789999999864322 2345789999998 79999999999999999999999996 5
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-----CCceEEccCCCccccCCCC
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-----NYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-----~~~~kL~DFGla~~~~~~~ 341 (496)
+|.+++...... ..+..++.++.||+.||.|||+ ++|+||||||+|||++. ...+||+|||+++......
T Consensus 103 ~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 103 TLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp EHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 999999765432 2334567899999999999999 78999999999999943 3468899999998775432
Q ss_pred Cc-cceecccccceeecCccccc---ccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccC-CcccHHHH
Q 047375 342 ET-AMSTMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVA-DESEMEEI 415 (496)
Q Consensus 342 ~~-~~~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~ 415 (496)
.. ......+||+.|+|||++.+ ..++.++|+||+||+++++++ +.+||...........+...... .......+
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHH
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccccc
Confidence 11 22345679999999999973 566778999999999999999 78887543322211111111111 11223455
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 416 EVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 416 ~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
..+.+||.+||+.||.+|||+.++++
T Consensus 258 ~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 258 VIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 67899999999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=316.86 Aligned_cols=241 Identities=24% Similarity=0.292 Sum_probs=188.3
Q ss_pred HHHHHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-------hhhHHHHHHHHhcC----CCCceeeEEEE
Q 047375 182 ELLKATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-------RITEWEFLGIISQV----KHKNVVKILGL 249 (496)
Q Consensus 182 ~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l----~hpnIv~l~~~ 249 (496)
+.....|.+.+.||+|+||.||+|.. .++..||||.+...... .....+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44556688899999999999999985 46889999998654321 11223678888887 89999999999
Q ss_pred EeeCCeeeEEEee-ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC-CCCceE
Q 047375 250 CLETKVTLLVYEF-VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAK 327 (496)
Q Consensus 250 ~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~-~~~~~k 327 (496)
+...+..++|||| +++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 78999999998754 37889999999999999999999 7899999999999998 889999
Q ss_pred EccCCCccccCCCCCccceecccccceeecCccccccccc-CCCCCchhhhhcccccccccchhhhcccchhhhhhhccc
Q 047375 328 VSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLT-GMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV 406 (496)
Q Consensus 328 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t-~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 406 (496)
|+|||++....... .....||+.|+|||++.+..+. .++|+||+|+++++++++..||..... +.....
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~ 250 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAEL 250 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCC
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhcc
Confidence 99999998765432 2345599999999998876654 489999999999999999988864321 121111
Q ss_pred CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 407 ADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 407 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
......+..+.+||.+||+.||.+|||+.|++
T Consensus 251 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 282 (312)
T 2iwi_A 251 --HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282 (312)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 12223456799999999999999999999995
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.60 Aligned_cols=246 Identities=16% Similarity=0.176 Sum_probs=177.9
Q ss_pred hcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhh--hhH-HHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIR--ITE-WEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~-~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||.||+|... ++..||||++....... ... .++..+++.++||||+++++++...+..|+||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 3677789999999999999964 68999999986543221 122 2445578888999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCC-CcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP-SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~-~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
+ ++.+..+..... ..+++..+..++.||+.||.|||+ + +|+||||||+|||++.++.+||+|||++.......
T Consensus 106 ~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp C-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred c-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9 556665554432 236889999999999999999998 4 79999999999999999999999999987664432
Q ss_pred CccceecccccceeecCcccc-----cccccCCCCCchhhhhcccccccccchhhhcc-cchhhhhhhcccC-CcccHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAH-----TELLTGMNPNSYVALASNEKISMVPYFLDSIE-NNSFRQILNFQVA-DESEMEE 414 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~-----~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~-~~~~~~~ 414 (496)
. .....||+.|+|||++. ...++.++|+||+|+++++++++..||..... ...+..+...... .+.....
T Consensus 180 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 180 A---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred c---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence 1 23446999999999984 45678899999999999999999988875322 2233333332211 1112234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 415 IEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 415 ~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
++.+.+|+.+||+.||.+|||+.++++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 567999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.22 Aligned_cols=244 Identities=20% Similarity=0.279 Sum_probs=194.9
Q ss_pred HHHHHHhcchhhhcccCCceEEEEeEeC--CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCe-
Q 047375 181 SELLKATKNFHHCLGMGGFGSVYKGVLP--DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKV- 255 (496)
Q Consensus 181 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~- 255 (496)
.+++...|.+.+.||+|+||.||+|.+. +++.||||++.... .......+|+.++.+++||||+++++++...+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 3444567888899999999999999964 58899999886432 223344588999999999999999999987655
Q ss_pred ----eeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccC
Q 047375 256 ----TLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331 (496)
Q Consensus 256 ----~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DF 331 (496)
.|||||||+|++|.+++.. .+++..++.|+.||+.||.|||+ ++||||||||+|||++.+ .+||+||
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEec
Confidence 6999999999999988754 37899999999999999999999 789999999999999976 8999999
Q ss_pred CCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCccc
Q 047375 332 ESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESE 411 (496)
Q Consensus 332 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 411 (496)
|+++..... ....||+.|+|||++.+.. +.++|+||+|+++++++++.+++........ ......
T Consensus 226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~ 290 (681)
T 2pzi_A 226 GAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPV 290 (681)
T ss_dssp TTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTCHH
T ss_pred ccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------cccccc
Confidence 999876542 3346999999999987754 8899999999999999999888765332211 011122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhHh
Q 047375 412 MEEIEVVAELASKCLRIRGTERP-TMKEVSEELDRLRR 448 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~ 448 (496)
...++.+.+||.+||+.||.+|| +++++...|..+.+
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 23457799999999999999999 46777777776654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.92 Aligned_cols=256 Identities=22% Similarity=0.218 Sum_probs=198.5
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEee------CCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLE------TKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------~~~~ 256 (496)
..|.+.+.||+|+||.||+|.. .+|..||||++.... .......+|+.+++.++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 3478889999999999999996 468899999886432 223345589999999999999999999765 6778
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCc---eEEccCCC
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYT---AKVSDFES 333 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~---~kL~DFGl 333 (496)
|+|||||++|+|.+++........+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999999876544457888999999999999999999 78999999999999986664 99999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchh--------------h
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSF--------------R 399 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~--------------~ 399 (496)
+........ .....||+.|+|||++.+..++.++|+||+|+++|++++|..||.+......+ .
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 987754322 23456999999999999999999999999999999999998888653211110 0
Q ss_pred hhhhc--------ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHH-----HHHHHhhH
Q 047375 400 QILNF--------QVADESEMEEIEVVAELASKCLRIRGTERPTMKEV-----SEELDRLR 447 (496)
Q Consensus 400 ~i~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei-----l~~L~~l~ 447 (496)
..... ..+.......++.+.+|+.+||..||.+|||+.++ .+.++.+.
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00000 01112234467889999999999999999999884 44555544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=314.42 Aligned_cols=235 Identities=13% Similarity=0.099 Sum_probs=181.2
Q ss_pred HHhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhh---------hhhHHHHHHHHhcCC---------CCceeeE
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI---------RITEWEFLGIISQVK---------HKNVVKI 246 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~---------hpnIv~l 246 (496)
...|.+.+.||+|+||.||+|.. +++.||||++...... .....+|+.+++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34578889999999999999998 7899999998754211 134457888877775 7777777
Q ss_pred EEEEe------------------------------eCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHH
Q 047375 247 LGLCL------------------------------ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASA 296 (496)
Q Consensus 247 ~~~~~------------------------------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~g 296 (496)
.+++. ..+..|||||||++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 77653 26789999999999977666643 236889999999999999
Q ss_pred HHHhH-hcCCCCcccCCCCcCceeeCCCC--------------------ceEEccCCCccccCCCCCccceeccccccee
Q 047375 297 IHYLH-SLASPSIIHSDVKSANILLDDNY--------------------TAKVSDFESLVPISSDDETAMSTMIRGTVGY 355 (496)
Q Consensus 297 L~~LH-~~~~~~ivHrDlKp~NIll~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y 355 (496)
|.||| + ++|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|
T Consensus 174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 8 7799999999999999887 8999999999876532 23699999
Q ss_pred ecCcccccccccCCCCCchhhhh-cccccccccchhhhcc-cchhhhhhh-----cccCCcccHHHHHHHHHHHHHhccc
Q 047375 356 LDPEYAHTELLTGMNPNSYVALA-SNEKISMVPYFLDSIE-NNSFRQILN-----FQVADESEMEEIEVVAELASKCLRI 428 (496)
Q Consensus 356 ~aPE~l~~~~~t~~~d~~s~g~~-~~~~~~~~~~~~~~~~-~~~~~~i~~-----~~~~~~~~~~~~~~l~~li~~cl~~ 428 (496)
+|||++.+.. +.++|+||++++ .++++.+..||..... ......+.. .....+.....++.+.+||.+||+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 322 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF 322 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence 9999998866 889999997666 7888889888865321 111122221 1112223456788999999999997
Q ss_pred CCCCCCCHHHHH
Q 047375 429 RGTERPTMKEVS 440 (496)
Q Consensus 429 dP~~RPs~~eil 440 (496)
| |+.|++
T Consensus 323 d-----sa~e~l 329 (336)
T 2vuw_A 323 S-----SATDLL 329 (336)
T ss_dssp S-----SHHHHH
T ss_pred C-----CHHHHH
Confidence 6 888775
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=300.00 Aligned_cols=228 Identities=9% Similarity=0.005 Sum_probs=183.3
Q ss_pred HHHhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhh----hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 184 LKATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEI----RITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
+...|.+.+.||+|+||.||+|... +++.||||.+...... .....+|+.++..++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3455888899999999999999964 5899999998754322 2445588999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||||+|++|.+++... .....+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 99999999999999543 1334678899999999999999 789999999999999999999998554
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhh---hhhhcccCC--cccHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFR---QILNFQVAD--ESEME 413 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~---~i~~~~~~~--~~~~~ 413 (496)
|++| ++.++|+||+|+++|+|++|..||........+. ......... .....
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 3333 5778999999999999999999998755433221 111111111 11123
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 414 EIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.++.+.+|+.+||+.||.+| |+.|+++.|+.+...
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 45779999999999999999 999999999988654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.28 Aligned_cols=245 Identities=17% Similarity=0.112 Sum_probs=182.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCC-Ccee-----------------
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKH-KNVV----------------- 244 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h-pnIv----------------- 244 (496)
+...+.||+|+||.||+|.+ .+|+.||||++..... ......+|+.++..++| +|+.
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 44457899999999999994 5789999998863222 12344578888888876 2211
Q ss_pred ----eEEEEEee-----CCeeeEEEeeccCCchhhhhhhc----CcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccC
Q 047375 245 ----KILGLCLE-----TKVTLLVYEFVSNGALSHYIHDK----SSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHS 311 (496)
Q Consensus 245 ----~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHr 311 (496)
.++.++.. ....+++|+++ +++|.+++... .....+++..++.++.||+.||.|||+ ++|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence 11111111 12356777766 57999998521 223347888999999999999999999 789999
Q ss_pred CCCcCceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCccc----------ccccccCCCCCchhhhhccc
Q 047375 312 DVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYA----------HTELLTGMNPNSYVALASNE 381 (496)
Q Consensus 312 DlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l----------~~~~~t~~~d~~s~g~~~~~ 381 (496)
||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|+||+|+++|+
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999999999999999998765432 344568 999999999 56678889999999999999
Q ss_pred ccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhHh
Q 047375 382 KISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEE--LDRLRR 448 (496)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~l~~ 448 (496)
|+++..||...........+..... ..++.+.+||.+||+.||.+|||+.++++. ++.+..
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGGSSCC------CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHHHhhcc------cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence 9999999977655554444433211 223679999999999999999999998753 444433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=296.40 Aligned_cols=222 Identities=22% Similarity=0.184 Sum_probs=173.8
Q ss_pred cchh-hhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHH-hcCCCCceeeEEEEEee----CCeeeEEE
Q 047375 188 KNFH-HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGII-SQVKHKNVVKILGLCLE----TKVTLLVY 260 (496)
Q Consensus 188 ~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~l~~~~~~----~~~~~lv~ 260 (496)
|.+. +.||+|+||.||+|.. .++..||+|.+... ....+|+.++ +..+||||+++++++.. ....|+||
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 4454 7899999999999996 57889999998643 2334667666 66689999999999987 67789999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCcccc
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVPI 337 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~~ 337 (496)
|||++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++...
T Consensus 95 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp CCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 99999999999987543 237889999999999999999999 78999999999999997 789999999987654
Q ss_pred CCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhh----hcccCCc--cc
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL----NFQVADE--SE 411 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~----~~~~~~~--~~ 411 (496)
.. ..++.++|+||+|+++|+++++.+||...........+. ......+ ..
T Consensus 171 ~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (299)
T 3m2w_A 171 TG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226 (299)
T ss_dssp TT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred cc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence 21 246778999999999999999999986654332211111 1111111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
...++.+.+|+.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 234678999999999999999999999853
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=290.01 Aligned_cols=187 Identities=13% Similarity=0.049 Sum_probs=131.0
Q ss_pred hhcccCCceEEEEeE-eCCCcEEEEEEeecch-----------hhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeE
Q 047375 192 HCLGMGGFGSVYKGV-LPDNTQVAVKKYMCAD-----------EIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----------~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l 258 (496)
...+.|++|.+..++ +-.|+.||+|.+.... .....+.+|+++|+++ .|+||+++++++.+++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346777777777665 3368899999986431 1122345899999999 69999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||||+||+|.++|..... ++. .+|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~~~~---l~~---~~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEE---IDR---EKILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHTTCC---CCH---HHHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHhCCC---CCH---HHHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999987643 443 3589999999999999 889999999999999999999999999998775
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchh
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFL 390 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~ 390 (496)
.... .....+||+.|||||++.+. +....|+|+.|++.+.+..+..++.
T Consensus 391 ~~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~ 439 (569)
T 4azs_A 391 QDCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWL 439 (569)
T ss_dssp ---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHHH
T ss_pred CCCc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchhH
Confidence 4322 23557799999999999874 5667899999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-29 Score=261.70 Aligned_cols=175 Identities=15% Similarity=0.147 Sum_probs=135.6
Q ss_pred hhhcccCCceEEEEeEeCCCcEEEEEEeecchh---------hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 191 HHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE---------IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.+.||+|+||.||+|.. .+..+++|+...... ......+|+.++++++||||+++..++...+..|||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999965 678899998643211 11234589999999999999966666667778899999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++.. +..++.|++.||.|||+ ++|+||||||+|||++. .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999865 35789999999999999 78999999999999998 99999999999875432
Q ss_pred Ccc-----ceecccccceeecCccccc--ccccCCCCCchhhhhcccc
Q 047375 342 ETA-----MSTMIRGTVGYLDPEYAHT--ELLTGMNPNSYVALASNEK 382 (496)
Q Consensus 342 ~~~-----~~~~~~gt~~Y~aPE~l~~--~~~t~~~d~~s~g~~~~~~ 382 (496)
... .....+||+.|||||++.. ..|+...|+|+..+-..+.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~ 531 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKD 531 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHH
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHH
Confidence 111 1235679999999999987 6777788999876554443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-25 Score=210.56 Aligned_cols=143 Identities=11% Similarity=0.085 Sum_probs=112.7
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh-------------------hhhhHHHHHHHHhcCCCCceeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE-------------------IRITEWEFLGIISQVKHKNVVKILG 248 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~hpnIv~l~~ 248 (496)
|.+.+.||+|+||.||+|...+|..||||.+..... ......+|+.+++.++ | +++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 344589999999999999997799999999854321 1233458899999998 4 55666
Q ss_pred EEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 249 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
++. .+..|+|||||+||+|.+ +.. .....++.|++.||.|||+ ++|+||||||+|||++ ++.+||
T Consensus 169 ~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 169 VYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp EEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEE
T ss_pred EEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEE
Confidence 543 355699999999999998 421 1234699999999999999 7899999999999999 999999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCccccc
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT 363 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~ 363 (496)
+|||+|+. +..|+|||++..
T Consensus 234 ~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 234 IDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp CCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EECCCCeE---------------CCCCCHHHHHHH
Confidence 99998753 344688887754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.4e-21 Score=182.29 Aligned_cols=135 Identities=17% Similarity=0.168 Sum_probs=102.4
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcE--EEEEEeecchhh-------------------------hhhHHHHHHHHhcCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQ--VAVKKYMCADEI-------------------------RITEWEFLGIISQVK 239 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 239 (496)
|.+...||+|+||.||+|.. .+|.. ||||.+...... .....+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45668899999999999997 67888 999986432110 113447888999988
Q ss_pred CCce--eeEEEEEeeCCeeeEEEeeccC-C----chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhH-hcCCCCcccC
Q 047375 240 HKNV--VKILGLCLETKVTLLVYEFVSN-G----ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH-SLASPSIIHS 311 (496)
Q Consensus 240 hpnI--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~~~~~ivHr 311 (496)
|++| +.+++. +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| + .+|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeC
Confidence 8754 444442 356899999952 4 56555422 123456789999999999999 7 789999
Q ss_pred CCCcCceeeCCCCceEEccCCCcccc
Q 047375 312 DVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 312 DlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.6e-19 Score=177.04 Aligned_cols=137 Identities=13% Similarity=0.107 Sum_probs=96.0
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh---------------hhhh--------HHHHHHHHhcCCCCcee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE---------------IRIT--------EWEFLGIISQVKHKNVV 244 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~e~~~l~~l~hpnIv 244 (496)
|.+...||+|+||.||+|...+|+.||||++..... .... ..+|...|.++.++++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 667789999999999999988899999998743210 0000 11344455555433332
Q ss_pred eEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC
Q 047375 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY 324 (496)
Q Consensus 245 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~ 324 (496)
...-+... ..+|||||++|++|..+... .....++.||+.+|.|||+ .+||||||||.|||+++++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred CCeeeecc--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 11111111 23799999999988765421 1235678999999999999 7899999999999998766
Q ss_pred ----------ceEEccCCCccccC
Q 047375 325 ----------TAKVSDFESLVPIS 338 (496)
Q Consensus 325 ----------~~kL~DFGla~~~~ 338 (496)
.+.|+||+-+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 38999999776543
|
| >3qfl_A MLA10; coiled-coil, (CC) domain, NLRS, nucleotide-binding domain, L rich repeat containing receptors, protein binding; 2.00A {Hordeum vulgare} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.6e-14 Score=116.67 Aligned_cols=81 Identities=20% Similarity=0.287 Sum_probs=76.1
Q ss_pred HHHHHHHHHHhHHHHHHHHhHHhHHHHHHhHHHHHHHHHHHhhhHHhh--ccchhHHHHHHHHhhhhhcchhhhhhhhhh
Q 047375 25 ESIEKIIKKLTKDWLGQFAREEQVQADLIGWKKILVKINEVVDDAVEK--QTKEESVKRWLGKLRNLACDVDYLLDEFQT 102 (496)
Q Consensus 25 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~i~~~l~dae~~--~~~~~~~~~w~~~l~~~~~~~~d~ld~~~~ 102 (496)
|++..+++||++.+.+++....++..+++.|+..|..|+++|.||+++ |.+|++|+.|+.++|+++||+||++|+|.+
T Consensus 1 a~v~~ll~KL~~ll~~E~~l~~gv~~~i~~Lk~eL~~m~a~L~da~~~~~~~~d~~vk~W~~~vrdlaYD~ED~iD~f~~ 80 (115)
T 3qfl_A 1 AAISNLIPKLGELLTEEFKLHKGVKKNIEDLGKELESMNAALIKIGEVPREQLDSQDKLWADEVRELSYVIEDVVDKFLV 80 (115)
T ss_dssp CTTCSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCGGGCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHhchHHHHHHHHHHHHHHHHHHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 356678999999999999999999999999999999999999999998 789999999999999999999999999999
Q ss_pred HHH
Q 047375 103 EAF 105 (496)
Q Consensus 103 ~~~ 105 (496)
+.-
T Consensus 81 ~~~ 83 (115)
T 3qfl_A 81 QVD 83 (115)
T ss_dssp HHH
T ss_pred Hhc
Confidence 874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.5e-12 Score=123.33 Aligned_cols=139 Identities=17% Similarity=0.051 Sum_probs=106.6
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecch-hhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD-EIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
|.+...++.|+.+.||++.. .+..+++|...... .......+|..+++.+. +.++.++++++...+..|+||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 55667788888899999986 47899999876432 22234557788888774 67888999999988999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC-----------------------------------------
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA----------------------------------------- 304 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~----------------------------------------- 304 (496)
.+|.+.+.. ......++.+++.+|..||+..
T Consensus 95 ~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 95 VLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred eehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999876321 1122467889999999999821
Q ss_pred ---------------CCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 305 ---------------SPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 305 ---------------~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
+..++|+|++|.|||++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876566799998654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=9.5e-12 Score=117.44 Aligned_cols=128 Identities=16% Similarity=0.084 Sum_probs=93.9
Q ss_pred ccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCc--eeeEEEEEeeCCeeeEEEeeccCCchhhhh
Q 047375 195 GMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKN--VVKILGLCLETKVTLLVYEFVSNGALSHYI 272 (496)
Q Consensus 195 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l 272 (496)
+.|..+.||++...+|..+++|..... ......+|+.+++.+.+.+ +.++++++...+..++||||++|.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 456669999998767788999987543 2233456777777775434 567899888888899999999998884 2
Q ss_pred hhcCcccccCHHHHHHHHHHHHHHHHHhHhcC------------------------------------------------
Q 047375 273 HDKSSQVLKNWKTCLRIAAETASAIHYLHSLA------------------------------------------------ 304 (496)
Q Consensus 273 ~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------------------------------------------------ 304 (496)
.. .+ ...++.+++..|..||+..
T Consensus 105 ~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 105 SH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp SC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred Cc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 11 11 1246778888888888742
Q ss_pred -------CCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 305 -------SPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 305 -------~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
+..++|+|++|.|||++.++.+.|+|||.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877667799999654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=6.7e-11 Score=117.47 Aligned_cols=139 Identities=18% Similarity=0.171 Sum_probs=102.6
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEee--cch--hhhhhHHHHHHHHhcCC--CCceeeEEEEEeeC---CeeeEEEee
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYM--CAD--EIRITEWEFLGIISQVK--HKNVVKILGLCLET---KVTLLVYEF 262 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~---~~~~lv~E~ 262 (496)
+.|+.|.++.||+.... +..+++|+.. ... .......+|..+++.+. +.++.++++++.+. +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 56899999999999874 5688888775 322 11234457788888776 46688999998876 458999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC--------------------------------------
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA-------------------------------------- 304 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-------------------------------------- 304 (496)
++|..+.+... ..++......++.+++..|..||+..
T Consensus 123 v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99988754221 12456777889999999999999731
Q ss_pred -----------------CCCcccCCCCcCceeeCCCCc--eEEccCCCccc
Q 047375 305 -----------------SPSIIHSDVKSANILLDDNYT--AKVSDFESLVP 336 (496)
Q Consensus 305 -----------------~~~ivHrDlKp~NIll~~~~~--~kL~DFGla~~ 336 (496)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999987653 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=3.6e-09 Score=102.39 Aligned_cols=136 Identities=16% Similarity=0.185 Sum_probs=95.1
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCc--eeeEEEEEeeCC---eeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVK-HKN--VVKILGLCLETK---VTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lv~E~~~~ 265 (496)
+.++.|.+..||+.. ..+++|..... .......+|..+++.+. +.. +.+++..+...+ ..|+||++++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 358899999999873 56888875433 22334457788887763 322 455665554333 45899999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC-----------------------------------------
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA----------------------------------------- 304 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~----------------------------------------- 304 (496)
.+|...... .++...+..++.+++..|..||+..
T Consensus 101 ~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 101 VPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp EECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred eECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 888754321 1455667778888888888888621
Q ss_pred --------------CCCcccCCCCcCceeeCC--CCceEEccCCCcccc
Q 047375 305 --------------SPSIIHSDVKSANILLDD--NYTAKVSDFESLVPI 337 (496)
Q Consensus 305 --------------~~~ivHrDlKp~NIll~~--~~~~kL~DFGla~~~ 337 (496)
...++|+|++|.||+++. ...+.|+||+.+...
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 134799999999999987 556889999987654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=2.4e-07 Score=89.60 Aligned_cols=135 Identities=14% Similarity=0.073 Sum_probs=88.8
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCC---ceeeEEEEEe-eCCeeeEEEeeccCCc
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHK---NVVKILGLCL-ETKVTLLVYEFVSNGA 267 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp---nIv~l~~~~~-~~~~~~lv~E~~~~g~ 267 (496)
..++.|....||+. +..+++|.-. .........+|..+|..+.+. .|.+++.++. ..+..|+||||++|.+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 35788888899988 5678888742 222334455788888887642 3667777764 4556789999999988
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhc--------------------------------------------
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL-------------------------------------------- 303 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-------------------------------------------- 303 (496)
|....-. .++......++.+++..|..||+.
T Consensus 100 l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 100 LGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp CHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred Cchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 8653211 012233344445555555555532
Q ss_pred -------------CCCCcccCCCCcCceeeCC---CCc-eEEccCCCccc
Q 047375 304 -------------ASPSIIHSDVKSANILLDD---NYT-AKVSDFESLVP 336 (496)
Q Consensus 304 -------------~~~~ivHrDlKp~NIll~~---~~~-~kL~DFGla~~ 336 (496)
.+..++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 355 58999986544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=9.8e-07 Score=83.40 Aligned_cols=134 Identities=12% Similarity=0.103 Sum_probs=91.6
Q ss_pred hcccCCce-EEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeeccCCchh
Q 047375 193 CLGMGGFG-SVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFVSNGALS 269 (496)
Q Consensus 193 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 269 (496)
.+..|..| .||+.... ++..+++|.-.... .....+|...|+.+. +--|.++++++.+.+..|+|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445444 68987753 45678899764332 223346777776664 334778899999999999999999998887
Q ss_pred hhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcC---------------------------------------------
Q 047375 270 HYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA--------------------------------------------- 304 (496)
Q Consensus 270 ~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--------------------------------------------- 304 (496)
+...... .....++.+++..|..||...
T Consensus 109 ~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 6653321 122345666777777777521
Q ss_pred ----------CCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 305 ----------SPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 305 ----------~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
+..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999987777799998654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.8e-06 Score=85.20 Aligned_cols=79 Identities=8% Similarity=-0.021 Sum_probs=52.8
Q ss_pred hhc-ccCCceEEEEeEeC-------CCcEEEEEEeecch---h-hhhhHHHHHHHHhcCC---CCceeeEEEEEeeC---
Q 047375 192 HCL-GMGGFGSVYKGVLP-------DNTQVAVKKYMCAD---E-IRITEWEFLGIISQVK---HKNVVKILGLCLET--- 253 (496)
Q Consensus 192 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~--- 253 (496)
+.| +.|..+.+|+.... ++..+++|...... . ......+|..+++.+. ...+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998753 26678888764432 1 1233446666666653 23577888887665
Q ss_pred CeeeEEEeeccCCchhh
Q 047375 254 KVTLLVYEFVSNGALSH 270 (496)
Q Consensus 254 ~~~~lv~E~~~~g~L~~ 270 (496)
+..|+||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35789999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.28 E-value=2.5e-06 Score=83.44 Aligned_cols=143 Identities=15% Similarity=0.199 Sum_probs=77.1
Q ss_pred hcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhc--CCCCceeeEE-E--EEeeCCeeeEEEeeccCCc
Q 047375 193 CLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQ--VKHKNVVKIL-G--LCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~l~-~--~~~~~~~~~lv~E~~~~g~ 267 (496)
.|+.|..+.||+....+ ..+++|...........+.+.++.|.. +..|.++... | +....+..+++|+|++|.+
T Consensus 39 ~l~gG~~n~~~~v~~~~-~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~~ 117 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDS-GAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGRP 117 (346)
T ss_dssp ECC----CEEEEEEETT-EEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCBC
T ss_pred eccccccCcEEEEEeCC-CCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCcc
Confidence 46667788999998744 459999886532111111222333332 2234444311 1 1234667899999999865
Q ss_pred hh-----------hhh---hhc-C-c--c-------cccCHHHH-------------------------------HHHHH
Q 047375 268 LS-----------HYI---HDK-S-S--Q-------VLKNWKTC-------------------------------LRIAA 291 (496)
Q Consensus 268 L~-----------~~l---~~~-~-~--~-------~~l~~~~~-------------------------------~~i~~ 291 (496)
+. ..| +.. . . . ....|... ..+..
T Consensus 118 ~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (346)
T 2q83_A 118 FELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFIE 197 (346)
T ss_dssp CCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHH
Confidence 42 111 110 0 0 0 00122110 11112
Q ss_pred HHHHHHHHhHh----------cCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 292 ETASAIHYLHS----------LASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 292 qi~~gL~~LH~----------~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
.+..++.+|+. ..+..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 198 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 198 DGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 24445666653 1236799999999999998788899999987643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=8.8e-06 Score=81.47 Aligned_cols=73 Identities=12% Similarity=0.057 Sum_probs=45.7
Q ss_pred hhcccCCceEEEEeEeC-CCcEEEEEEeecchh--------hhhhHHHHHHHHhcCCC--C-ceeeEEEEEeeCCeeeEE
Q 047375 192 HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADE--------IRITEWEFLGIISQVKH--K-NVVKILGLCLETKVTLLV 259 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~e~~~l~~l~h--p-nIv~l~~~~~~~~~~~lv 259 (496)
+.||.|.++.||++... ++..++||....... .......|..++..+.. | .+.+++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999753 467899997643211 11223456666665532 3 44566654 34456899
Q ss_pred EeeccCC
Q 047375 260 YEFVSNG 266 (496)
Q Consensus 260 ~E~~~~g 266 (496)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.07 E-value=2e-05 Score=79.59 Aligned_cols=31 Identities=19% Similarity=0.311 Sum_probs=27.4
Q ss_pred CCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
..++|+|++|.|||++.++ ++|+||+.+..-
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 6799999999999998776 999999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.99 E-value=7.6e-05 Score=71.90 Aligned_cols=74 Identities=15% Similarity=0.047 Sum_probs=55.5
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC---CCceeeEEEEEeeCCeeeEEEeeccCCch
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVK---HKNVVKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
..|+.|....+|+... ++..+++|..... .......|...|+.+. ...+.++++++...+..|+||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4588999999999987 5678999976533 2233346666666553 46688899998888889999999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.0002 Score=69.69 Aligned_cols=33 Identities=21% Similarity=0.222 Sum_probs=27.8
Q ss_pred CCCcccCCCCcCceeeCCC----CceEEccCCCcccc
Q 047375 305 SPSIIHSDVKSANILLDDN----YTAKVSDFESLVPI 337 (496)
Q Consensus 305 ~~~ivHrDlKp~NIll~~~----~~~kL~DFGla~~~ 337 (496)
+..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3679999999999999874 67899999977653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00015 Score=69.40 Aligned_cols=70 Identities=10% Similarity=0.034 Sum_probs=40.4
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCce-eeEEEEEeeCCeeeEEEeec-cCCch
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNV-VKILGLCLETKVTLLVYEFV-SNGAL 268 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~-~~g~L 268 (496)
+.|+.|....+|+. ..+++|..............|..+++.+...++ .++++++ ...-++++||+ +|.+|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 46888999999998 568888775432222222345555444431111 4566553 33357899999 66554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00032 Score=71.23 Aligned_cols=73 Identities=18% Similarity=0.056 Sum_probs=45.0
Q ss_pred hhcccCCceEEEEeEeCC-CcEEEEEEeecchhhhhhHHHHHHHHhcCCCCce-eeEEEEEeeCCeeeEEEeeccCCch
Q 047375 192 HCLGMGGFGSVYKGVLPD-NTQVAVKKYMCADEIRITEWEFLGIISQVKHKNV-VKILGLCLETKVTLLVYEFVSNGAL 268 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~g~L 268 (496)
..|+.|-...+|++...+ +..+++|+.............|..++..+...++ .++++.+. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 357778889999998754 4788888764322221222356667776654333 57777763 2 259999987555
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00072 Score=65.38 Aligned_cols=75 Identities=16% Similarity=0.004 Sum_probs=44.0
Q ss_pred hcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCC--CceeeEEEE-----EeeCCeeeEEEeeccC
Q 047375 193 CLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKH--KNVVKILGL-----CLETKVTLLVYEFVSN 265 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~l~~~-----~~~~~~~~lv~E~~~~ 265 (496)
.++ |....||+....+|..+++|..............|..++..+.. -.+++++.. ....+..+++|+|++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 356 77789999887667789999886332222222345555544421 123444432 1234566889999987
Q ss_pred Cch
Q 047375 266 GAL 268 (496)
Q Consensus 266 g~L 268 (496)
..+
T Consensus 112 ~~~ 114 (328)
T 1zyl_A 112 RQF 114 (328)
T ss_dssp EEC
T ss_pred CCC
Confidence 544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00032 Score=66.69 Aligned_cols=73 Identities=16% Similarity=0.001 Sum_probs=49.9
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCC---CceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEI-RITEWEFLGIISQVKH---KNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h---pnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
..+|.|..+.||+....+|+.|.+|+....... ...+..|...|+.+.- --+.+++++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 568999999999999988999999976543222 2233467777666632 2355566542 2478999998765
Q ss_pred h
Q 047375 268 L 268 (496)
Q Consensus 268 L 268 (496)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00028 Score=69.78 Aligned_cols=140 Identities=15% Similarity=0.129 Sum_probs=76.3
Q ss_pred hcccCCceEEEEeEeC--------CCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeec
Q 047375 193 CLGMGGFGSVYKGVLP--------DNTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 193 ~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|..|-...+|++... ++..+++|+............+|..+++.+. +.-..++++++.+. +||||+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i 132 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYI 132 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEe
Confidence 4666777889998864 2468888876332112223336666665553 22236677776532 899999
Q ss_pred cCCchhhh--------------hh---hcC---ccccc-CHHHHHHHHHHHHH-------------------HHHHhH--
Q 047375 264 SNGALSHY--------------IH---DKS---SQVLK-NWKTCLRIAAETAS-------------------AIHYLH-- 301 (496)
Q Consensus 264 ~~g~L~~~--------------l~---~~~---~~~~l-~~~~~~~i~~qi~~-------------------gL~~LH-- 301 (496)
+|.+|..- |. ... ...+. -|..+.++..++.. .+..|.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 98665311 10 000 00011 23444444443321 123332
Q ss_pred --hc-CCCCcccCCCCcCceeeCCC----CceEEccCCCccc
Q 047375 302 --SL-ASPSIIHSDVKSANILLDDN----YTAKVSDFESLVP 336 (496)
Q Consensus 302 --~~-~~~~ivHrDlKp~NIll~~~----~~~kL~DFGla~~ 336 (496)
.. .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 11 12469999999999999876 7899999987654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00028 Score=69.68 Aligned_cols=73 Identities=11% Similarity=0.071 Sum_probs=40.6
Q ss_pred hhcccCCceEEEEeEeCC---------CcEEEEEEeecchhhhhhHHHHHHHHhcCCCCc-eeeEEEEEeeCCeeeEEEe
Q 047375 192 HCLGMGGFGSVYKGVLPD---------NTQVAVKKYMCADEIRITEWEFLGIISQVKHKN-VVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E 261 (496)
..|+.|....+|+....+ +..+++|..............|..++..+...+ +.++++.+ . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 357778888899988643 267888876543222112234555555553222 44666554 2 368999
Q ss_pred eccCCch
Q 047375 262 FVSNGAL 268 (496)
Q Consensus 262 ~~~~g~L 268 (496)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0003 Score=71.04 Aligned_cols=72 Identities=13% Similarity=0.138 Sum_probs=45.2
Q ss_pred hhcccCCceEEEEeEeCC--------CcEEEEEEeecchhhhhhHHHHHHHHhcCCCCc-eeeEEEEEeeCCeeeEEEee
Q 047375 192 HCLGMGGFGSVYKGVLPD--------NTQVAVKKYMCADEIRITEWEFLGIISQVKHKN-VVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E~ 262 (496)
..|+.|-...||++...+ +..+++|+..... .......|..++..+...+ ..++++.+.+ .+||||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457888889999998643 4788999874321 1022235666666554222 3567776542 289999
Q ss_pred ccCCch
Q 047375 263 VSNGAL 268 (496)
Q Consensus 263 ~~~g~L 268 (496)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 987444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00076 Score=65.04 Aligned_cols=143 Identities=16% Similarity=0.167 Sum_probs=74.4
Q ss_pred hhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-----CCceeeEE-E--EEeeCCeeeEEEeec
Q 047375 192 HCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVK-----HKNVVKIL-G--LCLETKVTLLVYEFV 263 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~l~-~--~~~~~~~~~lv~E~~ 263 (496)
+.|+.|....+|+....++ .+++|...... .......|..++..+. -|.++... | +....+..+++|+|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3467788889999987544 78899876521 1112223444444332 23333211 1 112345678999999
Q ss_pred cCCchhh-----------h---hhhc----Ccc-----cccCHHHHHH------------HHHHHHHHHHHhHhc----C
Q 047375 264 SNGALSH-----------Y---IHDK----SSQ-----VLKNWKTCLR------------IAAETASAIHYLHSL----A 304 (496)
Q Consensus 264 ~~g~L~~-----------~---l~~~----~~~-----~~l~~~~~~~------------i~~qi~~gL~~LH~~----~ 304 (496)
+|..+.. . ++.. ... ....|..... +...+...+.+++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865421 0 1110 000 0011222100 011234445555532 1
Q ss_pred CCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 305 ~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
+..++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 35799999999999998776568999986543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0013 Score=64.16 Aligned_cols=31 Identities=19% Similarity=0.400 Sum_probs=27.1
Q ss_pred CCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 306 ~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5699999999999999878899999986544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0024 Score=57.09 Aligned_cols=142 Identities=7% Similarity=-0.002 Sum_probs=90.0
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
-+|.++|...+. +++++++|.++.|.+.+|.-+-... ++ ..+=+-|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 389999987754 5899999999999999987762111 11 2333457999999999988764 2110
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
.....+.|||... ...+.+.-|+|+|+++|..+. ..++...+...++.|..||..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD-------------------ygL~e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD-------------------YGLKENEERELSPPLEQLIDHM 153 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT-------------------TTCCTTEEECCCHHHHHHHHHH
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh-------------------cCCCcccchhhCHHHHHHHHHH
Confidence 0233467888763 233455668999999886543 2333444445556788888888
Q ss_pred ccc-------------------------CCCCCCCHHHHHHHHHhh
Q 047375 426 LRI-------------------------RGTERPTMKEVSEELDRL 446 (496)
Q Consensus 426 l~~-------------------------dP~~RPs~~eil~~L~~l 446 (496)
... .+..|++.++|++.-..-
T Consensus 154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp TTCCC--------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred HhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence 755 346788999998776544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0033 Score=63.04 Aligned_cols=73 Identities=10% Similarity=0.009 Sum_probs=44.2
Q ss_pred hhcccCCceEEEEeEeCC--------CcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEee
Q 047375 192 HCLGMGGFGSVYKGVLPD--------NTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.+..|-...+|+....+ +..+++++............+|..+++.+. +.-..++++.+. -++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 456667778899988642 578888886443222222235555555553 222456665432 2689999
Q ss_pred ccCCch
Q 047375 263 VSNGAL 268 (496)
Q Consensus 263 ~~~g~L 268 (496)
++|.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.77 E-value=0.094 Score=52.05 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=24.5
Q ss_pred cccCCCCcCceee------CCCCceEEccCCCccc
Q 047375 308 IIHSDVKSANILL------DDNYTAKVSDFESLVP 336 (496)
Q Consensus 308 ivHrDlKp~NIll------~~~~~~kL~DFGla~~ 336 (496)
++|+|+.+.|||+ +.+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999987654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.34 E-value=1.5 Score=39.11 Aligned_cols=82 Identities=10% Similarity=-0.009 Sum_probs=57.5
Q ss_pred CCCceeeEEEEEeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHH-HhHhcCCCCcccCCCCcCc
Q 047375 239 KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIH-YLHSLASPSIIHSDVKSAN 317 (496)
Q Consensus 239 ~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~-~LH~~~~~~ivHrDlKp~N 317 (496)
.||+. -..+-.+.+.+.|.++.-+++.=...++. ++...+++++.+|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 68887 34444566776666665433322223322 466788889998887766 5655 6888899999
Q ss_pred eeeCCCCceEEccCCC
Q 047375 318 ILLDDNYTAKVSDFES 333 (496)
Q Consensus 318 Ill~~~~~~kL~DFGl 333 (496)
|+++.++.++|.=.|+
T Consensus 115 L~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 115 LMFNRALEPFFLHVGV 130 (219)
T ss_dssp EEECTTCCEEESCCEE
T ss_pred EEEeCCCcEEEEEcCC
Confidence 9999999999987775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.11 E-value=1.6 Score=38.83 Aligned_cols=90 Identities=7% Similarity=0.006 Sum_probs=61.9
Q ss_pred HHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC-chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcc
Q 047375 231 FLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG-ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309 (496)
Q Consensus 231 e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~iv 309 (496)
++.+|. -.||+.+.. .+-.+.+.+.|.++.-+.+ ++.. ++. ++...+++++.+|+....+++. -+
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~------~~~~eKlr~l~ni~~l~~~~~~-----r~ 101 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS------FTKNEKLRYLLNIKNLEEVNRT-----RY 101 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG------SCHHHHHHHHHHGGGGGGGGGS-----SE
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh------cCHHHHHHHHHHHHHHHHHhcC-----ce
Confidence 344443 368988866 4555666655555544322 2222 222 4667889999999888766665 57
Q ss_pred cCCCCcCceeeCCCCceEEccCCCc
Q 047375 310 HSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 310 HrDlKp~NIll~~~~~~kL~DFGla 334 (496)
|--|.|+||+++.++.+++.=-|+-
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEET
T ss_pred EEEEecceEEEcCCCCEEEEEccCc
Confidence 8889999999999999999877753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 496 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-30 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-21 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-46
Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 26/273 (9%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKI 246
+G G FG+VYKG VAVK F G++ + +H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+G ++ +V ++ +L H++H ++ + IA +TA + YLH+
Sbjct: 70 MGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA---K 123
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELL 366
SIIH D+KS NI L ++ T K+ DF S + + G++ ++ PE +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 367 TGMNPNSYV--------ALASNEKISMVPYFLDSIENNSFRQILN---FQVADESEMEEI 415
+ S V L + + PY + + + +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQL----PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 416 EVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448
+ + L ++CL+ + ERP ++ ++ L R
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-44
Identities = 59/262 (22%), Positives = 112/262 (42%), Gaps = 12/262 (4%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVK 245
F +G G FG V+ G + +VA+K E ++E +F+ ++ ++ H +V+
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+ G+CLE LV+EF+ +G LS Y+ + + L +T L + + + YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTEL 365
+IH D+ + N L+ +N KVSDF + DD+ ST + V + PE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDF-GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 366 LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425
+ + + E S ++ N+ + ++ V ++ + C
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 426 LRIRGTERPTMKEVSEELDRLR 447
+ R +RP + +L +
Sbjct: 239 WKERPEDRPAFSRLLRQLAEIA 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-43
Identities = 57/298 (19%), Positives = 110/298 (36%), Gaps = 42/298 (14%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGL 249
+G G FG V++G +VAVK + +E + ++H+N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 250 CLETKVTL----LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS--- 302
+ T LV ++ +G+L Y++ + + +++A TAS + +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 303 --LASPSIIHSDVKSANILLDDNYTAKVSDF--ESLVPISSDDETAMSTMIRGTVGYLDP 358
P+I H D+KS NIL+ N T ++D ++D GT Y+ P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 359 EYAHT-----------------------ELLTGMNPNSYVALASNEKISMVP--YFLDSI 393
E E+ + +VP ++ +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 394 ENNSFRQILNFQVADE-SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQ 450
Q L + + E + V+A++ +C G R T + + L +L + +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-43
Identities = 56/258 (21%), Positives = 110/258 (42%), Gaps = 12/258 (4%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKI 246
LG G FG V+ G +T+VAVK + ++ FL ++ Q++H+ +V++
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+ + + ++ E++ NG+L ++ S L L +AA+ A + ++
Sbjct: 74 YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ER 128
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELL 366
+ IH D+++ANIL+ D + K++DF L + D+E + + + PE +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADF-GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 367 TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426
T + + E ++ + N Q L E + +L C
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 427 RIRGTERPTMKEVSEELD 444
+ R +RPT + L+
Sbjct: 248 KERPEDRPTFDYLRSVLE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-42
Identities = 57/260 (21%), Positives = 107/260 (41%), Gaps = 12/260 (4%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGL 249
+G G FG V G +VAVK + E +++Q++H N+V++LG+
Sbjct: 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAE-ASVMTQLRHSNLVQLLGV 68
Query: 250 CLETKVTL-LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+E K L +V E+++ G+L Y+ + VL L+ + + A+ YL +
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLEG---NNF 124
Query: 309 IHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTG 368
+H D+ + N+L+ ++ AKVSDF SS +T V + PE + +
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREKKFST 179
Query: 369 MNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRI 428
+ + E S I + ++ V E+ C +
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHL 239
Query: 429 RGTERPTMKEVSEELDRLRR 448
RP+ ++ E+L+ ++
Sbjct: 240 DAAMRPSFLQLREQLEHIKT 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (372), Expect = 2e-41
Identities = 63/273 (23%), Positives = 123/273 (45%), Gaps = 8/273 (2%)
Query: 178 FSKSELLKATKNFHHCLGMGGFGSVYKGVLPD-NTQVAVKKYMCADEIRITEWEF-LGII 235
+ K E+ + H LG G +G VY+GV + VAVK + D + + E+ ++
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVM 67
Query: 236 SQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETAS 295
++KH N+V++LG+C ++ EF++ G L Y+ + + Q + + L +A + +S
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISS 126
Query: 296 AIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGY 355
A+ YL + IH D+ + N L+ +N+ KV+DF ++ D TA + + +
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKW 182
Query: 356 LDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI 415
PE + + + E + I+ + ++L E
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 242
Query: 416 EVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448
E V EL C + ++RP+ E+ + + + +
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 9e-41
Identities = 54/257 (21%), Positives = 107/257 (41%), Gaps = 6/257 (2%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGL 249
LG G FG V+ G T+VA+K + ++ +++H+ +V++ +
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
E + +V E++S G+L ++ ++ + + +AA+ AS + Y+ + +
Sbjct: 81 VSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER---MNYV 135
Query: 310 HSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGM 369
H D+++ANIL+ +N KV+DF L + D+E + + + PE A T
Sbjct: 136 HRDLRAANILVGENLVCKVADF-GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 370 NPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIR 429
+ + E + + N + E E + +L +C R
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 254
Query: 430 GTERPTMKEVSEELDRL 446
ERPT + + L+
Sbjct: 255 PEERPTFEYLQAFLEDY 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-41
Identities = 58/258 (22%), Positives = 105/258 (40%), Gaps = 12/258 (4%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVK 245
F LG G FG V G VA+K E ++E EF+ ++ + H+ +V+
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+ G+C + + ++ E+++NG L +Y+ + + + L + + A+ YL S
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEYLE---S 118
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTEL 365
+H D+ + N L++D KVSDF L DDE S + V + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDF-GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 366 LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425
+ + + E S+ + N+ + + + E V + C
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237
Query: 426 LRIRGTERPTMKEVSEEL 443
+ ERPT K + +
Sbjct: 238 WHEKADERPTFKILLSNI 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (366), Expect = 2e-40
Identities = 59/295 (20%), Positives = 112/295 (37%), Gaps = 33/295 (11%)
Query: 178 FSKSELLKATKNFH-----------HCLGMGGFGSVYKGVLPDNTQ----VAVKKYMCAD 222
F+ + +A + F +G G FG V G L + VA+K + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSG 65
Query: 223 EIRITEWEFL---GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQV 279
+FL I+ Q H NV+ + G+ ++ +++ EF+ NG+L ++ Q
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 124
Query: 280 LKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF---ESLVP 336
+ + A+ + YL + +H D+ + NIL++ N KVSDF L
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN 396
+SD + + + + PE S V ++ Y +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYR---KFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 397 SFRQILNFQVAD---ESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448
+ + ++N D M+ + +L C + RP ++ LD++ R
Sbjct: 238 TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-40
Identities = 61/322 (18%), Positives = 127/322 (39%), Gaps = 18/322 (5%)
Query: 175 MKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVK---KYMCADEIRITEWE 230
++I ++E LG G FG+VYKG+ +P+ +V + K + E
Sbjct: 3 LRILKETEF-----KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 57
Query: 231 FL---GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCL 287
L +++ V + +V ++LG+CL + V L+ + + G L Y+ + + L
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN--IGSQYLL 114
Query: 288 RIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347
+ A ++YL ++H D+ + N+L+ K++DF + ++++ +
Sbjct: 115 NWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 348 MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA 407
+ + ++ E + T + + E ++ D I + IL
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 231
Query: 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEESEHLLG 467
V + KC I RP +E+ E ++ R + Y + +E
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSP 291
Query: 468 ESSTYATAVIAQPETQTVVSID 489
S + A++ + + VV D
Sbjct: 292 TDSNFYRALMDEEDMDDVVDAD 313
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-40
Identities = 59/307 (19%), Positives = 112/307 (36%), Gaps = 35/307 (11%)
Query: 166 DPPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYM 219
DP L + F ++ L +F LG G FG V + VAVK +
Sbjct: 8 DPTQLPYDHKWEFPRNRL-----SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-L 61
Query: 220 CADEIRITEWEFL---GIISQVK-HKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDK 275
+ ++S + H N+V +LG C TL++ E+ G L +++ K
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 276 SSQVLK---------------NWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILL 320
+ + + L + + A + +L S + IH D+ + NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178
Query: 321 DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASN 380
K+ DF I +D + R V ++ PE + T + +
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 381 EKISM-VPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEV 439
E S+ + ++ F +++ S + ++ C +RPT K++
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 440 SEELDRL 446
+ +++
Sbjct: 299 VQLIEKQ 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-39
Identities = 60/268 (22%), Positives = 120/268 (44%), Gaps = 15/268 (5%)
Query: 194 LGMGGFGSVYKGVLPDNTQ-----VAVKKYMCADEIRITEWEFL---GIISQVKHKNVVK 245
+G G FG VYKG+L ++ VA+K + A +FL GI+ Q H N+++
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+ G+ + K +++ E++ NGAL ++ +K + + + + A+ + YL +
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKYLAN--- 128
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE-TAMSTMIRGTVGYLDPEYAHTE 364
+ +H D+ + NIL++ N KVSDF + D E T ++ + + + PE
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 365 LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424
T + + E ++ + N+ + +N + M+ + +L +
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ 248
Query: 425 CLRIRGTERPTMKEVSEELDRLRRLQEN 452
C + RP ++ LD+L R ++
Sbjct: 249 CWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-38
Identities = 52/259 (20%), Positives = 102/259 (39%), Gaps = 17/259 (6%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQ-VAVKKYMCADEIRITEWEFL---GIISQVKHKNVVK 245
F +G G F +VYKG+ + T VA + + F ++ ++H N+V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 246 ILGLCLET----KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
T K +LV E +++G L Y+ K + + +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM---KIKVLRSWCRQILKGLQFLH 129
Query: 302 SLASPSIIHSDVKSANILLDD-NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEY 360
+ +P IIH D+K NI + + K+ D +++ + + + GT ++ PE
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLG----LATLKRASFAKAVIGTPEFMAPEM 184
Query: 361 AHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420
+ ++ ++ S PY +R++ + + I V E
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 421 LASKCLRIRGTERPTMKEV 439
+ C+R ER ++K++
Sbjct: 245 IIEGCIRQNKDERYSIKDL 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 54/286 (18%), Positives = 104/286 (36%), Gaps = 35/286 (12%)
Query: 190 FHHCLGMGGFGSVYKGVLPD------NTQVAVKKYMCADEIRITEWEFL---GIISQV-K 239
F LG G FG V + QVAVK + + +++Q+
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSELKMMTQLGS 99
Query: 240 HKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKN----------------- 282
H+N+V +LG C + L++E+ G L +Y+ K + ++
Sbjct: 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159
Query: 283 ---WKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339
++ L A + A + +L S +H D+ + N+L+ K+ DF I S
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSF 398
D + R V ++ PE + T + + E S+ V + + +F
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276
Query: 399 RQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444
+++ + E + + C +RP+ ++ L
Sbjct: 277 YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 5e-38
Identities = 53/289 (18%), Positives = 106/289 (36%), Gaps = 36/289 (12%)
Query: 189 NFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEIRITEWEFL---GIISQVK 239
+ +G G FG V++ P T VAVK + + + +F ++++
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREAALMAEFD 74
Query: 240 HKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLK------------------ 281
+ N+VK+LG+C K L++E+++ G L+ ++ S +
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 282 ---NWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338
+ L IA + A+ + YL +H D+ + N L+ +N K++DF I
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMN-PNSYVALASNEKISMVPYFLDSIENNS 397
S D + ++ PE T + +Y + + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 398 FRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446
+ + + E +E + L C +RP+ + L R+
Sbjct: 252 IYYVRDGNILACPENCPLE-LYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (350), Expect = 6e-38
Identities = 51/254 (20%), Positives = 91/254 (35%), Gaps = 20/254 (7%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
+G G FG+VY + ++ VA+KK + + +W+ + + +++H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
L LV E+ A K + + YLHS ++
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 309 IHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTG 368
IH DVK+ NILL + K+ DF S ++ + GT ++ PE
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQ 190
Query: 369 MNPNSYV---ALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425
+ V + E P + ++ I + E C
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 426 LRIRGTERPTMKEV 439
L+ +RPT + +
Sbjct: 251 LQKIPQDRPTSEVL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 8e-37
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 34/285 (11%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDN----TQVAVK---KYMCADEIRITEWEFLGIISQVKHK 241
+F+ +G G FG VY G L DN AVK + E+ E I+ H
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE-GIIMKDFSHP 88
Query: 242 NVVKILGLCLETK-VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
NV+ +LG+CL ++ L+V ++ +G L ++I +++ K + + A + +L
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL 146
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDFE--SLVPISSDDETAMSTMIRGTVGYLDP 358
S +H D+ + N +LD+ +T KV+DF + D T + V ++
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 359 EYAHTELLTGMNPNSYV--------ALASNEKISMVPYFLDSIENNSFRQILNFQVADES 410
E T+ S V L + P + D + +L + +
Sbjct: 204 ESLQTQ---KFTTKSDVWSFGVLLWELMTRGA----PPYPDVNTFDITVYLLQGRRLLQP 256
Query: 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR--LQENY 453
E + + E+ KC + RP+ E+ + + + E+Y
Sbjct: 257 E-YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 8e-37
Identities = 54/278 (19%), Positives = 107/278 (38%), Gaps = 20/278 (7%)
Query: 194 LGMGGFGSVYKGVL---PDNTQVAVK---KYMCADEIRITEWEFLGIISQVKHKNVVKIL 247
LG G FGSV +GV VA+K + + E I+ Q+ + +V+++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE-AQIMHQLDNPYIVRLI 75
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
G+C + +LV E G L ++ K ++ + + + + YL +
Sbjct: 76 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEE---KN 129
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET-AMSTMIRGTVGYLDPEYAHTELL 366
+H D+ + N+LL + + AK+SDF + +DD + + + + PE +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 367 TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426
+ + + E +S ++ + E E + L S C
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249
Query: 427 RIRGTERPTMKEVSEELDRLRRLQENYWARKNNEESEH 464
+ +RP V +R++ Y++ + E H
Sbjct: 250 IYKWEDRPDFLTV------EQRMRACYYSLASKVEGHH 281
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 9e-37
Identities = 60/284 (21%), Positives = 107/284 (37%), Gaps = 25/284 (8%)
Query: 189 NFHHCLGMGGFGSVYKGVLPDNTQ---VAVKK---YMCADEIRITEWEFLGIISQVKHKN 242
F +G G FG V K + + A+K+ Y D+ R E + H N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLK-------------NWKTCLRI 289
++ +LG C L E+ +G L ++ + + L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 290 AAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMI 349
AA+ A + YL IH D+ + NIL+ +NY AK++DF + TM
Sbjct: 133 AADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMG 186
Query: 350 RGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE 409
R V ++ E + + T + + E +S+ + + L E
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 410 SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENY 453
+ + V +L +C R + ERP+ ++ L+R+ ++ Y
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 2e-36
Identities = 53/253 (20%), Positives = 91/253 (35%), Gaps = 15/253 (5%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITE--WEFLGIISQVKHKNVVKILGLC 250
LG G +G V V VAVK + E + + I + H+NVVK G
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
E + L E+ S G L I R + + + YLH + I H
Sbjct: 73 REGNIQYLFLEYCSGGELFDRIEPDIGM---PEPDAQRFFHQLMAGVVYLHGI---GITH 126
Query: 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMN 370
D+K N+LLD+ K+SDF ++ + + GT+ Y+ PE
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 371 PNSY---VALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI-EVVAELASKCL 426
+ + + L ++ + ++ + + ++I L K L
Sbjct: 187 VDVWSCGIVLT--AMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244
Query: 427 RIRGTERPTMKEV 439
+ R T+ ++
Sbjct: 245 VENPSARITIPDI 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-36
Identities = 63/287 (21%), Positives = 100/287 (34%), Gaps = 29/287 (10%)
Query: 190 FHHCLGMGGFGSVYKGV------LPDNTQVAVK---KYMCADEIRITEWEFLGIISQVKH 240
LG G FG V + VAVK + E R E +I H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 241 KNVVKILGLCLETKVTL-LVYEFVSNGALSHYIHDKSSQVLK-------------NWKTC 286
NVV +LG C + L ++ EF G LS Y+ K ++ + +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 287 LRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346
+ + + A + +L S IH D+ + NILL + K+ DF I D +
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQ 405
R + ++ PE + T + + E S + + F + L
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253
Query: 406 VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQEN 452
+ + + C ++RPT E+ E L L LQ N
Sbjct: 254 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL--LQAN 298
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 4e-36
Identities = 54/255 (21%), Positives = 102/255 (40%), Gaps = 17/255 (6%)
Query: 190 FHHCLGMGGFGSVYKGVLP-DNTQVAVKK----YMCADEIRITEWEFLGIISQVKHKNVV 244
LG G FG+VY +A+K + + + I S ++H N++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
++ G + L+ E+ G + + S + + E A+A+ Y HS
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF---DEQRTATYITELANALSYCHSK- 125
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE 364
+IH D+K N+LL K++DF S ++ T + GT+ YL PE
Sbjct: 126 --RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 365 LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424
+ + + E + P F + ++++I + + E +L S+
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--EGARDLISR 237
Query: 425 CLRIRGTERPTMKEV 439
L+ ++RP ++EV
Sbjct: 238 LLKHNPSQRPMLREV 252
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 6e-36
Identities = 51/254 (20%), Positives = 92/254 (36%), Gaps = 15/254 (5%)
Query: 194 LGMGGFGSVYKGVLPD-NTQVAVKKYMCADEIRITEWEF-LGIISQVKHKNVVKILGLCL 251
LG G FG VYK + + A K E + ++ + I++ H N+VK+L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 252 ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHS 311
++ EF + GA+ + + + + +T A++YLH IIH
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPL--TESQIQVVCKQTLDALNYLHDN---KIIHR 134
Query: 312 DVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNP 371
D+K+ NIL + K++DF + + GT ++ PE E
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 372 NSYVALAS-----NEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI-EVVAELASKC 425
+ + S E + P + +I + ++ + KC
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 252
Query: 426 LRIRGTERPTMKEV 439
L R T ++
Sbjct: 253 LEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-36
Identities = 56/275 (20%), Positives = 100/275 (36%), Gaps = 21/275 (7%)
Query: 194 LGMGGFGSVYKGVLPD---NTQVAVKKYMCADEIRITEWEFLG---IISQVKHKNVVKIL 247
LG G FG+V KG VAVK + E L ++ Q+ + +V+++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 248 GLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPS 307
G+C E + +LV E G L+ Y+ K + + + + + YL +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQNRHV---KDKNIIELVHQVSMGMKYLEE---SN 127
Query: 308 IIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM-STMIRGTVGYLDPEYAHTELL 366
+H D+ + N+LL + AK+SDF + +D+ T + V + PE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 367 TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426
+ + + E S ++ + +L + +L + C
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247
Query: 427 RIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461
RP V L NY+ NE
Sbjct: 248 TYDVENRPGFAAVELRL-------RNYYYDVVNEG 275
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-36
Identities = 54/271 (19%), Positives = 108/271 (39%), Gaps = 22/271 (8%)
Query: 190 FHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADEIRITEWEFL---GIISQVKH 240
LG G FG VY+GV T+VA+K + EFL ++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNC 82
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKN-------WKTCLRIAAET 293
+VV++LG+ + + TL++ E ++ G L Y+ + N +++A E
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 294 ASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTV 353
A + YL++ +H D+ + N ++ +++T K+ DF I D V
Sbjct: 143 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 354 GYLDPEYAHTELLTGMNPNSYVALASNEKISMV-PYFLDSIENNSFRQILNFQVADESEM 412
++ PE + T + + E ++ + R ++ + D+ +
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD- 258
Query: 413 EEIEVVAELASKCLRIRGTERPTMKEVSEEL 443
+++ EL C + RP+ E+ +
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-35
Identities = 59/268 (22%), Positives = 106/268 (39%), Gaps = 23/268 (8%)
Query: 190 FHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLG----IISQVKHKNVV 244
F LG G F +V L + + A+K I+ + ++ ++S++ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
K+ + + + NG L YI S + AE SA+ YLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG-- 126
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE 364
IIH D+K NILL+++ +++DF + +S + + A + GT Y+ PE
Sbjct: 127 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL---- 181
Query: 365 LLTGMNPNSYVALASN-----EKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419
LT + L + + ++ +P F E F++I+ + +
Sbjct: 182 -LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF--FPKAR 238
Query: 420 ELASKCLRIRGTERPTMKEVSEELDRLR 447
+L K L + T+R +E+
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-35
Identities = 50/264 (18%), Positives = 93/264 (35%), Gaps = 16/264 (6%)
Query: 194 LGMGGFGSVYKGVLPDNT----QVAVKK----YMCADEIRITEWEFLGIISQVKHKNVVK 245
LG G FG V +G + VAVK + E + + + H+N+++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+ G+ L + +V E G+L + L T R A + A + YL S
Sbjct: 76 LYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL--LGTLSRYAVQVAEGMGYLES--- 129
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFE-SLVPISSDDETAMSTMIRGTVGYLDPEYAHTE 364
IH D+ + N+LL K+ DF +DD M + + PE T
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 365 LLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423
+ + + E + ++ + +I + + + +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV 249
Query: 424 KCLRIRGTERPTMKEVSEELDRLR 447
+C + +RPT + + L +
Sbjct: 250 QCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-34
Identities = 48/291 (16%), Positives = 91/291 (31%), Gaps = 54/291 (18%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGLC 250
LG G G V+K + V +K + + + + ++ + +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
+ E + G+L + + +++ + YL I+H
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT------- 363
DVK +NIL++ K+ DF +S +M+ GT Y+ PE
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 364 ----------ELLTGMNP---------------------NSYVALASNEKISMVPYFLDS 392
E+ G P + Y +DS
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 393 IENNSFRQILNFQVADESEMEEIEVV----AELASKCLRIRGTERPTMKEV 439
+ ++L++ V + V + +KCL ER +K++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 6e-34
Identities = 58/281 (20%), Positives = 104/281 (37%), Gaps = 27/281 (9%)
Query: 190 FHHCLGMGGFGSVYKGVLP--------DNTQVAVKKY---MCADEIRITEWEFLGIISQV 238
LG G FG V T+VAVK ++ E +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 239 KHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLK-------------NWKT 285
KHKN++ +LG C + ++ E+ S G L Y+ + L+ + K
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 286 CLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345
+ A + A + YL S IH D+ + N+L+ ++ K++DF I D
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ 405
+T R V ++ PE + T + + E ++ + ++L
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253
Query: 406 VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446
+ + + C ++RPT K++ E+LDR+
Sbjct: 254 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 7e-34
Identities = 54/269 (20%), Positives = 109/269 (40%), Gaps = 15/269 (5%)
Query: 190 FHHCLGMGGFGSVYKGVLPDNTQ----VAVK--KYMCADEIRITEWEFLGIISQVKHKNV 243
C+G G FG V++G+ VA+K K +D +R + + Q H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
VK++G+ E V ++ E + G L ++ + + + + + A + ++A+ YL S
Sbjct: 71 VKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLES- 126
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT 363
+H D+ + N+L+ N K+ DF L D ++ + + ++ PE +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDF-GLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 364 ELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422
T + + E + V F N+ +I N + + L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP-NCPPTLYSLM 242
Query: 423 SKCLRIRGTERPTMKEVSEELDRLRRLQE 451
+KC + RP E+ +L + ++
Sbjct: 243 TKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-33
Identities = 46/260 (17%), Positives = 100/260 (38%), Gaps = 12/260 (4%)
Query: 189 NFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVV 244
+ +G G +G K D + K+ + + ++ ++KH N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 245 KILGLCLET--KVTLLVYEFVSNGALSHYIHDKSSQVLK-NWKTCLRIAAETASAIHYLH 301
+ ++ +V E+ G L+ I + + + + LR+ + A+ H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 302 SL--ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
+++H D+K AN+ LD K+ DF L I + D + + T Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF-GLARILNHDTSFAKAFVG-TPYYMSPE 184
Query: 360 YAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419
+ + + E +++P F + +I + E +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE-LN 243
Query: 420 ELASKCLRIRGTERPTMKEV 439
E+ ++ L ++ RP+++E+
Sbjct: 244 EIITRMLNLKDYHRPSVEEI 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-33
Identities = 49/266 (18%), Positives = 105/266 (39%), Gaps = 46/266 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEF-LGIISQVKHKNVVKILGLCL 251
+G G G+VY + + +VA+++ + + + ++ + K+ N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 252 ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHS 311
+V E+++ G+L+ + + + + E A+ +LHS +IH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 312 DVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT-------- 363
D+KS NILL + + K++DF I+ + + + GT ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 364 ---------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEE 414
E++ G P +L+ + I + E+
Sbjct: 199 IWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATNGTPELQNPEK 241
Query: 415 I-EVVAELASKCLRIRGTERPTMKEV 439
+ + + ++CL + +R + KE+
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 121 bits (305), Expect = 3e-31
Identities = 41/279 (14%), Positives = 100/279 (35%), Gaps = 21/279 (7%)
Query: 167 PPGLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIR 225
P + + ++ ++L+ LG G FG V++ V K +
Sbjct: 17 PQPVEVKQGSVYDYYDILE-------ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD 69
Query: 226 ITEWEF-LGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWK 284
+ + I++Q+ H ++ + + +L+ EF+S G L I + ++ +
Sbjct: 70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM--SEA 127
Query: 285 TCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD--DNYTAKVSDFESLVPISSDDE 342
+ + + ++H SI+H D+K NI+ + + K+ DF ++ D+
Sbjct: 128 EVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183
Query: 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL 402
+ + T + PE E + + + +S + F + + + +
Sbjct: 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241
Query: 403 NFQVADESEMEEI--EVVAELASKCLRIRGTERPTMKEV 439
+ + + L+ +R T+ +
Sbjct: 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (298), Expect = 2e-30
Identities = 48/252 (19%), Positives = 95/252 (37%), Gaps = 14/252 (5%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWE-FLGIISQVKHKNVVKILGLCL 251
LG G FG V++ A K M E + +S ++H +V +
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 252 ETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHS 311
+ +++YEF+S G L + D+ +++ + + + + ++H + +H
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHNKM--SEDEAVEYMRQVCKGLCHMHEN---NYVHL 148
Query: 312 DVKSANILL--DDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGM 369
D+K NI+ + K+ DF + D + GT + PE A + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 370 NPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEI-EVVAELASKCLR 427
V + S +S + F ++ + R + + D+S I E + K L
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 265
Query: 428 IRGTERPTMKEV 439
R T+ +
Sbjct: 266 ADPNTRMTIHQA 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (293), Expect = 2e-30
Identities = 56/268 (20%), Positives = 92/268 (34%), Gaps = 19/268 (7%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKK----YMCADEIRITEWEFLGIISQVKHKNVVKILG 248
LG GG V+ L + VAVK + + + H +V +
Sbjct: 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74
Query: 249 LCLET----KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ +V E+V L +H + K + + A+ A+++ H
Sbjct: 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 128
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPI-SSDDETAMSTMIRGTVGYLDPEYAHT 363
IIH DVK ANI++ KV DF I S + + + GT YL PE A
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 364 ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI--EVVAEL 421
+ + + + E ++ P F + Q + S E + +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248
Query: 422 ASKCLRIRGTERP-TMKEVSEELDRLRR 448
K L R T E+ +L R+
Sbjct: 249 VLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 115 bits (289), Expect = 8e-30
Identities = 55/266 (20%), Positives = 97/266 (36%), Gaps = 29/266 (10%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVK-----------HK 241
LG G V + + P + AVK + E + H
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 242 NVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
N++++ LV++ + G L Y+ +K + + K +I I LH
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALH 127
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYA 361
L +I+H D+K NILLDD+ K++DF + ++ + GT YL PE
Sbjct: 128 KL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEII 181
Query: 362 HTELLTGMNPNSY------VALASNEKISMVPYFLDSIENNSFRQIL--NFQVADESEME 413
+ + ++ P F + R I+ N+Q +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 414 EIEVVAELASKCLRIRGTERPTMKEV 439
+ V +L S+ L ++ +R T +E
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-29
Identities = 53/299 (17%), Positives = 98/299 (32%), Gaps = 48/299 (16%)
Query: 194 LGMGGFGSVYKG--VLPDNTQVAVKKYMCAD------EIRITEWEFLGIISQVKHKNVVK 245
+G G +G V+K + VA+K+ I E L + +H NVV+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 246 ILGLCLETKVT-----LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
+ +C ++ LV+E V ++ V +T + + + +L
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV--PTETIKDMMFQLLRGLDFL 132
Query: 301 HSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEY 360
HS ++H D+K NIL+ + K++DF T + T+ Y PE
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGL---ARIYSFQMALTSVVVTLWYRAPEV 186
Query: 361 AHT-----------------ELLTGMNP----NSYVALASNEKISMVPYFLDSIENNSFR 399
E+ + L + +P D + +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 400 QILNFQVADESEMEEIEVVAELA----SKCLRIRGTERPTMKEVSEE--LDRLRRLQEN 452
+ + + + + + EL KCL +R + L R +EN
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 305
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-28
Identities = 50/286 (17%), Positives = 101/286 (35%), Gaps = 54/286 (18%)
Query: 176 KIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGI 234
+++ K + + LG G FG V++ V K ++ + + I
Sbjct: 2 ELYEKYMIAE-------DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISI 54
Query: 235 ISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETA 294
++ +H+N++ + + ++++EF+S + I+ + ++ N + + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL--NEREIVSYVHQVC 112
Query: 295 SAIHYLHSLASPSIIHSDVKSANILLD--DNYTAKVSDFESLVPISSDDETAMSTMIRGT 352
A+ +LHS +I H D++ NI+ + T K+ +F + D ++
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTA 166
Query: 353 VGYLDPEYAHT-----------------ELLTGMNPNSYVALASNEKISMVPYFLDSIEN 395
Y PE LL+G+NP FL
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-----------------FLAETNQ 209
Query: 396 NSFRQILNFQVA-DESEMEEI-EVVAELASKCLRIRGTERPTMKEV 439
I+N + DE +EI + + L R T E
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 5e-28
Identities = 54/280 (19%), Positives = 87/280 (31%), Gaps = 42/280 (15%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCA------DEIRITEWEFLGIISQVKHKNVVKI 246
LG G F +VYK N VA+KK D I T + ++ ++ H N++ +
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 247 LGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
L LV++F+ + T + YLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVL---TPSHIKAYMLMTLQGLEYLHQ---H 119
Query: 307 SIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT--- 363
I+H D+K N+LLD+N K++DF S + T T Y PE
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARM 177
Query: 364 ---------------ELLTGMNP----NSYVALASNEKISMVPYFLDSIENNSFRQILNF 404
ELL + + L + P + S + F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 405 QVADESEMEEI-----EVVAELASKCLRIRGTERPTMKEV 439
+ + I + + +L R T +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (274), Expect = 2e-27
Identities = 57/258 (22%), Positives = 100/258 (38%), Gaps = 18/258 (6%)
Query: 190 FHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVV 244
LG G FG V+ + A+K +R+ + E ++S V H ++
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
++ G + + ++ +++ G L + AAE A+ YLHS
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYLHS-- 122
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE 364
II+ D+K NILLD N K++DF + T + GT Y+ PE T+
Sbjct: 123 -KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTK 176
Query: 365 LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424
+ E ++ F DS ++ +ILN ++ E V +L S+
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN--EDVKDLLSR 234
Query: 425 CLRIRGTERPTMKEVSEE 442
+ ++R + E
Sbjct: 235 LITRDLSQRLGNLQNGTE 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (272), Expect = 4e-27
Identities = 49/268 (18%), Positives = 94/268 (35%), Gaps = 13/268 (4%)
Query: 178 FSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL---G 233
+ ++E ++ +F LG G F V VA+K + + E
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIA 59
Query: 234 IISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAET 293
++ ++KH N+V + + L+ + VS G L I +K + R+ +
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQV 116
Query: 294 ASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTV 353
A+ YLH L LD++ +SDF + + GT
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 173
Query: 354 GYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEME 413
GY+ PE + + + + + + P F D + F QIL + +S
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233
Query: 414 EI--EVVAELASKCLRIRGTERPTMKEV 439
+ + + + +R T ++
Sbjct: 234 DDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 8e-27
Identities = 53/282 (18%), Positives = 85/282 (30%), Gaps = 24/282 (8%)
Query: 169 GLAFSRMKIFSKSELLKATKNFHHCLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRIT 227
GL + I ++ LG+G G V + + A+K +
Sbjct: 1 GLQIKKNAIIDDYKVTS------QVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA 51
Query: 228 EWEFLGIISQVKHKNVVKILGLC----LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNW 283
E + ++V+I+ + K L+V E + G L I D+ Q
Sbjct: 52 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TE 110
Query: 284 KTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343
+ I AI YLHS+ +I H DVK N+L +
Sbjct: 111 REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167
Query: 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN 403
T T Y+ PE E + + + P F + +
Sbjct: 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227
Query: 404 FQVADESEMEEIEV------VAELASKCLRIRGTERPTMKEV 439
+ E E V L L+ T+R T+ E
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (266), Expect = 6e-26
Identities = 42/259 (16%), Positives = 86/259 (33%), Gaps = 20/259 (7%)
Query: 194 LGMGGFGSVYKGVLPD-NTQVAVK-------KYMCADEIRITEWEFLGIISQVKHKNVVK 245
+G GGFG VY D A+K K + + + E L ++S +V
Sbjct: 12 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 71
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+ + + ++ G L +++ + AAE + ++H +
Sbjct: 72 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEHMH---N 125
Query: 306 PSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTEL 365
+++ D+K ANILLD++ ++SD ++ D GT GY+ PE +
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAPEVLQKGV 181
Query: 366 LTGMNPNSY-VALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI-EVVAELAS 423
+ + + + + + F + + + L
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 424 KCLRIRGTERPTMKEVSEE 442
L+ R +
Sbjct: 242 GLLQRDVNRRLGCLGRGAQ 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 8e-26
Identities = 51/255 (20%), Positives = 86/255 (33%), Gaps = 16/255 (6%)
Query: 190 FHHCLGMGGFGSVYKGV-LPDNTQVAVKK-----YMCADEIRITEWEFLGIISQVKHKNV 243
H LG G FG V+ N A+K + D++ T E + +H +
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
+ + V E+++ G L ++I + AAE + +LHS
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHS- 121
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT 363
I++ D+K NILLD + K++DF D + GT Y+ PE
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLG 177
Query: 364 ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423
+ + E + F E F I +E + +L
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE--KEAKDLLV 235
Query: 424 KCLRIRGTERPTMKE 438
K +R ++
Sbjct: 236 KLFVREPEKRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 101 bits (253), Expect = 7e-25
Identities = 51/277 (18%), Positives = 91/277 (32%), Gaps = 39/277 (14%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGLC 250
+G G +G VYK A+KK E + I+ ++KH N+VK+ +
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 251 LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIH 310
K +LV+E + + T + + I Y H ++H
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD---RRVLH 123
Query: 311 SDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYA--------- 361
D+K N+L++ K++DF ++ + Y P+
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGSKKYSTT 181
Query: 362 ---------HTELLTGMNP----NSYVALASNEKISMVPYFLDSIENNSF-RQILNFQVA 407
E++ G + L +I P + + NF V
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 408 DESEMEEI-----EVVAELASKCLRIRGTERPTMKEV 439
+ E E +L SK L++ +R T K+
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-24
Identities = 58/282 (20%), Positives = 89/282 (31%), Gaps = 45/282 (15%)
Query: 194 LGMGGFGSVYKGVLPD-NTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE 252
+G G FG VY+ L D VA+KK + + E + I+ ++ H N+V++
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYFFYS 84
Query: 253 TKVT------LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASP 306
+ LV ++V H ++ + ++ Y+H S
Sbjct: 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SF 141
Query: 307 SIIHSDVKSANILLD-DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT-- 363
I H D+K N+LLD D K+ DF S + + R Y PE
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGAT 198
Query: 364 ----------------ELLTGMNP----NSYVALASNEKISMVPYFLDSIENNSFRQILN 403
ELL G + L K+ P E N
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 404 FQVADESEMEEI------EVVAELASKCLRIRGTERPTMKEV 439
F ++ L S+ L T R T E
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 5e-24
Identities = 52/260 (20%), Positives = 96/260 (36%), Gaps = 23/260 (8%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVK----KYMCADEIRITEWEFL---GIISQVKHKNVVK 245
LG G F V K Q A K + + ++ + I+ +++H NV+
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 246 ILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLAS 305
+ + +L+ E V+ G L ++ +K S + + + ++YLH S
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYYLH---S 131
Query: 306 PSIIHSDVKSANILLDDN----YTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYA 361
I H D+K NI+L D K+ DF I +E I GT ++ PE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV 188
Query: 362 HTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI--EVVA 419
+ E L + + + +S FL + + + E E +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 420 ELASKCLRIRGTERPTMKEV 439
+ + L +R T+++
Sbjct: 249 DFIRRLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 6e-24
Identities = 55/261 (21%), Positives = 100/261 (38%), Gaps = 35/261 (13%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVK------------H 240
LG GGFGSVY G+ + DN VA+K ++ RI++W L ++V
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHV---EKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 241 KNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYL 300
V+++L +L+ E + + + + A+ +
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHC 126
Query: 301 HSLASPSIIHSDVKSANILLD-DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPE 359
H+ ++H D+K NIL+D + K+ DF + + + T GT Y PE
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPPE 179
Query: 360 YAHTELLTGMNPNSY-VALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418
+ G + + + + + + F E + +V+ E
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE--------C 231
Query: 419 AELASKCLRIRGTERPTMKEV 439
L CL +R ++RPT +E+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 9e-24
Identities = 53/291 (18%), Positives = 103/291 (35%), Gaps = 51/291 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGL 249
+G G FG V+K +VA+KK + +E L I+ +KH+NVV ++ +
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 250 CLETKVT--------LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLH 301
C LV++F + + R+ + ++Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF---TLSEIKRVMQMLLNGLYYIH 134
Query: 302 SLASPSIIHSDVKSANILLDDNYTAKVSDF--ESLVPISSDDETAMSTMIRGTVGYLDPE 359
I+H D+K+AN+L+ + K++DF ++ + + T T+ Y PE
Sbjct: 135 R---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 360 YAHT------------------ELLTG------MNPNSYVALASNEKISMVPYFLDSIEN 395
E+ T +AL S S+ P +++N
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 396 NSFRQILNFQVADESEMEEI-------EVVAELASKCLRIRGTERPTMKEV 439
+ L + ++++ +L K L + +R +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 2e-23
Identities = 45/281 (16%), Positives = 93/281 (33%), Gaps = 39/281 (13%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGL 249
+G G +G V + +VA+KK + E + L I+ + +H+N++ I +
Sbjct: 16 IGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
+ + ++ + ++ + + + Y+HS +++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 131
Query: 310 HSDVKSANILLDDNYTAKVSDFE-SLVPISSDDETAMSTMIRGTVGYLDPEYAHTE---- 364
H D+K +N+LL+ K+ DF + V D T T T Y PE
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191
Query: 365 --------------LLTGMNP----NSYVALASNEKISMVPYFLD---SIENNSFRQILN 403
+L+ + L I P D I + +L+
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251
Query: 404 FQVADESEMEEI-----EVVAELASKCLRIRGTERPTMKEV 439
++ + +L K L +R +++
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.2 bits (241), Expect = 4e-23
Identities = 42/268 (15%), Positives = 79/268 (29%), Gaps = 21/268 (7%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE 252
+G G FG +Y G + +VA+K + E I ++ + + C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK-IYKMMQGGVGIPTIRWCGA 73
Query: 253 TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSD 312
++ + +L + S + + KT L +A + S I Y+HS + IH D
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHSK---NFIHRD 128
Query: 313 VKSANIL---LDDNYTAKVSDFESLVPISSDDETAM-----STMIRGTVGYLDPEYAHTE 364
VK N L + DF + + GT Y
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 365 LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI------EVV 418
+ + + + ++ S E+
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248
Query: 419 AELASKCLRIRGTERPTMKEVSEELDRL 446
A + C +R ++P + + L
Sbjct: 249 ATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 4e-22
Identities = 43/277 (15%), Positives = 84/277 (30%), Gaps = 37/277 (13%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGL 249
+G G +G VYK VA+KK E + ++ ++ H N+VK+L +
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
LV+EF+ D S+ + + + HS ++
Sbjct: 70 IHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVL 124
Query: 310 HSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT------ 363
H D+K N+L++ K++DF L + +
Sbjct: 125 HRDLKPQNLLINTEGAIKLADF-GLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 364 -----------ELLTGMNP-NSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESE 411
E++T + +I D + + +++ +
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 412 MEEI---------EVVAELASKCLRIRGTERPTMKEV 439
+ E L S+ L +R + K
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (232), Expect = 5e-22
Identities = 41/278 (14%), Positives = 87/278 (31%), Gaps = 39/278 (14%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGL 249
+G G +G+V+K + VA+K+ D+ L ++ ++KHKN+V++ +
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
K LV+EF ++ + + + + + HS +++
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 310 HSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT------ 363
H D+K N+L++ N K+++F L S +
Sbjct: 124 HRDLKPQNLLINRNGELKLANF-GLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 364 -----------ELLTGMNP-----NSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA 407
EL P + L ++ P + +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 408 DESEMEEI------EVVAELASKCLRIRGTERPTMKEV 439
+ +L L+ +R + +E
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 6e-21
Identities = 47/254 (18%), Positives = 83/254 (32%), Gaps = 15/254 (5%)
Query: 190 FHHCLGMGGFGSVYKGV-LPDNTQVAVKK----YMCADEIRITEWEFLGIISQVKHKNVV 244
+ LG G FG V A+K + A + ++ +H +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 245 KILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
+ V E+ + G L ++ + + + AE SA+ YLHS
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS-- 123
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE 364
+++ D+K N++LD + K++DF SD T GT YL PE
Sbjct: 124 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDN 180
Query: 365 LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424
+ + E + F + F IL ++ + L +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS--PEAKSLLAG 238
Query: 425 CLRIRGTERPTMKE 438
L+ +R
Sbjct: 239 LLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 91.4 bits (226), Expect = 8e-21
Identities = 51/277 (18%), Positives = 98/277 (35%), Gaps = 19/277 (6%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL----GIISQVKHKNVVKILG 248
LG G FG V A+K +++ + E I+ V +VK+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 249 LCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSI 308
+ +V E+V+ G + ++ + AA+ YLHSL +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLHSL---DL 162
Query: 309 IHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTG 368
I+ D+K N+L+D +V+DF + + + GT L PE ++
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFG-----FAKRVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 369 MNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCLRI 428
+ + E + P F + +I++ +V S + +L L++
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS--SDLKDLLRNLLQV 275
Query: 429 RGTER-PTMKEVSEELDRLRRLQENYWARKNNEESEH 464
T+R +K ++ + W + E
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 89.9 bits (222), Expect = 1e-20
Identities = 41/290 (14%), Positives = 75/290 (25%), Gaps = 48/290 (16%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE 252
+G G FG +++G L +N QVA+K + E+ + + E
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 72
Query: 253 TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSD 312
+LV + + S + KT A + + + +H S+++ D
Sbjct: 73 GLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRD 126
Query: 313 VKSANILLDDNY-----TAKVSDFESLVPISSDDETA-----MSTMIRGTVGYLDPEYAH 362
+K N L+ V DF + + GT Y+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 363 T-----------------ELLTG-MNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF 404
L G + A + +K + S
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP- 245
Query: 405 QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDR-LRRLQENY 453
E + + P + + L RL
Sbjct: 246 -----------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 89.5 bits (221), Expect = 3e-20
Identities = 48/288 (16%), Positives = 94/288 (32%), Gaps = 56/288 (19%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRI-TEWEFLGIISQVKHKNVVKILGLCL 251
LG G + V++ + + +N +V VK + +I E + L + N++ + +
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG--GPNIITLADIVK 100
Query: 252 E--TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSII 309
+ ++ LV+E V+N + E A+ Y HS+ I+
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYMYEILKALDYCHSM---GIM 151
Query: 310 HSDVKSANILLD-DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT----- 363
H DVK N+++D ++ ++ D+ E + + + PE
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYD 208
Query: 364 -------------ELLTGMNP-----NSYVALASNEKISMVPYFLDSIENNSFRQILNFQ 405
++ P ++Y L K+ D I+ + F
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 406 --------------VADESEMEEIEVVAELASKCLRIRGTERPTMKEV 439
V E++ + K LR R T +E
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 4e-19
Identities = 41/305 (13%), Positives = 100/305 (32%), Gaps = 53/305 (17%)
Query: 178 FSKSELLKATKNFHH------CLGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWE 230
F + E+ K +G G +G+V V +VA+KK + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 231 FL---GIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKN----W 283
++ ++H+NV+ +L + + +F ++ +++K+
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM---PFMGTDLGKLMKHEKLGE 120
Query: 284 KTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343
+ + + Y+H+ IIH D+K N+ ++++ K+ DF S+
Sbjct: 121 DRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--- 174
Query: 344 AMSTMIRGTVGYLDPEYAHTE-----------------LLTG------MNPNSYVALASN 380
M+ + + ++TG + +
Sbjct: 175 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 381 EKISMVPYFLDSIENNSFRQIL-NFQVADESEMEEI-----EVVAELASKCLRIRGTERP 434
+ F+ ++++ + + ++ + I + L K L + +R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 435 TMKEV 439
T E
Sbjct: 294 TAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (192), Expect = 2e-16
Identities = 50/261 (19%), Positives = 91/261 (34%), Gaps = 29/261 (11%)
Query: 194 LGMGGFGSVYKGVL----PDNTQVAVK---KYMCADEIRITEWEF--LGIISQVKHK-NV 243
LG G +G V+ A+K K + + TE ++ ++ +
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 244 VKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL 303
V + L+ ++++ G L ++ + E A+ +LH L
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERF---TEHEVQIYVGEIVLALEHLHKL 148
Query: 304 ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHT 363
II+ D+K NILLD N ++DF L DET + GT+ Y A
Sbjct: 149 ---GIIYRDIKLENILLDSNGHVVLTDF-GLSKEFVADETERAYDFCGTIEY----MAPD 200
Query: 364 ELLTGMNPNSY------VALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI-- 415
+ G + + + + E ++ F E NS +I + E +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 416 EVVAELASKCLRIRGTERPTM 436
+ +L + L +R
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.4 bits (192), Expect = 2e-16
Identities = 52/297 (17%), Positives = 92/297 (30%), Gaps = 64/297 (21%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKK----YMCADEIRITEWEFLGIISQVKHKNVVKILG 248
+G G G V + VA+KK + + E L ++ V HKN++ +L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE-LVLMKCVNHKNIISLLN 83
Query: 249 LCLETKVT------LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+ K LV E + + + + + I +LHS
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYA- 361
IIH D+K +NI++ + T K+ DF + + M T T Y PE
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 362 ----------------HTELLTG------MNPNSYVALASNEKISMVPYFLDSIENNSFR 399
E++ + + + P F+ ++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 400 QILN-----------------FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEV 439
+ N F E + +L SK L I +R ++ +
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.8 bits (190), Expect = 4e-16
Identities = 44/307 (14%), Positives = 92/307 (29%), Gaps = 63/307 (20%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE 252
LG G F +V+ + +NT VA+K + + ++ +V + K +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 253 TKVTLLVY-------------EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHY 299
+ LL + F G + K +I+ + + Y
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 300 LHSLASPSIIHSDVKSANILLD-DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDP 358
+H IIH+D+K N+L++ + + + ++ T T Y P
Sbjct: 141 MHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 359 EYAHT-----------------ELLTGMNP----NSYVALASNEKISMVPYFLDSIENNS 397
E EL+TG + ++ I+ + L + +
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258
Query: 398 FRQILNFQVADESEM-------------------------EEIEVVAELASKCLRIRGTE 432
R + S +E + +++ S L++ +
Sbjct: 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318
Query: 433 RPTMKEV 439
R +
Sbjct: 319 RADAGGL 325
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.7 bits (185), Expect = 2e-15
Identities = 43/284 (15%), Positives = 92/284 (32%), Gaps = 49/284 (17%)
Query: 194 LGMGGFGSVYKGV-LPDNTQVAVKKYMCADEIRITEWEFL---GIISQVKHKNVVKILGL 249
+G G +GSV +VAVKK + I ++ +KH+NV+ +L +
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 250 C-----LETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLA 304
LE + + + L++ + + + + + Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIH--- 138
Query: 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTE 364
S IIH D+K +N+ ++++ K+ DF ++ + M+ + +
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 365 LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEI--------- 415
V E ++ F + + + IL +E+ +
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 416 --------------------EVVAELASKCLRIRGTERPTMKEV 439
+ +L K L + +R T +
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.7 bits (162), Expect = 2e-13
Identities = 24/156 (15%), Positives = 49/156 (31%), Gaps = 21/156 (13%)
Query: 194 LGMGGFGSVYKGVLPDNTQVAVKKY----------MCADEIRITEWEFLGIIS-QVKHKN 242
+G G +V+ + VK + + + L I S + + +
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 243 VVKILGLCLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHS 302
+ K+ GL + Y + N L I K + + + +
Sbjct: 68 LQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFY- 120
Query: 303 LASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338
I+H D+ N+L+ + + DF V +
Sbjct: 121 --HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 496 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.63 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=413.09 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=205.6
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
|.+.+.||+|+||.||+|.+.++..||||++.........+.+|+.++++++|||||+++|+|..++..|+|||||++|+
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 66778999999999999998888899999997665555666799999999999999999999999999999999999999
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcccee
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 347 (496)
|.+++..... .+++..+..|+.|||.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 87 L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~ 160 (263)
T d1sm2a_ 87 LSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SST 160 (263)
T ss_dssp HHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred HHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-eec
Confidence 9999876533 36889999999999999999999 78999999999999999999999999999877544222 233
Q ss_pred cccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 348 MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 348 ~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
...||+.|+|||++.+..++.++|+||+|+++|++++ +.+|+........+..+.. ......+..+++.+.+|+.+||
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl 239 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMNHCW 239 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHT
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHHHHc
Confidence 4569999999999999999999999999999999998 4666655444444444443 2333344556678999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhHh
Q 047375 427 RIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 427 ~~dP~~RPs~~eil~~L~~l~~ 448 (496)
+.||.+|||+.||++.|+++.+
T Consensus 240 ~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 240 KERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-54 Score=417.66 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=217.7
Q ss_pred HhcchhhhcccCCceEEEEeEeC-CCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
..+.+.+.||+|+||+||+|.+. ++..||||++.........+.+|+.+|++++|||||+++|+|.+.+..|||||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 34777899999999999999964 68899999987655555566799999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+........
T Consensus 97 ~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~- 171 (287)
T d1opja_ 97 YGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 171 (287)
T ss_dssp TCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-
T ss_pred CcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCce-
Confidence 9999999976543 347899999999999999999999 78999999999999999999999999999887654222
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
......||+.|+|||++.+..++.++|+||+|+++|+|+++..|+...........++......+.+..+++.+.+|+.+
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 251 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHH
Confidence 23344589999999999999999999999999999999986555544444444444444455555556677889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHh
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
||+.||.+|||+.||++.|+.+.+
T Consensus 252 cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 252 CWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999987743
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=410.21 Aligned_cols=256 Identities=20% Similarity=0.215 Sum_probs=211.2
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+|+.+|++++|||||++++++.+++..|||||||+
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 77789999999999999996 4689999999865432 23345689999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.........
T Consensus 87 gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 87 GGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp TEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999997643 37899999999999999999999 789999999999999999999999999999876544444
Q ss_pred ceecccccceeecCcccccccc-cCCCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELL-TGMNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~-t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.....+||+.|||||++.+..+ +.++|+||+||++|+|++|.+||....... .+..+.............++.+.+|+
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 4456789999999999988765 567999999999999999999987654332 23333333333333445667899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 423 SKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
.+||+.||.+|||+.|+ .+++|.++..
T Consensus 241 ~~~L~~dP~~R~t~~ei----------l~hpwf~~~l 267 (271)
T d1nvra_ 241 HKILVENPSARITIPDI----------KKDRWYNKPL 267 (271)
T ss_dssp HHHSCSSTTTSCCHHHH----------TTCTTTTCCC
T ss_pred HHHcCCChhHCcCHHHH----------hcCHhhCcCC
Confidence 99999999999999998 4577876543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=406.90 Aligned_cols=251 Identities=19% Similarity=0.275 Sum_probs=213.5
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
|.+.+.||+|+||+||+|.. .+|+.||||++...... .....+|+.+++.++|||||++++++.+.+..|||||||+|
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 77778999999999999995 57899999998754433 33455899999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 102 g~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~ 172 (293)
T d1yhwa1 102 GSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (293)
T ss_dssp CBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence 9999988653 27889999999999999999999 7899999999999999999999999999988754322 2
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-ccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF-QVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~l~~li~~ 424 (496)
....+||+.|||||++.+..++.++|+||+||++|+|++|.+||.+......+..+... ......+...++.+.+||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 34567999999999999999999999999999999999999999876655555554433 22334445667889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHhhhhhhhhcc
Q 047375 425 CLRIRGTERPTMKEVSEELDRLRRLQENYWARK 457 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~ 457 (496)
||+.||.+|||+.|+ .+++|.+.
T Consensus 253 ~L~~dP~~R~s~~ei----------l~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKEL----------LQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHH----------TTCGGGGG
T ss_pred HccCChhHCcCHHHH----------hcCHhhCC
Confidence 999999999999998 45677764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=409.40 Aligned_cols=255 Identities=19% Similarity=0.279 Sum_probs=212.2
Q ss_pred HhcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
..|.+.+.||+|+||.||+|.+.++..||||++.........+.+|+.++++++|||||+++|++.+ +..|+|||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 3477788999999999999999888899999997655555566799999999999999999998865 567999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAM 345 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 345 (496)
|+|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+...... ...
T Consensus 92 g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~ 166 (272)
T d1qpca_ 92 GSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTA 166 (272)
T ss_dssp CBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EEC
T ss_pred CcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc-ccc
Confidence 999998865432 237999999999999999999999 789999999999999999999999999999875432 222
Q ss_pred eecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHH
Q 047375 346 STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASK 424 (496)
Q Consensus 346 ~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 424 (496)
.....||+.|||||++.+..++.++|+||+|+++|+|+++ .+|+........+..+.. ......+..+++.+.+|+.+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPDNCPEELYQLMRL 245 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCcccChHHHHHHHHH
Confidence 3445699999999999999999999999999999999985 555554444444444433 33334445567789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhH
Q 047375 425 CLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 425 cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
||+.||++|||+.+|++.|+.+-
T Consensus 246 cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 246 CWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHhhhhh
Confidence 99999999999999999998763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=401.74 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=209.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|.. .+++.||+|++.... .......+|+.+++.++|||||++++++.+++..||||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 77889999999999999996 468899999986432 2233445899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|++|+|.+++..... +++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 88 ~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 88 APLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp CTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred cCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 999999999987543 7889999999999999999999 789999999999999999999999999998765432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
....+||+.|||||++.+..++.++|+||+||++|+|++|.+||.+......+..+...... .+...++.+.+|+
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 235 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLI 235 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCTTSCHHHHHHH
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCccCCHHHHHHH
Confidence 34567999999999999999999999999999999999999999877666666666654433 2334567899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 047375 423 SKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~ 441 (496)
.+||+.||.+|||+.|+++
T Consensus 236 ~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHccCCHhHCcCHHHHHc
Confidence 9999999999999999853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=410.29 Aligned_cols=262 Identities=21% Similarity=0.239 Sum_probs=219.1
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||+||+|.. .+++.||||++..... ......+|+.++++++|||||++++++.+.+..|+||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 78889999999999999996 4789999999864321 223445899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|+||+|.+++..... +++..+..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 90 ~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999887543 7889999999999999999999 7899999999999999999999999999998765444
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.......+||+.|||||++.+..++.++|+||+||++|+|++|.+||.+......+..+....... +...++.+.+||
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li 241 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC--CTTCCHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC--CccCCHHHHHHH
Confidence 434455679999999999999999999999999999999999999998876666677776554332 334567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 423 SKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 423 ~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
.+||+.||.+|||+.|+++. ..+.+|+|.+..+|+
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~----~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGY----GPLKAHPFFESVTWE 276 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCH----HHHHTSGGGTTCCCT
T ss_pred HHHccCCHhHCcCHHHHcCC----HHHHcCCccCCCCHH
Confidence 99999999999999998653 234567888877664
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=407.21 Aligned_cols=255 Identities=21% Similarity=0.302 Sum_probs=203.3
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||.||+|.+. ..||||++.... .....+.+|+.+|++++|||||+++|++.. +..+||||||
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 3667789999999999999873 369999986432 223345589999999999999999998864 5689999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
++|+|.+++..... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+........
T Consensus 86 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999976543 37899999999999999999999 78999999999999999999999999999887654444
Q ss_pred cceecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC----cccHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD----ESEMEEIE 416 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~----~~~~~~~~ 416 (496)
.......||+.|||||++.+ ..|+.++|+||+|+++|+|++|..||.+................. .....+++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 44456679999999999875 357889999999999999999999997765444444443322221 22345567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+.+|+.+||+.||.+|||+.||++.|+.+.+.
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 899999999999999999999999999988753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-53 Score=398.43 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=217.6
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCCc
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 267 (496)
+.+.+.||+|+||+||+|+++++..||||++.........+.+|+.++++++|||||+++|+|.+++..++|||||++|+
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 56778999999999999999888899999998766566667799999999999999999999999999999999999999
Q ss_pred hhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcccee
Q 047375 268 LSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMST 347 (496)
Q Consensus 268 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 347 (496)
|.+++..... .+++..+.+++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 86 l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~ 159 (258)
T d1k2pa_ 86 LLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSV 159 (258)
T ss_dssp HHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCC
T ss_pred HHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eec
Confidence 9999766543 36788999999999999999999 78999999999999999999999999999877654322 233
Q ss_pred cccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHhc
Q 047375 348 MIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKCL 426 (496)
Q Consensus 348 ~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 426 (496)
...||+.|+|||.+.+..++.++|+||+|+++|+|++ +..||...........+... ...+.+...++.+.+||.+||
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl 238 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCW 238 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTT
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCcccccHHHHHHHHHHc
Confidence 4569999999999999999999999999999999987 78888877666665555543 334445566678999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 047375 427 RIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 427 ~~dP~~RPs~~eil~~L~~l 446 (496)
+.||++|||+.+|++.|.++
T Consensus 239 ~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 239 HEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CSSGGGSCCHHHHHHHHHCC
T ss_pred cCCHhHCcCHHHHHHHhhCC
Confidence 99999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=413.37 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=215.6
Q ss_pred HhcchhhhcccCCceEEEEeEeCC-C-----cEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPD-N-----TQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 256 (496)
..+.+.+.||+|+||+||+|.+.. + ..||+|.+..... ......+|+.++.++ +|||||+++|+|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 347788999999999999998532 2 3699998864322 333455889999988 899999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc--------------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcC
Q 047375 257 LLVYEFVSNGALSHYIHDKSS--------------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSA 316 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~ 316 (496)
|+|||||++|+|.+++..... ...+++..++.|+.||+.||.|||+ ++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 999999999999999976432 1347889999999999999999999 78999999999
Q ss_pred ceeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhccc
Q 047375 317 NILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIEN 395 (496)
Q Consensus 317 NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~ 395 (496)
|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|+||+||++|+|++ |.+||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999988766544444455678999999999999999999999999999999997 78998877666
Q ss_pred chhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047375 396 NSFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELD 444 (496)
Q Consensus 396 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 444 (496)
..+..++......+.+..+++.+.+||.+||+.||++|||+.||++.|.
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 6666776666666666677788999999999999999999999999885
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-52 Score=405.45 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=201.5
Q ss_pred hcchhhhcccCCceEEEEeEeC-CC---cEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP-DN---TQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.+.+.+.||+|+||+||+|.+. ++ ..||||++.... .....+.+|+.+|++++|||||+++|+|...+..|+||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 3566688999999999999964 23 258999876432 23344569999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|.+++..... .+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 107 Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999998876543 37899999999999999999999 78999999999999999999999999999877543
Q ss_pred CCccc---eecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHH
Q 047375 341 DETAM---STMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 341 ~~~~~---~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
..... .....||+.|||||++.+..++.++|+||+||++|+|++ |.+||.+.........+.. ....+.+..+++
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~ 260 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMDCPS 260 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTCCH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCccchH
Confidence 22211 123458999999999999999999999999999999997 7888877665555555443 233444556678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
.+.+|+.+||+.||.+|||+.||++.|+++.+
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 89999999999999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-52 Score=394.65 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=198.7
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEee----CCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLE----TKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv 259 (496)
+.|.+.||+|+||+||+|.. .++..||+|++..... ......+|+++|++++|||||+++++|.+ ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 35667899999999999996 4688999999865432 22344589999999999999999999875 4568999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC-CCCceEEccCCCccccC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD-DNYTAKVSDFESLVPIS 338 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~-~~~~~kL~DFGla~~~~ 338 (496)
||||++|+|.+++.... .+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999998754 3788999999999999999999932 2399999999999996 57899999999998654
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccc-hhhhhhhcccCCcccHHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENN-SFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 417 (496)
.. .....+||+.|||||++.+ .++.++|+||+||++|+|++|..||....... .+..+.....+...+...+++
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 32 2345679999999999876 58999999999999999999999997654333 334444333333344445678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil 440 (496)
+.+||.+||+.||++|||+.|++
T Consensus 242 ~~~li~~~l~~dp~~R~s~~ell 264 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSIKDLL 264 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHh
Confidence 99999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=402.67 Aligned_cols=247 Identities=20% Similarity=0.188 Sum_probs=208.9
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh-hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE-IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .++..||||++..... ......+|+++|++++|||||++++++.+.+..|||||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 377788999999999999996 4788999999865432 33455689999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
+|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 93 ~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~ 165 (288)
T d2jfla1 93 GGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 165 (288)
T ss_dssp TEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HH
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC--cc
Confidence 9999999876432 37889999999999999999999 78999999999999999999999999999765432 11
Q ss_pred ceecccccceeecCcccc-----cccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC-CcccHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAH-----TELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-DESEMEEIEVV 418 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~-----~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~l 418 (496)
.....+||+.|||||++. +..|+.++|+||+||++|+|++|.+||.+......+..+.....+ ...+...++.+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 223456999999999984 456788999999999999999999999887777777766654332 23345567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil 440 (496)
.+||.+||+.||.+|||+.|++
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHh
Confidence 9999999999999999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=398.95 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=202.3
Q ss_pred cchhhhcccCCceEEEEeEeCCC-----cEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDN-----TQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
+.+.++||+|+||.||+|.+..+ ..||||++..... ....+.+|+.++++++|||||+++|+|.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 56678899999999999986432 3699999864322 2234558999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||.+|++.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 89 e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 89 EYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp ECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999998876543 37889999999999999999999 78999999999999999999999999999876543
Q ss_pred CCc-cceecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 341 DET-AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 341 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
... .......||+.|||||++.++.++.++|+||+|+++|+|+++ .+|+........+..+ ......+.+..+++.+
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPMDCPSAI 242 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTCBHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-hccCCCCCchhhHHHH
Confidence 222 222345689999999999999999999999999999999985 4444443333333333 3344445555677889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+||.+||+.||++|||+.||++.|+++.+.
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 9999999999999999999999999987653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-52 Score=403.95 Aligned_cols=244 Identities=20% Similarity=0.237 Sum_probs=208.1
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
..|...+.||+|+||+||+|.. .++..||||++..... ......+|+.+|++++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3477788999999999999995 5788999999864322 2233458999999999999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|..++.... .+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999987765543 37899999999999999999999 78999999999999999999999999999876432
Q ss_pred CCccceecccccceeecCccccc---ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHT---ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~---~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
...+||+.|||||++.+ ..|+.++|+||+||++|+|++|.+||.+......+..+.....+.......++.
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 242 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHH
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHH
Confidence 34569999999999864 458899999999999999999999998776666666666655554445556788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047375 418 VAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
+.+||.+||+.||.+|||+.|+++
T Consensus 243 ~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 243 FRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHCcCChhHCcCHHHHHh
Confidence 999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-52 Score=406.26 Aligned_cols=248 Identities=20% Similarity=0.238 Sum_probs=197.6
Q ss_pred HHhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 185 KATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
...|.+.+.||+|+||+||+|.. .+++.||||.+...... .....+|+.+|+.++|||||++++++.+++..|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 34588889999999999999996 46889999998654322 2233489999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC---CCCceEEccCCCccccC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD---DNYTAKVSDFESLVPIS 338 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~---~~~~~kL~DFGla~~~~ 338 (496)
||+||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+. .++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999997654 37899999999999999999999 7899999999999994 57899999999998765
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCC--cccHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVAD--ESEMEEIE 416 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~ 416 (496)
... .....+||+.|||||++.+..|+.++|+||+||++|+|++|.+||.+.........+....... +.....++
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence 432 2345679999999999999999999999999999999999999998876666666666544332 33345678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.+||.+||+.||.+|||+.|+++
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhc
Confidence 8999999999999999999999853
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=401.36 Aligned_cols=251 Identities=18% Similarity=0.263 Sum_probs=197.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEee--CCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLE--TKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E 261 (496)
|.+.+.||+|+||+||+|.. .+|+.||||.+..... ......+|+.++++++|||||++++++.+ .+.+|||||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 77889999999999999985 4788999999865432 22334589999999999999999999975 456899999
Q ss_pred eccCCchhhhhhhcC-cccccCHHHHHHHHHHHHHHHHHhHhcC--CCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 262 FVSNGALSHYIHDKS-SQVLKNWKTCLRIAAETASAIHYLHSLA--SPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~--~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
||++|+|.+++.... ....+++..++.++.||+.||.|||+.+ .++||||||||+||||+.++.+||+|||+|+...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 999999999997532 2234789999999999999999999843 1359999999999999999999999999998875
Q ss_pred CCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
... ......+||+.|||||++.+..++.++|+||+||++|+|++|.+||.+.........+...... ..+...++++
T Consensus 166 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l 242 (269)
T d2java1 166 HDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDEL 242 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHH
T ss_pred cCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCcccCHHH
Confidence 432 2234567999999999999999999999999999999999999999876666666666654433 3344566789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 047375 419 AELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+|+.+||+.||.+|||+.|+++
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHHh
Confidence 99999999999999999999853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=400.92 Aligned_cols=255 Identities=20% Similarity=0.285 Sum_probs=207.0
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSNG 266 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 266 (496)
.+.+.+.||+|+||.||+|.+.++..||||++.........+.+|+.++++++|||||+++|+|.+ +..++|||||++|
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 478889999999999999998888899999997655555566799999999999999999999864 5578999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|..++...... .++|..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 97 ~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~ 171 (285)
T d1fmka3 97 SLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR 171 (285)
T ss_dssp BHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred chhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-eee
Confidence 999998764322 37999999999999999999999 7899999999999999999999999999987654322 223
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....||+.|+|||++....++.++|+||+|+++|+|+++ .+|+........+..+.. ....+.+..+++++.+||.+|
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~c 250 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQC 250 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCCcccCHHHHHHHHHH
Confidence 445699999999999999999999999999999999985 555554444444444433 334445566778899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhHh
Q 047375 426 LRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l~~ 448 (496)
|+.||++|||+.+|++.|+....
T Consensus 251 l~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 251 WRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cccCHhHCcCHHHHHHHHhhhhc
Confidence 99999999999999998887543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=410.49 Aligned_cols=247 Identities=19% Similarity=0.164 Sum_probs=199.8
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
..|.+.+.||+|+||+||+|.. .+|..||+|++.... .......+|+.+|+.++|||||+++++|.+.+..||||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4577789999999999999996 478999999986542 2234455899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|+||+|.+++.+... +++..+..++.||+.||.|||+. ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 ~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999987543 78899999999999999999972 37999999999999999999999999999876432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhh-----------------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFR----------------------- 399 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~----------------------- 399 (496)
.....+||+.|||||++.+..|+.++|+||+||++|+|++|..||.+........
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2345679999999999999999999999999999999999999986543221100
Q ss_pred -------------------hhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 400 -------------------QILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 400 -------------------~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
.+.....+.......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000000011123467999999999999999999999964
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=394.14 Aligned_cols=247 Identities=19% Similarity=0.252 Sum_probs=202.0
Q ss_pred hhcccCCceEEEEeEeC---CCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 192 HCLGMGGFGSVYKGVLP---DNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
+.||+|+||.||+|.+. .++.||||++..... ....+.+|+.+|++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999853 346799999864322 23345689999999999999999999965 457899999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc-
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA- 344 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~- 344 (496)
|+|.+++..... +++..+..|+.||+.||.|||+ ++||||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999987543 7899999999999999999999 789999999999999999999999999998775443222
Q ss_pred ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHH
Q 047375 345 MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELAS 423 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 423 (496)
......||+.|||||++.+..++.++|+||+|+++|++++ |.+||.+.........+.. ....+.+..+++.+.+|+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHH
Confidence 2234569999999999999999999999999999999987 7888877655544444443 3334445566788999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhh
Q 047375 424 KCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 424 ~cl~~dP~~RPs~~eil~~L~~l 446 (496)
+||+.||.+|||+.+|++.|+..
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCH
Confidence 99999999999999998888754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=394.49 Aligned_cols=253 Identities=20% Similarity=0.250 Sum_probs=207.7
Q ss_pred cchhh-hcccCCceEEEEeEeC---CCcEEEEEEeecch--hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHH-CLGMGGFGSVYKGVLP---DNTQVAVKKYMCAD--EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+.+.+ .||+|+||.||+|.+. ++..||||++.... .....+.+|+++|++++|||||+++|+|.. +..|||||
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence 33445 4999999999999753 35579999986432 223445589999999999999999999865 45799999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 89 ~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp CCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred eCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999865432 37889999999999999999999 789999999999999999999999999999876543
Q ss_pred Cc-cceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 342 ET-AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 342 ~~-~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
.. .......||+.|||||++.+..++.++|+||+|+++|++++ |.+||.+.........+... ...+.+..+++.+.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~ 242 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELY 242 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTTCCHHHH
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHH
Confidence 22 22234568999999999999999999999999999999987 78888776555444544443 23344556778899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
+||.+||+.||++|||+.+|++.|+.+.
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999887664
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.2e-51 Score=402.71 Aligned_cols=247 Identities=19% Similarity=0.243 Sum_probs=211.4
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhh-hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIR-ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .+|..||||++....... ....+|+.+|++++|||||++++++.+.+..|||||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 488889999999999999996 478999999986544332 334589999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC--CCCceEEccCCCccccCCCCC
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD--DNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~--~~~~~kL~DFGla~~~~~~~~ 342 (496)
||+|.+++..... .+++..+..|+.||+.||.|||+ ++||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 107 gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 107 GGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp SCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 9999999865432 37899999999999999999999 7899999999999995 46789999999998875432
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--CcccHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--DESEMEEIEVVAE 420 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~l~~ 420 (496)
......||+.|||||++.+..++.++|+||+||++|+|++|.+||.+......+..+...... .......++.+.+
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 234567999999999999999999999999999999999999999877666667776654433 3333456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~ 441 (496)
||.+||+.||.+|||+.|+++
T Consensus 259 li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=395.54 Aligned_cols=242 Identities=20% Similarity=0.149 Sum_probs=209.3
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||.||+|+. .+|+.||||++..... ......+|+.+|+.++|||||++++++.+.+..|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 77889999999999999995 5789999999865321 223445899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|+||+|.+++..... +++..++.++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+.......
T Consensus 87 ~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 87 ANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999987653 6888999999999999999999 7899999999999999999999999999987654322
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
.....+||+.|||||++.+..|+.++|+||+||++|+|++|.+||.+......+..+....... +...++.+.+||
T Consensus 161 --~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~dli 236 (337)
T d1o6la_ 161 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSLL 236 (337)
T ss_dssp --CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHHH
T ss_pred --ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC--CccCCHHHHHHH
Confidence 2345679999999999999999999999999999999999999998877776677776654433 345677899999
Q ss_pred HHhcccCCCCCCC-----HHHH
Q 047375 423 SKCLRIRGTERPT-----MKEV 439 (496)
Q Consensus 423 ~~cl~~dP~~RPs-----~~ei 439 (496)
.+||+.||.+||+ +.|+
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~ei 258 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEV 258 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHH
T ss_pred HhhccCCchhhcccccccHHHH
Confidence 9999999999995 5555
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-50 Score=400.75 Aligned_cols=247 Identities=17% Similarity=0.226 Sum_probs=212.1
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
.|.+.+.||+|+||.||+|.. .+|..||||++...... .....+|+.+|++++|||||+++++|.+++..|||||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 488889999999999999995 57999999998754433 3344589999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC--CCCceEEccCCCccccCCCCC
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD--DNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~--~~~~~kL~DFGla~~~~~~~~ 342 (496)
||+|.+++..... .+++..++.|+.||+.||.|||+ ++||||||||+||||+ .++.+||+|||+|+......
T Consensus 110 gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 110 GGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999988765432 37899999999999999999999 7899999999999997 67899999999999876532
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--CcccHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA--DESEMEEIEVVAE 420 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~l~~ 420 (496)
......||+.|||||++.+..++.++|+||+||++|+|++|.+||.+......+..+...... .......++.+.+
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 234556999999999999999999999999999999999999999887766666666654433 2333456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047375 421 LASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~eil~ 441 (496)
||.+||+.||.+|||+.|+++
T Consensus 262 li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999964
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=392.45 Aligned_cols=255 Identities=20% Similarity=0.231 Sum_probs=214.5
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh-------hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE-------IRITEWEFLGIISQVKHKNVVKILGLCLETKVTL 257 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 257 (496)
..|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+|+.+|++++|||||+++++|.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4588889999999999999996 5789999999864321 1234558999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC----ceEEccCCC
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY----TAKVSDFES 333 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~----~~kL~DFGl 333 (496)
||||||++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999998754 37899999999999999999999 7899999999999998776 599999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc--cc
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE--SE 411 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~ 411 (496)
|+....... .....||+.|+|||++.+..++.++|+||+||++|+|+++.+||.+......+..+.......+ ..
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 988754322 2345699999999999999999999999999999999999999988776666666665443322 22
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 412 MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 412 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
...++.+.+||.+||+.||.+|||+.|++ +++|.+..+
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil----------~hp~~~~~~ 278 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSL----------QHPWIKPKD 278 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH----------HSTTTCC--
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHh----------cCcccCCCC
Confidence 34567899999999999999999999984 467776554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=387.18 Aligned_cols=256 Identities=19% Similarity=0.269 Sum_probs=202.7
Q ss_pred HhcchhhhcccCCceEEEEeEeCC----CcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLPD----NTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
..|.+.+.||+|+||.||+|.+.. +..||||.+..... ....+.+|+.++++++|||||+++|++. .+..|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 347788999999999999998632 34688998754322 2344558999999999999999999996 4678999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||||++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+|+....
T Consensus 86 ~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999998876543 37889999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVV 418 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 418 (496)
.. ........||+.|+|||++.+..++.++|+||+|+++|+|++ |.+||........+..+.... ..+.+..+++.+
T Consensus 161 ~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 238 (273)
T d1mp8a_ 161 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTL 238 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHH
T ss_pred Cc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHH
Confidence 32 222345568999999999999999999999999999999886 788888776666666665543 234455677889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 419 AELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 419 ~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+||.+||+.||.+|||+.||++.|+.+.+.
T Consensus 239 ~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-50 Score=391.98 Aligned_cols=251 Identities=22% Similarity=0.229 Sum_probs=213.6
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
|.+.+.||+|+||+||+|.. .+|..||||++..... ......+|+.+++.++|||||++++++.+.+..|+||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 77789999999999999996 4689999999864322 223445899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|+||+|..++..... +++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 86 IEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred cCCcccccccccccc---ccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999887654 5778888999999999999999 78999999999999999999999999999887543
Q ss_pred ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHH
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELA 422 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 422 (496)
....+||+.|||||++.+..|+.++|+||+||++|+|++|..||.+......+..+....... +...++.+.+++
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li 232 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNEDVKDLL 232 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHHH
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--CCCCCHHHHHHH
Confidence 234679999999999999999999999999999999999999998877777777777654432 234557799999
Q ss_pred HHhcccCCCCCC-----CHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 423 SKCLRIRGTERP-----TMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 423 ~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
.+||+.||.+|| |++++ .+|+|.+..+|+
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~i----------l~Hp~f~~i~~~ 266 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDV----------KNHPWFKEVVWE 266 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHH----------HTSGGGSSCCHH
T ss_pred HHHhhhCHHhccccchhhHHHH----------HcCcccccCCHH
Confidence 999999999996 77777 346666655543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=392.90 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=203.8
Q ss_pred HhcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeC-Ce
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLET-KV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~-~~ 255 (496)
..|.+.+.||+|+||.||+|.+. +++.||||++..... ....+.+|..++.++ +|||||.+++++... +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 45788899999999999999852 346899999864322 223344666666665 689999999998764 46
Q ss_pred eeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC
Q 047375 256 TLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD 322 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~ 322 (496)
.++|||||++|+|.+++..... ...+++..+..++.||+.||.|||+ ++||||||||+||||+.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 8999999999999999976432 2347899999999999999999999 78999999999999999
Q ss_pred CCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhh
Q 047375 323 NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQI 401 (496)
Q Consensus 323 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i 401 (496)
++.+||+|||+|+...............||+.|||||++.+..++.++|+||+||++|+|+++ .+||........+...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999877655444444556799999999999999999999999999999999876 5667665555555555
Q ss_pred hhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 402 LNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 402 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
+......+.+...++.+.+|+.+||+.||.+|||+.||++.|+.+.+
T Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 54444455555667889999999999999999999999999998864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-51 Score=385.02 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=203.5
Q ss_pred cchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEee-CCeeeEEEeeccCC
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLE-TKVTLLVYEFVSNG 266 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E~~~~g 266 (496)
+.+.+.||+|+||.||+|.+ .|..||||++.... ......+|+.++++++|||||+++|+|.+ .+.+|+|||||++|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 66778999999999999998 58899999996543 33456689999999999999999999965 45689999999999
Q ss_pred chhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCccce
Q 047375 267 ALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETAMS 346 (496)
Q Consensus 267 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 346 (496)
+|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 87 ~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~ 157 (262)
T d1byga_ 87 SLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q 157 (262)
T ss_dssp EHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CHHHHHHhcCC-CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC-----C
Confidence 99999976532 247899999999999999999999 78999999999999999999999999999875432 2
Q ss_pred ecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHHHHHHHh
Q 047375 347 TMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAELASKC 425 (496)
Q Consensus 347 ~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 425 (496)
....+|+.|+|||++.+..++.++|+||+|+++|+|++ +.+|+...........+.. ....+.+...++.+.+|+.+|
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c 236 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMKNC 236 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHHH
Confidence 33458999999999999999999999999999999987 6777776655555555544 334444556668899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhHh
Q 047375 426 LRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 426 l~~dP~~RPs~~eil~~L~~l~~ 448 (496)
|+.||.+|||+.+|++.|+.++.
T Consensus 237 l~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 237 WHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=395.69 Aligned_cols=259 Identities=18% Similarity=0.261 Sum_probs=207.1
Q ss_pred cchhhhcccCCceEEEEeEeC-CCc----EEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNT----QVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
|.+.+.||+|+||+||+|.+. +|+ +||+|++..... ....+.+|+.++++++|||||+++|+|.++ ..+++|
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 777899999999999999863 343 589998864332 334456899999999999999999999865 467889
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||.+|+|.+++..... .+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 90 e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999998877543 47889999999999999999999 78999999999999999999999999999987655
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIEVVA 419 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 419 (496)
..........||+.|||||++.+..++.++|+||+|+++|+|++ +.+||.+.........+ ......+.+..+++.+.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~~~ 243 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVY 243 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCCCCCCTTBCHHHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCHHHH
Confidence 44434445569999999999999999999999999999999997 67777665444444433 33334444556678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhh
Q 047375 420 ELASKCLRIRGTERPTMKEVSEELDRLRRLQENY 453 (496)
Q Consensus 420 ~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~ 453 (496)
+|+.+||+.||.+|||+.||++.|..+.+....+
T Consensus 244 ~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~~ 277 (317)
T d1xkka_ 244 MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 277 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHHH
T ss_pred HHHHHhCCCChhhCcCHHHHHHHHHHHHhChHhh
Confidence 9999999999999999999999999886544433
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-50 Score=393.24 Aligned_cols=257 Identities=20% Similarity=0.259 Sum_probs=214.2
Q ss_pred hcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
.+.+.+.||+|+||+||+|++. ++..||||++..... ....+.+|+.+|++++||||++++++|...+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 3677789999999999999853 357899999865432 23445699999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcCc---------------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCc
Q 047375 259 VYEFVSNGALSHYIHDKSS---------------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSAN 317 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~N 317 (496)
|||||++|+|.+++..... ...+++..++.|+.||+.||.|||+ ++||||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccc
Confidence 9999999999999975321 1236888999999999999999999 789999999999
Q ss_pred eeeCCCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccc
Q 047375 318 ILLDDNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENN 396 (496)
Q Consensus 318 Ill~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~ 396 (496)
|||+.++.+||+|||+|+...........+...||+.|+|||.+.+..++.++|+||+|+++|+|+++ .+||.......
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 99999999999999999877554444444556799999999999999999999999999999999887 56777766666
Q ss_pred hhhhhhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 047375 397 SFRQILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLR 447 (496)
Q Consensus 397 ~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 447 (496)
....+.... ..+.+..+++.+.+|+.+||+.||.+|||+.||++.|+++.
T Consensus 251 ~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 VIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 666665544 33344556778999999999999999999999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.9e-50 Score=381.15 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=213.7
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----------hhhhHHHHHHHHhcCC-CCceeeEEEEEeeCC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----------IRITEWEFLGIISQVK-HKNVVKILGLCLETK 254 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~ 254 (496)
.|.+.+.||+|+||+||+|+. .+|+.||||++..... ......+|+.++++++ |||||++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 477889999999999999995 5789999999865321 1223458999999997 999999999999999
Q ss_pred eeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCc
Q 047375 255 VTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESL 334 (496)
Q Consensus 255 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla 334 (496)
..|||||||++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999998754 37899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCccceecccccceeecCccccc------ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc--
Q 047375 335 VPISSDDETAMSTMIRGTVGYLDPEYAHT------ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV-- 406 (496)
Q Consensus 335 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-- 406 (496)
+.+..... ....+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.........+.....
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 88765322 244679999999999875 3467789999999999999999999988777666777775543
Q ss_pred CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhcc
Q 047375 407 ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARK 457 (496)
Q Consensus 407 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~ 457 (496)
..+.....++++.+|+.+||+.||.+|||+.|| .+++|.+.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei----------l~h~~~~~ 275 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA----------LAHPFFQQ 275 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH----------TTSGGGCT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHH----------HcCHHHHH
Confidence 333445677899999999999999999999988 45666654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=390.69 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=220.7
Q ss_pred HhcchhhhcccCCceEEEEeEe------CCCcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL------PDNTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETKVT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 256 (496)
..+.+.+.||+|+||.||+|.+ .++..||||++..... ....+.+|+.+++++ +|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 3578889999999999999974 2456899999865432 233445889999998 699999999999999999
Q ss_pred eEEEeeccCCchhhhhhhcCc---------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC
Q 047375 257 LLVYEFVSNGALSHYIHDKSS---------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD 321 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~ 321 (496)
++|||||++|+|.+++..... ...+++..+..++.||+.||.|||+ ++||||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 999999999999999976431 2247889999999999999999999 7899999999999999
Q ss_pred CCCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhh
Q 047375 322 DNYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQ 400 (496)
Q Consensus 322 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 400 (496)
.++.+||+|||+++..............+||+.|+|||++.+..++.++|+||+|+++|+|++ +.+++........+..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999998766544444556779999999999999999999999999999999987 6777766666666777
Q ss_pred hhhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 401 ILNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 401 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
++........+...++.+.+||.+||+.||.+|||+.+|++.|+++..
T Consensus 260 ~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 776666666666667889999999999999999999999999987643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=388.56 Aligned_cols=247 Identities=17% Similarity=0.218 Sum_probs=213.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeeccC
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVSN 265 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 265 (496)
.|.+.+.||+|+||+||+|.. .+++.||||.+...........+|+.+|+.++|||||++++++.+.+..|||||||+|
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 478889999999999999996 4688999999976655555566899999999999999999999999999999999999
Q ss_pred CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC--CCceEEccCCCccccCCCCCc
Q 047375 266 GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD--NYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 266 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~--~~~~kL~DFGla~~~~~~~~~ 343 (496)
|+|.+++..... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++. .+.+||+|||+++......
T Consensus 86 g~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-- 158 (321)
T d1tkia_ 86 LDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC--
Confidence 999999976532 37899999999999999999999 78999999999999974 4589999999998765432
Q ss_pred cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCccc--HHHHHHHHHH
Q 047375 344 AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESE--MEEIEVVAEL 421 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~l 421 (496)
......||+.|+|||.+.+..++.++|+||+||++|+|++|.+||........+..+.......+.. ...++.+.+|
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 2344569999999999999999999999999999999999999998877777777777655443322 2456789999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 047375 422 ASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 422 i~~cl~~dP~~RPs~~eil~ 441 (496)
|.+||..||.+|||+.|+++
T Consensus 238 i~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=389.25 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=208.1
Q ss_pred cchhhhcccCCceEEEEeEeC-CCc--EEEEEEeecch--hhhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCeeeEEEe
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNT--QVAVKKYMCAD--EIRITEWEFLGIISQV-KHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
+.+.+.||+|+||.||+|.+. ++. .||||++.... .....+.+|+.+|+++ +|||||+++|+|.+.+..|+|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 567789999999999999964 343 57888875332 2334456999999998 79999999999999999999999
Q ss_pred eccCCchhhhhhhcC-------------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEE
Q 047375 262 FVSNGALSHYIHDKS-------------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKV 328 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL 328 (496)
||++|+|.+++.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEE
Confidence 999999999997542 22347899999999999999999999 78999999999999999999999
Q ss_pred ccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccc-cchhhhcccchhhhhhhcccC
Q 047375 329 SDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMV-PYFLDSIENNSFRQILNFQVA 407 (496)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~-~~~~~~~~~~~~~~i~~~~~~ 407 (496)
+|||+|+....... .....||+.|+|||.+.+..++.++|+||+|+++|+|+++. +||........+..+... ..
T Consensus 169 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~~ 244 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YR 244 (309)
T ss_dssp CCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CC
T ss_pred cccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CC
Confidence 99999986543221 23445999999999999999999999999999999999864 567665555555555443 33
Q ss_pred CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 408 DESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 408 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+.+..+++.+.+||.+||+.||++|||+.||++.|+++.+.
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 444556678899999999999999999999999999998653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=383.67 Aligned_cols=254 Identities=19% Similarity=0.225 Sum_probs=205.2
Q ss_pred hcchhhhcccCCceEEEEeEeC--C--CcEEEEEEeecch----hhhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP--D--NTQVAVKKYMCAD----EIRITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
.|.+.+.||+|+||.||+|.+. + ...||||++.... .....+.+|+.+|++++|||||+++|+|.+ +..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 3777889999999999999852 2 2378999886432 223345689999999999999999999976 46789
Q ss_pred EEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccC
Q 047375 259 VYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPIS 338 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~ 338 (496)
|||||++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998876543 47899999999999999999999 789999999999999999999999999999875
Q ss_pred CCCCcc-ceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhhhhcccCCcccHHHHH
Q 047375 339 SDDETA-MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQILNFQVADESEMEEIE 416 (496)
Q Consensus 339 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 416 (496)
...... ......||+.|+|||++.++.++.++|+||+|+++|+|++ |.+||.+.........+.......+.+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence 543322 2334568899999999999999999999999999999997 79999887777777777766666566666778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 417 VVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 417 ~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
.+.+|+.+||+.||++|||+.||++.|.+.
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 899999999999999999999999888764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-49 Score=389.38 Aligned_cols=251 Identities=18% Similarity=0.160 Sum_probs=214.1
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYE 261 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 261 (496)
.|.+.+.||+|+||.||+|.. .+|+.||||++..... ......+|+.+|+.++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 377788999999999999996 4789999999864322 12344589999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCC
Q 047375 262 FVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 262 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~ 341 (496)
||.+|+|..++..... +++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.+...
T Consensus 122 ~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999977643 7889999999999999999999 78999999999999999999999999999887543
Q ss_pred CccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHHH
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAEL 421 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 421 (496)
....+||+.|||||++.+..++.++|+||+||++|+|++|.+||.+......+..+....... +...++.+.+|
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~l 268 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHFSSDLKDL 268 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTCCHHHHHH
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--CccCCHHHHHH
Confidence 234579999999999999999999999999999999999999998776666667676554433 23456789999
Q ss_pred HHHhcccCCCCCC-----CHHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 422 ASKCLRIRGTERP-----TMKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 422 i~~cl~~dP~~RP-----s~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
|.+||+.||.+|+ |+.+++ .|+|.+..++
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell----------~Hp~f~~~~~ 302 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIK----------NHKWFATTDW 302 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHH----------TSGGGTTCCH
T ss_pred HHHHhhhCHHhccccccccHHHHH----------cCccccCCCH
Confidence 9999999999994 777774 4667666554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=386.02 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=203.6
Q ss_pred cchhhhcccCCceEEEEeEeCCC----cEEEEEEeecc--hhhhhhHHHHHHHHhcCCCCceeeEEEEEee-CCeeeEEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVLPDN----TQVAVKKYMCA--DEIRITEWEFLGIISQVKHKNVVKILGLCLE-TKVTLLVY 260 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~ 260 (496)
.+|.++||+|+||+||+|.+..+ ..||||++... ......+.+|+++|++++|||||+++|+|.. ++..++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 34567899999999999996432 35899998642 2233456699999999999999999999876 46889999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|.+++..... ..++..+++++.|++.||.|||+ ++|+||||||+||||++++.+||+|||+++.....
T Consensus 109 E~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp ECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999999876543 35778889999999999999999 78999999999999999999999999999876543
Q ss_pred CCcc--ceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhccc-chhhhhhhcccCCcccHHHHHH
Q 047375 341 DETA--MSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIEN-NSFRQILNFQVADESEMEEIEV 417 (496)
Q Consensus 341 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 417 (496)
.... ......||+.|+|||.+.+..++.++|+||+|+++|+++++..||...... .....+... .....+..+++.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~~ 262 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDP 262 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCCCTTCCHH
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCcccCcHH
Confidence 2221 223356899999999999999999999999999999999865555443333 333333332 233344455678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHh
Q 047375 418 VAELASKCLRIRGTERPTMKEVSEELDRLRR 448 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 448 (496)
+.+||.+||+.||++|||+.||++.|+.+.+
T Consensus 263 l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999998854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=384.95 Aligned_cols=259 Identities=22% Similarity=0.281 Sum_probs=211.2
Q ss_pred hcchhhhcccCCceEEEEeEeCC--------CcEEEEEEeecchh--hhhhHHHHHHHHhcC-CCCceeeEEEEEeeCCe
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPD--------NTQVAVKKYMCADE--IRITEWEFLGIISQV-KHKNVVKILGLCLETKV 255 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~ 255 (496)
.|.+.+.||+|+||.||+|+... +..||||++..... ......+|...+.++ +|||||+++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 47788999999999999998522 24799999865433 223445777788777 79999999999999999
Q ss_pred eeEEEeeccCCchhhhhhhcCc-------------ccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC
Q 047375 256 TLLVYEFVSNGALSHYIHDKSS-------------QVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD 322 (496)
Q Consensus 256 ~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~ 322 (496)
.++|||||++|+|.+++..... ...+++..++.++.||+.||.|||+ ++||||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecC
Confidence 9999999999999999976532 2347899999999999999999999 78999999999999999
Q ss_pred CCceEEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccc-cccchhhhcccchhhhh
Q 047375 323 NYTAKVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKIS-MVPYFLDSIENNSFRQI 401 (496)
Q Consensus 323 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~-~~~~~~~~~~~~~~~~i 401 (496)
++.+||+|||+++...............||+.|+|||.+.+..|+.++|+||+|+++|+|++ +.+||........+..+
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i 250 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 99999999999998766544444455679999999999999999999999999999999997 68888766555555444
Q ss_pred hhcccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 402 LNFQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 402 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
.+ ....+.+..+++.+.+||.+||+.||.+|||+.||++.|+++.++
T Consensus 251 ~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 251 KE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 43 344444556678899999999999999999999999999998654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-49 Score=381.25 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=205.4
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHHhcCCCCceeeEEEEEeeCC----ee
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGIISQVKHKNVVKILGLCLETK----VT 256 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~ 256 (496)
..|.+.+.||+|+||.||+|.. .+|+.||||++..... ......+|+.+++.++|||||++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 3478889999999999999995 5789999999864322 2234558999999999999999999998643 47
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|||||||+||+|.+++..... +++..++.++.||+.||.|||+ ++||||||||+|||++.++.++|+|||.+..
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence 999999999999999877543 7889999999999999999999 7899999999999999999999999999876
Q ss_pred cCCCCC-ccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc--ccHH
Q 047375 337 ISSDDE-TAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE--SEME 413 (496)
Q Consensus 337 ~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~ 413 (496)
...... .......+||+.|||||++.+..++.++|+||+|+++|+|++|.+||.+......+..+.......+ ....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 543322 2223456799999999999999999999999999999999999999987665555555554333222 2234
Q ss_pred HHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhH
Q 047375 414 EIEVVAELASKCLRIRGTERP-TMKEVSEELDRLR 447 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~ 447 (496)
.++.+.+||.+||+.||.+|| |++++++.|.+++
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 567899999999999999999 8999999888764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.8e-49 Score=390.93 Aligned_cols=253 Identities=19% Similarity=0.153 Sum_probs=202.7
Q ss_pred cchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hh---hhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEE
Q 047375 188 KNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IR---ITEWEFLGIISQVKHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 259 (496)
|.+.+.||+|+||.||+|.. .+|..||||++..... .. ..+.+++.+++.++|||||++++++.+.+..|||
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 77789999999999999996 4689999999864321 11 1223457788888999999999999999999999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
||||+||+|.+++..... +++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp ECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999987543 6788999999999999999999 8899999999999999999999999999987754
Q ss_pred CCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhh-hcccCCcccHHHHHH
Q 047375 340 DDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL-NFQVADESEMEEIEV 417 (496)
Q Consensus 340 ~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~ 417 (496)
.. ....+||+.|||||++.. ..|+.++|+||+||++|+|++|.+||............. ........+...++.
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence 32 234569999999999864 678999999999999999999999997654332221111 111222233445678
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 418 VAELASKCLRIRGTERPT-----MKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 418 l~~li~~cl~~dP~~RPs-----~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
+.+||.+||+.||.+||| ++|+ .+|+|.+..+|
T Consensus 236 ~~~li~~~L~~dP~~R~t~~~~~a~ei----------l~Hp~f~~i~~ 273 (364)
T d1omwa3 236 LRSLLEGLLQRDVNRRLGCLGRGAQEV----------KESPFFRSLDW 273 (364)
T ss_dssp HHHHHHHHTCSSTTTSTTTSSSTHHHH----------HTSGGGTTCCH
T ss_pred HHHHHHHHcccCHHHhCCCcccCHHHH----------HcCccccCCCH
Confidence 999999999999999999 4555 34566655443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=381.27 Aligned_cols=258 Identities=22% Similarity=0.272 Sum_probs=200.3
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeCC----eeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLETK----VTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~E~ 262 (496)
++.+.+.||+|+||.||+|++ +|..||||++............|+..+..++|||||+++|+|.+.+ .+|+||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 466678899999999999998 6899999998655433322234556667789999999999998654 57999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhc-----CCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSL-----ASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-----~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
|++|+|.+++++.. ++|..++.++.|++.||.|||+. ..++||||||||+||||+.++.+||+|||+++..
T Consensus 83 ~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 83 HEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999997642 78999999999999999999974 2368999999999999999999999999999887
Q ss_pred CCCCCcc--ceecccccceeecCcccccc------cccCCCCCchhhhhcccccccccchhhhcccc-----------h-
Q 047375 338 SSDDETA--MSTMIRGTVGYLDPEYAHTE------LLTGMNPNSYVALASNEKISMVPYFLDSIENN-----------S- 397 (496)
Q Consensus 338 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~------~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~-----------~- 397 (496)
....... ......||+.|||||++.+. .++.++|+||+|+++|+++++.+|+....... .
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 5543221 23456799999999998764 36778999999999999999987764322111 0
Q ss_pred ---hhhhhhcccCCc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 398 ---FRQILNFQVADE-----SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 398 ---~~~i~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
...+......+. ........+.+|+.+||+.||.+|||+.||++.|+++.+.
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111111122111 1234556799999999999999999999999999988754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=385.57 Aligned_cols=243 Identities=19% Similarity=0.162 Sum_probs=205.1
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh----hhhhHHHHHHHH-hcCCCCceeeEEEEEeeCCeeeEEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE----IRITEWEFLGII-SQVKHKNVVKILGLCLETKVTLLVY 260 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l-~~l~hpnIv~l~~~~~~~~~~~lv~ 260 (496)
.|.+.+.||+|+||+||+|.. .+++.||||++..... .......|..++ ..++|||||++++++.+++..||||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 377889999999999999996 4789999999964321 122334555555 4689999999999999999999999
Q ss_pred eeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCC
Q 047375 261 EFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSD 340 (496)
Q Consensus 261 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~ 340 (496)
|||++|+|.+++..... +++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 Ey~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999987543 6888999999999999999999 78999999999999999999999999999876543
Q ss_pred CCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccHHHHHHHHH
Q 047375 341 DETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEMEEIEVVAE 420 (496)
Q Consensus 341 ~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 420 (496)
.. ..+..+||+.|+|||++.+..++.++|+||+||++|+|++|..||.+......+..+...... .+...++.+.+
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--~p~~~s~~~~d 232 (320)
T d1xjda_ 157 DA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKD 232 (320)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred cc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCccCCHHHHH
Confidence 22 234567999999999999999999999999999999999999999887776666666654432 33345678999
Q ss_pred HHHHhcccCCCCCCCHH-HH
Q 047375 421 LASKCLRIRGTERPTMK-EV 439 (496)
Q Consensus 421 li~~cl~~dP~~RPs~~-ei 439 (496)
||.+||+.||.+|||+. ++
T Consensus 233 li~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCG
T ss_pred HHHHhcccCCCCCcCHHHHH
Confidence 99999999999999985 66
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=383.29 Aligned_cols=244 Identities=22% Similarity=0.190 Sum_probs=197.4
Q ss_pred hcchh-hhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhc-CCCCceeeEEEEEee----CCeeeEE
Q 047375 187 TKNFH-HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQ-VKHKNVVKILGLCLE----TKVTLLV 259 (496)
Q Consensus 187 ~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~----~~~~~lv 259 (496)
.|.+. +.||+|+||+||+|.. .+++.||||++.... ...+|+.++.+ .+|||||+++++|.+ ...+|||
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH----HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 36654 5699999999999995 578999999986432 34467887654 589999999999875 4678999
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC---CCceEEccCCCccc
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD---NYTAKVSDFESLVP 336 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~---~~~~kL~DFGla~~ 336 (496)
||||+||+|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 88 mEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeee
Confidence 999999999999986543 247999999999999999999999 78999999999999975 56799999999987
Q ss_pred cCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhh----hhccc--CCcc
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQI----LNFQV--ADES 410 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i----~~~~~--~~~~ 410 (496)
...... ....+||+.|||||++.+..|+.++|+||+||++|+|++|.+||.+.........+ ..... +.+.
T Consensus 164 ~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 164 TTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred ccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 754322 24456999999999999999999999999999999999999999876544333322 22222 2223
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
....++.+.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3456788999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=381.42 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=213.7
Q ss_pred hcchhhhcccCCceEEEEeEeC------CCcEEEEEEeecchhh--hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLP------DNTQVAVKKYMCADEI--RITEWEFLGIISQVKHKNVVKILGLCLETKVTLL 258 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 258 (496)
.+.+.+.||+|+||+||+|.+. .+..||||++...... ...+.+|+.++++++|||||+++|+|...+..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 4677789999999999999863 3578999998643322 2334599999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhcC-------cccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccC
Q 047375 259 VYEFVSNGALSHYIHDKS-------SQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDF 331 (496)
Q Consensus 259 v~E~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DF 331 (496)
|||||++|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++++||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeec
Confidence 999999999999987532 12235888999999999999999999 78999999999999999999999999
Q ss_pred CCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhccccccc-ccchhhhcccchhhhhhhcccCCcc
Q 047375 332 ESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISM-VPYFLDSIENNSFRQILNFQVADES 410 (496)
Q Consensus 332 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~ 410 (496)
|+|+...............||+.|+|||.+.+..++.++|+||+|+++|+|+++ .+|+.+......+..+.+... .+.
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~-~~~ 256 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDK 256 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCC
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC-CCC
Confidence 999877654443334455699999999999999999999999999999999987 477766666666666665433 333
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRL 446 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 446 (496)
+..+++.+.+|+.+||+.||.+|||+.+|++.|++.
T Consensus 257 p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 445667899999999999999999999999998765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=378.51 Aligned_cols=250 Identities=20% Similarity=0.193 Sum_probs=198.0
Q ss_pred hhcccCCceEEEEeEe-CCCcEEEEEEeecchhh------hhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeecc
Q 047375 192 HCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI------RITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 264 (496)
++||+|+||+||+|.. .+|+.||||++...... .....+|+.++++++|||||++++++.+++..|||||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999996 46899999998643221 2345589999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCcc
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDETA 344 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 344 (496)
++++..+..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 ~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 84 TDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp EEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred chHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence 887776664432 36778899999999999999999 78999999999999999999999999999876553222
Q ss_pred ceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC----------------
Q 047375 345 MSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA---------------- 407 (496)
Q Consensus 345 ~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---------------- 407 (496)
....+||+.|+|||++.. ..++.++|+||+||++|+|++|.+||.+......+..+......
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 234569999999998865 46789999999999999999999999776554444443321000
Q ss_pred -----Ccc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 408 -----DES-----EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 408 -----~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
... ....++.+.+|+.+||+.||.+|||+.|++ .++|.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L----------~Hp~f~~~p 287 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL----------KMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH----------TSGGGTSSS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh----------CCHhhCCCC
Confidence 000 012346799999999999999999999984 467776543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=366.48 Aligned_cols=256 Identities=19% Similarity=0.182 Sum_probs=200.3
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+|+++|++++|||||++++++.+++..|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 367778999999999999995 5789999999864332 234455899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
|.+ ++.+++..... ..+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~-~~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 83 LHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CSE-EHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred cCC-chhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 976 55555544332 237899999999999999999999 7899999999999999999999999999987754332
Q ss_pred ccceecccccceeecCccccccc-ccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc---------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTEL-LTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV--------------- 406 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~-~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--------------- 406 (496)
. .....||+.|+|||.+.... ++.++|+||+|+++|+|++|.+||.+......+..+.....
T Consensus 158 ~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 158 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp C--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 2 33456999999999877755 47789999999999999999999976544333333221000
Q ss_pred --------CCc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCc
Q 047375 407 --------ADE----SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNN 459 (496)
Q Consensus 407 --------~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 459 (496)
... .....++.+.+|+.+||+.||.+|||+.|++ +++|.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell----------~H~ff~~~~ 290 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL----------AHPFFQDVT 290 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH----------TSGGGTTCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh----------CCHhhccCC
Confidence 000 0012346789999999999999999999984 467776543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=366.40 Aligned_cols=245 Identities=22% Similarity=0.264 Sum_probs=198.5
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhh-------hhhHHHHHHHHhcCC--CCceeeEEEEEeeCCe
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEI-------RITEWEFLGIISQVK--HKNVVKILGLCLETKV 255 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~~ 255 (496)
..|.+.+.||+|+||+||+|.. .+|..||||++...... .....+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4588889999999999999995 57899999998643211 122347899999886 8999999999999999
Q ss_pred eeEEEeeccC-CchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-CCceEEccCCC
Q 047375 256 TLLVYEFVSN-GALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-NYTAKVSDFES 333 (496)
Q Consensus 256 ~~lv~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-~~~~kL~DFGl 333 (496)
.|+||||+.+ +++.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 67888887654 37889999999999999999999 78999999999999985 57999999999
Q ss_pred ccccCCCCCccceecccccceeecCcccccccc-cCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCcccH
Q 047375 334 LVPISSDDETAMSTMIRGTVGYLDPEYAHTELL-TGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADESEM 412 (496)
Q Consensus 334 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 412 (496)
|+..... ..+..+||+.|+|||++.+..+ +.++|+||+||++|+|++|..||.... .+...... .+.
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~--~~~ 225 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF--FRQ 225 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC--CSS
T ss_pred ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC--CCC
Confidence 9875432 2345679999999999988665 566899999999999999999986542 22222221 222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccC
Q 047375 413 EEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 413 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
..++++.+||.+||+.||.+|||+.|++ +++|.++.
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~s~~eil----------~hp~~~~~ 261 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPSDRPTFEEIQ----------NHPWMQDV 261 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHH----------TSGGGSSC
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHh----------cCHhhCCC
Confidence 3457799999999999999999999984 46676654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.5e-47 Score=365.03 Aligned_cols=246 Identities=21% Similarity=0.200 Sum_probs=196.3
Q ss_pred hcchhhhcccCCceEEEEeEeCCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEeec
Q 047375 187 TKNFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
.|.+.+.||+|+||+||+|.+.+|+.||||++..... ......+|+.+|++++|||||++++++.+.+..+++|||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 4677789999999999999988899999999865322 2345568999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCCc
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDET 343 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~~ 343 (496)
.++.+..+..... .+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||.|.........
T Consensus 83 ~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 83 DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp SEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred hhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 8877766665443 37889999999999999999999 78999999999999999999999999999876543222
Q ss_pred cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc----------------
Q 047375 344 AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV---------------- 406 (496)
Q Consensus 344 ~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~---------------- 406 (496)
.....||+.|+|||.+.+ ..++.++|+||+|+++++|++|.+||.+......+.++.....
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 157 --YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred --cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 234458999999999876 4568999999999999999999999976544333333221000
Q ss_pred --------C---CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 407 --------A---DESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 407 --------~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
. .......++.+.+|+.+||+.||++|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0 001122346789999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=363.28 Aligned_cols=255 Identities=19% Similarity=0.214 Sum_probs=197.8
Q ss_pred HhcchhhhcccCCceEEEEeEe-CC-CcEEEEEEeecchh---hhhhHHHHHHHHhc---CCCCceeeEEEEEee-----
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PD-NTQVAVKKYMCADE---IRITEWEFLGIISQ---VKHKNVVKILGLCLE----- 252 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~---~~~~~~~e~~~l~~---l~hpnIv~l~~~~~~----- 252 (496)
..|.+.+.||+|+||+||+|.. .+ ++.||||++..... ......+|+.+++. ++|||||+++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 3578889999999999999996 34 56799999864322 22234466666554 489999999999863
Q ss_pred CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCC
Q 047375 253 TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFE 332 (496)
Q Consensus 253 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFG 332 (496)
....+++||||++|++........ ..+++..+..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 346799999999877654443332 236889999999999999999999 789999999999999999999999999
Q ss_pred CccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc------
Q 047375 333 SLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV------ 406 (496)
Q Consensus 333 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~------ 406 (496)
+++..... ......+||+.|+|||++.+..|+.++|+||+||++|+|++|.+||.+......+..+.....
T Consensus 162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 98765432 223456799999999999999999999999999999999999999987655444444332100
Q ss_pred -------------------CCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccC
Q 047375 407 -------------------ADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 407 -------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
........++.+.+|+.+||+.||.+|||+.|++ .++|.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L----------~Hpff~~i 299 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL----------SHPYFQDL 299 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH----------TSGGGTTC
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh----------cChhhcCc
Confidence 0011123456789999999999999999999984 46677654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=365.29 Aligned_cols=246 Identities=20% Similarity=0.207 Sum_probs=192.6
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceeeEEEEEeeC------CeeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVKILGLCLET------KVTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~~~lv 259 (496)
+|+..++||+|+||+||+|+. .+|+.||||++....... .+|+.+|++++|||||+++++|... .+.|||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSC---CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHH---HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 367778999999999999996 478999999986543222 3689999999999999999998643 357899
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-ceEEccCCCccccC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPIS 338 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~ 338 (496)
||||++|.+..+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999876544444332233357899999999999999999999 8899999999999999765 89999999998775
Q ss_pred CCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc-------------
Q 047375 339 SDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF------------- 404 (496)
Q Consensus 339 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------- 404 (496)
.... ....+||+.|+|||.+.+ ..++.+.|+||+||++|+|++|.+||........+..+...
T Consensus 175 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 175 RGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp TTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4322 234569999999998775 56899999999999999999999999765544443333210
Q ss_pred ------ccC--------CcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 405 ------QVA--------DESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 405 ------~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
... .......++.+.+|+.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0011234567999999999999999999999853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=359.78 Aligned_cols=242 Identities=20% Similarity=0.230 Sum_probs=188.6
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCC------ee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETK------VT 256 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~ 256 (496)
+|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+|+.+|+.++|||||+++++|...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 477788999999999999995 4689999999864322 2234458999999999999999999998654 46
Q ss_pred eEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 257 LLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 257 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
|+||||| +++|..++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 99 ~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 9999999 55888777543 37899999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCccceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccC--------
Q 047375 337 ISSDDETAMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVA-------- 407 (496)
Q Consensus 337 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-------- 407 (496)
.... .+...||+.|+|||++.+ ..++.++|+||+||++++|++|.+||.+......+..+......
T Consensus 171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 6543 244569999999999876 45688999999999999999999998765443332222211000
Q ss_pred -----------------C----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047375 408 -----------------D----ESEMEEIEVVAELASKCLRIRGTERPTMKEVSE 441 (496)
Q Consensus 408 -----------------~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 441 (496)
. ......++.+.+||.+||..||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 011223467899999999999999999999953
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=357.39 Aligned_cols=247 Identities=17% Similarity=0.200 Sum_probs=189.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh--hhhhHHHHHHHHhcCCCCceeeEEEEEeeCC----eeeEE
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE--IRITEWEFLGIISQVKHKNVVKILGLCLETK----VTLLV 259 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~lv 259 (496)
+|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+|+.+|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 477789999999999999985 5799999999864332 2334558999999999999999999997653 23455
Q ss_pred EeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCC
Q 047375 260 YEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISS 339 (496)
Q Consensus 260 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~ 339 (496)
|+|+.+|+|.+++... .+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 5667799999999754 27889999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCc-cceecccccceeecCccccc-ccccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcc------------
Q 047375 340 DDET-AMSTMIRGTVGYLDPEYAHT-ELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQ------------ 405 (496)
Q Consensus 340 ~~~~-~~~~~~~gt~~Y~aPE~l~~-~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------ 405 (496)
.... ......+||+.|+|||++.. ..++.+.|+||+|+++++|++|.+||.+..............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 3221 12345679999999999855 566788999999999999999999986544322222211100
Q ss_pred ----------cC--Ccc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 406 ----------VA--DES-----EMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 406 ----------~~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.. ... ....++.+.+|+.+||+.||.+|||+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00 000 112235789999999999999999999995
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=355.55 Aligned_cols=256 Identities=18% Similarity=0.175 Sum_probs=207.6
Q ss_pred cchhhhcccCCceEEEEeEe----CCCcEEEEEEeecch-----hhhhhHHHHHHHHhcCCC-CceeeEEEEEeeCCeee
Q 047375 188 KNFHHCLGMGGFGSVYKGVL----PDNTQVAVKKYMCAD-----EIRITEWEFLGIISQVKH-KNVVKILGLCLETKVTL 257 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~ 257 (496)
|.+.+.||+|+||+||+|.. .+|+.||||.+.... .......+|+.++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 88889999999999999984 257899999885432 222334488999999976 89999999999999999
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+|||||.+|+|.+++..... ++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999987654 5678889999999999999999 78999999999999999999999999999876
Q ss_pred CCCCCccceecccccceeecCcccccc--cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhc--ccCCcccHH
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTE--LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNF--QVADESEME 413 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~ 413 (496)
..... .......||+.|+|||.+.+. .++.++|+||+||++|+|++|..||...........+... ....+.+..
T Consensus 180 ~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 180 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 54322 223456799999999998763 4677899999999999999999999877666555555432 222333445
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHhhHhhhhhhhhccCcc
Q 047375 414 EIEVVAELASKCLRIRGTERPT-----MKEVSEELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 414 ~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~l~~~~~~~~~~~~~~ 460 (496)
.++.+.+|+.+||+.||.+||| ++|+ .+|+|.+.-++
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~ei----------l~Hpff~~i~~ 300 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEI----------KEHLFFQKINW 300 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH----------HTSGGGTTCCH
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHH----------HcCHhhcCCCH
Confidence 6788999999999999999995 5666 35777766544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=352.18 Aligned_cols=257 Identities=20% Similarity=0.222 Sum_probs=196.0
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEee--------C
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLE--------T 253 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--------~ 253 (496)
..|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 3477889999999999999996 5789999998854322 23445689999999999999999999865 3
Q ss_pred CeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCC
Q 047375 254 KVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFES 333 (496)
Q Consensus 254 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGl 333 (496)
+..|+|||||.++.+..+..... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 46799999998877665544332 36778899999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCc--cceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhccc--C-
Q 047375 334 LVPISSDDET--AMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQV--A- 407 (496)
Q Consensus 334 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~- 407 (496)
++........ ......+||+.|+|||++.+. .++.+.|+||+||++++|++|.+||.+.........+..... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876543221 122345699999999998764 688999999999999999999999976554433333221100 0
Q ss_pred ---------------------Cccc------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccC
Q 047375 408 ---------------------DESE------MEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 408 ---------------------~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
.... ...++.+.+|+.+||+.||++|||+.|++ +++|.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL----------~Hpff~~~ 311 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL----------NHDFFWSD 311 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH----------HSGGGSSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH----------cChhhccC
Confidence 0000 01135678999999999999999999984 67777643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-44 Score=347.46 Aligned_cols=262 Identities=12% Similarity=0.068 Sum_probs=207.7
Q ss_pred HhcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCC-CceeeEEEEEeeCCeeeEEEeec
Q 047375 186 ATKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKH-KNVVKILGLCLETKVTLLVYEFV 263 (496)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~ 263 (496)
..|.+.+.||+|+||+||+|.+ .+|+.||||.+..... .....+|++++..++| +||+.+++++......|+|||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4578889999999999999995 4688999998754332 3344577888888875 89999999999999999999999
Q ss_pred cCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCC-----CCceEEccCCCccccC
Q 047375 264 SNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDD-----NYTAKVSDFESLVPIS 338 (496)
Q Consensus 264 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~-----~~~~kL~DFGla~~~~ 338 (496)
+|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 -~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 6799999876543 36889999999999999999999 78999999999999964 5689999999998765
Q ss_pred CCCCc-----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch---hhhhhhcccCCc-
Q 047375 339 SDDET-----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS---FRQILNFQVADE- 409 (496)
Q Consensus 339 ~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~---~~~i~~~~~~~~- 409 (496)
..... ......+||+.|||||++.+..++.++|+||+|+++|+|++|..||.+...... +..+.......+
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 43221 123456799999999999999999999999999999999999999975443322 222222211111
Q ss_pred --ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhh
Q 047375 410 --SEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYW 454 (496)
Q Consensus 410 --~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~ 454 (496)
....+++++.+++..|+..+|++||+++.+.+.|+++.+.....+
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence 112345679999999999999999999999998888765443333
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-44 Score=349.74 Aligned_cols=256 Identities=16% Similarity=0.111 Sum_probs=197.9
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCCCCceee-EEEEEeeCCeeeEEEeecc
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVKHKNVVK-ILGLCLETKVTLLVYEFVS 264 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~-l~~~~~~~~~~~lv~E~~~ 264 (496)
+|.+.+.||+|+||.||+|.+ .+|+.||||.+.... .......|+++++.++|+|+|. +.+++.+.+..++|||||.
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 478889999999999999995 568899999876543 2334568899999998776554 5555677888999999995
Q ss_pred CCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeC---CCCceEEccCCCccccCCCC
Q 047375 265 NGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLD---DNYTAKVSDFESLVPISSDD 341 (496)
Q Consensus 265 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~---~~~~~kL~DFGla~~~~~~~ 341 (496)
|+|...+..... .+++..+..++.|++.||.|||+ ++||||||||+|||++ .+..+||+|||+|+......
T Consensus 87 -~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 87 -PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp -CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred -CchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 577766655432 37889999999999999999999 7899999999999985 45579999999999875432
Q ss_pred Cc-----cceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhh---hcccCCc---c
Q 047375 342 ET-----AMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQIL---NFQVADE---S 410 (496)
Q Consensus 342 ~~-----~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~---~~~~~~~---~ 410 (496)
.. ......+||+.|||||++.+..++.++|+||+|+++++|++|.+||...........+. ......+ .
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 21 12345679999999999999999999999999999999999999987654433322221 1111111 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhh
Q 047375 411 EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRL 449 (496)
Q Consensus 411 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 449 (496)
...+++++.+|+.+||+.||++||++.++.+.|+.+...
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 123457799999999999999999999999988877543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.3e-44 Score=351.57 Aligned_cols=251 Identities=18% Similarity=0.194 Sum_probs=197.5
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEee--CCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLE--TKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||+||+|+. .+|+.||||++.... .....+|+.+|+.++ ||||+++++++.. ....++||||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 478889999999999999996 578999999986433 234558999999995 9999999999974 4568999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC-ceEEccCCCccccCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY-TAKVSDFESLVPISSDD 341 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~-~~kL~DFGla~~~~~~~ 341 (496)
|++|+|..+.+ .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+|+......
T Consensus 114 ~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 114 VNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred cCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 99999987643 26888999999999999999999 7899999999999998654 69999999998775432
Q ss_pred CccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccch-hhhh------------------
Q 047375 342 ETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNS-FRQI------------------ 401 (496)
Q Consensus 342 ~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~-~~~i------------------ 401 (496)
. ....+||+.|+|||.+.+. .++.++|+||+||++++++++..||........ ...+
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 3455699999999998764 578899999999999999999888764332110 0000
Q ss_pred ---------hh--------cccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccCccc
Q 047375 402 ---------LN--------FQVADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKNNEE 461 (496)
Q Consensus 402 ---------~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 461 (496)
.. ...........++++.+||.+||..||.+|||++|++ +++|++...++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L----------~Hp~F~~v~~~ 328 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM----------EHPYFYTVVKD 328 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH----------TSGGGTTSCCC
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh----------cCcccCCCCCC
Confidence 00 0001112223457799999999999999999999984 57788776553
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=350.25 Aligned_cols=249 Identities=20% Similarity=0.162 Sum_probs=187.9
Q ss_pred cchhhhcccCCceEEEEeEeC-CCcEEEEEEeecch---hhhhhHHHHHHHHhcCCCCceeeEEEEEee------CCeee
Q 047375 188 KNFHHCLGMGGFGSVYKGVLP-DNTQVAVKKYMCAD---EIRITEWEFLGIISQVKHKNVVKILGLCLE------TKVTL 257 (496)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------~~~~~ 257 (496)
|.+.+.||+|+||+||+|.+. +|..||||++.... .......+|+.+++.++|||||+++++|.. .+..|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 777789999999999999964 69999999986542 222344589999999999999999999964 36789
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
+|||||.++.+. .+.. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||+++..
T Consensus 99 iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeccchHHHH-hhhc-----CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 999999775544 4422 26889999999999999999999 78999999999999999999999999998876
Q ss_pred CCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccchhhhhhh--------------
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILN-------------- 403 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~-------------- 403 (496)
.... ..+..+||+.|+|||++.+..++.+.|+||+||+++++++|.+||.+.........+..
T Consensus 170 ~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 5432 23455699999999999999999999999999999999999999865443322222211
Q ss_pred --------cc------------------cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhcc
Q 047375 404 --------FQ------------------VADESEMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARK 457 (496)
Q Consensus 404 --------~~------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~ 457 (496)
.. .........++.+.+|+.+||..||++|||++|++ .|+|.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL----------~Hpw~~~ 316 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL----------QHPYINV 316 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH----------TSTTTGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh----------cCcccCC
Confidence 00 00111234567899999999999999999999994 5566664
Q ss_pred C
Q 047375 458 N 458 (496)
Q Consensus 458 ~ 458 (496)
.
T Consensus 317 ~ 317 (355)
T d2b1pa1 317 W 317 (355)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=341.09 Aligned_cols=246 Identities=15% Similarity=0.168 Sum_probs=195.9
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeCCeeeEEEee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
.|.+.+.||+|+||+||+|.. .+++.||||++..... ......+|+.+|+.++|||||+++++|.+....++|||+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 477788999999999999995 5788999999864332 234455899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCccccCCCCC
Q 047375 263 VSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPISSDDE 342 (496)
Q Consensus 263 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~~~~~~ 342 (496)
+.+++|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||.|+.......
T Consensus 83 ~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 83 CDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred cccccccccccccc---ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999988876543 36788999999999999999999 7899999999999999999999999999988765432
Q ss_pred ccceecccccceeecCccccccc-ccCCCCCchhhhhcccccccccchhhh-cccchhhhhhhcc---------------
Q 047375 343 TAMSTMIRGTVGYLDPEYAHTEL-LTGMNPNSYVALASNEKISMVPYFLDS-IENNSFRQILNFQ--------------- 405 (496)
Q Consensus 343 ~~~~~~~~gt~~Y~aPE~l~~~~-~t~~~d~~s~g~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~--------------- 405 (496)
. .....+++.|+|||.+.+.. ++.++|+||+||++++|++|..||... .....+..+....
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred c--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2 23345889999999987754 688999999999999999987765332 2222222221100
Q ss_pred ------------cCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 406 ------------VADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 406 ------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
.........++.+.+|+.+||+.||.+|||++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00011123346789999999999999999999983
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=347.52 Aligned_cols=250 Identities=18% Similarity=0.184 Sum_probs=194.8
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchh---hhhhHHHHHHHHhcCCCCceeeEEEEEeeC-----Ceee
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADE---IRITEWEFLGIISQVKHKNVVKILGLCLET-----KVTL 257 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 257 (496)
+|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+|+.+|+.++|||||++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 477789999999999999995 5799999999864322 223445899999999999999999998643 3346
Q ss_pred EEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEccCCCcccc
Q 047375 258 LVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVSDFESLVPI 337 (496)
Q Consensus 258 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~~ 337 (496)
++|+|+.+|+|.+++..+ .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||++...
T Consensus 99 ~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 777888899999999653 27889999999999999999999 78999999999999999999999999998765
Q ss_pred CCCCCccceecccccceeecCcccccc-cccCCCCCchhhhhcccccccccchhhhcccchhhhhhhcccCCc-------
Q 047375 338 SSDDETAMSTMIRGTVGYLDPEYAHTE-LLTGMNPNSYVALASNEKISMVPYFLDSIENNSFRQILNFQVADE------- 409 (496)
Q Consensus 338 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~------- 409 (496)
... .....||+.|+|||.+.+. .++.+.|+||+||++|+|++|.+||.+.........+........
T Consensus 172 ~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp TGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred Ccc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 432 2345699999999987764 467899999999999999999999976554443333332111100
Q ss_pred ------------------c----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHhhhhhhhhccC
Q 047375 410 ------------------S----EMEEIEVVAELASKCLRIRGTERPTMKEVSEELDRLRRLQENYWARKN 458 (496)
Q Consensus 410 ------------------~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 458 (496)
. ....++.+.+||.+||..||.+|||+.|++ .++|..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL----------~Hp~f~~~ 307 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL----------AHAYFAQY 307 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH----------TSGGGTTT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh----------cCHhhCCC
Confidence 0 012346789999999999999999999984 55676543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-38 Score=315.40 Aligned_cols=257 Identities=18% Similarity=0.133 Sum_probs=192.2
Q ss_pred hcchhhhcccCCceEEEEeEe-CCCcEEEEEEeecchhhhhhHHHHHHHHhcCC-----------CCceeeEEEEEee--
Q 047375 187 TKNFHHCLGMGGFGSVYKGVL-PDNTQVAVKKYMCADEIRITEWEFLGIISQVK-----------HKNVVKILGLCLE-- 252 (496)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~l~~~~~~-- 252 (496)
+|.+.+.||+|+||+||+|+. .+|+.||||++...........+|+.+++.++ ||||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 488899999999999999995 57999999999766544445557787777664 5889999998864
Q ss_pred CCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCC------ce
Q 047375 253 TKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNY------TA 326 (496)
Q Consensus 253 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~------~~ 326 (496)
....+++|+++..+..............+++..+..++.||+.||.|||+. .+|+||||||+||||+.++ .+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccccee
Confidence 456677777776655444433333334478889999999999999999972 5799999999999997654 39
Q ss_pred EEccCCCccccCCCCCccceecccccceeecCcccccccccCCCCCchhhhhcccccccccchhhhcccch------hhh
Q 047375 327 KVSDFESLVPISSDDETAMSTMIRGTVGYLDPEYAHTELLTGMNPNSYVALASNEKISMVPYFLDSIENNS------FRQ 400 (496)
Q Consensus 327 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~t~~~d~~s~g~~~~~~~~~~~~~~~~~~~~~------~~~ 400 (496)
||+|||.+...... ....+||+.|+|||++.+..++.++|+||+|+++++|++|.+||........ ...
T Consensus 172 kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999998765432 2345699999999999999999999999999999999999998864322110 000
Q ss_pred hhh---------------------------c-------------ccCCcccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047375 401 ILN---------------------------F-------------QVADESEMEEIEVVAELASKCLRIRGTERPTMKEVS 440 (496)
Q Consensus 401 i~~---------------------------~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 440 (496)
... . ..........++.+.+|+.+||..||.+|||+.|+
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~- 325 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL- 325 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH-
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH-
Confidence 000 0 00111234567889999999999999999999998
Q ss_pred HHHHhhHhhhhhhhhccCcc
Q 047375 441 EELDRLRRLQENYWARKNNE 460 (496)
Q Consensus 441 ~~L~~l~~~~~~~~~~~~~~ 460 (496)
.+++|.+....
T Consensus 326 ---------L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 326 ---------VNHPWLKDTLG 336 (362)
T ss_dssp ---------HTCGGGTTCTT
T ss_pred ---------hcCcccCCCCC
Confidence 35778775543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=6.5e-24 Score=190.26 Aligned_cols=133 Identities=13% Similarity=0.142 Sum_probs=103.7
Q ss_pred chhhhcccCCceEEEEeEeCCCcEEEEEEeecchh-------------------hhhhHHHHHHHHhcCCCCceeeEEEE
Q 047375 189 NFHHCLGMGGFGSVYKGVLPDNTQVAVKKYMCADE-------------------IRITEWEFLGIISQVKHKNVVKILGL 249 (496)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~hpnIv~l~~~ 249 (496)
.+.+.||+|+||.||+|...+|+.||||.+..... .......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45678999999999999988899999998643211 01112256778889999999998876
Q ss_pred EeeCCeeeEEEeeccCCchhhhhhhcCcccccCHHHHHHHHHHHHHHHHHhHhcCCCCcccCCCCcCceeeCCCCceEEc
Q 047375 250 CLETKVTLLVYEFVSNGALSHYIHDKSSQVLKNWKTCLRIAAETASAIHYLHSLASPSIIHSDVKSANILLDDNYTAKVS 329 (496)
Q Consensus 250 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlKp~NIll~~~~~~kL~ 329 (496)
.. .+++|||++++.+.++ +......++.|++.||.|||+ ++|+||||||+|||++++ .++|+
T Consensus 83 ~~----~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred cC----CEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence 32 3799999998665432 223456789999999999999 789999999999999965 58999
Q ss_pred cCCCccccCC
Q 047375 330 DFESLVPISS 339 (496)
Q Consensus 330 DFGla~~~~~ 339 (496)
|||+|.....
T Consensus 145 DFG~a~~~~~ 154 (191)
T d1zara2 145 DFPQSVEVGE 154 (191)
T ss_dssp CCTTCEETTS
T ss_pred ECCCcccCCC
Confidence 9999877643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=3.2e-07 Score=84.00 Aligned_cols=131 Identities=18% Similarity=0.088 Sum_probs=86.9
Q ss_pred CCceEEEEeEeCCCcEEEEEEeecchhh-hhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEeeccCCchhhhhhh
Q 047375 197 GGFGSVYKGVLPDNTQVAVKKYMCADEI-RITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEFVSNGALSHYIHD 274 (496)
Q Consensus 197 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 274 (496)
++.+.||+... ++..+++|+....... .....+|...+..+. +--+.+++.++..++..++||++++|.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 44468999875 5677888887544322 223346666665553 43467788888888999999999999888654422
Q ss_pred cCcccccCHHHHHHHHHHHHHHHHHhHhcC--------------------------------------------------
Q 047375 275 KSSQVLKNWKTCLRIAAETASAIHYLHSLA-------------------------------------------------- 304 (496)
Q Consensus 275 ~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-------------------------------------------------- 304 (496)
.. . ...++.+++..|..||+..
T Consensus 104 ~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 104 EQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp CS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred cc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 11 1 1234555555566666421
Q ss_pred ------CCCcccCCCCcCceeeCCCCceEEccCCCccc
Q 047375 305 ------SPSIIHSDVKSANILLDDNYTAKVSDFESLVP 336 (496)
Q Consensus 305 ------~~~ivHrDlKp~NIll~~~~~~kL~DFGla~~ 336 (496)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999776667999986543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=5.9e-06 Score=74.87 Aligned_cols=75 Identities=13% Similarity=0.043 Sum_probs=49.9
Q ss_pred cccCC-ceEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCC--CCceeeEEEEEeeCCeeeEEEeeccCCchhh
Q 047375 194 LGMGG-FGSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVK--HKNVVKILGLCLETKVTLLVYEFVSNGALSH 270 (496)
Q Consensus 194 lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~ 270 (496)
+..|. .+.||+....++..+++|........ ....|...++.+. .-.+.++++++.+++..++||++++|-++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~--~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN--ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS--CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh--HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 44444 36799998877778888876443322 2234455444442 3346778888888888999999999866643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=9.2e-05 Score=71.48 Aligned_cols=74 Identities=14% Similarity=0.036 Sum_probs=44.9
Q ss_pred hhcccCCceEEEEeEeC-CCcEEEEEEeecc----hh----hhhhHHHHHHHHhcC---CCCceeeEEEEEeeCCeeeEE
Q 047375 192 HCLGMGGFGSVYKGVLP-DNTQVAVKKYMCA----DE----IRITEWEFLGIISQV---KHKNVVKILGLCLETKVTLLV 259 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~----~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~~~~~~lv 259 (496)
+.||.|....||++... +++.|+||.-... .. ...+...|...|..+ -...+.+++.+. ....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 46899999999999864 4678999964321 10 112233455555544 234566777654 4456799
Q ss_pred EeeccCCc
Q 047375 260 YEFVSNGA 267 (496)
Q Consensus 260 ~E~~~~g~ 267 (496)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.00073 Score=63.11 Aligned_cols=68 Identities=18% Similarity=0.021 Sum_probs=41.2
Q ss_pred eEEEEeEeCCCcEEEEEEeecchhhhhhHHHHHHHHhcCCC-----CceeeEE--EEEeeCCeeeEEEeeccCCc
Q 047375 200 GSVYKGVLPDNTQVAVKKYMCADEIRITEWEFLGIISQVKH-----KNVVKIL--GLCLETKVTLLVYEFVSNGA 267 (496)
Q Consensus 200 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-----pnIv~l~--~~~~~~~~~~lv~E~~~~g~ 267 (496)
-.||++...+|..|++|...+..........|...+..|.. |..+..- ..+...+..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47999998889999999876543333334456655554431 1111111 12234567788999987643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.02 E-value=0.0011 Score=63.54 Aligned_cols=73 Identities=15% Similarity=0.118 Sum_probs=45.0
Q ss_pred hhcccCCceEEEEeEeCC--------CcEEEEEEeecchhhhhhHHHHHHHHhcCC-CCceeeEEEEEeeCCeeeEEEee
Q 047375 192 HCLGMGGFGSVYKGVLPD--------NTQVAVKKYMCADEIRITEWEFLGIISQVK-HKNVVKILGLCLETKVTLLVYEF 262 (496)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~ 262 (496)
+.|+-|-.-.+|++...+ ...|.+++.-. ........+|..+++.+. +.-..++++++.+ .+||||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 457778888999988643 24566665542 222223336666666654 3334578887753 589999
Q ss_pred ccCCchh
Q 047375 263 VSNGALS 269 (496)
Q Consensus 263 ~~~g~L~ 269 (496)
++|.+|.
T Consensus 123 i~g~~l~ 129 (395)
T d1nw1a_ 123 IPSRPLS 129 (395)
T ss_dssp CCEEECC
T ss_pred eccccCC
Confidence 9875543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.63 E-value=0.027 Score=51.54 Aligned_cols=31 Identities=19% Similarity=0.309 Sum_probs=26.9
Q ss_pred CCCcccCCCCcCceeeCCCCceEEccCCCcc
Q 047375 305 SPSIIHSDVKSANILLDDNYTAKVSDFESLV 335 (496)
Q Consensus 305 ~~~ivHrDlKp~NIll~~~~~~kL~DFGla~ 335 (496)
+.++||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3679999999999999988777899999654
|